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PREFACE 
This thesis embodies much of my work done over the past 25 years. The impetus 
for these studies was the need to provide the best tissue typing available for organ 
transplantation and to overcome the problems of defining HLA antigens in 
different ethnic groups. These goals were achieved by extensive international 
collaboration and participation in the International Histocompatibility Workshops. 
The discovery that the HLA antigens are associated with many diseases led to an 
epidemic of investigations in which over 500 diseases have been studied. In 
retrospect, it is not surprising that auto-immune diseases such as diabetes and 
rheumatoid arthritis showed such marked associations with HLA antigens. The 
studies in Part II of this thesis were aimed at finding out if the HLA associations 
reported in Caucasian populations were also present in the Black and Indian 
populations. 
These research interests led to my being invited by the National Science Council 
of the Republic of China in Taiwan to be a Visiting Professor at the National 
Taiwan University in Taipei for the 1989 academic year. I investigated the 
association between HLA and naso-pharyngeal carcinoma in Chinese during that 
year. 
I wish to express my appreciation to Dr Peter Brain who inspired the early 
investigations and continued to encourage and support my research. I am grateful 
to all my co-authors and the many colleagues, clinicians and laboratory staff who 
have contributed to the various research programmes. 
Studies of the relationship of the HLA system to cancer, diabetes, arthritis and 
other diseases have been supported in part by grants from the National Cancer 
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Human lymphocyte antigens (HLA) occur on lymphocytes and all other 
nucleated cells. They were catapulted into importance when their function as 
histocompatibility antigens made them an essential part of transplantation 
programmes. 
The defmition of the antigens, in all their complexities of 'splits' and cross-
reactions was facilitated by International Histocompatibility Workshops. The 
study of HLA antigens in different race groups emphasised the complexities 
of this system and revealed the difficulties in defming the antigens in different 
races. 
The HLA syst~m is one of the most complex antigenic systems known in man. 
There are at least 15 loci determining histocompatibility antigens and they are 
sufficiently close to exhibit linkage, ie they segregate together. The products 
of the A, B and C loci are glycoprotein components of the plasma membrane 
of nucleated cells and are referred to as Class I antigens while the Class 11 
genes control the expression of DR, DQ and DP antigens which have a 
restricted distribution, notably on B lymphocytes. The number of clearly 
defined antigens has increased dramatically as a result of a series of 
International Histocompatibility Workshops and the fact that nearly all the 
genes have now been sequenced. There are now 82 Class I antigens and 33 
Class 11 antigens that can be serologically defmed. However, 153 Class 11 
alleles have been defmed by DNA sequencing and this has proved a useful tool 
in establishing defined serological reactions for use in tissue typing for 
transplantation. 
The frequency of these antigens varies in different races and antigens which 
are rare or of low frequency in Caucasians are often more common in other 
races. Linkage disequilibrium is the tendency for some alleles at different loci 
to occur together more often than would be expected from the frequencies of 
the individual alleles concerned. In different populations, linkage 
disequilibrium produces different haplotypes; these haplotypes are frequently 
characteristic of population groups. 
The first HLA antigen was described by Dausset in 1958 and was called 
'Mac'.- In 1959 van Rood et al. described leucocyte antigens 2 and 3. Rapid 
progress followed the observation that leucocyte antibodies are present _in the 
sera of about 10% of parous women. 
2 
Tremendous progress was made as a result of a series of International 
Histocompatibility Workshops. In 1964, the first International 
Histocompatibility Workshop was held to compare various tissue typing 
methods. The second Workshop in 1965 showed that different laboratories, 
using different techniques, could detect the same specificities. The third 
Workshop studied families and showed the inheritance patterns. The locus was 
named HLA. A standardised technique - the microlymphocytotoxicity test of 
Terasaki - was introduced for the fourth Workshop in 1970. The use of micro 
quantities of serum made it possible for many laboratories to participate by 
sending small amounts of sera through the mail. 
Anthropology was the focus of the fifth Workshop in 1972 and our early work 
on the distribution of HLA antigens in three race groups led to an invitation 
from the organiser of the Workshop, Jean Dausset, to present our results. 
Only 29 laboratories in the world participated in testing 49 different ethnic 
populations. I have since participated in all the International 
Histocompatibility Workshops and our studies have been accepted in the series 
"Histocompatibility Testing" which is published after each Workshop. The C 
locus was clearly identified during the sixth Workshop (1975) and the seventh 
Workshop concentrated on the definition of the DR antigens by typing B 
lymphocytes in 1977. The eighth Workshop (1980) was able to define 78 
specificities and in 1984 the ninth Workshop explored the DQ and DP loci. 
Molecular biology was introduced at the Tenth Workshop (1987). By this time 
157 laboratories were involved with the serological aspects but we were one 
of only 80 laboratories world-wide that performed Southern blots on DNA 
extracted from lymphocytes in one of the earliest attempts to defme the genes 
responsible for the Class II determinants. The Eleventh International 
Histocompatibility Workshop introduced a refinement of the earlier methods 
of studying the DNA of HLA genes by using the polymerase chain reaction 
(PCR) to amplify specific alleles and detecting slight variations with sequence 
specific oligonucleotide probes (SSO' s) by means of "dot-blots" . 
In addition to the International Histocompatibilty Workshops, I participated in 
the Asia-Oceania Histocompatibility Workshops which are organised on a 
regional basis and involve most of the HLA laboratories bordering the Pacific 
ocean. I participated in the Second and Third Asia-Oceania 
Histocompatibility Workshops and I am now a Councillor for this series of 
Histocompatibility Workshops. 
The forty nine papers dealing with the definition of HLA antigens in the 
different races from 1968 to the present form Part I of this thesis. 
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LEUCOCYTE AN'flGENS IN THREE RACE GROUPS 
PETER BRAIN, M.D. 
and 
M. HAMMOND 
Tbe Natal Imlill/le 0/ Immullology, Dllrbtlll'" 
The antigens of leucocytes are important in 
transplantation, and there is 1Ilready some 
evidence'-
3 .that their incidence, like that of the 
red cell antigens, varies from one race to 
another. rn this country tissue typing may have 
to be done on donors and recipients of at least 
3 dirferent races . .It is therefore necessary to 
know :;{) (JJcthing of the distribution of these 
antigens in the main p opulation groups. This 
paper reports a preliminary study in which a 
number of antisera were characterized and 
tested lIgainst the white cells of 3 groups of 
donors, viz. White (Europeln), Bantu and 
Indian. 
MATERIAL AND METHODS 
The EDTA agglutinat ion test of van Rood et 111.' 
W3S used with certain modifications. Red cells were 
sedimented with 3% gelatin in normal saline. Only 
one drop of antiserum W3S used for each test; the 
quantities of the other reagents were correspond-
in,!!'" '''''"("(''1. All test.s were read by the same 
wo.k !' r. ,'J " ,('(:1 were :t"mrb~(I. 
St." ;! tr"on pregnant wOl\len were screened daily 
against the white cells of 4 blood donors, and 
larger samrlrs ohtained from wme of the women 
found to have an.ihodies. From these samples 39 
of the most avid sera were selected. Nothing was 
known in advance of their specificity; 19 were from 
Colollr!.·,1 (mixed Banrtl ·White), 14 from White, 4 
frolll l"di;1" ntHI 2 from Bantu donors. Reference 
sera ohtained through the collaborative programme 
of the Transplantation Immunology Branch, Natio-
nal Institutes of Health, Bethesda, Md., were run in 
parallel with these antisera. 
White cell donors (40 each of Whites, Bantu and 
Indians) were healthy adult staff members or blood 
donors. These race groups are relatively pure in the 
sense that there has been little intermarriage be-
tween the groups. Bantu were of the Zulu tribe. 
The Indians were inhabitants of Natal whose fore-
fathers (mostly Hindi, Tamil and Telegu speakers) 
came from India about 60 years ago. 
The White series was begun first, and 3 sera (84, 
R6 and 8R) were introduced too late to be included 
in i •. \'{Tith this exception all the sera were tested 
3j!:,i "" Il l(' white (e lls of nil the donors . From the 
b[', .> ' ,I,. 'n ",." ,ncol s the results for each race group 
were ""<:IlIhlcd in a large matrix, coding any posi-
tive result as 1, negative as O. The rows of these 
3 matrices (each representing the reactions of one 
serum with tbe cells of 40 donors) were transferred 
to punch cards and the reactions within the race 
"POJ/"! ,1tldrcJJ : P.O. Box 2356, Durban. South 
Africa. 
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group of each serum comp3red with those of every 
other, u5ing It compuOIor that h3s been described 
elsewhere.s The OUtput of this comp3rator was fed 
10 a Diehl Combitron calculator programmed IQ 
compute X2 for 2 x 2 ubles. Yates" correction was 
not applied. 
A further 32 White donors were studied. but in 
order to make the r~sults eX3ctly comparable in the 
3 popularions these results were not considered 
when calculating x~. The frequencies with which 
the \Vhite sera react, however. are calculated from 
the brger sample. 
RESULTS 
Fig. 1 shows the associations of the sera in 
each p:>pulation group. Each serum is repre-
sen:ed by a circle of diameter proportional to 
the frequency with which it reacts. Positive 
associations between sera with X' of 6.6 or 
more are rerresented by solid lines. Those 
with a X 2 0 10 or more have thicker lines. 
Dotted lines represent negative associations 
with a X! of at least 3.0. 
The sera faU into 5 well-defined groups, cor-
responding to the antigenic complexes 7d, 
6b-7c. 1a, 4b and an unidentified group de-
fined by the 2 sera 27 and 29. The 4a and 4b 
groups, against which no reference sera were 
included in the run, were identified afterwards 
by 2 sera of known specificiry. The anti-Sa re-
ference serum (Pinquette) is not consistently 
associated with any Ilroup; neither is ,the serum 
TO/OI/II of Ceppellini, which recognizes his 
antigen Tol. 
DISCUSSION 
The criteria of aSSOCIation must be explained. 
Two sera with identical reactions (as long as 
these are neither all positive nor all negative) 
will be positively associated by a x' equal to 
the number of individuals in the panel. here 40. 
The maximum value of l thus depends on 
the size of the panel, and any quoted value of 
x' means little unless this is stated. A com-
paratively high Jevel of x' can be adopted as 
the criterion of positive association. But where 
2 reliable antisera are recognizing the products 
of a pair of antithetical alleles, many indivi-
duals will type positive with both sera because 
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they are heterozygotes. This greatly reduces the 
maximum value of x2 for the kind of negative 
association of the greatest interest, that b~tween 
alleles. As Dausset l has shown, it is therefore 
only reasonable to adopt a much lower stan-
dard of x' for negative associations. 
No 2 sera gave identical results in all race 
groups, but 49 and 88 were identical in the 
Bantu. In rhc' Indian woup they are associated 
by a \" III ,;; 
The S.IIlll· well-marked ,Ijroups of tightly 
associated sera appear in all 3 populations, and 
each of these ,~roups of sera identifies a com-
plex of al1tigenic factors that are frequently in-
herited in association.r. The important entities, 
at this sta,!~e of knowledge, are the anti,~enic 
complt:xes: rhey must not be regarded as simple 
antigens. An antiserum described as anti-4a, for 
example, recognizes a certain arbitrary though 
common combination of antigens within the 4a 
group. It is of no greater or less value in tissue 
ryping than another antiserum in the same 
group that recogniz~s a slightly different com-
bination of antigens. Hence it is essential to 
use batteries of related antisera against each of 
the comp!exes when undertaking tissue typing 
for transplantation. They will not all give the 
same results. 
TAnl.E 1: 1.'1'1'1 FRE(){Il'NCIE~ OF ANTI GENIC Cml-
l'I.I'sr.S IN TIIREE RACE GROUPS 
(FIGURES IN BRACKETS SIIOW NUMnER OF SERA USED TO 
IDENTIFY TilE COMPLEX) 
% Frfqlltnty 
COlllpltx W'hilt IItdian Banlfl 
4a 54(6) 78(5) 68(7) 
4h 84(3) 82(5) 93(5) 
8a 52(1) 60(1) 70(1) 
6b 47(1) 55(1) 52(1) 
7c 32(4) 24(5) 36(5) 
7d 28(8) 30(10) 42(9) 
Tol 72(1) 78(1) 70(1) 
Unknown 21(2) 22(2) 26(2) 
(sera 27, 29) 
Many (lf the sera appear in the same tightly 
associated groups in all 3 ropulations. Such, 
e.g. are 12, 72, 25, ()1, ()() and Willett in the 
anti-7d group; 9. to, 14 and 76 in anti-6b-7c; 
44, 7, :md 32 in anti-4a; and 23, 46 and 49 in 
anti-4b. From such sera a general-purpose 
tissue-typing kit could be assembled for use 
with any of the 3 race groups. But to do this 
would exclude many sera; examples are 51, 48 
and 52 which are tightly associated with the 
7d group in the Indians but not in the Whites, 
Dallsset
t 
has also observed that some of the 
sera identifying a complex in one population 
do not identify it in another. It is better, there-
fore, to have a special set of sera for use with 
each race group. Such sera should be chosen 
because they have several strong positive asso-
ciations within the group and few or none, 
except negative ones, outside it. Using such sets 
of sera we can calculate a mean frequency of 
each amigwic comp'tex in each race group, as 
Tab!e 1 shows. 
There are some interesting differences be-
tween the race grours: 
Scrum 73 is a member of the anti-4a grour ill 
White~ and BalllU, but amollg the Indians it is 
a~50ciated with 54, a member of the anti-4b grour: 
54 in its turn is a respectable member of anti-4h 
in Indians alld Bantu, but in the Whites it has a 
much lower frequency and no strong associations 
wilh this group; 
48 is not strongly associated with the anti-7d 
group in Whites; in both the other populations it is; 
51 is in the anti-7d group in the Indians, bur in 
anti-6b-7c in the Banlu; 
84 is connected with the anti-4a group in the 
Bantu; in the Indian its only strong associations 
are negative ones with the new group 27/29. whose 
specificity is unknown. , 
The complex of anti-7d sera is larger and shows 
more numerous and stronger associations between 
its members in the Indians than in Whites. 
The 4a and 4b complexes, by our criteria of 
association, are negatively associated in the Whites. 
less strongly so in the Indians, and not at all in 
the Bantu. In the Bantu there are many strong nega· 
tive associations between 6b-7c and 4a. These are 
weaker in the Whites and absent in the Indians. 
The sera of the anti-7c group are almost en-
tirely contained in the reference serum ami-6b 
(Rens) when tested against the Indian and 
White panels (i.e. they seldom give positive re-
sul,ts when Rens is negative), but there are 
many exceptions to this in the Bantu, Fig. 1 
shows seveml other differences between the race 
groups. Because the panels are small, such 
associations (or the lack of them) should be 
treated with some reserve. 
Differences in the frequencies of leucocyte 
amigens may be of interest to anthropologists. 
Dausset,l in a study of a small samrle of 
Negroes from the West African state 0 Mali, 
found lower frequencies of Ra, 4a, 4b, 7d and 
Gb than in the French population. New York 
Negroes! also had lower frequencies of 8a, 4a, 
7c and 7d; they were not tested for 4b, The 
findings in the Bantu are quite different. Every 
antigen we could test for, except'Tol, had a 
higher frequency in the Banto than in the 
White group. The Indian group appears to 
have a higher incidence of 4a, and a lower one 
of 4b, than either of the other poplllations. 
Figures such as these are, of course, to some 
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of sera used to obtain them. Until more work 
has been done they should, therefore, be regar-
ded as provisional. 
It is not clear why we failed to find a good 
anti-Sa serum. Such sera are common. They 
are avid and would thus not be excluded by 
our crilcri;t of selecti on. These criteria may 
well Iwve exclllded sera like anti-7a and anti-
7b, which are said! to give weak and unreliable 
results. No allowance has been made in this 
study for fal se negative reactions cau~ed by the 
ANAP (ngglutinntion ne,gntive absorption posi-
tive) 1'" " "'"11"1111 11 . hilI o llr choice of avid ~era 
prohahl r "' d.," th is IInilllp:Ht;I IIr.! 
S~ve r a l of the sera that ha ve not been classi-
fied prcba!Jly detect known spEcificities; 61 
may be anti-5b. The group detecd by the sera 
27 and 29 is a well -defined one, bue does not 
appear to correspond to any of van Rood's 
speci/icities. 
The knowledge gained from this study will 
hel p lIS to undertake tissue ty'pi ng in 3 race 
groups with more confidence, but it is still in-
comple ~e . Rubinstein et aP have pointed out 
that new antigenic specificities may be found as 
new populations are examined and that to de-
tect some of these it may be necessary to use 
anti sera derived from the population groups 
concerned. \Y/ e had relatively few Bantu and 
Indian sera in this study, and not surprisingly 
did not detect convincingly any new groups 
confined to one population. If experience with 
red cell antigens is any guide, we may expect 
to find sw" sl'cci/icities in the future. 
SUMMARY 
Thirty-nine leucoagglutinating sera from preg-
nant women were tested against the white cells 
of 3 panels of 40 donors each, from the White, 
Indian and Bantu race groups_ 
Many of the !era could be classified into 
groups detecting the 7d, Gb-7c, 4a and 4b anti -
genic complexes, together with another com-
plex of unknown specificity. 
The sera identifying each of these complexes 
differed in number . and in their interrelation-
ships from one population group to another. 
The frequency of the 7d, 6b-7c, 4a, 4b and 
Sa anti genic complexes was higher in the Bantu 
than in the Whites. The Bantu thus differ 
notably from West African and American 
Negroes, who have been found by other 
workers to have lower frequencies than Whites 
for most of these complexes. 
Groups of sera chosen to identify the anti-
genic comp!exes in each race group . were 
assembled for me in tissue typing. 
We are grateful to Dr. Kayhoe and Dr. Ohanesian 
of the NIH Trlnsplantation Immunology Branch 
for valuahle reference sera. and to Mrs. G . C. 
Buckle, Miss B. H all and Mrs. A. D. Skinner (or 
help in the laboratory. 
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Reactions of HL-A Antisera in Three Populations 
M. G. HAMMOND and P. BRAIN 
Natal Institute of Immunology, Durban 
Abstract. Cytotoxic antisera against HL-A antigens were tested in panels of Cau-
casian, Bantu and Indian donors. A serum that gives reliable results in Caucasians 
may prove quite uureliable when used in Bantu or Indians, since it may possess 
extra antibodies against antigens that are very rare in Caucasians but common in 
the other groups. Every serum that is to be used in a population different from 
that in which it was standardized must therefore be re-standardized in the new 
group before use. Results obtained in previous studies by EDTA agglutination 
cannot be compared with those obtained by cytotoxicity. The NIH serum WILLETT 
(anti-HL-A 8) gives identical results by agglutination and by cytotoxicity when 
tested in Caucasians; but in the Bantu it reacts with 49% by agglutination and 
only 8 % by cytotoxicity. The Bantu evidently possess several unidentified HL-A 
antigens. 
It is now well established [2-4, 7, 8] that the frequency of HL-A 
antigens differs considerably from one population group to another. 
In an earlier study, [2], using leukoagglutination, we found - as 
DAUSSET [3] had previously observed - that a serum giving reliable 
results in one population group would not necessarily do so in another. 
The hospital population in this part of South Africa consists of 3 im-
portant groups, Bantu, Caucasians and Indians, and it soon became 
clear to us that if we were to perform reliable tissue typing we must 
have ~1'r;1 th at have heen tested and found effective in" all 3 groups. 
Since ado p Ling the micro cytotoxicity test we have screened some 
20,000 sera of parous women in our own laboratory. We present in 
this paper some of the results obtained with selected sera of our own, 
and with sera from the National Institutes of Health and other sources. 
Received: August 6, 1970; accepted: January 5, 1971. 
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Jlr1 aterials and Methods 
Lymphocytes were isolated by the method of BOYUM [1], using a Ficoll-Isopaque 
mixture, and a final suspension was made to contain between 4,000 and 6,000 
cells/cu mm. The cytotoxicity test was performed in 6O-well Microtest tissue culture 
plates (Falcon Plastics) using the two-stage method recommended by the National 
Institutes of Health plus trypan blue, as follows: antisera were dispensed in 1 ~l 
amounts under paraffin, and 1 ~ of the cell suspension added. Mter 30 min at room 
temperatllTe 5 ~tl of fresh unabsorbed rabbit serum was added and the plates left to 
stand for 60 min. Five micro lit er of a fresh preparation of trypan blue, made daily 
by diluting a 1 % aqueous stock sohition with an equal volume of 1.7% saline, was 
then added. Mter 15 min at room temperature (20 0 C) the excess dye was flicked 
off the plates and they were examined with an inverted microscope and 20 x objec-
tive; phase contrast was not used. We have not found the results in plastic trays 
to be unreproducible, as suggested by DICK [5], as long as the two-stage procedure 
is used. 
The serum donors were parous women of all race groups, but up to the time of 
this study there were relatively few Bantu among them. There were, however, a large 
number of coloured (mixed European and Bantu origin) donors, as many coloured 
women attended an antenatal clinic situated near our laboratory. Sera were screened 
daily against the lymphocytes of 6 blood donors. Screened but uncharacterized 
sera were obtained also from the South Mrican Institute for Medical Research, 
Johannesburg. Reference sera were obtained from the National Institutes of Health 
bank and through them (in ready prepared trays) from Dr. P. I. TERASAKI; also 
from the National Tissue Typing Reference Laboratory, Bristol (Dr. G. H. TOVEY), 
from commercial sources (identified by the prefix C), and one (394 CH) from the 
Massachusetts General Hospital (Dr. PAUL S. RUSSELL). Positively reacting sera 
from the screening tests were put up, together with reference sera, against panels 
of donors who were all in the first instance Caucasian. An IBM 1130 computer was 
used to compare the reactions of every serum with those of every other and to print 
out XI [2]. Selected sera were later tested in the same way against panels from the 
other 2 race groups. 
Donors of lymphocytes were healthy unrelated adult blood donors and staff 
members of either sex. The Caucasian population of South Mrica is of Western 
European origin. Bantu were almost all of the Zulu tribe. Indians are the descendants 
of immigrants who arrived about a century ago, principally from the Madras Pre-
sidency. TJw J groups are quite distinct in appearance and none of the individuals 
used by us appeared to be of mixed origin. The group of mixed origin which appears 
among the serum donors was not included among the lymphocyte donors. 
The groups of antisera identifying the antigenic complexes were characterized in 
previous unpublished studies. Those groups used in this study that do not include 
a reference serum obtained from elsewhere contained (among others) sera charac-
terized as follows against those supplied in trays by the National Institutes of Health 
(tray NIH 202), using a panel of 30 Caucasian donors: 
Anti-HL-AlO: Serum V 104, X2 19.3 with both sera 2527.0 and 1617.1. 
Anti-HL-A5: Serum S 21: X2 23.1 with both 951.0 and 2532. 
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Table I. Percent frequency of reaction of sera in 3 population groups 
Anti- Serum Origin! % frequency 
Caucasian Bantu Indian 
HL-Al 324 I 49 0 38 
Cl 49 3 43 
89 C 46 20 38 
HL-A2 291 G 33 20 40 
C2 33 20 40 
317 C 36 25 40 
HL-A3 394 CH 33 8 20 
C3 33 8 33 
STORM 31 8 35 
125 C 46 8 38 
HL-A9 275 Co 23 23 10 
300 I 26 18 18 
C9 33 28 20 
JONES 05 36 25 18 
42 Co 33 50 38 
HL-AI0 VI04 8 30 15 
HL-A5 310 C 13 5 35 
521 13 5 40 
HL-A7 101 I 21 25 15 
247 Co 23 28 15 
130 C 26 35 18 
HL-A8 GT29 33 13 8 
311 C 33 15 10 
284 C 46 15 8 
571 44 63 23 
C8 41 45 20 
HL-A12 137 C 28 18 20 
271 C 28 20 25 
GT61 23 18 18 
328 C 23 18 10 
320 I 28 38 23 
Te10(BB) V8 21 15 25 
Te10+HL-A7 253 C 33 28 33 
TeI7(SL) 35 C 18 53 43 
S90 21 53 28 
24 Co 28 60 30 
131 B 21 45 33 
Te50(4c) 204 Co 31 15 43 
301 Co 31 10 45 
1 Origins of sera: C = Caucasian. Co = coloured. B = Bantu. I = Indian. 
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Anti-liL-A7: Serum 247, X 2 25.5, 17.9, 17.9, and 25.5 respectively with Te 473.2, 
4070, 3186.0 and 1953.0. 
Anti-HL-A 12: Serum 271: X2 19.8 with each of 719.1 and 975.1. 
Anti-Te 17: Serum 35, X2 17.4 with each ofTe 3346.4 and Te 479.5. 
Anti-Te 10: Serum V 8: X218.5 with 2717.0,18,9 with 2659. 
Anti- Te 50: Scrum 204, X2 25.5 with each ofTe 889.1 and Te 10.21; 15.1 with 2526.0. 
Results 
Table I shows the frequencies of reaction of each serum in each 
population, together with the population group (where known) of 
the serum donor. 
Table II. Alleles detected in individuals of 3 population groups, Caucasian, Bantu 
and Indian 
First (LA) sub-locus Second (Four) sub-locus contd. 
Alleles Number Alleles Number 
of individuals of individuals 
C B I C B I 
HL-A1 7 0 7 Te10(BB) 3 3 2 
2 3 5 4 Te17(SL) 1 10 7 
3 3 3 2 HL-A5,7 0 1 1 
9 5 6 6 5,8 1 0 0 
10 2 5 3 5,12 0 0 2 
1,2 tj. 0 6 5,Te10 0 0 3 
1,3 4 0 2 5,Te17 0 0 4 
1,9 3 0 0 7,8 1 1 1 
2,3 4 0 3 7,12 3 2 1 
2,9 2 0 1 7,Te10 1 2 1 
2,10 0 3 2 7,Te17 I 4 0 
9,10 1 3 0 8,12 1 0 0 
Blank 1 15 4 8,Tel0 2 0 0 
Totals 39 40 40 8,Te17 0 2 0 
Second (Four) sub-locus 12,TelO 0 0 3 
HL-A5 3 0 5 12, Te17 3 2 0 
7 2 2 2 Te10, Te17 2 1 0 
8 8 1 2 Blank 4 8 5 
12 3 1 1 Totals 39 40 40 
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TaLle Il shows the alleles detected in the individuals of the 3 popu-
lation groups (39 Caucasians, 40 Bantu, 40 Indians) at each of the 
sub-loci LA and Four. 
Table III shows the reactions of one serum (Willett) tested by both 
EDTA agglutination [2] and by cytotoxicity in three population 
groups. 
Table I I I. Antiserum Willett: % frequency of reaction in 3 population groups 
Method Caucasian Bantu Indian 
Cytotoxicity 31 8 13 
(NIH) 
Agglutination 31 49 40 
(EDTA) 
Discussion 
It is of interest to compare these results with those obtained by 
agglutination in our earlier study [2]. There we concluded that the 
Bantu were quite different from the West African and American 
Negroes, since they showed higher frequencies of most of the common 
antigens than did Caucasians. Negroes had been found, by cytotoxicity, 
to have lower frequencies. It is now cleaT that although our findings 
were correct our conclusions were not. Although the numbers tested 
are small it is probably safe to say that by cytotoxicity the Bantu 
show lower frequencies than Caucasians for. HL-A 1, 2, 3, 8, Te 50. 
and perhaps HL-A 9, 5 andl2. Bantu frequencies are higher for Te 17 
and HL-A 7. Using agglutination the findings are very different, the 
frequencies for HL-A 2 and 8 being higher in the Bantu than in the 
Caucasians. The NIH anti-HL-A 8 reference serum Willett, which 
works by both agglutination and cytotoxicity, is of great interest, 
It was used in earlier studies by us but not in this one since supplies 
were exhausted. The 1969 edition of the NIH catalogue states that 
its activity as an agglutinin corresponds exactly to its cytotoxic 
activity. In taLle III we see that this is perfectly true as long as 
18 
HL-A Antisera in Three Populations 497 
testing is confined to Caucasians. (The panels on which Willett was 
tested were not the same as in the present study.) But in the Bantu 
the frequency of reactions by cytotoxicity is 8 % and by agglutination 
49 %, and there is also a lesser but still marked difference in Indians. 
Results obtained in a population by agglutination are internally per-
fectly consistent, but they cannot be compared with those obtained 
by cytul,oxicity. It is obvious that the serum Willett is not identifying 
the same antigens by agglutination and by cytotoxicity. In Cauca-
sians it appears to be doing so because the 2 antigens have the same 
frequency and are associated. In the Bantu and Indians they are quite 
distinct. The moral of this is that a serum that behaves perfectly in 
the population group against which it was originally characterised 
may perform quite differently in another. Consider the commercial 
cytotoxic serum C 8. When used in Caucasians, against whom it must 
have been originally standardised, this is an excellent serum. In the 
Bantu, however, it reacts with a frequency of 45 %, whereas the 
frequency of a true anti-HL-A 8 is 15 % or less. Results with the 
Bristol reference scrum GT 29 and our serum 311 are similar in all 
3 race groups; C 8 gives similar results in Caucasians (X2>23) but quite 
dissimilar in the Bantu (X2 1.3). This commercial serum tested in the 
Bantu includes GT 29, but it is reacting also against another antigen 
that is evidently common in the Bantu and very rare in Caucasians; 
too rare, that is, to have been observed in the doubtless very extensive 
tests the serum received before being released for sale. We are not 
criticising this serum; in Caucasians it is almost perfect. The point 
we are making is that any serum that has been standardised in one 
population group must be re-standardised before it is used in another; 
We suspect that there may be no such thing as a monospecific serum; 
to mis(l'lOtl ~ WIENER, the number of antibodies that cau" be detected 
is limited ouly by the ingenuity of the experimenter. Other sera that 
behave differently in different races include S 71, which resembles 
the commercial serum in its reactions but is not strongly associated 
with it in the Bantu and must therefore contain a different second 
antibody; 89, which might have been regarded as an acceptable anti-
HL-A 1 had it not been tested in the Bantu; and 320. Some sera, 
however, are encouragingly uniform from one population to the next. 
Of the anti-HL-A 2 sera, the commercial product C 2 and our 291 are 
absolutely identical in all the 3 groups, and 317 is identical with them 
in Indians. All 4 anti-HL-A 3 sera (C 3, 394 CH, 125 and Storm) are 
identical in the Bantu. , 
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We were gratified that table 11 shows no individual with more than 
2 alleles at 1 sub-locus. We have not reported our findings for HL-A 11 
and Te 19, since the sera are inadequately characterised; if included, 
they would abolish the only blank at the first sub-locus in the Cau-
casians and 3 of the 4 in the Indians. There would still be 14 individuals 
blank for the first sub-locus among the Bantu; while among those 
in whom only 1 allele was detected, some may be heterozygotes for 
an unknown antigen rather than homo zygotes for a known one. The 
behaviour of some of the sera makes it clear that unknown antigens 
must be common in the Bantu. As RUBINSTEIN et al. [7] have observed, 
such antigens are likely to be found by using sera derived from the 
population groups concerned; we have already begun a study of sera 
from Bantu women in the hope of finding some of them. 
Our frequencies for the antigens in the 3 race groups must · be 
regarded as tentative because of the size of the panels and the un-
certain reliability of the sera detecting some of the more obscure 
factors. The anthropological significance of these findings deserves 
more work on larger panels, and another paper. 
Acknowledgments 
This study was supported by a grant to P. B. from the Medical Research Council 
of South Africa. We are grateful also to all the laboratories which seut us sera, and 
to Mr. GRAHAM WEBB for the computer programme. 
References 
1. BOYUlIl, A.: Separation of leucocytcs from blood and bone marrow. Scand. J. 
din. lab. Invest. 21: supp!. 97, p. 7 (1968). 
2. BRAIN, P. and HAIIIMOND, M.: Leucocyte antigens in three race groups. Med. 
Proc. 14: 589 (1968~ 
3. DAussET, J.; IVANYI, P., and IVANYI, D.: Tissue alloantigens in humans _ 
identification of a complex system (Hu-I). Histocompatibility testing, p. 51 
(Munksgaard, Copeuhagen 1965). 
4. DAussET, J.; IVANYI, P.; COLOIlIBANI, J.; FEINGOLD, N., and LEGRAND, L.: 
The Hu-I system. Histocompatibility testing, p. 189 (Munksgaard, Copen-
hagen 1967). 
5. DICK, H. M.: cit. KISSMEYER-NIELSEN and THORSBY Human transplautation 
antigens. Transp!. Rev. 4: I (1970). 
6. KISSMEYER-NIELSEN, F. and KJERBYE, K. E.: Lymphocytotoxic microtech-
nique: purification of lymphocytes by Hotation. Histocompatibility testing, 
p. 381 (Munksgaard, Copenhagen 1969). . 
20 
HL-A Antisera in Three Populations 499 
7. RUBINSTEIN, P.; COSTA, R.; VAN LEEUWEN, A., aud VAN ROOD, J. J.: The 
leukoeyte antigens of Mapuehe Indians, ibid., p. 251 (Munksgaard, Copenhagen 
1969). 
8. SINGAL, D. P., IvlIcKEY, M. R., and TERASAKI, P. 1.: Serotyping for homo-
transplantation XXIX. Two new HL-A antigens. Transplantation 8: 235 (1969). 
Authors' address: Mr. M. G. HAMMOND and Dr. PETER BRAIN, Natal Institute of 
Immunology, P. O. Box 2356, Durban (South Mriea) 
21 
TIU:"RPLA.';TATlON 
Copyright © In72 b>' Th~ WillinlllR & Will;i", Co. 
Vol. 14 , No. 2 
.Printed in U.S.A. 
HL-A ANTIGENS AND ANTIBODIES IN SOUTH 
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SUMMARY 
Wr pl'I · '. i<l llc h i'fll11HI 11t:11 11(';11'1.\' :3,l:j';t" of the Bantu had 110 alltigPlIs at the first 10clI;'; 
d('l c('l;dll,· Iliil, 111(' ;ll1li .~('J':1 :I\'ailaule to us. The sera of I,OU4 Balltu women \',,·ere 
thrrefore S('J'c('IH'd and t.ho"(' ('ontaining antibodies \\'ere tested against 50 unrelated 
B:11l tlJ dOllors ill p:lr:dld wit h known ant i,;;cra, using the 2-st.age microlymphocytotoxic 
It'st. AIlI is(,I':l 1'01' '1'(' Ii:{ alld Tc (lI; \\'cl'e obtailJ('d from the National Institutcs or 
Hea 11 h (N 111 ). Th('se 1 \\'() sp('('ificiti('s almost completely filled the gap pre\'iousl~' 
fOlllld :11 Ill(' fi 1':,1 [O(,IIS. T\\'o IlIlIldl'ed t\\'o of the 1.00-1: J3antu scra contained HL-A 
tlnlibodi('s, Illlt ollly 011(' h:ld Ill(' spc('ificil~' anti-Te G:~. Oll(' hundred bventy selected 
sera \\'('['(' tlH'1l 11 :,;('<1 10 t('sl a flll'll1('r 100 Bantu and 100 CaueHsians. Wc tested for 10 
antigen" al t h(' fin:it, IOClIS, HL-A1.2.3,~),IOJ1, W28, W19, Te 63, and Te 66; and at the 
second 10('11:' we tested for 1~ [llltigens. HL-A.5,7,8.12.1;~ , WS. vY22 , W1.5, WIi. WIO. 
:lI1d W~i. IlL-AI has :1 \'('1'\' 10\\' freq1l('II('Y in tll(' Bantll (5'1r) and no Bantu were 
f01111(1 wilh HL-All, whih' HL-A:~ had a lo\ver frequency (12%) than in Caucasians. 
,ns (H)'/C,), HL-A9 (Ii'le), HL-AlO (2:3%), Te 63 (13% ), and Te ul) (:31%) all had 
higher frequencies in Bantll than in Caucasians . At the second locus, the frequenc~· of 
HL-A7 was only 11% but \V22 was found in 34'10 of the Bantu (5'10 in Caucasians). 
Thirt~--fi\-e anti-HL-A12 srra could be divided into two groups, onc reacting as a short 
anti-HL-AI2. 
There are' significant ditTel'CIH'CS in the fre-
qllc[Jcies of HL-A ant.igens in various races (i-S, 
7, S, 11-13). We have reported (:j, ,9) the anti-
g('n frequenci(,R in small sample'S from t.he three 
Iargr population gronps of DmlJan: Caucasian, 
IJldian, and Bantl!. 
This ~1t1dy is fhl' result of Oil[ finding UJ) that 
IH'arly ;:)5% of t.he Bantll had no antigens nt the 
fir:"t 10CllS deter table wit.h the antis('ra avnilable 
to liS. The corresponding prrcrlltage's for Cau-
('n~iaIlS and Indians were 2.,5 and 10%, respec-
ti\-r1y. Eviclenll~' , t.he Ranlll Jl0f'';;CSS , at. rela-
ti\'('I~! high frrqllrll('ips, alltig('Il'" Ihnl al'(, un-
kllown or rarc in Callcasians. Antihodies against 
sw'h a III igf'l1s, t.hewf ore. might 1)(' cxpected to 
()('('ur in Bantu women, nnd thc original aim of 
I hi,;; st ndy was to find them. 
MATEBIALS AND .METHODS 
LYIIlJlho::'~-tes W(,l'e isolated h~- I he method of 
BO.\'Ilm (4), IIsillg a Ficoll-HypaqllP mixt.ure, 
I SlIpport.ed h~' a grant frolll thr SOlllh African 
i\11'dic:d H(':"(':lI'!'11 COlln('il (I'. TU. 
and the c~·totoxieit~- test was performed in Fal-
con mirrotest trays using the 2-stage procedure 
reromll1elldrd b~- the NIH (6) as follows: 1 f.d 
of antisCrll1l1 amI 1 ,ttl of cell suspension were 
added to each well under paraffin _ Aftpr ao min 
at. room temperature , 5 ,ttl of unabsorbed rabbit 
complement was added and, after a further 60 
mill nt room temperature, 5 ,ttl of freshl~' pre-
llnred 0.6% trypan blue in sHline was added. 
After 15 mill at room temperature. excess dye 
was flicked off and the wells were examined with 
an in-;rrted mieroscope. 
Blood samples were collected from 1,00-1: 
Bantu women of the Zulu tribe attending ante-
natal and postnatal clinics. The number of preg-
lIancics was not. recorded. but more than olle-
half werp mUltiparas. The serum was separnted 
and stored at. -80 C. 
Their SNa were screened dail~' against the 
Iymphor~-tes of normal ndlllt Bantll blood do-
nors or staff members. A serum was not re-
garded ns negative until it had gin'll no positive 
reaction~ with 40 different. Banlll dOllor~. Po:"i-
22 
TABLE 1. Numbers and sources of antisera used to TABLlt 3. Percentage of frequency of HL-A 
identify IlL-A antigens antigens in three race groups 
Antisera Nos. from 
Antigen 150 Bantu 147 Indians 100 Caucasians 
Antigens Natal NIII Total Institute N HI tray 
of Im- serum N621 
munology bank HL-Al 5 27 27 
HL-A2 20 31 51 
HL-AI 9 1 3 13 W28 19 12 6 
HL-A2 14 1 3 18 EL-A3 12 15 35 
HL-A3 3 3 3 9 HL-All 0 25 13 
IlL-A9 2 3 2 7 HL-A1O 23 7 8 
IlL-A1O 4 1 4 9 HL-A9 17 16 13 
IlL-All 1 1 3 5 W19 17 10 14 
W28 4 3 2 9 Te 63 13 1 5 
W19 1 2 2 5 Te 66 31 2 5 
Te 63 1 ° 2 3 Blank 3 3 0 Te 66 ° 1 2 3 IlL-A5 (j 2 3 11 HL-A5 4 37 12 
W5 :\ 3 7 W5 9 34 22 
HL-A7 !I :2 "* 15 HL-A7 11 13 26 
W22 3 1 1 5 W22 34 3 5 
HL-Mj 4 4 3 11 W27 3 1 12 
W14 a 1 3 7 HL-A8 13 5 21 
HL-A12 11 0 3 14 W14 7 1 6 
HL-A1a 4 2 2 8 IIL-A12 22 10 28 
W15 ;~ 0 2 5 HL-Ala 5 7 7 
W17 .5 1 :3 !) W15 16 17 15 
W10 3 1 3 7 W17 29 26 9 
W27 1 1 0 2 W10 5 34 16 
Total !}4 32 5G 182 Blank 3 1 2 
TABLl', 2. Specificity of antibodies detected in sera of 1,004 parous Bantu women 
Specificity No. Specificity No. 
HL-AI 0 HL-A5 0 
HL-A2 3 W5 1 
Associated with HL-A2 4 Associated with W5 6 
Associated with IlL-A2 + W28 1 HL-A7 3 
W28 1 HL-A7 + W22 12 
Associated with W28 1 Associated with HL-A7 + W22 17 
<W28 1 Associated with HL-A7 + W27 1 
HL-A2 + W28 + W17 1 HL-A8 1 
HL-A3 1 Associated with HL-A8 3 
HL-All 0 WI4 0 
HL-A9 2 HL-AI2 3 
Associated with HL-A9 2 Associated with HL-AI2 10 
HL-A9 + 8 1 <HL-AI2 5 
Associated with IlL-AlO 3 HL-AI3 2 
Associated with HL-AI0 + W28 2 Associated with IlL-AI3 1 
W19 1 HL-AI3 + W17 1 
Associated with W19 2 Associated with W15 2 
Te 63 + IlL-A13 1 W17 4 
Te 66 0 Associated with W17 8 
Associated with WI0 1 
M ul tispecific 32 W27 1 




August, 1972 HAMIVIOND ET AL. 161 
FIGUlm 1. Reaction pattcl'll of anti-HL-A7 and W22 sera with 50 Balltu cell donors. 
tively reacting sera were kept for further study. 
These sera were tested, together with a large 
number of others, against the lymphocytes of 50 
unrelated n(1nn :iI n!llltt1. Of the other sera, some 
had been characLerised by us in the past, some 
came from the NIH serum bank, and others 
were obtained already dispensed on tissue typing 
trays (No. N621) from the NIH. In addition to 
sera of our OWIl that were regarded as monospe-
cilic or of known specificity, we included 96 that 
had previously given obscure reslllts. In all, 480 
sera were tested against this panel; 120 srlrcted 
sera were then used to test. two further panels of 
100 Bantu and 100 Caucasians. The results were 
analysed using an IBl\,r 1130 computer (5). 
We used large numbers of sera because we 
have previol1sl~· foullc! that. n S('l"\llll which np-
pears to be mOllospeeifie in Oil(' populn tion may 
not be so at all in allother (7). This is usunlly 
because it contains extra antibodif's against anti-
gens very rare in the first populat.ion and rela-
tively common ill the second. As a rule the ant.i-
sera with the lowest frequency within a particu-
lar group arc usually defining the antigen cor-
rectly. The numbers used and the origins of 
these sera are shown in Table 1. 
RESULTS 
Table 2 shows the specificities of the 202 out 
of the 1,004 Bantu sera that were found to have 
lymphm:ytotoxic nntibodies. 
Table :3 shows the freC)llencies of the HL-A 
antigens in Bantu and Caucasians. For t.he sec-
ond sample of Bnntll, no more preloadecl trays 
were available and the results for Te 63 and Te 
66 should therefore be treated with reserve, as 
Te 66 was detected with only a single serum and 
Te 63 was detected with only two sera, both of 
which are mixtures. For comparison, freql\encies 
obtained 011 a panel of 147 Indians are included 
in this table. 
Figure 1 shows the reaction patterns of sera 
containing antibodies to HL-A7 and W22 in the 
fir.'3t 50 Bantl\. Tablc 4 gives the 2 X 2 tables of 
these sera. Figure 2 and Table 5 illustrate the 
reactions of antisera against 150 Bantu. Figure 3 
and Table 6 show the reaction pattern and 2 X 
2 tables of sera with antibodies recognising HL-
A12 or l)art of it. 
DISCUSSION 
Antisera for Te 6:3 and Te 66 which were 
availnble for this study almost completely filled 
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TAIILI·; 4. 2 X 2 comparisons of sera illustrated 
in Figure 1 
Leading Antisera %H serum ++ - - +- -+ 
-- -- - - -
I{-N 8498 Te 31860 100 22 27 0 1 
N456 100 22 28 0 0 
B507 82 22 28 0 0 
B606 95 22 28 0 0 
B730 100 22 28 0 0 
B486 100 21 27 1 1 
N:3R~ R') ,~ 21 27 1 1 
N t::') ,",1 I 21 28 1 0 
ll2:2 \)5 21 27 1 1 
BnO 68 21 27 1 1 
Bn5(i 100 20 27 2 1 
BnOO !l5 20 2G 2 2 
B5Hi SI 20 27 2 1 
13247 71 21 28 1 0 
B3D5 R!l 18 2S 4 0 
13735 71i 20 27 2 1 
B()73 95 18 27 4 1 
13317 57 11 25 11 3 
13155 SS 17 28 5 0 
B5:~,) 83 18 28 4 0 
B65:1 53 13 2(} 9 2 
B5S0 6n 13 28 9 0 
B652 54 12 27 10 1 
B563 50 6 26 16 2 
13857 n 15 28 7 0 
N:2SI 27 1f) 27 12 1 
N431 (i4 13 27 9 1 
N549 73 15 28 7 0 
N28G 80 14 27 8 1 
B232 57 13 27 n 1 
B8f1l 70 10 28 12 0 
Te A4!l2!l 83 Ii 2~ 1G 0 
B](Hi G3 8 28 14- 0 
N5S2 H7 G 28 Hi 0 
NDn 67 6 28 16 0 
N7G 50 (j 28 16 0 
NlOl 50 4 28 18 0 
BU7 33 3 28 19 0 
B705 71 (j 27 Hi 1 
B41!l ~3 :~ 28 In 0 
B72!l 33 :; 28 19 0 
N30(j 0 3 28 19 0 
N247 0 3 28 In 0 
N533 75 4 28 18 0 
N489 100 4 28 18 0 
N403 50 4 28 18 0 
Te 569l.1 50 4 28 18 0 
Te 5fi!J1. 2 75 4 28 18 0 
D ()6-15!l03 75 4 28 18 0 
. " \ ' 
FIGURE 2. Heaction pattern of nnti-HL-Ai nnd 
W22 i'Pnt with 150 B:1nlu cplI donors. 
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TAnr,g 5. 2 X 2 comparisons of sera illustrated 
in Figure 2 
Leading Anti5era %4+ ++ +- -+ serum 
K-N 8498 N456 !)2 60 85 0 5 
B!)OO 100 57 83 3 7 
B652 6G 32 SG 28 4 
B155 97 36 87 24 3 
B395 !)3 53 S5 7 5 
N431 83 47 84 13 6 
N286 55 45 84 15 6 
13S57 73 48 86 12 4 
B8!)1 71) 34 86 26 4 
N54!J 76 35 87 25 3 
B232 n 34 R4 2G G 
BHif; " 
.) --') Sfi :15 5 
B!J51j ;'1S ;lS S5 22 5 
N2Rl 50 20 S9 40 1 
N4R!) (j5 20 RS 40 2 
N5aa 7!1 12 !)O 4R 0 
the gap previously found ill the lhntu at the 
first locus. No cell donor was found with more 
than two antigens and in only three donors were 
none detected at the first locus. 
It is interesting that we did not find antibod-
ies to these specificities among our 202 positive 
sera, except for one in a mixture. Presumably 
the antigenicity of these factors is low. Several 
good antisera were found. Antisera listed in 
Table 2 as specific did not have more than one 
discrepancy wit h 11](' reference serum for that 
specificity. Those associated with a specificity 
had two or more discrepancies. Some of the 32 
multispecific antisera included common specifici-
ties, e.g., HL-A2, but generally reacted with 
three antigens or more. The 59 antisera that 
showed no relation to any other recognised spec-
ificity generally hnd a yery low frequency of 
reaction (10%) and few of the reactions gave 
100% kill. They were not restricted to those cells 
with only one detectable allele at either locus. 
One possible explanation is that they are recog-
nising products of IlL-B locns (14). 
In Caucasians, HL-Al and HL-AS have simi-
lar frequencies and a high degree of association 
and consequently antisera containing anti-HL-
Al and anti-HL-AS may be diflicult to identify. 
Indians, however, have a very low frequency of 
HL-AS (5%) while 27% possess HL-A! whereas 
in the Bantu the reverse is found. Only' 5% were 
HL-Al-positive while 13% are positive for HL-
AS. These differences can be put to good use by 
using a selected panel from each race group for 
characterising antisera. 
Figure 3 shows the reaction pattern of sera 
associated with or included in HL-A12 in 150 
Bantu. It appears that HL-A12 is a heteroge-
nous antigen which can be subdivided into two 
parts. The 2 X 2 tables of these reactions are 
listed in Table 6. Next to each serum is shO\vn 
the percentage of reactions that gave 100% kill-
ing of lymphocytes. The (- +) reactions of 
sera N 137 and B374 are with cells that are posi-
tive for W19. Svejgaard et aI. (1.5. 16) have de-
scribed an antigen, EL*, which is defined by an 
antiserum that reac.ts with HL-A12 cells and 
with cells that are EL*-positive. However, the 
differences in the Bantu presented here are 
within HL-A12. 
The most interesting difference was the high 
fr8quency of W22 and the large number of sera 
that contained antibodies to HL-Ai and W22 
(Table 2). Figuf(' 1 illustrates the reaction pat-
terns obtained with the sera in the first panel of 
50 Bantu. Table 4 lists the 2 X 2 tables for 
these sera and the percentage of 4+ reactions 
for each serum. Six sera, including Engelfriet's 
serum D66-15903 (obtained from the NIH) and 
Te 5691.1 gave identical results and all have 
been previously characterised as anti-HL-A7. 
They reacted with only 4 out of 50 donors. Four 
TABLE 6. 2 X 2 comparisons for sera shown in 
Figure 3 
Antigen Antisera %4+ ++ +- -+ 
HL-A12 N399 81 31 118 0 1 
B12 100 30 118 1 1 
BS72 100 25 117 6 2 
B894 100 30 lln 1 0 
B855 97 31 119 0 0 
B836 97 30 111) 1 0 
B364 67 27 119 4 0 
1338!J 75 28 119 3 0 
N513 65 26 119 5 0 
B315 !J6 27 118 4 1 
BR!)R 44 5 117 26 2 
N32R 50 3 llR 28 1 
PEI02 25 8 119 23 0 
B374 89 22 114 9 5 
N137 5R 23 115 8 3 
N541i 100 22 un H 0 
13225 74 22 118 9 1 
B228 75 21 116 10 3 
N36G 37 19 119 12 0 
B849 31 15 llR 16 1 
N320 50 10 119 21 0 
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FIGURE 3. Reaction pattern of anti-HL-A12 sera with 150 Bantu cell donors. 
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antisera gaye identical reactions to K-N 8498 
(from Kissmeyer-Nielsen) which is anti-HL-A7 
+ W22 and were positive ,,,ith 22 out of 50 
donors. AnotlU'r 11 sera including Te 3186.0 
(HL-A7 + W22) nll had a cocIlieient of correla-
tion (r = .y x "/N) grmter than 0.8i ,,·ith K-~ 
8498. Eight sem appear to identify W22. The 
negative reactions of these eight sera are not 
attributable to weakly reacting sera because at 
least 50% of the reactions giv"e total killing of 
lymphocytes (Table 4). Another six sera (B232, 
N286, N549, N431, )1281, BSGi) react with HL-
A7 and part of W22. 
We then tested a further 100 Bantu using two 
anti-HL-A7 sera and two anti-HL-Ai + W22 
sera and 12 other sera that showed associations 
with this complex. Figure 2 shows the overall 
pattern of reactions of these sera with cells from 
150 Bantu. Two sera, B155 and B652, appear to 
recognise W22 only. Three cell donors appear to 
possess both HL-A7 and W22. 
Kissmeyer-Nielsen (personal communication) 
has found that the antigen AA (W22) can be 
subdivided into 1,yo catq!;ories which he calls 
AA* and A;\-.\I Till, ;:; llI.[\· (Ii' till' Bantu has 
shown that there a re c\·cn lllorc parts to this 
complex. The identification of these subgroups 
may only ue possible ill a race group such as the 
Bantu where the frequeucy of this antigen is so 
much greater thall ill Caucasians. 
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HL-A Antigens and Antibodies 
in South African Indians 
Iv£' G. HAMMOND, B. ApPADOO AND P. BRAIN 
The Natal Institute of Immunology, 
Durban, South Africa 
The Indian population of South Africa has been found to have a higher frequency of the 
antigens HL-A5 and W5 than do either Caucasians or Bantu. Some antisera that appeared 
to be good anti-HL-A5 or anti-W5 in South African Caucasians gave anomalous results when 
tested in Indians. The sera of 1,000 Indian women were tested for lymphocytotoxic anti-
bodies and those sera found to contain antibodies were tested in parallel with known antisera 
against the cells of 150 Indians. 
We tested for 10 antigens at the first locus, HL-Al, 2, 3, 9, 10, 11, W28, W19, Te63 
(= WI9-I) and T e66 (= WJ9-4) and at the second locus for 12 antigens, HL-A5, 7, 8, 
12,13, W5. \\ ' I 'L \\'15 , W17, W22 , W27 and WlO. 
The freqlll'llc y or H L-A 1 is 22 %, which agrees with the Caucasian origin of the Indian 
population. There apparently are subdivisions of HL-A5 and W5, and one serum was found 
to be a "short" W 10. HL-A 11 has a relatively high frequency in Indians and may also be 
subdivided. 
Received for publication 24 Ma)" accepted 24 July 1972 
The frequency of HL-A antigens varies in 
the different race groups, and antigens 
which are rare in one race group may be 
more common in other race groups. We 
have previously reported an intensive 
search in South African Bantu for new 
antigens (Hammond et al. 1972). This 
paper describes a similar search in the 
Indian population for antisera that would 
resolve the allolIlalous results we obtained 
with antisera for HL-AS and WS. The In-
dian population has a relatiVely high fre-
quency of these antigens and we were more 
likely to find antibodies to these specifici-
ties in such a population. 
There are three distinct racial groups in 
Durban: Caucasian, Bantu and Indian. 
The Caucasian population is of Western 
European origin. The Indian population is 
concentrated in the province of Natal and 
accounts for approximately 13 % of its 
total population. In Durban (population 
650,000) the proportion of Indians is much 
higher (34 % ). The Indians are descen-
dants of immigrants who arrived about a 
century ago, principally from the Madras 
Supported by a grant from the South African Medical Research Council. 
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Presidency. They speak mostly Hindi, Ta-
mil and Telegu. There has been little ad-
mixture with other groups. 
Materials and Methods 
Lymphocytes were isolated by the method 
of Boyum (1968) using a Ficoll-Hypaque 
mixture, and the cytotoxicity test was per-
formed in Falcon microtest trays using the 
two-stage procedure recommended by the 
National Institutes of Health. 
Blood samples were collected from 1,000 
Indian women attending ante-natal and 
post-natal clinics. The serum was separated 
and stored at - 30° C. All the sera were 
screened against a panel of 12 selected 
donors, but as this panel would not contain 
antigens that were "new" , the sera were 
also screened against the cells of 40 ran-
dom Indian blood donors. 
A serum was not regarded as negative 
until it had~i\('1I Jl(l positi\'(' reactions with 
40 dOllurs. The positively reacting sera 
were tested in parallel with previously 
characterised sera against the lymphocytes 
of 99 randomly selected but unrelated In-
dians. Altogether 318 sera were tested and 
the results analysed by computer. A total 
of 120 selected sera were then tested against 
the cells of a further 51 Indians. 
Results 
Table 1 shows the number and specificity 
of the antibodies detected. Table 2 shows 
the 2 X 2 comparisons of the sera illu-
strated in Fig. 1. Table 3 shows inclusions 
in HL-A2. Table 4 and Fig. 2 show the 
relationship between sera reacting with the 
HL-A5-W5 complex. Table 5 and Fig. 3 
illustrate a subdivision of W 10. Tables 6 
and 7 give the phenotypic and gene fre-
quencies of HL-A antigens in the Indian 
population with those of Bantu and Cau-
casians for comparison. Table 8 gives the 
calculated haplotype frequencies in the 
three races, using the method described by 
Mattiuz et al. 1970. 
Discussion 
Two recent studies by Ting et al. (1971) 
and Singal et al. (1971) of HL-A fre-
Table 1 
Number and specificity of antibodies detected in 1000 Indian women 
Specificity No. Specificity No. 
HL-Al 2 Associated with HL-AS + WS 12 
HL-A2 4 HL-A7 3 
Associated with HL-A2 2 HL-A7 + W22 6 
W28 1 HL-A7 + WI0 1 
·HL-A2 + W28 3 HL-A8 1 
HL-A3 1 W14 
Associated with HL-A3 1 HL-AI2 2 
Associated with HL-All 3 HL-A13 1 
HL-A9 2 Associated with HL-AI3 3 
HL-AI0 2 Associated with W15 6 
Associated with W19 1 W17 3 
Te63 (= WI9-1) Associated with WI0 4 
Te66 (= WI9-4) W27 
Multispecific 69 Unknown S7 
Total 190 
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quencies in Asian Indians show similar 
antigen frequencies except that we have 
found a much higher incidence of HL-A5 
and HL- Al1. These differences may be 
attributable to sectarian differences. Milner 
& Calitz (1968) and Milner (1970) have 
shown differences in the strength of the B 
antigen in various I ndian religious sects. 
Of the 190 antisera from Indian women, 
126 gave reactions that could not be iden-
tified (Table 1). Of these sera, 57 had a 
frequency of less than 10 % and showed no 
correlation with any other known antisera, 
nor were their reactions included in those 
of any known sera. I t does not seem pos-
sible that they are all recognising specific 
HL-A antigens or combinations of rare 
antigens, and one explanation is that some 
of them may be recognising non-HL-A 
antigens such as those described as HL-B 
antigens by Singal et al. (1970), although 
these authors found HL-B antibodies pri-
marily as extra antibodies in HL-A anti-
sera. 
The Indian population has a higher fre-
quency of HL-All than do either Cauca-
sians or Bantu, but the reactions of the sera 
we used differed significantly among them-
selves. Serum N597 contains antibodies to 
HL-A3 and HL-Al1, and when it was 
characterised in Caucasians there were no 
positive reactions outside these two spec i-
ficities. In the Indians this serum has a 
frequency of 42 %, of which 32 % ap-
peared to be HL-Al1. HL-A3 was iden-
tified with two monospecific sera. Three 
antisera obtained from Indian women gave 
a reaction pattern which was included in 
HL- All , but they had no significant cor-
relation with each other. This is shown in 
Fig. 1 and Table 2. 
Two sera gave reactions w~ich were in-
cluded in HL-A2 but the possibility exists 
that these are· reacting with only some cells 
from homozygous subjects, although there 
were no weak reactions with these sera. 
The 2 X 2 comparisons are shown in 
Table 3. 
o N ~ " 
r~;;;;;;;;;;;;;;;;;;~mL'------------------~IL-------------------~~.~ Hl-Al 6&3::. uta 
Hl-A11 _-;.~~~~~~~~; N597 _____ -A2l •• 
A25 • ._
A 289 _. 
Figure 1. Reac tion pa ttern of antisera associated with HL-AII in 150 Indian donors. 
Table 2 
2 x 2 comparisoll$ of sera illustrated in Figllre 1, tested in 150 Indian donors 
%,4+ Serum Serum ++ +- -+ 
97 N597 anti-HL-A3 + 11 66 2 4 78 
97 N597 anti-HL-All 46 22 2 80 
82 A23 anti-HL-Al1 31 3 17 99 
66 A25 anti-HL-A11 27 2 21 too 
73 A2R <) anti-HL-All 25 1 23 tOl 
82 A23 A25 24 10 5 111 82 A23 A289 15 19 11 . 105 
66 A25 A289 18 11 8 113 
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Table 3 
2 X 2 comparisons of sera included in HL-A2 tested in 150 Indian donors 
Serum Serum %4+ + + I + - I -+ 
anti-HL-A2 A689 100 34 12 0 
Al 89 35 11 3 
A689 Al 89 26 8 12 
Table 4 
2 X 2 comparisons of sera reacting with the HL-A5, W5 complex 
(as in Figure 2) tested in 150 Indian donors 
Leading serum 
AGST 92 N442 97 63 1 3 
N310 93 58 6 1 
PE27, 78 43 21 2 
S152 88 38 26 2 
V52 78 36 28 0 
AltO 86 40 24 1 
,A168 69 16 48 0 
A803 46 13 51 0 
Al77 55 11 53 0 
N579 38 5 59 3 
N335 88 10 54 6 
N429 89 N277 94 43 .. 2 4 
A568 100 43 '2 7 
AI25 70 36 9 4 
A911 89 34 11 3 
N482 83 20 25 3 
A831 84 26 19 5 
A587 86 14 31 0 
N335 88 16 29 0 





























------- -------------------__ 0: 
Figure 2. Reaction pattern of antisera associated with the HL-5 - W5 complex in 150 Indian donors. 
The most interesting results, however, 
are those ohtained with the antisera re-
cognising IlL- AS amI WS. These antigens 
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are relatively frequent in the Indian pop-
ulation, so that differences in reaction pat-
terns are conspicuous. Table 4 shows 2 X 
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2 tables for several sera that show associa-
tions with this complex, which is illustrated 
in Fig. 2. It seems that there may be more 
factors involved than the three described in 
the 1970 Workshop data, i.e. HL-A5, W5 
and W 18. AGST, N442 and N310 are ope-
rationally monospecific anti-HL-A5 sera 
in Caucasians, and in the Indian series they 
agree very well. Four sera, V52, PE27, 
S152 and A11O, have patterns that are in-
cluded in HL-A5. The reactions of sera 
A168 and A803 are included in these four 
sera. 
Across the middle of Fig. 2 is the reac-
tion pattern of sera that are associated with 
W5. The block at the right centre repre-
sents cells that are positive for W5 and 
negative for HL-A5. Two sera from this 
group (N429 and N277) have previously 
been characterised as anti-W5. At the top 
are four sera which appear to react with 
both HL-A5 and W5. Unfortunately no 
sera for \V 1 B '.11'11- ;l\ailablc alld this spe-
cificity has beell sltO\\'n to be associated 
with W5 (Albert et a!. 1971). It appears 
that there are other antigens present which 
cross-react with antisera against HL-A5, 
W5, and W18. 
Table 5 shows the 2 X 2 comparisons 
of sera reacting with the W 10 antigen, and 
these reaction are also shown in Fig. 3. The 
serum A488 appears to be a short W 10 and 
this serum gives strong reactions with no 
weak positives. Serum A150 appears to be 
even shorter than A488. 
The serological identification of HL-A 
antigens is not yet complete and if (as 
Dausset (1971) suggests) each specificity 
consists of several factors, then the HL-A 
system may have an almost individual-
specific configuration. On the other hand, 
unrelated individuals have been found 
(Ei jsvoogel et al. 1971) who are pheno-
typically identical in mixed lymphocyte 
cultures (MLC), which indicates that 
there is a restricted, though large, number 
of allelic variations. : 
The data presented here show that 
these antigenic factors can be more easily 
identified by testing different race groups 
Table 5 
2 X 2 comparisons of WlO antisera illustrated in Figure 3 
tested in 150 Indian donors 
Leading serum 
AlSO 64 A488 94 10 1 10 129 
A530 96 10 1 36 103 
AS61 90 10 1 30 109 
BAUER 94 10 1 21 118 
V8 9S 10 1 29 110 
N253 100 8 3 22 117 
A488 l/4 A530 96 19 27 103 
A561 90 18 2 22 108 
HAUER 94 17 3 14 116 
V8 95 19 1 20 110 
N253 100 16 4 14 116 
BAVER 94 A530 96 30 1 16 103 
A561 90 24 7 16 103 
V8 95 30 1 9 110 
N253 100 23 8 7 112 
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in which these factors have a higher fre-
quency. Our studies in the Bantu (Ham-
mond et al. I ()72) have shown this to be 
0 10 20 
true for other antigens. The elucidation of 
all the factors governed by the HL-A locus 
may be possible only in this manner. 
30 40 ,. ... 0 
Figure 3. Reaction pattern of antisera associated with WlO in 150 Indian donors. 
Table 6 Table 7 
PerCel1tfl{!e f"eqllellcy of allti{!ens in HL-A gene frequencies in 
Caucasians, Balliu and Indians Caucasians, Bantll and Indians 
Antigen Caucasian I Bantu I Indian Gene Caucasian I Bantu Indian 
N=446 N=150 N=150 HL-Al .165 .024 .117 
HL-Al 30.3 4.7 22.0 HL-A2 .280 .109 .167 
HL-A2 48.2 20.7 30.1 W28 .039 .098 .080 
W28 7.6 18.7 15.3 HL-A3 .162 .062 .080 
HL-A3 29.8 12.0 15.3 HL-Al1 .052 .000 .175 
HL-All 10.1 0.0 32.0 HL-A9 .078 .124 .144 
HL-A9 15.0 23 .3 26.7 HL-AI0 .044 .087 .034 
HL-AI0 8.5 16.7 6.7 W19 .051 .095 .017 
W19 9.9 18.0 3.3 Te63 .022 .069 .003 
Te63 4.3 13.3 0.7 Te66 .017 .163 .003 
Te66 JA JO.O 0.7 Blank .002 .017 .003 
Blank (lA 3.3 0.7 
HL-A5 .052 .013 .239 
HL-A5 10.1 2.7 42.0 W5 .071 .058 .146 
W5 13 .7 11.3 26.7 W15 .065 .080 .084 
W15 12.6 15.3 16.0 HL-A7 .126 .055 .073 
HL-A7 23 .5 10.7 14.0 W27 .048 .017 .013 
W27 9.4 3.3 2.7 W22 .017 .196 .024 
W22 3.4 35.3 4.7 HL-A8 .177 .062 .031 
HL-A8 22 .0 12.0 6.0 W14 .026 .041 .007 
W14 5.2 8.0 1.3 HL-A12 .161 .121 .058 
HL-AI2 29.6 22.7 11.3 HL-A13 .031 .024 .041 
HL-A13 6.1 4.7 8.0 WI0 .081 .027 .102 
WlO 15 .5 5.3 19.3 W17 .046 .163 .109 
W17 9.0 30.0 20.7 Blank .016 .013 .003 
Blank 3.1 2.7 0.7 
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Table 8 
llap[ulype frequencies for Caucasian, Balltll alld Indian papIIlatiollS 
(1l7ol/ber per 1000) 
If) r--
<t: If) i r-- N If) - N N I ~ ~ ~ ~ ....:l ....:l :r: :r: 
HL-Al 0 2 8 14 7 0 
0 2 0 2 0 0 
24 26 21 10 0 5 
HL-A2 15 9 28 36 18 5 
2 0 0 0 2 0 
43 I S 17 19 1 4 
W28 3 4 2 0 4 4 
2 5 19 9 6 6 
11 2 12 0 6 2 
HL-A3 2 20 10 59 0 9 
3 4 0 0 0 0 
8 19 13 8 0 2 
HL-All 6 11 0 11 5 0 
0 0 0 0 0 0 
46 0 21 14 9 0 
HL-A9 3 8 6 6 2 1 
0 0 17 8 0 37 
35 31 2 25 0 0 
HL-AI0 3 0 4 0 1 2 
6 2 19 6 2 9 
12 6 0 1 3 10 
W19 0 0 8 3 7 0 
0 28 7 2 9 16 
4 1 17 2 0 3 
Te63 1 3 1 0 0 2 
3 0 5 7 0 13 
0 3 0 0 0 0 
Te66 3 0 0 0 0 0 
1 13 5 10 0 76 
0 0 0 0 0 0 
Blank 2 0 0 0 0 
0 .\ 2 :I 0 8 
3 U 0 0 0 0 
C = Caucasian, B = Uantu, I = Indian . 
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Subdivision of HL-A5 and 
Comparative Studies of the HL-A Polymorphism 
in South African Indians 
M. G. I-lAM MONO, B. ApPAOOO AND P. BRAIN 
The Natal Institute of Immunology, 
Durban, South Africa 
The HL-AS antigen has a higher frequency in the Indian population than in either the 
Caucasian or Bantu populations of South Africa. Ninety-five Asian Indians were tested by 
microcytotoxicity using 34 anti-HL--AS and nine anti-WS sera. The results confirm the 
heterogeneity of the HL-AS antigen and show that it may be subdivided into at least four 
parts. The Indian population of South Africa is here subdivided into four groups. The HL--A 
antigen frequencies in each group are compared, and haplotype frequencies and gametic 
associations (delta values) have been calculated. The genetic distances (f) between these 
groups and lwtwf'f'n Indians, Caucasians and Bantu also are calculated. The results may 
indicate a differential selection with respect to the HL-A polymorphism. 
Received for publication 15 June, revised, accepted 1 November 1973 
A previous investigation (Hammond et al. 
1972b) revealed significant differences in 
the reaction patterns of different anti-HL-
AS sera when tested in the Indian popula-
tion of Durban. Further work is described 
in this paper. 
Materials and AI ethods 
Subjects 
The Indians of Natal are the descendants 
of immigrants who arrived about a century 
ago to work on the sugar plantations. They 
can be grouped firstly into Tamil and Te-
legu speakers from southern India, both 
Hindu by religion but subdivided here by 
language, and secondly into two groups 
from the north, northern Hindus from the 
eastern side of the continent and a group 
from the west who are Moslem by religion. 
Most of the latter would have been Hin-
dus before conversion but are separated 
geographically from the Hindu group in 
the north-east. 
Caucasians are of western European ori-
gin. The Bantu are Negroes, mostly of the 
Supported by a grant from the South African Medical Research Council (P.B.) 
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Zulu tribe. The Coloured population is of 
mixed Caucasian and Bantu origin. The 
proportion of each race group in the 





















Although Indians are normally consid-
ered to be Caucasians, for the purposes of 
this paper the terms Caucasians, Indians 
and Bantu will refer to the populations as 
defined above. 
Serology 
A total of 250 antisera were used in a two-
stage microlYlllphocytotoxicity test as re-
commended by the National Institutes of 
Health (Brand et al. 1970); of these, 34 
were anti-HL-A5 and nine were anti-W5. 
Serum Lindford was kindly donated by 
Dr. M. Shapiro of the South African Blood 
Transfusion Service, Johannesburg, and 
several antisera were obtained from the 
N.I.H. serum bank. More than 120 of 
these sera have been characterised in pa-
rallel with N.I.H. tray N621 (Hammond 
et al. 1972a). Lymphocytes from 95 ran-
domly selected Indians were isolated by 
the method of Boyum (1968) usmg a 
Ficoll-Hypaque density gradient. 
Statistical Analysis 
The distribution of the different groups in 








The subdivision of HL-A5 emerged from 
the analysis of the reaction patterns of 
these 95 Indians. A total of 303 Indians 
was used for the population frequencies 
and 258 of these could be classified by 
language and religion into the four groups 
mentioned. There were 45 other Indians 
who could not be classified. 
Haplotype frequencies and delta values 
were calculated according to Mattiuz et al. 
(1970), and the genetic distances (f) be-
tween populations were calculated accord-
ing to Cavalli-Sforza & Bodmer (1971) 
using the formula 
f = 4 (I-Cos 8 )/K-l 
K 
where Cos 8 = L VPil X Pi2, 
i=l 
K is the number of alleles, and Pi 1, Pi2 
are the respective allele frequencies in the 
two populations. 
Results 
Fig. 1 shows the reaction pattern obtained 
with 34 anti-HL-A5 sera, nine anti-W5 
sera and serum Laskey (anti-WI8). Also 
shown is the distribution of the other anti-
gens at the second segregant series and the 
distribution of Indians from the North and 
South of India. Table 2 lists the 2 X 2 
comparisons for these sera versus HL-A5 
and W5, as illustrated in Fig. 1. Table 3 
shows the distribution of subdivisions of 
HL-A5 amongst the. four groups of In-
dians and the significance is calculated in 
Table 4. 
Tables 5 and 6 show the HL-A antigen 
frequencies at the first and second segre-
gant series in each of the Indian subgroups 
compared with the frequencies in Cauca-
sians and Bantu. Table 7 shows the fre-
quency of haplotype HL-Al, W17 in all 
the populations with the standard error 
and delta values. 
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Figure 1. Reaction pattern of HL-A5 and W5 antisera in Indians. 
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Table 2 
2 X 2 comparisons of antiseta reacting with HL-AS and WS as defined in Fig. 1 
Antisera I Dilution %8+ ++ +- -+ ;.:2 
HL-A5 LINFORD 2 100 4 23 0 .. 68 10.5 
PE27 30 75 4 23 O· 68 10.5 
NS(d H 75 4 23 0 68 10.5 
N475 2 33 3 24 0 68 7.8 
V52 3 80 5 22 0 68 13.3 
N348 2 56 8 19 1 67 17.9 
K. KLAASEN 44 9 18 0 68 25 .0 
A803 37 8 19 0 68 22.0 
S152 20 90 9 18 0 68 25.0 
N583 1 33 9 18 0 68 25.0 
WOLF 1 86 7 20 0 68 19.0 
COUPER 1 71 13 14 1 67 33.5 
PE468 1 36 11 16 0 68 31.3 
N204 4 92 13 14 0 68 37.9 
N693 2 79 17 10 2 66 43.5 
N442 5 52 21 6 0 68 67.9 
D66-6222 2 32 18 9 1 67 51.3 
MARSON 1 50 17 10 1 67 47.6 
N619 2 79 18 9 1 67 51.3 
N680 1 53 19 8 0 68 59.8 
NM4 1 91 23 4 0 68 76.4 
N35S 6 68 24 3 1 67 76.2 
N711 1 72 25 2 4 64 68.5 
N301 1 79 24 3 4 64 M.1 
V323 1 79 26 1 8 60 60.1 
AGST 100 93 25 2 4 64 68.5 
N298 1 96 26 1 2 66 81.0 
WESA 1 86 27 0 2 66 85.8 
BYRON 1 87 26 1 5 63 69.5 
N310 1 90 26 1 3 65 76.9 
FUJINAKA 1 100 27 0 3 65 81.7 
N615 1 74 27 0 7 61 67.7 
N400 1 71 26 1 8 60 60.1 
AI06 1 71 25 2 10 58 50.4 
W5 N615 1 74 9 2 25 59 11.5 
N400 1 71 10 1 24 60 16.4 
A106 1 71 11 0 24 60 21.3 
N706 2 100 11 0 6 78 57.1 
A911 1 92 11 0 2 82 78.5 
A368 1 45 9 2 2 82 59.9 
PE286 4 38 11 0 2 82 78.5 
FINLEY 1 50 9 2 3 81 54.0 
N374 1 80 10 1 0 84 85.3 
N429 1 75 10 1 2 82 69.1 
8126 30 44 8 3 1 83 58 .0 
A587 1 40 7 4 3 81 37.3 
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Table 3 Table 4 
Distrihutio/l of sllb-divisions of HL-A5 Association between subgroups of HL-A5 
and Indians from the North and South of India 
HL-A5 
5.1 5.2 5.3 5.4 
I 
HL-A5 I HL-A5 I 
.1 + .2 + .3 .4 Total 
Hindu 1 0 1 7 North of India 
Moslem 0 0 0 3 2 10 12 
Telegu 1 1 0 0 Moslem and Hindu 
Tamil 2 3 5 2 
Note: One cell donor (No. 25) of unknown origin South of India 
had been omitted. 12 2 14 
Tamil and Telegu 
14 12 26 
X2 = 12.4 P < 0.001 
Fisher's exact method P = 0.00064 
Genetic distances (f) between the pop-
ulations are shown in Tables 8 and 9. The 
calculated gene frequencies for Caucasians, 
Bantu and Indians are given in Table 10. 
Note: One cell donor (No. 25) of unknown origin 


























// L - .I (IIItigl'll frpl[lIencies at the first 10Clls in Indian mb-grollps compared 
7).:ilh the frequencies in Caucasians and Bantu 
Hindu IIVIoslem Telegu Tami! North South Indian Caucasian 
70 38 45 105 108 150 303 704 
15 .7 21.1 24.4 32.4 17.6 30.0 25.7 31.5 
17.1 42.1 33 .3 31.4 25.9 32.0 30.0 46.3 
17.1 15.8 6.7 10.5 16.7 9.3 13.2 7.8 
21.4 10.5 17.8 17.1 17.6 17.3 17.8 30.0 
31.4 10.5 26.7 28.6 24.1 28.0 26.7 11.4 
30.0 36.8 28.9 25.7 32.4 26.7 28.7 16.5 
2.9 10.5 11.1 8.6 5.6 9.3 7.9 9.0 
10.0 7.9 8.9 6.7 9.3 7.3 7.9 7.0 
0.0 0.0 2.2 1.0 0.0 1.3 0.7 3.6 
2.9 0.0 0.0 0.0 1.9 0.0 0.7 3.3 
51.5 44.8 40.0 38.0 48.9 38.8 40.7 33.6 
Table 6 
HL-A antigen frequencies at the second locus in Indian sub-groups compared 
with the frequencies in Caucasians and Bantu 
Hindu I M~s~em I Telegu Tamil North South Indian Caucasian 70 45 105 108 150 303 704 
40.0 36.8 33.3 33.3 38.9 33.3 36.0 9.9 
17.2 13.2 28.9 23.8 15.7 25.3 21.8 13.6 
7.1 7.9 17.8 13.3 7.4 14.7 12.2 23 .3 
0.0 0.0 4.4 1.9 0.0 2.7 2.6 3.8 
8.6 0.0 0.0 1.9 5.6 1.3 3.3 7.8 
5.7 5.3 13.3 4.8 5.6 7.3 5.9 23.7 
0.0 5.3 0.0 0.0 1.9 0.0 1.0 6.4 
14.3 21.1 8.9 9.5 16.7 9.3 12.9 29.8 
8.6 2.6 6.7 6.7 6.5 6.7 6.3 5.1 
27.1 29.0 33 .3 23.8 27.8 26.7 25.4 13.4 
14.3 13.2 20.0 12.4 13.9 14.7 14.9 11.4 
18.6 23 .7 20.0 22.9 20A 22.0 21.1 7.8 
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Table 7 
Distribution of the HL- Al, W17 haplotype. All figures are X 103 
Hindu I Moslem 
Frequency 25 49 66 86 
s.e. 40.4 57.7 37 .3 37.1 
Delta 16.7 34.9 52.5 64.6 
Table 8 
Genetic distances (f) between the four Indian 
groups based on the HL-A gene frequencies 
at the first and second loclls 
Hindu - Moslem 
Hindu - Telegu 
Hindu - Tamil 
Moslem - Telegu 
Moslem - Tamil 

























Genetic dislrmrC's hC'ln'C'C'lI Ca/lcasians and 
J IIdill/l slIht:roll/'s 
l First locus 
Caucasian - Hindu 
Caucasian - Moslem 
Caucasian - Telegu 
Caucasian - Tami\ 
Caucasian - North 
Caucasian - South 
Caucasian - Indian 
Caucasian - Bantu 































The reaction p~lt('rns illustrated in Fig. 1 
show how the aIlti-HL- A5 sera may be 
subdivided into groups. We have called 
these groups 5.1, 5.2, 5.3 and 5.4, and 
together they make up HL-A5. Those cells 
which are 5.1 (the first four subjects) 
reacted positively with almost all the HL-
A5 antisera. Those which are 5.2 reacted 
North South Bantu 
33 80 61 19 7 
33.2 28.3 19.4 10.0 23.5 
23.3 61.1 45.1 11.7 3.1 
Table 10 
HL-A. gene frequencies 




















































N. O. = Not observed 



















































positively with most of the antisera except 
the first five sera, which reacted only with 
5.1 cells. 5.3 cells reacted with fewer anti-
sera and 5.4 with fewer still. There were 
no antisera that reacted specifically with 
5.2,5.3 or 5.4, although one serum (N442) 
reacted only with 5.1 + 5.2 + 5.4 and not 
with 5.3, and four sera (Linford, PE 27, 
N564 and N475) reacted only with 5.1. 
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There is no question of the "short" sera 
reacting only with cells homozygous for 
HL-A5 because only three of the 27 cell 
donors did Ilot have another antigen pre-
sent at the second locus. Two of these 
subjects are in group 5.3, with which se-
rum N442 did not react. 
There is, of course, the possibility that 
only the cell donors on the left of Fig. 1 
possess the HL-A5 antigen and that the 
extra reactions are caused by an antigen 
(or antigens), common in Indians but ex-
tremely rare in other populations, cross 
reacting with anti-HL-A5 sera and com-
monly associated with HL-A5 in Indians. 
Fig. 1 and Table 4 also show that 5.4 seems 
to be closely associated with Indians from 
the north of India. It is known that these 
northern populations were subjected to 
successive waves of infiltration of Mon-
goloid races from the northeast. These 
waves did not penetrate to the south of 
India, which is occupied by Dravidian 
races who originated in Western Asia and 
settled in India in prehistoric times. This is 
confirmed by the frequency of the HL-A1 
antigen in the sub-groups investigated 
here. It is ImV('st in the: Hindu population 
which l'llIigr:lt"d to South Africa from the 
northeast of India, slightly higher in Mos-
lems from the northwest and is the same in 
the Caucasians as in the Tamil population 
which emigTated from the southern-most 
part of India. (The Telegu occupy provin-
ces to the North of the Tamils.) The signif-
icance of the differences in antigen frequen-
cy was tested by calculating X2 values for 
each antigen between all possible pairs of 
Indian subgroups. The only value with P 
< 0.01 was that for HL-A2 between Hindu 
and Moslem (X2 = 7.99). Considering the 
total number of comparisons and the small 
number of Moslems tested, this value is not 
significan t. 
If only one antigen was detected at the 
first segregant series the cells were c1as-
sified as, e.g., HL-A3, X,HL--A7, W27. 
Thus 'X' represents an unknown, or more 
precisely, an undetermined antigen be-
cause of the possibility of homozygosity. 
Similarly a 'Y' is used at the second segre-
gant series. The frequencies of cX' and 'V' 
are therefore, to some degree, a measure 
of heterozygosity, because of the Iow fre-
quency of null genes ('0') at each locus. 
The frequency ofcX' at the first segre-
gant series ranges from 33.6 % in Cauca-
sians to 51.5 % in the Hindu population. 
At the second segregant series similar fre-
quencies are observed for cV' except for the 
Telegus where the frequency is only 13.4 
%. The next lowest frequency of cV' is in 
Hindus (38.5 %) and the difference is 
significant (X2 = 6.97; P < 0.05), perhaps 
even more so, considering that the genetic 
distance (f) between Telegu and Hindu at 
the second locus is only 0.0383 (Table 8). 
The difference in the frequency of cV' 
between Telegu and Tamil is highly signif-
icant (X2 = 14.3; P < 0.0005). This im-
plies that there may be a selective advan-
tage to the heterozygote at the second se-
gregant series in .. the Telegu populations. 
We have found (Brain & Hammond, sub-
mitted for publication) a correlation be-
tween heterozygosity at the first segregant 
series and the ability to make Rh anti-
bodies. There may be a correlation be-
tween heterozygosity at the second segre-
gant series and the ability to make anti-
bodies to pathogens which are (or were) 
common in the Telegu provinces of India. 
Haplotype frequencies and delta values 
were calculated from the phenotype data 
for each population. The only significant 
delta values were for the haplotype HL-
A1, W 17 and these are shown in Table 7. 
Singal et a!. (1971) found the frequency 
of this haplotype to be 24/1000 in a study 
of 80 Indians of whom more than half 
(47) were from Northern India. Its delta 
value was not significant and their figures 
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are almost the same as our figures in the 
Hindu population. Ting et a1. (1971) 
found a significant delta value for HL-AI, 
Wl7 in a study of Indians in Singapore. 
In our Caucasian population the delta 
value is greater than the standard error of 
the haplotype frequency. The data col-
lected during the Fifth Workshop (Histo-
compatibility Testing 1972) show an in-
creasing frT(l'lency of the HL-Al, Wl7 
haplotype with increasing distance east of 
Europe. 
If Caucasians and Dravidians have pre-
historic ancestors in common it may be 
interesting to speculate on the high fre-
quency of the W 17 antigen and the HL-
AI, W 17 haplotype in the Tamil and Tele-
gu groups, compared with the frequency 
of HL-A8 and the HL-Al, HL-A8 haplo-
type in Caucasians. There is also a nega-
tive delta value (- 0.0096) for the HL-
AI, HL-A8 haplotype in Indians from the 
south of India. In fact only one individual 
out of 150 possessed both HL-Al and HL-
A8. What selective pressures can there 
have been to favour the HL-Al, W17 
haplotype (and act against HL-AI, HL-
A8) in the Dravidian races? There also 
must have been different selective pressures 
at work in the Caucasian population that 
were advantageous to the HL-Al, HL-A8 
haplotype and did not affect the HL-A 1, 
W I 7 haplotype. 
Table 8 shows t he genetic distances (f) 
between 1111' Indian slIbgroups. The lowest 
values are between Tamil and Telegu from 
the south of India. The genetic distances 
between Caucasians and the other popula-
tions are shown in Table 9. 
The f-values between Caucasians and 
Bantu and between Indians and Bantu are 
lower at the second segregant series than 
at the first segregant series. But the f-
values between Caucasians and the Indian 
sub-groups are greater at the second segre-
gant series than at the first, with the excep-
44 
tion of Hindus, who show the greatest dis-
parity with Caucasians. 
References 
Bodmer, J. G. & Bodmer, W. F. (1970) Studies 
on African pygmies. IV. A comparative study 
of the HL-A polymorphism in the Babinga 
Pygmies and other African and Caucasian 
populations. Amer. ]. hum. Genet. 22, 396-
411. 
H6yum, A. (1968) Separation of leucocytes from 
blood and bone marrow. Scand. ]. clin. Lab. 
Invest. 21, SuppJ. 97. 
Brand, D. L., Ray, ]. G., Hare, D. B., Kayhoe, 
D. E. & McClelland, J. D. (1970) Preliminary 
trials toward standardization of leukocyte 
typing. Histocompatibility Testing 1970, p. 
357-367. Munksgaard, Copenhagen. 
Cavalli-Sforza, L. L. & Bodmer, W. F. (eds.) 
( 1971) T hI] Genetics of Human Populations. 
Freeman, San Fransisco. 
Dausset, ]. & Colombani, 1. (eds.) ( 1972) 
Histocompatibility Testing 1972. Munksgaard, 
Copenhagen. 
Hammond, M. G., Appadoo, B. & Brain, P. 
(1972a) HL-A antigens and antibodies in 
South African Bantu. Transplantation 14, 
159-165. 
Hammond, M. G., Appadoo, B. & Brain, P. 
(1972b) HL-A antigens and antibodies III 
South African Indians. Tissue Antigens 2, 
389-396. 
Mattiuz, P. L., Ihde, D., Piazza, A., CeppeIlini, 
R. & Bodmer W. F. (1970) New approaches 
to the population: Genetic and segregation 
analysis of the HL-A system. Histocompati-
bility Testing 1970, p. 193-205. Munksgaard, 
Copenhagen. .. 
Singal, D. P., Mickey, M. R. & Terasaki, P. I. 
(1971) HL- A typing in Asian Indians. Tissue 
Antigens 1, 286-289. 
Ting, A., Wee, G. B., Simons, M. J. & Morris, 
P. J. (1971) The distribution of HL-A leuko-
cyte antigens in Singapore Chinese, Malays 
and Indians. Tissue Antigens 1, 258-264. 
Address: 
M. G. Hammond 
The Natal Institute of Immunology 
P.O. Box 2356 




HLA ANTIGENS IN SOUTH AFRICAN NEGROES AND INDIANS. ~.G. Hammond, 
8. Appadoo and Peter 8rain. Natal Institute of Immunology, Durban, South 
Africa. 
The Seventh Workshop serum set was tested in Zulu Negroes and Indians (the 
descendants of 19th century immigrants from India) because of the high frequen-
cy in these races of antigens that have been 'split'. At the A locus Aw30 is 
very common in Zulus and the reaction pattern of Aw30 sera shows that this 
antigen is probably heterogeneous although no clearcut split could be defined. 
As in the Sixth Workshop there were no sera recognising Aw3l but Aw32 was 
clearly defined by sera W3l2 and W327. Aw33 was detected only in Indians and 
a possible split is defined by two workshop sera which reacted as 'short' Aw33 
(W33l and W427). Only serum W427 did not react wi th ~HLA AlO cells. 
SeVE:eI ;ll splits can now be defined at the 8 locus. The Seventh Workshop sera 
confirm our earlier subdivision of HLA 85 (M.G. Hammorid et aI, Tissue Antigens 
(1974) 4. 1 2 1, although serum W336 appears to define 85.3 and not 85.2 while 
85.1 is-split into 85.1 and B5.2. HR is not as clear as in the Sixth Workshop 
and the relationship between HR and 85.4 needs clarification. These subdivi-
sions are common in the Indian population but Zulus have only BS.l and HR. 
8w35 was fairly well defined except for two Indians whose cells reacted with 
only some of the Bw35 sera. Nearly all BwS.l, 5.2, 5.3, 5.4 and HR cells were 
4a positive. while Bw35 cells were 4b. 
8w42 was found only in Zulus and was clearly different from 8w22 although some 
sera reacted with cells that were also positive with Bw4l. 
It is clear that Bw40 can be split. Bw40.1 is defined by serum W4S7 but the 
other Bw40 sera showed a very complex reaction pattern which was confined to 
Indians. Further splits cannot be excluded. There were no helpful 4a or 4b 
associations. The question of a split of Bw17 defined with 8wlS sera is not 
clear at all. Only Indians were positive with the short 8wlS sera in the 
workshop set. Eight local sera and one workshop serum (W436) reacted as long 
BwlS sera with five Zulus and four Indians. Four of these local sera were 
positive with a further four Indians and two Zulus. Eleven of these donors 
were also Bw17 and ten of them had another antigen present at the B locus. 
However, six local sera and six workshop sera defining Bwl7 showed no dif-
ferences between these 10 cells and 16 other Bwl7 cells. All Bwl7 cells were 
4a while the short BwlS cells were 4b. 
The first five antigens at the C locus presented no problems. At the Sixth 
Workshop we reported that Cw2 was absent in Indians but we have since found 
that it is present at a low frequency. T7 was present in 42% of Indians and 
35% of Zulus. 
A preliminary analysis of the 8 cell antisera gave the following percentage 
frequencies for the 0 locus antigens. A split of Ow2 was present in Indians. 
Zulu Indian 
Dw2 8 26 
< Dw2 0 10 
Dw3 19 13 
DwS 14 8 
LDID7 11 21 
W8S-W86 11 10 
Owl, Ow4, Ow6 could not be dsf insd • 
45 
Reprinted from tile "S.A . Medical' JOllma/", Vol . 44, 28 Marc" 1970, pages 380·381 
LEUCOCYTE GROUPS IN BABOONS TESTED WITH HUMAN ANTISERA >I< 
M. G. HAMMOND AND p, BRAIN, Natal Institute of Immunology, Durban 
The South African baboon (Papio papio) is a useful animal 
for research in transplantation, and Murphy et aL' have 
already shown that its leucocytes will cross-react with 
human leuco-agglutinating sera. The human antisera used 
in Murphy's study, however, were not characterized by 
leucocyte group, We report here a study of 29 baboons 
tested with 62 leuco-agglutinating sera previously character-
ized in a human panel. 
MATERIAL 
Twenty-nine adult baboons, of which 13 were male, were 
examined. They had been collected in five widely separated 
parts of South Africa and, as far as is known, were un-
related. 
The human antisera were obtained from parous women 
as previously described. They had been characterized by 
x' and sometimes by factor analyses against the leuco-
cytes of panels of Caucasian donors varying in size from 
40 to 188 individuals. A study of some of the sera has been 
previously published" A composite x' map of all these 
results is seen in Fig. I. The antigenic complexes which 
the sera were recognizing were identified in earlier studies 
by the use of reference sera obtained from the National 
Institutes of Health and elsewhere, and many of the sera 
have also been examined by another laboratory. Many 
antisera that fell into positions intermediate between the 
main complexes, and some of unknown specificity, were 
deliberately included in the survey. 
• Dale received: 16 October 1969 
METHODS 
The EDTA agglutination test of Van Rood et al.' was used 
with certain modifications. Red cells were sedimented with 
3 % gelatin in normal saline. Only one drop of antiserum 
was used for each test, and the quantities of the other 
reagents were correspondingly reduced. All tests were read 
by the same worker. 
From the laboratory protocols the results were assembled 
in a 29 x 63 matrix, coding any positive reaction as I, 
negative as 0. An IBM 1130 computer was programmed to 
perform the following analyses: 
1. Compare the reactions of every serum with those of 
x' 
every other, and print out x' and r. (r == ..; - ) 
29 
2. Compare the pattern of reactions of each individual 
baboon with that of every other, and perform a x' analysis 
as above. 
RESULTS 
Fig. I shows the x' associations of the sera in the human 
and Fig. 2 in the baboon panel. Each serum is represented 
by a circle of diameter proportional to the frequency with 
which it reacts. The unbroken lines between circles repre-
sent positive associations with x' such that r>0'5 (thick 
lines) or >0'32 (thinner lines). Negative associations with 
r < 0'20 are shown by dotted lines. 
Table I shows the percentage frequencies with which the 
sera react in humans and baboons and the antigenic 
clusters to which the sera correspond in the human panel. 
380 
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TABLE I. SPECIFlCITY OF ANTISERA. AND FREQUENCIES OF 
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Mean of all frequencies in man 52'7% 










































































































group detected by agglutination tests with these sera differs 
from the HL-A 8 group detected by cytotoxic tests. Studies of 
baboon leucocyte groups using cytotoxic sera of human origin 
would be interesting, and we hope to undertake them. 
SUMMARY 
The leucocytes of 29 South African baboons (Papio papio) were 
tested with 62 EDTA agglutinating human antisera, mostly of 
known specificity against human leucocytes. All these sera 
reacted with the cells of some baboons. Before it can be 
assumed that baboons have the equivalent of human white 
cell groups, however, it must be si1nwn that the same sera that 
identify an antigenic complex in man are associated to form 
a complex in baboons also. This was found to be so only with 
some of the anti-7c (HL-A 7) sera. There was no evidence of 
the equivalent of a human 4a or 4b group in the baboons 
tested, but the X' map showed several antigenic complexes 
that do not appear to be related to human groups and may 
represent groups peculiar to the baboon. It is concluded that 









































































the South African baboons tested have a leucocyte group that 
is related to the human 7c group, but no groups related to the 
human 4a or 4b groups. 
We wish to thank Prof. J. V. O . Reid of the Department of 
Physiology, University of Natal, and the proprietors of the 
Natal Lion Park for permission to take blood from baboons in 
their possession; and Mr G. L. Webb for the computer pro-
gramme. 
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Fig. 1. X' associations of sera tested against human 
leucocytes. 
In Table II the data on the sera making ur the antigenic 
clusters in baboons are summarized for convenience. 
The x' map of the comparisons between individual 
baboons showed only one complex of 19 positively asso-
ciated individuals. It is not reproduced here. 
DISCUSSION 
If a human antiserum that detects an antigen, say 8a, in 
man is tested in baboons it may well react with the cells 
of some individuals. This does not mean, however, that 
these individual baboons possess the equivalent of the 8a 
antigen. For this to be so, we must find that the same 
sera that fall into the anti-8a cluster in the human x' map 
are associated in an equivalent cluster in the baboon 
analysis. Even in different human popula tions, for example 
in Caucasians and Bantu, it has been found '" that a serum 
that identifies a certain factor in one population does not 
necessarily do so in another. Tt would thus be surprising 
if there was much similarity between the leucocyte groups 
of human beings and baboons, and this study in fact 
shows that there is little. 
The X' map of the baboon tests does show however a 
number of clusters, of which only the central o~e compo;ed 
of sera 10, 19, 40, 113, 124 and 145 is well defined. 
[he x' map shows that all the clusters are in fact sub · 
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Fig. 2. Xl associations of sera with baboon leucocytes. 
groups of one major cluster, and it is interesting to note 
from Table II that almost all the sera composing them 
have anti-7c or anti-7d affiliations in the human panel. In 
the tight central cluster of the baboon analysis most of 
the sera fall into the anti-7c group in human subjects. This 
strongly suggests that baboons have a leucocyte group 
that somewhat resembles 7c (HL-A7). The other clusters 
seen in the baboon Xl map may represent antigenic com· 
plexes that have no homologues in man. It appears un-
likely that the baboons tested have anything equivalent to 
the human 4a or 4b complexes. We can say nothing about 
the 8a complex since only one pure anti-8a serum, from an 
impeccable source, was included in the study. It worked 
very well in the human panel but did not react with the 
cells of the baboons at all. 
Further studies of baboon leucocyte groups would be of 
great theoretical interest, but should be carried out with 
sera derived from parous or transplanted baboons rather 
than from human subjects. After some well-defined groups 
have been detected in this way we may be able to investi-
gate further their relationship to the leucocyte groups of 
man. If methods of immunosuppression improve enough in 
the futur~ to ~ake baboon-to-man transplants practicable, 
such studies wIll be of great practical importance. 
ADDENDUM 
The results with our anti-7d sera shOUld be accepted with 
reserve. since we have subsequently ' shown that the human 
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Leukocyte Antigens of Baboons 
By H. J. Downing, P. Brain, M. G. Hammond, G. H. Vos, and G. R. Webb 
THE BABOON IS BEING USED in large 
numbers for transplant programs and it is 
therefore desirable to be able to identify its 
tissue antigens. It has been shown that the 
leukocytes of baboons will react with hu-
man leukoagglutinating sera. l Using 26 
sera, Murphy et al. found that the greater 
the number of differences in the leukocyte 
antigens between the donor and the recip-
ient of a skin graft, the shorter was the 
period of survival of the graft. This sug-
gested that these human antisera were rec-
ognizing tissue antigens of the baboon. This 
was supported by their observation that 
homogenates of baboon kidneys reacted 
with the same antisera as did the leukocytes 
from the same baboon. Unfortunately, how-
ever, the sera used had not been previously 
characterized in man. Even if a serum had 
been characterized in one species it is diffi-
cult to apply it to another species. For ex-
ample, if a human antiserum that detects an 
antigen, say, HL-A2, in man, reacts with 
the leukocytes of some baboons, it does not 
necessarily mean that these individual ba-
boons posses the equi va lent of the HL-A2 
antigen. Even in different human popula-
tions it has been found that a serum that 
identifies a certain antigenic complex in one 
of these populations does not necessarily do 
so in the other.2•3 An illustration of this is 
the serum Willett which has been described 
as having an agglutinin activity that corres-
ponds exactly with its cytotoxicity activity.4 
This is certainly true for a white popula-
tion, but it is not the case for Indians and 
blacks where the agreement between the 
two tests falls to 20%. Similarly, two sera 
that give a close correlation in a white pop-
ulation need not necessarily correlate with 
From the Natal Institute ot lml11lHlotogy and 
tIle University of Natal, Durban, South Africa. 
one another when tested in another popula-
tion. In a white' population the two sera 
WiIlett and 571 gave a close agreement 
with a x2 of 27.7, while in a black popula-
tion there was very little association be-
tween these sera, and the x2 was reduced to 
2.2. The reason for this is that many sera 
thought to be monospeciffc contain second 
antibodies against determinants that are 
very rare in one race but common in an-
other, and this is far from being a rare 
occurrence. In a survey of white, Indian, 
and black populations, Brain and Ham-
mond3 found that although many leukocyte 
antisera appeared in the same tightly as-
sociated groups in all three populations, 
other sera closely associated in one race 
group were not associated in one of the 
other race groups. Where the same groups 
of closely associated sera are found in all 
three populations, it can be concluded that 
each of these groups of sera identifies a 
complex of antigenic factors frequently in-
herited in association.5 
On the basis of thi9 principle, human 
leukoagglutinating sera were used to study 
the leukocyte groups of baboons.6 The re-
sults are illustrated in Fig. 1. The numbers 
are the reference number of the sera, the 
diameter of the circles represent the num-
ber of positive tests expressed as a percent-
age of the total, and the thickness of the 
lines represents the degree of association as 
measured by the x2 test. This method of 
drawing maps was first used by Oausset. 
There is little resemblance between the x2 
maps for the two species except for one 
cluster of sera that detect HL-A7 in man 
and form a corresponding cluster in ba-
boons. This strongly suggests that baboons 
have a leukocyte antigen that resembles 
HL-A7, but as this study did not reveal any 
other antigen shared by humans and ba-
Transplantation Proceedings, Vo!. IV, No. 1 (March), 1972 
49 





POSITIVE ASSOCIATIONS: - r ~ 0·50 r> 0·32 
Fig. 1. Relations of 13 sera in man and baboon recognizing 7c complex in man. 
boons, an attempt was made to develop 
isoantibodies in baboons. 
Baboons were immunized by skin grafts7 
followed by s.c. booster injections of leuko-
cytes in Freund"; adjuvant. Ten days later, 
samples of blood were taken from the 16 
baboons concerned and the sera tested by 
cytotoxicity against a panel of baboon 
lymphocytes stored in liquid nitrogen. Of 
the 16 baboons, 15 gave positive results 
and were plasmapheresed to give bulk sup-
plies of plasma. The remaining baboon was 
given a further injection of lymphocytes 
but again failed to develop antibodies. The 
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results of the cytotoxicity tests between the 
15 sera and the lymphocytes from 45 
baboons were analyzed by a computer and 
the x2 relationships between sera and be-
tween cells determined. The x2 values for 
the sera are shown in Fig. 2. Sera C7 and 
B8 are from baboons immunized by tissues 
from the same donor E3 and show a high 
degree of association. Although baboons 
A3 and E5 were immunized by donor C3, 
the sera from these ' baboons are not as-
sociated. Serum E5, however, is related to 
C7 which is also related to serum TII. Tis-
sues from baboon 7 were used to immunize 
five baboons, and the sera from these ba-
boons fall into two unrelated groups. Serum 
T8 is associated with sera TI3 and TII, 
thus forming a group of six sera as shown 















two baboons, T2 and T7, that received tis-
sues from baboon 7 are associated with one 
another but belong to a separate group of 
4 sera (T2, T7, 28, and C6) as shown at 
right of Fig. 2. Outside these two groups of 
sera are four other sera (plus one serum not 
shown in Fig. 2) that are not related to any 
other serum. 
Absorption studies have not been per-
formed on any of these sera as the sera were 
produced by random immunizations and 
are unlikely to be mono specific. Instead, 
the sera have been used to compare the 
lymphocytes from the various baboons in 
our colony. From the analysis of these re-
sults, six pairs of baboons have been se-
lected and are shown in Table 1. The two 
baboons in the first pair gave identical re-
















the other pairs differ from one another with 
respect to only one serum. 
The next stage of the immunization pro-
gram will be to exchange skin grafts be-
tween the members of each pair in an 
endeavour to produce more specific sera. 
These sera will be tested by absorption to 
see if any of them are monospecific. This 
work is being performed in one species of 
baboon, Papio ursinus, and it would be of 
interest to test these sera in other species of 
baboon. For this reason we hope to col-
DOWNING ET Al. 
Iaborate with other laboratories working in 
this field, especially Dr. Barnes and his 
colleagues at the University of Birmingham. 
They have already tested our first batch 
of sera. 
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An Antigen Resembling HL-A 7 on the Leukocytes 
of Vervet Monkeys I 
H.]. DOWNING, A. CRITlCOS, L.E. BURGERS and M.G. HAMMOND 
Natal Institute of Immunology and Department of Biological Sciences. University of 
Natal, Durban 
Key Words. Leukocyte antigens· Vervet monkeys· Tissue typing· HL-A 
Ahslracl. Human leukocyte typing sera of known specificities were used to test the 
leukocyte antigens of vervet monkeys. The results suggest that these leukocytes contained 
°an antigen resembling the HL-A7 antigen of human leukocytes. This is similar to a pre-
vious observation with leukocytes from baboons. These findings are consistent with the 
suggestion that the 4a/4b complex is the precursor substance from which the other 
specificities have evolved. 
There have been numerous reports in which isoimmune typing sera devel-
oped in one species of primate have been used to study platelet and leuko-
cyte antigens of other species. Human sera have been used to investigate 
the platelet antigens of the chimpanzee, gibbon, orangutan, baboon, rhesus 
monkey and African green monkey [19]. Other investigators [3-5, 14] have 
lI ,;cd hllm:1I1 sera to test the leukocyte antigens of chimpanzees. In the re-
verse situation, sera developed in chimpanzees, by immunization with cells 
from other chimpanzees or human beings, have been used to test human 
leukocyte antigens [3-5, 14, 18, 19]. 
H 1I11lan typing sera have also been used to study the leukocyte antigens 
of baboons by means of the agglutination technique [8, 15, 16] and the 
cytotoxicity test [9]. Human typing sera of specificities anti-4a and anti-4b 
were used to test the leukocytes of rhesus monkeys by the absorption tech-
nique [6]. 
1 Supported by a grant from the South African Medical Research Council to H.J.D. 
and from the CSIR to A.C. 
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We describe here an investigation in which human typing sera were used 
to test the leukocytes of vervet monkeys by the cytotoxicity test. In such 
studies, however, where sera that have been developed in one ,pecies have 
been used to test leukocytes of another species, the results have to be inter-
preted with caution [3]. Even within a species, a serum that gives a reliable 
result ill one population will not necessarily do so in another [8, 10]. For 
this reason we have chosen a number of human sera for each specificity and 
have analysed the results to see if those sera that show a close relationship 
when used to test human leukocytes also show a similar correlation when 
used to test the leukocytes of vervet monkeys. This can be best seen from 
a diagram showing the relationships between the sera. Sera that cluster to-
gether when used to test human leukocytes show a similar cluster when they 
are used to test the leukocytes of monkeys. 
Materials and Methods 
Species. The vervet mo~key (Cercopithecus pygerythrus Cuvier) is a species belonging 
to the superspecies C. aetlriops of which the superspecific type species is the grivet monkey. 
Hill (13) recognises 13 subspecies of C. pygerytlrrus. No attempt, however, has been made 
in this paper to classify beyond species although the geographical distribution suggests 
that the specimens concerned were of the subspecies C. pygerythl'lls. The 80 individuals 
tested were housed at the NIl Primate Centre, and had been collected from Natal and 
Northern Transvaal. 
Anaesthetics. The monkeys were anaesthetized by intramuscular injection of ketamine 
hydrochloride ('Ketalar', Parke-Davis, Detroit, Mich.) at a dose of J 5 mg/kg body mass. 
Blood samples, 5 ml, were collected from the femoral vein and defibrinated. 
Cytotoxicity test. The Iymphocytes were obtained by density gradient separation using 
ficoll-hypaque. The test was a modification of the microcytotoxicity test of SINGAL et al. 
[20) in that trypan blue was used instead of eosin to eliminate the need for phase contrast 
optics. The spccificitics, and the number of sera for each, are shown in table J. 
Analysis 0/ results. The results were analysed at the Computer Centre of the University 
of Natal using a program designed by G.R. WEBB to calculate Xl between each pair of 
sera in turn [11]. 
Results 
Only associations between sera where the X2 was equal to or greater than 
30 have been considered. These results have been summarized in table II and 
have been represented diagrammatically in figure I where the strength of the 





Fig. 1. Associations between human leukocyte-typing sera when tested with leukocytes 
from vervet monkeys. Diameter of circle represents percentage of positive results. Thick-
ness of line represents strength of association. Numbers are the identification numbers of 
the sera. 
pairs of sera. The percentage of positive results is indicated by the size of 
the circle representing each serum. 
As there were 80 sera tested and compared with each other, there were 
3,160 pairs of sera, but of these pairs only 24 had X 2 values equal to or 
greater than 30 (table If). These 24 pairs were made up from only) 6 of the 
ori.L!inal 80 sera (fig. I). The specificities of these sera were 4 HL-A7 + 
W 22, 3 H L-A 7, 2 H L-A 12 and one of each of HL-A 1, HL-A2, HL-A3, 
HL-A5, I-I L-A 13, H L-A17, and WlS. When this list is compared with the 
number of sera of each specificity (table I), it can be seen that of the five 
sera with speciflcities HL-A 7 + W22 there are four that show relationships 
with other sera. Similarly, of all four HL-A 7 sera, three are associated 
with other sera. Of these seven sera, one (No. 24) is associated with an 
H L-A 1 serum (No. 3) while the remaining six are related to one another 
and to six other sera as shown in figure 1. The specificity that occurs most 
frequently in this cluster of sera is therefore HL-A 7, and only the sera of 
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TaMe I. The specificities and number or sera ror each speciflcity 




HL-A3 + HL-AII 1 
HL-AS 6 
HL-A7 4 
HL-A7 + W22 S 
HL-All 2 
IIL-!\') 6 




HL-AI] f- WIO 2 
HL-AI4 2 






anti-H L-A 7 specificity, with and without anti-W22, show any tendency to 
cluster among themselves as they do if tested with human Iymphocytes. 
Discussion 
The cluster of sera with H L-A 7 specificity that has been observed when 
human typing sera were used to test the leukocytes of vervet monkeys is 
similar to the earlier ohservation when a panel of human sera was used to 
test baboon leukocytes [12]. In this earlier paper the sera were associated 
in one major cluster that had some su bclusters. I n the tight cen tral cl uster 
that was formed when the baboon cells were tested, most of the sera be-
longed to the anti-7c (anli-H L-A 7) group when tested with human leuko-
cytes. This strongly suggested that baboons have a leukocyte group that 
somewhat resembles H L-A 7. The results of the present investigation, which 
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Table 11. Comparison of results obtained between pairs of human cytotoxic sera when 
tested with leukocytes of vervet monkeys 
Serum I Serum 2 Results Xl 
No. speci lici ty No. specificity -+ +- ++ 
3 HL-AI 24 HL-A7 72 3 0 5 48.00 
45 HL-AI3 68 7 0 5 30.22 
!) HL-A2 29 HL-A7 + W22 40 9 5 25 32.04 
12 HL-A3 19 HL-A5 42 3 10 25 36.30 
19 HL-A5 23 HL-A7 48 4 7 21 38.38 
25 HL-A7 + W22 49 3 10 18 32.19 
26 HL-A7 + W22 49 3 7 21 41.54 
29 HL-A7 + W22 42 10 3 25 36.30 
21 HL-A7 25 HL-A7 + W22 48 3 11 18 30.15 
23 HL-A7 25 HL-A7 + W22 52 3 7 18 39.31 
26 HL-A7 + W22 49 6 7 18 30.55 
25 HL-A7 + W22 26 HL-A7 + W22 53 6 3 18 42.09 
28 HL-A7 + W22 57 2 4 17 51.45 
29 HL-A7 + W22 44 15 20 30.67 
42 HL-AI2 44 15 20 30.67 
44 HL-AI2 56 3 8 J3 31.25 
49 HL-AI7 56 3 5 15 41.50 
58 W15 54 5 6 15 32.74 
26 HL-A7 + W22 28 HL-A7 + W22 53 3 8 16 34.87 
29 HL-A7 + W22 43 J3 2 22 31.99 
28 HL-A7 + W22 29 HL-A7 + W22 45 16 0 19 32.04 
42 HL-AI2 45 16 0 19 32.04 
49 . HL-AI7 56 5 5 13 32.38 
29 HL-A7 + W22 49 HL-Al7 45 0 16 18 30.85 
lI sed cytotoxicity rather than agglutination, suggest that this is also the 
si tuation '.vith vervet monkeys. 
These two sets of observations, in which human H L-A 7 sera react with 
the cells of baboons and vervet monkeys. are similar to the findings of 
BALNI:R e/ al. [3]. These investigators found that certain of their chimpanzee 
sera (group 3) showed 7c- or H L-A 7-like reactivity. They postulated that these 
sera might have a specificity related to AA (or W22) which is known to 
cross-react with HL-A 7 antigens when used with human cells. Our findings 
in which the W22 specificity was associated with four of the six HL-A 7 sera 
in the cluster are consistent with BALNER'S suggestion. 
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Further evidence that there are cross-reactions is offered by our obser-
vations that not all our H L-A 7 were associated when tested with leukocytes 
of vervet monkeys. Although six of the sera were associated, three (No. 22, 
24 and 27) were not. Furthermore, six of the sera (No. 23, 24, 25, 26, 28, 29) 
were each found to be associated with at least one serum of another speci-
ficity. The antigens on the leukocytes of the vervet monkey are therefore 
dilTerent from the human H L-A 7 antigen which they resemble. This is similar 
to the situation with the chimpanzee where BALNER et al. [4] have used human 
cells to absorb chimpanzee sera and have shown that there are dilTerences 
hetweC'1l the H L-A 7 antigens on human leukocytes and their apparent coun-
ter-paIL 011 chimpanzee leukocytes. BALNER et al. concluded therefore that the 
'7c' on the chimpanzee cells consists of an additional specificity, or that the 
7c (chimp) and 7c (human) have dilTerent configurations but are cross-
reactive. 
BALNER [I] has also identified antigens on rhesus leukocytes that may well 
be the counterparts of the human 4a and 4b antigens. 
These observations have led to the suggestion [2, 3, 17] that the basic 
substances from which the other antigens evolved are the 4a/4b antigens. As 
this complex is closely related to the seven series of antigens, our findings 
concerning the HL-A 7 antigen in vervet monkeys are consistent with the 
suggestion that the 4a/4b antigens are the precursor substances from which 
the other specificities have evolved. 
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Frequency of HL-A Antigens in South African 
Bantu, Indians and Caucasians 
P. BRAIN & M. G. HAMMOND 
The Natal Institute of Immunology, 149 Prince Street, Durban, South Africa 
Description of the Populations 
There are three distinct race groups in Dur-
ban: Caucasian, Bantu and Indian. 
The Caucasian population is of Western 
European origin. Bantu are mostly of the 
Zulu tribe. Indians are the descendants of 
immigrants who arrived about a century 
ago, mostly from the Madras Presidency. 
The Indians in Durban can be subdivided 
according to language, by their names; the 
proportions are approximately: Tamil 36, 
Hindi 28, Telegu 15, Other 21 (including 
those with Muslim names). The series tested 
here, however, was not classified in this 
way. 
The three races are about equally repre-
sented in the population of Durban (about 
650,000). There is a small Coloured (mixed 
Caucasian and Bantu) population that was 
not studied. 
The Bantu and Indian populations of the 
city maintain a Western way of life with 
little or no mixture between the races. 
Materials and Methods 
One hundred and fifty unrelated individuals 
of each race were tested for the antigens 
listed in Table 1. 
Lymphocytes were isolated by the method 
of Boyum (1968) and the cytotoxicity test 
was performed in Falcon microtest trays 
Supported by a grant from the South African 
Medical Research Council (P. B.) 
After the Vth International Histocompatibility 
Conference the WHO Committee on HL-A 
Nomenclature agreed on the following equiv-
alents: Te 63 = W 29; Te 66 = W 30 + W 31. 
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using the two-stage procedure recommended 
by the N. 1. H. 
Sera were obtained from the N. 1. H. bank 
and elsewhere and used in parallel with sera 
obtained from the screening of over 50,000 
parous women and standardised in this 
laboratory. In an intensive search for anti-
sera that might detect new antigens in the 
Bantu and Indian populations, samples were 
taken from 1,000 parous women of each 
race and tested against the lymphocytes of 
at least 40 random donors of the same race. 
Table I shows the number of sera used to 
detect each antigen, and th~ir origins. 
Results 
Table 11 shows the frequencies of the vari-
ous antigens in the three population groups. 
Table III shows the gene frequencies in the 
three population groups. Figure 1 illustrates 
the reaction pattern of HL-A 7 and HL-A 7 
+ W 22 antisera with 50 Bantu and Figure 
2 with 150 Bantu. Figure 3 shows the reac-
tion pattern of sera with, or included in, 
HL-A 12 in 150 Bantu. Figure 4 illustrates 
the reaction pattern of sera included in 
HL-A 11 and Figure 5 that of sera associ-
ated with the HL-A 5, W 5 complex. Table 
IV shows the phenotype frequencies of other 
polymorphisms. 
Discussion 
Our earlier studies on the Bantu showed 
many individuals who had no detectable an-
tigens at the first locus. When we obtained 
sera against Te 63 and Te 66, however, we 
found that these specificities accounted fQr 
62 
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most of the blanks. Both have a far higher 
incidence in the Bantu than in the other 
races, and the difference in incidence, here 
and with other sera, between Bantu and 
Indians shows clearly that the population 
groups are, for practical purposes, unmixed 
with each other. 
The Bantu are otherwise distinguished by 
low frequencies of HL-A 1, 11, 5 and 7 and 
high frequencies of HL-A 10, W 22 and 
W 17. The Indians are remarkable for low 
frequencies of W 19, Te 63 and Te 66 (lower 
than in Caucasians); HL-A 8 and W 14; and 
for high frequencies of HL-A 11, HL-A 9, 
HL-A 5 and W 10. The Indians, unlike other 
non-Caucasian populations, have a fre-
quency of 22 % for HL-A 1 but this may be 
the result of a common Indo-European an-
cestry. 
In an earlier published study (Hammond 
& Brain 1971) we said that the frequency of 
HL·A IN THREE RACES OF SOUTH AFRICA 
HL-A 7 in the Bantu was about 28 %. We 
did not then realise that many of our sera 
contained antibodies for both HL-A 7 and 
W 22. Figure 1 illustrates the reaction pat-
tern obtained with these sera in the first 
panel of 50 Bantu. Six sera including 
N. I. H. serum D 66-15903 and Te 5691.1, 
gave identical reaction patterns and all have 
been previously characterised as anti-
HL-A 7. They reacted with only 4 out of 50 
donors. Four sera gave identical reactions 
to K-N8498 from Kissmeyer-Nielsen which 
is anti-HL-A 7 + W 22 and were positive 
with 22 out of 50 donors. Another 11 sera 
including Te 3186.0 (HL-A 7 + W 22) all 
had a coefficient of correlation (r = VX2/N) 
greater than 0.87 with K-N 8498. Eight 
sera appear to identify W 22 with some 
variations. 
We then tested a further 100 Bantu using 
two anti-HL-A 7 sera and two anti-HL-A 7 
TABLE I 




















































N.I.H. N. I. H. Tray Total 
Serum Bank N621 
1 3 13 
1 3 18 
3 3 9 
3 2 7 
1 4 9 
1 3 5 
3 2 9 
2 2 5 
0 2 3 
1 2 2 
2 3 11 
1 3 7 
2 4 15 
1 1 5 
4 3 11 
1 3 7 
0 3 14 
2 2 8 
0 2 5 
1 3 9 
1 3 7 
1 0 2 
32 56 182 
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TABLE Il TABLE III 
Percentage frequency of antigens in Caucasians, HL-A gene frequencies in Caucasians, Bantu 
Bantu and Indians and I ~dians 
Antigen Caucasian Bantu Indian Gene Caucasian Bantu Indian 
HL-A 1 26 5 22 HL-A1 .140 .025 .117 
HL-A2 52 20 31 HL-A2 .307 .106 .169 
W28 7 19 15 W28 .036 .100 .078 
HL-A3 33 12 15 HL-A3 .182 .062 .078 
HL-A 11 12 0 32 HL-A 11 .062 .000 .175 
HL-A9 14 17 27 HL-A9 .073 .089 .146 
HL-A 10 9 23 7 HL-A 10 .047 .123 .036 
W19 11 17 3 W19 .057 .089 .015 
Te63 6 13 1 Te63 .031 .067 .005 
Te66 5 31 2 Te66 .025 .169 .010 
HL-A5 10 4 42 HL-A5 .051 .020 .239 
W5 19 9 27 W5 .100 .047 .146 
W15 18 16 16 W15 .100 .084 .084 
HL-A 7 27 11 14 HL-A7 .146 .057 .073 
W27 9 3 3 W27 .047 .015 .015 
W22 3 34 5 W22 .015 .188 .025 
HL-A8 21 13 6 HL-A8 .111 .067 .031 
W14 5 7 1 W14 .025 .036 .005 
HL-A 12 31 22 11 HL-A 12 .169 .117 .057 
HL-A 13 9 5 8 HL-A 13 .046 .025 .041 
WlO 15 5 19 W10 .078 .025 .100 
W17 6 29 21 W17 .031 .157 .111 
i. :. , 
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REACTIONS OF. HL A 7 
RELATED SERA IN THE BANTU 
Fig. 2. Reaction pattern 0/ HL-A 7 alld HL-A 7 
+ W 22 antisera with 150 Balltu. 
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+ W 22 sera and 12 sera that showed as-
sociations with this complex. Figure 2 shows 
the overall pattern of reactions of these sera 
with 150 Bantu. Two sera, B 155 and B 652, 
showed some agreement and appeared to 
recognise W 22 only. Three cell donors ap-
pear to possess both HL-A 7 and W 22. It 
is clear that this complex must consist of 
more than two or even three antigens. Kiss-
meyer-Nielsen (personal communication) 
has found that the antigen AA (W 22) can 
be subdivided into two categories which he 
calls AA* and AA-AJ. 
When we tested these same sera with 150 
Caucasians we found only 3 % positive for 
W 22 and 27 % for HL-A 7. This makes it 
extremely difficult to differentiate this com-
plex by testing the Caucasian population; 
but, as we have shown here, the Bantu pop-
ulation has a high frequency of these anti-
gens and this will make further investiga-
tions easier. 
Figure 3 shows the reactiori pattern of 
sera associated with or included in HL-A 12 
in 150 Bantu. It appears that HL-A 12 is a 
heterogeneous antigen which can be sub-
divided into at ieast two parts. The sera on 
the left apparently recognise the shortened 
HL-A 12 and those on the right the short 
HL-A 12 plus another component. Three 
sera seem to react only with this new an-
tigen or part of it. Svejgaard et al. (1970 a, 
b) have described an antigen EL * which is 
defined by an antiserum that reacts with 
HL-A 12 c~lls and with cells that are EL * 
positive. However, the variation in the Bantu 
appears to be within HL-A 12 because sera 
that have given identical patterns of reac-
tion in Caucasians show differences in the 
Bantu, Serum N 320 has only 10 positive 
reactions. This is not a weak serum that 
reacts only with those cells that are homo-
zygous for HL-A 12, because two of the cell 
donors have another antigen present at the 
second locus. Colombani et al. (1971) has 
recently described a subdivision of HL-A 12 
into HL-A 12' and HL-A 12" and this may 
explain the differences in the Bantu. 
Several interesting points have emerged 
from the studies of the Indian population 
with sera obtained from Indians. There 
were 57 sera reacting with the cells of less 
than 10 % of the population, that showed 
BRAIN & HAMMOND 
Fig. 3. Reaction pattern of sera associ-
ated with HL-A 12 in 150 Bantu. REACTIONS OF HL A 12 SERA IN THE BANTU 
HL_A3F~ ~9i ~~g:~. c=\tjI.~ HL-All N597 ____ • _ 
A23 _ •• 
A25 • •• 
A 289 - - • 
HL- All IN S. A. INDIANS 
Fig. 4. Reaction pattern of sera included in HL-A 11 in 150 Indians. 
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Hl,-A5 AND W51N S. A.INDIANS 
Fig. 5. Reaction pattern of sera associated with HL-A 5 and W 5 in 150 Indians. 
no correlation with any of the known an-
tigens, nor were their reactions included in 
those of any known antigens. It does not 
seem possible that they are all recognising 
specific HL-A antigens or .combinations of 
rare ones, and one explanation is that they 
may be recognising HL-B antigens, as de-
TABLE IV 
Phenotype frequencies of other polymorphisms 
in Caucasians, Bantu and Indians 
Caucasian Bantu Indian 
A 37.2 29.7 21.0 
B 11.3 19.0 32.3 
0 47.9 44.1 37.1 
AB 3.6 4.4 8.9 
Weak A 0.0 1.8 0.2 
Weak AB 0.0 0.9 0.5 
Rh+ 85.5 96.4 95.2 
Rh- 14.5 3.6 4.8 
Le (a+b-) 17.2 24.0 27.1 
Le (a-b+) 76.8 55.9 61.4 
Le (a-b-) 6.0 20.1 11.4 
MMS 21.3 8.1 21.4 
MsMs 11.1 16.1 14.3 
MNS 24.8 12.9 34.5 
MsNs 23.9 33.9 19.0 · 
NNS 5.2 9.7 7.1 
NsNs 13.7 19.4 3.6 
p+ 78.2 93.5 69.7 
p- 21.8 6.5 30.3 
K+ 9.3 0.0 2.2 
K- 90.7 100.0 97.8 
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scribed by Singal et al. (1970), although they 
found HL-B antibodies primarily as extra 
antibodies in HL-A antisera. The analysis of 
1,004 sera from Bantu women showed 59 
sera that had no correlation with known an-
tigens. 
The Indian population has a higher fre-
quency of HL-A 11 than either Caucasians 
or Bantu, but the sera we used were signifi-
cantly different. Serum N 597 contains anti-
bodies to HL-A 3 and HL-A 11 and when 
characterised in Caucasians there were no 
positive reactions outside these two speci-
ficities. In the Indians this serum has a fre-
quency of 42 %, of which 32 % appeared to 
be HL~A 11. Three antisera obtained from 
Indian women gave a reaction pattern which 
was included in HL-A 11 but they had no 
significant correlation with each other. This 
is shown in Figure 4. 
The most interesting results, however, are 
those concerning the antisera recognising 
HL-A 5 and W 5. The relatively high fre-
quency of these antigens in the Indian pop-
ulation emphasises variations in reaction 
patterns of the different sera. Figure 5 
shows the reaction pattern of several sera 
that show associations with this complex. 
It seems that there may be more factors in-
volved than the three described in the 1970 
workshop data, viz. HL-A 5, W 5 and W 18. 
N 310 and AGST appear to be operationally 
monospecific anti-HL-A 5 sera in Cauca-
sians and in the Indian series they agree 
vcry \vell. V 52 is also a good anti-HL-A 5 
serum in Caucasians but in Indians V 52 
BRAIN & HAMMOND 
reacts with only 26 of the 42 HL-A 5 cells. 
Serum D 66-6222 from the N. 1. H. is also 
a good HL-A 5 reagent in Caucasians but 
reacts with only 15 of the cells that are 
positive with V 52. Three other sera (PE 27, 
S 152 and N 442) also have patterns that are 
included in HL-A 5, W 5 and W 18. 
We have previously shown (Hammond & 
Brain 1971) that an antiserum that is ap-
parently mQnospecific when characterised in 
Caucasians may give very different results 
if tested in another population, and this has 
been the experience of other workers also. 
For the purely practical purposes of tissue 
typing in South Africa, therefore, it is ne-
cessary that every serum used should be 
characterised and found suitable in each 
population group. The work we have put 
into this has produced quite a lot of inform-
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HL-A Antigens in Bantu and Indians 
M. G. Hammond, B. Appadoo and P. Brain 
The Natal Institute of Immunology 
Durban, South Africa 
This Investigation served a dual purpose. The workshop sera were us~d to type 
unrelated individuals from each race to determine the antigen and gene frequencies 
of each population . At the same time 'difficult' antigens could be studied because 
the Bantu and Indian populations have high frequencies of these antigens. 
Materials and Me thod s 
The Indians of Natal are the descendants of immigrants who arrived about a century 
ago to work on the sugar plantations. They can be grouped firstly into Tamil and 
Telegu speakers from Southern Indian , both Hindu by rei igion but subd i vided here 
by language; and secondly into two groups from the north, Hindus from the north-
east and Moslems from the north-west. In this study fifty unrelated Tamil and 
fifty unrelated Telegu speakers as well as one hundred Bantu, all of the Zulu 
tribe, were tested. 
The workshop sera were tested in parallel with our ovm battery of 180 selected 
typing sera. Lymphocytes were isolated by the method of Boyum (1968) and the 
cytotoxicity test was performed, in Falcon mictrotest trays using the N. I .H. 
technique'stipulated for the workshop. 
Results and Discussion 
Table I 5 hm ,., " ",~ .lr lli gcn f p.: que nc ies at the SO I loc us . The division of HL-A9 
into 1.,123 and '.12', \'ia S well de fined. The Bantu are predominantly 1.,123 while nearly 
all the Indians a re 1.,124 . 
TABLE I 
SO antigen frequencies in % 
Antigen Tami I Telegu Indian Bantu 
HL-AI 32 42 37 6 
MO " 0 0 0 I 
HI-A2 20 36 28 18 
1.,128 18 12 15 19 
HL-A3 ,12 6 9 12 
HL -A II 34 28 31 I 
1.,123 0 2 1 18 
w24 36 14 25 4 
1.,125 2 0 I 9 
1.,126 8 6 7 13 
W29 0 0 0 16 
W30 6 8 7 39 
1.,131 0 2 I 13 
1.,132 6 2 4 2 
1.,119 . 6 8 10 9 0 
WI9 NEW 0 0 0 8 
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TABLE 11 
SO 2 antigen frequencies in t 
Antigen Tarn i 1 Telegu Indian Bantu 
HL-A5 . 1 14 24 19 3 
HL-A5.2 12 8 10 0 
HL-A5.3 6 2 4 0 
HR 4 6 5 3 
1,,15 16 22 19 4 
1,,118 4 4 4 6 
1,,115 6 4 5 2 
1,116 2 4 3 4 
W21 0 0 0 1 
HL-A7 18 16 17 14 
1,,122 0 0 0 0 
MWA 0 0 0 35 
W27 0 0 0 0 
401'" 0 0 0 1 
HL-A8 6 6 6 13 
HL-AI4 0 0 0 4 
HL-AI2 14 4 9 14 
TT 0 0 0 8 
HL-AI3 4 8 6 8 
WIO.1 20 18 19 0 
WIO.2 14 20 17 0 
Sabe I I 0 0 0 I 
Oa34 2 0 1 0 
Oa35 2 0 I I 
TY 10 2 6 0 
HS 0 0 0 0 
1,,117 28 32 30 39 
The components of \.119 were more difficult to distinguish. Figure I illustrates 
the reaction pattern of al I the sera involved. A new antigen which we have 
called \.119 :lE '"' appea rs to be included. It is defined by positive reactions with 
two of the \.129 vlorkshop sera (W034 Fabre, W036 abs. 8.53) and negative reactions 
vllth the other two '>129 sera (1,,1033 Fe71, W035 /2385.1). In addition WII4 RC and 
W142 HIB are nf'gative I-lith WI9 NEW but positive with W29 . Workshop serum 1,,1040 
Fe 51A is positive with 1,130 + WI9 NEW and negative with 1,,129 . 1,,119 ~EW was only 
present in the Bantu. W30 has a frequency of 39% in the Bantu and I-lOrkshop sera 
W032 Nakumura and 1,,1048 SAL may define subdivisions of 1,,130 judging by their 
reaction patterns which are alrrost completely included in 1,,130 (Fig . I). The 
workshop sera did not define 1,,131 but two sera from the NIH (Thompson and Quinones) 
which both react with W31 + W32 were used on our own trays. 1,,119.6 was not detected 
in the Bantu but had a frequency of 9% in Indians. 
Table I I shows the antigen frequencies of the SO 2 locus. We have confirmed the 
high frequency of the MWA antigen and the absence of 1,,122 in the Bantu . tlei ther 
of these antigens was detected in Indians. The antigen TT .was present in 8% of 
the Bantu but was absent from the Indians tested. W17 has 'a high frequency in 
the Bant ·.1 iLl» <lnd in Indians (JOl). Figure 2 shows h0 \~ HL-A5 can be subdivided 
into t hre~ P0 r tS. HL-A5. I is defined by the two workshop sera 1,,1129 298E and 1,,1130 
PA 101 . 11. The other I-/orkshop serum (W128 191E) that was submi tted as a short 
HL-AS reacted as a 'standard' HL-A5 as did serum 1,,1119 Bechard. The difference 
71 
between the 'standard' HL-A5 sera and WI20 Eiden may define a further subgroup, 
HL-A5.3. 
Serum WI20 Eiden is positive with HL-A5. I + HL-A5.2. Six local sera reacted 
similarly to Eiden. In a previous investigation (Hammond et al. 1974) we showed 
four subdivisions of HL-A5 in the Indian population, one of which appeared to be 
confined to Indians from the north of India. In this study however, we tested 
only Ind i ans from the south of India. Figure 3 illustrates the reaction pattern 
of antisera associated ~dth WIO and HL-AI3. WIO.I is defined by se·rum 
W0752608/72. Serum W078 10234. I appears to be HL-A7 + WIO.I. Only the anti-
HL-AI3 sera show good agreement, however, and the WIO complex needs further 
study especially in the Indian population. The an~igen TV had a frequency of 
6% in Indians but was not detected in the Bantu. 
TABLE III 
SO 3 an t i gen frequencies in % 
Ant i gen Tami I Telegu Indian Bantu 
Tt 8 2 5 
T2 0 0 0 
T3 8 14 11 
T4 14 16 15 
T5 2 2 2 
Table I II shows the antigen frequencies at the SO 3 locus. TI was not found in 
the Bantu and T2 was absent in the Indians. The associations between antigens 
of the SO 3 series and the SO 2 series are quite different in these populations 






all three races and T4 and W5 in Indians and Caucasians. An interesting associa-
tion is that between T2 and the blanks in the Bantu, which may indicate the 
presence of an undefined antigen more common in the Bantu and associated with 
T2. Table IV shows the haplotype frequencies, standard errors and delta values 
in the four population groups. Significant delta values are underl ined. Also 
shown are the delta-haplotype ratios suggested by Thomsen et al . (1974) which 
indicate how much the delta value contributes to the haplotype frequency. The 
correlation coefficients (r) between the antigens are also shown in Table IV. 
These associations show that Is easier to charatterise antisera by using p~nels 
from all three race groups, and that the identification of complex antigens 
may only be possible in this wa~. 
Acknowledgement: This work was supported by a grant from the South African 
Medical Research Council (P.B.). 
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Testing I 77 
Report of the 7th International Histocompatibility 
Workshop and Conference 
The Workshop Conference took place 
in Oxford, England from 










HLA IN NON-CAUCASIAN POPULATIONS 
M.G. Hammond, B. Appadoo, and Peter Brain, Natal Institute of 
Immunology, Durban, South Africa. 
BS + HR: BS.l, BS.2, BS.3, BS.4 and HR all present in Indians. 
BS.l and HR in Zulus. All groups included in W4. 
Comparison with BS patterns in Dutch Caucasians are 
presented in ta6le: 
BS PATTERNS WITH 7W SERA 
o NCOM'<1'lf)\.D01N t-.-l OCO 01 Zulu Indian Dutch Cauc. MMNMMMMNMMM'<1'MM 












++ + +- + ++ + + + + 1 BS.l 10 BS.l 16 BS.l 
++ + +- + ++ + + + + 0 4 BS.2 0 
+- + ++ + ++ + +++ 0 0 S BS.2 - -- ~ - - - -+ + ++ + +++ 0 3 BS.3 0 - --- - -- - -- - +++ 0 1 BS.4 0 
- - - -- - -- - - - + 2 HR 0 0 
- - - - - - -- - +-+ 0 1 HR 0 
- - - -- + +- - + - + 0 0 1 HR -
heterogeneous in Indians (see Schreuder and Bos). 
'Short' BwlS, only present in Indians; included in W6. 
'Long' BwlS: 7W436 and BW17 sera reacted with both In-
dians and Zulus; local sera recognized two patterns; 
inclusion in W4. Bw17 was well defined with 7W sera; 
included in W4. 
B cell serology: Owl, Dw4 and Dw6 could not be defined. 
Dw2: heterogeneous in Indians; S sera reacted with all 10 
--- Dw2 individuals whereas 9 only reacted with 6 of them. 
ASSOCIATIONS BETWEEN HLA-A, -B AND -0 LOCI AND DIABETES IN 
SOME SOUTHERN AFRICAN POPULATIONS 
M.C. Botha, B.R. Briggs, E.O. du Toit, E. Campbell, D. Tal-
jaard, W.P.U. Jackson*. Provincial Blood Grouping Laboratory 
and *Department of Medicine, Cape Town, South Africa. 
The known increases of A2, B8 and BwlS and decreases of B7 in 
European juvenile onset diabetes (JOD) were confirmed (n=29). 
Of most interest were the Xhosa maturity onset diabetes (MOD) 
in which the following antigens demonstrated significant in-








19 ( . 2 S ) 
8 ( . 11 ) 
1 ( . 01) 
FIRST STUDY 
(n=20) p 
pOSe (freq) (fisher) 
9 ( . 4 S) .OS3 
6 ( .30) .03S 
3 ( . IS) .027 
SECOND STUDY 
(n=30) p 
pos, (freq) (fisher) 
IS ( . SO) .011 
8 ( . 27) .041 
6 ( . 20) .001 .. 
In a .small group of 11 Xhosa JOD Bw35 was increased with a fre-
quency of .30 and p = .001. For Dw3 (the only antigen for 
which typing was done) the frequency was 0.73 as compared to 
.33 in the control group (p .= .020). 
No significant deviations were noted in 30 non-Malay Coloured 
MOD's and in two consecutive studies of respectively 24 and 
3S Malay Coloured MOD's. 
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SV=PR: A NEW B LOCUS ANTIGEN - DISCOVERED 
Ieke Schreuder, Alie Bos. Dept. of Immunohaematology, Universi-
ty Hospital Leiden, Holland. 
Ella van den Berg-Loonen. Central Laborator~ of the Dutch Red 
Cross Bloodtransfusion Service, Amsterdam, HOlland. 
Two sera recognized the same specificity: 
Serum VR30087: B5, B18, Bw15.2, Bw35, HR, Bw21, SV; Leiden. 
Serum CLB23 B5, B18, Bw15, Bw35, HR, Bw37, PR; Amsterdam. 
SV=PR found in 2 out of 200 individuals used for cell exchanges: 
TB: Aw36, Aw23, B12, SV=PR, W4, W6 
JM: A3, A28, Bw22, SV=PR, W6 
VR30087 + 
VR30087 + 
SV and PR were found to segregate in families. 
CLB23 + 
CLB23 + 
SV=PR is a new B locus specificity with a very low gene fre-
quency «1%) and is included in w6. 
HLA-BW40 IS HETEROGENEOUS 
Ieke Schreuder, and Alie Bos.' Dept. of Immunohaematology, 
University Hospital Leiden, Holland. 
Several HLA-Bw40 related patterns were observed with local 
sera in 239 out of 1350 HLA typed blood donors. 
PATTERN SERUM: 1 2 3 4 5 6 N=239 SERUM ORIGIN: 
1. Bw40-W6-Cw3 + + + + + + 177 nr.1, 2 VR: w40+13 
2. Bw40-W6-Cw2,Cneg + + ~ + + - 43 nr.3, VR: w40+7 
3. KSO-W6 + + + + - - (2) nr.4, USSR: w46 
4. Bw40-W4=407* + + 3 nr.5, Japan: w40 
5. Bw41-W6 - - - - - + 16 nr.6, Nij: w40+w41 
Pattern 1 and 2 are distinct and associated with the presence 
of Cw3 and Cw2 (or occasionally C negative) respectively. 
Pattern 3 was only seen on two cells send to us by Dr. Kiss-
meyer -Nielsen. 
Pattern 4, 407*in the Dutch population: 
1. segregates in families. 
2. is included in W4. 
3. has a gene frequency of less than 1%. 
4. is in link. diseq. with A3: hapl.freq.=.0035;delta =.003. 
5. is mainly found together with T7 (Cw7). 
6. can be recognized by several Bw40 and B27 antisera. 
7. is best defined by serum 7W387-anti Bw40C. 
Bw40 patterns with 7W sera as observed in Dutch Caucasians, 
South African Zulus and in Asian Indians (M.G. Hammond et al). 
~~o~~mMomOOM~N~~~OON~ Dutch cauc. Zulu: Indian 
~~~~m~oomoo~~~oooooooooo~oo 
~,~~~M~MMM~~~MMMMM~M N spec. N I N spec. 
+++ + + + +++ ++ + ++ - - - 14 w40-Cw3 1 I 2 w40.1 
- + + +++ +++ +++ +- - - - - - 10 w40-Cw2 0 I 3 w40.2 - - I - - - - + + +++ +++ +- - - - - - 0 0 I 7 w40.2 
+++ - 407* 
" I - - - - - - +++ + - - - + + + 4 0 I 0 
+- - I - - - - - - - - - - - + + + - - - 0 0 3 w41 I 




Serum 322 was positive with many American Black and 
Japanese Aw33 cells but did not appear to give such 
strong 
correlations in other groups. There was 'a suggestio
n from 
the French data which was analysed separately, that 
a "short" 
version of Aw33, comparable to the behaviour of Fe55
 in other 
Workshops may exist and that cells +ve with 328 and 
-ve with 
331 are a variant of Aw33, which is related to the A
19 cross 
reactive group (CREG) and in linkage disequilibrium 
with 
B14.2. The remaining Aw33 cells, +ve with 331 and 3
28 
appear to be more closely related to the A28 CREG an
d show 
some resemblance to the antigen previously described
 as 
"Malay" (Joysey et al., 1972 in Histocompatibility T
esting 
1972) with a high ~with B12. 
Working Party As AIO. 
The "Black" antigens Aw36, Aw34, Aw43 and Bw42 (Ta
ble 4.6) 
Aw36 
Aw36, found only in Blacks, was originally defined b
y 
unexpected extra reactions in some Al sera(Histocom
patibility 
Testing 1972). Aw36 could not be clearly defined w
ith the 
1977 Workshop sera. There was a weak and therefore
 
unreliable Aw36 component in sera 301 and 473. Seru
m 303, 
reference serum for Al in previous Workshops, does n
ot react 
with Aw36 positive cells. 
Aw34 
Using the 1977 Workshop sera, this specificity could
 only be 
defined in the absence of A25 and A26. Sera 317, 
331 and 
423 had strong Aw34 activity, whereas sera 316 and 3
84 
reacted weakly with some of the Aw34 positive cells 
tested. 
Sera 310, 311, 312, 313, 314, 327, 420, 421 and 422 
were 
negative with Aw34 and Aw43 cells. 
Aw43 
Dr. Botha's laboratory submitted 10 Aw43 positive ce
lls of 
Xhosa origin. The definition of Aw43 on these cells
 was 
principally based on local sera not included in this
 
Workshop. Serum 315, used in the 1975 Workshop to d
efine 




In the African Blacks, there was good agreement in d
efining 
Bw42 by the different laboratories in spite of the 
heterogeneity of the Bw22/Bw42 sera used in this Wo
rkshop. 
The apparent absence of Bw22 in this ethnic group ma
de the 
definition of Bw42 easy. In contrast, Bw22 was pres
ent in 
the American Blacks, which may complicate the interp
retation 
of Bw42. The results obtained from the African and 
the 
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TABLE 4.6 
Reaction Pattern with Al and Aw36 Positive Cells 
301 303 





Aw43 + + 
Bw42. Ft:?<'l :-;~~vi ty of 7w 
+ve (50-100% kill) 
+ve (30-50% kill) 



















377, 378 (457) * 
443, 446, 449, (459)* 
445, 447, 450, (455)* 
* These sera are primarily anti B40. 
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American Blacks showed that there was a strong Bw42 
component in sera 373, 374, 377, 378 and 457. In addition, 
sera 416, 442, 443, 446, 449 and 459 reacted strongly with 
Bw42 posi1jve cells from African Blacks, but gave equivocal 
results in the American Blacks. Some other sera (372, 376, 
445, 447, 450 and 4S5) seemed to contain a weak Bw42 
component. 
When analysing sera which have such complex reaction 
patterns as the Bw22 and B40 sera used in this Workshop, 
negative reactions can b~ extremely informative. Serum 416, 
together with the heterogenous B40 sera 457 and 459, may help 
in differentiating between Bw42 and Bw22. All three sera 
reacted with B7 and Bw42 positive cells but not with any 
Bw22 positive cells (Table 4.6). 
Editorial Note .- This report on Bw42 should be read in 
conjunction with the report on Bw22. 
Working Party A. Biegel,M.C. Botha, C. Bouysou, B. Briggs, 
B. Hasty, S. Herbert, M. Pollack, E. Wolf (data also from 
R. Duquesnoy and M. Hammond). 
Additional note, contributed by Dr. A. Biegel, on B7 - Bw22 -
Bw42 Group in American Blacks. 
In Region USl, 170 American Blacks were typed: in addition 
to the conventional B7, Bw22.1 and Bw42, two variants were 
found, and out of a total of 51 cells 12 remain unclassified 
with regard to this antigen group. 
The firs~ \l ;ll~iant is a "short" Bw42 ("42.2" N = 4) 
differing [rum Bw42 by negative reactions for sera 373, 374, 
377, 416, 446, 447 and by positive reactions in 379 and 455. 
These cells were not B7, as shown in this and previous 
workshops: they carried neither Cwl nor Cw3. 
The second variant (N = 2) is a variant of Bw22.1, with 
negative reactions in 376, 444 and 448 : and positive in 
379 and 457, distinct from the standard Bw22.1 pattern. 
Bw22.1 in American Blacks is rare, but when present is Cw3 
associated. This variant is negative for Cwl and Cw3, as is 
Bw22.2 in this population group. For each of these variants, 
the antigen assignment for one or more cells was confirmed 
by family analysis. For additional details, see the USl 
regional report (this volume). 
BS, BwSl, BwS2, BwS3, Bw3S (formerly BS, BS.l, BS.2, HR and 
Bw35) 
The specificities within the BS - Bw35 complex have in this 
Workshop become more clearly delineated. For the first time 
agre~ment can be reached on the definition of BwS3 (formerly 
HR) ln the five populations studied. However, no monospec-
ific reagent for BwS3 was detected. BwSl (formerly B5.1) was 
differentiated from Bw52 (formerly BS.2) monospecific 
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TABLE 4.7 
Sera for B5-Bw35 comE lex 
332 333 334 335 336 337 338 339 340 341 342 343 428 429 430 431 432 470 
Bw5l + + + + -/+ + + + + + + + + + 
Bw52 +/- + +/- +/- + + +/- +/- +/-
Bw35 +/- + + + +/- +/- +/- + 
Bw53 + + + + +/- + +/- + 




Antigen Fre9uencies (%) from the Patterns of 20 Selected Laboratories 
(N = population size) 
Europ. Caucas. N. AIDer. Caucas. AIDer. Blacks African Blacks Japanese 
(N = 363) (N = 358) (N = 221) (N = 102) (N = 374) 
Total B5 15.55 10.61 14 .93 NO 32.89 
Bw5l 9.91 5.03 7.24 NO l2.jO 
Bw52 1. 65 1.6.8 0.45 NO 9.36 
Bw35 16.53 NO 14.48 10.78 10.43 
Bw53 0.55 NO 5.88 1. 96 1. 87 
NO Not done 
TABLE 4.9 
B5 
Europ. N. AIDer. AIDer. African Japanese 
337 432 335 338 334 333 336 Caucas. Caucas. Blacks Blacks 
BS + + + + + + + 5 6 6 0 18 
Bw51 + + I + + + 28 13 9 2 37* 
+ + + + + 3 2 1 0 0 
Bw52 + + +/- +/- +/- + 4 3 0 2 21 
+ + + + + + 0 2 0 0 0 
Serum 337 was negative in 3 Japanese cells. 
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examples of anti-Bw51, Bw52 ar.d Bw35 sera were found among 
the submitted s e ra. There was suggestive evidence, but not 
clear defin i t i on , o f a further possible split of B5 in two 
populations , n ame].y Black and Asian Indians, but the patterns 
for these are not provided since more study is required. 
The patterns o f serum reactions shown represent a summation 
based on all the cells from 20 selected laboratories. 
Bw51 
The serum pattern for the Bw5l specificity was aefined by 13 
sera. The pattern was essentially the same in the European 
Caucasoids, North American Caucasoids and Blacks, African 
Blacks and Japanese (Table 4.7). The four sera, 332, 333, 
334 and 335, were all specific for Bw51 (333 also contained 
anti B8). Bw5l was a frequently occurring antigen in all 
populati o J] ,: ".!i th a range from around 11% - 34% (Table 4.8). 
This is a rather conservative estimate. This also applies 
to all the calculations for the other specificities in this 
table. 
Bw52 
Nine sera c o uld be used to define Bw52. Only serum 336, of 
Japanese origin, · was almost monospecific for Bw52. This 
serum in a few laboratories gave some weak reactions in 
single typings of individuals with Bw51 cells (defined by the 
Workshop criteria). However, this may be the consequence of 
the cross-reactivity since Bw52 cells can absorb anti-Bw51 
antibody. The - frequency of Bw52 was highest in the 
Japanese population, and occurred with a lower frequency in 
the other populations with the exception of the African 
Blacks (Table 4.9). 
Bw35 
There were eight sera that could be employed to define Bw35. 
Serum 342 was monospecific (Table 4.7). Serum 344, submitted 
as anti-Bw35, was actually anti-Cw4 serum. Serum 433, sub-
mitted as having Bw35 specificity, was non-reactiVe in most 
laboratories. Sera 341 and 343 both had activity for Bw35 
and Bw53 together. The remaining sera in the pattern gave 
! reactions, i.e. these did not react with all Bw35 cells. 
Serum 470, submitted as Cw4, also gave ± reactions with 
Bw35 cell s wtl ich ma y result from the linkage disequilibrium 
between tll ( ~ t wo speci ficities. It is likely to contain Bw35 
since this ± reaction is present in the Japanese population 
in which Cw4 has a low frequency. No information was 
av a ilable on the relationship of the! patterns to the 
postulated antigens Bw35A and Bw35C. 
Bw53 
No monospecific Bw53 serum was submitted. There were two 
groups of Bw53 sera, one with B5 and one with Bw35, with a 
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TABLE 4.10 
BwS3, comEared with BS (BwSl + BwS2) 
Europ. N. Amer . Amer. African Japanese 
428 429 431 432 339 340 Caucas. Caucas. Blacks Blacks 
"BS" + + + + + + 40 22 19 NO 
HR +/- +/ - +/- + + 12 1.7 NO 
NO Not d OTH 
TABLE 4.11 
Bw3S/BS 
Europ. N. Amer. AIDer. African Japanese 
339 340 429 431 342 343 341 470 403 344 Caucas. Caucas. Blacks Blacks 
B5 (BwSl) + + + + +/- 34 15 13 6 12 
Bw3S + + + + + 23 21 0 0 
+/- + + + + + 13 0 0 7 0 
Not Bw3S' + +/- + + + + + 0 (, 0 0 
, Cells listed as B5, B1S, Bw3S by submitting laboratories 
TABLE 4.12 
"LA-Bl2 I Bw44, Bw4S (formerly B12, not TT- and TT') 
Europ. N. Amer . Amer. African Japanese 
345 346 434 349 347 348 Caucas. Caucas. Blacks Blacks 
BwH + + + + + + 4 4 13 2 
(B12, not TT·) + + + + + 41 14 7 18 
+ + + + 23 20 2 8 
+ + + + 6 9 4 3 
+ + + 8 26 5 11 
Other variants, + + + + + 1 0 0 0 0 
probably Bw44 + + + + + 0 1 0 0 0 
+ + + + 2 0 0 0 0 
Bw4S + + + + + 1 1 2 1 0 
(TT') + + + + 0 0 3 1 1 
+ + + + ] 0 0 0 0 
+ + + 2 1 0 0 1 
Other variant. + + + + + 0 9 0 
(Pattern. with less than three positIve reactions are not included) 
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total of 8 sera. The Bw53 specificity can now be readily 
defined, the specificity being present in most populations 
at low frequency except for the Blacks. The disparity 
between African and American Blacks could perhaps be due to 
differ e nt tribal origins, or misclassification in the 
patterll d,=,fining B5. 
B5 
In all populations there were cells that reacted with both 
Bw51 and Bw52 sera. These cells frequently had another well-
defined B locus specificity, suggesting that the result may 
be due to serologic rather than genetic considerations. 
Perhaps this flows from the antigen density, although in 
family studies reported elsewhere, the subdivisions are 
inherited as Mendelian dominants. Cells not defined as Bw51 
or Bw52 are referred to in the tables of frequency as B5. 
Two reports in the literature (Hammond and Payne et al.) 
indicate the presence of other subdivisions of the B5 - Bw35 
complex in restricted populations which were not observed in 
the Workshop data. 
Editorial Note: Tabulations of the PATTERN analysis of the 
Workshop data are appended to provide additional information 
on this group of antigens, and comparisons of serum 
behaviour. (Tables 4.9, 4.10. and 4.11) 
Working Party : D.B. Amos, P. Engelfriet, M. Hammond, 
C. Mazzilli, R. Payne, P. Richiardi, A. Ting. 
HLA-B12 Bw44, Bw45 (formerly B12 (not TT*) and TT*) 
There were six sera submitted to the Workshop to define the 
parts of B12. Two of these appeared to be of special 
importance in defining the split between the Bw4 associated 
Bw44 and the Bw6 associated Bw45. Serum 345 reacted as 
anti Bw45 with a few extra reactions and serum 434 appeared 
to recognise only the Bw44 antigen in the Caucasian 
population. The exact definition of Bw44 and Bw45 still 
presents problems when analysing the total 7th Workshop 
data. As in the 6th Workshop, the various patterns 
indicate the heterogeneity of the antigens and the antisera 
used to determine them. The clearest correlation using 7th 
Workshop sera is shown in the 2 x 2 tables in the 
Scandinavian Regional report on a Caucasian population. The 
majority of B12 typings in all ethnic groups agree with 
these Scandinavian findings (q.v.). The results for the 
Bw45 antigen are similar but less clear cut, probably 
because of the small number of Bw45 cells recognised in the 
analysis. There is · a group of cells of American and . 
African Black origin which are Bw6 associated and show a 
pattern of reactivity which does not occur in Caucasoids. 
These cells are recognised by a negative reaction with 
serum 348 and positive reaction with all the other B12 sera. 
Japanese cells do not appear to have a definable Bw45 
85 
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FURTHER SPLITS OF HLA-B5 
M.G. Hammond 
The Natal Institute of Immunology, Durban, South Africa 
Received August 20, 1979 
The reaction patterns of 8W sera show a further 8W502 may be a key serum. Cell 55 is BW52 as defined in 
subdivision of 85 . the newsletter and the four cells below this appear to be a 
Table 1 shows the reaction patterns of three families . short 8W52 but only two sera (8W133 and 8W782) reveal 
The mother and five shildren all possess a short 8W51 . Sera this split. Cell 65 is 8W66 and is clearly different from these 
8WOS7. 059. 268. and 060 are all negative . The father has splits. 
8W64. These findings lent support to my earlier description 
The second family has 8W52 as defined in the Work· - of four splits of B5 (1). The 19th International Cell Ex· 
shop prescreening specificity patterns. The mother and 
both children are 8W52 positive. The father and one child 
have 8W35. The third family shows the inheritance of a 
short 8W52 from the father to three children. The key sera 
are 8W338. 8W595. and 8W278. 8W35 is inherited from 
the father by the other two children. Some of the 8W35 
sera appear to be very weak . The mother appears to be 
8W59 positive. 
Table 2 shows the reaction patterns of the disease 
trays. There is no clear-cut split of 8W51 although serum 
change featured splits of 85 and I reported then. on 85.1. 
85 .2. and 85.3. It would be interesting to see how those 
cells react with the Workshop sera. 
REFERENCE 
1. Hammond MG. Appadoo B. 8rain P. Subdivision of 
H L·A5 and comparative studies of the H L·A poly· 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CONFIRMATION OF ST1 (8W12) IN SOUTH AFRICAN INDIAN FAMILIES 
M.G . Hammond and D. Appadoo 
Natal Institllte of Immunology, Durban, South Africa 
Received October 24, 1970 
The new OR specificity ST1 reported by Colombe et al 
(1) is clearly demonstrated in three Asian Indian families 
and in two other individuals (Table 1) . Several interesting 
points emerged from these studies in a different race. 
In all three families the haplotype carrying STl also 
carries the BfF allele . The gene frequency of BfF is 0.357 in 
As ian Indians (unpublished ob se rvation.;; on 380 Indians! 
and shows significant lin" ;,,! ., olisE'quilibrium with HLA·B37 . 
This consistent finding of ST1 and BfF together suggests 
that the Bf locus is closer to the OR locus than to the 8 
locus. 
One family has the 837 antigen on the same haplotype 
as ST1 . The other two have BW35. Family 02 also demon· 
strates a crossover between the A and C loci and the ST 1 
travels with B37, CW1, and BfF . 
Only one South African Negro was found (cell 62) 
with the reaction pattern defining ST1. DRW2 was also 
present but the 8f typing has not been done. The frequency 
of BfF in South African Negroes is 0 .623 and shows strong 
linkage disequilibrium with the AW30·BW42 haplotype (2). 
There is only one discrepancy between serum 691 
(8W12) and serum 1097 (8W14) and no conclusions can be 
drawn. The OC·l specificity is clearly distinct. 
Finally, the rarity of ORW1 in Asian Indians «2%) has 
facilitated the definit ion of STl because the antibody is so 
often found as an extra in ORW1 sera. 
REFERENCES 
1. Colombe B, Payne R, Cann H. Reactivity to a new OR 
specificity, ST·1, in selected 8th I nternational Work· 
shop antisera. This volume. 
2 . Teng YS, Kirk RL, Hammond MG. Linkage disequil. 
ibrium between H LA and Bf in Black South Africans. 
Human Genetics 1979, In press. 
Table 1. Eighth workshop sera containing ST·1. 
DR 
Family Member~ Ph~not~ 
02 13 4; ST-l 
14 3; ST-l 
15 7: ST-l 
12 3; 7 
3: 4 
47 3 : 4 
07- • 241 5 ; ST-l 
~ 242 -; ST-l 
64 s ; ST-l 
7, '; 5T-J 
;~ :. i: 
71 2 ; 5 
OS 7° 2; ST-l 
B5 2 ; 5T-J 
193 2; ST-l 
194 2; ST-l 
BO 2 : -
Bl 2 ; -
82 2 ; -
83 2; -
84 2: -
Random 62 2; ST-l 
lndvd . 97 5, ST-l 
------------------------.----~------------
5T-l DCl 
691 1097 1211 611 1044 763 1229 1070 72~ 7BE S67 
Bw12 Bw14 ? 7J DCl 6+2 1+2+6+x 
e e e e 6 6 6 6 
6 6 6 6 6 6 0 6 (, (, 
e e 6 e e e (, (, 
6 
6 6 4 (, 6 (, 
e (, e 8 6 8 0 
f, 6 e (, 6 0 . ~ ~ 
B 6 (, e (, 8 0 '6 
6 0 8 
0 C ~ 
e 6 8 6 6 " 0 S f 6 6 (, 0 0 6 6 
B 6 8 (, (, (, B f f 
6 B 8 (, 6 8 E (, ~ 
1 6 e 
8 8 
4 (, 8 
2 (, 6 6 
6 6 
8 6 8 8 6 6 6 (, .4 
8 4 6 (, 0 0 6 0 
Parents arr undpr~lned ·Brother and sister of 64 
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HETEROGENEITY OF 840 
M.G. Hammond 
The Natal Institute of Immunology. Durban, South Africa 
Received November 12, 1979 
Since our first report on the heterogeneity of 840 (1). 
successive International Workshops have emphasized the 
complexity of the crossr r active group of antigens which 
include 87, 813, 8W41, arl U E'W48 (1,2). 
Table 1 shows the reaction pattern of the sera used in 
the family studies. The first cell (195) is the only one which 
can be classified as 8W60 (840.1). The -other 840 cells are ' 
all classified as 8W61 (840.2) although the reaction pattern 
reveals further heterogene ity. 
Table 1 has been divided to show a possible further 
split of 8W61, although many of the sera clearly have weak 
extra antibodies which makes it difficult to decide on a 
clear-cut split. 
All the B40 cell donors are Asian Indians_ 8W41 
is well defined and was only found in Negroes_ 8W47 
and BW48 were not found in families. 
Table 2 shows the reaction pattern using the disease 
trays. The first three cells show the reaction pattern of 813. 
Five cells are classified as 8W60 and the remaining 840 cells 
as 8W61. Positive reactions with serum 8W086 seem to 
Table 1. Reaction pattern of 840 antisera . .. 
'" 
., "ray ~ 
~ 
~ 
~ ~ .. .. 
~ 
.. 
~ E 09 :!: 0 ~ ., .. (; .. ., ., ... .. .. 
~ 19 20 21 22 2] 24 2S 26 27 2. )0 ]1 12 
195 a 8 0 • a • 8 8 a I I • • 
252 8 8 0 4 8 8 • 8 I 
251 6 8 0 • 8 6 
[189 
I 0 I 8 • 6 6 
059 8 • 0 • 8 8 8 • , 
060 I e 0 6 , 8 8 6 , 
[ 04e e f 0 6 B • 
005 8 8 0 • , • [012 8 8 0 8 , 
015 B 8 0 8 • 8 
079 6 a 0 
081 8 8 0 8 • 
082 • 8 0 
08] 8 0 6 
~08' , 8 0 
097 6 • 0 
16' • 8 0 
095 • 8 0 , • 
[111 0 073 , 0 
074 0 , • • 
[m 0 III I 0 • • • I • • • , 
1)1 0 • • , 
UI 0 • • I I I U. 0 • , 











define a split of 8W61. The extra reactions of serum 8W346 
are with 85 and 87 cells. Three B7 cells with other antigens 
present at the B locus have been included to show that cell 
235 could be either 8W60 or 8W61 and that BW48 can only 
be assigned to 87 negative cells such as cell 093. Again, all 
the 840 cells are Asian Indians whereas all the BW41 cells 
are from Negroes. 
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AlC CROSSOVER IN SOUTH AFRICAN INDIAN FAMILY 
M.G. Hammond and 1. Lamm 
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Received December 5, 1979 
One of the Indian families typed for the 8th Workshop 
showed a crossover between the A and C loci. The pedigree 
is illustrated in Figure 1. 
This family was also typed for Bf, C'2, and C'4. The 
C'2 and C'4 typings were not informative. The BfF allele 
traveled with the C, B, and OR alleles which does not 
contradict the positioning of the Bf locus between Band O. 
Figure I. South African Indian family with a crossover between A and C. 
FAMILY 02 
012 013 
All Aw3l A28 Aw31 
Cwl 
8w6l B8 8w59 B37 
DRw7 DRw3 DRw4 DRw12 
Bf F Bt F BfS Bf F 
Aw3l A28 Aw31 A28 All Aw3l Aw31 A28 
Cwl Cwl 
88 8w59 88 8w59 Bw6l 837 BB B37 
DRw3 DRw4 DRw3 DRw4 DRw7 DRw12 DRw3 DRw12 




The Natal Institute of Immunology, Durban, South Africa 
History .. 
This antigen was first described by Engelfriet et al in 
1972 (1) as the antigen HR. This antigen can only be 
defined by extra reaction s I' , ,', l'C 55 and B\~35 antisera 
but during the 7th Workshop it was decided .that this 
definition was clear enough for the provisional designation 
BW53. 
&rology 
No mono specific al1ti,~'a were available for the 8th 
Workshop but the definition of BW53 was quite clear in the 
absence of 85 and 8\'\'35 , The sera used in the disease set 
gave a better definition than the genetic set. It was impossi· 
ble 10 define BW53 in the presence of BW35 using the 
genetic set (when no other antigen was present) unless the 
presence of BW4 is taken to indicate that BW53 is present. 
In the disease set it was impossible to distinguish between 
BW35 and BW53 in the presence of 25 Except by using the 
absence of BW6 to indicate the absence of BW35. 
Linkage 
No linkage disequilibrium was evident in the predata 
analysis but the estimated haplotype frequencies in Cauca-
sians showed that the A28·BW53 haplotype had the highest 
frequency followed by AW30-8W53. These two A-locus 
antigens have much higher frequencies in Negroes who also 
have the highest frequency of BW53. 
Conclusions 
The definition of BW53 continues to be difficult since 
monospecific sera are lack ing. 
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Call('a~ian : 1.5 Negro: ] 2.6 Oriental: 0.2 
Random Population 
Card Serum % Frequency With Antigen 
Column Number Lab C N 0 % 8s Other Specificities 
06-79 196 CAN 25 25 41 39 60 BW51,BW52,B 13,BW49, 
BW59,8W66 
07·27 665 CRB 16 27 9 42 60 BW35 
07-28 678 GAN 21 27 19 40 77 BW35 
07-30 034 Gal 33 37 42 49 85 BW51,BW35,BW52 
07-33 228 FES 21 27 16 54 89 BW35 
13-78 541 BOT 27 46 37 36 85 BW51,BW52,BW49,BW63, 
BW57,BW58,BW59 
14-1 9 248 GAZ 25 37 29 46 83 BW35,BW51,CW4 
14-21 269 MYR 16 23 35 56 87 BW51 ,BW52 
14-22 494 ENG 20 27 34 55 90 BW51,BW52,BW49,BW63, 
8W66 
14·23 493 ENG 14 17 29 71 64 BW51,BW52 
14-24 035 Gal 15 25 33 71 88 BW51,BW52,8W66 
14-25 596 MYE 21 29 32 50 86 BW51 ,BW52 ,BW49,BW63, 
8W66 
14-26 1159 GEL 16 23 13 86 86 BW35 
14-27 133 PER 27 30 37 62100 BW35,BW51,BW52 
14-28 784 ENT 37 51 54 55100 BW35,BW51,BW62,BW52, 
8W59 
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678 82 62 
665 75 44 71 
196 08 57 21 00 




133 76 82 
1159 60 62 73 
596 39 38 40 
035 42 54 55 14 72 
493 44 54 56 11 70 92 
494 41 39 45 10 87 74 77 
269 51 61 66 27 63 85 87 72 
248 70 78 89 76 32 44 43 33 53 
541 39 36 ' 38 12 80 58 60 76 60 30 
782 784 133 1159 596 035 493 494 269 248 
Serum PUR 07 Serum VIl 03 
Number P P 1 2 3 HLA Number P P 1 2 3 4 HlA 
1152 - + + - - 53.35 1152 - 53.35 
665 - + + - - 53.35 665 - ,- - + - - 53.35 
678 - + + - - 53.35 678 + + + + - - 53.35 
034 - + + - - 53.35 034 - + + + - - 53.35 
228 + + 53.35 228 + + + 53.35 
426 - + + + - 53.35 426 - + + + - - 53.35 -783 - + + - - 53.35 783 - + + + - - 53.35 
1116 - - - - - 35 1116 - - - - - - 35 
1040 - - - - - 35 1040 - - - - 35 
058 - - - - - 5 058 - - - - - - 5' 079 - - - 5 079 - - - - 5 
338 - 5 338 5 
196 - + + - - 5 196 - - 5 
308 - 5 308. 0 5 - - - - - -
256 - - - 51 256 - - - - 5} 
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Michael G. Hammond, Natal Institute of Immunology, Durban, South Africa 
Bw35 was well defined by the sera used in this Workshop. Eight sera (see tables) gave strong reactions and together were able to define Bw35 even in the presence of B5 or BJ5. Sera 249 and 446 reacted with some Bw5] cells, sera 237, 238, 42] and 449 were positive with nearly all B5 splits and sera 447 and 448 were positive with Bw63 cells. Bw35 is usually associated with Bw6 but there were 2 of 43 Caucasian cells that were Bw35 positive Bw6 negative. In the Japanese 18 of ] 75 cells were in this category while in Chinese only 5 of 9 Bw35 cells were positive for Bw6. The definition of Bw6 presented some difficulty and I have therefore counted those cells which were negative for all Bw6 sera as being Bw6 negative for this analysis. 
Frequency of Bw35 in the three populations: 
Chinese Japanese 
N = 164 N = 992 
Frequency"" 5.5 16.3 
Caucasians 
N = 520 
7.7 



















































































































































































































































































































The Most Frequent Bw35 Haplotype (xlO~) 
Caucasian Japanese Chinese 
N .. 688 N .. 994 N • 164 
* A2, Bw35 21 275 80 
• A3, Bw35 88 6 0 
• All, Bw3S 105 93 35 
Aw24, Bw35 68 268 94 
• Bw3S, Cw3 15 600 71 
• Bw3S, Cw4 325 23 150 
* Bw3s, OR1 114 0 0 
.' 
* Bw35, DN 41 374 0 
* Significant linkage disequilibrium 
Figure 1 




249 64 51 
421 62 78 49 
446 64 41 62 45 
447 57 36 55 37 77 
448 44 25 46 28 61 ~2 
449 52 37 47 38 46 41 38 
237 238 249 421 446 447 448 
100 
I1w53 
Michael G. Hammond, Natal Institute of Immunology, Durban, South 
Africa 
It is not possible to define Bw53 with the Workshop sera. The four cel
ls defined as 
Bw53 in previous workshofJs gave inconsistent reaction patterns which
 could not be 
differentiated from the reaction patterns of the various splits of B5. T
hree sera were 
submitted as containing Bw53 antibodies. Serum 241 gave hardly any 
strong positive 
reactions. Sera 249 and 446 had many extra reactions besides Bw35, e
specially in the 
Japanese, but no consistent pattern could be found in order to define B
w53. 
Bw53 is a low frequency antigen in all races except Blacks who were not 




Michael G. Hammond, Natal Institute of Immunology, Durban, South Africa 
Cw4 was very closely defined by five antisera (541, 542, 543, 544, 545) and by serum 
55 I which also reacted with Cw6 cells. Sera 542 and 544 were not as strong as the 
others. 











There are marked differences in the assocIatIons of Cw4 with other A and B locus 
antigens in the different races. The well known linkage disequilibrium between Cw4 and 
Bw35 is present in Caucasians but not in Japanese or Chinese. lJistead, Cw4 is associated 
with Bw6:? \\ ilh a significant delta value. Also noticeable is the lack of an association 
between AJ, Cw4 and B13, Cw4 in Japanese and Chinese. 
Table I Cw4 Sera in Each POEulation 
Serum Caucasian Japanese Chinese Other 
No . r 7.8+ r 7.8+ r 7.8. SEecificities 
541 74 96 64 9) 82 100 
542 61 67 65 81 56 50 
543 85 98 73 95 83 82 
544 77 79 "73 76 87 72 
545 81 95 75 95 84 95 
551 49 94 57 100 58 91 Cw6 
Table 2 C,,4 Haplotypes (x 10 4) 
Caucasian Japanese Chinese 
N = 688 N = 992 N = 164 
A3, C,,4 109* 0 0 
All. Cw4 119* 157* 214 
A,,31, Cw4 6 58* 61 
B13, Cw4 62* 0 0 
Bw35, Cw4 325* 23 150 
Bw56, Cw4 0 50* 0 
Bw62 , Cw4 .,- 75 224* 31<1* 
* S ignlf icant linkage disequilibrium 
Figu re 1 Serum x serum r values x 100 for Cw4 sera 
Serum Number 
542 65 
543 85 69 
544 73 71 75 
545 74 59 75 70 
551 61 43 62 52 56 
541 542 543 544 545 
102 
Suhdh'ision of H LA B 15 in Indians 
M .G. Hammond, Natal Institute of Immunology, Durban, South Africa
. 
Two splits of B15 have been given official numbers, Bw62 and Bw63. T
he definition 
of 8w66 or il15.3 at the Eighth Workshop was not clear enough .to 
be given a W 
num ber, nor \\las the definilion of 8w59 which includes BU and SV. T
he sera used in 
the Second Asia-Oceania workshop, however, were able to give a bette
r definition of 
these splits. 
Three monospecific sera gave a good definition of Bw62 but Bw63 c
ould only be 
defined by extra rC;l ctiollS of Iwo BI7 sera (404, 405) in the absence of B
17 because the 
broad BI5 sera (340, 341, 343) reacted weakly with BI7 cells. 8\\'66 or 
B15.3 was best 
defined in the absence of Bw 35 by sera 447 and 448 together with the 
broad B 15 sera · 
and sera 337, 344 and 345 which had different extra specificities as lis
ted in Table 1. 
The number of cells with each pattern in each race \vas derived fro
m a computer 
programme, run in Melbourne, utilising all the data and included famili
es, disease data 
and panel cells but nevertheless the frequency of 8\\'62 is very low in all 
the populations 
tested. Table 2 shows the segregation of 8w66 in an Indian family. 
8w59 was only defined by a single serum (356) in the absence of 8w62, 
8\\'63, 8w66, 
B\\'35 and B 17, but it is apparent that there is a relatively high fre
quency of this 
specificity in Chinese and Indians. 
Segregation of 8w59 was shown in another family with the following ha
plotypes. 
No. 
013 Mother A28, 8wj9 II Aw31, B37,Cwl 
077 Father Al1,Bw611IAw31,B8 
060 Child 1 A28,8w59 Aw31,B8 
097 Child 2 Aw31,B37,Cwl Al1,Bw61 
078 Child 3 Aw31,B37,Cwl Aw31,B8 
079 Ch i Id 4 Aw31,B37,Cwl Aw31,B8 
103 
Table 1 
Reaction pattern of sera used to define splits of B15 
Serum Bw62 Bw63 Bw66 8w59 Other 




347 .. ± 
346 .. ! Cwl 
348 .. t 
337 .. .± B13 
345 .. :!: .t Cw1 .. B7 
344 .. .. + 
1f' 
342 .. .. .. 
340 .. .. .. B17 
341 .. .. .. B17 
343 .. .. .. BI7 
508 :t .1 t Bw46 
447 .. Bw35 
448 .. Bw35 
404 .. B17 
405 + B17 
356 .. + + + Bw35 +B17 
CAUC 34 4 1 4 452 cells 
JAP 112 0 11 59 1124 cells 
CHIN 25 13 34 218 cells 
INDIAN 3 2 6 16 122 cells 
104 
Table 2 
Segregat ion of Bw66 (15.3) 
H F Cl C2 C3 







337 + .± 0 
345 + + + + 
344 + + ~ 
342 + + + 
340 + + + 
)4 1 + + + 
343 + + + 
508 + + ~ 
447 + + + 
448 + + + 
404 
405 
356 + + + 
105 
Anomalous Reactions n ith Bn 4 Sera in Indian Families 
M. G. Hammond, Natal Institute of Immunology, Durban 4000 South Africa 
The classical division of B locus specificities into Bw4 associated and Bw6 associated 
antigens places BI3 in the Bw4 group and B40 (Bw60 and Bw61) in the Bw6 group. 
Two Indian families studied in this workshop showed exceptions to this classification. 
The reaction patterns of family 0 I are shown in Table l. The inheritance of the 
haplotype containing Bw6) and Bw6 can be followed through four generations. (Only 
the B locus antigens will be discussed for simplification). It is unlikely that the great 
grandmother (cell 024) is homozygous for Bw6) because of the presence of Bw4. Her 
daughter (cell 004) inherited Bw61, Bw6 from her mother and BB, ~ from her father. 
The existence of a blank instead of being homozygous for Bw6 is proved by two of her 
children (006 and 007) being negative for Bw6 and only having Bw4 together with either 
B5 or Bw44 from their father (003). The possibility of cell 004 being homozygous for 
Bw61 and thus causing false positive reactions with BB sera can be discounted because 
her grandson (cell On) is in fact homozygous for Bw61, Bw6. 
The existence of a short Bw4 occurs in family 02 where two HLA identical siblings 
have inherited Bw61, Bw6 from their father and BB, Bw4X from their mother. 
This pattern was also seen in two unrelated individuals (cells 062 and 084) the latter 
cell also having Bw61 present. The last two cells show a conventional BB, Bw4 pattern 
for comparison. 
These families illustrate the necessity for caution in using the presence or absence of 
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Table 1. Split of A28 into two subtypic speciticities (Aw68 and Aw69) with Ninth
 Workshop reagents 
Cells 9WS Sera' 
A2 
000 
o () () 
I I 
Bodmer lab data I .\ I 
A2 Homozygotes +++ 
A2 Heter (most) +++ 
Aw68(28) (Regular) 
Aw69 (28) (Rare) -- ?-




o 00 0 
I I I 2 





o 0 0 0 000 
0000000 
2 2 222 3 3 
34579 I 2 
?--?---







I I I 
I I I 
I I I 
I I I 
I I 
I I 
000 344 5 5 







I I I I 
I I I I 
3 4 o 3 




Aw69 (28)(Less common) - - - 0 + + + + + + + ? +? + + + 
+ + + + + + + 
Aw68(28) (Common type) - - - 0 - - - + + + + ? +? + + + 
+ + + + + 
, Details of other reactivities not given 
b Serum 32 appears to lack Aw69 reactivity 
References 
J. Kennedy U, Bodmer JG (1983) A2 variants. Ninth Inter-
national Histocompatibility Workshop Newsletter 5 
Antigen Report: HLA-A29 
M.G. Hammond 1, H. Betuel 2, and L. Gebuhrer
2 
I Natal Institute of Immunology, Durban 4000, South Africa 
2 Blood Transfusion Center, 69007 Lyon, France 
The A29 antigen has been well defined since 1975 
[I], and the five sera submitted as monospecific 
A29 sera for this workshop gave a clear definition 
in all races. 
All five sera have high Q scores (Table I), and the 
average strength scores show that nearly all positive 
reactions with A29 were very strong. Sera 9w I 04 
and 9wlO8 had some extra reactions with A 11 and 
AI cells, respectively. 
Table I. A29 serum analysis 
Serum Q score Ave strength 
with A29 
9wlO2 9.9 7.6 
9wlO3 10.0 7.6 
9wlO4 9.7 7.9 
9wlO6 12.0 7_7 
9wlO8 J 1.0 : ., 
Extras 




• Antigens in parentheses show that only some cells were 
positive 
t26 Histocompatibility Testing 1984. 
Edited by E_ O. Alhcrt ct al. 
'" Springer-Vcr/ag nerlin 1 kiddh,.,!, I?R4 
2. Richiardi P, Amoroso A, Conighi C, Menicucci A, Savi 
M, Marsico D, Fina C, Curtoni ES (1984) Further splits of 
A28. Ninth International Histocompatibility Workshop 
Newsletter 6 
The other extra reactions were only seen in the Ne-
groid populations. Three sera, 9w 103, 9w I 04, and 
9w106, reacted with Aw43 cells, and serum 9wl04 
also reacted with cells carrying Th. Several broad 
Awl9 sera also recognized A29 : 9w149, 9w150, 
9w062, and 9w301. There were no discrepancies in 
the segregation patterns of 45 families. 
A29 was not found in Chinese or Japanese cells but 
was present at low frequency in some southeast 
Asian populations. 
As at previous workshops, A29 and B44 showed a 
positive linkage disequilibrium in Caucasoid and 
Negroid poputations. 
Reference 
J. Bodmer T. Curtoni ES. van· Leeuwen A, et al (1975) The 
ABC of HLA. A serological report of the Sixth His-
tocompatibility Testing Workshop. In: Kissmeyer-N ielsen 
F (ed) Histocompatibility testing 1975. Munksgaard, 
Copenhagen, p 21 
109 
This antigen is mainly found in Negroids. Aw36 is 
closely related to A I and it is normally defined by a 
subset of AI sera. At the Sixth Workshop, the A lo-
cus assignment of this antigen was confirmed by 
segregation patterns in a large Zambian family [4). 
Although Aw36 is observed mainly in Negroids, 
sera with anti-Aw36 activity commonly originate 
from Caucasoids with no apparent Negroid an-
cestry. Anti-Aw36 activity is only found in anti -A I 
sera and not in combination with any other single 
A locus specificity. 
Three anti-Aw36 plus allti -A I sera were submitted 
to the Ninth Workshop: 006, 007 and 009 (Table I), 
with which Aw36 can be easily assigned in cells 
which are negative for AI. 
Table 1. Anti-HLA-Aw36 sera 
9W serum Avera ge % % Serum Quality 
no. score Reactions Extra strength score 
missed reactions 
006 7.1 11 83 88 7.7 
007 6.5 38 89 83 3.1 
009 6.4 11 84 80 7.3 
Antigen Report: HLA-Aw43 
Although the majority of cells typed in this work-
shop as Aw36 reacted with all three anti-Aw36 
sera, five cells were positive with 006 and 009 and 
negative with 007. However, the patterns of re-
actions were variable and probably do not signify a 
split of this specificity. 
In a recent study of Nigerian cells, Aw36 was found 
in linkage disequilibrium with Bw53and Cw4 [3]. 
References 
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History 
In 1972, the occurrence of apparent triplets as-
sociated with HLA-A JO and A29 in the Khoisan 
populations of Namibia was reported [I]. In 1975 
[6J, an HLA-A 101 A29 allele was defined in terms 
of the Fifth International Histocompatibility 
Workshop antisera and designated BK. The Sixth 
and Seventh Workshops [2, 3J provided further op-
portunities for studying BK. At both these work-
shops BK was serologically well defined with re-
actions involving HLA-AJO, A26, and A29 antisera 
and was shown to segregate clearly within families. 
During the Eighth Workshop a monospecific HLA-
Aw43 antibody was used for the first time, sim-
plifying the assignment of this antigen [4J. 
Although at the tillll' of the Eighth Workshop, 
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HLA-Aw43 had only been found in Khoisan, Cape 
Colored, Xhosa, and South African Caucasoid in-
dividuals in Cape Town [4], we felt that HLA-
Aw43 would eventually be detected in other 
Southern African groups. The assumption that 
Aw43 could be present in Southern African Ne-
groes other than the Xhosa was based on the find-
ing of lenkins et al. [5J that there was a consider-
able San admixture in most Southern African Ne-
groes. 
Serology 
The Ninth International Histocompatibility Work-
shop antisera allow good definition of the allele 
HLA-Aw43. No splits are apparent, and problems 
of identification should not arise. In our hands 
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Table 1. Serum analysis in South African Negroes 
9W Antigens r t % % 
Serum Missed Extras 
072 Aw43 0.67 54 0 44 
A26 0.91 86 7 0 
074 Aw43 0.65 52 0 46 
A26 0.95 911 0 0 
075 Aw43 11.1 •. ' , 51 0 46 
A26 0.<.)5 95 0 0 
079 Aw43 0.62 47 0 50 
A26 0.87 82 0 13 
081 Aw43 0.62 47 0 50 
A26 0.87 82 () 13 
082 Aw43 0.61 44 0 51 
A26 0.79 66 7 20 
100 Aw43 0.68 55 6 39 
A26 0.65 45 38 I1 
101 Aw43 0.92 102 6 0 
103 A29 0.70 59 0 37 
Aw43 0.91 81 0 7 
106 A29 0.69 57 0 39 
Aw43 0.87 74 0 13 
9wJOI is an excellent anti-Aw43 serum, with an r 
value of 0.92, as shown ill Table I. Four families, 
with 15 individuals positive for HLA-Aw43, were 
submitted from South Africa. The serum analysis 
of the ten best antisera for identifying HLA-Aw43 
is shown in Table I. 
Gene Frequel/cies and Link{/ge Disequilibrium. The 
gene frequencies of HLA-Aw43 in various 
Southern African Negroid population groups ran-
Antigen Report: HLA-Aw66 
ges between 0.02 (Zulu) and O. JO (Central!Kung) 
Aw43 is in linkage disequilibrium with B7, Bw70, 
anct 'Cw4. 
Conclusion 
The antigen HLA-Aw43 ~'as seen in South Africa 
during the Ninth Workshop. It was again well de-
fined, particularly with antiserum 9w 101. 
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History 
During the Eighth International Histocompatibility 
Workshop [3] it was agreed that HLA-A25, A26, 
and Aw34 were well defincd. ",ithout evidence for 
further splits. 
Recently, however, a new H LA-A antigen, called 
LN (= Aw66), was described . which is closely re-
lated to A25, A26, and Aw34 [4]. The definition of 
Aw66 was based on the reaction pattern of 
"monospecific" A25 and A26 sera and more com-
plex "AIO cross-reacting" sera containing Aw66 
reactivity and on segregation in families. Es-
pecially important for uefining Aw66 were sera re-
acting with both All and Aw66. Linkage dis-
equilibrium of Aw66 with Bw41 was observed [4]. 
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In conclusion, there were a number of monospecific 
BSI sera, the most specific being nos. 152, 153, 156, 
157, 158, 159. Other use fu l 135 1 sera without Bw52 
(but with B35 and Bw53) were 171 and 172. There 
were no monospecific Bw52 sera, the best being 
nos. 162 and 414. No. 162 was a weak Bw52 serum 
containing weak B5 [ and 849 acti vity . Serum 4 [4 
Antigen Report: HLA-Bw53 
did not react with BSI-positive cells but had an an-
ti-B49 reactivity. Despite the lack of monospecific 
sera, Bw52 could be easily defined with a combi-
nation of the B5 and BSI sera (see Table I in the 
Bw53 report, Taylor et aI., this volume). There was 
no evidence of splits or variants of 85 [ or Bw52 at 
this Workshop. 
C. Taylort, A. Tingt, M.G. Hammond 2, L.P. de Waal 3, G.G. de Lange 3, and P. Engelfriet 3 
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OnJy one serum (Workshop no. 163) was submitted 
as a monospecific anti-Bw53 serum. Other sera 
~ubmitted as having anti-Bw53 as well as other 
antigens were: 170 (B5) ; 171, 172 (B5, B35); and 
177 (B5, B35, BI8). 
For each serum the Q score, number of "correct" 
positive reactions, and "tail" antigens derived from 
2 x 2 comparisons are shown in Table I. 
Serum no. 163 was submitted as a monospecific an-
ti-Bw53 serum but the Worksh~p data did not con-
firm this. Bw53 could be differentiated from BSI, 
Bw52, B35, and Bw70 with the Workshop sera, but 
there was no monospecific serum for Bw53. How-
ever, there are still some problems when the above-
mentioned antigens are present. The definition of 
Bw53 is shown in Table 2: sera 174 and 176 reacted 
with BSI, Bw52, and Bw53; sera 312, 181, and 182 
with B35, and Bw53; sera 171 and 172 with BSI, 
B35, and Bw53; and sera 199, 315, and 317 with 
B51, Bw52, B35, Bw70, and Bw53. 
Table 1. Q score. percentage of "correct" to reactions with the listed antigen (% Correct). and ad-
ditional specificities in each serum. The sera are listed in order of quality 
9WS no. Antigen Q score % Correct % 8's Other specificities 
177 BwS3 8.3 100 89 B3S,SI,wS2.18 
172 BwS3 7.9 98 92 B35. SI 
199 Bw53 4.8 98 84 B3S . 51. (w52) 
\71 BwS3 6.7 96 89 B35 , 51 
176 BwS3 5.5 91 86 B51, w52, ~9, (w63), 8w66 
181 BwS3 7.0 90 79 BJ5. (51) 
182 BwS3 6.5 91 84 B35 (SI. wS2) 
174 BwS3 S.1 89 78 BSI. wS2. 49 
317 BwS3 4.6 96 73 B35. 51. w52. 18. w62. + 
312 Bw53 4.4 92 76 B35. w62, SO. w70 (wS7) 
31S Bw53 5.8 92 84 B35, SI. w52. w62, w70 
316 BwS3 
., , 
.;..0 78 56 Bw62. 35, (w63, 51, w57, w46) 
Table 2. Definition of B51. Bw52. BwS3. B35. and Bw70 with the Ninth Workshop sera 
I I I I 2 I I J J 3 I 3 3 3 I I I I I I I 2 I I I I 2 I I I 4 
5 5 S 6 0 8 7 I I 3 9 I I I 8 8 7 7 7 7 7 0 6 6 7 7 5 7 6 6 I 
3 6 7 0 2 0 9 6 I 8 9 5 7 2 I 2 I 2 7 4 6 I 4 9 3 5 3 0 7 2 4 
BSI + + + + - ? - - + + + - - - + + + + + + + + + + + +. + 
BwS2 - - - - - - + + + - - - + + + + + + + + + ? ? ? + 
BwS3 - - - - - - + + + + + + + + + + + - - - - - - - -
B35 - - - - + + + + + ? + + + + + + + + + - - - - - - - - - - - -
Bw70 - - - - + + + + + + ? + + + ? ? - - - - - - -
1: weak reaction 
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Antigen Report: HLA-Bw62 and Other Bw6-Associated Variants of B15 
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History 
Subdivisions of B t 5 were suggested at the Fourth 
International Workshop [t 8] and were reported at 
the Sixth Workshop to be found often in Malay and 
Chinese populations [11]. Sera against these vari-
ants were described as early .15 1974 [14]. During 
the Seventh Workshop, one component appeared 
to be associated with Bw4 and another with Bw6 
[9]. At the Eighth Workshop, two splits were de-
fined: Bw62. which is Bw6 associated [17], with one 
exception recently published [I], and Bw63, which 
is Bw4 associated [19]; a third split was proposed in 
Negroids: 8w66, which is Bw4 associated [7]. Dur-
ing the Seventy-second International Cell 
Exchange, further splits of 815 were suggested: 
B 15.3 in Chinese [12] and a new B 15 variant in 
Vietnamese (13], both of which are Bw6 associated. 
At the Second Asia-Oceania Histocompatibility 
Workshop. an antigen report on 8 IS described a 
short pattern of reaction within 8w62, called 
Bw62.1 [IS]. 
Serology 
During this Workshop, the complexity of B I 5 has 
been described in nine newsletters [2 - 6, 8, 10, 16. 
20], and the different patterns of reactions are 
shown in Table I. 8w62 was clearly detined by 
' positive reaction with four monospecific sera: 
9w285. 9w286, 9w284, and 9w289, with Q scores of 
8.9, 8.5, 7.4, and 5.3 respectively. Bw62.1 or · sh 
(short) was defined by negative reaction with these 
four key sera for Bw62. Twenty-five families in this , 
Workshop, six from Japan, four from Thailand and 
China, 11 from South Africa and four from the 
USA, with 28 infonnative sibs, showed clear segre-
gation of this split. B 15.3 and B t 5 SL were negative 
with the above-mentioned sera and also with a 
number of other sera (see Table I). B 15 G and B 15 
Sau seem to be rather similar, and further data are 
needed in order to support a clear difference be-
tween the two. BI5 S (Siamese), in contrast, seems 
to have a pattern different from that of other splits 
mentioned and to react with some Bw45 sera. 
Separate segregation of 815 S (Siamese) and B 15 T 
(Thai; see report on Bw63) was also seen in one 
family (FAM ANZ DCH 06; Fig. I). 
Linkage Disequilibrium 
The gene frequencies of Bw62 as calculated in the 
Workshop Central Analysis were 0.06 for Cau-
casoids and 0.08 for Mongoloids. A strong linkage 
disequilibrium was noted with Cw3.1 and with 
Cw3.2, and an association with DR4 in Caucasoids 
and DRw9 in Mongoloids. 
Conclusion 
8w62 was well defined in this Workshop and a 
number of other Bw6-associated 815 components 
were defined. Bw62.1 or sh (short) seems to be well 
. defined, but the other splits need further studies. 
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Table 1. Reaction pattern ofBI5 on Ninth Workshop sera 
I I I I 2 222 2 2 222 2 3 3 3 3 3 3 3 344 
7 7 7 7 8 7 7 7 8 8 8 8 8 8 9 0 000 I I I 100 
34590 6 7 8 I 2 4 5 6 9 9 5 7 890 ) 2 3 I 2 
Bw62 - + + + + +1+ + + +1- - + + + + + + + 
Bw62.1 (sh): 
Ts-I [16) 
B 15 Short Thai (5) 
B15 KEMP [3] 
SH 7 [20] 
Bw62 S [10] 
: ::::: :1= = = T = ::::::: + 0 + + + + ~. - - - - 0 - + + + + + + + 
+ + + + + + + - - - - 0 0 + + + + + + + 
o 0 + + + + + - - - - 0 0 + + + + + + + 
B15.3 
BI5 SLI [2) 





B I 5 T (Thai) [4) 
o 0 - - w 
w - w -
1- -1+++0 
+ - + -
++ ++w-
& + +1_ -1+ + + +1 - -Iw 
& + +1- - ± ± ± ± - - - - -
- - - - -1+ + +1- 0 j - -
(0 : not tested; w: weak reaction) 




ac ad ad 
o - -1+ + + + + +1 
ol~' + + + + + + +1 
+ + + + + + - w wl 
-1+ + + + + + +1 
- 1+ + + + + +1 
be 
a = A2, B15S, Cw3 BW6 b = A2,B15T, Cw-,BW4 
c = All, B 51, Cw -, BW 4 d = Aw19,Bw44, Cw7,BW4 
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Antigen Report: HLA-Bw63 and Other Bw4-Associated Variants of B15 
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History 
8w63 was clearly defined at the Eighth Inter-
national Histocompatibility Workshop as a 8w4-
associated subdivision of B 15, as had been suggest-
ed at previous workshops [3]. At the same work-
shop another component of B [5, also included in 
8w4, and found preferentiall y in Negroids, was al-
so described: 8w66, which had been first suggested 
in the 31 st International Cell Exchange of Terasaki 
[2]. 
Serology 
At the Ninth Workshop, among the 25 sera reacting 
strongly with at least one component of B 15, none 
was monospecific for Bw63. This antigen was de-
fined by positive reaction with sera directed against 
815 + 817: 9w3[0, 307, 309, 308, 305, 278, and 
299, with Q scores from 9.6 to 5.0, or against 8 [5 
alone: 9w276, 28[, and 277, with Q scores of 6.3, 
4.8, and 4.8, respectively. Among these sera, 9w30S 
and 299 did not react with Bw62-positive cells. 
Serum 9w278 was negative on Negroid Bw63-posi-
tive cells and positive on Caucasoid Bw63-positive 
cells. Some sera reacted only with cells from Bw63-
homozygous individuals: 9w289, 290, 314. Bw63 
was also defined by negative reactions with the 
Bw62-specific sera (9w282, 284, 285, 286, and 289). 
The following sera also had some Bw63 activity in 
the tail analysis: 9w 176, 3 [6, 323, 306, 234, 286, 
163, and 302. Antigen 8w66 was assigned only to 
seven cells in the Negroid popUlation. The pattern 
of reactivity was shorter than that of Bw63: nega-
tive reaction with 9w299 and variable pattern with 
9w176, 277, 278, and 281. In addition, three sera 
directed against BS and B49 reacted with 8w66-
positive cells: 9w[73, 174, and 175; 9wl73 and 174 
also contained some anti-Bw63 activity. Another 
pattern of B15: BIST was described in a Thai fam-
ily: ANZ DCH 06 [I]: this variant had the same 
pattern as 8w66, but sera 9w [ 73, J7 4, and [75 were 
negative. All the reaction patterns are tabulated in 
the report on Bw62 in this volume. 
Linkage Disequilibrium 
The gene frequency of Bw63 is 0.006 in Caucasoid 
and Mongoloid populations. The most frequent as-
sociations were with A24, A32, Cw7, Cw-, DRw6, 
and BfF in Caucasoids, while Bw63 was associated 
with A26, Cw3, and DR5 in Mongoloids. 
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TABLE I 
Bw62 
REACTION PATTERN or B15 ON 9TH WORKSHOP SERA 
1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 333 3 3 3 3 344 
7 7 7 7 8 7 7 7 8 8 8 8 8 8 9 0 0 0 0 1 1 1 100 
3 4 5 9 0 6 7 8 1 2 4 5 6 9 9 5 7 8 901 2 312 
- - + + + + +[+ + + d - - + + + +t+ + + 
+ + + + + + + o - + + + + + + + 
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l+ + +1 0 - (+ + + + + + +J 
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The antigen Bw53 has always been difficult to defme, especially in the 
presence of other antigens of the B5-35 complex. 
The Ninth Workshop sera give a better defmition than the Eighth Work-
shop sera1 because it is now possible to recognise BwS3 in the presnce 
of Bw] 5 without relying on the presence of Bw4. However it is still not 
possibie to distinguish Sw5) in the presence of Bw5!. 
Sw5l and Bw52 were well defmed; serum 441 being exceptionally strong 
and only giving extra reactions with homozygous Bw 51 cells. 
Figure 1 shows the reaction patterns of each of these specificities and 
Figure 2 shows the inheritance of Bw53 through three generations. 
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NINTH WORKSHOP SERA 
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Figure 1. Reaction panern of HLA 85-35 complex. 
Figure 2. Inheritance of Ilw53 . Family 23 . 
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.. + .. 18 cel!J 
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SPLITS OF DR4 IN SOUTH AFRICAN INDIANS 1 5 
B. Appadoo and M.G. Hammond 
Natal Institute of Immunology, P.O. Box 2356, Th,lrban, South Africa 
A number of investigators have reported on the heterogeneity of the DR4 
antigen both in the 8th International Histocompatibility Workshop (l980) 
6-10 and in the 9th Workshop Newsletters, 1;5 but the splits of the antigen 
was not admitted to DR status at the 8th Workshop. 10 
We support these investigators' observations and report here three splits 
of DR4 in two families of South African Indians (Table 1). We designated 
these antigens DR4.l, DR4.2 and DR4.3. 
DR4.l is in agreement with other reports in that all the DR4 antisera 
reacted positively as seen in family 23(a). 
DR4.2, as seen in family 23(b) is negative with 5 antisera 9w 59 1,592, 
593, 594, 582 and is similar to that reported by Borelli et al in News-
letter ll, ] and Gcbuhrer et al. in Newsletter Ill.4 
A very short DR4.3 in family 15 is negative for the 5 sera as in DR4.2 
but in addition sera 595,590,578 and 587 are also negative. 
Two random cells, 92 (DR4.2) and 104 (DR4.l) are also shown. 
REFERENCES 
1 Borelli, 1., Richiardi, P., Curtoni, E.S. 
Splits of DR4 with ws alioantisera and monoclonal antibodies and 
correlation with HLA-D factors. 
9th Histocompatibility Workshop Newsletter 11. 
2 Fauchet, R., Bonhallier, 0., Jalais, E., Jejour, G., Genetet, B. 
Complexity of DR4 specificity: serological defmition. 
9th Histocompatibility Workshop Newsletter Ill. 
3 Tait, B. and Boyle, A. 
DR4 Serology. 
9th Histocompatibility Workshop Newsletter Ill. 
4 Gebuhrer, L., Betuel, H., Lambert, J., Fredel, A.C. and Farre, A. 
Subtypes of HLA-DR4. 
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6 Betuel, H., Gebuhrer, L., Bertrand, 1. 
Division of HLA-DRw2 and of DRw4. 
In Histocompatibility Testing (1980) p 800-801, ed. P.!' Terasaki. 
7 Colombe, B., Pask, S., and Payne, R_ 
Further complexity associated with DR4 typing .. 
In Histocompatibility Testing (1980), p 802, ed. P.I.Terasaki. 
H Mizrachi, Y., Orgad, S., lonash, A_, Arigad, S., Yaron, M., Schiff, B. and 
Gazit, E. 
Heterogeneity of DRw4 in an Israeli population. 
Histocompatibility Testing (1980), p 803, ed. P.!' Terasaki. 
9 Walker, M., and Rubinstein, P. 
On splits of DRw4: genetics vs serology. 
In Histocompatibility Testing (1980) p 804, ed. P.!' Terasaki. 
10 Festenstein, H. 
DR4 Histocompatibility Testing (I980) p 515, ed. P.1. Terasaki. 
TABLE J. SEROLOGICAL PATTERNS OF SPUT DR4 iN SOt.rTlf AFRICAN INDIANS 
Ninth Workshop Sera 
S S S S 5 5 S .5 S .5 S S 
I 7 7 I a • I 9 I 9 7 9 9 S 6 0 4 .5 1 .5 7 0 & 
FAM 23(.) ORCENoryps 
129 MOTHER 4.1. 7 6 6 6 .. , , .. , 6 6 6 .. 
121 FATHD WIO, 7 1 1 1 1 4 1 1 1 1 I I 1 
130 SIB 1 4.1, 7 I I 6 I • • I I I I I I 147 SlBl 4.1. 7 1 , , , 4 4 , , .. ... , .. 
FAJoI l3(b) 
t 145 MOTHER. 4.2. 1 , , , , , , , 1 , , 1 136 FATHER 4.2. 1 6 a I , • , I • , , , 1 131 SIB 1 4.2. 1 , • , 4 , , 4 6 ... 4 , 1 137 SIB 1 4.2, ... .2 4 I 6 4 , , 1 , , , , 1 
14' SIB 3 4.1, 4.2 .. 6 6 1 4 , 1 6 ... 1 , 1 
FA)( 15 
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THE HLA AI0 ANDAw19 COMPLEX IN , 
SOUTH AFRICAN INDIANS AND NEGROES 
M.G. HAMMOND 
Natal Institute of Immunology P.O. Box 2356 Durban South Africa 
Figure 1 shows the reaction pattern of sera recogni~ing antigens of the 
HLA AIO complex. The Aw34 was only found in one Negro family and in 
a Coloured family. The reaction pattern of LN 1 is similar to that given by 
Moreno and Kreisler2 and Gebuhrer et al.3 except that sera 071 and 151 
were positive. This antigen was only found In one South African Indian 
family. 
The Aw 19 complex is illustrated in Figure 2. Aw33 was seen in five Indian 
families with the same reaction pattern except that sera 135 and 144 were 
occasionally negative. None of the variations described by Chandanaying· 
yong4 were found. Campbell et al.s described an antigen 19BAC similar to 
TH.6 The antigen 19NEW in Figure 2 is positive with serum 106 as well. It 
was found in two grandchildren of a large Coloured family but unfortun-
ately the father was not available for testing. 
REFERENCES 
1 Mesman, B., De Lange, G. and Engelfriet, C.P. (1983). A new HLA-A 
antigen, called LN, closely related to A25, A26 and Aw34. Tissue 
Antigens 21,192. 
2 Moreno, M.E. and Kreisler, J.M. (1983). Definition of antigen LN with 
9th Workshop sera in two infonnative families. Ninth IHW Newsletter 
Vp4. 
3 Gebuhrer, L., Primard, Y., Labonne, M.P. and Betuel, H. (1983). 
Recognition of antigen LN (Locus A) in an informative family. 
Ninth IHW Newsletter III p14. 
4 Chandanayingyong, D. (1983). Further splits of antigen Malay. 
Ninth IHW Newsletter III P18. 
S Campbell, E.M., TaIjaard, D.G. and du Toit, E.D. (1983). 19BAC - A 
possible new Negroid HLA-A locus specificity. Ninth IHW Newsletter 
VP8. 
6 Wolf, E., Pritchard, J., Watson, B. and Festenstein, H. (1981). 
Characterisation of a new Negroid A locus specificity TH In: Histocom-
patibility Testing 1980. Ed.P. Terasaki UCLA Los Angeles p744. 
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HLA B15 COMPLEX IN SOUTH AFRICAN INDIANS 
M.G. HAMMOND 
Natal Institute of Immunology P .0. Box 2356 DVRBAN South Africa 
The cross-reactiilg group of antigens comprising Bw62, Bw63, B153, BU 
and SV have been dermed in many different ways with many variations 
such as B15 KEMP, B15 THAI, B15 G and others. I -IO 
Table 1 shows the reaction pattern found in South African Indians. Bw62 
was clearly defined. Bw62S was also clear and also associated with Bw6 
and shows a close similarity with B15 THAI and B15 KEMP. Bw63 was 
associated with Bw4 and easily confinned by sera 176,305 and 299 in the 
absence of Bw52. 
Only scrum 314 defined SV; serum 180 also reacted with many of the 
Bw62S cells. 
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A possible new Thai variant of B15. 
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The BU, SV or 8w59 antigen. 
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B 15 3 (Chinese) specificity. 
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Natal Institute of Immunology P.O. Box 2356 Durban South Africa 
Tibensky et al. 1 reported a variant of Bw41 in a family of East European 
ancestry. We report here a similar reaction pattern in an Asian Indian. The 
key serum (9w241) was negative as well as sera 9w380, 381 and 386 as 
shown in Figure I. The other Bw41 cells were from a Negro family. 
The split of Bw60 reported by Chiewsilp and SUjirachato2 was not seen in 
the A~ian Indians we tested and the difference between Bw61 and Bw47 
was clear. 
REFERENCES 
1 Tibensky, D., Morochove, L. and Mervart, H. Possible variant of Bw41. 
Ninth IHW Newsletter III p26 1983. 
2 Chiewsilp, P. and Sujirachato, K. B40 (Bw60, 61),48,41,47. Ninth 
• IHW Newsletter II 1983. 
Figure 1. Reaction pattern with 840 and related antigeru 
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ANTIGEN REPORT HLA A3 
MG HAMMOND 
Natal Institute of Immunology, Durban, South Africa 
The HLA A3 antigen was well defined with the four sera listed
 in Table 1. 
The pattern analysis shows that there were very few extra rea
ctions with 
any of these sera and the lower Q-scores for sera 100 and 803
 were caused 
by missed reactions. Serum 100 was a weak serum with only 6
0% 8+ react-
ions but serum 803 (a monoclonal antibody) had 88% strong rea
ctions. 
The frequency of 1\3 ranges from 25.0% in the West (Caucasian
s) 'to about 
n in the East (Chinese and Japanese). The exceptions to this trend are 
the African Blacks (13%) and the New Zealand Maoris (12%). T
he 
distribution is shown in the map. 
There was linkage disequilibrium between A3 and B7 in Northe
rn Chin~se, 
Malays and Maoris as well as in Caucasian ' populations. , .' 
The Japanese and Koreans had A3, B44 .while the A3, BB haploty
pe was found 
in Koreans, Chinese in Thailand and African Blacks. 
TABLE 1 HLA-A3 antisera ' 
Key sera StTength r Q-score -
3AG 103 0.94 0.93 8.0 
3AO 102 0.93 0.90 7.S 
3AG 803 0.88 0.75 4.2 
3AO, 100 O.Sl 0.72 4.2 
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Antigen Report fILA All 
MG HAMMOND 
Natal Institute of Immunology, Durban, South Africa 
HLA All was very well defined by three key sera, 025, 028 a
nd 022 and 
several other sera also reacted with All cells (see Table 1). 
One of the monoclonal sera (809) together with serum 038 was
 reported by 
Chandanayingyong and Bejrachandra in a pre-workshop newsl
etter CMinipaper 
No. 5) as a short All in Thais. The same reaction pattern in
 southern 
Chinese was described by Hawkins at a symposium on HLA typ
ing in Chinese. 
Although about 50~ of positive reactions with serum 414 were 
with HLA All 
cells. Zhao (this volume) reported that absorption studies sho
wed , that 
this serum did nut contain All antibodies but recognised an a
ntigen CSH2 
which was in strong linkage disequilibrium with All . . 
The distribution of All is shown in the map. The highest fre
quencies 
(40-58%) are found in southern China. Phillipines,- Thailand, M
alaya and' 
Nepal. The frequencies decrease westward to European Cauca
sians (12%), 
and eastward to Japan (16%) . , Australian aborigines have a fr
equency of 
18% but All is absent from African blacks so that the frequen
cy of All in 
American blacks can be used to measure the amount of admixt
ure with North 
American Caucasians. 
Linkage disequilibrium between All and B5 was significant' in 
all 
Caucasoid populations as far as Nepal and also in Phillipinos. 
The 
southern Chinese. Koreans and Thais had the All.B15 haplot
ype. 
TABLE 1 HLA All antisera 
Key sera Strength r Q-score Remarks -
3AO 025 0.93 0.95 7.7 
3AO 028 0.97 0.94 7.3 
3AO 022 0.94 0.93 7.0 
Other sera 
3AO 808 0.89 0.84 4.8 Monoclonal 
3AO 035 0.84 0.84 4.6 
3AO 034 0.88 0.79 4.3 A26 
3AO 087 0.88 0.78 4.2 AIO 
Possible sElit 
3AO 809 0.87 (\.80 4.4 A26 Monoclonal 
3AO 038 0.90 0.87 5.2 Weak At 
M ultispecific sera 033, 036, 117, 810 also reacted with All. 
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NORTH INDIANS - ETHNIC STUDY 
.. 
Mehra N.K., Taneja V, Kailash 5, Chaudhuri T.K. and Vaidya M.C. 
Cellular Immunology laboratory, Department of Anatomy, All India 
Institute of Medical sciences, NEW DELHI-II0029 India. 
and 
K. Ba lokrishnan , Hoxworth Blood Centre, University of Cincinnati, 
Ohio 45267 USA; N. Contractor Institute of Immunohematology, Seth G.S. Medical 
College and K.E.M. Hospital, Bombay-4000l3, India; M.G. Hammond Transplantation 
Unit, The Natal Institute of Immunology, Durban 400, Republic of South Africa; 
and J.V. Undevia Cancer Research Institute, Tata Memorial Hospital, Bombay-
400013, India; Khan R, Memorial Sloan Kettering Hospital, New York, USA. 
INTRODUCT ION: 
India was predestined by its geographical structure to be one of the great 
breeding grounds of humanity. In the diversity of its natural conditions, it 
constitutes a whol e world in itself. The people of India are largely the 
product of succes 3Jve invasions that swept into this continent from times 
immemorial. Though the Indian population can be divided into various groups 
with different castes, languages, religion and tribes; broadly it could be 
classified as Dravidians and Aryans. The former were considered the original 
inhabitants of India who were driven Southwards following invasion by Aryans 
who crossed the Hindu Kush Mountains from the NortHwest during second and 
third millenium B.C. This was followed by periodic intrusions by Moguls 
and.Arabs between 12th and 16 Century A.D. and the Mongols thereafter. 
Historically, therefore, the Indian sub-continent constituted a cul-de-sac 
for different migratory racial groups who largely halted here and led to a 
considerable intermingling of culture and races,. Presently language rather 
than ethnic origin is the primary distinction between diverse Indian peoples, 
and terms such as Aryans or Dravidian have no significance when attached 
indiscriminately. -
The Aryans who were mostly descendants of the Bronze age invaders 
introduced the major features of the Hindu religion to India and the framework 
of an elaborate caste system with its basic fourfold division into priests 
(Brahmins), warriors (Ksatriyas), tradesmen and cultivators (vaisya) and 
inferior craftsmen (Ksudras). By practising endogamy and observing strict 
die try restrictions, they have preserved genetic continuity with their 
Aryan ancestors to a considerable extent, particulary in the upper castes; 
while the lower castes physically suggest in varying extents, the absorption 
of earlier Dravidians, particularly in skin colour. Thus, fairest skin is 
~ound in the Northwest India and Pakistan; the black element predominates 
In the Deccan (but does not present the hair and lips of the Negroid) 
yellow skins with high cheek bones live in the neighbourhood of Tibet' upper 
Burma and Eastern India. ' 
:he North Indi~~s studied her~ are the descendants of Aryans. They 
are lIght to darkSKlnned people Wl th dark hair and light eyes. In the 
present workshop. HLA data on North Indians was comr>i1eri from th,)<'p of the 
n at i veT IlIl i ; 111 i I \1 t;J! I i f; H " :; ,I ' .~ W 1 ~ 1 I ; I '~ r r ()/II U 11 \'., I: "t:I I 1 1 "I , \1, I' ,; \1 I , 
MATERIALS AND METHODS: 
A total of 156 unrelated healthy individuals representing the North 
Indian Hindus were studied for the 3 AOH workshop. (Table 1). Care was 
taken to exclude any blood relatives and individuals belonging to South India. 
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D;J!:;J rJlI : 11 111 lliJI"LIl llllli alls previously sLudied by us (Mehra et al, 1986) was 
also combined for analysis so as to have a reasonably larger sample size. 
This report, therefore, it based on 556 individuals (156+400) studied for 
HLA class I antigens and 275 individuals (141+134) for class 11 (OR and DQ) 
antigens. 
RESULTS AND DISCUSSION: 
The p p rrr'r)t. an tigen and gene frequencies for HLA-A,8,C, OR and DQ 
alleles i s rnl' resent ecJ in t able Il, III and IV. Most of the antigens 
detec ted i n the north Indians are found in the European and North American 
caucasoids sugges ting a close kinship of the two population groups. 
The antigens appearing wi th highest frequencies in the A locus are Al 
(25.7%), A2(23. 9% ), A9(27.5%), All(25.2%) and -Aw19 (32.5%). In the A9 
specificity, A23 was low while most of the ~plit was that of A24. 
Similarly, the AIO antigen was represented almost exclusively by the A26 
split. Th e genes for Aw34, Aw66 and Aw43 could not be detected in this 
population. 
In the 8 locus, the most frequent antigens are 85 (28.2%), 835(27.1%) 
and 840 (22.3%) in that order. These frequencies are comparable to those 
reported amongst the western-caucasoids. However, the most remarkable 
difference was concerning antigens 814 and 816. While the former was 
almost absent, the latter appeared with a significantly decresed frequency 
amongst the North Indians as compared to the European and North American 
caucasians. The only two individuals positive for 814 originated from 
South Africa and were ethnically muslims. It is interesting to note that 
814 occurs with a significantly high frequency amongst the Pars is living 
in and aroung 80mbay (reported in this workshop). A comparison of the 
frequencies of thise two antigens amongst various population groups around 
the world yields important results. Whereas 814 is absent or rare amongst 
the Mongol nids,Australian aborigines and most Asiatic populations, it occurs 
with ;:J !' , <" I'n lcy of 3-19 ?6 amongst the western caucasoids and Negroids. 
An alloo~1 I C ' J~ r se trend is seen for antigen 816. This antigen is absent or 
rare in negroes, Australian aborigines and scots whereas the caucasords and 
the Japanese present it with a frequency of 4-9%. 
Another important point in this popUlation is that concerning the split 
of 'broad' 8 locus specificities. Most of the split antigens detected in the 
North Indians are 844 for 812, 862 for 815, 8w50 for 821 and 8w61 for 840. 
Genes for 8w42, 8w46, 8w59, 8w70 and 8w71 were not detected. The HLA-C 
locus antigens in the present study showed an almost similar distribution as 
in European caucasoids except for Cw7 which was significantly more frequent 
amongst the North Indians. 
In the OR locus, HLA-DR2 appears to be the most frequent allele in this 
population occuring with a frequency of 46.2% which is significantly much 
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higher than the value of 25.1 % reported amongst the European Caucasoids (Baur 
and Oanilovs, 1980) Similarly ORw6 occurs much more significantly amongst 
the North Indi ans _ 
The most common haplotypes with significant positive and negative 
linkage disequilibria are given in tables V and VI respectively. Amongst 
these, AIO-B8 and A26-B8 appear to be the characteristic haplotypes in the 
North Indians. The characteristic caucasion haplotype AI-B8 was not present 
amongst North Indians. Other more frequent haplotypes observe9 in this 
population are AI-B17, AW33-B44, A3-B7, AI-B37, B35-CW4, B27-CW2, B17-CW2, 
Bl8-DR5, B8-DR3, Bl7-0R7, OR3-0Qw2, OR2-0QWl most of which are common with 
the European and North American caucasians. 
CONCLUSIONS: The populations of the Indian subcontinent are essentially 
caucasions. There is a complete lack of B14 and low prevalence of B16 
antigens amongst North Indians. The most characteristic Nor III fndian 
haplotypes are AID-B8 and A26-B8. 
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tA8LE 11: '.rc.nt C.n. and antto.n 'r.Qu.ncl •• 'or HLA-A.!.C antloenw 
In lliO;-ih 'ndlon. 
. I I 
III A r ] IIOHUC Study ~ubll.h.d Data Totol U"rth I 
AntI9_n. I Indlonl I 
r H-IS6 I Hr~OO I H-SS6 1 
1----------- ----------- ---------------------- - ------ - ---- --1 
I I 1 
I I Ill' eF I /IF' r:F I AI' r:1' I 
1----------1--------------- ----1---------------------1------- ------~--I 
I I 1 , 
0111. A - A I I 2r . ~ 11 . , I 2T.0 '4 . 5 , !!5 . 1 13 . e , 
r .\:! n S I ~ ., cc S 11 . , cl . ' 1< . 8 , 
I IIJ " 2 10 I " 8 
, , 1 ~ 2 , All 2 J . 1 '2 . , 25. I) . e 25 I! 13 5 
I A' e~ 8 '5 . 6 cT . 14 . 5 el . S 14 . 8 
I Ae) I. , O. , 
I AZ4 2&.4 H . 2 
I AIO 6 3 . , ' 0 . 5 5 . 4 ' . 1 4. ' 
I Aes O. 0 . 0 
I Ae6 0 ) . 5 
AUJ4 I 0 . 8 0 4 
AU66 , O. 0 0 
AEe I " . 0 8 '5 . 2 1., 15 .5 1) . 0 AUH' 4 . 7 2 . 
AU6' , O. 0 O. 
AU'" JO I " . 4 J3 5 18.4 J2 . 5 I' . 8 
A29 , J . 2 , . 6 4 . < r . I l . , I , 
AJO , O. 0 , 7 J . S 7 . 0 J . S 
A)' , 4 . 4 2 < 4 . 2 2 . I . ) 2 . 
AJ2 , 7 . 6 J . , 9 . S . O 2 4 . 7 
AUJJI 16 . 0 8 . J 4 . 0 t.O 1 . 4 J . S 
AUJ6' 1 . 3 O. , 
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AX , S 4 4 . 7 S.2 
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el2 12 . 8 6 . 6 11 . 2 , . 0 " . 0 8 . 3 B14 12 . ~ . 6 , 4 . 5 T. 5 ,4 . 0 1 . 2 
POS 0 0 0 2 . 1 I . J , . 9 O . , 
81J I . , O . 8 . 0 4 . 0 , . 1 3 . 1 
PI4 ! I .e 0.0 0 . 0 0.) O. , 
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PU6S' 0 . 0 O . 
BIS , 11 . J , 1 J 5 ' . 9 '4 . 5 1.5 
PU6e' 1 J 4 6 , 10 . 5 S . 4 " . J 5 . 8 
PU6l' 3 . 6 I . ~ l. 0 ' . 5 l . O , .5 
Pl6 , 2 5 1 . 2 2 . 2 ' . 1 2 . J , . 1 
BlS I . T O. J . < 0 . 6 1 . 0 0 . 5 
PH , ., 0 . ' 0 0 5 1 . 2 0 . 6 
~Il , 16 . 0 8 . J '5 0 1 . 8 15 . 2 T. ' 
8US1' T. 1 J . , ' . 1 !.' . O 7.2 4 1 
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~21 , ~ . 3 4 r 5 1 . l 1 . 0 l . S 
P49 r 2 . , 1 . 0 , . 5 0 T 1.6 0 . 8 
BUSO I 1 J 3 . 
lHJc ~ ' 6 . 4 J .t. 
SUS: 4 ! 0 0 O. 0 
BUSS' 5 , 2 . a I 
eUS61 1 2 O. , , 
B21 I 5 . I ::: . 6 6 . J . O I S . 7 2 . ' 
.35 , 21 . 5 14 . ., 21 . '4 . 5 , 21 . I 14 . ' 
8)7 , I ., O. , 4 . 2 . 4 , l . ' , . , 
P~O , 20 . 5 10 . 8 <3 . 12 . 2 , 22.3 I I . " I 
PUIO, 4 . 4 2 . < , I 
DU" , " . 0 8 . 3 I , 
8U41' O. 0 . 0 o . e o. , , O. 11 0.081 
PU4 e' O. o . 0 . 2 O. I 1 0 . 11 0.08' 
,.UU, q . O. I , 
8U4T , I . 4 O. , , 
DU4"I O. O. , I 
PUSJI 1 . 2 0 . , 1 
BUS" 0 . 0 0 . 0 I 
{IU'll 0 . 0 0 . 0 1 
aUl01 I . , O . ~ 1 
I BUll 1 O. 0 0 . 0 1 
1 BU12! 0 . 0 0 . 0 1 
1 PUlll 0 . 0 0 . 0 1 , ax I S.T 3.' 1 5 . 1 
1 1 I 
1 1 1 
nIL A - CUI 1 ' . 4 1 . 2 4 . 2 . 0 1 4 . ' 2 . 3 
I CUi! '4. I T . l ~ .0 't o 0 I '.8 1 . 4 
I eUl " . 0 8 . 1 a . z 8 . 4 1 .. 16 . , 8 . 4 
CU~ Z'i 0 I J . 4 11. 8 , I It . < 10 . 1 
tU; l . l! I . , 0 . 5 0 . 2 1 I 2 0 . ' eu, e . , 4 5 J.l 1 . 8 1 5 . < 2 . ' 
NI 22 . 4 • 11 . , 1 
CU8 0 . 8 0 . 4 1 
1 ClI 1 H.I 16 . 1 1 72. , 
1---------- 1-------------- -----1---------------------1 ________________ 
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Table Ill: Percent gene and antigen frequencies in North Indians for 
HLA - OR Locus antigens. 
---------- ----------------- -------------------i- -------------------
Antigens 3 AOHWC study Published Data Total North 
Indians 
N=141 N=134 N=275 
---------------- -------------------- ------------------
AF GF AF GF AF GF 
----------- ---------------- -------------------- ------------------
HLA - OR1 7.9 3.9 14.1 7.3 10.9 5.6 
OR2 45.3 26.1 47.0 27.2 46.2 26.6 
OR3 27.6 14.9 26.1 14.0 26.9 14.5 
OR4 9.9 5.0 26.1 14.0 17 .8 9.3 
OR5 22.7 12.0 23.1 12.3 22.9 12.2 
ORWll 0.0 0.0 
ORW12 1.0 0.5 
ORW6 i8.4 9.6 17.9 9.4 - 18.2 9.5 
ORW13 5.4 2.7 
ORW14 0.7 0.3 
OR7 23.4 12.4 22.3 11.8 22.9 12.2 
ORW8 10.6 5.4 0.7 0.3 5.8 2.9 
ORW9 1.4 0.7 2.9 1.5 2.2 1.1 
ORW10 7.0 3.6 2.2 1.1 4.7 2.4 
ORX 5.8 1.1 4.6 
---------- ----------------- --------------------- ------------------
AF=Antigen Frequency GF=Gene Frequency * Mehra et al 1986 I 
Table IV: Percent Gene and antigen frequencies in North Indians for 
HLA - OQ Locus antigens. 
Antigens Number Number Positive AF GF 
HLA -ORW52 141 93 65.9 41.6 + 2.1 -
ORW533 141 51 36.1 20.1 + 1.7 -
OQWl 1 Lll 101 71.6 46.7 + 2.1 -
LJWW2 I Lit 32 2'2../ 12.0 
~ , 
1.4 -
OQW3 141 56 39.7 'L . .3 + 1.7 -
OQWA 73 0 0.0 0.0 
TAI0 91 25 27.4 14.8 + 1.8 -
------------ ----------- --------------------- ------- ------------
AF=Antigen frequencies GF=Gene frequencies 
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Table V: Positive linkage disequilibrium (4) between HLA-loci A,b,c 
and OR in North Indians (per 104). 
HaQloti:Qe {556) L1 X~ H.F. HaQloti:Qe (2:Z5 l Ll X2 H.F. 
Loci A and B Loci A and OR 
AIO-B8 179 80.6 202 Aw32-0RwlO 72 9.1 85 
A26-B8 149 69.8 166 A24-0Rw9 60 6.8 71 
A19-B12 229 22.2 375 Aw33-0Rw53 136 8.7 191 
A19-B4l1 209 21.1 337 Loci B and OR i 
A30-B13 50 14.8 58 B18-DR5 143 16.8 175 
A23-8w57 17 13.8 17 B17-0R7 225 16.1 313 
Aw33-B44 17 13.8 17 Bw63-0Rwl0 50 14.3 53 
AI-B17 140 10.7 248 B8-0R3 146 10.6 199 
AI-B37 75 10.5 104 B44-0R7 160 8.9 237 
A3-B7 105 9.5 169 B52-0Rw53 124 13.5 153 
Aw33-B12 76 9.4 107 B52-0Rw52 171 14.3 227 
A28-Bw63 45 8.0 56 Bw57-0Rw53 85 9.1 103 
A23-B17 29 6.7 34 B17-0Rw53 146 -7 :8 218 
AI-Bw63 52 6.5 72 Bw58-0Rw53 72 7.8 86 
Loci Band C Bw61-DRw53 116 7.7 160 
B35-Cw4 850 82.2 1183 Loci Band DQ 
Bw57-Cw2 399 71.4 431 Bw61-DQwl 222 13.6 308 
B52-Cw8 839 67.2 · 934 Bw5z-0Qw2 120 11.4 139 
Bw58-Cw3.1 563 61.6 603 Bw57-0Qw3 357 11.1 403 
Bw61-Cw" n 1 511.7 796 Bw52-0Qw2 95 9.5 106 
Bw55-Cwl Yl4 51.7 366 Loci C and OQ 
Bw22-Cwl 376 49.6 410 Cw8-0Qw3 110 8.1 235 
B51-Cw7 824 28.1 934 Cw7-0Qw3 107 5.9 258 
Bw60-Cw8 813 21.6 904 Loci OR and OQ 
B52-Cw5 709 20.2 786 DR3-DQw2 46.21 20.68 618.23 
B17-Cw3 438 19.2 575 DR2-0Qwl 948.02 19.83 1988.3 
B27-Cw2 381 16.8 426 ORw53-0Qw3 381.04 9.51 615.76 
B17-Cw2 394 15.9 473 OR5-TAIO 183.04 5.02 276.60 
Bw60-Cw5 690 l LI.9 757 
B5-Cw4 267 8.3 592 
Bw61-Cw2 357 7.0 391 
B35-Cw2 203 6.5 329 
Bw60-Cw6 678 6.1 757 
*Only haplotypes with X~ more than 5 have been considered. 
Table VI: t~~g8.tiv~ linkage di~equilibrium~A) between HlA-loci A,B,C, 
;)nd OR In North IndIans (per 10 
HaQlottQe .6 X~ H.F. HaQloti:Qe Ll Xl H.F. 
loci A ana Ei loci A and OR 
AI-I:H -103 6.1 -7 Aw36-0Rw9 -0.3 13.1 -0.2 
AI1-B17 -93 4.4 14 All-ORw7 -88 5.8 -25 
A3-0R2 -177 4.5 14 
loci B -and OR 
B13-0Rw52 -112 6.2 -63 
B45-0Rw9 -0.7 6.0 -0.39 
Loci A and OQ 
A2-0Qw3 -139 4.0 -17 
B13 OQwl -77 5.8 -23 
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HLA ANTIGENS IN · AFRICAN BLACKS, 
MG HAMMOND and B APPADOO 
Natal Institute of Immunology I ' Durban. South Africa 
We tested 160 African Blacks with the 3AOH workshop serum 
seL. They were 
randomly selected blood donors and staff and were :a11 Zulus •
. Only i34 were 
tested for n IYlllphocyte antigens. 
Table 1 shows the frequencies at the A 10cus for this worksho
p and compares 
them with the frequencies obtained from previous ' Workshops a
nd with local 
assignments. The frequencies were similar except for ' Aw30 a
nd 31 which 
were difficult to define with 3AO sera. t" HLA All is virtUally 
absetlt from 
African ; Black populations. We have only · found one ' cell witH '
this antigen 
and thus the frequency is 0.05%. ' , 
At the B locus the frequencies found for this workshop ' were 
similar to 
previous workshops. The antigens ' Bw22,. B3t I1rld ' Bw52 .' are '
abs~nt or 
extremeiy rare in African Blacks {Table 2). We W~re ' surprised
 to find 
three random cells positive for ,ALA B27 and analysed all B27 
Black cells as 
shown il1 Table 3. This shows that the frequency of 1.9% for this t
vorkshop 
was a chance event and the, true frequency of HLA" B27.in At
dcati, 8lacks is 
0.4%, ' . ' , . . 
. " .: 
Cw2 could not be defined with 3AO sera but Cw1 t Cw3 and C
w4 were as 
expected (Table 4). The other C-Iocus antigens were difficu
lt to define 
because of the variations between antisera. 
The frequenri(>~ of DRl and DR7 were increased fot this Workshop but these 
antigens nI' " ·,' ,,, 11 defilled in both this and previous workshops
. Unfortuna-
tely, DQ2 could not be defined with the workshop serum set b
ut the 
frequencies of DQ antigens in African Blacks are shown in Ta
ble 5. 
Haplotypes showing significant linkage ' disequilibrium are show
n in Table 6. 
The A and B locus ha,P lotypes are distinctive and typical of A
frican Blacks t 
e.g. Aw30, Bw42; AI, B7; A3, BS but the associations of B l
ocus and DR 
locus antigens are also found in other races t e. g. B7 t DR2 a
nd BS f DR3. 
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TABLE 1 SOUTH AFRICAN BLACKS 
HLA 3AO Other WS Total 
N = 160 + Local 1867 
1707 
Al I !) , (i 6,9 7,2 
A2 23,1 21,9 22,0 
A3 13,8 12,7 12,8 
All 0 0,06 0,05 
A23 20,6 18,5 18,6 
A24 3,8 5,0 4,9 
A25 0 0,5 0,4 
A26 13,1 11 ,0 11,7 
A28 21,3 21,0 21,0 
A29 12,5 16,5 16,1 
Aw30 23,1 36,0 34,9 
Aw31 10,6 5,4 - 5,8 
Aw32 0,6 2,1 2,0 
Aw33 4,4 2,3 2,5 
Aw34 11,3 13,6 _ 
. 13,4 
One nnt. 31,3 26,7 26,8 
TABLE 2 SOUTH AFRICAN BLACKS 
HLA 3AO Other WS Total 
N = 160 + Local 1867 
1707 
B7 27,5 21,4 21,9 
BB 13,1 13,0 13,0 
B13 2,5 3,7 3,6 
B14 4,4 5,7 5,6 
B15 3,8 . 3,7 3,7 
B16 6,3 3,3 3,6 
B17 38,8 38,4 38,5 
B18 5,6 5,4 5,4 
B21 2,5 1.,8 1,8 
Bw22 0 0,06 0,05 
B27 1,9 0,3 0,4 
B35 5,0 7,0 7,0 
B37 0,6 0,06 0,1 
B40 0 0,5 0,5 
Bw41 0 1,6 1,4 
Bw42 13,8 22,1 21,2 
B44 13,1 15,8 15,6 
B45 6,9 8,6 8,4 
Bw47/48 0,6 0,06 0,1 
Bw51 2,5 1,1 1,2 
Bw52 0 ° 0 Bw53 1,9 1,4 1,4 
Bw70 25,6 17,1 17,8 
One 1I1lt. 23,8 28,0 27,2 
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TABLE 3 HLA B27 IN SOUTH AFRICAN BLACKS 
Pos N Percentage 
Random 8 1867 0,4
3 
Rheum. arthritis 1 172 0,5
8 
Cancer 2 732 0,2
7 
Henrt disease 2 264 0,76 
Choriocarcinoma 1 90 1,11 
Hyperimmune 2 153 1,31 
Renal disease 1 186 0,54 
Tuberculosis 3 509 0,59 
Schistosomiasis 1 194 0,52 
Thyroid disease 1 112 0,89 
Diabetes ° 176 0,0 
Other 1 631 0,16 
15 3219 0,47 
Ankylosing spondylitis 7 27 25,9 
TABLE 4 SOUTH AFRICAN BLACKS 
Other WS 
3AO + Local Total 
HLA-C N = 160 1707 1867 
Cvi1 0,6 0,3 0,3 
Cw2 NT 17,6 
Cw3 8,1 11,3 11 ,0 
Cw4 15,6 11,7 12,0 
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TABLE 5 SOUTH AFRICAN BLACKS 
- --
Other WS 
3AO + Local 
HLA DR 134 275 
DR1 10,4 2,2 
DR2 21,6 25,5:-
DH3 38,8 34,6 
DR4 6,7 11,6 
DR5 29,1 30,9 
DRw6 11,2 17,1 
DR7 23,9 12,4 
DR8 7,5 2,2 
DR9 1,5 0,4 
DRIO 1,5 2,6 
134 128 
DRw52 75,4 73,4 
DRw53 - 25,4 , 35,2 
134 64 
..•. 
DQl 53,0 68,8 
DQ2 NT 23,4 
DQ3 29,1 31,3 
TABLE 6 SOUTH AFRICAN BLACKS 
HAPLOTYPES WITH SIGNIFICANT DELTA 
Aw30 - Bw42 
Al - B7 
A24 - B7 
A~9 - B44 
A25 - B44 
A~9 - B13 
A2 - B45 
A~ - B8 
A28 - B14 
B7 - DR2 
B8 - DR3 
B17 - DR7 
Bw42 - DR3 
Bw70 - DR5 
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Antigen Society #9 Report (Bw46 and the Subgroups of BI5) 
E. D. Albert.' D. Chandanayingyong. 2 1.S. Thompson. J T. Zhao. 4 M .G. Hammond. 5 S. Naito, t; 
and G.M. Sierp' 
History 
The antigen HLA-B 15. first described as LND (Thorsby 
et al. 1970 (29) ) or TE IS (Albert et al. 1970 (I) ). was 
first recognized to be heterogeneous at the Fourth Inter-
national Workshop (Thorsby et al. 1970b (30». In the 
following Workshops. a growing number of reports docu- _ 
Among the Bw4-associated splits of B15. there is. in 
addition to th~ classical Bw63_ an antigen found in 
Negroid populations and named 8w66 (31). which has a 
shorter reaction pattern than Bw63. One further split of 
B 15 with a clearly shorter reaction pattern than Bw63 
occurs in the Thai population and is named BI5T (9). 
mented the heterogeneity of BI5 (Richiardi et al. 1974 815 Serology X. International Histocompatibility 
(23), Joysey et al. 1975 (18). Dick et al. 1978 (IS). Sin- ~Workshop 
gal et al. 1980 (27). Danilovs and Pollock 1980 (13). 
Saueracker et al. 1981 (24). Alonso et al. 1983 (2) . Zhao 
and Shiraki 1986 (33) ) It \Va ~ becoming clear that most 
of the variants of B 15 ~ Jl" 't' lI nd in Sputh e a~t Asian popu-
lations. During the Ninth International Histocompati-
bility Workshop. the complexity of B 15 was discussed in 
nine different ,), .. ,. ,j '.'rtcr contributions 13.6.9.11.12, 
14. 17.25, < ~J and summameu by Lnanuallil) ;r;g;'ong et 
aL (IVI ,md Cambon-Thomsen et al. (5). From this SUni-
mary it :Ippears that next to the classical Bw62 antigen 
there exists a Bw6-associatetl short Bw62 ant igen. which 
has been observed by several different authors (6.9.11 
17.25.34) mostly in Asian populations. and named 
Bw62 . 1. TS l. B 15short Thai. B 15 Kemp. SH7. Bw62S . 
This antigen is characterized by cross-reactions with 
B35 sera. There was evidence for an even shorter split of 
B 15. which is also Bw6-associated and which was 
named B 15.3 or B 15SLI. Two further antigens 
described B 15SA U and B 15G (4) mayor may not be 
e4uivalent with B 15.3. In the Thai population. there 
exists one further split tlf B 15. named B 15S, with a 
characteristic cross-react ion with anti -B45 sera (9). 
R"portinl: Ulhortltories: GERALB.' ANZOCH.I US ITHP. I 
CHIZHA.' SAFHAM.' JAPNAI' 
P/lrriciputing Ulhortltorie.c ;\;..lZCRS. ANZT AT. BENBER. 
SAFOUT. UKIAST. UKIBRS . UKIFES . US7POL. i'lCYMRV 
. "irrHJgl:r.vcrla~ New \i.rk 19)(9 
IlI1rt1unoninlogy of IIL,\ 
\ '"lIl1nc I 
Using Core sera and Antigen Society sera. seven differ-
ent sUbtypes of B 15 could be identified. The reaction 
patterns and the key antisera for the definition of the var-
ious sUbtypes are given 'in Tables I and 2. It is quite likely 
that several more sUbtypes of B 15 do exist; however. in 
the absence of family segregation data it was difficult to 
assess slight differences in reactivity. 
Antigen 8w62 . Thi~ antigen is by far the most common 
sUbtype of B15. It is characterized by association with 
Bw6 and it can be very well defined using a large number 
of antisera. of which only the best examples were chosen 
for the reaction patterns given in Tables I and 2. There 
are many antisera reacting with all B 15 sUbtypes. but 
only [wo antisera (nos. 250 and 252) distinguish Bw62 
and Bw76 from the rest of the B 15 group. 
Antigen 8\\"75 !Equivalents: 8,,62.1. TSI. 815shClrt 
Thai. 815 Kemp. SH7. 8w62S). This anti!!en was 
already clearly defined in the Ninth Internatilln;1 Histo-
compatibility Workshop (10) as a short . Bw6-associated 
variant of Bw62. which is characterized bv a cross-
reactivity with B35 (i .e .. in the presence of 'Bw75 a'~d 
the absence of B35 and Bw53 some of the anti-B35. 
Bw53 antisera react positively). Among the cells. whose 
r:acti~n pattern corresponds cl\l~dy tothe Bw75 pattern 




















































































































































































































































































































































































































































































































































































































































































































































































































































Bw62. Bw62.1. B15Sw6. B15. TE79, BI5K. As all four 
cells coded TE79 and all \3 cells coded B 15K show a 
reaction pattern that is very similar to that of Bw75 . it is 
possible that one should add TE79 and BI5K to the list 
of equivalents for Bw75. For Te79 this is also borne out 
by the fact that the three antisera (nos. 215. 216. and 
221) submitted as anti-Te79 react with all cells positive 
for Bw75. For the specificity called B 15,SLI. there is 
different coding in different laboratories. The cells from 
. Dr. Zhao in Shanghai. which have been called BI5SLI. 
correspond exactly to the Bw75 reaction pattern. while 
one cell from Dr. Festenstein's laboratory has a different 
reaction pattern. Also in the Ninth International Histo-
compatibility Workshop, B 15SLI showed a reaction pat-
tern clearly different from that of Bw75 (then Bw62.1) 
(10). Bw75 is found mostly in Chinese. Thais. and 
other Southeast Asian populations and only very occa-
sionally in cells coded as Caucasian. The relatively 
frequent occurrence of this antigen in the Cape colored 
popUlation of South Africa probably reflects the contri-
bution of Southeast Asian ;: ' : Il ::S 10 the gene pool in this 
population. 
Antigen Bw76 (Equivalent: 815S (Siamese». This 
Bw6-associated split of B 15 was first described during 
the Ninth International Histocompatibility Workshop 
(9) , It is characterized by a strong cross-reactivity with 
anti-B45 sera. This antigen seems to be restricted to the 
Southeast Asian populations. The characteristic reaction 
pattern for Bw76 is given in Tables I and 2. 
Antigen BI5.3. This designation characterizes a Bw6-
associated antigen with a short Bw62 reaction pattern. It 
has been noted that in this workshop there was an incon-
sistent use of this designation. as cells belonging to 
clearly distinct sUbtypes of BI5 were called BI5.3. 
Among the cells coded as B 15.3. there is a group charac-
terized by a short Bw62 reaction pattern (see Tables I 
and 2). with reactivity wilh long B35/Bw62/Bw70 
antisera. It must be stressed however. that this specific-
ity is ill-defined and there is considerable indication for 
the existence of several more Bw6-associated short vari-
ants of B15. 
Antigen Bw63. This antigen is characterized by its 
association with Bw4 and by a short reaction pattern (see 
Tables I and 2). Reactivity with Bw63 cells is frequently 
found in anti-Bw57 and anti-Bw58 sera. There appears 
to be a variant of Bw63. tentatively called Bw63.1. 
found in Negroid populations ":!ikil reacts. in addition 
to tne ~w63 typIcal pattern. with antisera directed 
against B51. Bw53, and B49. This antigen may be iden-
tical to the specificity 8w66 (20.21). Unfortunately. 
there were too few cells coded for this specificity in 
or<.ler to <.Ietermine i<.lenlity or non-i<.lentity with what 
has been called Bw63 .1. 
Antigen Bw77 (Equivalent BIST). This antigen was 
first describe<.l in the Ninth International Histocompati-
bility Workshop in the Thai population (9). It is 
-
Table 3. Reaction Pattern ofBw46 on the Tenth Workshop Core 
Sera Set 
Specificities Bw46 Bw6 
9 9 9 
WS Sera No 2 2 2 2 2 2 2 2 5 5 5 4 5 2 
6 5 5 6 6 4 5 5 0 0 0 9 0 I 
3 7 8 1 2 6 0 I 0 7 1 9 4 6 
Bw46 + + + + + + + + + + + - - -
associated with Bw4 and characterized by a short B 15 
_ reaction pattern and cross-reactivity with antisera con-
taining anti-Bw53 activity (see Tables I and 2). 
Antigen Bw46. This antigen does not belong to the B 15 
complex even though in almost all long B 15 antisera. 
anti-Bw46 activity can be detected . The antigen occurs 
almost exclusively in Chinese. Japanese, Thais. or other 
Southeast Asians. Bw46 is strongly associated with 
Cwll and DRw8 among Japanese and DR9 among 
Chinese. At the Ninth International Histocompatibility 
Workshop, there was a suspicion of a split of Bw46 (7) 
that could not be s_ubstantiated in the Third Asia-Oceania 
Histocompatibility Workshop (8). 
In this Workshop, Bw46 was very well defined with 
three narrow antisera (263,257, and 258)and two broad · 
sera (261 and 262) as well as with three broad sera from 
the Antigen Society set (nos. 9246. 9250. and 9251). 
With anti-serum 258, there was some suspicion of a 
mixup. as apparently this serum was a perfect anti-Bw46 
in some laboratories and completely negative in other 
laboratories (Kennedy et al.. Newsletter No. I (19) ). In 
cells that possess in addition to Bw46 a Bw4-associated 
B-Iocus antigen, it has been observed that there is a short 
~action pattern for Bw6 as given in Table 3. This may be 
in accordance with the finding from DNA sequencing of 
the Bw47 gene that the Bw46 gene carries in the position 
covering aminoacid 79-83. which is responsible for the 
Bw6/Bw4 variability-a sequence coming from a Cw3 
gene (Parham et al.. this volume (22) ). 
Computer Cell Typing 
Using the computer cell-typing procedure developed 
for the Ninth International Histocompatibility Work-
shop (26). HLA-A,B.C computer cell-typing was per-
fonned on the basis of local assignments. For the antigen 
Bw75. cells that were coded as BI5SLl or SH7 and 
corresponded in their reaction pattern to the reaction 
pattern of Bw7S were recoded as Bw75. As is shown 
in Table 4 for the antigens discussed in this report. 
there is a very high percentage of cells for which the 
local assignment and the computer assignment is identi-
cal. It can be seen that the two least well detined and 
probably heterogeneous antigen groups. Bw63 an<.l 




Tahlr 4. Computer-Cell Typing and Correlation with Local 
Assignment 
No. Cells Lah+ Lah + Lah-
Antigen Tested Prog. + Prog. - Prog. + R value 
Bw46 738 110 10 8 
Bw62 738 169 17 J I 
Bw63 738 16 5 14 
Bw75 562 55 2 6 
Bw76 562 18 0 0 
Bw77 717 10 I 
B15 .3 562 9 2 2 
Listing of Sera Tn)i n!.~ JiJforJIwtiorl of All Sera 
Relevant to the Antigell'; of the Antigen Societ)· 








Sera typing was performed using the procedure and the 
format developed for the Ninth International Hi~!ncom­
patibility Workshop . The definition of most of the 815 
subgroups is dependent 011 t he react ions of many broad 
antisera and therefore it is important to investigate the 
inclusion of narrow specificities into the broad ones. For 
a restricted analysis. this is only possible if the narrow 
spccificities are analyzed first. The sera typing of the 
relevant Core sera is given in Table 5 and those of the 
Amigen Society sera in Table 6. 
T-Cell Defined 8w62 Variants 
Information ohtained from Dr. Beatty. SealtJe. indicates 
that a cytolytic T-cell clone (HAN 4) and a proliferative 
T-cell clone LAY -1 recognize all core cell lines express-
ing 8w62 . In addition. the T-cell clone HAN 4, when 
tested with Bw62 variants, appears to be recogniz.ing 
subtypes. which are positive for the Workshop sera 250 
and 252 (Bw62 and Bw76). 
Correlation Between Biochemical Subtypes 
and Serology 
Inloflll u: inn from Dr. Ch~~. S:Z1l!ie. shows that the 
biochemical variant HIS . I corresponds to Bw75. B15.2 
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Antigen Society 812 Report (Bw54, Bw55, Bw56 and Bw42) 
S Sekiouchi I H. Neumeyer,2 N. Kashiwagi,l K. Tsuji,4 K. Kobayashi, I Y. Konoeda, I M. Ohkubo, 
M. Atoh. K.·Tokunaga.s A. Yagita, H. Inoko,4 R. Fong/ H. Mer~art,6 Y. Paik,8 P. Reekers,9 
M . Hammon.! PI F. DII Tnit. 11 and E. Call. 11 
History 
The antioen 8w54 was officially designated as a split of 
8 w22 at"th~ Seventh Internat ional Histocompatibility 
Workshop. This antigen was primarily defined in the 
Japanese population by several laboratories indepen-
dently. and designated as J-l by Juji et al. (l). as SAP-I 
by Nakayama et al. (2) and as SN-l by Saito et al. (3). 
Splits of 8w22 in Caucasians were recognized main.ly by 
the association with either Cw 1 or Cw3 . The antIgens 
8w55 and 8w56. splits of 8w22 in Caucasians that were 
primarily called 8T22 (4) and Tel2.(5). Da30 (6~ and 
AA-AJ (7), were confirmed at the EIghth International 
Workshop in 1980. The antigen 8w55 is associated with 
Cw3 in Caucasians and with Cwl in Japanese. The anti-
gen 8w56 is Jss()c iated with Cw 1 in Caucasians and 
;'ith C\\i4 in Japanese. A new 8w22 antigen as a split of 
8w56 was primarily described by Tokunaga in 1983 at 
the Eighth Japanese Histocompatibility Workshop. but 
Reporting Lahom{()ries : lAPSEK.' GERNEU.'.1APKSH.l 
JAPTSU! JAPTOK.' ANZFON .· NCYMRV.' US5PAK." 
8ENREE' 
Participating Lahomrories: SAFHAM.'o SAFDUT" 
was not clearly defined . The antigen Bw42. previously 
called MWA (8). was defined at the Fifth International 
Workshop in 1972. This antigen was primarily found in 
Negroid populations. 
Serology 
At this Workshop. 43 antisera and 3 extra antisera were 
submitted for this society set. Many of the sera were 
polyspecific (87 + 8w42. 87 + 8w55. 8w42 + 8w55. 
and so on). Several sera, however. were confirmed as 
monospecific for Bw55 and B7. The following sera 
formed clusters. identifying the Bw55 specificity (4592. 
4590, 4595. 4581. and 4578), and the B7 (4607 and 
4613). Other sera were polyspecific. The monospecific 
sera for 8w54. Bw56. and 8w42 were not obtained in 
this society set. Twenty-one sera (4602. 4608. 4605 . 
4610.4586.4593,4600.4601.4612.4614. 4615,4582. 
4583.4613 . 4607.4578.4581, 4590. 4592. 4588. and 
4589) had R values greater than 0.7 with 8w22 antigen 
. group. The reactivities of these sera are given in Table l. 
The reaction patterns of these antigens are shown in 
Table 2. It seems that four sera (4584, 4593. 4617, and 
4614) could split 8w56 into two distinct portions (long 
Table l. Analysis of the Correlation 8el~en Serum Activity and Anligenic Specilicity 
of the Sera 
Scrum R 
luenlity Specificilies value 
~582 8w22 0.89 
~58J 8w22 0.77 
~592 8w55 0.82 
~590 8w55 0 .82 
~595 8w55 0.76 
~5 81 8w55 0.75 
4578 8w55 0.85 
~607 87 0.87 
4613 87 0.82 
~588 8w55+w42 v.52 
~589 8w5 ~ ",',':.1: 0.76 
4593 8w22+w42 0.78 
~586 8w22 +w42 0.77 
·Ih()~ B7 + w~2+w55 0 .84 
JflOX U7+ w~~+w55 0.83 
..loll) B7 "" wJ~ +w55 0.79 
Jol~ 87+w-l2 + w55 0 .75 
-Ih06 87 + w-l2 + w55 + 56 0.91 
-1015 87 .... w-l2 O.!!!! 
Jhl2 87 +w~2 0.87 
-1001 87 +w-l2 0 .84 
-1600 87 +w~2 0.77 
Sprif1~\.'r \·l·( f:t~ '' "ow )j1rl ItJH9 
































































Tahle 2. Rl'action P'.Jllcrn or the Scm 
Scrum No. 
.1 .1 4 .1 4 4 ~ 4 4 
) S ) ) S S 5 5 5 
9 9 9 7 8 8 8 8 9 
HLA 0 5 2 8 :,:\ 2 6 :,:\ 
Bw5~ 
.. + + + -
HwSS + + + + + "' + + + 
B\\ ) () - - - + - - + + * 
8\\42 - - - + + 
87 - - - -
pattern and short pattern. Table 3). Most of the Japanese 
are positive for the cluster sera, but all Caucasians 
except one are negative. Two families were a\lai!a~!e f~: 
the segregation of Bw56 short, but the family having 
B\\'56 long was not found . There were a few false posi-
tives or false negatives, but the segregations were con-
firmed in these families . The cells of family I were the 
same celIs that were used at the Eighth Japanese Work-
shop. No distinctive patterns suggestive of a split were 
detected in the 52 positive cell~ of B7, 20 positive celIs 
of B\\'42 , 57 positive cells of Bw54, and 48 positive cells 
of Bw55 (Table 4) . 
A cluster of sera appears to split the Bw56 antigen into 
two portions. Bw56.1 and Bw56.2 . The "short" Bw56. 1 
antigen, seen predominantly in Caucasians, reacts only 




Lab ID Ethnic C Locus 8 
TSU 412 Jap 4 + 
TSU 401 Jap 1 3 + 
KSH 6015 Jap 4 + 
KSH 6021 Jap 4 + 
TOK 2515 Jap I 3 + 
PAK 122 Jap I 3 + 
SEK 3697 Jap 1 7 + 
MRV 846 Cau 1 7 
NEU 8 Cau 7 + 
NEU 9 Cau 6 + 
NEU 12 Cau 4 + 
NEU 53 Cau + 
NEL.! 4 ? + 
TOK 1072 Jap 7 + 
TOK 1853 Jap 5 + 
TOK 1854 Jap 3 + 
NEU Cau 4 + 
NEU 2 Cau 7 
NEU 3 Cau I + 
NEU' 4 Cau 7 + 
NEU 5 Cau 4 + 



























4 4 4 4 4 4 4 4 4 4 4 4 
5 6 6 6 6 6 6 6 6 6 6 6 
8 I I 0 I 0 I 1 0 0 0 1 
4 7 4 6 0 8 5 2 1 0 7 3 
- - - - .. - - - - - - -
+ + .. + + + - - - -
* .. ~ + + - - -
+ + + + + + + + + + 
+ + + + + + + + + + + 
with the sera 457~ .~ ~ ~: . 4605, 4606, and 4610. t;u; does 
not react .... iin the sera 4584, 4617,4614, and 4593. The 
"iung" Bw56.1 + Bw56.2 antigen seen predominantly in 
Japanese reacts with both groups of the tested sera. 
In the Core serum set, Bw54 can be defined by three 
sera, and one serum of Bw42 monospecific sera was 
found from 30 sera submitted as containing Bw54, 
Bw55, ' Bw56, and/or Bw42. The reactivities of these 
sera are given in Table 5. Sera 303, 304, and 305 as 
Bw54, and 320 as Bw42 were confirmed as monospe-
cific sera respectively. There were sera in the Core set 
showing concomitant specificities of Bw56, B35. and 
Bw62 but not with Bw55 or Bw54. This may be of some 
significance in that antigen Bw56 is different from the 
other B""'22 complex antigen in its epitope. 
Serum No. 
4 4 4 4 4 4 4 
6 6 6 5 6 6 5 
0 0 1 8 1 I 9 
5 6 0 4 7 4 3 
+ + + + + + + Long 
+ + + + + + + pattern 
+ + + + + + + 
+ + + + + + + 
+ + + + + + + 
+ + + + + + 
+ + + + 0 + + 
+ + + + + + 
+ + + + Short 
+ + + pattern 
+ + + 
+ + + 
+ + + 
+ 0 + Family 1 F 
+ + + M 
+ + + C 
+ + + Family 2 F 
+ + + M 
+ + + Cl 
+ + + C2 
+ + 0 C3 
+ + C4 
Table 4. Pattern Analysis in Antigens of Antigen Society #12 Positive 
Cells 
Serum No. 
4 4 4 4 4 4 4 4 4 4 4 
B7 6 6 6 6 6 6 6 6 6 6 6 
N=:;~ 0 0 I 0 I I 0 0 1 0 I 
:! 8 0 6 5 2 0 4 7 3 n= Freq. 
- -- - - --
40 76.9% pattern 1 + + + + + + + + + + + 
pattern 2 + + + + + + + + + - + 3 5.8 
pattern 3 + + + + + + + + - + 2 3.8 
Serum No. 
4 4 4 4 4 4 4 4 4 4 4 
Bw4~ 5 5 6 6 6 6 6 6 6 6 6 
N=20 9 8 0 0 I 0 1 I 0 0 1 
3 6 2 8 0 6 5 2 0 4 n= Freq . 
pattern I + + + + + + + + + + + 9 45.0% 
pattern 2 + + + + + + + + + 2 10.0 
pattern 3 + - + + + + + + + + + 2 10.0 
pattern 4 + - + + + + - + + + + 2 10.0 
Serum No. 
4 4 4 4 4 
Bw54 5 5 5 5 6 
N=57 7 8 8 8 I 
9 2 3 6 0 n= Freq. 
paltern 1 + + + + 17 29.8% 
pattern 2 - + + + - 17 29.8 
pattern 3 + + + + + 11 20.-1 
pattern 4 - - - 7 13 .0 
Serum ~o. 
4 4 4 4 4 4 4 4 4 4 4 4 4 
Bw55 5 5 5 5 5 5 5 5 5 6 6 6 6 
N=48 9 9 9 8 7 7 8 9 8 0 0 I 0 
2 0 5 I 8 9 2 3 6 2 8 0 6 n= Freq. 
paHern I + + + + + + +~+ + + + + + 28 58 .3% 
Serum No. 
4 -I 4 4 4 4 4 4 4 
Bw56 5 5 5 5 5 5 6 6 6 
N=13 7 7 8 8 9 8 0 1 0 
8 9 0 2 3 6 0 0 6 n= Freq. 
pallern I + + + + + + + + + 3 23.1% 
pattern 2 + - + + - + + 2 15.4 
pattern 3 + - - + - 0 + 2 15.4 
Table 5. Analysis of Correlation Between Serum Activity and Antigenic Speciticity of the Sera of Core Serum Set 
Sc:rum R 
Identity Specificities ++ +- -+ Total value 
303 Bw54 .. I I 20 312 374 0 .78 
:;u4 Bw54 39 4 14 319. 376 0.78 
303 Bw54 33 9 10 320 372 0.74 
320 Bw-C ~ J 3 15 318 369 0.76 
325 B7 + I:lw..!~ 76 IJ IJ 260 362 0.80 




The following ~Cla Ill rllled clusler~ defining Bw54 
(10\\'303.304 . :lIld 305). Bw55 (IOW4578. 4581. 4590. 
4592 . and 45951. hroad Bw22 (10\\,296. 4582. and 
4583). and Bw42 (IOW320) . Bw54 and Bw42 could he 
defined well with the tenth Core serum set and Bw55 
with the sera of Antigen Society set 12. Bw56. however. 
was not defined a~ a n1onospeci f ic scrum. It was possible 
to detect Bw55 and Bw56 based on reactivity with 
several polyspecific senl of the Core serum set contain-
ing Bw22 ant igen group. We can split Bw56 into tW() por-
tions, Bw56. 1 and Bw56.2, hy a cluster of sera . Most 
Japanese belong to Bw56.1 + 56.2 (long Bw56). Cauca-
sian, Bw56.1 (short Bw56). The (short) Bw56. 1 was 
seen in a Caucasian family. a Japanese family, and a ran-
dom Caucasian population. The report by E.L. Milford 
et al. on The Serologic Exercises of the 10th Jnterna-
tional Histocompatihility Workshop gives additional 
detail on the serolofY d Antigen Society #12 . 
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Antigen Society #13 Report (B7, B27, Bw47, Bw73) 
Danny A. Youngs. ' Sharon A. Alosco,2 Leo P. de WaaP 
HLA-B7 and HLA-B27 are well defined by mono· 
specific Tenth International Workshop sera listed in 
Table I (Core sera) and Table 2 (Antigen Society 13 
sera). There are no monospecific Workshop sera to 
define BW47, but this specificit)' is easily defined using 
B27 + Bw47 sera and B40 + BI3 + Bw47 sera (Tables 
I and 2). Bw73 was originally described by Mayr and 
Kirnbauer as "ka" in 1977 (1). and was given WHO 
nomenclature after the Ninth Workshop. based on the 
reactivity of three sera (9w245. 246, 247), which also 
reacted with other B7-CREG (cross reactive group) anti-
gens (2). In the Tenth Workshop there are five Core sera 
plus seven Ant igen Society 13 sera that define Bw73 in . 
the absence of other B7-CREG antigens. In addition, 
there are two Core sera, IOw336 (9w440) and IOw338, 
that were submitted as monospecific Bw73 sera . Al-
though these two sera were not strictly monospecific, 
having extra reactivit \' toward Bw46 and Cw7 thev were 
not reactive with other B7-CREG antigens.' Th~ Cw7 
reactivity in these two sera does not appear to be an 
artifact of Cw7 linkage with B7 and Bw73. A "new" 
B7-like antigen . pot , previously described by Reekers et 
al. (3), is identified by three Core sera and five sera from 
Antigen Society 13. These eight sera are positive with 
other B7-CREG antigens , so assignment of B pot is pos-
sible only in the absence of other B7-CREG antigens. 
Reponing LaboraTOries: US7HAN, I NCYYUN ,1 BENENG.' 
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Table 1. Best Core Sera 
Percent Inclusion 




275 95 Bw42(65) 




292 91 . 92 
288 94 56 
368 90 Bw60(94).Bw61(92). 
BI3(89) 
353 99 Bw60(98).Bw61 (98), 
B13(96),Bw48(91) 
375 97 Bw60(98) .Bw61 (98), 
B 13(97),Bw48(95) 
370 87 Bw60(95).Bw61 (94), 
BI3(90) 
339 98 89 68 Bw42(65).Bw67(50) 
341 98 97 76 
343 98 95 ~9 Bw48(68) 
340 98 92 77 100 Bw42(93).Bw48(77), 
333 96 21 
Bw60(69}.Bw55(74) 
86 67 Bw42(47) 
336 70 Bw46(55),Cw7(32) 
338 70 Bw46(23).Cw7(31) 
381 97 90 100 Bw42(81 ).Bw48(78). 
Bw67(57) 
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18. Watson K. Ness D. Gantan Z. Pcrkins H. Grumet Fe. 
ST40: A new 8w40 suhlypc identified by 3110antisera and 
a monoclnnal antihody. Hum ImmunoI1982:5:170-179. 
Antigen Society #15 Report (Dw4 and Bw6) 
A. Arnaiz-Villena; M. Belvedere. 2 F. Decary,J M. Fotino,4 E. Heise. 5 V. Hogan,6 M. Martinetti/ 
C. Muller,' P. Richiardi. B lL. Vicario,1 M. Barbanti(haIYI, J. Bruyere. 9 C. Caruso(halyl, C. Conighi. 1O 
K. Gelsthorpe. M. Hammond. 12 C. Lopez-Larrea.1 H. Mervart,6 D. PerucciolhalYI, J.R. Regueiro. 1 
and 1. Schreuderu 
During the Tenth Workshop. 27 anti-sera in the Antigen 
Society and 22 anti-sera in the Core serology serum set 
were provided for the serologic analysis of the super-
typic HLA-B locus specificities Bw4 and Bw6. The 
serum sets included 12 monoclonal:mt ibodies with Bw4 
or Bw6 specificity. For each of the submitted sera. Q 
score. R values. % extra. and missed reactions. as well as 
"tail" antigens derived by 2x2 comparison of their reac-
tivity on Caucasians. Negroes. and Orientals. are shown 
in Tables 1 and 2. 
The Bw4 specificity was best defined with the allo-
antisera 493. 495. 498 and the monoclonals 2064.2065. 
2102 of the Core serum set. as well as the alloantisera 
4750. 4751. 4752. 4758. 4759. 1701711 MUE of the 
Anligen Society with highly concordant positive reac-
tion patterns in 87% of the Bw4 positive cells in all ana-
Iyzed different ethnic groups. Among the anti-Bw6 
anti-sera reagents. 4765. 4766. 4768. 4769 and the 
monoclonal antibody 2BC WES of the Antigen Society. 
as well as the sera 494. :;O() and the monoclonals 2106, 
2107. showed the highest Q scores and R values in all 
Reponing Laborawries: FRAARN. I IT~FER.' US8DEC! 
US8FOT.' USIHEI;' NCYMRV." GERMUe.' ITICEP" 
PanicipOling LaboralOrics: BENBRU.· IT 1 CNG. 10 UKIGEL. It 
SAFHAM.t2 BENROOtJ 
analyzed races. Pattern analysis revealed that in 96% of 
Bw6 positive cells of all ethnic groups there was a posi-
tive reaction with at least six of the nine best Bw6 sera. 
Three of the anti-Bw4 alloantisera (4750, 4751. 4752) 
appeared to be "monospecific" for HLA-Bw4 in all 
ethnic subpopulations. As in previous Workshops. a 
'arger group (4758. 4759. 1701711 MUE. 27IMUC. 
493. 498. 2064. 2065. 2102) of anti-Bw4 alloantisera 
and monoclonals were found to recognize also deter-
minants ort HLA-A locus antigens. in panicular A23. 
A24. A32. A2. In tail and pattern analysis most of these 
anti-Bw4 sera showed extra-reactions with A24, A23, 
A32 in Caucasians (Table 3). whereas in Negroes and 
Orientals only the monoclonals 2064 and 2065 detected 
these HLA-A locus antigens frequently. Two anti-Bw4 
alloantisera (495. 260 MUC) revealed extra-reactivity 
with subgroups of the Bw6-associated HLA-B locus 
antigens B50 and B35 in Caucasians. Monoclonal anti-
bodies 2101 and 2198 appeared to have Bw4 reactivity. 
but were frequently negative with Bw4 and Bw6 positive 
cells. In serum-to-serum correlations. 16 of the 25 sub-
mitted anti-Bw4 anti-sera were included in one cluster 
with three serum subgroups of highest correlations 
(Table 4). 
In contrast. all anti-Bw6 anti-sera except the alloanti-
serum 4764 were operationally monospecific and had 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Tahh.' 2. Tenth Workshop Antigen Society Ser<l With Anti-Bwo. -Bw6 Reacti\'ity 
< 
Q score R v<llue <;; extras 'ii misses 
10th WS No. Origin Specificity C N C N C N C N Other Specificities 
4750 YAG Bw4 4.7 \.6 0.76 0.57 I 6 11 16 
4751 BRN Bw4 3.5 3A 0.74 0.78 5 6 8 3 
4752 ROO Bw4 8.2 1.3 0.89 0.51 2 8 3 16 
4753 BRU Bw4 2.4 2.4 0.62 0.26 6 7 13 32 
4755 ROO Bw4 3.9 \,2 0.64 0.49 0 5 21 22 
4756 KWC Bw4 2.8 \.9 0.58 0.58 20 18 I 3 
4757 MIW Bw4 \.5 \.4 o.·n OS~ 6 16 21 6 
4758 CEI' Bw4 5.4 1.7 0.84 0.59 2 16 3 3 A32. A23. A24 
4759 DPT Bw4 45 1.7 0.73 0.50 6 24 2 I A32. A23. A24 
4760 DPT Bw4 4.1 3.6 0.67 0.68 15 16 0 
1702311# MUE Bw4 \.4 0.51 12 5 A23. A24 
1701711# MUE Bw4 3.7 0.74 6 
1 A:'5. r:.:: .. -' 
260ft MUC Bw4 4A 0.71 ' ' 0 B35 .~ 
271ft IvlUC Bw4 \.6 0.53 16 6 A2 
4761 OHA Bw6 2.7 lA 0.5:\ OAO 2 IO 22 12 
4762 BAC Bw6 2.7 \.0 0.59 OA2 3 5 16 .." 
4763 BAC Bw6 OA 0.7 0.15 0.33 2 4 60 33 
4764 ROO Bw6 3.5 1.7 0.71 0.55 I 6 7 IJ A3 
4765 BRU Bw6 7.3 3.0 0.93 0.74 1 6 1 2 
4766 B.RU Bw6 5.4 2.2 0.84 0.64 4 7 2 5 
4767 MAC Bw6 7.4 2.5 0.94 0.67 I 6 I 5 
4768 PN\\' Bw6 6.3 3.6 0.87 0.78 2 6 3 I 
4769 ROn Rw6 0.6 2.6 0.81 0.70 I 16 7 3 
4770 HFP Bw6 4.6 2.2 0.78 0.61 - I 5 9 IO 
4771 ROO Bw6 5.4 1.9 0.79 0.59 2 6 6 8 
307ft MUC Bw6 3.4 0.67 3 \0 
2BC4*1t WES Bw6 4.9 0.80 4 3 
It = Local assignment: * = monoc1onal antibody: C = Caucasians (N=585); N = Negroes (N=141) 
Table 3. Serologic Patterns of Selected Anti-Bw4 Sera on A23". A24+ or A32 +. 8w4- Cells 
Wth WS Sera 
'lC 493 498 2064 2065 2\05 2057 4758 4759 
In 50 Caucasians 32.0 + + +1- +1- + + 
26.0 + +1- + + +1-:- +1- + + 
I" () + + + + + + + + 
,~ . 11 + + + +1- +1- + + 
6.0 + +1- + + 
4.0 +1- + + + 
2.0 + + + + + + 
2.0 + + + + + + 
2.0 + + + 
2 .0 + + + + , 
In 161 Negroes 56.5 + + + nt nt 
and Orienta1s 8.6 nt nt 
7A + + nt nt 
7.4 +1- + + + + nt nt 
6.2 + +1- + + + nt nt 
4.9 + nt nt 
4.8 + nt nt 
1.8 + + + + nt nt 
1.8 +1- +1- +/- +1- +1- nt nt 
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Tahle .t. Internal Correlat ions or Selected Anti· Awol and Bwo 
Sera 




2102 .7 .7 .8 
2064 .7 .7 .7 .7 
2065 .7 .7 .7 .7 .9 
4756 .6 .6 .6 .6 .6 
4760 .7 .6 .7 .7 .7 .7 .8 
4758 .6 .6 .6 .6 .8 .8 .8 .8 
ol759 .5 .5 .5 .5 .7 .7 .7 .8 .8 
4750 .6 .6 .7 .6 .6 .6 .6 .7 .7 .6 
4752 .6 .6 .7 .7 .6 .6 .7 .7 .7 .6 .8 
4751 .7 .7 .7 .6 .6 .6 .7 .7 .7 .6 .8 .8 
499 
500 .7 
2106 .7 .8 
2107 .7 .8 .9 
476-1 showed extra-reactions with AJ in Caucasians. 
Two monoclonal antibodies 2106 and 2107 were excel -
lent 8w6 rea!!ents in all races. A further monoclonal 
antibody 2103 with 8w6 reactivity missed many 8w6 
posit ive cells. 
In summary. inclusion analysis of the Bw4 and Bw6 
specificities revealed no significant deviation with 
previous reports. The anti-8w4 sera submitted to the 
Tenth Workshop were more heterogenous in their reac-
ti vitv with HLA-A locus antigens than the anti-Bw6 
anti~sera and showed differences in this reaction in vari-
ous ethnic groups. All anti-Bw4 monoclonal reagents 
with high performance in this serologic analysis also 
were found to cross-react with HLA-A locus antigens 
and thus did not lead to a further differentiation of the 
HLA-8w4 specificity. 
Antigen Society #16 Report (Cwl, Cw3, Cw9, CwlO, Cwll) 
P. Chiewsilp.1 K. Sujirachato. 1 W.R. Mayr,2 P. Perrier.J H. Hasekura.~ M. O
ta. 4 M. Aizawa. 5 
A. Wakisaka .' H. Ikeda.
5 S. Naito. 6 T. Akaza.
7 M . Jeannet.R A. Zachary.9 and W. Braun
9 
History 
HLA-Cwl and HLA-CwJ were first described in the 
Fourth and the Fifth International Histocompatibility 
Workshops. respectively (1.2). The three sUbtypic fa~ 
tors of Cw3. namely Cw3.1. Cw3.2. and Cw3 .3. were 
demonstrated in the Ninth International Histocompati-
hility Workshop (3) . The expression ofCwl and Cw3 on 
the same haplotype in (l ri \~ n (;.Jl s was ohscrvcd by P:lyne 
ct al. in 1975 (-l) and '.~; I " b ter found to be strongly 
associated with 8w46. Cw8 had been proposed as a new 
C locus ant igen for this Cw I-C\'.-3 co-segregat ing pheno-
type in the Second Asia and Oceania Histocompatibility 
(AOH) Workshop (S). However. CX46 was more 
recently used to designate this C locus antigen in the 
Third AOH Workshop (6). In the present \Vorkshop. the 
new assignment of HLA specificities is given by the 
WHn nnmcnclature committee (7). This included anti-
gens in C locus. i.e . . Lw:'; IC,:: ! \. CwlO (Cw3 .2). and 
Cwll (CX46. C\VI + 3. CwIX3. C-BangKti ~. CSHI). 
Linkage Disequilibrium 
There are strong associations of Cw I with B27 in Cauca-
soids: with 8w54. 8w55. and 8w59 in Japanese. anll 
with 8wS4. 8w5S . and 8-l0 in Chinese and Thais (Table 
. Rcp"rtillg LlIhortltory: ANZCHI' 
PClrticipClIing Ll.lhomtorics: EAEM YR.' FRAPRR. I JAPHAS.· 
JAPAIZ.' JAPNAI: JAPJUJ. ' FRAJEA." US6BRN' 
• "rrtnccr .VcrLJ1,! ~l' ''''' ) i lrk IClXlJ 
11I11I1t1l11lh1010 I!)' 01111. :\ 
\'.,111111 ... ·1 
I). Further strong associations were observed for Cw9 
with 8wS5 and 8w62: CwlO with 8w62. Bw60 in Cau-
casians: Cw9 with 835. Bw55: Cw 10 with 840: Cw II 
with 8w46 in Japanese: and Cw9 with B IS: Cw 10 with 
Bw58 and 840; Cw II with 8w46 in Chinese and Thais. 
Serology 
Cw l. Eight sera were submitted as anti-Cw I, six from 
the Core set and two from the Antigen Society (Table 2 
and Table 3). The Cwl antigen was well defined by the 
Tenth Workshop anti -sera : S08. 512. SI3. 514 . 2S9. 
510. ' and 4773 .. Pattern analysis among Caucasians. 
Japanese. and Thais indicated that they \\'ere strongly 
correlated with one another. 
CwJ. Cw9. Cw 10. and Cw I I. Twenty-nine sera were 
submitted as anti-Cw3. 10 from the Core set and 19 
from the Antigen Society (Table 2 and Table 3). There 
appeared to be seven possible sUbtypes of Cw3. all of 
which were identified by patterns. It was confirmed that 
Cw 3 could be divided into Cw9 and Cw 10 by the sera 
524. 525. 526. 527. 529, 530. 260. 528. 9064. 532, 
4777.4778.4779.4783 . 4785.4786.4787.4788.4780. 
4781 . 4793 . and 9035 (Table 4) . Cw9 reacted with all of 
the above anti-Cw3 sera. while CwlO gave negative 
reactions with sera 9064 and 532. 
Only a few Thai individuals were found to be Cw9 
short (Cw9S). Appnl.'(imately 45 cells of several ethnic 
origins appeared 10 have the Cw9S pattern as displayed 
in the CXS Workshop data base. Cw9S c:ln be ditTeren-
217 
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Antigen Society ~17 Report (Cw5 and Cw8) 
W.R. Mayr.' L. Contu. 1 M. Kirnbaucr.' and H. Mervare 
As in the previous Workshops. the definition ofCw5 and 
Cw8 was rather difficult because of the cross-reactivity 
between Cw5 and Cw8 and because of the strong linkage 
disequilibrium between Cw5 and B44 as well as between 
Cw5 and B14. 
Cw5 and Cw8 were nearly absent in non-Caucasian 
populations: therefore. the reactivity of the anti-sera 
used to define these factors was analyzed by taking into 
account only the cells of Caucasians tested in Antigen 
Society 17 (n = 164). 
The best sera for the definition of Cw5 and Cw8 are 
listed in Table I. Serum IOw552 contains, besides an 
anti-Cw5 + Cw8. a strong anti-B44. 
There was no good indication for the existence of 
splits of Cw5 or Cw8. 
In spite of the fact that one good anti-Cw5 (serum 
IOw55 I ) and one anti-Cw8 of reasonable quality (serum 
Participating Lalwra/tlrin: EAEMYR.' ITICON. 2 NCYMRVJ 
IOw554) have been found. difficulties remain with 
regard to the definition of Cw5 and Cw8. 
Table I. Reactivity of Ihe lOw Anli-Cw5 and Cw8 Sera 
IOw serum antigen ave.str %fp %fn Qsc 
551 # - Cw5 7.5 0 0 0.98 8.96 
550 # Cw5 5.3 0 30 0.79 5.63 
554 # Cw8 6.3 25 IO 0.78 5.21 
9004 # Cw5 7.2 41 0 0.72 5.91 
Cw8 2.5 29 77 0.35 1.51 
553 # - Cw5 5.1 37 26 0.61 4.58 
Cw8 8.0 10 0 0.90 7.48 
4794 ## Cw5 3.0 60 65 0.28 1.01 
Cw8 6.4 55 IO 0_59 5.21 
# serum of the Core set 
## serum of Antigen Society 17 
ave.str = average strength 
%fp = percentage of false positive reactions 
% fn = percentage of false negative react ions 
r = correlation coeffici~nt 
Qsc = quality score 
Antigen Society #18 Report (Cw4 and Cw6) 
C. Conighi,1 L. Contu,2 M.T. Grappa,3 E. Du Toit,4 M. Hammond,5 P. Lulli,6 W.R. Mayr,1 
A. M~nicucci,8 H. Mervart,9 and M. Pupura10 
HLA-Cw4 (formerly T4, RH315) and HLA-Cw6 (form-
erly T7) obtained the formal HLA designation after the 
Sixth and Seventh International Histocompatibility 
Workshops respectively (1,2). Since then, it has been 
ReportinK LaboralOr\,: IT I CNG' 
Participating Labor~lOries: IT I CON, 2 IT2FER, J SAFDUT,. 
SAFHAM,5 ITlGAN," EAEMYR,7 ITIMTT." NCYMRV' 
ITIPURIO • 
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observed that some troubles arise in identifying Cw6 
when Cw4 is present: The difficulty is due to the fact 
that while bispecifie Cw4+Cw6 and monospecific Cw4 
~era are comparatively frequent, Cw6 sera not recogniz-
mg Cw4 are quite rare (3,4). 
This work was partly supported by "Regione Emilia-
Romagna: Progetti di ricerca sanitaria finalizzata" and partly by 
Lagitre S.R.L., Milano (One Lambda. Los Angeles). 
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Tahle l. Core Set Sera Analysis: Blacks 
STR SPEC AVE INCL N TP FN FP TN
 Q R CHP 
533 BEN ENG CL8105 
CW4 90 99 7.5 96 357 137 5 3
 212 7.735 0 .948 320.593 
RES 14 CW6 = 20% AI = 10% A30 = 1
0% 827 = 10% 8W57 = 10% 
536 US5 CRO Manincz2 .': 1.83 
CW4 76 99 6.6 87 357 122 19 
3 213 6.023 0.867 268 .529 
RES 14 A2 = 10% BW46 = 10% B- = 10% CWI = 10% All = 10% 
537 UKI 8RS 5956.CBT 
CW4 93 95 7 .5 94 356 134 8 11
 203 5.806 0.884 278.261 
+ 87 47 97 2.1 19 214 6 26 5
 177 0 .544 0.262 14.708 
+ BW57 78 99 2.0 14 182 3 18
 2 159 0.694 0.262 12 .534 
OR 92 99 6.0 73 356 143 52 2
 159 4.752 0.726 187.595 
RES 14 CW6 = 20% A3 = 10% AWI9 = 10% BW65 = 10% BW70 = 10% 
539 EAE ZAR MZ467 
CW4 75 93 6.7 90 337 121 14 14 18
8 4.475 0.822 227.680 
+ BW50 33 94 5.3 75 202 3 I I1 
187 3.669 0.380 29.240 
OR 74 94 6.6 89 337 124 15 11 18
7 4.588 0.835 235.124 
RES 52 CW6 = 10% A2 = 9% B7 = 7% CW2 = 7% 
541 NCY MRV 22166 .0 
CW4 76 100 7.0 94 355 133 9 212 7.4
57 0.936 311.197 
RES 33 
543 US8 JLE Billing 
CW4 78 77 7.0 92 349 127 11 49 162 2.895 0.669 156.
128 
CW6 55 98 6.2 88 211 45 6 4 156 5.839 0.859 155.5
15 
OR 72 98 6.7 91 349 172 17 4 156 6.045 0.877 268.406 
RES 27 A30 = 11 % BW42 = 11 % 
-
545 US5 TER TER.C46108 
CW4 93 70 7.7 98 358 139 3 65 151 3 .668 0.666 158.673 
CW6 51 88 6.0 87 216 45 7 20 144 3.728 0.686 101.511 
+ CW5 54 90 5.6 71 164 5 2 15 142 3.021 0.380 23.650 
... TECIO 33 90 0 .0 0 157 - 0 0 15 142 12.532 0. 106 1.751 
OR 82 90 7.2 94 358 189 12 15 142 5. 122 0.842 253.736 
RES 33 A2 = 7% CW2=7% AI =6% A28 = 6% 
540 FRA DDC Pierson 
CW4 95 7() 7.6 <J6 356 134 6 64 152 2.648 0.646 148.446 
CW6 86 L)\J 7 . 1 90 216 47 5 17 147 3.382 0.741 118.589 
OR 93 90 7.4 94 356 181 11 17 147 4.070 0.837 249.426 
RES 84 AJO = 7% CW3=7% 87 = 6% 
547 GER MUE MUE23928 
CW6 74 92 6.5 84 359 53 10 23 273 3.939 0.706 178.731 
RES 42 CW4 = 17% BW53 = 12% AW36=7% 835 = 7% A2 = 6% 
558 FRA DDC Devinat 
CW7 71 78 4.9 61 358 43 27 64 224 0 .777 0 .338 40.946 
+ B39 38 79 4 .3 71 388 5 2 59 222 1.493 0 . 187 10.087 
+ AW34 44 81 3.3 42 281 11 15 48 207 0.484 0.170 8.117 
+ BW60 45 82 4.7 67 255 4 2 44 205 1.489 0. 193 9.461 
+ A24 47 84 3.1 43 249 6 8 38 197 0 .661 0.167 6.942 
+ A26 65 86 3.3 35 235 7 13 31 184 0 .620 0.162 6. 164 
+ BW4 77 96 2.2 18 215 29 129 2 55 0.259 0.178 6.794 
OR 67 96 3.1 35 358 105 196 2 55 0.705 0 .246 21.607 
RES 43 A30 = 22% A29 = 11 % B45 = 1I % BWn = 11 % CW6 = 11 % 
205 GER BRA 918B 
835 78 77 5 .7 74 360 48 17 67 228 1.825 0.419 63.304 
+ B39 6 "'9 3.7 70 295 7 J 60 225 1.254 0.211 13 . 181 
+ AWJ4 33 82 3.4 48 285 12 13 48 212 0 .585 0.207 12.204 
+ BW70 24 85 2.9 42 260 13 18 35 11)4 0.452 0 .225 13.122 
+ AI 33 87 2.8 35 229 9 17 26 177 0.41)8 0.197 8.851 
+ 8W71 38 89 3.5 42 203 5 7 21 170 1.113 0 .224 10.204 
+ A29 I) 91 2.5 36 191 4 7 17 163 0.942 0 .211 8.542 
OR 51 91 4.0 54 360 98 82 17 163 1.199 0.479 82 .771 
RES 24 CW4 = 12% A2 = 10% BW53 = 7% A30 = 6% 
223 
195 
Table I. Continllcd _______________________________ _ 
SI" SPEC AVE INCl N TP FN FP TN Q R CHI' 
















M 92 4.8 
20 93 2.0 
45 97 1.8 
2(1 98 1.3 
55 97 2.9 
23 CW3 = 17'if 
BCCr.CHAD 
70 79 6.3 
75 90 0.2 
73 96 6.3 
43 CW4 = 10<;; 
CNTS.105 
76 99 6.4 
20 A26 = 20<;; 
535 EAE MYR FurJinger 
CW4 82 98 7.2 
RES 71 BW53 = 22% 














4.9 OR 68 
RES 27 A2 = "'if 
196 FRA BET EI218 















+ CW2 2(, 
OR 87 
RES 9 AI = 10<;; 
214 US2 WOl NW14002 
CW4 95 73 7.4 
B\\'53 62 79 7.1 
B35 84 86 6.9 
B51 58 90 6.5 
+ BW58 33 92 4.8 
BW70 20 94 2. I 
'" BW52 20 95 3.5 
'" TE79 33 94 0.0 
OR 87 94 6.6 
RES 37 CW3 = 10% 
538 BEN BOU 64307 617184 
CW4 63 98 5 .9 
RES 43 A30 = 10% 
204 ITJ CON CAI81 
CW4 8R 








62 354 40 24 24 266 I.R04 OSW 
23 290 6 20 18 246 0.386 0.177 
15 264 Ij 72 5 174 0.314 0.230 
7 179 I 14 4 160 0.283 0.105 
34 354 59 116 5 174 0 .946 0.398 




358 73 13 56 216 2.297 0.569 
272 47 10 Q 206 3.1166 0 .7110 
358 120 23 9 206 4.214 0.809 
CW6 = 7'7c BW70 = 7% 
84 357 120 23 , 212 5.200 0.852 
A30 = 20,}( BW42 = 20% BW58 = 20% CW3 = 20% 
94 322 118 7 3 194 6 .365 0.928 








All = 11% BW61 = 11% 
o 90 222 4.185 
I 50 221 4.588 
75 4 146 1.338 
o 4 146 17 .600 o 







































B8 = 11% B45 = 6% 






3 30 168 3.227 
5 16 163 2.766 
4 12 159 2.054 
34 4 125 0.375 
50 4 125 4.795 



















3 .033 0.640 
3.709 0.468 
3 .253 0.536 
5.065 0.522 
2.799 0.337 
0 .356 0 .225 
3.186 0.263 
14.100 0 . 151 
3.938 0.766 
79 
835 = 10% 














CW7 = 10% A23 = 10% 
19 196 4.098 0 .791 
16 194 1.909 0.286 
16 194 4.068 0.798 
RES 37 A2 = 7% CW7 = 7% 
534 UKI FES Langlais 
CW4 49 100 
RES 33 
62 213 2.872 0.646 4.3 56 355 79 
2101 GER MUC TUI09 
* BW4 52 95 2.7 29 347 70 175 5 
RES 23 A24 = 8 % 87 = 8 % A2 = 8 % 845 = 8 % 
97 0.533 0.258 
2103 UKI GEL 103.1.51 
8W70 = 8% 
* BW6 76 35 5.6 72 351 199 78 48 








































Table 2. Core Sel Sera Analysis : Caucasians 
STR SPEC AYE INCL N TP FN FP TN Q 
R CHI' 
533 BEN ENG CLBI05 
CW4 90 100 7.8 100 382 98 0 
283 10.199 0.986 371. 724 
RES 33 
536 US5 CRO Martinez2.21.83 
CW4 85 100 7.3 95 382 93 5 283
 8.857 0.952 346.275 
RES 33 
537 UKI BRS 5956 .CBT 
CW4 91 98 7.7 99 381 96 I 7 
277 9.334 0 .940 336.847 
RES 38 CW6 = 15 % A:!4 = 12% BI3 = 8% AI=8% BW60 = 8
% 
539 EAE ZAR MVh: 
CW4 75 ')7 7.2 98 378 95 2 9 272
 6.798 0.920 320.215 
+ BW50 54 99 3.5 45 281 5 6 
4 266 2.192 0.482 65.314 
OR 74 99 6.8 93 378 100 8 
4 266 6.246 0.916 317.000 
RES 27 AI = 12 % A24 = 12% BW57 = 12% CW6 = 12% A2 = 6% 
541 NCY MRY 22166.0 
CW4 71 99 6.5 88 382 86 12 2 282 
7.280 0.897 307. 135 
RES 20 A2 = 17 % A31 = 17% BW50 = 17% B44 = 17% CW6 = 17% 
543 US8 JLE Billing 
CW4 78 71 7.2 98 381 95 2 81 203 
3 .447 0 .603 138.355 
CW6 74 99 6 .9 94 284 78 5 3 198 8
.465 0.924 242 .343 
OR 77 99 7. 1 96 381 173 7 3 198 
8.152 0.943 338.464 
RES 78 · A2 = 13% A3 = 7% B7 = 7% BI3 = 7% CW2 = 7% 
545 US5 TER TER.C46lOB 
CW4 90 64 7.7 99 382 97 1 101 183 3.794 0.55
0 115.722 
CW6 74 89 7.0 95 284 79 4 22 179 5.22
9 0.794 179.039 
+ B5 64 91 4 .0 SO 201 4 4 18 175 1.317 0
.263 13.880 
* TECIO 33 91 0.0 0 193 0 0 18 175 
13.381 0.097 1.833 
OR 83 ql 7.2 95 382 180 9 18 175 5.196 0 .
855 279 .357 
RES 44 .\ 2 = 11 % CW7 = 8% B7 = 7% CW5 = 7% -
540 FRA DDC Pierson 
CW4 98 69 8.0 100 382 98 0 89 195 4 . 191 0.596 135.617 
CW6 92 97 7.8 100 284 83 0 6 195 8 .886 0 .943 252 .745 
OR 96 97 7.9 100 382 181 0 6 195 9 .758 0 .964 354.97
2 
RES 33 A2 = 7% A23 = 7% B49 = 7% B51 = 7% AI =7% 
547 GER MUE MVE:!3928 
CW6 79 94 6.8 90 380 81 9 16 274 4.278 0 .818 254.447 
RES 61 B35 = 17% CW4 = 17% A3 = 11 % A2 = 7% 
558 FRA DDC Devinal 
CW7 81 68 6.8 89 381 119 IS 78 169 1.840 0.544 112.608 
+ CW7L 81 71 7.6 100 247 9 0 69 169 2.850 0.278 19. 101 
OR 81 71 6 .9 90 381 128 15 69 169 2.092 0 .583 129.S43 
RES 56 CW4 =9% B35 = 7% A3 = 6% AI = 6% A2 = 6% 
205 GER 8RA 918B 
B35 95 95 7.9 100 382 78 0 16 288 8.081 0.880 295 .958 
+ CW7L 33 96 2.7 30 304 3 7 13 281 1.207 0.221 14.901 
+ 839 56 96 2.4 21 294 3 11 10 270 0.799 0 .202 12.054 
OR 92 96 6 .6 82 382 84 18 10 270 4.504 0.804 246.907 
RES 30 CW7 = 9% AI=7% CW6 = 7% 
192 US5 PNW Juli 
835 73 95 6.9 94 382 73 5 14 290 6.377 0.849 275.409 
+ BSI 20 97 1.7 15 304 6 33 8 257 0 .275 0 .204 12.629 
* BW53 60 97 2.0 14 265 I 6 7 2S1 0.958 0.150 5.944 
OR 69 97 5.2 68 382 79 38 8 257 2.998 0.704 189.591 
RES 26 AI = \0% CW7 = 10% B8 = 8% CW6 = 8% A24 = 8% 
191 US2 MBC BC.CYCHAD 
835 61 96 5.9 81 382 63 15 13 291 4.412 0.767 224.624 
BW53 69 97 5.4 71 304 5 2 8 289 4.329 0.503 76.985 
+ 85 11 98 3.1 38 297 3 5 5 284 3.053 0.370 40.642 
+ CW4 33 99 LX 16 289 3 16 2 268 0.888 0.295 25.173 
OR 59 9'1 5.0 66 382 74 38 2 268 4.263 0.740 209.121 
RES 14 A2 = 18% B44 = 18% CW5 = 18% BSI = 9% CW2 = 9% 
225 
197 
Table 2. Continu('d 
STR SPEC AVE INCL N TP FN FP TN Q R CHP 
562 rn PUR CNTS. 105 
CW4 86 100 6.3 78 376 76 21 278 5.818 0.840 265.000 
RES 33 
535 EAE MYR Furlinger 
CW4 79 99 6 .9 93 373 87 7 3 276 6.511 0.922 316.906 
RES 14 A26 = 10% All = 10% B8 = 10% 839 = 10% CW7L = 10% 
347 US5 MIT B5612.4 
B7 96 80 7.9 100 374 74 0 60 240 5.861 0 .660 162 .918 
CW4 4~ 97 4.~ 59 300 53 37 7 203 2.455 0 .631 119.551 
+ 8W60 "'-: lJ!:I :.0 .,., 210 4 14 3 189 0.810 0 .328 22.570 
• BW67 33 98 0 .0 0 192 0 0 3 189 19 .330 0 .243 11.321 
• 8W42 60 99 8.0 100 192 I 0 2 189 9 .370 0 .524 52 .690 
OR 74 98 5 .5 72 374 131 51 3 189 3.604 0.730 199. 194 
RES 56 All = 12% A2 = 12% CW7 = 12% A25 = 6% B51 = 6% 
196 FRA BET EI~18 
+ CW4 99 95 7.9 99 382 97 I 13 271 7.207 0 .905 312 .595 
835 45 97 7.0 100 284 4 0 9 271 6.542 0.526 78.619 
• 8W53 71 97 8.0 100 280 2 0 7 271 7.075 0.447 56.037 
OR 97 97 7.9 99 382 101 9 271 j·.5 ;f, 0 .930 330.413 
RES 62 A2 = 10% CW7 = 10% A24 = 6% 85 = 6% All = 6% 
214 US2 WOL NW I 4002 
CW4 96 87 7.7 97 382 95 3 38 246 4.843 0.761 221.408 
B51 57 94 5.4 71 284 24 10 14 236 3.635 0 .613 106.827 
+ 85 79 98 6.8 89 250 8 r - 6 235 4 .877 0 .679 115.309 
B35 78 99 8.0 100 241 3 0 3 235 7.421 0 .654 103.234 • 8W52 33 99 1.3 0 238 0 12 3 223 1.611· 0 .041 0.395 • 8W53 71 100 8.0 100 238 2 0 I 235 9.444 0 .718 122.600 • 8W70 33 99 1.0 0 238 0 6 3 229 0.674 0.074 1.308 • TE79 33 99 0.0 0 238 0 0 3 235 19.862 0.244 14.195 
OR 89 99 7. 1 90 382 ' 130 14 3 235 6.219 0 .900 309.756 
RES 56 CW6 = 18% A29 = 12% BW53 = 12% A25 = 6% A30 = 6% 
538 BEN BOU 64307 617184 
CW4 62 98 5 .9 83 382 81 17 · 6 278 4 .709 0 .833 265 . 101 
RES 45 A24 = 10% 
204 ITI CON CAI81 
CW4 87 99 7.4 95 380 93 5 4 278 6.754 0.932 329.811 
RES 33 A2 = 12% B7 = 12% A24 = 12% B27 = 12% CW2 = 12% 
534 UKI FES Langlais 
CW4 56 100 4.3 57 380 55 42 282 3.419 0.688 179.707 
RES 33 
2101 GER MUC TU 109 
+ CW6 66 86 4.5 56 359 48 37 37 237 1.131 0.428 65.637 + 85 71 89 6.3 82 274 9 2 28 235 3.186 0 .405 44.866 • BW4 71 98 2 . 1 17 263 26 124 2 III 0.443 0 .244 15.600 OR 69 98 3. 1 34 359 83 163 2 III 1.104 0 .345 42 .716 RES 43 CW8 = 17% A3 = 8% AW33 = 8% BW64 = 8% B35 = 8% 
2103 UKI GEL 103. 1.51 
B\\'6 74 81 5.3 68 360 205 97 11 47 1.220 0.364 47.776 + CW4 38 88 3.8 50 58 5 5 6 42 1.078 0.355 7.324 OR 73 88 5.3 67 360 210 102 6 42 1.537 0.377 51.144 RES 47 B44 = 14% A2 = 10% A32 = 7% CW5=7% CW7 = 7% 
198 
Table 3. Core Set Sera Analysis : Orientals 
STR SPEC AVE [NCL N TP FN FP 
TN Q R CHP 
533 BEN ENG CLBI05 
CW4 86 99 7 . 1 91 586 50 5 
5 526 7.209 0..89[ 465 .682 
RES 9 A26 = 12 % BW61 = 12% A24 = 
12% CWI = 12% CW3=8% 
536 US5 CRO Martinez2.2 I .83 
CW4 79 02 6.8 87 567 47 7 42 
471 3.936 0. .632 226.767 
+ BW46 40 0:- 2.8 31 513 20 44 22 
427 0.856 0.319 52.0.70. 
+ CWI 57 100 2. 0 18 449 22 103 0 
324 0 .812 0. .361 58.538 
OR 66 100 3.3 37 567 89 154 
0. 324 2 .015 0..495 139.153 
RES 33 
537 UKI BRS 5956.CBT 
CW4 92 96 7. t 87 584 48 7 20. 509 
6.259 0..755 332.629 
RES 22 A24 = 13% A26 = 10.% CWI = 9% A2 = 7% BW61 = 7% 
539 EAE ZAR MZ467 
CW4 77 99 6 .5 85 572 47 8 5 512
 5 .973 0. .858 421.570. 
RES 27 All = 16% CW6 = 11 % A2 = 11% 
541 NCY MRV 22166.0. 
CW4 78 99 6 .7 87 584 48 7 4 525 
6 .345 0 .879 451.257 
RES 14 A24 = 17% A2 = 8% B38 = 8 % BW54 = 8%
 CWI = 8% 
543 US8 JLE Billing 
CW4 78 97 6.7 89 579 49 6 18 506 
4 .829 0 .779 351.478 
CW6 54 100 5.1 67 524 16 8 2 498
 4.198 0..747 292.310 
OR 73 100 6.2 82 579 65 14 2 
498 5.560 0..872 440.521 
RES 43 A32 = 10% B44 = 10% A2 = 10% BW63 = 10% 
CW3 = 10% 
-
545 US5 TER TER.C4() IOR 
CW4 83 'oH 7.2 93 583 51 4 31 497 5.281 0..725 3
0.6.637 
CW6 54 97 5 .0 67 528 16 8 15 489 3.06
8 0 .560 165.657 
+ BW59 45 98 2 .3 22 504 4 14 I1 475 0.7
\3 0..232 27.045 
.. TECIO 20 98 6.0 100 486 1 0 10 475 8.491 0.300 43.878 
OR 75 98 5.7 73 583 _ 71 26 I1 475 3.67
3 0.756 332.831 
RES 36 A24 = 16% CW3 = 11% All = 7% B7 = 7% AW33 = 7% 
540. FRA DDC Pierson 
CW4 93 94 7 .7 98 584 54 I 31 498 6.096 0. .759 336.583 
CW6 69 99 7.1 100 529 24 0 7 498 8. 153 0.859
 390.401 
OR 86 99 7.5 99 584 78 I 7 498 8.264 0 .938
 513A80 
RES 41 A24 = 17% BW62 = 10% AW33 = 7 % B44 = 7% A26 = 7% 
547 GER MUE MUE23928 
CW6 63 96 4 . 1 52 561 12 11 20. 518 1.951 0..415 96.718 
+ CW4 60 98 2.4 22 538 11 40 9 418 0.153 0.30.8 50.953 
+ CWI . 
3 11 99 2.0 27 487 3 8 6 470 IA02 0.304 44.989 
OR 56 99 2.8 31 561 26 59 6 470 1.183 DA5[ 114. [30. 
RES 20 A2 = 10.% AW33 = 10% All = 10% B44 = 7% CWI =7% 
558 FRA DDC Devinat 
CW7 73 89 6 . 1 81 586 112 21 50 397 2.682 0..657 253.217 
+ All 52 94 2.7 29 447 30 74 20 323 0,492 0.JD8 42.402 
+ B7 64 95 3.4 40. 343 4 6 16 317 1.377 0 .264 23 .962 
OR 69 95 4 .6 58 586 146 107 16 317 1.944 0 .584 199.587 
RES 31 A2 = 12% A24 = \0% CW/ =8% CW3 = 6% 
205 GER BRA 918B 
B35 69 85 6.4 87 580. 60 9 76 435 3 .088 0..548 174.250 
+ BW54 47 88 2.7 31 51/ 21 46 55 389 0 .263 0.IH2 16.883 
+ B27 69 89 4.9 62 444 5 3 50. 386 1.747 0.210 19.635 
+ BI5 56 89 4 .8 60 436 3 2 47 384 1.792 0 . 172 12.831 
+ CW8 60 90 2 .8 30 431 6 14 41 370. 0 .479 0..143 8.797 
+ TSI 33 4 1 3.4 43 411 3 4 38 366 1.162 0.156 10..0.21 
+ CW4 24 < )~ 1 , 23 404 9 30 29 336 0 .256 0..159 10.173 
+ BW58 33 9) 2.6 38 365 3 5 26 331 1.004 0 . 178 11 .532 
OR 60 93 3 .9 49 580 110 113 26 331 1.178 OARI 134.119 
RES 27 A2 = 11% A24 = 10.% CW3=8% All = 6% 
199 
Table 3. COlllinucd 
STR SPEC AVE INCL N TP FN FP TN Q R CHI' 
192 US5 PNW Juli 
B35 58 95 6. 1 85 562 58 10 24 470 4.072 0 .738 306.432 
+ BI5S-
Ll 60 96 6.3 86 494 6 I 18 469 6.522 0.446 98.270 
+ CW8 9 97 1.8 21 487 4 15 14 454 0 .658 0 . 199 19.269 
• BW53 33 97 1.0 0 468 0 I 14 453 4.704 0.081 3.079 
OR 55 97 5 .2 72 562 68 26 14 454 3.344 0 .729 298.730 
RES 29 A2 = 12% A24 = \0% CW3 = 10% B\\'62 = 7% BW52 = 6% 
191 US2 MBC BC.CYCHAD 
B35 68 96 6 .0 81 572 55 13 21 483 3.781 0.727 302.233 
+ B51 28 98 2. 1 20 504 JI 43 10 440 0 .563 0.284 40.536 
• BW53 60 Q8 8.0 100 450 I 0 9 440 8.689 0.314 44.355 
OR (i! l)~ ·n 54 572 66 56 \0 440 2. 138 0.623 221.938 
RES 39 A24 = 19% A2 = 6% EW60 = 6% BW52 = 6% CW3 = 6% 
562 ITI PUR CNTS. I05 
CW4 86 97 7 .0 89 565 47 6 13 499 5.679 0 .808 369.230 
+ 8W62 38 98 1.5 8 512 5 55 8 444 0.157 0. 142 10.304 
OR 8] 98 4.0 46 565 52 61 8 444 2.027 0 .571 184 .480 
RES 26 A24 = 13% A31 = 10% A2 = 10% 844 = 6% CW3 = 6% 
535 EAE MYR FurJin!!er 
CW4 90 98 6 .9 87 575 47 7 12 509 5.276 0.808 375.230 
RES 52 A24 = 12% A2 = 8% CW3 = 8% 844 = 6% A26 = 6% 
347 US5 MlT 85612.4 
87 89 88 7.6 98 583 61 i 63 458 5.320 0.646 243.489 
CW4 73 93 4.4 54 521 28 24 35 434 1.709 0.426 94.381 
8W67 7 94 2.7 46 469 6 7 29 427 1.277 0.256 30.617 
+ 8W56 11 94 3.2 60 456 3 2 26 425 2.396 0.241 26.517 ' 
+ 8W48 38 95 2.0 16 451 5 26 21 399 0.460 0 . 131 7.709 
+ BW55 27 96 1.9 15 420 4 22 17 377 0.731 0 .135 7.621 
+ B40 27 96 1.8 14 39~ 4 25 \3 352 0.403 0 .144 8. 135 
+ BW60 23 97 1.4 8 365 5 55 8 297 0 .166 0 .121 5.366 
• BW42 33 97 1.0 0 305 0 I 8 296 4.502 0 . 106 3.423 
OR 69 97 3.6 42 583 116 162 8 297 1.545 0.475 131.515 
RES 26 A2 = 15% CW3 = 12% A26 = 8% 8W61 = 8% 
196 FRA 8ET EI218 
+ CW4 96 84 7.7 96 575 53 2 81 439 4 .411 0.559 179.453 
B35 73 92 6.0 77 520 43 13 38 426 2.969 0.583 176.826 
+ 851 14 95 2.5 31 464 17 37 21 389 0 .856 0.310 44.522 
+ 827 33 96 3. 1 43 4\0 3 4 18 385 1.596 0 .240 23.697 
* 8W53 20 96 6 .0 100 403 I 0 17 385 7.650 0.234 22.111 
OR 74 96 5.3 67 575 116 56 18 385 2.640 0.679 265.296 
RES 38 A24 = 13% BW60 = 8% 
214 US2 WOL NW 14002 
CW4 91 77 7.6 96 584 53 2 123 406 3.386 0.463 124.928 
835 69 84 5.8 78 529 47 13 76 393 1.887 0.464 114.004 
B51 77 90 5.0 62 469 33 20 43 373 1.681 0.445 92 .706 + BI5S-
Ll 54 91 5 .6 71 416 5 2 38 371 3.492 0.265 29.216 BW52 35 94 2.5 28 409 17 44 21 327 0.547 0.269 29.700 + B5 56 95 5.8 75 348 3 1 18 326 3.860 0.316 34.757 * BW53 20 95 6.0 100 344 1 0 17 326 8.618 0.233 18.619 • 8W70 33 95 1.0 0 344 0 3 18 323 1.272 0.033 0.381 • TE79 33 95 0 .0 0 344 0 0 18 326 17.346 0. 105 3.806 OR 75 95 5.2 66 584 158 82 18 326 2.354 0.647 244.739 RES 49 BW62 = 11 % CW3 = 11 % A2 = 9% A24 = 9% BW46 = 6% 
538 BEN BOU 64307 617184 
CW4 69 98 5.8 76 579 41 13 10 515 4.866 0.753 328 .587 + BW60 38 99 1.3 7 525 5 69 5 446 0.171 0.149 11.731 OR 66 99 3.2 36 579 46 82 5 446 1.801 0 .507 148.884 RES 8 A24 = 18% A2 = 9% B7 =: 9% CW1=9% 
200 
Table J. Continued 
STR SPEC AVE INCL N TP FN 
FP TN Q R CHI' 
204 IT! CON CAI81 
CW4 79 93 6.5 85 580 
46 8 36 490 4.437 0 .649 244.548 
+ CW3. 
2 4 95 1.9 22 526 
\0 35 26 455 0.451 0.191 19.276 
+ B27 56 95 4.2 50 
481 3 3 23 452 2.411 0 .234 26.434 
OR 65 95 4.4 56 580 
59 46 23 452 2.162 0.565 185.191 
RES 14 A24 = 8% CWI=8% BW
61 = 8% All = 8% CW3=8% 
534 UKI FES Langlais 
CW4 61 99 5.1 67 581 37 
18 6 520 4.597 0.733 312.372 
RES 8 AZ = 13% BW61 = 9% A24 = 9% 
ZIOI GER MUC TUI09 
+ B27 87 91 6.4 75 570 6 
2 50 512 3.761 0.263 39.364 
BW4 37 98 1.9 16 562 43 
224 7 288 0.352 0.239 31.971 
OR 45 98 2.0 18 570 49 
226 7 288 0.409 0 .257 37.626 
RES 41 A26 = 11 % BW60 = 9% A24 = 9
% A31 = 9% A2 = 6% 
Z\03 UKI GEL 103.1.51 
• BW6 75 17 6.6 88 573 450 60 52 11 
0 .064 0.058 1.944 
RES 79 AZ4 = 14% A2 = 8% B44 = 7% 
AW33=7% 851 = 7% 
Core Set Serology 
Results of the Core set 'L~r : \ :!nalysis in the three main eth-
nic groups (Blacks. Cw.: I' i:!fIs. Orienlals) are reported 
in Tables I. 2. and 3. 
The analysis includes the sera submitted as recogniz-
ing Cw4 and/or Cw6 as well as the sera whose reactions 
have been observed to be associated with these antigens 
in the previous central Jata analysis. 
The high number and the good quality of the sera sub-
milled allow a very good definition of Cw4. The situa-
tion regarding definition of the Cw6 antigen with the 
Tenth Workshop Core 'iet sera is not satisfactory: when 
Cw4 is absent. Cw6 may be assigned because of the posi-
tivity of the cluster of Cw4+Cw6 sera (lOW 543. 
IOW540. and IOW545): serum IOW547. the only Cw6 
monospecific serum. is negative in 14% of Cw4-ve. 
Cw6 + ve cells and positive in 15% of Cw4 + ve.Cw6 - ve 
cells. Thisprdblem is clearly shown in Table 4. in which 
the reaction patterns of some selected sera in the three 
main ethnic groups are reported. 
Antigen Society Serology 
The results of the Antigen Society sera analysis are 
reported in Tables 5 and 6: Analysis has not been per-
formed in Orientals because of the very low number (18) 
of cells tested. Among the 15 sera submilted. two recog-
nize both Cw4 and Cw6. ten Cw4. and two Cw6. The 
reaction patterns of some selected sera are shown in 
Table 7: The problems in the definition of Cw6 appear to 
be similar to those observed with Core set sera. 
201 
1':1"1(' 4. FI ('<I " ,. / 1(11. 11 nllhe He:ll'Iinn Patlern
s or Selected Core Set Sera (Pallerns Observed in 
Only Onc Cell/I:I\\' Nni Bee" Rep!"ie!!) 
Phrnotype Tenth W No. 
Population 
----- _. --_._.- .. - _. 
Cw4 Cwo :; 5 .~ :; 5 5 5 
Black Caue Ori 
.J ·1 I 4 .1 4 3 , 0 :; 7 3 I 5 
a a a h c c c 
+ 
(N= 118) (N=73) (N=56) 
+ + + + + + 63 75 
57 
+ + I + + + + 14 
4 16 
+ I + 8 
+ + + + + 
4 7 
+ + + + + + 3 
+ + + + + 5 
+ + + + 
4 
+ + + + + + 2 
+ + + + + + 2 
+ 
(N=54) (N=84) (N=26) 
f- + + 50 74 
46 
+ + + 9 
8 15 
+ + + 6 
+ + + 11 5 8 
+ + 
8 
+ + + 11 
(N= 174) (n=198) (n =498) 
98 87 91 




a = Cw4+Cw6: h = Cw6: c = Cw4 
Table 5. Antigen Society Sera /\naly~ i~ : Illad; ~ 
.. ... • .' - ' . ... - - -.- - -. -- .- - ._- .-
STR SPEC /\\T INeL N TP FN FP T
N Q R CHP 
4795 US5 MIT C5902.4 
CW4 66 88 5.2 66 200 19 10 20 
151 1.642 0.474 44.873 
+ AI 7 91 .1.4 55 171 6 5 
14 146 1.818 0 .351 2 \.108 
+ CW6 57 97 2.4 24 160 10 32 4 
114 0.569 0 .314 15 .813 
+ BW42 45 lOO I.(i 11 118 4 :n 0 81 0.312 
0 .261 8.068 
OR 53 lOO 2.9 :13 200 39 80 
() 81 1.129 0 .398 31.699 
RES 33 
4796 NCY KAP CWR.PLA.241 
+ B35 65 94 7.4 100 200 7 0 11 182 5.
736 0 .587 68.853 
+ A26 9 96 1.7 17 193 4 20 7 162 0.576 0 . 189 6.8
97 
+ A23 33 97 1.8 14 169 3 19 4 143 0.487 0 . 197 6.541 
* CW4 71 98 1.7 10 147 2 19 2 124 0 .280 
0 . 185 5.035 
OR 42 C)7 2.5 26 200 14 39 4 143 0.733 0.361 26.064 
RES 82 ." 21) I \ ~! Ill' ~ 1.1 % BW42 = 13% BI3 = 13% BW70 = 13% 
4797 US5 MIT D4155.1 
CW4 28 95 4 . .1 62 200 18 1\ 9 162 2.239 0 .578 66.768 
+ 835 56 96 7.3 100 171 3 0 6 162 6.478 0 .539 49 .628 
+ A26 45 99 2.1 19 168 4 17 2 145 0.700 0 .317 16 .882 
OR 36 99 3.6 47 200 25 28 2 145 1.869 0 .583 68 .019 
RES 14 A2 = 17% /\29 = 17% RI3 = 17% 839 = 17% CW2 = 17% 
4798 GER GAZ T.1758 
CW4 97 89 R.O "Xl 2oo 29 0 19 152 6 .247 0 .722 104.182 
+ AI 33 94 5 .3 R2 171 9 2 10 150 3.559 0.577 56.976 
OR 82 94 7.3 95 20{) 38 2 10 150 4.961 0.820 134.457 
RES 57 A30 = 12% A26 = 8% CW6 = 8% A29 = 8% 
230 
202 
Thble S. Contillued 
STR SPEC AVE INCL N '1'1' FN 
1·1' TN Q R CHI! 
. . -- --- - - '-'-" 
4799 FRA BET 1268 
cw4 43 91 5.0 79 200 23 b 16 155 
2.681 0.613 75 .254 
+ A23 39 96 3.0 40 1
71 \0 15 6 140 1.770 0.432 3 \.873 
OR 42 96 4.1 61 200 
33 21 6 140 2.861 0.631 79.623 
RES 7 A30 = 14% A26 = 7% B7 = 7% B15 = 7% CW3 = 7% 
4800 US5 PNW BORT 
CW4 30 99 4.1 59 200 1
7 12 2 169 2.647 0.677 9\,727 
RES 33 
4801 IT1 MTT FIOII3 
CW4 75 92 7.1 93 199 26 
2 14 157 5.001 0.723 \04 . 112 
+ AI 26 96 4.6 73 171 8 
3 6 154 3.264 0.603 62.195 
+ A30 7 100 \,4 10 160 6 53 
0 101 0.287 0.246 9 .655 
OR 54 100 3.4 41 199 40 
58 0 101 \.643 0.501 50.044 
RES 33 
4802 UKI CXH Lopian 
CW4 90 95 7.9 100 200 29 0 
8 163 7. 126 0.850 144.433 
+ B44 9 1)7 1.8 16 171 4 21 
4 .142 0.763 0.229 8.987 
+ A29 R' 11)11 .1 .11 2(
) 146 .t 10 () 132 \.645 0.495 35.750 
OR ~2 I ' Hl .1. () 54 200 37 31 
0 132 2.909 0 .655 85 .790 
RES 33 
4803 EAE ZAR ~'IZ435 
CW4 49 87 4.7 67 198 18 9 22 
149 2. \04 0.455 41.073 
+ BI3 26 91 5.4 80 171 8 2 14 1
47 3.447 0.491 41.229 
+ AW68 5 95 2 . 1 24 161 8 26 6 
121 0.476 0.273 11. 987 
+ 845 9 (18 1.8 27 127 4 11 2
 110 1.376 0.377 18.054 
OR 29 98 3 .2 44 198 38 48 2 
110 1.505 0 .516 52.774 
RES 14 A30 = 33% B44 = 33% BW58 = 33% BI5 = 33% CW3 = 33% 
4804 FRA PRR SCH 1423 
CW4 88 93 6.8 85 198 23 4 12 159 4.510 
0.692 94.920 
+ AI 7 96 3.4 55 171 6 5 6 
154 2 .738 0.483 39.914 
+ B44 45 99 1.9 17 160 4 19 2 135 
0.592 0.296 14 .013 
OR 68 99 4.3 54 198 33 28 2 135 
2.580 0.629 78.248 
RES 14 A30 = 20% A26 = 20% B7 = 20% BI5 = 20% CW3 = 20% 
4805 BEN OPT SMEETS.80 
CW4 96 91 8.0 100 198 27 0 16 155 6 .668
 0.742 \09 . \06 
+ Al 7 94 3.4 55 171 0 5 III 150 2.680 
0.407 28.279 
+ A30 47 98 1.7 14 160 8 51 2 99 0.268 0.22
5 8.092 
OR 74 <)8 3 .6 42 198 41 56 2 99 1.232 0.481 45.8
96 
RES 71 AW68 = 20% A29 = 20% BW57 = 20% BW70 = 20% CW6 = 20% 
4803 EAE ZAR MZ435 
CW4 49 87 4.7 67 198 18 9 22 149 2 . 104 0.455 4\.073 
+ BI3 26 91 5.4 80 171 8 2 14 147 3.447 0.491 41.229 
+ AW68 5 95 2.1 24 161 8 26 0 121 0.476 0 .273 11.987 
+ B45 9 98 1.8 27 127 4 11 2 110 1.376 0 .377 18.054 
OR 29 98 3 .2 44 198 .18 48 2 110 1.505 0.516 52.774 
RES 14 A30 = 33% B44 = 33% BW58 = 33% BI5 = 33% CW3 = 33% 
4804 FRA PRR SCH 1423 
CW4 88 93 6.8 85 198 23 4 12 159 4 .5\0 0 .692 94.920 
+ AI 7 96 3.4 55 171 6 5 6 154 2 .738 0.483 39.914 
+ B44 45 99 1.9 17 loO .t 19 2 135 0.592 0.296 14.013 
OR 68 99 4 .3 54 198 3.1 28 ~ US 2.580 0.629 78.248 
RES 14 A30 = 20% A26 = 20% B7 = 2() 'Ir 1315 0:. 20'):'; CW3 = 20% 
4805 BEN DPT SMEETS.80 
CW4 96 91 !U) lOO I<JX 27 (J l(i 15:'i 6.668 0.742 109. 106 
AI 7 IJ·t .1.-1 .'is 111 h .'i III I 'of) .! .hHO 0 .·107 2K.27') 
+ A30 47 98 1.7 14 160 H 51 2'J'1 O. 
.~(,X 0 .225 8.092 
OR 74 98 3.6 42 I<)X 11 ,r, IN 1.232 0.481 45 .896 
RES 71 AW68 = 20% A29 = 20% 8W57 = 20'ic I!Will = 20% CW6 = 20% 
231 
203 
Tahle 5. Ctlll/ill/lcd 
STR SPEC AYE INeL N T
P fN FP TN Q R CHP 
4806 UKI GEL YAU20802 
CW4 84 94 7.6 100 2
00 29 0 10 161 7.504 0 .823 135.4
68 
+ AI 33 98 3.4 55 
171 6 5 4 156 2.434 0.535 48 .9
26 
+ B44 9 100 1 ~ 
17 160 4 19 0 137 0.870 0.378 
22.824 
OR 68 100 
1 ( , h:! ZOO 39 24 0 137 3.343 0.716 102
.621 
RES 33 
4807 BEN ROD YR61809 
CW4 74 80 6 .6 86 198 
25 4 34 135 2.377 0.504 50.332 
CW6 45 93 4 .0 52 1
69 26 24 8 III 1.278 0.509 
43.761 
OR 60 9.' 5 .0 65 
198 51 28 8 III 2.(1I4 0 .612 74
.275 
RES 26 A30 == 12% nW58 = 12% 
AI =6% n7 = 6% BW65 = 6% 
4808 US5 SIN 13782 
CW6 67 91 4.() 62 200 
32 20 14 134 :. 1.778 0.537 57.701
 
+ BW 45 '11 
:; 1\ (,7 148 4 2 10 132 2.674 0.400 23.7
22 
OR 65 
.I, t ) f -l .~ 200 36 22 10 132 2.069 0.587 68 .
854 
RES 22 B\V58 ~ 14 % B44 = 14% A3
0 = 14% AW68 = 10% BW70 = 10% 
4809 UKI AST DB5424 
CW6 71 80 (d in 200 43 9 30 118 
1.937 0.563 63 .284 
+ B39 33 In 6 .7 100 148 
6 0 24 118 4.012 0.394 23.028 
+ CW4 74 RR J .h 'W 142
 10 15 14 10] 0.655 0.285 11 .560 
+ A3 45 I)() .10 .1 .1 
117 4 8 10 95 0.621 0 .232 6.310 
OR 67 l}(} 5 .2 1>(
, ZOO fJ.1 32 10 95 1.718 0 .583 67 ,961 
RES 39 AJO = IIl'X 11\ no ~ - 1 2 "I c\V:! == 12% A26 = (i% 
B7 = 6% 
Tahle 6. Allligen Society Sera Analysis : Caucasians 
STR SPEC AYE INCL N TP FN FP TN
 Q R CHI' 
4795 US5 MIT C5902.4 
CW4 61 95 5.3 71 348 • 63 26 14
 245 2.931 0 .682 162.059 
+ BW57 20 97 2.7 29 259 6 15 8 230
 1.224 0.310 24.927 
+ B37 33 98 2.5 23 238 3 10 5 
220 1.163 0.278 18.445 
OR 56 08 4.5 59 348 72 51 5
 220 2.595 0.644 144.328 
RES 38 AI = 11% CW6 = 11 % A24 = 7% B44 = 7% CW3 = 7% 
4796 NCY KAP CWR.PLA.241 
+ B35 61 97 5. 1 69 346 47 21 9 
269 3.132 0 .705 171.945 
+ BW53 54 99 5.1 71 278 5 2 
4 267 3.922 0.602 100.862 
+ B51 33 100 1.5 8 271 3 35 
I 232 0.466 0 .217 12.817 
.. CW4 33 lOO 1 ., Il 2.n 0 13 I 219 1.073 0.075 1.294 
OR 59 lOO 1'1 .\1" 'i5 58 I 23
2 2.470 0.609 128.438 
RES 60 A2 = lO';; , 'I ' 1 ' 20 '/'. 1\7 = 20% B44 = 20% CW7 = 20% 
4797 US5 MIT D4155 . 1 
CW4 74 92 6 .3 8.1 349 74 ' 15 22 238 3.634 
0.724 182 .982 
+ B51 27 t}7 3.2 44 260 15 19 7 219 1.530 0.493
 63 . 114 
+ BJ5 33 98 5 .. ' 100 226 3 0 4 219 7.8/7 0.610
 84 .090 
OR 65 98 5.4 TJ .149 92 34 4 219 3.610 
0.761 202 . 141 
RES 64 A2 = 14% A:!·t = 9% 87 = 9% CW7=9% A29 = 9% 
4798 GER GAZ 1'.1758 
CW4 93 91 7.7 98 348 87 2 24 235 5.534 0.823 235.494 
+ BSI 35 96 3.3 41 259 14 20 10 215 2.071 0.426
 . 46 .979 
+ B35 78 97 8 .0 100 225 3 0 7 215 6.424 0 .516 59 .796 
OR 86 97 6.5 83 348 104 22 7 215 4.322 0 .813 230.287 
RES 65 CW7 = 11 % A2 = 8% 87 = 8% CW6 = 8% 
4799 FRA BET 1268 
CW4 61 98 5.8 80 347 71 18 4 254 4.841 0.824 235.405 
RES 33 A2 = 13% A24 = 13% BSI = 13% B7 = 7% B44 = 7% 
4800 US5 PNW BORT 
CW4 54 98 5.6 81 349 72 /7 4 256 4.633 0.832 241.471 
RES 33 CW6 = 12% B44 = 12% A26 = 6% A30 = 6% BI3 = 6% 
232 
204 
lhhle 6. COlllillllCd 
STR SPEC AYE INCL N 
TP FN FP TN Q R C
HP 
4801 ITI MTT FI0113 21 236 3 .747 0 .730 184.366 
CW4 80 91 6.5 
84 346 74 14 
56 93 7 .3 100 25
8 3 0 19 236 5 .469 
0 .346 30.928 
+ B35 211 0.443 0 .251 16.061 
47 95 2.4 24 255 
8 25 11 
+ CW3 211 2.768 0.677 158 .442 
OR 77 95 5 .5 
69 346 85 39 11 
RES 36 ( . \\,7
 == 14 % A2 = 12% 87 == 10% AI == 9 % 
4802 UKI CXH Lopian 4 3 257 6 .945 0.940 
308.401 
CW4 86 99 7.4 
96 349 85 
RES 60 A2 = 20% A24 = 20% 87 =
 20% 844 = 20% CW7 == 20% 
4803 EAE ZAR MZ435 234 2.275 0 .615 131.455 
CW4 78 90 5.7 7
2 347 63 24 26 
58 97 2.5 26 260 
20 58 6 176 0 .616 0 .33
8 29.718 
+ CW6 1.746 0.534 98 .832 
OR 74 97 4 .2 50 
347 83 82 6 176 
RES 47 87 = 12% A2 = 9% CW2 = 6%
 CW7 == 6% A24 = 6% 
4804 FRA PRR SCII1423 225 4.568 0 .761 201.685 
CW4 87 87 7.4 97 
348 86 3 34 
A23 85 88 4 .9 5
6 259 5 4 29 221 
1.326 0 .244 15 .371 
+ 3.854 0.764 203 .098 
OR 88 88 7 .2 
93 348 91 7 29 221 
RES 74 AI = 9% A2 = 9% CW6=9 %
 
4805 BEN DPT SMEETS.80 
CW4 94 95 7.7 98 
319 80 2 11 226 7 .739 
0.892 254 .021 
+ B49 11 96 1.8 27 
237 3 8 8 218 1.005 0 .
254 15.317 
+ CW5 11 97 1.4 10 
226 3 27 5 191 0.232 
0 . 150 5.057 
OR 87 97 5.6 70 
319 86 37 5 191 3.259 
0 .721 165.869 
RES 38 CW6 = 15% AI = 12% A2 = 12% 
A24 = 8% A29 = 8% 
4806 UKI GEL YAU20802 
CW4 92 98 7 .7 99 
349 88 I 6 254 8. 136 0 .942 
309 .646 
RES 23 CW6 = 16 % A2 = 12% U44 = 12 % 
AI == 8% CW5 = 8 % 
4807 8EN ROO YR61809 
CW4 66 76 6 .6 92 
346 81 7 62 196 2.584 0.597 
123.490 
CW6 51 98 5.3 76- 258
 58 18 4 178 4.322 0 .783 
158 .309 
OR 60 98 6 .0 85 
346 139 25 4 178 4.915 0 .832 2
39.641 
RES 64 A2 = 15% CW7 = 15 % 117 == 10 'J{· A24 ==
 10 % 
4808 US5 SIN 13782 
CW6 38 98 3.5 44 340 3
7 47 Cl 250 2.321 0.537 97 .973 
RES 54 .' ~ : , 12 r:r rW4 == 12% A2 == 12 % B51 == 8% 
. CW7 = 8% 
4809 UKI AST llB .· I . I 
CW6 73 91 6 .0 80 350 69 
17 25 239 2.788 0 .683 163 ~ 163 
+ AW68 20 92 3.2 46 264 6 
7 19 232 1.324 0 .291 22 .344 
+ 8W73 33 93 3.2 50 251 
, ., I ', 229 1.955 0 .263 17 .384 
OR 67 93 5.5 74 J.'iO i s 
1":' I , ~ 2() 2.537 0 .696 169 .558 - , 
RES· 60 A2 = 13 % CW4 = 11 % B35 = l)'X- .. u -
)'., U51 = 7 % 
When there are taken into account the cells typed 
both with the Core set and the Antigen Society set sera 
(Table 8) the definition of Cw6 appears improved, 
a lthough in some Cw4-ve,Cw6+ve cells the Cw6 sera 
reac! as in the Cw4 + ve,Cw6 - ve cells: This improve-
ment is clearly due to the increase in the number of the 
monospecific Cw6 sera. 
Scgrcglltion nulll 
Some interesting segregation data (S.A . Blacks and 
Cape colored) have been kindly supplied by Dr. E. Du 
Toil. In Table 9 the segregation pattern of some Core set 
sera in family Out 228 is shown. The four children 
receive from the father the pattern IOW543 +, 
IOW540 +, IOW545 +: IOW537 and IOW539 segregate 
together and in repulsion with IOW547 (the mono-
specific Cw6 serum) ; in this family the sera IOW537 and 
IOW539 segregate with the haplotype Aw68 ,Cw6,Bw72. 
Similar segregation patterns have been observed in fami-
lies Out 10 and Out 20, associated respectively with 
BI5K and with Bw57. 
Poplllation Dala 
In Cw4-ve unrelated Black population IOW537 and 
IOW534 are ;)ssociated (r=0.54); there are eight cells 
IOW537 + , IOW539 + : seven of them are Cw6+ve, and 
five out of them are Bw57 + ve. Among the 10 cells 
Cw4-, Cw6-, Bw57 + none has been observed to be 
233 
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Tahle 7. Frequency ( X ItlO) 01111(' 1(," . - , - " , ' " f( """ , .W Il' 1 'L'1.I I "'"l' 't. ,K g I t:gillllJlI , ' ,HIt:1 II~ VI .1lll lle ,-VI <: ,,<:. " C ' d "' ,.111111] 
Antigen Society Sera (Pall erns Oh\enul ill ( ' 101 ,1 I)IIL' Crllllavc _0_u_I_2_2_8 __________________ _ 
Not Been Reportcd) Tenth W No, 
Phenotype 
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a = Cw4 + Cw6; b = Cw6: e = Cw4 
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(N = 66) 
70 
5 











lo\V537 + , IOW539+; among the 38 cells Cw4-, 
Cw6+, Bw57-, only two are positive with both sera, 
These family and populalinl1 data may suggest that 
toW537 and IOW539 " ' ''''' 11 / '' :1 " I,l il (If (\vc, or, 































































I! :'pllllypcs: fI = Aw6/l, Cw6. 13w72 : b = A3, Cw6, Bw58: 
c = A30, Cw2, Bw71; d = Aw34, Cw7, B8 
Cw4 and Cw6 and in linkage disequilibrium with Bw57 
in Blacks, 
Ackll()1I'/edg1llellf , We gratefully acknowledge the help-
ful support of Or. Fiorenw Quoghi. 
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Table 8. Frequency ( x 100) of the Reaction Pallerns of Selected Core and Antigen Society Sera (Pallerns Observed in Only One 
Cell Have Not Been Reported) 
Phenotype Tenth W No. Pupulation 
Cw4 Cw6 5 5 5 4 5 4 4 4 5 5 5 4 4 Black Cauc 
4 4 4 8 4 8 8 8 3 4 3 8 8 
3 0 5 0 7 0 0 0 3 I 5 0 0 
7 9 8 6 2 5 
a a a a b b b c c c c c c 
+ (N = 13) (N =63) 
+ + + + + + + + + + 15 67 
+ + + + + + + + + + + 8 6 
+ + + + + + + + + 6 
+ + + + + + -f + + 3 
+ + + + + + + + + + 3 
+ (N=26) (N =67) 
+ + + + + + + 4 29 
+ + + + + + 4 23 
+ + + + + 6 
+ + + + + 4 
+ + + + + + + + 8 3 
+ + + 3 
+ t + 3 , f f + + 4 3 
+ ,- f f + + + 3 
+ + + + + + 15 
+ + + + + 15 
-I- + + + + 8 
(N=59) (N= 156) 
68 86 
+ 4 
+ + 3 
+ 2 
+ + I 
+ 3 
-- . ~ -- -•... _-_ .... __ . - ---. . 




With some variation of standard techniques. it is possi-
ble to achieve excellent serologic typing of LCLs. DR4 
remains heterogeneous with one obvious split. Undoubt-
edly. other splits exist. but the various patterns cannot be 
classified until additional well characterized LCLs are 
available. 
Reference, 
I. Williamson J. Tait B, Richiardi p, et al. Antigen report: HLA-
DR4. In: Albert ED. Baur MP, Mayr WR (eds): Histocompat-
ibilityTesting 1984. Springer-Verlag, Berlin, 1984:188-189. 
2. Grimsley G, Homes P. Townsend D, Williamson J, Dawkins 
RL. HLA typing of Iymphoblastoid cell lines (LCL) . In: 
Aizawa M (ed): HLA in Asia-Oceania 1986. Sapporo, Japan: 
Hokkaido University Press, 1986:909-913. 
Antigen Society #24 Report (DRwll, DRw12, DRw8) 
P. Stastny, I Z. Layrisse, Z D.P. SingaJ,l A. Svejgaard;' E. van den Berg-Loonen,s K. Dohi,6 
L. Caraballo,1 P. Chiewsiip,8 B. Coiombe,9 R. Fauchet,IO E. Haas,11 M.G. Hammond, Il 
B. K. lakobsen,4 S. Knight,13 1. Lee,14 H. Mervart,15 G. M.T. Schreuder;6 and K. Sullivan 17 
HLA-DR5 
Groups of sera defining a DR5 specificity correlated 
with HLA-Dw5 were first observed in the Seventh 
Workshop. However. sera of excellent quality recogniz-
ing a distinct DR5 antigen have been rare. In the Ninth 
Workshop. it was disc! 1\ <'led that most DR5 sera con-
tained antibodies against rt:iated DQ-specificities. and 
shorter patterns (DRwll and DRw12) were defined. 
In the present Workshop no reagents for definition of 
DR5 have been found, However. DRwl1 and DRwl2 
can be seen quite clearly. 
Reporting Laboratories: US4ST A.' LATLAY.' US5SIN. J 
SCASVE! BENBER.' JAPDOH6 
Participating Laboratories: LATCOL! ANZCHI," US3GVY. • 
FRAFAU.'o LATHAA." SAFHAM." UKIKNT,tJ US8JLE." 
NCYMRV." BENROO.'6 USITUL 17 
HLS-DRwll 
A large group of sera defining DRw 11 was observed. 
While many of these do have some contaminating anti-
bodies (especially DQw3 and DQw7), enough very 
good reagents could be selected that reacted in block and 
established DRw 11 typing quite unequivocally (see 
Tables I and 2). 
HLA-DRw12 
Three reagents of the Workshop (IOW. 9999, 9050. and 
3068) recognized DRwl2 monospecifically. These were 
three different aliquots of the same monoclonal antibody 
(DN I). which clustered with high correlation values. 
Coincident reaction of the replicates provided excellent 
definition for this antigen in most of the participating 
laboratories. The continuity of the definition of this 














• Sr"nger.verl,,~ New \ink I'IK'I 
'f."munCJhlolo~> 0;-ULA 
\oluOlc , 
Core Set Alloantibodies 
1096. 1103. 1113. 1114 
1085. 1086. 1087. 1089. 1091 
1152.1198.1199.1201. 
1204. 538-l 














3086. 3088. 3090 
3122 
Ag. Soc. 24 
5154.5157,5170 
5172. 5175. 5181 























































































































































































































































































































































































































































































































































































































































































































antigen with the previous definition in the Ninth Work-
shop was demonstrated by typing of the cell line Herluf 
and several other cells and members of families that 
had been tested in the previous Workshop. In some 
laboratories occasional reactivity of DNI with DRw8 
cells was observed. It was brought to our attention that 
a T-cell clone from M. Thomsen reacted uniquely with 
DRw 12-positive cell lines. 
DRw8 
DRw8 antigen was. defined in this Workshop by several 
good sera (Table I). In addition. many other sera on 
the Antigen Society tray appeared to react with DRw8 
cells and to contain antibodies against the new DQw4 
specificity. 
Haplotype Associations of HLA-DRw 11 , 
HLA-DRw12, and DRw8 With DRw52 
and DQ Alleles 
The haplotype associations are summarized in Table 2. 
DRwll, DRw12, and DRwR all reacted with broad DR 
sera defining DRw52 . HI".'. ·\ ·!f. a ~ubse t or reagents 
among those clustering with DRw52 gave shorter pat-
terns. some of which are observed to be negative with 
DRwl2-positive cells and/or DRw8-posilive cells. 
DQ haplotype associations observed with DRwl1 and 
DRwl2 were similar. The most common haplotypes 
were with DQw3, and these were almosl always positive 
for DQw7. While a few DRwll, DQw3. DQw7-nega-
live cells were present . their number was sufficiently 
small to likely represent a residual of typings with tech-
nical problems. 
Other haplotypes observed with DRw 11, DRw 12. and 
DRw8 carried DQw I. Such cells reacted either with 
IOW1141. defining DQw6. or with IOW I 136, an anti-
body correlated with LYI327 (4), reported to define 
DQw5. Most DRwl1 and DRw8. DQwl cells were posi-
tive with IOW 1141 (DQw6); the DRw 12, DQw I cells 
were IOW 1141-negative and sometimes reacted with 
IOW I 13·6, suggesting they were positive for DQw5. 
The frequency of haplotype associations with DRw8 
and DQ antigens varies in different ethnic groups. In 
Caucasoids the most common haplotype was DRw8. 
DQw4. In Orientals. DRw8, DQwl was more com-
monly observed. Other haplotypes observed were 
DRw8, DQw7, and less frequently. DQw3-positive, 
DQw7-negative. 
A cluster of antibodies defining the broad DQ speci-
ficity IlB3 reacted with DRwll. DRwl2, and DRw8, 
DQwl-associated cells. Also included were the DRw8. 
DQw4, and DRw8, DQw3. DQw7-negative haplotypes. 
Relationship with DRw13 and DRw14 
Cells having DRwll frequently gave patterns of weak 
reactivity with sera used to define DRwI3. This was also 
true of cells that were coded as DRwI2 . DRwl4 was 
defined in the Core set by only one reagent (IOW9060). 
In addition, IOW 1111 was a duospecific serum reacting 
with both DRwl1 and DRwI4. 
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ORwl2 specificity could be clearly distinguished from 
ORwl3 (Table 3). ORwl2 was predominantly observed 
with OQw7. Some of these cells were reported as OB6 
(0 Herluf). 
Laboratory OUT originally reported some cells as 
OR6x 12 but the analysis suggests that they could be 
ORw 12 in association with OQw5 (Table 3) . This pattern 
has thus far only been observed in South African blacks. 
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General Introduction 
There were 1,019 cells analyzed in the Antigen Society 
(795 Caucasians, 202 Negroes. 22 Orientals); 1.011 
were tested both on Core serology and Antigen Society 
reagents. The total number of sera and monoclonal anti-
bodies (MAbs) in the antigen group was 182, distributed 
as shown in Table l. 
The list of these reagent ~ is given in Table 2 with their 
identity and lab of origin. It must be noted that due to a 
heterogeneity in the tray layout between the different 
Reporring Lnboratories: FRAOHA,' NCYGOE.' FRAMUL,l 
ITIMTT' 
Parricipming Laboratories: ANZCRS.5 ANZTAI,· EAEBUC.' 
FRAJEA." FRAMYE." ITICON.'o ITlPUR." NCYNIK. u 
NCYMRV," USITUL," US5SWE.'5 US7HAN.'· SAFDUT.17 
SAFHAM ,. 
labs, the central data analysis team cut down the results 
of 15 anti-OR7 sera from the Antigen Society as indi-
cated between the two horizontal lines in Table 2. The 
results concerning these sera could not be analyzed in 
detail. 
Table l. Type and Number of Serologic Reagents Toward the 
Specifici!ies Studied in Antigen Group 26 : OR3. DR7, OQw2 
Core Core Antigen 
Specificity Serum MAb Society 
DR3 (mainly) 14 5 41 
Related to DR3 IO 3 I 
(DRw52 ... ) 
DR7 (mainly) 12 4 59 
Related to DR7 6 2 
(DRw53. DRw9 . .. ) 
DQw2 12 3 11 
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Table 2. List and Identification of Serologic Reagents for Anti- Origin · IOWID Original ID 
gen Group 26 
Order = 32 ITI FER 1213 FE200 
Origin IOWID Original ID Specs: ORw53 
Order = I US6 BRN 1039 CC434.1 Order = 33 GER BRA 1170422B 
Specs: OR3 Specs: OQw2 
Order = 2 UKI ORK 1043 WILLlAMS.773 Order = 34 ITI MTT 1174 FI03295 
Specs: OR3 Specs: OQw2 
Order = 3 SAF HAM 1040 NI165 Order = 35 US2 MBC 1175 BC.CA.MAGN 
Specs: OR3 Specs: OQw2 
Order = 4 SAFHAM 1037 NII64 Order = 36 BEN BER Iln MSD20 
Specs: OR3 Specs: OQw2 
Order = 5ANZP;li j(1(,F SPA R KS Order = 37 US5 TER I I 17 TER.OPI 
Specs: OR7 Specs: OPwl 
Order = 6 ANZ OAW 1070 SIMMONOS.P6.5590 Order = 38 NCY YUN 1144 BLOUOETTE 
Specs: OR7 Specs: OR30R6 
Order = 7 ITI MRA 1071 PV35 Order = 39 UKI TAT 1041 WINTER.SOH.487 
Specs: OR7 Specs: OR3 
Order = 8 IT2 GAN 1075 C0812 Order = 40 FRA PRR 1064 VELI557 
Specs: OR7 Specs: ORw9 
Order = 9 UK1 JOY 1152 HA YES Order = 41 ANZ OAW 1195 R5.6295 
Specs: OR3 ORw6 ORw8 Specs: OR40R5 
Order = 10 NC), MRV 1201 18660 Order = 42 NCY MRV 121224784 
Specs: ORw52 Specs: ORw53 
Order = 11 SAF HAM 1069 NIIOI Order = 43 UKI ORK 1078. 0WEN.812 
Specs: OR7 Specs: OR7 
Order = 12 UKI AST 1072 OB24 10 Order = 44 NCY MRV 1167 11028 
Specs: OR7 Specs: OQw2 
Order = 13 US5 TER 1182 TER.OQ3A Order = 45 FRA FAU 1066 ANTIN 
Specs: OQw3 Specs: OR70R .... -9 
Order = 14 IT! MTT 1169 FI02406 Order = 46 9060 
Specs: OQw2 Specs: UNK 
Order = 15 FRA F.A. L' 1173 CHEVRIER Order = 47 FRA JEA 11510ROZ 
Specs: OQw2 Specs: OR30Rw6 
Order = 16 US6 BRN 1168 CC413.1 Order = 48 FRA MYE 1147 LECOINTRE 
Specs: OQw2 Specs: OR30Rw6 
Order = 17 FRA FAU 1067 JEGU Order = 49 BEN BER 1135 MS06 
Specs: OR70R .... -9 Specs: DRwl30Rwl4 
Order = 18 US8 RUB 1038 NYBCOO2 Order = 50 IT! MTT 1180 F101404 
Specs: OR3 Specs: OQw3 
Order = 19 NCY f-mv 1035 10466 Order = 51 ITI FER 1186 FE94 
Specs: OR3 Specs: OQw3 
Order = 20 NCY MRV 1034 11552 Order = 52 USI OUQ 1171 QUAGLlER 
Specs: OR3 Specs: OQw2 
Order = 21 UKI FES 1036 ALLEN Order = 53 UKI ORK 1208 PRATT.80% 
Specs: OR3 Specs: OR3 0R5 ORw6 
Order = 22 US2 BAC 1150 REYNOLOS DRw52 
Specs: OR30Rw6 Order = 54 ITI MTT 1200 FI02422 
Order = 23 GER NEU 1077 G0810468B Specs: ORw52 
Specs: OR7 Order = 55 GER WAN 3005 C5C5 
Order = 24 FRA BET 1079 E915 Specs: ORI OR) OR4 
Specs: OR7 ORw8 
Order = 25 US6 BRN 1080 CC327.5 Order = 56 FRA OOC 3010 CHEI53 
Specs: OR7 Specs: ORIOR7 
Order = 26 GER GOL 1076924.4 Order = 57 JAP AIZ 301 I HU30 
Specs: OR7 Specs: 0R2 ORI 
Order = 27 US1 THP 1042 EUlNK Order = 58 GER WAN 3020 M4FI I 
Specs: OR3 Specs: OR30Rwl3 
Order = 28 NCY GOE 1202 PL855 Order = 59 FRA OOC 3023 CHE41.2 
Specs: ORw52 Specs: OR30Rw6 
Order = 29 US5 SIN 1205 15886 Order = 60 UKI FES 3031 JAI 
Specs: ORw52 Specs: OR3 
Order = 30 FRA OOC 5384 P6465 Order = 61 JAP 1UJ .. 3048 PLM3 
Specs: ORw52 Specs: OR7 OR .... -9 ORwl2 
Order = 31 US8 JLE 1216 H 181 Order = 62 UKI BOO 3049 17.3.3 




. (11 ·f Origin IOWID Original ID Origin IOWID Original 10 
Order ::& 6) NCY SFR )050 SFRI6.0R7M Order = 94 US6 BRN 5230 CC519.2 
Specs:- ' OR7 Specs: OR3 
Order == 64 US7 GSC )051 GSP65 . 1 Order = 95 US6 BRN 5231 CCB 1060. 1 
Specs:'-" l OR7 ORw 10 Specs: OR) 
Ordei .... 6S GER WAN )062 M4G8 Order = 96 UKII0Y 5232 OENNING 
SpeCs(: ORw52 Specs: OR3 
Order:' 66 )105 Order = 97 EAE RIC 5233 H1195.1 
Specs: DQw2 Specs: OR3 
Order - 671TI FER ) 106 MPI Order = 98 NCY GOE 5234118571 
Specs: OR2 OR3 OR4 ORS Specs: OR3 
ORw6 Order = 99 EAE KAS 5235 KAS7292 
Order - 681TI GAN ~ 107 XII1358 Specs: OR3 
Specs: OQw2 Order = 100 US8 JlE 5236 M325 
Order = 69 US7 GSC JI13GSP91.1 Specs: OR3 
Specs: OQw) Order = 101 FRA OHA 5237 MARCHE 
Order = 70 )025 Specs: OR3 
Specs: OR3 OR5 ORw6 Order = 102 BEN BER 5238 MS08 
Order '" 71 GER WAN JO~6 C6E2 Specs: OR3 
Specs: OR3 OR4 OR7 Order = 103 SAF HAM 5239 NI163 
Order = 72 ITI CEP 1081 TORPI017 Specs: 0R3 
Specs: OR7 Order = 104 SAF HAM 5240 NI233 
Order == 73 FRA PRR 5006 PUY.A.217 Specs: OR3 
Specs: OR7 Order = 105 US7 OUP 5241 1'114050 
Order = 7~ UKI BRS 5210 10726.lCS SJJecs: OR3 
Specs: OR) Order = 106 FRA PRR 5242 ROU.A212 
Order = 75 NCY MRV 5211 27026 Specs: OR3 . 
Specs: OR) Order = 107 US4 SNO 5243 SI5L1 78 
Order = 76 NCY MRV 5212 18835 Specs: OR3 
Specs: OR3 Order = 108 US5 TER 5244 TER.OR3 
Order = 77 NCY ~1RV 521) 20571 Specs: ORJ 
Specs: ORJ Order = 109 UKI JOy 5245 W A TERHOUSE 
Order = 78 NCY MRV 521~ 2551.6 Specs: OR) 
Specs: OR3 Order = 110 US3 PER 5246 WOOOAROPOI09A 
Order = 79 US2 MBC 5215 BC.HE.BURl Specs: OR3 
Specs: OR3 Order = II1 Usl OUQ 5247 Y.CARROlL 
Order == 80 US2 ~IBC 5216 BC.JA.SAOO Specs: OR3 
Specs: OR) Order = 112 UKI TAT 5248 OURNFORO. 
Order = 31 US2 :VIBC 52 17 BC.VE.BREE Specs: OR3 SOH .517 
Specs: OR) Order = 113 UKI ORK 5249 MARSHAlL.1070 
Order = 82 ITI MIT 5218 F101972 Specs: OR3 
Specs: OR) Order = 114 USI OUQ 5250 YURUS 
Order = 83 FRA BIG 5219 HI2 Specs: OR3 
Specs: OR3 Order = liS US5 SIN 5251 15452 
Order = .84 FRA OOC 5220 P298) Specs: OR7 
Specs: ORJ Order = 116 NCY KAP 5252 CWRPI51S 
Order = 85 ANZ CRS 5221 PAGE Specs: OR7 
Specs: OR) Order = 117 US7 pal 525) 045 
Order = 86 US7 HAN 5222 SEA 1250 Specs: OR7 
Specs: OR) Order = 118 NCY MRV 5254 11542 
Order = 87 ANZ OAW 5223 SlEEPY.F29026 Specs: OR7 
Specs: OR3 Order = 119 GER Gal 5255 15924.4 
Order = 88 NCY MRV 52243953.5 Specs: OR7 
Specs: OR3 Order = 120 EAE SHA 5256 SHA .S 
Order = 89 NCY MRV 52259134.2 Specs: OR7 
Specs: OR3 Order = 121 GER GOl 5257 16738 
Order == 90 USS ABS 5226 ABS.17 Specs: OR7 
Specs: OR) Order = 122 NCY MRV 5258 19330 
Order = 91 UKI MID 5227 BEl55)O Specs: OR7 
Specs: OR) Order = 123 NCY MRV 5259 20387 
Order = 92 NCY CAR 5228 BOS/BA T Specs: OR7 
Specs: OR) Order = 124 NCY MRV 5260 20502 
Order = 93 FRA FAU 5~29 BRIANO Specs: OR7 




Origin IOWID Original ID Origin IOWID Original ID 
Order = 126 NC), MRV 526225552 Order = 155 SAF HAM 5292 N 1234 
Specs: DR7 Specs: DR7 
Order = 127 BEN BOU 5263 64352 9/11/82 Order = 156 SAF HAM 5293 N9.t5 
Specs: DR7 Specs: DR7 
Order = 128 NC), MRV 5264 7128 Order = 157 FRA PRR 5294 PHI 1466 
Specs: DR7 Specs: DR7 
Order = 129 NC), MRV 52669235 Order = 158 UK I JOY 5295 RICHARDSON 
Specs: DR7 Specs: DR7 
Order = 130 GER BRA 5267950 Order = 159 US8 FOT 5297 STRA TIS 
Specs: OR7 Specs: DR7 
.. 
Order = J:I I US~ AIlS 526R ABS .20 Order = 160 US5 TER 5298 TER .DR7 
Specs: OR"; Specs: DR7 
Order = 132 IT I (i .: \l.l 5269 ANI27 Order = 161 FRA MYE 5299 THOMAS 
Specs: OR7 Specs: DR7 
Order = J.B UK I JOY 5270 ANDREWS Order = 162 ITI CNG 5300 TSRPI70 
Specs: DR7 Specs: DR7 
Order = 134 ITI MIT 5271 B08 .3 Order = 163 IT! CNG 5301 TSRP307 
Specs: DR7 Specs: DR7 
Order = 135 ITI CEP 5272 COS9031 Order = 164 US3 PER 5302 UlRlCHPOOI9C 
Specs: DR7 Specs: DR7 
Order = 136 UKl MID 5273 BEL2130 Order = 165 US8 JLE 5303 W283 
Specs: OR7 Specs: DR7 
Order = 137 UK I MID 5274 BEL522D Order = 166 UKI DRK 5304 JONES. 
Specs: DR7 Specs: DR7 GERRARD.807 
Order = 138 FRA OHA 5275 BERNON Order = 167 UK I LAW 5305 WILLlAMS 
Specs: OR7 Specs: OR7 
Order = 139 EAE RlC 5276 BH3747 Order = 168 NCY KAP 5306 CWR.PlA.1355 
Specs: DR7 Specs: DR7 
Order = 140 UKI GEL 5277 CLA22677 Order = 169 NCY KAP 5307 CWR.NIE.3 
Specs: OR7 SPecs: DR7 
Order = 141 IT:? GAN 5278 C0868 Order = 170 NCY KAP 5308 CWR.PLA.l007 
Specs: DR7 Specs: OR7 OR\\'9 DR3 
Order = 142 US5 SWE 5279 OElMASTRO Order = 171 UKI GEL 5309 DA )'20558 
Specs: DR7 Specs: DR7 
Order = 143 FRA FAU 5280 ESNAULT Order = 172 US6 BRN 5310 CCB.1045.2 
Specs: DR7 Specs: DR3 DR7 
Order = 144 ITI MIT 5281 F101577 Order = 173 IT2 GAN 5311 COl 178 
Specs: DR7 Specs: DRJ DR7 
Order = 145 1T2 FER 5282 FE208 Order = 174 UK I GlA 5312 HUITON 
Specs: OR7 Specs: OR7 OR3 OQw2 
Order = 146 1T2 FER 5283 FE216 Order = 175 NCY KAP 5313 CWR.PRIM 
Specs: OR7 Specs: OR3 OR7 DRw9 
Order = 147 ANZ CRS 5284 HENNING Order = 176 US6 BRN 5314 CCB. 1035.1 
Specs: OR7 Specs: DQw2 
Order = 148 US6 GAT 5285 JH Order = 177 US2 SAC 5315 M.lARSEN 
Specs: OR7 Specs: OQw2 
Order = 149 US4 STA 5286 KWI Order = 178 NCY GOE 9104 PLl758 
Specs: OR7 Specs: DQw2 
Order = 150 USI OUQ 5287 MCCLOSKEYI2.84 Order = 179 NCY GOE 9105 PL2051 
Specs: DR7 Specs: DQw2 
Order = 151 FRA KRE 5288 MTC8122 Order = 180 NCY GOE 9106 Pl2282 
Specs: OR7 Specs: DQw2 
Order = 152 FRA KRE 5289 MTC8337 Order = 181 NCY GOE 9107 Pl244 I 
Specs: OR7 Specs: OQw2 
Order = 153 SAF HAM 5290 NII88 Order = 182 NCY GOE 9108 PL2451 
Specs: OR7 Specs: DQw2 
Order = 154 SAF HAM 5291 NI201 
Specs: DR7 
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History 
The discovery thatalloactivated T lymphocytes express 
new class II antigens (1,2) stimulated experiments in 
which activated lymphocytes were studied for the 
expression of new antigen~ 11·'1 detected at the quiescent 
stage. Other workers have Shll\\1l that resting T lympho-
cytes could be subdivided by the use of sera recovered 
from patients with juvenile rheumatoid arthritis (3) or 
from alloimmunized volunteers (4,5). Later (6), TCA-
TCB system expressed on T gamma-enriched cells was 
also identified by aIloantisera. When PHA-activated 
Iymphocytes were used in the screening of pregnancy 
sera, it appeared that some sera reacted exclusively with 
the lectin-activated Iymphocytes, but not with the rest-
ing T or B lymphocytes separated from the same 
individual (7). Cross-absorption experiments indicated 
that, indeed, these determinants were not shared by the 
resting autologous lymphocytes. In blocking experi-
ments, it was shown that the new determinants are 
associated with B-2 microglobulin, which classified 
them into the c1ass-I gene product family. Their absence 
from thymocytes suggested that they may be the human 
counterpart of the murine Qa·like gene products (8). 
Family studies have shown that the reactivity segregated 
ReporTing Laboratories: GERGAZ. I FRAFAU. 2 UKILAW. J 
BENROO: IT2FER,' NCYMAH," UKIFES/ ITlCEP.s 
FRAMYP 
Participating Laboratories: ITI MRA,'o IT2GAN," SAF· 
OUT.12 NCYYUNIJ 
Table l. Cellular Targets Tested in the Workshop 
Name of Target 
I) Peripheral blood leucocytes 
2) Nylon wool purified T-cells 
3) Nylon wool purified B·cells 
4) PHA activated Iymphocytes 
5, Alloactivated Iymphocytes 
6) EBV transformed B cell lines 
7) Leukemia T·cell lines (HPB. lurkat. MOLT-4. 
8402, PEFR. HSB-2) 
8) Leukemia Iymphoblasts 
T·cell acute lymphoblastic (ALL) 
Common acute lymphoblastic (C·ALL) 
Acute Myeloid (AML) 
Chronic lymphoid (CLL) 
Unclassified 
f~' Sprin~cr-Vcrlag New 'ilrk 19H9 
















with HL1\, which maps it to chromosome VI (7). When 
the Iymphocytes used for screening were assigned their 
HLA phenotype, linkage disequilibrium with HLA was 
observed, specifically with locus A gene products. Thus, 
some sera exhibited linkage disequilibrium with HLA-
A3,AIO,A2,A9 or HLA-Al (7-10). It was originally 
suggested by Gazit et al. to term them HT (human n 
because of their similarity with the mouse T-region gene 
products (8) or later H-A by Fauchet et al. (9) because 
they were expressed by PHA or alloactivated on T cells 
and B-ce\l lines. In biochemical experiments, it was 
shown that the antigenic determinant which was precipi-
tated by the specific alloantibody was a 41-12 K dimer 
distinct from the HLA class I 44-12 K antigen (7). 
Sequential immune precipitation with the w6/32 or 
HLA-A3 monoclonal antibodies did not remove the 
antigenic reactivity of this determinant, indicating that 
it is different from HLA-ABC antigens. Taken together, 
the reports published so far indicate that PHA activa-
tion, alloactivation, or beta interferon stimulation (11) 
induces the expression of new non-HLA class I antigens. 
This system is distinct from HLA for the following 
reasons. The reactivity is not absorbed by either plate-
lets or resting T or B lymphocytes. Lysostripping with 
HLA alloantibody does not remove the reactivity (7). 
There is a linkage disequilibrium with HLA; however, 
there are cells that do not express the linked HLA anti-
gen, but do react with the serum. The mofecular weight 
of the heavy chain is 41 to 42 K and not 44 K, which is 
typical for the heavy chain of HLA. To date, all efforts 
have failed to produce a murine monoclonal antibody 
that specifically reacts with the PHA-activated lympho-
cyte· and precipitates the antigen. 
Results 
This is the first international HLA workshop in which 
these novel antigens have been studied. The objectives 
Table 2. PHA Activation Protocol 
Gazit (8) 




Harvest + freeze 
Cytotoxicity Testing 
I + 2 hours 
215 
Fauchet (9) 




Harvest + freeze 
I + I hours 
281 
Table 3. P.dl1ern~ of Rcaclivilies of Ihe Alloanlibodies 
Group I Group 2 
Peripheral blood Iymphocytes + 
T Iymphocytes + 
B Iymphocytes + 
PHA T cells + 
Allogenic T cells + 
EBV cell lines + 
Number of sera 5 13 
I I 
Po~siblc interprelalion ncglllive lIn1i-HLA-A. -8 
were to compare the different protocols of PHA T-cell 
preparations to define the linkage with the classic HLA 
antigens and to identify the serologic clusters. Fifteen 
Laboratories took active part in these studies. The pro-
tocol requited a study of 20 to 30 unrelated selected cells 
and two or three families including different Iymphocyte 
targets: PBL or T cells. PHA T cells. B cells. and EBV 
cell lines. Additi , 'n;i1 targets were selected as an optional 
study. They included thymocytes, pathologic cells, 
leukemia T-ceJllines, and Ieukemia Iymphoblasts. Sixty-
nine platelets, allosera. and six monoclonal antibodies 
were submitted by eight laboratories. Classic class I and 
class 11 sera were added as control (Fel-Fa7: HLA-A2, 
HLA-DR4.Fe3-Fa9: HA 10, Fe2-Fa8: negative sera). 
Table 1 summa"rizes the Iymphocyte targets that were 
used. Two protocols were followed for the preparation of 
the activated Iymphocytes (Table 2). The difference 
between Gazifs and Fauchet's protocols lies in the use of 
Group 3 Group 4 Group 5 Group 6 Group 7 
+ + + 
+ + + + 
+ + + + 
+ + 
25 14 6 
I 
anti-HLA-DR. -DQ New Class 1 markers? 8 cell 
crude PHA by Fauchet and length of the tissue culture (a 
total of 7 days in the first protocol and 4 days in the 
second) . From preliminary experiments (5). it appeared 
that the crude PHA is superior for the preparation of 
blasts. but it has not been decided whether short- or 
long-term culture is superior. In Table 3. the overall pat-
tern of the reactiyities is summarized. It is clear that 
several sera reacted like HLA ABC or DR antibodies. 
They were subsequently identified and removed from 
the analysis. The serum by serum (SxS) analysis resulted 
in 10 clusters. 4 of which were found to be the classic 
HLA. Toe remaining six clusters are summarized in 
Table 4. It is worth mentioning that some sera that 
reacted as classic HLA antibodies clustered with the 
corresponding sera, which showed linkage dis-
equilibrium with a particular HLA antigen. In four 
clusters, there is a significant linkage disequilibrium 
with HLA, and the r value is given in Table 4. There is 
Table 4. PHA Activated Lymphocytes Form Clusters of Reactivity. 



















































































Table 5. The Reactivity of Sera from Cluster 3 with Leukemia 
Lymphoblasts 
Leukemia Type 
Serum T-ALL AML c-ALL B-CLL 
Number (n = 12) (n = 28) (n = 16) (n = 14) 
4844 NS NS 0.027 0.054 
4890 NS 0.017 0.027 0.011 
BRAN NS NS NS NS 
The number in the table is the p value. which was calculated for 
the numbers of cells reacting with the sera in the cluster and 
having HLA-A3. NS = nonsignificant. 
a cluster that is associated with HLA-AI, A2. A3. and 
A 10. The sera in the clusters were analyzed by their 
reactivities with B-cell lin~~,. thymocytes. T cell lines. 
segregation in families and reactivities with leukemia 
Iymphoblasts (Tables 4 and 5). Two groups of s~ra from 
clusters 2 and 3 were found to react with B-cellltnes. and 
cluster 5 reacted with thymocytes (Table 4). 
Leukemia T-cell lines were found to react with sera in 
clusters 3. 5. and 6. The segregation of the reactivities 
was studied in several families. and clusters I to 4 were 
found to segregate with HLA. ALL, which classified as 
c-ALL and were HLA-A3-positive, reacted with sera in 
cluster 3 (HT-3.), i.e .. the reactivity was associated with 
the presence of the HLA-antigen, and not with the leuke-
mia per se. 
Discussion 
The experiments performed in this Workshop success-
fully identified and defineu six clusters of non-HLA 
alloantibodies. four of which were in linkage disequi-
librium with HLA. Sera in the remaining two clusters 
also reacted with thymocytes, T-cell lines. and some 
T-ALL Iymphoblasts. Thus, it is possible to divide the 
clusters into two groups: Qa-Iike and the TL-like anti-
gens. In family studies. the reactivities of most clust~rs 
segregated with HLA. Clusters 2 and 3 also reacted w~th 
EBV-transformed B-celI lines. and cluster 5 reacted with 
T-celllines and thymocytes. The reactivity of these non-
HLA antibodies with human thymocytes extends the 
findinl!~ in early reports (12-14). Common ALL Iympho-
blasts in HLA-A3-positive individuals reacted with sera 
in cluster 3. 
These results indicated that the serologic aspects of the 
new system are almost resolved, even though the repro-
ducibility of the tests have not, as yet. been worked out. 
Unfortunately, the biochemistry experiments failed. 
Therefore, no biochemistry data were presented in this 
Workshop. Also, Qa-Tla-like probes were not assayed in 
the molecular biology experiments of this workshop. 
It is hoped that immune precipitation and Southern 
blot analysis will be studied in future workshops using 
specific monocIonal antibodies in biochemistry experi-
ments and non-HLA class I probes in DNA experiments. 
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Antigen Society #31 Report Part 3: Leukemic Blasts Express New HLA 
Class I-Like AlIoantigens 
D. Peruccio. I T. Crepaldi. I C. Castagnoli, I M. Lecchi, I E. Lovisone, I P. Saracco, I E. Olivetti. I 
and P. Richiardi' 
New HLA. p2m-associated alIoantigens. undetectable 
on resting T and 8 cells and platelets. are detected on 
PHA-activated Iymphocytes (PHA-L) using platelet-
absorbed alIoantisera (1-4). The expression of these new 
HLA class I-like specificities was examined in newly 
nlCEP' 
.') Sprin~cr.y .. I"g N~w v.,,~ I"HI) 
Immunoh,ology of ULA 
·.,Illum. I 
diagnosed acute leukemias. Bone marrow blasts 
obtained at onset and peripheral blood Iymphocytes dur-
ing remission were tested by the complement-dependent 
Iymphocytotoxicity technique using platelet-absorbed 
alIoantisera. Allleukemia samples (26 cALL. 6 T-ALL. 
28 ANLL) were tested with locally selected alIoantisera 
(I). while only a limited number (8 cALL, 3 T-ALL. 19 
ANLL) was examined with the alloantisera submitted 
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W2.19 Antigen Society no. 112: HLA-B40 crossreacting group, 
HLA-BBO, -BB1, -B47, -B48, -B13 
M. G. HAMMOND, K. TOKUNAGA, M. FOTINO, N. GRUNNET, B. GRAUGAARD, 
and J. VIVES 
Svejgaard et al. was the first to describe the B40 
antigen in 1970 [1] . The various splits were described 
subsequently [2-6]. HLA-Bllhas been well defined 
since 1970 [7] but many of the sera show cross-
reactivity. We analysed the reactions of the antisera 
used in both sets of the Eleventh International 
Histocompatibility Workshop (IHWS) in order to 
produce reaction patterns that define each antigen. 
Results and discussion 
There were 12870 cells typed for this IHWS and the 
serographs (Figure 1) produced by the IHWS computer 
programs [W2.3, this volume] analysed 1106 cells that 
reacted positively with the sera used to define the 
antigens of the B40 crossreacting group (creg). 
Consensus was reached among the members of 
Antigen Society no. 112 (AS-I12) as to the reaction 
pattern that best defined the different antigens. The 
reaction pattern of the sera used in Eleventh IHWS 
core sera set I is shown in Table l. 
• B13 was very well defined by three Eleventh IHWS 
allosera. Serum no. 0344 (MIDI07) had a Q score 
of 14.04 but serum 0345 (DDC2l3) had weak 
reactivity in some laboratories. Six monoclonal sera 
were tested but only one had an r value greater than 
0.9. Previously reponed splits [8] of BI3 that had 
been confirmed by isoelectric focusing (IEF) could 
not be seen in the reaction pattern of the sera used 
in this IHWS. 
.B60 was detected by 14 Eleventh IHWS sera but 
only two were monospecific no. 0355 (JUJ204) and 
no. 0356 (HSE207). However, three other sera were 
positive with only B60 + B48 and so were very useful 
because of the low frequency of B48. 
• B61. There were no operationally monospecific sera 
so this specificity could only be defined by 'sub-
traction', i.e. if the B40 sera were positive and the 
B60 sera negative. The B60 + B48 sera were helpful 
in this regard. It was not possible to differentiate 
between B60 homozygotes and B60/B61 hetero-
zygotes. There was no evidence of new splits 
of B60 or B61 that could not be explained by weak 
reactions. 
• B47 was defined by positive reactions with Eleventh 
IHWS sera 0346 (PRR21O), 0347 (NOS208), and 
0348 (FER206). One of the B27 Eleventh IHWS sera 
0342 (SCN204) also reacted with B47 so that it was 
possible to define B47 in the presence of B60, B61, 
and Bl3. Serum 0347 (NOS208) was very useful 
because there were no extra reactions outside of 
these four antigens. 
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• 848 was well defined by seven sera, but there is only 
one monospecific Eleventh IHWS serum 0360 
(AKA216) to rely on if B60 is present. Three sera 
reacted only with B60 + B48, but the others were 
broadly reactive with many other antigens. 
• BFU. The definition of BFU depends on a negative 
reaction with Eleventh IHWS serum 0360 (AKA216) 
and positive reactions with the other B48 sera which 
means that BFU cannot be distinguished in the 
presence of B60. This antigen was first described 
by Kawaga et al. [8] in the Fifth Japanese Red 
Cross HLA Workshop and was well defined in the 
Tenth IHWS when several B48 sera failed to react 
with BFU. In this IHWS, BFU was confirmed to 
be different from B48 by IEF. In addition, family 
studies were reported in the Tenth IHWS [9]. It 
was not possible to distinguish between B60 
homozygotesand B60/B48 heterozygotes. Analyses 
of the complete Eleventh IHWS data showed that 
suggested further splits of B48 could not be 
confirmed because of the many extra weak 
reactions. 
• B41. This was best detected with Eleventh IHWS 
serum 0401 (LEV201) and four other sera also 
reacted with B41. There were some cells that reacted 
with both B42 and B41 sera when there was another 
B-locus antigen present. This pattern has been 
reported previously as a split of B41 [10], but it 
could just as easily be a split of B42. Further studies 
will be needed to elucidate these anomalous 
reactions. 
The reaction patterns defining the B40 group of 
antigens with the Eleventh IHWS core sera set 2 are 
shown in Table 2. Similar conclusions can be drawn 
except that it was not possible to define BFU with set 
2 sera. 
The distribution of these antigens varies widely in 
different populations as can be seen in Table 3. In 
general, they are all low-frequency antigens with only 
a few notable exceptions. B61 and B48 have much 
higher frequencies in Eskimos and B60 and B48 are 
very high in Taiwanese aborigines. 
Serology: Antigen Society reports W2.S.S3 
Conclusions 
The antigens in this group could be clearly Eleventh 
IHWS discriminated except for difficulty with B60 
heterozygotes. The Eleventh IHWS sera confirmed 
earlier reports of the BFU antigen. No other suggested 
splits could be confirmed by serology. 




No. Name B13 861 B60 B47 B48 BFU B41 
0343 LEP213 + 
0344 MID 107 + 
0345 DDC213 + 
0346 PRR210 + + + + 
0347 NOS208 + + + + 
0348 FER206 + + + + 
0349 DUQ209 + + + 
0350 TSU207 w + + 










0401 LEX201 ' 
0402 CEP204 
0532 KOL602 + 
0533 DUP502 + 
0534 TER508 + 
0535 MUC604 + 
0536 WES608 + 
0537 GOLS03 + 





















Bw4 Bw6 Bw6 Bw4 Bw6 Bw6 Bw6 
No. of cells 140 266 202 17 88 3 47 
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Table 2. Reaction patterns with Eleventh IHWS sera (set 2) 
Eleventh IHWS 
serum 
No. Name B13 B61 B60 B47 B48 BFU B41 
1307 DDC213 w 
1308 LEP213 + 
1309 MID 107 + 
1310 PRR210 + + + + 
131\ TOK214 + + + + 
1312 DUQ209 w + + 
1313 SAJ212 + + 
1314 FAU217 + 
1315 DDC221 + + 
1316 AST103 w + + + + 
1317 HAJ115 + + + 
\318 AND214 + + 
\319 KAW206 + + 
1320 FTW21 0 + 
1321 ENG201 + 
Bw4 Bw6 Bw6 Bw4 Bw6 Bw6 Bw6 
No. of cells 91 80 175 16 32 31 
Table 3. Frequency distribution in selected populations 
Population Code BB B61 B60 B47 848 BFU B41 
Black South Africa 10200 2.5 0.0 0.0 0.0 1.0 0.0 1.5 
Black Zimbabwe 10204 2.0 0.0 0.0 0.0 0.0 0.0 2.0 
Black USA 10400 1.8 0.4 2.2 0.0 0.0 0.0 2.7 
Denmark 30111 2.3 1.6 9.4 0.4 0.8 0.0 1.9 
France 30113 2.9 2.8 3.5 0.2 0.0 0.0 1.6 
Italy 30117 3.2 1.3 0.8 0.6 0.2 0.0 1.3 
Japan 40101 2.0 11.1 5.5 0.0 2.8 0.5 0.0 
Korea 40104 6.1 9.4 4.0 0.0 4.2 0.0 0.0 
Chinese 40210 15.5 1.1 3.0 1.0 1.0 0.0 0.0 
Eskimo 41102 0.0 30.0 0.8 1.7 8.9 0.0 0.4 
Papua New Guinea Highland 20202 8.5 2.0 14.9 0.0 0.0 0.0 0.0 
Taiwan Aborigine TAYA (local) 1.9 5.3 30.6 0.0 19.3 NT 0.0 
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.. 
• 
Positive Panels: 111)6 
ScaIe:K 100 
9 10 
Fig. 1. Serograph of the B40 creg. 
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polymorphism, such as some form of balanced 
selection due to heterozygote advantage, as already 
suggested [8,9 J • However, there are indications, from 
HLA class II analyses, that these factors have been 
very similar in most population groups, and therefore 
have not interfered with the differentiation patterns 
of allelic frequencies throughout the world [Tiercy 
et al., submitted J . This hypothesis remains to be tested 
for HLA class I loci as well. 
Conclusions 
Following the Fifth IHWS directed by J. Dausset in 
1972 and devoted to population studies, the Eleventh 
IHWS held in Yokohama in November 1991 offered 
the opportunity to gather the largest HLA data set 
with identical methods in human populations from all 
over the world. Preliminary analyses of these data 
show that present HLA genetic differentiations are 
closely related to historical events and can therefore 
be used to reconstruct human peopling history. 
However, an important sampling effort should be 
made, such as incorporating evenly spaced areas of 
the world, especially on the African continent where 
population data are still lacking. Moreover, well 
defined and large samples should be preferred in order 
to compute unbiased estimations of allele and haplo-
type frequencies, and to relate the genetic results with 
other kinds of information, such as linguistic classifica-
tions and archaeological data records. These require-
ments were not entirely fulfilled in the African 
continent study reported here. This may explain some 
of the discrepancies found between HLA class I and 
class II frequency patterns. 
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WS.4 HLA in southern African populations 
M. G. HAMMOND, E. D. du TOIT, J. A. SACHS, C. KAPLAN, and K. MBAYO 
The southern African populations tested for the 
anthropology component of the Eleventh International 
Histocompatibility Workshop (IHWS) consisted of 103 
San (Bushman), 65 Khoi (Hottentots), 101 Zulus, 99 
Shona, and 51 Zaireans. 
It is believed that the Khoi-San diverged from 
the Negroid peoples and spread south and west 
from east or central Africa about 30000 years ago 
[ 1 ). The Negroid peoples expanded southwards 
through central and east Africa between 500 and 
1500 years ago. They can be divided into chiefdoms 
or tribes such as the Shona and Ndebele, resident 
predominantly in Zimbabwe, and the Zulu, Sotho, 
and Xhosa in South Africa. The San, Khoi, Shona, 
and Zulu from southern Africa as well as a 
population from Zaire in central Africa were 
selected for the Eleventh IHWS anthropology compo-
nent. 
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Table 1. HLA gene frequencies Table 2. HLA gene frequencies determined by DNA 
typing 
Gene frequencies l~o) in population lethnic 
code no.) Gene frequencies (Oio) in population (ethnic 
HLA- San Khoi Zulu Shona Zaire 
code no .) 
(10201) (10202) (10200) (10204) (10206) San Khoi Zulu Shona 
(n=51) 
(10201) (10202) (10200) (10204) (n = 103) (n=65) (n= 101) (n=99) 
HLA- (n = 108) (n=113) (n=84) (n = 82) caLL: ; Bold italic/ Italic throughout All 0.0 0.8 0.0 0.5 0.0 
ORBl A30 21.8 13.2 13.9 30.8 11.8 
A43 12.4 17.7 2.0 1.1 1.0 1501 1.4 27.0 6.5 0.0 
2.9 
02LU 0.0 2.7 0.0 0.0 B41 4.0 9.7 1.5 2.0 
1503 0.0 0.0 0.0 13 .3 B42 1.5 2.3 13.1 6.8 2.0 
853 2.0 0.0 1.0 7.1 9.8 0301 1.9 7.9 5.6 7.7 B57 2.5 5.5 2.1 8.1 2.9 0302 0.4 0.9 18.6 4.4 B58 36.1 10.6 16.8 14.6 8.4 
B70 9.7 18.7 21.7 3.4 7.8 0401 41.2 14.2 3.0 0.7 
0404 4.6 6.6 0.6 0.0 
(n= 59) (n= 19) (n = 101) (n = 99) (n=5l) 04CT 4.6 0.0 0.0 0.0 
0405 0.0 0.5 0.6 3.7 DRI5 1.7 23.9 5.4 8.5 17.1 
DR3 1.7 5.4 27.6 10.3 8.4 1101 1.4 0.9 21.0 NT DR4 44.8 17.3 3.1 2.0 2.0 
DRll 5.2 0.0 23 .2 23 .8 12.4 OQAl 
DR12 1.7 0.0 4.5 4.2 1.0 
0101 0.9 11.5 5.9 16.7 
0201 0.0 0.4 5.3 6.9 
03 60.6 25.7 9.1 4.2 
0401 5.1 1.8 19.2 6.3 Results and discussion 
OQBl 
In Table 1 we list the gene frequencies of some of the 0601 0.0 0.4 0.0 0.0 antigens that distinguish African populations and 0602 12.5 26.5 21.5 30.4 those that show marked differences between the 
0301 4.6 5.8 16.7 9.0 Khoisan and the Negroids. A43 has a high frequency 0302 46.8 15 .0 2.9 1.2 in the Khoisan but a low frequency in the Negroid 
popuiations probably caused by recent admixture. B42 0402 6.9 8.4 19.6 7.1 has the highest frequency in the southern Zulus 
OPAl and decreases northwards where B53 becomes more 
dominant. The splits of B17 are typical of African 01 46.2 30.4 populations. B70 has a high frequency but the IHWS 02 40.3 35.0 sera were unable to distinguish the splits of this 02A 5.6 antigen. The DR antigens show clear differences 028 1.1 
among these populations especially in respect to DR3. 
DPBl DR4. and DRll. 
HLA typing with sequence-specific oligonucleotide 0101 23.1 18.1 29.7 26.2 probes (SSO) and in respect to polymerase chain 0401 28.2 9.7 9.9 2.8 reaction (PCR)-amplified DNA was done on four of 0402 11.6 31.4 17.9 21.9 the populations (Table 2). This confirmed the 
serological results but was also able to subdivide many 1801 0.0 0.9 5. 1 11.6 
of the specificities. Again. there were marked differ- CTl 5.1 1.9 ences between the Khoisan and the Negroids. The splits CT2 12.9 2.8 of ORBl 03 (0301, 0302) and OQBl 03 (0301. 0302) CT3 6.9 1.4 
had opposite distributions. In addition. several new CT4 2.8 0.9 
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alleles were detected by this technique-ORB! 02LU, 
ORB! 04CT, OPAl 02A and 02B, and four new alleles 
at the OPBI locus. 
Table 3 lists representative haplotypes that exhibit 
Table 3. Representative haplotypes showing linkage 
disequilibrium 
San A30, Cw4, B58, DR!3, DQl 
A13. Cw6. B58. OR4. OQ3(8) 
A43. Cw7. B7, DR4. OQ3(7) 
Zulu A13, Cw-. B70, DRll. DQ7 
A30, Cw-, B42, OR3, DQ4 
Shona A30. Cw- B45, DRl, DQI 
A30, Cw6, B58, DRI5, DQI 
Zaire A30, Cw6, B58 . DRll . DQ! 
A28. Cw4, B53. DR3, DQ2 
linkage disequilibrium and are typical of these popula-
tions . 
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W5.5 HLA in North American and South American Negroids 
PETER STASTNY and JORGE KALIL 
It has been known for some time that African-
Americans have many HLA variants and combinations 
of HLA class I and class II alleles that are rare or not 
observed in other ethnic groups [1-6]. Among the 
class I specificities observed in these populations are 
HLA-A23, A28, A30, A33, A34. A36, A74, B42, B45, 
B53, B58, B70, B71, and B72. A variety of class II 
alleles, including subsets of OR8, ORll, ORl2, ORB, 
and ORl4, are known to occur in American Negroid 
subjects and a number of class II combinations (such 
as ORI8. OQ4; ORll, OQll, OQl, etc.) are charac-
teristic of this population. 
The Eleventh International Histocompatibility 
(IHWS) data set included corrected data on 348 North 
American (NA) and 113 South American (SA) Negroid 
individuals for whom serologic typing was available. 
DNA typing results were analysed in panels of 124 NA 
and 42 SA Negroid samples. 
Results and discussion 
Class r antigens 
At the HLA-A locus prevalent alleles were A23, 
A28, A30. A33, A34. and A36. Among HLA-B 
locus antigens B42, B45, B53, and B70 were 
prominent. Cw4 was the highest frequency allele at 
the HLA-C locus in both populations. The blank 
alleles in NA and SA Negroid populations were 
higher than in Caucasian populations. The frequency 
of A-locus blank genes was 5.1 and 8.5 per cent, 
respectively, for the B locus 3.0 and 2.8 per 
cent of genes were blank, and for the C locus 
38.0 and 28.4 per cent of blank genes were 
found. A comparison of frequencies with those in 
West Africans and NA Caucasoids is shown in 
Table I. 
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Table J (continued) 
Haplotypes Ethnic groupsl 
B Br C4A C4B DR ARM UKR URA UZB lYE SAC MXM 
53 5 3 I 4 2.6 
52 S 3+2 QO 15 2.1 
57 5 6 I 7 2.9 
S8 F J I 13 2.0 
62 5 3 I 4 2.2 
63 F 3 2 13 2.0 
63 5 3 I 4 2.0 
'Ei.ht HLA-B blank haplotypes are not listed here. ' " • 
'ARM, Armenians; UKR, Ukrainians; URA, Uralics; UZB, Uzbeks; lYE, Iyen; SAC, South Afncan Caucaso,ds; BRA, BrlD"ans; MXM, 
Mexican Mesti~os. 
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Wtt.6 Complement polymorphism in African Blacks 
M. c. HAMMOND. A . MARCELLI and J. C. POIRIER 
Only two African Black populations were tested for 
Bf and C4 as part of the Eleventh International 
Histocompatibility Workshop (IHWS). They were not 
tested for C2. The two populations tested were lOO 
Zulus from southern Africa (SAF-HAM) and 101 
people from Mali in West Africa (FRA-DDC). Bf 
typing was by immunofhation after agarose gel 
electrophoresis [I). C4 typing was by electrophoresis 
of samples pre-treated with carboxypeptidase Band 
neuraminidase type VI and immunofixation with 
anti-C4 
Results and discussion 
The gene frequencies are shown in Table I. BfF and 
Brs07 have a higher frequency in West Africans. C4AI 
has a high frequency in West Africa while C4A6 has 
a higher frequency in southern Africa. The frequency 
of C4AQO seems high in southern Africa, but this 
frequency is an estimate based on the frequency of 
heterozygote!. C4B3 has a higher frequency in 
southern Africa. 
The joint occurrence of alleles at different loci are 
referred to as complotypes ~nd the common complo. 
types are often a reflection of the high frequency of 
some alleles. Linkage disequilibrium between alleles 
is of greater interest as an Indication of selective 
pressures in the population. 
Table 2 lists those combinations of antigens at three 
loci that show linkage disequilibrium in the two popu. 
lations studied here. There are noticeable differences 
in the complotype distribution in the two populatlons 
and some complotypes are only present in one or the 
other popUlation. 
The strong negative linkage disequilibrium between 
C4A3 and C4B3 (fable 3) is present irrespective of the 
Bf allele and seems specific for Africa, because in those 
populations where C4BJ is present there is noflinkage 
diseqUilibrium. The complotype consisting of the most 
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Table 1. Gene frequencies of Bf and C4 poly-
morphisms 
South Africa West Africa 
Zulu Mali 
(n= 100) (n=IOI) 
Bf 
F 0.605 0.712 
FI 0.060 0.024 
FOSS 0.010 0.0 
S 0.305 0.202 
507 0.020 0.059 
C4A 
I 0.005 0.113 
2 0.015 0.039 
3 0.5S0 0.638 
4 O.OOS 0.034 
5 0.005 0.019 
6 0.057 0.019 
Other 0.0 0.196 
QO 0.333 0.133 
C4H 
1 0.458 0.722 
2 0.12S 0.084 
3 0.23S 0.099 
4 0.0 0.0 
5 0.0 0.0 
QO 0.179 0.094 





























BI IS .S 7.4 
B3 13.9 9.1 
B2 5.9 3.6 
B2 S.O 2.4 
BQO 4.2 3.6 
B3 2.2 2.0 


















Complement component Wl1.1.2S 
Table 3. Complotypes showing negative linkage 
disequilibrium (LD) 
South Africa West Africa 
Frequency Frequency 
Of C4A C4B (010) LO (010) LO 
F A3 BI 13.7 -2.6 19. 1 -6.4 
F A3 B3 4.6 -3 .8 
S A3 B3 2.0 -2.0 
Table 4. Linkage disequilibrium with HLA-B and 
HLA-DR 
HLA-B Bf C4A C4B HLA-OR 
South Africa 
7 S A3 BI IS 
8 S A3 BQO 10 
42 F AQO B3 3 
44 F A6 BI 11 
58 S07 A3 BI 14 
70 Ft A3 HI It 
West Africa 
18 S A3 BI 13 
42 F A3 BI 3 
45 S07 A3 BI 
49 F AQO BI 4 
51 F A3 Bt 7 
53 AQO BQO I 
frequent allele5 at each IOCU5 (OfF. C4A3, C401) 
shows significant negative linkage disequilibrium in 
Africa and also in Mexico and Italy but not in other 
European population!. In Oriental populations there 
is significant positive disequilibrium. 
The linkage disequilibrium with HtA-O and HLA-
DR antigens (Table 4) is also different except for the 
well known 042, DR3 (0302) association. Of interest 
is the C4A6 disequilibrium with 044 and DR11 in 
southern Africa. 
It would be interesting to investigate the role of 
C4 null genes in the pathogenesis of malaria because 
of the marked linkage disequilibrium between C4QO, 
and OS3 in the light of the recently described 
association of OS3 with protection from severe 
malaria [3]. 
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Wl1.1.26 Complement component 
Conclusions 
Bf gene frequencies in Africa are quite different 
from those in Caucasian and Oriental populations. 
The most frequent C4 alleles in African populations 
are also the most frequent in other populations but 
some alleles (e.g. C4AI, C4B3) that are rare in other 
populations have a higher frequency in African Blacks. 
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Wi1. 7 Complement polymorphism in North and 
South American N egroids 
NANCY L. DELANEY, ROBERT MCLEAN, TOSHIO MAZDA and KATSUSHI TOKUNAGA* 
The two Negroid populations studied in this report are 
a North American group of 75 from Baltimore, 
Maryland, USA obtained by Or Wilma Bias of The 
J ohns Hopkins University School of Medicine and a 
South American group of 158 from Guapi, Colombia 
on the Pacific coast of South America obtained by Or 
Shunro Sonoda, Kagoshima University, Japan. Both 
groups were obtained as normal controls and/or 
for the anthropology component of the Eleventh 
International Histocompatibility Workshop (IHWS). 
C4 phenotypes were determined by classical electro-
phoretic techniques [1,2] using EDTA samples treated 
with neuraminidase and carboxypeptidase B, 
a glycine-barbital buffer system, followed by 
immunof1Xation. Haemolytic overlay was used to 
confirm questionable C4 phenotypes. 
The comparison of complement types in these 
populations yields the following similarities and 
differences. 
Results and discussion 
Table I shows the frequencies of Bf and C4 alleles in 
North and South American Negroids. Only two alleles 
differ significantly: C4A*1 and C4A*QO. C4A*1 was 
present in 10 per cent of the North American Negroid 
population but in less than 1 per cent of the South 
American sample. Of the data collected for the IHWS, 
the highest population frequency for C4A * 1 was 
On behalf of Wilma Bias and Shunro Sonoda. 
Table 1. Allele frequencies of factor B (Bf), C4A, and 
C4B in North and South American Negroid populations 
(ethnic codes 10400 and 10600, respectively) 
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RFLP Standardization Report for DP Beta/HindIll 
G. Paulsen,1 G.Markussen,1 B.o. Barger,3 R. Fauchet,l M.G. Hammond,5 and J.M. Tiercy4 
Thirty-two bands were identified by RFLP in the OP 
beta/HID system as shown in Table I and in Figure 1. 
The distribution among core cell lines of 16 bands with 
Panicipating Laboratories: SCATSB.' FRAFAU! US5UAB,3 
FRAJEA,· SAFHAM' 
high OPB specificity is shown in Table 2. A cross-
hybridization table for the HLA class IIIHID system can 
be found in the OR BetalHID report. 
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Table l. Standard Bands in the DRBeta/HID System Table 3. Cross-Hybridization Table- Enzyme: HID-Probe: 
Band kb Locuso FrequencY' % Faint
C 56d 32d HLA Class II Beta 
9.66 I 2 2 0 0.029 0 .000 
DRB kb DQB kb DPB kb 
1 
2 9.65 I 02 0 0.014 0.000 12.80 13 .07 
3 8.44 1 0 2 0 0.257 0.000 2 11.42 3 11.66 
4 7.17 1 200 0.300 0.000 1 9.66 3 9 .76 4 9 .76 
5 6.94 2 3 I 0 1.000 1.000 2 9.65 5 9 .64 
6 6. 10 100 0 0.071 0 .000 
7 3.84 1 o () 0 1000 1.000 3 8.44 6 8.59 
8 3.43 1 2 I !l 1) .071 O.DOO 4 7.17 7 7.24 
9 3.32 1 020 0. 143 0 .000 5 6.94 8 7.08 7 7.05 
\0 3. 13 1 000 0.300 0.000 \0 5.48 9 5.43 
11 3.02 . 1 230 0.071 0 .000 
12 2.96 102 0 0.500 0.000 11 
5.13 10 5.06 
13 2.89 I 0 I 0 0 .529 0 .000 s 8 3.43 15 3.47 14 3.50 
14 2.85 1 020 0 . 171 0.000 s 16 3.41 15 3.42 
15 2.70 I 000 0.057 0.000 9 3.32 16 3.37 
16 2.60 I 2 0 0 0 . 129 0.000 3.31 
17 2.55 100 0 0.057 0.000 
17 3.30 17 
18 2.51 1 320 0.429 0.000 19 3.20 18 3.42 
19 2.49 I 3 2 0 0 .443 0 .000 1I 3.02 20 3.09 19 3.09 
20 2.36 I 000 1.000 0 .361 12 2.96 20 2.99 
21 1.83 I 200 0.029 0.000 13 2.89 21 2.90 
22 1.72 1000 0.014 0.000 
23 1.68 I 2 I 0 0.343 0.000 14 2.85 22 2.83 
24 1.63 I 2 I 0 0.414 0.000 16 2.60 25 2.62 
25 1.58 I 2 I 0 0.171 0.000 18 2.51 26 2.52 23 2.51 
26 1.44 I 2 I 0 0.300 0.000 19 2.49 27 2.50 24 2.50 
27 1.30 2 I ~ \1 0 .086 1.000 
28 1.15 2 1 ~ 0 1.000 1.000 21 1.83 28 1.79 
°Locus assignment in the order DRB. DQB. DPB. DOB. I indi-
23 1.68 29 1.70 27 1.68 
cates high specificity: 2 and 3 indicate lower specificity. 24 1.63 30 1.66 28 1.65 
bBand frequency in the core cell lines. 25 1.58 JI 1.61 29 1.60 
{"Frequency of faint bands 26 1.44 32 1.51 30 1.48 
dDiscrepancies in faint b:mds (f) or strong bands (s) of the hid-
-
27 1.30 33 1.35 31 1.32 
den duplicates (WS. ID. 9056 and 9032). 
28 1.15 34 1.19 32 1.17 
Underline denotes primary locus assignment. 
Table 2. Distribution of Bands With High DR Beta Specificity in the DRB/HID System 
Band number 
0 0 0 0 0 0 0 0 I I I I I 1 1 I 2 2 2 2 2 2 2 
WSID DR I 2 3 4 6 7 8 9 0 2 3 4 5 6 7 8 9 0 2 3 4 5 6 
9106 7 2 2 2 8 2 2 8 1 
9052 7 2 2 8 2 2 8 I 
9047 7 2 2 8 2 2 8 I 
9O-l8 7 2 2 8 2 2 8 1 
Y050 7 2 2 8 2 2 8 I 
9051 7 2 2 8 2 2 8 1 
9104 11 2 2 8 2 2 8 I 
9007 4/16 2 2 8 2 2 2 I 
9025 4 2 2 8 2 2 8 I 
9026 4 2 2 8 2 2 8 
9028 4 2 2 8 2 2 8 
9029 4 2 2 8 2 2 8 
9030 4 2 2 8 2 .. 2 8 
9031 4 2 2 8 2 2 8 
YOJ3 4 , , ~ 2 2 8 - -
9034 4 2 2 8 2 2 8 
9091 4 2 2 8 2 2 8 
9092 4 2 2 ~ 2 2 8 
9107 4 2 2 8 2 2 8 
599 
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lable 2. COllfillued 
Band numher 
0 0 0 0 0 0 0 0 I I I I I I I 2 2 2 2 2 2 2 
WS ID DR I 2 J 4 6 7 8 9 0 2 J 4 5 6 7 8 9 0 2 3 4 5 6 
9032 4 2 2 8 2 2 8 I I 
9032 4 2 2 8 2 2 8 
9075 9 2 8 2 2 8 2 
9002 I 2 8 3 8 
9003 I 2 8 3 8 
9004 I 2 8 3 8 
9005 2 8 3 8 
9006 2 8 3 8 
9010 15 8 3 2 2 
9011 15 8 3 2 2 
9082 15 ~ 3 2 2 
9017 15 8 3 2 2 
90D 15 8 3 2 2 
9014 15 8 3 2 2 
9008 15 8 3 2 2 
9009 2 !\ I ., 2 2 ... 
9016 16 8 2 2 2 
9019 3 I; 3 3 2 2 8 
9020 3 8 3 2 2 2 8 
9018 3 8 3 2 2 . 2 8 
9022 3 8 3 2 2 2 8 
9023 3 8 3 2 2 2 8 
9088 3 8 3 2 2 2 8 
9021 3 8 3 2 2 8 
9036 11 8 3 3 2 2 8 
9037 11 8 3 2 2 2 8 
9039 11 8 3 3 I 2 8 
9042 11 8 3 2 2 2 8 
9043 11 8 3 3 2 2 8 
9060 13 8 3 3 2 2 8 
9105 " 8 3 3 2 8 9045 11112 8 3 2 2 2 8 I 
9038 12 8 3 3 2 8 2 
9040 11 8 3 2 2 8 
9054 14 8 3 3 2 8 
9061 14 8 3 3 2 8 
9057 14 8 3 3 2 8 
9058 13 8 3 2 2 8 
9062 13 8 3 2 2 8 
9065 13 8 3 2 2 8 
9064 14 8 3 2 2 8 
9055 6 8 3 2" 2 2 8 
9059 J3 8 3 2 2 2 8 
9063 13 8 3 2 2 2 8 
9056 13114 8 3 2 2 2 8 
9056 13/14 8 3 2 2 2 8 
9066 8 8 3 8 ) 
9067 8 8 3 8 ) 9068 8 8 3 8 I 9069 8 8 3 8 I 9070 8 8 3 8 I 9071 8 8 3 8 ) 
9072 8 8 3 8 I 0 0 0 0 0 0 0 0 1 ) ) I I ) I I I 2 2 2 2 2 2 2 I 2 3 4 6 7 8 9 0 2 3 4 5 6 7 8 9 0 I 2 3 4 5 6 
Bands designation: 1-3 - increasing imensity; 8 = faint. 
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distributed among the participating laboratories. The 
"variant" analyzed by FAU and TSB has been included in 
the report. ' . 
The DRw53 association of two fragments ID accor-
dance with bands 3 and 4 in the present report has previ-
ously been described. A fragment correspondi~g. to 
standard band 3 was associated with a HLA restrIctIOn 
element, which seemed to be more narrow than the sero-
logically determined DRw53 specificity (1). This is in 
agreement with the present standardization where ~and 
3 was missing in two of seven HLA-DR7 core cell hnes. 
Reference 
I. Paulsen G, Qvigstad E, Gaudernack G, Rask L, Winchester 
R, Thorsby E. Identification, at the genomic level, of an 
HLA-DR restriction element for cloned antigen-specific T4 
cells. J Exp Med 1985;161:1569. 
RFLP Standardization Report for DR ~eta/~lsPI 
M. Segalt,t L. Schluender, I A. Arnaiz-Villena,z N. Kashiwagi,l and C. Mull~r4 
DRbetalMspI blots were received from four laborato-
ries. In spite of the standardized technique, the overall 
intensity of the blots and the number of fragments 
detected were somewhat variable. Marker bands were 
re measured where necessary and the data were pooled as 
follows: 
I. Faint bands were listed as standard fragments when 
they were identified by at least two of the four labora-
tories. 
2. Faint bands seen by only one laboratory, sometimes 
in only one lane, were not included. This was seen 
most often with bands of high kb and may have been 
due to incomplete digestion. 
3. Discrepancies between blots were resolved in favor of 
the majority, or in favor of the positive identification 
when two labs recorded a band and two did not. 
4. Faint bands in particular were sometimes resolved as 
a doublet in one lab's blots. but appeared as a singlet in 
others. Such bands were considered as two standard 
fragments when they could be consistently resolved 
on the blots from at least two labs; otherwise they 
were considered as one band. 
5. Because of small differences in measurement from blot 
to blot and from lab to lab. the standardized molecular 
sizes of cross-hybridizing bands were not always 
exactly the same. In addition. the pattern of positives 
and negatives of the same band with different cross-
hybridizing probes was not always identical. There-
fore. cross-hybridizing bands were identified by 
Participating Laboratories: US2flAC.' FRAARN.' JAPKSH.' 
GERMUC' 
This is publication #498 from the lmmunobiology Research 
Center. University of Minnesota. Minneapolis. Minnesota 
55455. USA. The work was supported in part by Juvenile Dia-
betes Foundation Grant #186175 and March of Dimes Birth 
Defects Foundation Grant #6-496. 
t Springcr-Vcrl.ag ~cw "hrk I'JH9 
IntUl1lon",,,lo!!} Ht" ffl/\ 
VIIIUI11C I 
overlaying the pairs of autoradiographs of blots hybrid-
ized with the relevant probes. 
The DRB/MspI system identified 27 fragments on the 
core cell lines, as shown in Table I a·nd the Figure I. Nine 
of these were uniquely seen with the DRB probe. and 
eight additional ones were strongest with DRB; one 
(fragment 6) was equally strong with DRB and DQB. In 
Figure 1, the DRB-unique or "dominant" fragments are 
indicated by a dot next to the fragment number. 
Table 2 shows all cross-hybridizing bands for MspI 
with the class II beta probes; the "primary" assignment 
for each fragment is underlined (e.g., DRB fragment 1 
was strongest with the DQB probe and was also seen 
with the DRB probe, but not with the DPB or DOB 
probes). It should be noted that the intensity of many 
fragments varied from lane to lane within a single blot 
in patterns that were· not due to loading of different 
amounts of DNA in different lanes; hence, for example. 
a fragment with the strongest hybridization to the DRB 
probe would still be faint for certain lanes and might 
have a stronger signal with the DQB probe in certain 
lanes. Fragments detected with only one probe are not 
shown in Table 2. 
Discrepancies for the "hidden duplicates" (9056 and 
9032) were due to faint bands or to difficulties in reading 
fainter blots where a fragment was not identified by all 
four labs. As mentioned above, some of the fragments 
could not be identified or doublets resolved on all blots. 
largely due to relatively dark background in some blots. 
Fragments 14a, 2la. and 22a(see Figure I) were clear on 
one lab's blots. very faint on :i second lab's, and could not 
be identified on the other two. Fragment 27 was classi-
fied by the computer analysis as freq 0.000.% faint 
0.000, although this fragment was identified by two labs 
in exactly the same manner as Fragments 23.24.25. and 
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Twenty-eight bands were id'entified by RFLP in the 
DRB/HID system, as shown in Table J and Figure J. The 
distribution among core cell lines of 25 bands with high 
DRB specificity is shown in Table 2. 
A cross-hybridization table for the HLA class II!HID 
systems is indicated in Table 3. Bands 13 and 14 had 
almost identical migration, but were decided to be two 
distinct fragments. The same decision was made for 
bands 18 and 19. This made the band number assign-
ment of these bands difficult. 
Panicipa1in8 LaboraTories: SCATSB. I US5UAB.' FRAFAU. J 
SAFHAM: FRAJEA J • 
Regarding WS. ID. 9037 (RFLP gel load number 26), 
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Figure 1. RFlP of 25 Dt>:A samples run in 0.9% agarose gel. 
Representative core bands are shown on the right. The WS. ID. 
of the core cell lines is shown from the left following marker I 
and marker2 : 9013.9033 . 9004. 9018.9055 . 9063.9022 . 9043. 
9023.9006.9005.9050.9056.9104.9051. 9047. open lane. 
9075.9061. 9067. 9038. 9008. 9/06. 9032. 9072. and 9052. 
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ULocus assignment in the order DRB, DQB. DPB. DOB; I indi-
cates high. 2 and 3 lower specificity. 
bBand frequency in the core cell lines. 
CFrequency of faint bands. 
dDiscrepancies in faint bands (f) or strong bands (s) of the hid-
den duplicates (WS ID 9056 and 9032) . 
Table 2. Distribution of Bands With High DPB Specificity in 
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Figure 1. RFLP in the DP beta/HID ~ystem of 19 DNA 
samrles run in 0.9'7. agarose geL Representative core 
blmds are ~h()wn in the figure numbered on their right 
side . The WS ID of the core cell lines are from the left 
following marker I and marker 2: 9013, 9033. 9004. 
9063 . 9022.9043.9023.9(~6.9005 . 9050.9056.9104. 
9051. 9047 . 9106. 9032 . 9072. 9052. and 9020. 
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RFLP Standardization Report for DP Beta/MspI 
M. Segall,J* L. Schluender,l* A. Arnaiz-Villena,2 N. Kashiwagi,3 and C. Muller4 
DP beta/MspI blots were received from four laboratories 
and were analyzed as detailed in the report on DR 
Beta/MspI. The DP beta/MspI system ident ified 20 frag-
ments on the core cell lines (Figs. I and 2). Nine of these 
fragments were unique to DPB, and three were cross-
hybridizing but strongest with DPB. as shown in Table 2 
of the report on DR Beta/Mspl. Unique fragments are 
Participating whoratorics: US2BAC,' FRAARN! JAPKSH. ' 
GERMUC 
*This is publicat ion #496 from the Imrnunobiology Research 
Center. University of Minnesota . Minneapolis. Minnesota 
55455. USA . Supponed in parI hy luvenile Diabetes Founda-
tion Grant #186175 and March of Dimes Binh Defects Founda-
tion Grant #6-496. 
are not shown in that table. DPB-dominant or unique 
fragments are .indicated in Figures 1 and 2 with a dot next 
to the fragment number. 
Discrepancies for the "hidden duplicates" (9056 and 
9032) were found in bands identified by only two or 
three of the participating laboratories and generally 
involved faint bands. Fragments 17 and 18, which were 
both' unique to DPB, were separable on one lab's blots 
and are certainly a doublet, but could not always be 
clearly distinguished on the blots of other labs. 
Presence/absence data for the polymorphic DPB frag-
ments are shown in Table I ; the cells are arranged in order 
by DPw specificity. Fragments 2 and 3 both were positive 
in 6/8 DPwl (both were negative with cell #9022); frag-
ment 2 also was positive with 112 DPw5. Fragment 13 
was positive with 16/16 DPw2 and I DPw4. 
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CORRELATION BETWEEN SEROLOGY AND DNA TYPING 
. M.G. Hammond.! 
The Eleventh International Histocompatibility Workshop included a protocol 
for testing DNA using sequence specific oligi-nucleotide probes (SSOP). We 
were able to test 92 African Blacks by this technique as well as the standard 
serological method. 
There was very close agreement by these two methods but the discrepancies 
need to be studied further. There were nine cells in the DR 1, 2, 10 group 
and two differences. 
There was almost total agreement in the DR53 group of DR4, 7 and 9. Only 
one sample tested positive with SSOP's for DR4 and negative by serology. 
Th,e DR52 group of DR 3, 5, 6 showed several discrepancies especially the 
splits of DR 6 (DR 13 and DR 14). It seems probable that the serological 
definition of the narrow antigens is not clear cut. 
In the DQ group of specificities, the most recently defined antigen - DQ4 -
also had many discrepancies. There were four cells positive by DNA testing 
and negative by serology and six cells where the opposite occurred. 
! Natal Institute of Immunology, 
Durban, South Africa 
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AFRICAN BLACK 
Sero + Sero -
Specificity ++ DNA- DNA + 
---------------- ------- ------------- ------------ --------
DR 3 37 2 1 48 
DR 5(11) 40 0 2 46 
DR 5(12) 8 1 0 79 
DR 6(13) 22 2 1 63 
DR 6(14) 3 2 0 83 
DR8 4 0 0 84 
DR 52 80 0 0 8 
---------------- ------- ------------- ------------ --------
DR4 5 0 1 82 
DR 7 12 0 0 76 
DR9 3 0 0 85 
DR 53 21 0 0 67 
---------------- ------- ------------- ------------ --------
DR 1 3 1 0 84 
DR 2(15) 11 0 0 77 
DR 2(16) 0 0 0 88 
DR 10 3 0 1 84 
---------------- ------- ------------- ------------ --------
DQ 1 59 1 1 27 
DQ2 25 1 1 61 
DQ 3(7) 26 1 2 59 
DQ 3(8) 5 1 0 82 
DQ4 26 6 4 52 
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0604 1 eel 
22 C€ 
0605 1 eel 
2 cel 
5 eel 
0604 4 eel 
0604 0605 1 eel 
0605 7 eel 
1 eel 
1 eel 
0301 24 eells 
0301 0302 2 cells 
0301 
0301 
0302 3 cells 
04 06 1 cell 
02 1 cell 
06 1 eell 
02 1 cell 
DQ4 
SEROLOGY D N A 
5 2 2 
8 8 8 8 8 8 7 3 3 
1 1 1 1 5 5 D D D 0 0 0 
2 3 4 5 0 2 a a a 8 1 2 DaS DaS 
+ + + + + + 4 + - + 0402 26 cells 
+ + + + + + 4 - - - 6 cell 
+ + - w + + + - + 0402 4 cell 
DQ4 
SEROLOGY D N A 
5 2 2 
8 8 8 8 8 8 7 3 3 
1 1 1 1 5 5 D D D 0 0 0 D D D 
CELL 2 3 4 5 0 2 a a a 8 1 2 a a a 
32 8 8 8 8 8 8 4 7 1 1 1 0301 0302 
41 8 8 8 6 8 8 4 1 1 1 1 0602 0603 
44 8 1 8 8 1 1 4 1 1 1 1 0501 0602 
52 8 6 6 1 1 6 4 1 1 1 1 0301 0602 
57 8 8 8 8 1 1 4 1 1 1 1 0501 0602 
72 8 8 8 8 8 6 4 1 1 1 1 0201 0301 
26 8 8 1 1 1 1 2 7 8 1 8 0402 0301 
36 8 1 1 1 8 8 1 3 8 1 9 0402 
49 1 1 1 6 6 8 1 7 8 1 8 0402 0602 
69 1 1 1 6 1 1 1 - 8 1 8 0402 0603 
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Introduction 
The number of investigations into associations between HLA and disease 
. increased dramatically with the discovery that HLA B27 confers a relative risk 
for ankylosing spondylitis enormously greater than any other genetic 
polymorphism. More than 500 diseases have now been investigated and the 
strongest patterns of association are with auto-immune diseases. However, all 
the early work was done on Caucasian populations and my investigations were 
aimed at discovering if these associations with specific antigens were present 
in different races. 
Part 11 contains forty four papers dealing with the relationship between HLA 
and several diseases in the different races. I was particularly interested in 
those diseases which occurred more commonly in the Black and Indian 
communities than in Caucasian populations because the distribution of HLA 
antigens varies greatly in the different races. 
Chapter 2 contains eight papers dealing with the relationship of HLA to 
cancer. The prospective study of cancer in black patients showed an 
interesting association between cancer of the oesophagus and HLA B45 but a 
follow-up study could not confirm the original finding. These published 
reports led to an invitation to contribute a chapter to a book, 'Cancer of the 
Oesophagus'. Other publications include a similar prospective study in Indians 
and the research carried out .while I was Visiting Professor at the National 
Taiwan University in Taipei. 
Diabetes mellitus has strong associations with the HLA system and the ten 
papers in Chapter 3 reflect the initial studies of Class I antigens and later 
reports covering Class 11 antigens as well as some interesting findings in non-
insulin dependant diabetes. Another auto-immune disease, rheumatoid 
arthritis, was investigated as part of collaborative studies included in the 
International Histocompatibility Workshops and followed by detailed reports 
of HLA associations in Blacks and Indians. 
The remaining 19 publications cover a wide variety of topics from unusual 
diseases such as tropical spastic paraparesis to paternity tests and even the 
possible influence of HLA on mate selection. 
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Summary 
Tumour tissue from patients with inoperable cervical carcinoma was studied to 
determine the significance of humoral antibody involvement. Comparative elution 
studies using normal and cancerous tissues revealed that various classes of 
immunoglobulin and complement, either singly or in combination could only be 
recovered from the cancerous tissues. Some cancer tissue eluates possessed 
antibodies which sensitized normallymphocytes by the cytotoxicity test suggesting 
the host's recognition of structural modification of the tumour cell. It is possible 
that the various classes of immunoglobulin found in cancer tissue eluates represent 
antibodies to cytoplasmic constituents, cell membranes or antigen-antibody 
complexes. It was found that the serum from the cancer patients possessed a 
significantly higher incidence of "non specific" lymphocytotoxic antibodies than the 
controls. Our inahility to associate these antibodies with sp'ecificities for normal 
histocompatibility antigens suggests that this type of antibody may symbolize 
humoral responses towards a combination of tumour-related and normal trans-
plantation antigens. It seems apparent that their activity is of an autoimmune 
nature capable of altering the in vil'o functions of the cell-mediated immune 
mechanism. 
THERE is evidence to show that neoplasia in man 
can stimulate a host's immunological response 
towards tumour-associated antigens (Gold and 
------- --------- ---
• Present address: Department of Health and 
Rehabilitative Services, lacksonville, 32201, Florida, 
U.S.A. 
t Present address: Grey's Hospital, Pietermaritzburg, 
Natal, South Africa. 
Freedman, 1965; Hellstrom et al., 1971). In 
experiments on rodents by Maller (1963) and 
Batchelor (1968) it was found that the formation 
of humoral antibodies to tumour-associated 
antigens blocked the rejection of these cell lines 
and could lead to their enhanced growth. As a 
result the tumour apparently remains inaccess-
ible to the host's cell-mediated defense mechan-
1040 
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ism. Failure of the host to reject tumour cells has 
also been said to be due to a severely impaired 
cellular immune system (Keast, 1970; Alexander 
and Fairley, 1967). The concept that some 
cancers may develop as a result of a breakdown 
in "immunological surveillance" at a time when 
humoral antibody 'synthc"i~ to foreign structures 
of the cancer cell remains active, prompted the 
present study which measures antibody responses 
in patients with cervical carcinoma. 
A working hypothesis was the acceptance that 
(a) the recovery of various immunoglobulins 
from tumour cells reflects the stimulated activity 
of the host towards altered cell constituents and 
that (b) the recognition of increased antibody 
activity to histocompatibility antigens by the 
Iymphocytotoxicity test can be regarded as a 
host's' response to a hybridized antigen on the 
surface membranes of tumour cells. Evaluation 
of these serological parameters was carried out 
on Southern African Negro women with carci-
noma of the cervix and a representative number 
of controls. 
MATER!ALS AND METHODS \ 
Patients Investigated 
Two groups of women with histologically 
confirmed squamous cell carcinoma of the cervix 
were examined: (a) patients with active disease 
tested before treatment and (b) patients who had 
confirmed carcinoma of the cervix but were 
symptom-free five years ;,ftcr treatment. 
Preparation of Soluble Cytoplasmic Tissue 
E/uafes 
Specimens of cervical tissue were obtained 
from patients with inoperahle cervical carcinoma. 
For purposes of control normal cervical tissue 
was obtained from hysterectomy specimens. 
Pieces of tissue, approximately 20 g. in weight 
were stored in liquid nitrogen immediately after 
collection. For the preparation of cytoplasmic 
eluate, 5 g. (solid mass) cif tissue in isotonic 
saline was homogenized at low speed in a tissue 
blender. The separation of tissue mass into 
microscopically recognized clusters of intact cell 
particles was essential for efficient removal of 
capillary protein by saline washings. Four 
saline washings were considered sufficient. 
Complete disruption of a 50. per cent suspension 
of the washed cells in saline was obtained by 
insonation at 25 kc per second for ten minutes in 
a vessel standing in iced water. On microscopy 
the tissue mass then appeared as remnants of 
broken nuclei and membrane particles. From 
then on the cervical tissue was treated in a 
similar manner to washed red cells sensitized 
in vivo by acquired haemolytic anaemia auto-
antibodies. Antibody globulins, when present on 
the tissue, were recovered by the ether elution 
procedure of Vos and Kelsall (1956), modified 
only in that four volumes of ether was added 
directly to the saline suspension of the disrupted 
tissue. The recovered eluate was dialzyed against 
phosphate buffered physiological saline (0· ISM, 
pH 7· I) for 24 hours at 4 dc. Particulate matter 
present after dialysis was removed by centrifuga-
tion and the eluate stored as a lyophilized 
product. 
Determination of IlIlmunoglobulin 
Characteristics 
In view of the relatively low concentration of 
protein recovered from S g. of tissue mass 
(Table I), the immunoglobulins were character-
ized by the passive protein coupling procedure 
of Gold and Fudenberg (1967). A concentration 
of 2 mg. per ml. of protein was found most 
suitable for the coating of saline-washed group 0 
red cells with 0'037SM (one per cent) chromic 
chloride solution diluted to 1 in 20 in a O' ISM 
solution of sodium chloride. The coated cells 
and appropriate antiserum were mixed together 
on agglutination plates and allowed to stand for 
two hours. Monospecific antisera to IgG, IgA 
and IgM heavy chain were used to determine 
the presence of different immunoglobulins. 
Anticomplement sera (C3 and C4) were kindly 
donated by Dr. L. D. Petz, Harkness Community 
Hospital, San Francisco. 
Lymphocytotoxicity Test 
For the determination of Iymphocytotoxic 
antibodies a selected panel of 18 cell donors was 
used. The tests were done on Falcon micro test 
trays using the two-stage procedure recom-
mended by the National Institutes of Health. 
Thus one [Ll. of serum and one [Ll. of cells were 
placed into each well under paraffin oil. After 
30 minutes at room temperature S "d. of un-
absorbed rabbit complement was added to the 
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TABLE I 
Reactions of various specific olltisera to cells coated with pr:parati?ns of c>.'toplaslllic proteiJ.' obtained from cerl'ical tisslle 
, taken from 4 1I0rma[ and 8 patients wl,h corCIllOIllO of 'he cervIx 
Total protein 
Agglutination of coated cells by n~onospecifk content of 
antisera'" eluates in 
Eluates from Patient Control relation to 
serum mass 
equivalence 
IgG IgA IgM C3 C4 of tissue 
(mg. per m1.) 
Normal cervical tissues MJ 1 0 0 0 0 0 2·3 
CM 0 0 0 0 0 0 2·5 
NS 0 0 I 0 0 0 1 · 8 
KM 0 0 0 0 0 0 2·7 
Cancerous cervical tissue RN 2 4 0 4 0 0 18·1 
CS 4 1 0 I 0 0 15·7 
GB 4 0 0 0 0 0 38·4 
MP I 3 2 4 0 0 26·3 
MU 4 4 0 4 1 0 33·5 
DT 4 0 3 4 0 0 21·4 
PS 3 1 4 4 2 0 30·1 
RU 4 0 0 1 0 0 18·3 
'" Group 0 red cells were coated with tissue eluate containing 2 mg. per m1. of protein. 1,2,3,4 denotes intensity 
of agglutination reaction. 0 denotes no agglutination. 
cell-serum mixture. After a further 60 minutes 
at room temperature 5 /1,1. of freshly prepared 
trypan blue (0·6 per cent) in saline was placed 
into each well and left to stand for a further 
] 5 minutes. After this time the excess dye was 
flicked off and thc cell<; examined with an inverted 
microscope. Scrulll \\hich killed lymphocytes 
with known H L-A antigen determinants, e.g. 
H L-A 7 positive cells but not H L-A 7 negative 
cells were identified as containing "specific" 
anti-HL-A. Cytotoxic antihody activity which 
could not be identified as "specific" when tested 
against the panel of 18 known H L-A cell types 
were classified as "non-specific". Similar methods 
for defining Iymphocytotoxic antibodies into 
"specific" or "non-specific" reagents have been 
reported by Waters et al. (1971) and Kreisler 
et al. (1971). 
RESULTS 
To establish whether humoral antibodies were 
bound to tumour cells, eluates from a number of 
normal and . C<llll'l:rOllS cervical tissues were 
examined. By our method of recovering protein 
from cervical tissues, which is a modification of 
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the method used to study the characteristics of 
autoantibodies in acquired haemolytic anaemia 
(V os et al., 1971). it was found that the cancerous 
tissue contained on a mass equivalent basis" more 
protein than the non-cancerous tissue (Table I). 
Following passive coating of the protein onto 
red cells and evaluating their agglutination 
reactions for various antisera it was found that 
the tumour eluates often possessed a variety of 
immunoglobulins. These immunoglobulins were 
predominantly of the JgG class occurring either 
singly or in combination with IgM and comple-
ment component C3. No definite reactivity for 
anti-C4 was evident in this small series of cases. 
The low concentration of protein found in 
normal cervical tisslle eJuates could not be 
classified as immunoglobulins. 
Assuming that the immunoglobulins recovered 
from the cancerous cervical tissues were anti-
bodies capable of sensitizing other cell lines we 
then measured the presence of Iymphocytotoxic 
antibody activity. Using a selected panel of 
eightecn Iymphocytes which were used routinely 
to characterize H L-A antibody specificities it 
was found that four Ollt of the eight cancerous 
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tissue e1uates lysed Iymphocytes by the cyto-
toxicity test (Table ll). In tissue e1uates CS and 
GB the reactions were extremely intense for all 
panel cells, whilst tissue eluates MU and RV 
only reacted with a small number of the cells. 
In spite of this variation the reactions could not 
be classified as "specific" antibodies for known 
HL-A determinants. Although the cancerous 
tissues possessed recognizable immunoglobulins 
(Table 1) only some were found to have lympho-
cytotoxic antibody activity. It is hoped that 
further studies will determine why this difference 
exists. 
The significance of finding cytotoxic anti-
bodies in the cancerous tissue eluates led us to 
compare the incidence of these antibodies in 
patients with carcinoma of the cervix and in a 
large number of healthy women. It was impor-
tant to classify antibodies capable of recognizing 
known combinations of HL-A types from those 
lacking these characteristics. Table III shows our 
findings in 69 Southern African Negro women 
with histologically confirmed sq uamous cell 
carcinoma of the cervix tested prior to treatment, 
33 women examined five years after successful 
treatment and 1000 healthy women of the same 
race. There were no significant differences 
observed in the incidence of HL-A "specific" 
cytotoxic antibodies between the cancer patients 
and the controls (X2 0·04, P>O· 8). However, 
some inexplicable variation in the incidence of 
HL-A "specific" antibodies was observed 
between those cancer patients examined prior 
to treatment (21 ·7 per cent) and those who were 
symptom free five years after treatment (3·0 per 
cent). 
In a comparative evaluation of "non specific" 
lymphocytotoxic antibodies the cancer patients 
were found to possess a significantly higher 
, incidence of "non specific" cytotoxic antibodies 
. than the controls (X2 55·48, P<O· 001). Although 
it may be that the increased incidence of "non 
specific" cytotoxic antibodies observed among 
the five-year-cure series was influenced by 
therapy, this could not be so for the patients 
tested prior to treatment. 
We could not establish the presence of HL-A 
"specific" antibodies in patients with "non 
specific" cytotoxic antibodies by testing their 
serum at various dilutions. However, selective 
absorption studies may help to determine the 
nature of these unusual antibodies. 
DISCUSSION 
Numerous studies have demonstrated that 
tumour antigens can be found in a variety of 
neoplasms (Prehn, .. 968; Boyse et al., 1968; 
TABLE 11 
Lymphocytotoxic antibody activity in preparations of normal and cancerolls cervical/issue eluate 
Eluates Known Iymphocyte panel Percentage 
from Patient kill* 
2 3 4 5 6 7 8 9 10 I1 12 13 14 15 16 17 18 
Normal MJ 0 
cervical CM 0 
tissue NS 0 
KM 0 
Cancerous RN 0 
cervical CS + + + +(+)+(+)+(+)+ + (+)(+) + + + + + lOO 
tissue GB + + + + + + + + + + + + + + + + + + 100 
MP - ---- ------ 0 
MU -- - + ---- + - + + - + -(+)(+)- 38 
DT - -- ------- -- -- 0 
PS --- -- - - - -- -- -- 0 
RU --(+)+ + ---(+)+ ------ 27 
+ Denotes strongly positive reaction, 90 to 100 per cent kill of Iymphocytes. 
(+) Denotes moderate positive reaction, 40 to 70 per cent kill of Iymphocytes 
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TAilLE III 
The incidence 0/ H L-A "specific" and "non-specific" lympllOc)'toto.xic antibodies 
in patients lI'ith cen'ical carcinoma and healthy womell used as controls 
Cervical cancer patients 
Lympho-
cytotoxic 69 patients 33 patients 
antibody tested prior to symptom-free 
activity treatment five years after 
treatment 
HL-A specific 15 21'7% I 3'0% 












X, 0 ' 04, P < 0'8 
X, 55'48, P < O'OOI 
. . .... .. _ . . _ . __ . ... _-- -- -----------
Gold et al., 1968; Jehn et al., 1970; Alexander, 
1972). Under normal circumstances the presence 
of cell lines which difTer in genetic composition 
from the host should induce ill rim an immune 
response resembling a homogrart reaction. The 
inability of the host to do so may be due to a 
profound defect in cell-mediated immunity. 
Cancer studies in rodents (Maller, 1963) have 
shown that humoral antibodies actually block 
the rejection phenomen thereby enabling the 
tumour cell line to proliferate in the host. 
Evidence for linking tumour growth with the 
presence of a similar humoral antibody blocking 
mechanism was reported by Hellstram et al. 
(1971). In the studies of Gold et al. (1968) the 
formation of rabbit antibodies to carcino-
embryonic antigens and the actual finding of 
similar antibodies in patients with carcinoma 
suggested that tumour growth may be enhanced 
by an active humoral antibody responsiveness. 
Using cancerous cervical tissue for the 
evaluation of humoral antibody involvement, 
we found that they contained a much greater 
concentration of cell-bound protein than non-
cancerous tissues. These abnormally high levels 
of protein . contained a variety of immuno-
globulins, fndicating the presence of some form 
of humoral antibody activity towards the 
tumour. Although no detailed studies were 
carried out to characterize the specificity of these 
antibodies, our preliminary investigations 
established that only some tumour tissue eluates 
possessed intense Iymphocytotoxic activity, 
suggesting that the recovered immunoglobulins 
constitute antibodies with a variety of character-
istics. 
It has been shown that the presence in vivo of 
antigen-antibody determinants can result in the 
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formation of other antibodies to these complexes 
(Harboe el aI., 1965; Abbruxxo and Christian, 
1961; Kano and Milgrom, 1968). This activity is 
said to be influenced in vivo by antibodies which 
have been subjected to molecular transformation 
during their interaction with antigens. Tt can 
therefore be assumed that humoral antibodies 
to immune complexes may also be generated in 
patients with active cancer, as a consequence of 
released antigen-antibody determinants during 
the procl~ss of tumour cell necrosis. A factor to 
be considered in the development of secondary 
humoral antibody responses, particularly in 
proliferating carcinomas, is the overwhelming 
presence of released antigen-antibody complexes 
and their corresponding antibodies which may 
enhance tumour growth more effectively than 
the antibody which initially sensitized the 
surface antigen. And so the question arises 
whether the "blocking factors" described by 
Hellstrom and Hellstrom (1970) actually repre-
sent the primary antibody response to tumour-
related surface antigen or the product of 
subsequent responses to a variety of antigen-
antibody determinants. 
Although the presence of "non specific" 
lymphocytotoxic antibodies does not provide 
any definite information concerning their role in 
tumour biology, their implication as a product of 
tumour immunology cannot be ignored. This is 
evident from the observation that "non specific" 
lymphocytotoxic antibodies were more often 
found among patients with carcinoma than in the 
controls (P<O·OOl). To classify them as tumour-
related antibodies requires the acceptance that 
they possess a marked degree of cross-reactivity 
for normal histocompatibility determinants. 
That this is so is obvious from their ability to 
ANTIBODY RESPONSES IN CARCINOMA OF THE CERVIX 1045 
react with Iymphocytes from normal donors 
(Table I I). It is possible that these "non specific" 
antibodies may have developed through a 
sequential process of immune responses by 
altered tumour antigen presentation. A similar 
explanation for the variability in antibody 
responses was recently reported in studies 
concerning the specificities of autoantibodies in 
acquired haemolytic ;II1:IC' lllias (Vos et aI., 1971). 
Although our lindlllg ) indicate that "non 
specific" cytotoxic antibodies are autoimmune 
in nature and therefore capable of abrogating 
the function of the host's own cell-mediated 
immune system, they do not appear to have 
impaired the function or the non-thymus or 
bursa analogue dependent Iymphocyles which 
take part in the formation of circulating immuno-
globulin antibodies. If unrestricted synthesis of 
JgG and IgM ill1munoglobulins does occur, with 
specificities towards cancer tissue and cross-
reactivity towards thymus-derived Iymphocytes, 
it might be that the bursa analogue dependent 
Iymphocytes lack some of the transplantation 
antigens which are commonly present on the 
thymus-derived cell J i ncs. I n stud ies concerning 
CERVICAL 
TUMOUR CELL 
..... -- Surface antigens 
autoantibodies in patients with acquired llaemo-
lytic anaemia it has become apparent that the 
active synthesis of various classes of humoral 
antibodies towards red cells is specifically 
directed against the Rhesus genome (Vos et al., 
1971). By contrast this is seldom found in 
lymphoid tissue (Gurner and Coombs, 1958; 
Lawler and Shatwell; 1962). These observations 
are to some extent analogous to the concept 
proposed for the activity of "non specific" 
cytotoxic autoantibodies observed among cer-
vical cancer patients becuause only selectivity 
would allow the antibody-producing cell clones 
to survive the effects of their own antibodies . 
Figure I outlines the basic concepts discussed 
in this study. 
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I nitially tumour-specific antibody 
may be produced _ . _ 
HUMORAL ANTIBODY-PRODUCING 
LYMPHOCYTE 




- - - then gradual variations in surface antigen 
presentation stimulate the formation of anti-
bodies which cross-react wi th Iymphocytes_ 
This is an auto-immune response causing: 
Inhibition of CMI; 
Tumour cell proliferation; 
Release of antigen-antibody 
complexes from dying cells; 
Manifestations of hyperactive 
antibody responses_ 
Dingram of immunological events suggested by this study of patients with carcinoma of the cervix. 
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Changeable Lymphocytotoxic Antibody Activity in Patients 
with Cervical Carcinoma1 
G. H. Vos, M. G. HAMMOND and G. MARESCOITI 
Natal Institute of Immunology, Durban, and District Hospital, Empangeni, Zululand 
Abstract. In patients with cervical carcinoma examined over an extended period of 
time we observed Iymphocytotoxic antibody activity more often in patients with terminal 
invasive carcinoma than in patients with preinvasive carcinoma. Antibody activity was 
very variable and it is postulated that this may reflect in vivo consumption of such anti-
bodies as a consequence of qualitative or quantitative variations in cancerous tissue mass. 
In almost all instances we were unable to establish the specificity of the Iymphocytotoxic 
antibodies with respect to known histocompatibility antigens. This suggests that their 
activity may be directed against a nucleus of HL-A determinants present in all human 
cell lines. 
Introduction 
In a previous study we found that extracts from cervical cancer tissues 
sometimes contain antibodies which sensitize normal lymphocytes by the 
cytotoxicity test [11]. It was suggested that this reaction represented a host's 
humoral antibody response to a structural modification of the tumour cell 
membrane. On the basis of population studies patients with cervical tumours 
also possessed a significantly higher incidence of so-called 'non-specific' 
lympho.9ytotoxic antibodies than a comparable control series of women of 
the same race (p < 0.001). The term 'non-specific' implies only that the 
structure or the origin of the corresponding antigens is not yet known. A 
more accurate description of these antibodies may be 'non-HL-A'. The de-
monstration that these cytotoxic antibodies can lyse Iymphocytes of almost 
all normal subjects who are not suffering from the same disease also indi-
cates that there is at this stage only an indirect association between the fre-
quent occurrence of 'non-HL-A' antibodies and cervical tumours . 
. J This study was supported by a grant from the South African Medical Research Council. 
Received: July 1, 1974; accepted: September 2, 1974. 
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By performing lymphocytotoxic antibody tests on stored samples of serum 
from the same patients collected over several weeks we were able to obtain 
a profile of the reaction pattern of these antibodies among patients with 
both invasive and preinvasive cervical tumours. 
Materials and Methods 
Subjects. Samples of blood were collected at weekly or fortnightly intervals from 
multiparous Southern African Negro women with his to logically confirmed carcinoma of 
the cervix. Of the 14 patients studied 9 had developed invasive carcinomas with distant 
metastases of the bowel, bladder, vagina, vulva and kidneys and 5 were recognized to 
possess a preinvasive variety of carcinoma. Patients who required blood transfusions or 
immediate anti-tumour therapy during these follow-up studies were not included in the 
final analysis. Both groups of women had delivered a comparable number of livebirths, 
e.g. preinvasive carcinoma patients 4.7 livebirths/mother as opposed to 4.2 livebirths/ 
mother among the invasive carcinoma patients. No reliable information could be obtained 
with respect to the number of abortions experienced by the two groups of women. Routine 
tests for treponemal infections confirmed the absence of syphilitic conditions in all the 
women examined. 
/m:rhOC.l't()t(lxicif.1' tcst. The presence of cytotoxic antibodies to peripherallympho-
cytC$ \",:\: . determined by testing the patient's serum against a selected panel of 23 cell 
donors using the modified two-stage microcytotoxicity test of BRAND et al. [4J. Over 40% 
kill of the viable Iymphoeytes of each donor was accepted as a positive result. The spe-
cificity of the Iymphocytotoxic antibody was resolved by testing the serum against Iympho-
cytes having many different HL-A genotypes. Cytotoxic antibodies which could not be 
identified as 'specific' when tested against a large panel of known HL-A cell types were 
classified as 'non-HL-A'. 
Absorption method. To absorb serum containing lymphocytotoxic antibodies, leuco-
cytes and platelets were obtained from 50 ml of ACD blood. The red cells were removed by 
dextran sedimentation and the plasma layer was centrifuged at 2,000 g for 20 min. The 
cells were washed four times in isotonic sodium chloride solution buffered to pH 7.2-7.3 
with Sorensen buffer. 1 ml antiserum was added to the packed cells and absorption was 
carried out for 60 min at 37°C with regular agitation of the test tube to pn:ivenfsettling 
of the cells. . . 
Results 
To establish the serological characteristics of the lymphocytotoxic anti-
bodies found among patients with carcinoma of the cervix uteri, follow-up 
studies were performed on the same patients to elucidate the comptexity of 
the antigen involved in the formation of the so-called 'non-HL-A' lympho-











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































for 5 patients with localized tumours and 9 patients with disseminating 
tumours. The findings indicate that lymphocytotoxic antibodies were more 
frequently found in patients with disseminating cervical carcinoma and that 
such antibodies could either show a progressive increase or decline in activity 
as the disease progressed. The frequent absence of measurable cytotoxic 
antibodies in the serum of patients with localized tumours appeared as a 
distinguishing feature of antibody activity between the two groups. 
Tb<: i'ormatiol1 of a specific variety of HL-A antibody before the rapid 
development of a non-HL-A type of antibody was observed on one occasion 
(table 11; patient N. N.). This patient initially lacked lymphocytotoxic anti-
body activity, then on two occasions cytotoxic antibodies for lymphocytes 
possessing HL-AI2 determinants were detected. Subsequently the lympho-
cytotoxic reactions lacked specificity. Absorption experiments using cell 
lines lacki ng H L-A 12 determ i nan ts failed to separate the non-HL-A cytotoxic 
antibody from the specific antibody. This suggests that continued in vivo 
immunization, perhaps by the growing neoplasm, has altered the initially 
specific nature of the antibody. 
A different pattern of cytotoxic antibody behaviour was observed for 
patient S. M. (table HI). Strong cytotoxic antibody of the so-called 'non-
HL-A' variety was detected on first examination. During follow-up studies 
the intensity and characteristics of the cytotoxic antibody reactions gradually 
changed until the presence of a 'specific' variety of antibody (anti-W-5) was 
clearly evident. It seems improbable that this change in antibody activity 
was due to her sudden inability to make antibodies. A more likely explana-
tion would be the increased availability or accessibility of the corresponding 
antigen through advancing tumour growth or increased blood circulation 
through the tumour mass. Either way one would have to assume that this loss 
of 'non-HL-A' antibody activity reflects in vivo consumption of the anti-
bodies and not reduced synthesis. The gradual loss of 'non-HL-A' antibody 
activity observed in this patient also happened to . take ·place without af-
fecting the continuous appearence of the 'specific' variety of HL-A antibody. 
This again suggests that some form of ill vivo consumption of 'non-HL-A' 
antibody activity is involved. 
Discussion 
A significant feature of the investigation was the almost complete absence 
of measurable lymphocytotoxic antibody activity in patients with localized 
cervical tumour and the remarkably variable antibody activity found in 
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patients with terminal disseminating cervical carcinomas. If this changeable 
cytotoxic antibody activity is due to in vivo consumption of the antibody 
rather than sudden variations in synthesis, then a combination of progres-
sive tumour growth and changes in availability or accessibility of antigen 
sites may be the major cause of the transient appearance ofthe antibody. The 
variable pattern of cytotoxic antibody behaviour also recalls the changes of 
antibody reactivity commonly found among patients with auto immune dis-
eases [5,8,10]. In our previous study [11] we showed that the 'non-HL-A' type 
of antibody can be recovered from the patient's own cervical cancer tissue. 
This indicates that the activity is directed against cancerous tissues as well 
as normallymphocytes. Whether the 'non-HL-A' antibodies do have auto-
immune activity in vivo or merely act as anti-tumour membrane antibodies 
will be the subject of further investigation. 
We suspect that the development of lymphocytotoxic antibodies among 
patients with cervical carcinoma occurs at a very late stage of the disease and 
that the initial defect is associated with a fundamental change in cervical cell 
growth. In this respect strong evidence has recently been presented to im-
plicate herpes virus type 2 (HSV-2) with carcinoma of the cervix [1, 3, 9]. It 
has also been established that cervical tumour cells possess DNA sequences 
which are in part related to the HSV-2 genome [2, 6]. Ifwas suggested that 
if tl1'.' Ilpc 2 herpes virus has oncogenic potential for human cervical tissue 
that some of its function may be associated with the transformation of cells 
from normal to neoplastic cell lines [7]. The immunological reaction of the 
host against its own tumour may in this situation be very similar to a reaction 
of the host against allogeneic tissue graft. However, these studies suggest 
that intensification of humoral antibody activity may protect rather than 
prevent tumour cell proliferation. It is conceivable that progressive tumour 
growth may be facilitated by the presence of cytotoxic antibodies which are 
capable of blocking the effect of Tcell activity. On the other hand, no at-
tempts have so far been made to determine whether herpes virus type 2 
infection can cause a primary defect in Tcell function. Until such investi-
gations are described no definite conclusion with respect to the 'blocking 
antibody' hypothesis can be reached. 
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HLA and Cancer in South African Negroes 
M. G. Hammond, B. Appadoo and Peter Brain 
The Natal Institute of Immunology, Durban, South Africa" 
Five hundred patients with cancer were tested for 32 HLA antigens and the antigen frequencies 
compared with those of 500 control subjects matched for race, sex and age. Although the overall 
frequencies showed no significant differences, detailed analysis with regard to site of cancer, age 
and the number of antigens detected at each locus revealed significant differences. Phenotype 
tables and haplotype frequencies have been included. 
Received for publication ~ May, accepted 1 September 1976 
There are significa,nt differences in the 
frequencies of HLA antigens in various 
races. The Negroes of South Africa have 
higher frequencies of A28, A29, Aw30, 
Bw42, Bw 17 and TT than Caucasians and 
lower frequencie~ of AI, All, B5, B27 and 
Bw40 (Hammond ct al. 1975). The overall 
cancer incidence in South African Negroes 
is similar to that in Caucasians but there 
are differences in the incidence rates for 
different sites of cancer. A survey of cancer 
in Durban Negroes (Schonland & Brad-
shaw 1968) showed that cancer of the 
esophagus is the commonest male malig-
nancy and it has the highest reported 
incidence in the world. Cancer of the liver 
and lung are the next most frequent in 
males. In females, cancer of the cervix has 
the highest incidence and is nearly four 
times more frequent than in Caucasians. 
Materials and Methods 
Blood samples were , taken from 500 
confirmed cancer cases over a period of 
18 months. Confirmation was obtained 
by cytology, histology , or hematology. 
Blood samples were also taken from 500 
control subjects, not suffering from malig-
nancies, matched for race, age and sex and 
180 antisera were used to define 13 antigens 
at the A locus, 17 at the B locus and two at 
the C locus. Their specificity was confirmed 
during the Sixth Histocompatability Work-
shop by testing them in parallel with the 
workshop sera against the cells of 100 
unrelated Negroes of the Zulu tribe (Ham-
mond et al. 1975). The N.I.H. standard 
micro cytotoxicity test was used through-
out. 
Supported by a grant from the National Cancer Association of South Africa. 
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Results 
Table 1 gives the antigen frequencies in 
controls, cancer cases and In subgroups 
according to site of cancer. Table 2 shows 
the percentage frequency of individuals 
with only one detectable antigen at the 
first and second locus in relation to age and 
site of cancer. Tables 3-6 give the pheno-
type distributions at each locus In the 
cancer patients and in the control group. 
Gene frequencies were estimated from 
Table 1 using the formula G = 1 -..;t=f 
where f is the antigen frequency, and the 








































































• uncorrected p < 0.05 
•• uncorrected p < 0.005 
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Table 3 
A locus phenotypes of 500 cancer patients 
HLA-A 1 2 3 w23 w24 w25 w26 
1 2 3 6 3 1 3 5 
2 15 13 8 4 8 6 
3 8 6 0 3 
w23 12 1 8 










X~8 = 70.03 
0.7 < p < 0.8 
quencies was calculated. Table 7 shows the 
most common haplotype frequencies for 







There are no significant differences in the 
HLA antigen frequencies when comparing 
all the cancer cases with the controls. When 
11 28 w29 w30 w31 w32 Blank 
0 3 6 8 1 1 
1 14 11 18 9 0 
0 9 5 12 2 1 
0 10 7 21 10 2 
0 2 7 9 4 1 
0 8 11 11 7 0 
0 6 7 9 1 1 
0 0 0 0 0 0 
7 12 21 8 2 
6 16 2 0 
27 14 2 
6 1 
1 
considering various sites of cancer, however, 
there are differences worthy of comment. 
HLA-Al has a significantly higher fre-
quency in cancer of the liver than in the 
controls and the antigen TT is significantly 
increased in cancer of the esophagus. The 
probabilities are both less than 0.005, but 
when corrected for the number of antigens 
tested they are no longer significant. 
Table 4 
A locus phenotypes of 500 control subjects 
HLA-A 1 2 3 w23 w24 w25 w26 11 28 w29 w30 w31 w32 Blank 
1 1 1 2 2 0 1 2 0 2 3 8 3 0 
2 10 7 9 3 3 4 1 10 16 31 6 2 
3 8 8 3 9 3 0 7 7 13 14 0 
w23 8 0 15 4 0 10 5 20 5 0 
w24 4 2 2 0 1 1 6 2 0 
w25 11 0 0 5 7 20 5 0 
w26 4 0 7 6 9 3 1 
11 0 0 0 0 0 0 
28 19 10 29 5 1 
w29 8 15 5 2 
w30 32 13 1 
w31 6 0 
w32 2 
Blank 0 
X~8 = 74.23 
0.5 < P < 0.6 
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Table 5 
B locus pbenotypes of 500 cancer patients 
HLA-B 5 7 8 12 13 14 17 27 w5 wl0 w15 w16 w18 w21 w22 w42 TT Blank 
5 2 0 1 2 0 0 5 0 0 0 0 0 0 0 0 0 0 
7 21 8 5 2 2 27 1 3 1 2 2 1 1 0 22 2 
8 14 3 3 0 25 0 3 3 '0 0 0 1 0 12 4 
12 20 2 3 19 0 1 0 1 0 0 0 0 10 0 
13 4 1 2 0 0 0 0 0 0 0 0 3 0 
14 6 4 0 0 0 0 0 1 0 0 6 2 
17 81 0 4 0 2 2 6 2 0 15 11 
27 0 0 0 0 0 0 0 0 0 0 
w5 7 0 1 1 1 0 0 4 3 
wl0 2 0 0 0 0 0 0 0 
w15 1 0 1 0 0 7 1 
w16 1 0 0 0 4 0 
w18 7 0 0 5 1 
w21 2 0 0 1 
w22 0 0 0 
w42 31 7 
TT 8 
Blank 18 
XI~6 = 144.16 
0.3 < P < 0.4 
Table 6 
B locus pbenotypes of 500 control subjects 
HLA-B 5 7 8 12 13 14 17 27 w5 wl0 w15 w16 w18 w21 w22 w42 TT Blank 
5 1 0 1 1 0 0 1 0 0 0 0 0 0 0 0 1 1 
7 24 4 10 3 0 14 1 6 1 2 4 2 0 0 16 2 
8 26 9 4 2 17 0 1 0 1 1 0 0 0 11 2 
12 15 2 4 25 0 2 0 3 1 2 0 0 5 0 
13 4 0 6 0 2 1 0 0 1 0 0 1 0 
14 4 9 0 1 0 0 0 3 0 0 0 3 
17 71 1 5 1 4 2 2 0 0 39 9 
27 1 0 0 0 0 0 0 0 0 0 
w5 4 0 0 0 0 1 0 7 2 
wl0 1 0 0 0 0 0 1 0 
w15 7 0 1 0 0 2 1 
w16 2 1 1 '0 4 0 
w18 6 0 0 0 1 
w21 1 0 0 0 
w22 0 0 0 




XI~6 = 174.4 
0.025 > P > 0.01 
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The frequency of individuals with only 
one detectable antigen at the first or 
second locus ranges from 12.9% at the first 
locus for patients with cancer of the 
esophagus to 51.2% at the second locus 
for patients with cancer of the lung or 
larynx. The frequency of 12.9% is signifi-
cantly different from that in the controls 
(p < 0.05) and this might mean that 
individuals who are heterozygous at the 
first locus are more susceptible to cancer 
of the esophagus. Moreover, this fre-
quency is significantly different from the 
frequency of 29.3% in patients with 
cancer of the lung or larynx (p < 0.02). At 
the second locus the same trend is apparent 
but the differences are not significant. 
Gerkins cl :d. ( 1974) and Macurova et a1. 
(1975) presented data indicating increased 
heterozygosity in aged persons. Table 2 
shows that there are no significant differ-
ences in the frequency of individuals with 
or without cancer in the age groups less 
than 40 or greater than 60. However, the 
frequencies in patients with cancer of the 
lung or larynx show significant differences 
between those younger than 40 and those 
older than 60. At the A locus the difference 
is significant at the 0.05% level while at the 
B locus p < 0.02. This might mean that 
young people who are homozygous at the 
A or B loci or at both are more susceptible 
to cancer of the lung or larynx. Thus we 
may say that among Negroes with cancer, 
those who are homozygous at the A or B 
locus or at both may be more liable to 
cancer of the lung or larynx while those 
who are heterozygous may be more likely 
to get cancer of the esophagus. Unfor-
tunately the numbers of individuals in 
these subgroups are small and the statistical 
inferences should be treated with great 
reserve. 
Table 7 shows the most common ha plo-
Table 7 
Haplotype frequencies in cancer patients and 
controls (All values X 103 ) 
Haplotype Controls Cancer 
Aw 30 Bw42 75- 67-
A 28 Bw 17 37 38 
Aw30 Bw 17 34 32 
A2 Bw 17 31 39 
Aw2S Bw 17 30 11 
A3 Bw 17 28 34-
Aw 30 B8 25 19 
Aw2S B 12 22- 17-
A 29 B 12 19- 23-
Aw26 Bw 17 18 19 
Al B7 17- 24-
A3 B8 14 22-
A2 BwTT 13- 17-
A 29 B13 13- 13-
Aw24 B7 12- 22-
Aw 31 Bw 35 9 n-
-Absolute value of ~ greater than twice the S.E. 
type frequencies for the controls and 
cancer patients calculated from the pheno-
types by the method of Mattiuz et a1. 
(1970). The most common haplotype is 
Aw30, Bw42 which might be called a 
negroid haplotype in the same way that 
AI, B8 is a Caucasoid haplotype. Several 
other haplotypes show significant linkage 
disequilibrium, notably At, B7; A2, TT; 
A24, B7;Aw25, BI2;A29, BI2;A29, B13. 
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HLA and Cancer in South African Indians 
M. G. Hammond, B. Appadoo and Peter Brain 
The Natal Institute of Immunology, Durban, South Africa 
Two-hundred-and-forty-nine Indian cancer patients were tested for 39 HL
A antigens and the anti-
gen frequencies were compared with those of 603 control subjects. Com
parisons were also made 
between cancer patients and controls for each ethnic group and for each s
ite of cancer. There was 
an increase in the frequency of the HLA antigens All and Bw52 in pat
ients with malignancies. 
Heterozygosity at the B locus was significantly increased in patients with c
ancer of the breast. The 
Aw24, B 17 haplotype was also associated with breast cancer. 
Received for publication 11 January, revised, accepted 5 March 1979 
A survey of cancer in the Negro and Indian 
populations of Durban (Schonland & 
Bradshaw 1968) showed that the overall 
cancer incidence in females of both races 
and in Negro males is as high as in most 
Western countries, but Indian males have a 
low overall cancer incidence which is not 
readily explained. We have previously 
reported our findings with regard to HLA 
and cancer in South African Negroes 
(Hammond et ai. 1977a). The Indian popu-
lation can be divided into four major 
ethnic groups and we have shown that 
there are differences in the frequencies of 
the HLA antigens In these groups. 
(Hammond et al. 1974). 
Material and Methods 
The Indian Population 
The Indians of Natal are the descendents of 
immigrants who arrived about a century 
ago to work on the sugar plantations. They 
are composed of Dravidians from Southern 
India and Aryans from Northern India. In 
South Africa, the Dravidians can be divided 
into Tamil and Telegu speakers while the 
Aryans can more conveniently be divided 
by religion into Hindus from the north-east 
(mostly Hindi speaking) and Muslims from 
the north-west. Intermarriage between 
these four groups is rare and there has been 
almost no .admixture with other races. 
(Mistry 1965). 
The Indian population of greater 
Durban is over 43:0,000 and the proportion 
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All Indians who were classified as "other" 
have been omitted from this survey. 
Blood samples were taken from 249 
confirmed cancer cases over a period of 2 
years. Confirmation of carcinoma was 
obtained by cytology or histology and con-
- firmation of leukemia by hematology. Con-
trols consisted of 603 unrelated donors or 
staff members, 140 of whom have been 
typed with workshop sera and another 250 . 
who were typed concurrrently with the 
cancer patients. Two-hundred-and-ten anti-
sera were used to define 14 antigens at the 
A locus, 22 at the B locus and three at the 
C locus. Their specificity was confirmed 
during the Sixth and Seventh Histocom-
patibility Workshops. The subdivision of 
Bw40 in Indians into Bw40.1, Bw40.2, and 
of B5 into four components was reported 
at the Seventh Workshop (Hammond et al. 
1975, 1977b). In this report, B5 cells that 
were not Bw 51 or Bw52 were classed as 
Bw5 IND. The N.I.H. standard micro-
cytotoxicity test was used throughout. 
Results 
The control group, 250 unrelated donors 
typed concurrently with the cancer patients 
were matched for age, sex and racial sub-
group. A comparison of antigen fre-
quencies between this control group and 
another group of 35 3 unrelated donors 
showed no significant differences and con-
sequently the data were combined to pro-
vide a larger control population. 
The numbers of patients and controls in 
each of the four racial subgroups are shown 
in the column headings of Table 1. The 
Tamil and Telegu results are combined in. 
the Dravidians, and Hindi and Muslim are 
combined to form the Aryan category. The 
total is shown in the column "Total 
Indians". 
The significance of the difference 
between the frequency of each antigen in 
the control group and in the cancer patients 
for each of the four racial groups was 
calculated using a computer program for 
2 X 2 chi-squares. If the difference was sig-
nificant the calculations were repeated 
using Yates' correction or, if any number 
in the 2 X 2 table was less than 10, Fisher's 
exact method was used. The same pro-
cedure was followed in examining the total 
population and the Dravidian and Aryan 
sub-groups. The frequencies that were still 
significantly different are marked with 
asterisks in Table 1. 
We then looked in more detail at those 
antigens which showed significantly differ-
ent frequencies. In Table 2 the frequencies 
of these antigens in patients with cancer of 
the breast and patients with cancer of the 
cervix are compared with the control 
group. Fisher's exact method was used to 
calculate probabilities. 
Gene frequencies were estimated from 
Table 1 using the formula g = I - v'1=f 
where f is the antigen frequency, and the 
haplotype frequencies were estimated from 
the phenotype data by the method of 
Mattiuz et al. (1970). 
Discussion 
Significant differences between the antigen 
frequencies in patients and controls are 
marked with asterisks in Table 1. However , 
when corrected for the number of antigens 
and the four race groups (39 X 4) only one 
shows borderline significance. The very 
high frequency of All in Tarriil cancer 
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Table 2 
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* Uncorrected P < 0.01. ** Uncorrected P (exact) = 0.00046. 
* ** Uncorrected P (exact) = 0.00005. 
a P value after correction of 0.078. Table 2 
shows that the frequency of All is increased 
in both cancer of the breast and cancer of 
the cervix in Tamils. The increase of Aw24 
in Telegu patients with breast cancer is not 
significant after correction. 
The inverse relationship between . Bw51 
and Bw52 in cancer of the breast and 
cancer of the cervix is most noticeable in 
the Telegu although the same trend is seen 
in the TamiI. Bw51 has an increased fre-
quency in cancer of the cervix, while Bw52 
is increased in cancer of the breast. The 
increase is greatest in Telegus with breast 
cancer. This relationship is not found in 
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in all cancer patients and this increase is 
seen in both types of cancer, except in 
Muslims. 
The frequency of individuals with only 
one detectable antigen at the B locus is 
reduced in cancer of the breast in all four 
ethnic groups and when considering the 
Indians as a whole the exact P = 0.00005. 
This should be multiplied by eight (four 
ethnic groups x 2 loci) to give a P = 0.0004, 
but even if we were to consider the individ-
uals with only one detectable antigen as 
possessing some rare, as yet serologically 
undectable antigen, and apply a correction 
of 39 x 4 x 2 we arrive at a P = 0.016. 
However, this low frequency means that 
more of these patients are heterozygous at 
the B locus in contrast to patients with 
cancer of the cervix who have frequencies 
similar to the control population. 
Gerkins et al. (1974) investigated the 
number of antigens present at each locus in 
old and young people with and without 
cancer. The results showed a trend towards 
homozygosity in cancer patients but the 
results included all types of cancer. In an 
earlier study of HLA and cancer in South 
African Negroes (Hammond et al. 1977) 
we did not find any significant differences 
in the number of antigens detected at the 
A or B loci in cancer of the breast but 
heterozygosity at the A locus was increased 
in cancer of the esophagus. 
Table 3 shows the haplotype frequencies 
with significant linkage disequilibrium. The 
Al, B17 haplotype is the most common 
and typical of Asian Indians, with the high-
est frequency occurring in the Telegu 
speaking Dravidians from Southern India. 
The contrast in frequency of the A 1, B37 
haplotype and the Aw24, B17 haplotype is 
noteworthy. Cancer patients do not show 
the significant linkage disequilibrium that 
is evident in the control population. The 
delta value is positive for the Al, B37 
haplotype but it is negative for the A24, 
B17 haplotype. The presence of the Aw24. 
B 17 haplotype may indicate susceptibility 
to cancer of the breast because the fre-
quency of this haplotype was .024 in all 
Indians with cancer of the breast and .044 
in Dravidians with cancer of the breast, 
whereas there were no patients with cancer 
of the cervix who had the antigens Aw24 
and B17 together. 
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In a previous investigation (Hammond et 
al. 1977) we found an increased frequency 
of HLA-Bw45 in Negroes with cancer 
of the esophagus (uncorrected P < 0.005). 
This was not significant after correcting 
for the number of antigens tested but 
nevertheless we felt that a follow-up study 
was necessary because of the very high 
incidence of this cancer in the Negro 
population and the relatively high fre-
quency of HLA-Bw45 in Negroes com-
pared to other races. 
A further 153 patients with confirmed 
cancer of the esophagus were HLA typed 
using almost the same set of 180 sera as 
in the original investigation. Table 1 
shows the antigen frequencies of the two 
groups of patients, the total number of 
patients and the controls. 
The frequency of HLA-Bw45 in the 
second group of patients was not sig-
nificantly different from the frequency 
in controls, which means that our original 
observation was probably due to chance. 
In the first group there was also a 'signifi-
cant decrease in the frequency of patients 
with only one detectable antigen at the 
A locus but this was not confirmed in. the 
second group. 
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PerCe1ltage frequency of HLA antigens in Negroes 
witb cancer of tbe esopbagus 
Group la Group II Total Controls 
HLA 101 153 254 756 
Al 6.9 7.2 7.1 5.8 
A2 28.7 17 .6 22.1 20.1 
A3 12.9 11.1 11.8 13 .5 
All 0 0 0 0.1 
Aw23 17 .8 17.6 17.7 19.2 
Aw24 8.9 6.5 7.5 3.3 
A 25 18.8 15.7 16.9 13.9 
A 26 11.9 12.4 12.2 7.5 
A 28 17 .8 18.3 18.1 20.0 
A 29 16.8 16.3 16.5 16.7 
Aw30 36.6 37.3 37.0 39.6 
Aw31 8.9 10.5 9.8 12.6 
Aw32 1.0 4.6 3.2 1.6 
1 Antigen 12.9 24.8 20.1 26.2 
B 5 0 1.3 0.8 2.7 
B 7 19.8 24.8 22.8 16.0 
B 8 13.9 19.6 17.3 13.9 
B13 4.0 2.0 2.8 4.8 
B 14 4.0 4.6 4.3 6.1 
B 15 4.0 0.7 2.0 5.8 
B 16 2.0 2.6 2.4 2.4 
B 17 42.6 32.7 36.6 38.1 
B 18 5.9 8.5 7.5. 3.8 
Bw21 2.0 2.6 2.4 0.5 
Bw22 0 0 0 0 
B 27 0 0 0 0.3 
Bw35 4.0 5.2 4.7 7.3 
B 40 0 1.3 0.8 1.6 
Bw42 24.8 25.5 25.2 27.7 
Bw44 15.8 17.6 16.9 16.0 
Bw45 15.8 7.2 10.6 6.4 
1 Antigen 36.6 47.1 42.9 46.2 
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l. THE HLA SYSTEM 
The major histocompatibility system of man is called HLA. It refe
rs to a genetic 
region on the SIH" I anll (lf chrolllosome 6' that plays a dominan't role
 in the survival 
of grafts. The kll cl s H L stanJ for Human Leukocyte and the A ori
ginally stood for 
the A locus, but in 1975 HLA was made the official designation for th
e whole region.' 
At first only two loci were recognized, A and B, and these two hav
e been studied 
the most. Nearly all the work 011 Ir ansplantation, disease associations
, and population 
studies has been J Olle on antigens of the A and B loci. The C locus w
as first proposed 
in 1970/ but because of difficulties in defining the antigens, only 
eight have so far 
been recognized. 4 The D locus was included in 1975
J and more recently, the OR (0-
related) locus has been defined using B lymphocytes.
5 
Each well-defined antigen is identified with a letter for the locus a
nd a number. 
Historically, the numbers used for the A and B loci do not overlap b
ut the C, D, and 
OR antigens are numbered starting with one. Antigens identified du
ring the Interna-
tional Histocompatibility Workshops are prefixed with a W, and when
 complete agree-
ment is reached, the W is dropped . Table I lists the currently identi
fiable antigens at 
each locus. 
A haplotype is the combination of closely linked HLA genes on the
 same chromo-
some transmilleJ from parent to child. Two haplotypes; one from 
each parent, em-
body all the HLA genes in any individual. Thus, there is a maximu
m of two A and 
two B loci antigens present. In those individuals where only one ant
igen is identified 
at a locus, there is a strong probability of homozygosity. 6 
Not all the genes have been defined but the combined frequency o
f unidentified 
genes is only about 2% at the A locus and about 4070 at the B lo
cus in European 
populations, while in other populations the frequency of unidentified
 genes is larger. 7 
The frequencies of individual antigens vary widely in different pop
ulation groups 
and Table 2 compares the antigen frequencies in Caucasians, Negro
es, and Asian In-
dians. It is noteworthy that some antigens are restricted to certain pop
ulations. 
Linkage disequilibrium is the phenomenon of two genes occurring on
 the same hap-
lotypesignificantly more frequently than would be expected by chan
ce. Thus, the AI 
and B8 genes are present on the same chromosome in the Caucasian 
population about 
four times more frequently than would be expected from random 
matings. Table 3 
shows that linkage disequilibrium between two genes can . be chara
cteristic of some 
populations. 
It. HLA AND DISEASE 
The histocompatibility locus (H-2) of mice has been shown to be invo
lved in suscep-
tibility to cancer" and the discovery that specific immune response gen
es, Ir, are located 
in the H-2 complex of mice9 led to numerous studies in man. 
Kourilsky et al. '0 and Amiel et al." were the first to study the HL
A antigens of 
patients with rnalipnant diseases, but in general only weak associ
ations have been 
found betweelJ IILA antigellS and cancer. The combined relative ris
k of the antigen, 
HLA At, in 25 independent investigations of Hodgkin's disease was 
highly significant 
but the risk of 1.38 was not nearly as great as that found for some H
LA antigens and 
nonmalignant diseases such as ankylosing spondylitis, U where the combined
 relative 
risk was 87.4 ill Caucasians. 
Ill. HLA AND CANCER OF THE ESOPHAGUS 
The overall cancer incidence in South African Negroes is similar to 
that in Cauca-
280 





SHOWN IN BRACKETS) 
HLA-A HLA-B HLA-D 
Al B5 Dwl 
A2 B7 Ow2 
A3 B8 Ow3 
A9 BI2 Ow4 
AIO B13 OwS 
All BI4 Ow6 
Aw23 (9) B15 Ow7 
Aw24 (9) Bw16 Ow8 
A25 (10) 817 Ow9 
A26 (10) B18 OwlO 
A28 Bw21 Owll 






Aw34 Bw39 (16) 
Aw36 B40 ORI 
Aw43 Bw41 DR2 
Bw42 DR3 
8w44 [12) DR4 
Bw45 (12) ORS 
HLA-C 8w46 ORw6 
8w47 OR7 
Cwl 8w48 ORw8 
Cw2 Bw49 (21] ORw9 
Cw3 Bw50(21) ORwlO 
Cw4 Bw51 (5) 
Cw5 BwS2 (5) 
Cw6 Bw53 
Cw7 BwS4 (22) 
Cw8 Bw55 (22) 
Bw56 (22) 
Bw57 (17) 
HLA-B BwS8 (l7) 
Bw59 




sians, but there are differences in the incidence rates for different sites of cancer. A 
survey of cancer in Durban Negroes by Schonland and Bradshaw u showed that cancer 
of the esophagus is the most common male malignancy and that it has, in this popu-
lation, one of the highest reported incidences in the world. They reported an age-ad-
justed incidence rate of 26.1 per 100,000 for Negro males and 8.3 for Negro females. 
Our first investigation determined the HLA antigens of 500 confirmed cancer cases 
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Table 2 
PERCENTAGEFREQUENCYOFHLA 
ANTIGENS IN THREE RACIAL GROUPS 
Caucasian Negro Asian Indians 
1100 1000 706 
AI 29.7 6.5 27.2 
A2 45.3 21.3 32.0 
A3 29.6 13.3 14 .4. 
'\ I 1 1~ . 4 0.1 27 . 1 
,\" 2.1 1.9 IS.4 0 .6 
A .... 24 1/1 .S 3.9 27 .S 
A25 3.7 15.3 2.0 
A26 4 .9 S.S 6.2 
f.2R S.7 20.3 14.3 
A29 5.5 16.3 1.0 
I\w:lO ·u :.n .6 4.0 
1\ .... 31 5.2 10.9 3.4 
I\w32 2.J I.S 2.4 
Aw33 O.S· 0 .7· 7.S" 
One antigen 2R.7 25 . 1 30.2 
m 26.2 IS.2 12.5 
BS 22.0 14.1 6 .2 
BI3 4.6 4.S 6.5 
BI4 7.2 6 .2 0 .3 
BIS 12.0 5.2 10.8 
Bwl6 3.2 2.3 2.4 
1I1 7 7.5 38.5 21.5 
BIR 2.5 4 .0 3.3 
Hw21 1.0 0.8 2.0 
B .... 22 4.6 0 2 .7 
B27 6.3 0.3 2.3 
Bw3S 12.5 6.5 21.5 
B37 0.7 0 4.2 
Bw4J 0 .3" /.0· O· 
Bw42 0 25.5 0 
Hw44 28.9 16.4 11.8 
Bw45 0.9 7 .6 0.1 
Bw46 o· o· o· 
BwSI 9.5· 1.8· 21.2· 
HwS2 1.4 0 10.1 
BS IND 0 0 3.1 
Rw53 0.3 2.2 1.7 
Bw60 13 .2 1.2 16.9 
Dw61 0.2 0 12.2 
One antigen 35.2 43.4 26.8 
Cwl 8.0· 5.0· O· 
Cw2 6.0 1.2 14 . 1 
Cw3 14 .6 8.8 7.7 
Cw4 14 .3· 15 .0· 14.0· 
CwS 12.0· 2.0· 4.0· 
eN = 300 ON = 146 oN = 150 
over an 18 mont h period. I~ The most common malignancy was cancer of the cervix 
(143 cases). r olto\ved by cancer of the esophagus with 101 cases. Table 4 compares the 
frequency of HLA antigens in these patients with the ,frequency in 500 control subjects 
who were typed concurrently. The frequency of the antigen HLA Bw45 is significantly 
282 
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Table 3 
CHARACfERISTIC HAPLOTYPE 
FREQUENCIES ( x H},) IN THREE 
DIFFERENT RACES 
Caucasian Negro Indian 
N = 1000 N = 1000 N = 706 
AI. B7 10 19·· 9 
AI. BR 90 0 • 0 g 
AI. BI7 21" 7 5R" 
AI. B37 2 0 16
0• 
A2. Bw44 670 12 4 
A2, Bw45 I 17" I 
A3, B7 65 0• 12 
A3. BR 12 17" 
Aw24, B7 13 14" 17 
Aw24, Bw52 2 0 19· 
AlS, Bw44 4 19 0 I 
A26. BI7 2 24·· 3 
A29. BI3 14 0 • 0 
A'19. Bw44 16 0 23 0 • 0 
,',w)O. BI3 So 3 8· 
A ..... 30. Bw42 0 7R·· 0 
Aw31. Bw3S I 12" 
Aw33, Bw44 0 14·· 
• /:; > 2SE 00 /:; > 3SE 
greater in patients with cancer of the esophagus (p < 0.005), but in studies of this kind 
a correction must be applied by multiplying the probability by the number of compar-
isons. In this case the frequencies of 32 antigens were compared and the resulting 
probability was no longer significant. The frequency of patients with only one detect-
able antigen at the A locus was 12.9070. This is significantly different from the fre-
quency in the controls at the 50io level and this might mean that individuals who are 
heterozygous at the A locus are more susceptible to cancer Df the eSDphagus. Data has 
been presented '5 . '6 indicating increased heterozygosity in aged persons, but Table 5 
shows that both young « 40 years) and old (> 60 years) groups of patients have a 
decreased frequency of homozygosity compared to cDntrols . 
These findings prompted a follow-up investigation and an additional ]41 confirmed 
cases in Durban were tested. Epidemiological studies have show~ that the Transkei 
and Ciskei (part of the hinterland Df the port of East London) are regions with a very 
high incidence of esophageal cancer.I7.18 Or. E. F. Rose of the National Research In-
stitute for Nutritional Diseases has sent 67 blood samples to us for HLA typing. The 
total of 309 was divided into two groups for analysis: 93 Xhosas, Fingoes, and others 
who originated from the high-incidence areas of Transkei and Ciskei, and 2]6 Zulus. 
Analysis of the 1000 random controls revealed that 55 were Xhosa but there were no 
significant differences between the frequencies of the HLA antigens of Xhosa and 
Zulu. This is not surprising because all sub-Saharan Negroes are broadly alike in ge-
netic constitution. 19 
Table 6 delineates the antigen frequencies in bQth groups Qf patients and in all the 
patients, while in Table 7 selected frequencies are shown in more detail. The antigen, 
AIO, consists Qf A25 and A26. We see that the increased frequency of AlO in the total 
group Qf patients is caused by the increased frequency of A26 and also. that this in-
crease is due to the significant increase in Xhosas. Correcting the probability by mul-
. 283 
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Table 4 
PER CENT AGE FREQUENCY OF 
HLA ANTIGENS IN 101 PATIENTS 
WITH CANCER OF THE 
ESOPHAGUS COMPARED WITH 
CONTROLS 

























Aw3/ 11.4 8.9 
Aw32 1.8 1
.0 
Aw33 N.T. N.T. 
One antigen 22.6 12.9 
B7 17.8 /9.8 
B8 /5 .8 13.9 
BI3 4 .8 4.0 
BJ4 5.2 4.0 
B15 4.2 4.0 
BI6 3.2 
·2.0 
017 41.2 42.6 
B18 3.8 5.
9 
Bw2/ 0.6 2 .0 
B27 0.6 0 
Bw35 6.2 4.0 
Bw42 25.0 14.8 
Bw44 15.8 15.8 
Bw45 7.2 15.8 
Bw51 J.2 0 
Bw53 N.T. N.T. 
Bw60 1.0 0 
One antigen 42.8 36.6 
Cw2 13.0 15.8 
Cw3 6.0 7.9 
tiplying by the number of antigens tested yielded a p < 0.016 and a relative risk of 
2.8. The frequency of A26 in the small number of Xhosa controls wa
s only 9. ] 0J0 so 
that the increase in Xhosa patients does not seem to be because of an
 increased fre-
quency of the A26 antigen in the Xhosa population. 
The initial findings of an increase in Bw45 and increased heterozygosit
y was not 
confirmed in the larger sample but the increased frequency of Cw2 rea
ches borderline 
significance (after correction, p < 0.033) in the total group of patients with a relative 
risk of J. 7. 
Haplotype frequencies were estimated from the population data by th
e method of 
Mattiuz et a1./o and some of these are shown in Table 8. There are
 no significant 
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Table 5 
PERCENTAGE FREQUENCY OF INDIVIDUALS WITH ONLY ON
E 
DETECTA BLE ANTIGEN AT THE FIRST AND SECOND LOCUS I
N 
RELATION TO AGE 
Cancer of 
Controls esophagus 
Age <40 >60 <40 >60 
Number 161 89 IS 2A 
) antigcn at A locus 23 21 
7 8 
) antigcn at H locus 47 43 
20 29 




OF HLA ANTIGENS IN 
XHOSA AND ZULU PATIENTS 
WITH CANCER OF THE 
ESOPHAGUS 
Xhosa Zulu Total 
(93) (216) (309) 
AI 5.4 6.5 6.1 
A2 20.4 21.8 21.4 
A3 11.8 11.1 11.3 
Aw23 17.2 18.5 18.1 
Aw24 5.4 6 .9 6.5 
A25 12.9 18.1 16.5 
A26 20.4 13.0 15.2 
A28 18.3 17.6 17.8 
A29 12 .9 16.7 15.5 
Aw30 41.9 37.5 38.8 
Aw31 8.6 9.3 9.1 
Aw32 5.4 2.8 3.6 
Oneamigen 19.4 20.3 20. 1 
B7 24.7 22.7 23.3 
B8 14 .0 18. 1 16.8 
BI3 0 3.2 2.3 
814 8.6 4.2 5.5 
B15 6.5 1.4 2.9 
BI6 4.3 2 .8 3.2 
BI7 37.6 34 .3 35 .3 
BI8 8.6 6.5 7.1 
Bw21 1.1 2.8 2.3 
B27 2.2 0 0.6 
8\\'35 8.6 4 .6 5.8 
B40 2.2 0.5 1.0 
Bw42 23.7 25.5 24.9 
Bw44 7.5 IS.I 14 .9 
Bw45 8.6 10.6 10.0 
Bw51 3.2 0.5 1.3 
One antigen 38.7 44.5 43.7 
Cw2 21.5 22.2 22.0 
Cw3 8.6 12.0 11.0 
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Table 7 
SELECfED ANTIGEN FREQUENCIES ~N 
p 1\ TIENTS \VITH CANCER OF THE ESOPHAGUS 
Cancer of the esophagus 
Controls Xhosa Zulu Total 
(1000) (93) (216) (309) 
A2~ 1~.3 12.9 \8.1 16.5 
A26 8.5 20A··· 13.0 15.2·· 
AIO 23.8 33.3 31.1 31. 7· 
One antigen al A 25.8 19.4 20.3 20.1 
locus 
Hw45 7.6 8.6 10.6 10.0 
Cw2 14.1 21.5 22.2· 22.0·· 
Uncorrected p. < 0.005 
•• < 0.001 
••• < 0.0005 
Table 8 
HAPLOTYPE FREQUENCES (x 103 ) IN 
PATIENTS WITH CANCER OF THE 
ESOPHAGUS 
Xhosa Zulu Total 
(93) (2J6) (309) 
AI, B7 21 28· 26·· 
A2,8",45 26 26· 26·· 
A3. B8 20 15 J7 
Aw24,87 21 25" 24· 
A25, Bw44 3 26 19 
A26. B17 44 J7 25 
A29. BI3 0 14- 10· 
A29. Bw44 27 26 27" 
Aw30, Bw42 83· 66" 71" 
Aw31. Bw35 4 9 7 
• A> 2SE -. A> 3SE 
differences between patients and controls. In another study of HL~ antigens and can-
cer in the Indian population of Durban20 we found only 18 cases of esophageal cancer 
out of a total of 250 patients (Table 9). The small numbers Ilecessitated the use of 
Fisher's exact method 2 • for calculating probabilities and only the increased frequency 
of Aw32 was significant with p = 0.01. However, when corrected for the number of 
antigens tested, this was no longer significant. The HLA and Disease RegistryU pro-
vided data on the HLA antigen frequencies in Caucasians with cancer of the esopha-
gus.12 The increased frequency of HLA B7 carried a relative risk of 2.4 but after cor-
rection this was not significant. Also shown in Table 9 are the frequencies found by 
Hashemi et a1. 23 in Iranians living in the Caspian littoral, an area noted for the high 
incidence of esophageal cancer. H A preliminary report (quoted by Simons and AmieP5) 
of a significant increase of B40 in 71 patients was not confirmed in this larger series. 
Their detailed analysis of the four ethnic groups studied showed an increase of B 18 in 
Persians with cancer of the esophagus but they suggest that this may be a chance event. 
2~6 
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Table 9 
PERCENTAGEFREQUENCYOFHLA 
ANTIGEN IN CAUCASIANS, ASIAN 
INDIANS, AND IRANIAN PATIENTS WITH 




HLA (N = 47) (N "" 18) (N "" 151) 
Al 27 .7 5.6 22.5 
A2 51.1 33.3 22.5 
AJ 36.2 16 .7 27.8 
All 4.3 
...... ., L __ . _ 12.6 
AW23~ 5.6 29.1 12 .R 16.7 Aw24 
A v. 25 f 0 12.6 10.6 0 Aw26 
A28 12 .R 16.7 9.3 
A29 I 4.3 0 
Av.30 4.3 16.7 
AW") 33 .R N.T. 11.1 Aw J2 12.8 16.7 
I'. \'. 1 ~ N.T. !6 .7 
87 44 .7 11.1 7.9 
BR 8.5 0 5.3 
BI3 8.5 5.6 2.6 
BI4 12.8 0 7.9 
1315 8.5 11.1 3.3 
BI6 N.T. 11.1 6 .6 
RI7 6 .4 22.2 6.6 
BIB 8.5 0 12.6 
Bw21 0 5.6 6.6 
Bw22 4.3 5.6 " .9 
B27 6.4 0 2.0 
Bw35 12.8 16.7 33 .8 
1337 N.T. 0 2.6 








B51ND N.T. 0 N.T. 






Bw61 11.1 . 
This needs to be confirmed . Thus it would appear that if there is a "susceptibility" 
gene within the HLA region, then it must be associated with different HLA antigens 
in different populations. 
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INTRODUCTION 
Simons et al. (1) were the first to report an association between 
nasopharyngeal carcinoma (NPC) and HLA antigens in Chinese patients. 
Expanded studies on 153 patients by Simons et al. (2) showed a 
borderline increase in HA A2 and Bw46. Simons et al..(3) reviewed the 
data collected during the Second Asia-Oceania Histocompatibility 
Workshop with respect to NPC in Chinese. The close linkage 
disequilibrium between Bw46 and DRw9 in controls was not seen in NPC 
patients but there was a high frequency of blanks. The HLA profile 
sho~ed differences between newly diagnosed patients. and long-term 
survIvors. 
o This study was supported by a ~ant from National Science 
Council (NSC78-0412-B002-125) TaIwan, Republic of China 
*' Present address: Transplantation Unit, The Natal Institute of 
Immunology, P.O.Box 2356 Durban 4000, Rep. of South Africa. 
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These interesting findings led to the inclusion of NPC as one of the 
diseases studied in .the Third Asia-Oceania Histocompatibilty Workshop 
and the report by "than et al. (4) confirmed the previous findings in 
southern Chinese and also reported that HLA B17(58) had a lower 
frequency in long term survivors. In contrast northern Chinese showed 
none of these associations but instead showed an increased frequency of 
HLAB35. 
A comprehensive review by Simons (5) points out that the original 
findings have been amply confirmed in several reports of both overseas 
Chinese and in mainland Chinese but only in southern Chinese patients 
MATERIALS AND METIIODS 
SUBJECTS 
Patients and controls were of Chinese descent and resident in 
Taipei. The patient group consisted of 74 unrelated confirmed cases of 
nasopharyngeal carcinoma who were attending the ENT clinic at the 
National Taiwan University Hospital.. The control group consisted of 200 
unrelated random staff, blood donors and parents of patients awaiting 
transplantation. Class IT antigens were determined in 97 controls. 
HLA TYPING 
Lymphocytes were isolated on a density gradient and T and B cells 
were separated by means of nylon wool columns (6) in the first phase of 
the investigation. Many of the patients, however, had very low 
lymphocyte counts and we changed to using immunomagnetic beads 
(Uynal) for separating B cells (7). The yield of B cells was significantly 
improved but we were still unable to perform satisfactory HLA Class IT 
typing on all the patients. 
A complete set of Tenth International Histocompatibility 
Workshop antisera was used in a two-stage microlympho-cytoxicity test 
(8) to determine the HLA antigens in the patients., Antigen assignment 
was based on the Antigen Society reports in the pro'ceedings of the Tenth 
Workshop (9). Commercial typing trays designed for use in Oriental 
populations (One Lambda) were used in parallel and appeared 
satIsfactory for nearly all specificities. Some difficulty in antigen 
assignment was found fo~ A30/ A31 an.d Bw57/Bw62/Bw75 when they 
occurred together. The antigen frequencIes of the control population was 
based on typing with these commercial trays. 
ANTIBODY TESTS: 
. Antibo~ies agai~t EBV early antigens (anti-EA) and viral capsid 
~mhgens (antI-VCA) In IgG and IgA were tested by the indirect 
Immunofluorescent techniques (10). 
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RESULTS AND DISCUSSION 
The frequency of HLA A2 was increased in the patients (62.2% vs 
47.0%, P 0.05) and although the corrected p-value was not significant, this 
confirms earlier reports. The frequency of B46 was increaseabut this was 
not significant. There were no singificant differences at the C locus. HLA 
DR9 was increased (27.3% vs 21.7%) but not significantly so and there 
were no differences at the DQ locus. These figures are in agreement with 
previous reports of increased frequencies of A2, B46 and DR9. The 
difference was greatest with A2 and feast with DR9, giving the impression 
that ·the A locus has the most influence. The joint occurrence of 
combinations of these antigens in patients and controls showed increasing 
relative risks up to a value of 2.3 for the combination of A2, B46, DR9. 
A very interesting finding was the decreased freguency of the All 
antigen in patients (33.8% vs 60.0%, p 0.0005). This may indicate a 
protective effect that is in linkage disequilibrium with this A locus antigen 
although Svejgaard et al (11) has explamed the difficulties in establishing a 
negative correlation. Table 1 shows the frequency of selected HLA 
antigens in all patients and in three broad categories. Patients in group A 
are descendants of families who have lived in Taiwan for many 
generations. Group B are from the central provinces on the mainland and 
group C are Cantonese. It is difficult to establish statistical significance 
with small numbers as happens when subdividing into small groups but 
some interesting trends have emerged. The A2, B46 and DR9 antigens do 
not have increased frequencies in patients from the central provinces. This 
agrees with the report of Chan et al. ' (4) HLA All was cfecreased in all 
groups. B57 was increased in patients with origins on the mainland but 
not in those from Taiwan. The joint occurrence of A2, B46, DR9 was more 
frequent in patients from Taiwan. Dividing the patients according to the 
extent of tIle carcinoma showed that B46 and DQwl were greatly 
increased in patients where the cancer had a limited spread whereas DR9 
was not. HLA B57 was increased in all stages (Table 2). . . 
Not all the patients were tested for the presence of antiEA and 
anti-VCA in IgA an IgG. As shown in Table 3, DR9 was decreased in 
those patients with antibodies. The difference in frequency for B46 was 
less marked and was not observed for A2. HLA All was not present in 
patients with anti-EA and markedly decreased in patien~s with anti-VCA 
ill IgG. Thus, it seems that Chinese with All who make antibodies are less 
likely to develope NPC. An interesting finding was the increase in B13 
and DRw6 in patients with antibodies and a decrease in patients with low 
titre of antibodies. There was also an inverse relationship between DQwl 
and DQw3 in patients with and without antibodies which may be c~used 
by linkage disequlibrium with DRw6 and DR9. 
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Table 1. Selected antigen frequencies in NPC patients 
RANDOM ALL A B C 
N= 200 74 54 9 11 
A2 47 62 67 33 64 
All 60 34 35 33 27 
B35 5 9 7 0 27 
B46 22 31 39 11 9 
B57 2 19 7 33 27 
Cwll 18 16 20 0 9 
DR9 22 27 33 13 11 
DQwI 38 53 53 63 44 
D#w3 75 62 67 25 67 
A2B46 
DR9 10 21 25 13 11 
A=Taiwan B=Central mainland . C=Cantonese 
Table 2 Selected antigen freqencies in NPC patients 
RANDOM I 11 III IV 
N= 200 6 30 16 12 
A2 47 67 50 75 58 
All 60 50 43 19 42 
B35 5 0 7 19 17 
B46 22 50 23 44 8 
B57 2 17 20 19 17 
Cwll 18 17 10 25 • 8 
DR9 22 0 28 36 10 
DQwl 38 80 55 57 30 
DQw3 75 20 62 50 70 
A2B46DR9 10 0 21 29 0 
I,ll, Ill, IV Stages of NPC 
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Table 3 Antigen frequencies in NPC patients with antibodies 
RANDOM ALL ~~ l~ ~A ~ CA 
N= 200 74 7 
7 18 26 
A2 47 62 71 86 
56 69 
All 60 34 0 0 22 
15 
B13 5 9 29 29 
28 19 
B46 22 31 14 29 
22 27 
DRw6 11 12 43 29 22 
17 
DR9 22 27 0 14 6 
9 
DQwI 38 53 86 71 56 
61 
DQw3 75 62 29 43 39 
48 
A2B46DR9 10 21 0 15 0 
4 
The calculations to estimate haplotYfe frequencies only showed 
significant linkage disequilibrium in the tota group because of the sma
ll 
numbers involved wnen considerin§ subgroups. Significant linkag
e 
disequalibrium was bresent for A2, 46 andB46, DR9 in both contro
l 
~oups, and patients, ut for A33, B57 and B57.Dr3, it was only present 
in 
t e patients, and in fact, the frequency of these latter pairs was extremely
 
low in the random controls. 
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In trod uction 
Amiel (1), in his introduction to the first study of the human histocompatibility (HLA) antigens and 
disease, postulated that as susceptibility to the Gross virus, which gives rise to spontaneous 
leukaemias in mice, associates with the mouse histocompatibility (H2) antigens (2), the same 
mechanism might operate in human susceptibility to viral disease. As Hodgkin's Disease (HD) was 
suspected to be of viral origin, a suggestion that has been in, out and is now back in fashion (3), 
this was the disease chosen for this first study. Careful analysis of the serological results indicated 
that one antigen, then called 4C, related to what are now called B35, B5 and B 18, was significantly 
raised in patients with HD. 
Since then a number of other studies have confim1ed the association with these and other Class I 
HLA antigens (4-10). If data from several studies are pooled an increase in susceptibility to HD is 
seen in association with HLA-Al, B5, B8 and B18 (10). Nevertheless the relative risks were small 
and variable in the random patient studies and so the most convincing evidence for the role of HLA 
in susceptibility to HD came from studies of multi case HD families with more than one affected 
member, in which an excess of HLA identity between pairs of affected sibs was observed (11). 
Following the early HLA Class I studies, Class n, specifically HLA-DR alleles, were investigated 
in HD but no significant associations were seen (10,12,13) . As improved methods of typing for 
HLA-DP were developed, such as restriction fragment length polymorphism (RFLP) (14,15), it 
was decided to investigate the possibility that aIleles at this locus might reveal a Hodgkin's Disease 
susceptibility gene. In 1989 Bodmer et al (16) described the results of a study using RFLP to type a 
small number of patients and controls. In this study a significant decrease in a fragment associated 
with DPw2 was seen in patients compared to controls along with a non-significant increase in a 
fragment associated with DPw3, 5 and 6. 
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Following the pilot study mentioned above, an international collaboration was set up as part of the 
11 th International Histocompatibility Workshop to study the association of HLA-DPB with 
Hodgkin's Disease using a panel of sequence specific oligonucleotide (SSO) probes in conjunction 
with the techniques of enzymic amplification of DNA and dot blotting. Twenty officially named 
DPB alleles were defined by DNA sequencing techniques (17,18). 
This study was carried out at two levels, firstly to look for an association between HLA-DPB and 
overall susceptibility to Hodgkin's Disease and secondly to look for associations of particular 
alle1es with the clinical course of the disease. There is evidence for impaired immunity at 
presentation in Hodgkin's Disease, and this may correlate adversely with survival (19). The role of 
HLA in immune function is well established and this could make HLA alleles possible factors in 
determining survival in patients with Hodgkin's Disease. Some of the early published studies 
analysed HLA results according to survival, HLA-Al and B8 being found in increased frequency in 
long term survivors. The HLA types in long term survivors can be compared with those of patients 
who died shortly after the onset of disease to explore the role of HLA in influencing disease 
progression. For example in an early study investigating HLA in Hodgkin's Disease, Falk and 
Osoba (4) found an increase in antigens AI, B5, formerly A5, and B8, formerly A8, in patients 
with Hodgkin's Disease as a whole, B8 being particularly prevalent in patients who had survived 
more than 5 years. In addition, the frequency of HLA-A3 was increased in patients with recent 
onset, suggesting that this could be associated with poor prognosis. Osoba and Falk studied 
prospectively 79 previously untreated patients who were diagnosed between 1972 and 1973 at The 
Princess Margaret Hospital, Toronto. The HLA phenotype Aw 19 was found to be a highly 
significant prognostic factor, on univariate as well as multivariate analyses and was independent of 
stage, age, histology or sex (20). The significance of HLA-AwI9 was also confirmed by 
comparing the frequency of this antigen between patients in good and bad survival groups. Another 
recent study reported a significant increase in HLA-B5 in patients who relapsed (21). This is of 
interest as a preliminary analysis of the patients reponed by Osoba et al (20) had also associated this 
antigen with poor survival, being present relatively frequently in patients who had died ~ithin three 
years of diagnosis (22) . 
Thus examination of a possible correlation of the frequency distribution of HLA-DPB alleles with 
clinical parameters is an important component of the study. 
2 
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The HLA-DPB typing was carried out at the DNA level using a panel of 25 sequence specific 
nucleotides (SS Os) as described in the Hodgkin's Disease abstract (Tonks et al volume U). A total 
of 741 patients with Hodgkin's Disease and 686 controls from 17 centres in 12 countries were 
included in the typing analysis. Table 1 shows a list of the collaborating clinical centres and 
laboratories involved. The populations included Caucasoid, Black and Oriental patients with 
ethnically matched controls. 
Methods 
The clinical centres were asked to provide their collaborating tissue typing laboratory with an EDTA 
blood sample, 5-10 mls of serum and clinical details for each patient. They were also asked to 
provide histological slides for central analysis. The laboratories extracted DNA from the blood 
samples provided and HLA-DPB typed both the patient and controls according to the workshop 
protocol (DNA Methodology report, this volume). Eight homozygous typing cells were sent to each 
laboratory for typing as controls. The completed typing data were then sent to the disease study 
organisers along with copies of the autoradiographs and the clinical pro-formas for analysis. The 
HLA-DPB alleles were assigned using a computer program designed by A. Wasik and 1. G. 
Bodmer (ICRF). Relative risks and X2 were calculated on the patients and controls to whom alleles 
had been assigned (23). Data from each centre was analysed against their matched controls and then 
data from ethnic groups compared (table 2). Using the scores for each SSO, X2 and RR for 
different sequence motifs were also calculated. 
The information obtained from the clinical questionnaires (table 3) was used to construct a clinical 
database. All completed pro-formas were checked at St. Bartholomew's Hospital for any obvious 
inconsistency. Clinical information for analysis was available on 551 patients from 12 centres. 
Survival analyses could not be performed on the entire set of data as all patients typed were alive 
relatively recently, at least at the time of venesection. Historical data from patients treated and 
followed-up at St. Bartholomew's Hospital was used to illustrate the differences between the 
popUlation studied for this workshop and an 'unselected' population. 
Proportions of patients achieving complete remission (CR) in different prognostic groups were 
compared using the X2 test with Yates's correction (24). Duration of remission curves were plotted 
using standard life table methods (25) and compared usi~g the log rank method (26). The 
significance of prognostic factors in determining the achievement of CR was evaluated by logistic 
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regression analysis, whereas duration of CR differences were determined u
sing a stepwise linear 
regression method based on Cox's proportional hazards model (27). 
Results 
a. Overall analysis 
Analysis of the data comparing the frequencies of HLA-DPB alleles in pat
ients and controls was 
carried out for each patient group separately (table 2) . In addition, sets of da
ta from closely related 
populations were combined if the heterogeneity between the them was show
n to be small. On this 
basis the nine sets of data from centres in Britain, France, Germany, Italy, H
ungary and the U.S.A 
were combined into a relatively homogeneous Caucasoid group and data fr
om Taiwan and Japan 
were combined into an Oriental group. 
Increased risk with DPBl *0301 in Caucasoids 
The combined Caucasoid population, made up of the European and Ameri
can patients (544) and 
controls (464), showed the allele DPBl*0301 to have an increased risk 
(RR 1.95, P<l%) for 
Hodgkin's Disease. This confirmed the observation of an increase in the RFL
P fragment associated 
with DPw3 seen in the pilot study (16). Two individual data sets in which thi
s allele was seen to be 
significantly increased were from France (RR 6.19, P<l%) and German
y (RR 2.69, P<5%), 
though all the other data showed a trend towards an increase in this allele in
 patients compared to 
controls (Table 2). No other allele showed a disturbed frequency in the combin
ed Caucasoid data. 
Decreased risk with DPBl *0401 in Orientals 
The DPBl*0401 allele was seen to be significantly decreased (RR 0.14
8, p<l%) in patients 
compared to controls in the Oriental population, consisting of the data from J
apan and Taiwan. The 
same observation was made in several other individual data sets, particular
ly from Japan, and the 
U. K (Marsden). 
Individual patient groups 
No significant associations were seen in the South African data as a w
hole, however in an 
independent analysis of 21 Cape Coloureds Jacobs et al (workshop commun
ication) calculated the 
RR to be 3.8 for DPB 1 *0301, in agreement with the prior hypothesis. 
Two data sets from Israel were analysed. A trend towards an increase in the 
DPB 1 *0401 was seen. 
However, there were technical difficulties in the assignment of DPB alleles i
n one of the sets (from 
Haifa) and since the controls were used for both groups, these results are not
 conclusive. 
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The previously reported decrease in DPB 1 *0201, while seen in the Gennan data was not confmned 
overall. 
Hypervariable region analysis 
Since HLA-DPB alleles have the interesting property of being composed of a relatively small 
number of variable stretches of sequence, or motifs, which are shuffled to fonn the different alleles, 
a given motif may be found in several different alleles. Therefore if the susceptibility site were 
encoded by a particular sequence motif, a higher relative risk would be expected with this motif than 
with any of the alleles containing it. Analysis of these sequence motifs, based on probe frequencies, 
while confinning the results of the allele analysis, did not reveal any more significant correlation 
between susceptibility to BD and a single motif than that seen in the allele analysis. SSOs DPB3502 
(FV) and DPB5504 (DED) both specific for DPB 1 *0301 showed a significant increase in sorile 
groups; for example DPB5504 was significantly increased in the French and Gennan data, while 
DPB3502, was significantly increased in the Hungarian data. In the combined Caucasoid group a 
number of motifs associated with the DPB 1 *0301 allele were significantly increased; DPB0902 
(VYQL), DPB3502 (FV), DPB5504 (DED), DPB6502 (QKDL), DPB6903 (LLEEK), DPB7602 
(M) and DPB8503 (DEA V). SSOs specific for the DPB 1 *0401 allele showed the same trend as the 
allele in the Oriental populations; the probe DPB3501 (FA) was significantly reduced in the 
combined Oriental data and also in the Japanese and the U. K. (Marsden) data. 
Linkage disequilibrium 
Since the level of recombination between the DP and DR loci is now estimated to be about 1 % (28) 
the question arises whether an association of HD with alleles at other HLA loci would have been 
seen in this study. In the 11 th Workshop DP DNA report (this vol) significant linkage disequilibria 
were seen between DPB1 *0301 and both DRB1 *0301 and DRB1 *1302 in random Callcasoids and 
between DPB 1 *0401 and DRB 1 * 1302 in Japanese. This indicates that DRB 1 * 1302 is associated 
with the DPB 1 *0301 allele, increased in BD in Caucasoids, but with DPB 1 *040 1 in Oriental 
patients, where this allele is reduced in BD. Data on HLA loci other than DP were available only on 
a small number of patients in this study but in the French data which showed a significant relative 
risk for DPB 1 *0301, there was no significant linkage disequilibrium with DPB 1 *0301 in the 
patients although linkage disequilibria were seen in the French controls with both DR3 and B 18. 
300 
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In the overall analysis of linkage disequilibria (LD) between DP alleles and alleles at other loci, data 
from random individuals from other populations in the 11 th Workshop were studied. These were: 
France (192 individuals), Italy (359), Germany (65), UK (44), U.S.A (123) and Japan (314). For 
the HLA-A locus no alleles were found in significant ill with DPB 1 *0301 in Caucasoids or with 
DPB 1 *0401 in Japanese. For HLA-B only very weak LD were seen for DPBl *0301 with B7 and 
B50 in Italy and B27 in France. A weak non significant LD was seen in Japanese between B44 and 
DPB*0401. 
b Clinical analysis 
To discover whether any HLA-DPB allele was associated with clinical state or progression of the 
disease, subsets of the patients were compared. 
Characteristics of the overall patient population are shown in table 4. 
HLA-DPB and remission rate 
The overall complete remission rate was high (79.5%). If patients in equivocal complete remission 
(29) are included, the remission rate is 89%. The proportion of patients who do not respond to 
initial therapy is very small (1.5%), considerably lower than in other published series. The duration 
of remission is long, being significantly better in comparison with all previously untreated patients 
treated at St Bartholomew's Hospital over a 24 year period (figure la). This, coupled with the fact 
that all these patients are alive, demonstrates the significant, albeit inadvertent, selection of patients 
in this study. The distribution of patients is heavily skewed towards a predominance of survivors, 
in a good prognostic group. 
The duration of remission in patients with different HLA-DPB alle1es was compared. On univariate 
analysis HLA-DPB 1 *0901 was associated with with shorter overall duration of remission (figure 
1 b). In the Japanese population, where this allele is most prevalent, the remission duration of the 
eight patients with DPB I *0901 was significantly less (Figure lc). There was no significant 
correlation between HLA-DPB I *0301 (Figure Id) or other HLA-DPB alleles and remission 
duration. 
HLA-DP and other clinical features 
The distribution of HLA-DPB alle1es in patients who had a positive family history of Hodgkin's 
Disease was identical to the overall distribution. 
301 
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There was a statistically significant increase in the frequencies of HLA-DPB 1 *0202 and 
DPB 1 *0501 in patients with Lymphocyte Deplete Hodgkin's Disease; however, this histological 
sUbtype is the least common one and as numbers are small, this finding should be treated with 
caution. 
There was no correlation between HLA-DPB type and stage, extent of disease, outcome to initial 
therapy, presentation blood count, serum albumin or erythrocyte sedimentation rate. 
Discussion. 
The most interesting and significant findings to emerge from this study were 
a] an increased frequency of DPB 1 *0301 in Caucasoid patients compared with controls. 
b] a decreased frequency of DPB 1 *0401 in Oriental patients compared with controls. 
c] shorter remission duration associated with HLA-DPB1 *0901. 
While it is impractible to carry out a prospective study on patients to ascertain the relationship of 
HLA type to disease progression, an alternative approach is available; to type a cohort of patients 
retrospectively, using stored material. This was performed for a group of patients with poor 
prognosis from St. Bartholomew's Hospital. The results (unpublished data) showed a highly 
significant increase in the frequency of HLA-DPB 1 *0901 in this group, compared with patients in 
follow up (largely composed of 'survivors') or normal controls. The poor remission duration 
associated with HLA-DPB 1 *0901 in these patients provides independent verification of this 
Workshop result. This finding also suggests that DPB 1 *0901 or a gene in strong linkage 
disequilibrium with it predicts a poor outcome. 
In conclusion it appears from this study that the HLA association with Hodgkin's Disease, up until 
now most securely indicated by HLA concordance in affected sibs, is to be found closer to the 
HLA-DPB locus than to other loci previously studied. This is confirmed by the analysis of linkage 
disequilibria of DPB 1 *0301 and *0401 in random donors from the populations studies which show 
that there are no HLA-A, B or DR alleles consistently in strong LD with these DPB alleles and 
which might be considered candidates for the primary association with Hodgkin's Disease. 
Though the relative risks seen with DPB alleles are highly significant, the increased risk overall is 
still relatively modest. It is therefore possible that future studies which will be directed towards 
confirming these results should also examine genes near to HLA-DP which have been shown to be 
polymorphic (Nomenclature repon). The interesting suggestion that DPB 1 *0901 is associated with 
7 20/1/92 
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poorer remission duration will be further investigated for both its immunological and clinical 
implications. 
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Table 3: Clinical Infonnation 
Age 
Ethnic Origin 
Family History (Hodgkin's, Non-Hodgkin's or other malignancy) 
History of Infectious Mononucleosis 
Histology 
Date of Diagnosis 
Stage, clinicaVpathological 





Erythrocyte Sedimentation Rate 
Serum Albumin 





Table 4: Characteristics of the overall patient population 
TOTAL 551 
HISTOLOGY 
Nodular Sclerosis 281 
Lymphocyte Predominant 62 
Mixed Cellularity 136 










Complete Remission 400 
Complete Remission (u) 46 
Partial Remission 47 
Fail 8 
Early Death 2 










Remission duration of patients In HLA study compared with all patients treated at St. 
Bartholomew's Hospital, London. 
Fig. 1 b 
Remission duration of patients with the DPB 1*0901 allele compared with the rest. 
Fig le 
Remission duration of Japanese patients with and without the DPB 1 *0901 allele. 
Fig Id 
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HLA and Insulin Dependent Diabe.tes in 
South African Indians 
M. G. Hammond1 and A. C. Asmal2 
I The Natal Institute of Immunology and 2 University of Natal Medical School, Durban, South Africa 
The HLA antigens of 44 Asian Indians with juvenile-onset, insulin-dependent diabetes were 
determined. The frequency of HLA-B8 was increased but that of HLA-B15 was not. There was 
a significant increase in the frequency of some of the subdivisions of B5. 
Received for publication 27 August, accepted 10 September 1979 
Studies of the HLA system in diabetes 
mellitus have broadened our insight into 
the role of genetic mechanisms in its devel-
opment and have highlighted the significant 
genetic heterogeneity of the disorder 
(West 1978, Fajans et al. 1978, Cahill 
1979). Most of these . studies have been 
carried out on white Caucasian populations 
and have shown that, whereas insulin-
dependent diabetes (IDDM) has certain 
clear associations with the HLA antigens 
B8, B15 and B18 (Nerup et al. 1977), non-
insulin dependent diabetes does not have 
such direct relationships. 
Studies of the HLA system in non-
Caucasian populations have revealed an 
association between HLA-B8 and IDDM 
in Black Americans (Cahill 1979), but no 
association between either BB or B15 and 
diabetes in Japanese. In contrast, in the 
latter group, diabetes has been associated 
with Bw54, a variant of Bw22 (Kawa et al. 
1977, 1978), and with B12 (Nakao et al. 
1977). In addition, both groups of workers 
also reported a decreased incidence of B5 
in their diabetics. Kawa et al. (1979) 
reported that the decreased incidence of 
B5 was due to the significant decrease in 
the frequency of Bw52. 
Within the European Caucasian popu-
lation itself there is considerable variation 
in the distribution of HLA antigens (Cahill 
1979). There have been few (if any) studies 
of the HLA relationship to IDDM in non- . 
European Caucasian populations. 
Material and Methods 
The diabetic subjects were seen either at 
the King Edward VIII Hospital, Durban, 
which is the main teaching hospital of the 
University of Natal, or at one of the 
satellite hospitals in the group. The IDDM 
patients were characterized by onset under 
35 years and a dependence on insulin for 
control of symptoms and for the prevention 
of basal ketosis (West 1978). The antigen 
frequencies were compared with those 
found in. a healthy control population, 
many of whom were typed for Inter-
• Supported in part by a grant from the South African Medical Research Council (MGH). 
0001-2815/80/030244-05 $02.50/0 © 1980 Munksgaard, fopenhagen 
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national Workshops (Hammond et al. 1975, 
1977). 
The Indian subjects studied represent 
two ethnic subgroups - the Aryans and the 
Dravidians - whose predecessors came to 
South Africa more than 100 years ago from 
north and south India, respectively (Mistry 
1965). 
A total of ISO antis'era were used in a 
two-stage microlymphocytotoxicity test to 
determine the HLA antigens of 44 Indians 
with IDDM. Lymphocytes were isolated on 
a Ficoll-Hypaque density gradient. 
Results 
Table 1 shows the antigen frequencies in 
Aryans, Dravidians and in all the Indian 
patients compared with the controls. 
HLA-B5 has been subdivided into Bw51, 
Bw52 and B5 IND. This last category 
probably includes the specificity Bu = 
SW59. The distribution of antigens at the 
A and B loci conform to Hardy-Weinberg 
equilibrium. Estimates of haplotype 
frequencies are not very reliable for small 
numbers but no linkage disequilibrium was 
evident. Some haplotypes are shown in 
Table 2. 
higher incidence in Aryans (19.1 % vs 4.S%). 
This difference was not significant. 
None of the Indians with IDDM was 
found to have B40.1 but the corrected 
probability was not significant. B40.2 
was increased, but the frequency of B40 
overall was approximately the same in the 
total Indian sample. This inverse relation-
ship in the subdivisions of B40 was also 
seen in the subdivision of B5. Bw52 was 
significantly increased in Dravidians with 
IDDM (corrected P < 0.04) and B5 IND 
was significantly increased when consider-
ing all Indians (corrected P < 0.02), while 
Bw51 was decreased. The same trend was 
also present in Aryan Indians. The splitting 
of B5 and B40 into subdivisions still poses 
problems which may be solved in the 
future by better sera and International 
Workshops. These results should therefore 
be treated with reserve. The overall increase 
of B5 (43.2%vs 34.2%) contrasts with the 
decrease of B5 observed in European 
Caucasians (Nerup et al. 1977) and in 
Japanese (Kawa et al. 1979, Nakao et al. 
1977). 
Probabilities were calculated by X2 or, if Discussion 
any of the numbers in the 2 X 2 table were Studies on White Caucasian populations 
less than 4, by Fisher's exact method. have shown that both HLA- BS and B15 
Probabilities have been corrected by are associated with an increased risk of 
multiplication by the number of antigens IDDM. Rotter & Rimoin (197S) have 
tested. hypothesized that there are two distinct 
There were no significant differences at forms of IDDM, one associated with BS 
the A locus. At the B locus, HLA-BS was and characterized by autoimmunity, micro-
increased in the total Indian sample angiopathy and a stronger association with 
(13.6% vs 5.9% N.S.) this being due to the the D locus antigen Dw3. It has also been 
high frequency in Dravidians (21.7% vs noted that B7 and Dw2 have lower than 
6.4%), but was not significant after correc- normal frequencies in BS positive diabetics. 
tion for the number of antigens tested. The The B 15 type is characterized by antibody 
frequency of B15 was unaltered. The response to exogenous insulin and a 
frequency of B 13 was also increased in the stronger association with the C locus 
total Indian sample but this was due to the antigen, Cw3, but it now appears that these 
314 
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Table 1 
Percentage frequency of HLA antigens in Indians with JOD 
ARYAN DRAVIDIAN TOTAL INDIAN 
Control . JOD Control JOD Control JOD 
HLA N 208 21 424 23 632 44 
Al 18.8 23 .8 32.2 26.1 27.9 25.0 
A2 25 .5 23.8 34.2 34.8 31.3 29.6 
A3 14.9 9.5 14.4 13 .0 14.6 11.4 
All 31.3 28.6 25.7 30.4 27.5 29.6 
Aw23 0 0 0.9 4.4 0.6 2.3 
Aw24 30.8 33.3 25.2 30.4 27.1 31.8 
A25 2.4 9.5 1.7 0 1.9 4.6 
A26 5.8 4 .8 6.6 0 6.3 2.3 
A28 18.3 23.8 12.5 0 14.4 11.4 
A29 1.0 0 0.7 0 0 .8 0 
Aw30 3.9 14.3 4.0 4.4 4.0 9.1 
Aw31 5.3 0 2.6 0 3.5 0 
Aw32 2.9 0 2.4 0 2.5 0 
Aw33 7.2 14.3 7.6 13.0 7.4 13 .6 
One 
antigen 32.2 14.3 29.3 43.5 30.2 29.6 
B7 7.2 14.3 15.1 8.7 12.5 11.4 
B8 4.8 4.8 6 .4 21.7* 5.9 13.6 
BB 4.8 19.1 7.8 4.4 6.8 11.4 
B14 1.0 0 0 0 0.3 0 
B15 12.5 9.5 10.1 13.0 10.9 11.4 
B16 2.4 0 2.1 0 2.2 0 
B17 17.8 19.1 22.9 8.7 21.2 13.6 
B18 5.8 0 1.7 4.4 3.0 2.3 
Bw21 1.9 0 1.7 8.7 1.7 4.6 
Bw22 1.9 0 2.8 0 2.5 0 
B27 5.3 0 1.2 4.4 2.5 2.3 
Bw35 20.2 4.8 20.8 8.7 20.6 6.8 
B37 2.4 14.3 5.0 0 4.1 6.8 
B40.1 10.6 0 14.9 0 13.4 0 
B40.2 13.9 38.1 * 16.5 17.4 15.7 27.3 
Bw42 0 0 0 0 0 0 
Bw44 19.7 14.3 8.3 13.0 12.0 13.6 
Bw45 0.5 0 0 0 0 .2 0 
B5 33.7 28.6 34.4 56.5 34.2 43 .2 
Bw51 23.6 4.8 21.9 8.7 22.5 6.8 
Bw52 7.7 9.5 8.7 30,4-* 8.4 20.5* 
Bw53 1.4 4.8 2.1 0 1.9 2.3 B5IND 2.4 14.3 3.8 17.4* 3.3 15.9--
One 
antigen 32.2 28.6 26.4 30.4 28.3 29.6 
-Uncorrected P < 0.01. 
* *Corrected P < 0.04. 
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Table 2 
Selected haplotype frequencies (X 10
3
) in Indians with lOD 
ARYAN 
Haplotype Control JOD 
208 21 
I, 17 27 44 
1,37 7 47 
24, 7 0 14 
24, 52 19 0 
30,13 7 47 
33,44 18 21 
.,6 > 2SE. 
**,6 > 3SE. 
are secondary to the increase in Dw4 
(Christy et al. 1979). When both B8 and 
B15 are present their effect is additive. 
In the present study, B8 and not B 15 
was associated with IDDM. This association 
was confined to the Dravidians and the 
relative risk (RR) was 2.5 which is the same 
as that found in European Caucasians. It is 
known that the northern populations of 
India were subjected to successive waves 
of infiltration of Mongoloid races from the 
northeast. These waves did not penetrate 
to the south of India, which is occupied by 
Dravidian races who originated in western 
Asia and settled in India in prehistoric 
times. 
The Aryans with IDDM show s\milarities 
with Japanese, i.e. there is no increase in 
the frequency of B8, B15 or B5, while the 
Dravidian patients show an increase in B8, 
as found in European Caucasians and an 
increase in Bw52 which is the opposite of 
the finding in Japanese. 
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HLA and Insulin-dependent Diabetes in South African Negroes 
M. G. Hammond1, A. C. Asmal2, and M. A. K. Omar2 
INatal Institute of Immunology and 2University of Natal Medical School, Durban, South Africa 
Summary. The HLA antigens of 57 South African 
negroes with juvenile-onset, insulin-dependent dia-
betes were determined. The frequency of B8 was 
increased (29.8% vs 13.9%) as was the frequency of 
B14 (17.5% vs 6.1%). The frequency of patients with 
either one of these cross-reactive antigens was sig-
nificantly increased after correction for the number 
of antigens tested (45.6% vs 19.2%, P (corrected) 
<0.005). 
Key words: HLA, insulin-dependent diabetes, ne-
groes. 
Numerous studies of the HLA system in diabetes 
have shown clear associations between insulin-
dependent diabetes mellitus (IDDM) and certain 
HLA antigens. Increased frequencies of HLA B8, 
B15, B18, Cw3, Dw3, Dw4, DRw3 and DRw4 have 
been found in white Caucasian populations with this 
disease [1]. An association between HLA B8 and 
IDDM has also been found in South Africa Indians 
[2] and in American Blacks [3, 4], but not in Japanese 
with IDDM [5, 6]. 
Materials and Methods 
The diabetic patients attended the Diabetic Clinic of the King 
Edward VI.II H?spital, Durban which is the main teaching hospital 
of the U.llJverslty of Natal Medical School. The patients were 
charactensed by an acute onset of illness below 35 years old, and a 
depe~dence on insulin for control of symptoms and prevention of 
ketosIs [7]. They were typed over a two year period for the HLA-
A-B-C. antigens and the frequencies were compared with those 
found m a ~ealthy control population, many of whom were typed 
for Inter~atlOna.1 Workshops [8, 9]. The Negro population of Dur-
ban consists mamly of Zulus and the patients a.nd controls studied 
by us were of pure descent. A total of 180 antisera were used in a 
two-stage microlymphocytotoxicity test [10] to determine the HLA 
antigens of 57 Negroes with IDDM. Lymphocytes were isolated on 
a Ficoll-Hypaque density gradient [11]. Frequency differences 
were tested for significance with a X2 test (without Yates' correc-
tion) and the resulting probabilities corrected by multiplication by 
the number of antigens tested. 
Results 
Table 1 shows the antigen frequencies in the IDDM 
patients compared with the controls. The distribution 
of alleles at the A and B loci conform to Hardy-
Weinberg equilibrium. 
There were no significant differences between 
diabetics and control subjects at the A and C loci. 
The frequency of HLA B8 was increased in the 
diabetics (29.8%) compared to the controls (13.9%) 
but this was not significant after correction for the 
number of antigens tested. The frequency of HLA-
B14, on the other hand, was significantly increased 
even after correction (17.5% vs 6.1%, P (corrected) 
<0.04). As HLA-B8 and B14 form part of a cross-
reacting group, the number of patients and controls 
with either of these antigens were compared. The 
d~f~erence in the frequeJ1cies (45.6%) was highly sig-
mflcant (Pc <0.004). The relative risk (3.5) was about 
the same as for B14 alone (3.3) but greater than the 
relative risk for B8 alone (2.6). 
There was a slightly stronger negative association 
between Bw42 and IDDM. The relative risk was 0.25 
a.nd. t~e uncorrected p <0.005. This was no longer 
slgmfIcant after correction for the number of antigens 
tested. 
Discussion 
Nerup et a!. [12] discuss the possibility that there are 
two genes conferring increased risk of IDDM: one 
associated with B8 and the other with B15 or B18. In 
0012-186X18010019/0101I$01.00 
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Table 1. Percentage frequency of HLA antigens in Negroes with 
insulin-dependent diabetes mellitus (IDDM) 
HLA Control IDDM Control IDDM 
n = 756 n = 57 n = 756 n = 57 
Al 5.8 7.0 B7 16.0 22.8 
A2 20.1 14.0 B8 13.9 29.8' 
A3 13.5 10.5 BB 4.8 3.5 
All 0.1 0 B14 6.1 17.5
b 
Aw23 19.2 26.3 B15 5.8 1.8 
Aw24 3.3 3.5 B16 2.4 3.5 
A25 13.9 5.3 B17 38.1 21.1 
A26 7.5 7.0 B18 3.8 5.3 
A28 20.0 24.6 Bw21 0.5 1.8 
A29 16.7 12.3 Bw22 0 0 
Aw30 39.6 36.8 B27 0.3 0 
Aw31 12.6 10.5 Bw35 7.3 3.5 
Aw32 1.4 8.8 B37 0 0 
Aw33d 2.7 3.5 Bw60 1.6 3.5 
Only one 23.6 29.8 Bw61 0 0 
antigen Bw41
d 2.1 3.5 
detected 
Cw1d 0 1.8 Bw42 27.7 8.8' 
Cw2d 18.5 21.1 Bw44 16.0 14.0 
Cw3d 9.6 17.5 Bw45 6.4 10.5 
Cw4d 15.8 17.5 Bw51 2.7 0 
Cw5d 4.1 3.5 Bw52 0 0 
Bw53 3.4 3.5 
B8+B14 19.2 45 .6< Only one 41.1 45 .6 
antigen 
detected 
, P <0.005 
bp <0.001 
< P <0.0001 
d N = 146 (Number of controls) 
all the Caucasian populations studied to date the 
association with B8 has been a constant finding. The 
relationship with B15 and/or B18 has been confined 
to certain population groups. The association of 
these antigens appears to be secondary to the 
increased frequency of DRw3/Dw3 and DRw4/Dw4 
[1,13]. 
This study has demonstrated an increased fre-
quency of B8 and of B14 in South African Negroes 
with IDDM. Since these antigens form a cross-react-
ing group it is probable that the same susceptibility 
gene is associated with either of these antigens in 
Negroes. Alternatively, it may be postulated that 
another susceptibility gene, associated with B15 or 
B18 in Caucasians, is linked to B14 in Negroes. This 
latter explanation seems less likely. 
The Bw42 antigen has been detected only in 
Black populations. It is, however, one of the cross-
reacting antigens associated with B7 which may be 
linked to some protective mechanism against IDDM 
[121· The protective effect is not associated with 
HLA B7 in Negroes, indeed, the frequency of the 
M. G. Hammond et al.: HLA and Diabetes in Negroes 
antigen is greater in the IDDM group than in the 
controls. The relatively low frequency of Bw42 in 
Negroes with IDD.M may have a bearing on the low 
prevalence of IDDM in Negroes. Alternatively, it 
may be a reflection of the increased frequency of B8 
and B14. The difficulties of establishing the signifi-
cance of a negative association between HLA and 
disease have been discussed by Svejgaard et al. [13]. 
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INSULIN-DEPENDENT DIABETES MELLlTUS 
,\ " S \"(' i!.!~~rcl, P. Platz, and LP. Ryder 
l ~ j g~ lJo spi talet, Copenhagen, Denmark 
Introduction 
Since the discovery 0 1 Sillqal ilnd Blajchman (1) of an 
association between insulill dl'lJf' ndent diabetes mellitus 
(lOOM) and HLA-815 and later between both 815 and 88 
and lOOM (2). a large number of studies has been carried 
out on HLA and lOOM (3,4 for references)' These studies 
have shown that there are even stronger associations be· 
tween lOOM and HLA·OW3 and OW4 than with B8 and 
B15, respectively (5,6), and that HLA·OR3 and OR4 seem 
to be increased to the same extent as OW3 and OW4 (7). 
H LA typing of affected sibpairs has shown a considerable 
increase of H LA identical sibpairs and a strong decrease of 
sibpairs not sharing H LA haplotypes (8). 
Various genetic mod e l~ inl'p lJeen advanced to explain 
these observations: (a) a I l: l.'l~. !; ive model with incomplete 
penetrance (9,10) (b) a dominant model with incomplete 
penetrance (11), and (c) more complicated models invol-
ving two HLA-linked susceptibility genes associated with 
HLA·OW3 and 4, respectively (12). and perhaps even an 
HLA·OW2·associated gene conferring resistance (13,14). 
When the lOOM part of the 8th Workshop was planned it 
was uncertain which of these models fitted the findings best 
although evidence against both the dominant and the 
recessive models was available (3). 
Plans for the IDDM study 
The plans for the lOOM part of the 8th Workshop were 
prepared by a committee consisting of A. Green and M. 
Hauge, University of Odense; M. Christy and J . Nerup, 
Steno Memorial Hospital, Copenhagen; and the authors of 
this report. The major goal of the lOOM study was to 
provide more data which would enable the distinction 
between various genetic models of lOOM. In addition, we 
had the following scopes: (a) to study the H LA associations 
in various ethnic groups, (b) to investigate whether the 
HLA association(s) differ between familial and nonfamilial 
cases, and (c) to search for heterogeneity within lOOM in 
relation to the HLA determinants associated with lOOM. 
To approach these goals, we recommended that inves-
tigators participating in the study (a) select a homogeneous 
population living in a defined geographical area; (b) include 
all patients who had di,I( I' l"'s 'oI IDUM rim ing a certain 
period in that area; (c) delt!lIl1l1ll? which of these patients 
had at least one affected sib; (d) randomly select 10 to 20 
affected sibpairs and type them and their parents; and (e) 
randomly select and type 30 to 40 patients having no first 
degree relatives affected wi tl! IODM but havinB one or more 
unaffected sibs aged 20 or more at the time. Obviously, this 
pro.cedure was not possible for all investigators. In particu· 
lar, complete determination was difficult although desirable 
because earlier studies (15) indicated that the ascertainment 
method might influence the results. The call for studying 
affected sibpairs was abandoned for investigators studying 
particularly interesting ethnic groups, e.g., African and 
American Blacks, Japanese, and Basques. The reason for 
not typing healthy sibs or the parents of nonfamilial cases 
was to save serum and time and seemed justified because 
the information inherent in such relatives is limited. 
The following diagnostic criteria for lOOM were 
recommended: the disease should have onset before age 40, 
and should be idiopathic, ketosis-prone, and the patients 
should be nonobese and insulin-dependent (Le., not just 
insulin treated). 
The cl inical information required on all diabetics typed 
appears from the punch card format shown in Table 1 (this 
card was first called 'OM' but later '44' by the Los Angeles 
analyzers) . 
The family history requested for each propositus is 
exemplified in Table 2. 
Participants and data obtained 
Table 3 gives the names and institutions of the inves-
tigators of the 24 groups participating in this study and 
Table 4 summarizes the number of propositi used in this 
analysis. In some cases, more data were received but not 
analyzed because the information received was ambiguous. 
It appears that 636 nonfamilial, 158 familial, and 85 
'unknown' propositi were included in the study. Because 
parents, affected sibs, and sometimes unaffected sibs were 
also typed for the familial cases, the total number of 
typings performed exceeds 1200. These typings include 
both HLA-A,B,C, and OR typings, although the latter were 
not always successful. In addition, we sought and obtained 
information from the participants about the HLA-A,B,C, 
and OR types of about 1600 controls, most of whom 
were typed with the 8th Workshop sera. 
Results 
Familial versus nonfamilial ID OM. Only a limited 
number of groups had studied and given information about 
sufficient numbers of both non familial cases (group B 
patients) selected according to the strict criterion of at least 
one healthy sib aged 20 or more and patients with affected 
first degree relatives (group A patients). It appears from 
Table 5 that there are no significant differences between 
these two groups concerning the frequencies of the OR3 
and OR4 antigens or the OR3,4 phenotype although there 
is a tendency to a higher frequency for each of these 
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antigens and in particular for the DR3,4 phenotype among 
the familial propositi. I fuwever, when the phenotypes 
involving only DR3 and/or DR4 were pooled, there was a 
significant difference between familial and nonfamilial 
cases. Nevertheless, because all the differences in Table 5 
are quite small and because most data sets did not allow 
distinction between familial and nonfamilial cases, it was 
considered justified (and necessary) to pool familial and 





















































HLA-8 versus DR associations. These associations were 
studied in a number of Caucasian populations. Table 6 
summarizes the results of these analyses. It appears that 
DR3 is significantly increased both in BB positive and in 88 
negative patients compared to B8 positive and B8 negative 
Table 1. Patient coding form. 
C~r(! Humbt r 






~.scertalnment: Ilr06ano c 1. other a 0 
--rfiDH Tilfirst de!1ree relatIves = I. Isolated case = 0 J Family ---Other tvpes of [jH in fIrst ile'lree relatives = '1. no =-'! J 
!DDM in other relatIves. yes = I. no = 0 I his tory 
Age at onset (years) 
Month of onset (01= January. . . . . .• 12 =. December) 
Present weight in kilograms 
-
Present height in centimeters 
EiDisooes 01 ketoacidosI s No = O. Yes = 1 
Duration of insulin treatment (years) 
Pr p(",nnt i ns u1 in requ i r ement (IU . pr. kg. day. two deci ma 1 pla c" , ) 
~-- .... .. ..-
Type of insulin (fill out name(s): ) 
SDe cles ot InsulIn (Pork = p. Beef'" B. mIXed = H. other = X ) 
Present fasting blood glucose (mg. pr. 100 rnl) 
Present postprandial blood glucose (mg . pr. 100 ml) 
Present daily glucose excretion In urine (g pr. 24 hours) 
KetonUria presently 
-lfetlnOPjt Y presen~JY 
Abnorma tendon re 1exes presently 
Decreased vlbrat10n sense presently 
l'rotel nur a presently 
Ho· O. Yes· 1 
Present serum-creatinine (rn-mol pr. If tre) 
Fasting C-peptide level (pi co-mol pr. 1 i tre. two decimal places) 
l eA never iletecteo • li. Eresen{ '" 1. earlIer " 2. not lnves tlqateil • I>lank 
leA first Investigated (years after di agnosis) 
leA persisted (years after diagnosis. If still present" 99) 
Other endocrl ne (11 sorders. 00 • no 05 " Hypergonadotroplc hYi 
G:ve coornents. name (5 ) of other chro-
01 • Graves' disease gonadism 
02 • Hypothyroidism 06 c Idiopathic hypopara-
nlC diseases and name. full address 03 • Addison's disease 
and phone number of the person who thyroidism 
filled out this form: 
04 c Pernicious anemia 07 • other 
(use reverse side) example: 13 c both Graves' and Addison's disease 
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controls. In contrast, B8 is not increased either in DR3 
positive or in DR3 negative patients compared to the 
corresponding control groups. Accordingly, it can be 
concluded that the deviation seen for B8 in IDDM is 
entirely secondary to th" ;11(:1 ea ~e of D n3 . In analogy, 
the increases of B 15 and HI :!Ippear to be secondary to 
increases of DR4 and OR3, respectively, and the decrease 
of B7 is secondary to that of OR2 (the significant decrease 
of B7 in 0 R2 positive patients may be considered a chance 
deviation) . The significant heterogeneity seen in some of 
these comparisons is probably due to the fact that the asso· 
ciations between DR antigens and IDDM and between 
HLA·B antigens and DR antigens vary considerably among 
the populations studied. 
Because of these n!" . ,',' I i, ,,, .. ;lIl t! I WCJus(~ the time 
available for the analyses Vd ,; , a lil e l limited, we dec ided to 
concentrate the remaining studies on the DR antigens 
alone. 
Unfortunately, sufficient control materials allowing us 
to analyze the DR3 versus th e BfF , fr equencies were not 
available. 
DR antigen frequencies '(Table 7). For the patients, we 
have shown both the Los Angeles arid the local DR antigen 
assignment, but because local D R antigen assignments were 
used for the controls, we have also used local assignments 
for the patients in the calculations of relative risks. The 
following picture emerges: DR 1 shows no significant devia· 
tions in any population; OR2 is decreased in all populations 
stud ied; DR3 is increased in almost all populations except 
perhaps the Japanese. The highest relative risk is seen for 
the Basques but it is also high for Yugoslavians and non· 
Ashkenazi Jews; DR4 is uniformly increased in all popula· 
tions including the Japanese. The relative risk for OR4 
positives is generally higher than for DR3 positives; OR5 
was decreased in most populations; DRW6 was not ana· 
Iyzed because this antigen was poorly defined by the 
disease serum set; DR7 was decreased in most populations; 
and DRW8 showed no significant deviations in Caucasians 
but was significantly increased in Japanese. 
In brief, OR4 was increased in all lOOM patients 
studied throughout the world and OR3 was increased in all 
Table 2 
IODM· Family sheet. 
TYPING LAB CODE: PEDIGREE No. IF TY
PED ItI UGTll WOqKSIIOP: 
ID-no. if Sex Ethnic group Year of Uon-diabe
tJc·N A live:/\ IILA· phenotype if 
typed in F=female Use 8. work- birth If ml, Y. of dla!Jn. 
I f deceased typed outs i de Comments 
8. work- M=male shop code IDOl I O
ther types Y. of death 8. wor~ 












This scheme should be filled out for each proband typed as part of t
he workshop (isolated as well as familial cases). 
Ty~ing Lab code = positions 3-5 of Card 01 ; Pedigree no .• position
s 35-36 of Card 01 . 
If information on more than three generatIons is available. please f
ill out more sheets. 
Note: Information on all non-diobetic relatives is also required (se
x, year of birth, death, ) I 
whether they are al i': '" nf'H (". not. 
etc. , rrespectively 
Please give name, full ' address and phone number 
of the person who filled out this sheet : 
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Table 4. 
No. of propositi In' 
(thnlc affm;tad 
Normal 
LAB-code Bw cod a Group sporadic
 romilinl o1bships unknown conlro
lll 
OEn 21 German 59 
15 14 53 
17 44 
BOO 19 English 
BRA 24 Ashk.Jew 33 
4 3 46 
25 non-A . Jew 25 10 
4 35 
Jl1 36 BRG 02 Amer.Block 25 7 
11 Amer.Cauc. 9 
BRT 17 Czeck. 9 
4 I 74 
BSH 14 /lu~tr 9 1ltln 2J 
13 12 57 
CEP )0 r\o . I .)" 
Z) 11 10 57 
OOf "J4" 1'




flAH 01 IIf r .I!lack ) 1 
9 54 




JUJ 06 JApanese 54 
2 104 
KAS )1 Yugos1. )2 10 
B 63 
KRE 29 Srflni ~ h 29 12 10
 52 
HOl 26 Sw('ri i ~:h 20 2 1
 8J 




RUB 02 Amer.B1ack 5 {26 Spanillh 
u34" 20 25 non-" 
00 unknown 5 
SAl 06 Jepenese 29 
sur 1 
SVE 26 Oonish 44 20 20
 174 
TI1 J2 rinnish 17 13 6
 49 
TSU 06 Japonese 64 
116 
VIl 29 SpaniBh 24 24 10 
75 
Total 636 158 
134 85 1.591 
Table 5. Familial versus non-familial lOOM. 
I - - - -hlhd Ollw4 DRw), 4 ORwJ and/or" alone 
lnvesti- No. of cases Per cent pos. Odds Per cent pos. Odds 
Per cent pos. Odds Per cent pos. Odds 
gator rllln. Non-r. fam. Non-r . R[)ti[) ram. Non-r. Rstio
 fam . Non-f. Ratio fam. Non-f. Ratio 
BER 15 59 40 51 .66 73 47 2.B2 1
3 15 .98 7J 51 2.47 
8SH 13 5 69 BD .70 85 BO 1.53 62 60 1
.10 92 60 5.95 
1 
CEP 11 15 64 60 1.14 7J 7J .95 36 40 
. BB 64 60 1.14 
KAS 10 15 90 67 3.32 70 60 1.47 70 27 5.48 BO
 33 6.49 
SVE 20 44 60 59 1.03 75 00 .75 45 41 1.10 75 
00 .75 
" 
TH 12 5 50 20 3. 00 92 100 .70 50 20 3.00 5B 40 1
.91 
Combined 81 143 1.10 1.33 1.46 1.90 
'1..
2 sign. .11 .02 1.59 
4.40'" 
'1..2 heterog. 3.50 2.97 4.19 6.32 
Familial caaes involved one or onore afrected rirat degree relatives
 (ueually eibs) in addition to the propositus. 
Non- fnmilial caaes had no yfrected rirat -degree relativea end et le
ast one healthy aib at the age of 20 or more. 
Odds ratio were calculated for the frequenciea of the phenotypsa in
dicated in familial varaus non-r~ilial caeee. 
X
2
eign. = chi aquaqe (1 d.f.) for the deviation of the odda ratio from unity. 
11
2 
heterog. = chi equare for heterogeneity betwaen the individual odda ratioe. 
_: p < . 05 
The co~arisona under "DRw3" and "DRw4" involve all DRw3-poaHive and DRw4-p
oaitive patients againat DRw3-negative and 
DRw4-negative patients, respectively. Ths "DRw3,4" comparison comp
eres the DRw3,II-phenotype againat 011 other phenotype •• -
In the "DRw3 and/or 11 alone" comparison, patienta having only DRw3 
and/or 4 (but no other detectable OR IIntigens) were 
tested againat the remaining patients. . 
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Table 6. HLA·B versus OR associations (Caucasians). 
Antigens Lab. Odds Ratio 
B OR B- pos. B-neg. OR-pos. DR-neg. 
B 3 BER 3. 00 2.77 1. 17 1. 08 
BSH 2. 24 3.16 1.59 2.24 
OEH 1.89 17.02* .60 5. 36 
KAS 3.26 27.05- .19 1.59 
IIYR 1.21 I.B7 1.30 2.00 
SVE 3. BS 5. 58* .56 .Bl 
TlL .55 4.09 .42 3.1B 
MOL 3.00 1.51 1.22 : 61 
VIL 16 . 33 4.58 1.50 .42 
Combined 2.21 4.93 .76 1. 44 '/..2 . 
5.53 70.3B 1. 47 1.31 2 sIgn. 
5.63 19.03 B.67 4. 43 'X. het. 
B B B B d. f. 
- -_ . . . .. _.-
15 BER 4.22 5.46- .75 .97 
- BSH 19.00 3.35 4.05 .71 
OEH 25.00 5.91" 1.06 .25 
KAS 17.00 12.47" .41 .30 
MYR 3.21 5.16" .70 1. 13 
SVE 45.00* 4.70* 2.Bl .29 
TlL 21.00 12.76-' 1.05 .64 
MOL 4.37 16.69" .63 2. 42 
VIL 7.00 5.97- .53 .45 
Combined 7.79 6. 07 1.16 .77 5 sign . 35.73 125.78 .471 . 761 
7. 41 7. 18 12.14 4.64 X het. 
8 B 8 8 d. f. 
lB 3 BER 1.17 3.B3· 1.07 3.4B 
BSH 65.00· 2.76 4.57 .19 
OEM 10.43 B.Ol· 2.25 1. 73 
KAS 2. 14 13.26" .27 1. 67 
Tll 3.00 1.92 1.00 .M 
WJL 2.33 1. 7B 3.53 2. 70 
VIL 15.92- 3.52 1. 58 .35 
Combined 4.79 3.B3 1.48 1.2B 5 sign . 15.07 47.51 1. 7B . 60 
9.BO 11.27 7.35 9.76 "X: het. 
6 6 6 6 d. f. 
7 2 BER .10· .09* 1.60 1. 54 
BSH .27 .36 .65 .66 
OEH .14 . 07 .69 . .33 
KAS .OZ· .76 .Z4 11 . 57· 
MYR .04· :2B .26 2.07 
SVE .09* .06" .50 1.07 
TIl .15 .27 .29 .54 
MOL .22 1. 12 .31 1. 5B 
Vll .44 3.57 .18 1.47 
Combined . 13 .37 .46 1. 28 ~ sign. 
37.37 19.12 4.42 1. 54 x: het. 
6.44 30. 09 4.25 14.64 d. f. 
8 8 8 8 
[Kplanat!on: Odd!! ratios in column "B-pos." give the risk of developing 1001.f 
for individuals having both the B and OR antigen in question as 
compared to controls having both antigens. for . eKampl e, for "BE
R", 
the odds ratio of J.OO for "B-pos." is the risk of 1001.1 for 
OwJ-positives among BB-pas. patients compared to BB-pas. contro
ls, 
i.e. OwJ is increased even in BB-pas. patients. In analogy, ORJ 
is olso increased in OB-neg. patients (odds ratio = 2.77), While 
BB is not increased in ORJ-pos. or DRJ-neg. patients (odds rutio
s = 
1.17 and 1.0B, respectively). 
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Table 7. OR antigen frequencies. 
Antigen I I. ~". Patients, L.A. Patients, local Controls, loc. reI. .' N ~ N ~ N risk .. A .-- .-
~--
Oil 1 m .1l 
14.9 74 24.5 53 .5 
PI''' 1,7 . 1 17 
47 . 1 17 29.5 44 2.1 
111'1 U 13 
7.7 13 4.1 74 2.5 
U511 11.0 34 
1.1.1 36 26.3 57 .4 
KAS 0 IB 
14.3 42 20.6 63 .7 
KRE 
13.5 37 26.9 52 .4 
I 1nL 
9.1 22 15.7 B3 .6 
I-IV R 
IB.9 53 IB.7 150 1.0 
SV[ 9.4 64 
9.4 64 20.7 174 .4 
III 
6.7 30 26.5 49 .2 
VII . 13.6 44 
14.6 4B 9,B 137 1.7 
.. _._--'- 436 ·936 0.72 
COlRlJjned p. slgnl ficance : .04 
p. heterog. > .05 
Oil 2 BER 
6 . B 74 39.6 53 .1 
BOO 0 17 
0 17 27.3 44 .1 
ORI 0 13 0 
U 25.7 74 .1 
0511 5.9 34 
5.6 36 22.B 57 .2 
KII 5 27.0 18 1
9.0 42 34.9 63 
.5 
KRE 
2.7 37 30.B 52 .1 
HOL - 9.1 22 26.5 B3 
.3 
HYR 
5.7 53 2B.7 150 .2 
SVE 4.7 64 
4.7 64 30.5 174 .1 
III 3.3 
30 26.5 49 .1 
V1L 2.3 44 1






p. heterog. = .01 
OR 3 BER 4B
.6 711 15.1 53 5.1 
BOO 47.1 17 47.1 17 
29.5 44 2.1 
BRT 30.B 13 30.B 13 
25.7 74 1.3 
BSH 70.6 34 66.7 36 
35.1 57 3.6 
KAS 77.B IB 76.2 42 
22.2 63 10.6 
KRE 59.5 37 
17.3 52 6.6 
HUL 27.3 22 
32.5 B3 .B 
IWfl 37.7 53 
22.0 150 2.1 
SVE 59.4 64 59.4 64 
2B.2 .. 174 3.7 
III 33.3 30 
20.4 49 1.9 
' - TI ',7 . 7 1,1, 52.1 4B 16.9 1
37 4.6 
~- ... --.---- ---
ComlJj"ed 
436 936 3'~9o 
p. signifiCBnce< 10 
p. heterog. = O.OOB , 
OR 4 BER 55 . 4 7
4 7.5 53 13.6 
BOO 58 . e 17 5B.B 17 
25.0 44 4.1 
fml 5~.8 lJ 69.2 13 17.6
 74 9.6 
U511 71J.6 v , 66.7 36 31.6 57 
4.2 
KI\S 50.0 10 66.7 ' 42 15.
9 63 10.0 
KRE 51.4 37 . 21.2
 52 3.B 
HOL 59.1 22 25.3 
B3 4.1 
IWR 5B.5 53 23.3 
150 4.6 
SVE 7B.l 64 76.6 64 32.
2 174 6.7 
TII 03.3 30 26.5 
49 12.5 
VIL 3B.6 44 54.2 4B 12.0 
137 IB.7 
Combined 
436 936 6,~6 
p. significance<10- 0 
p. heterog. > .05 
i:lil 5 DER B.l 74 
1.9 53 3.3 
iJOi) 0 17 0 17 
22.7 44 .1 
BRT 7.7 13 69.2 13 
24.3 74 .7 
I B511 14.7 34 0 36 
26.3 .57 0 , 
I KAS 
16.7 IB 7.1 42 42.9 63 
.1 
I I:n[ 
5.4 J7 15.4 .. 52 .4 
i : H' t 
0 22 1O.B BJ .2 
II'. R 11. 3 53 
25.3 150 .4 
S'.[ 4.7 64 4.7 64 
6.9 ]7u .7 
TII 
VIL 4.5 44 B.3 4B 1'1.9
 1J? .6 
---
Combined 406 !lB7 
• J9 
[' . sio'1 .l ric~nc,' =7-<JO-6 
p. .,r,t crr1 · = .Or. . -_._--.. --_.---.. ---_. ---
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Table 7 continued. 
Antigen Lab. Patients, L.A. Patients, local 
Controls, loco reI. 
~ N risk 
~ N ~ N .. 
12.2 74 S.7 S3 2.1 
OR 7 BER S.9 17 2S.0 44 .3 BOO 5.9 17 36.S 74 .4 mn 7.7 13 lS.4 n .2 
2.9 34 2.8 36 
17.S S7 
IISI/ 20.6 63 .1 
KAS 0 IB 2.4 42 .3 1O.B 37 34.6 52 KRE 4.5 22 10.B B3 .5 I·IOL 
20.B 53 26.0 150 .B HYR 4.7 64 24.1 174 .2 4.7 64 SVE 3.3 30 10.2 49 .4 Tll IB.B 4B 17.1 137 1.2 VIL 18.2 44 
436 936 .51 
Ccxnbined si gnificance = 10-4 p. 
P. hcleroa. = .OZ 
Oil B III'R 
aou 0 17 0 17 
2.3 44 .B 
BRI 30.B 13 
IISH 2.9 34 2.B 3
6 5.3 S7 .7 
KIIS S.S IB 4.B 42 
4.B 63 1.2 
KRE 
HOL 4.5 
22 3.6 BJ 1.6 
IiYR 9.4 64 7.5 174 1.3 SVE· 9.4 64 3.3 3D 2.0 49 1.6 Tll 
Vll 2.3 44 0 
4B 
-. .... -
~ : . . Id IJ ~ d 
259 470 1.19 
p. sign1 ficance > .05 
p. heterog. > .05 
Table 7 continued. Special groups. 
.- Patients, L.A. Patients, local Controls, local reI. 
Antigen lab . ~ N % N .' N risk .. .- . 
OR 1 OEH IB.4 49 3l.8 44 5 
RUB/}4 25.0 ZO 19.2 2r. , 1.4 
BRA!Z4 11.8 17 10.8 37 6.5 46 1.7 
BRA/ZS 6.7 30 Z.9 35 14.3 35 .7. 
IIAI1/13 0 11 0 16 2.4 41 .B 
BRG/OZ 6.7 30 3.1 32 16.7 36 .2 
HAH/Ol 14 9.7 31 3.7 S4 Z.6 .. .. ............... ........... ............ ...... ................... •••••••• 0: •••••••••• . . ............. 
JUJ 13.0 54 12.7 55 9.6 104 1.4 
TSU 13.1 61 10.9 64 9.S 116 1.2 
SAl§ 3.4 29 10.7 792§ .4 
Combined Jap. § 145 1.08 
p. signi ficance > .05 
p. helerogen. > .05 _._--' 
OR 2 OEH 0 49 22.7 44 0 ...... I 
RUB/34 0 20 19.2 Z6 .1 I 
BRA/24 5.9 17 5.4 37 17.4 46 .3 
BRA/2S 0 30 0 35 25.7 35 0_ 
HAH/lJ 1B.2 11 lZ.5 16 Z9.3 41 .4 
BRG/02 0 30 3.1 32 30.6 36 .1 #-4' 
11A11/01 14 6.5 31 13.0 54 .5 .......... . . .. ....... .................. ........ . ......... .............. .. ... ........ . ...... 
JUJ 11.1 54 10.9 55 35.6 104 .2 oH' 
lSU 11.5 61 10.9 64 33.6 116 .3 ".". 
SAI§ 13.B 29 35.6 792 .3 ". 
Combined Jap. § 145 .27 
p. significance = 6xl0-7 
p. heterogen. > .OS 
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Table 7 contInued. Special groups. 
Antigen Lab; 
I'otlents, l.A. Patients, local Controls, locol rel. 
~ N ~ N ~ N 
risk 
OR 3 DEH 87.8 49 
34.1 44 12.7 '"' 
RUB/34 30.0 20 19.2 
26 .. LB 
n!1/1 l 711 IlL 2 17 40.5 37 13.0 46 . 
4.3 .., 
I q 1,\ .' 1'- 6(, . 1 .m 65.7 35 14 . 3 35 10.4 ..,., 
""" 1 ' 27 .J 10 25.0 16 9.8 
41 3.0 
HRG/OZ 43.3 30 37.5 32 n.9 36 
3.5 #" 
IIAH/OI IQ 41.9 3J 33.3 54 
L4 
........... ............. .................. .................. ................... ................ 
JUJ 3.7 54 3.6 55 0 104 
9.B 
lSU 0 61 0 64 1.7 116 
.4 
SAI§ 6.9 29 1.9 7
92 4.6 
Combined Jap. § 145 
3.25 
p. algni ficance = .02 
p. heterogen. > .05 
OR 4 orn 34.7 49 6.8 44 6.4 "'" 
RUO/34 BO.O 20 )4.6 26 6.8 " 
8RA/24 88.2 17 78.4 37 37.0 46 
5.9 oI"H' 
BRA/25 B3.3 30 85.7 35 20.0 35 2Ll '"' 
HAH/13 54.5 11 56.3 16 4.9 41 
20.0 ..,., 
BRG/02 40.0 30 40.6 32 5.6 36 . 
9.6 ,., 
111\1-1/01 14 35.5 31 7.4 54 6.3 
H-
............ ..... ...... . .................. .................. . .................. ................ 
JUJ 53.7 54 58.2 55 46.2 104 L6
 
lSU 78.7 61 82.8 64 47.4 116 
5.2.,.... 
SAI§ 86.2 29 40.7 792 
8.3 ",..., 
Combined Jap. § 145 p. significance = Ij~lO-B 
p. heterooen. = .Q03 
--.- --.. ----- p-~ I 
Antigen Lab. 
Patients, l.A. Patienta, local Controls, locol rcl. .. N ~ N ~ N risk .. 
OR 5 Onf 0 49 13.6 
44 .1 .. 
RUB/J4 30.0 20 19.2 26 1.8 
ORA/24 0 17 8.1 37 47.8 46 .1 
.,..,.., 
BIIA/ 25 3.3 30 11.4 35 40.0 35 .2 of' 
111\11/13 9.1 11 12.5 16 19.5 41 .7 
ORG/U2 6.7 30 3.1 32 11.1 36 .3 
HAM/Ol 14 12.9 31 20.4 54 .6 .......... .............. ................ ........... ....... . ................. . ............ 
JUJ 0 54 0 55 3.8 104 .2 
lSU 8.2 61 7.8 64 4.3 116 1.9 
SAI§ 0 29 3.4 792 .5 
Combined Jap. § 145 .97 
p. significance> .05 
p. heterogen. > .05 
OR 7 DEI~ 14.3 49 14.3 44 .1 .... , 
RUB/34 15.0 20 19.2 26 .9 
BRA/24 17.6 17 21.6 37 21.7 46 1.0 
BRA/25 6.7 30 14.3 35 17 .1 35 .8 
IIAH/lJ 9.1 11 12.5 16 19.5 41 .7 
ORG/02 23.3 30 12.5 32 11.1 36 1.1 
IIAH/Ol 14 22.6 31 14.8 54 1.7 .......... .............. ................ .................. .................. .............. 
JUJ 1.9 54 0 55 1.0 104 .6 
lSU 0 61 0 64 2.6 116 .3 
SAI§ 6.9 29 .6 792 13.0 ~ 
COIIIbined Jop. § 145 2.82 
p. signi ficence > .05 
p. heterogen. = .006 
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Table 7 continued. Special groups . 
I Antigcn . _-,-----,- - ------ reI. !'ali cnts, l.A. Patients, local Controls, local Lab. " N ~ N ~ N risk ~ 
OR 8 OEl1 2.0 49 0 44 2.8 
RUB/34 
BRA/24 5.9 17 2.7 37 4.3 1.6 .7 
BRA/25 0 30 2.9 35 2.9 3) 1.0 
HAf1/l} 9.1 11 0 16 2.4 41 .8 
. BRG/U2 3.3 30 
.. HAH/Ol 14 6.5 31 1.9 54 3.0 ........... .............. ................ .................. .................. . ............. 
JUJ 24.1 54 18.2 55 13.5 104 1.4 
lSU 27.9 61 28.8 59 8.5 116 4.3 "..,. 
SAI§ 44.B 29 16.8 792 4.0 oH 
Combined Jap. § 145 3.0 -6 
p. signi ficance = 3.hlO 
p. heterogen. > .05 
l.A. = Los Angeles, "local" = local antigen assigrvnent. 
The special ethnic groups were as follows: OEH=Bosques; RUB/34='Spanish', Puerto Rican; 
DRA/24=Ashkenazi Jews; BRA/25=Non-Ashkenazi Jews; HAH/D=Asian Indians ('lamil'); BRG/02= 
A:neric&n Blacks; HA!VOl=African Blacks (Zulu). JUJ, TSU, and SAJ = Japanese. 
Combined estimates of relative risks have been calculated for the Caucasian groups not listed 
as special. and for the three Japanese groups. One, two, and three asteriscs indicate signi-
ficance at the 5, 1, and .1 per cent level, respectively. These p-values and those for the 
combined estimates are uncorrected. 
§ No loc"l controls were received from SAJ's laboratory and so we have used Los Angeles 
controls for these data which is not strictly correct because these controls include those 
From JUJ and TSU but the error(s) arc unlikely to be lorge. 
Table 8. Relative risks for some OR phenotypes. 
Old vs (u+x) 3.4 vs (Il.X) 4 vs (O.X) }. x VB tU.X) 4.X va 
n.n. x n. II. X' 11.11. X2 11. 11 . x' n.II. 
IllR 9.6 14.11 24.5 14.5 JU.J 14.0 4.7 6.5 10.3 
UOIl 10.2 4.U 1U.4 U.5 10.4 4.7 I.J .1 
}.2 
unA- A 10.2 3.9 42 . 8 17.7 2J.8 15.2 7.3 4.1 9.3 
-Non-A 114.} 12.6 19U.6 25.2 42.5 n.8 5.4 2.3 20.0 
BRT 2.7 .6 14 . 5 8.9 10.6 ll.} 2.2 .7 11.8 
BSI! 11.4 8.6 43.0 20.7 16.0 9.9 .6 .3 .6 
C[P 10.4 4.3 IJ7.9 21. 3 56.0 12.0 12 . 9 1.0 10.0 
KAS 47.4 14.1 1027.0 }0.5 43.9 10.5 20.0 12.0 20.0 
KR( 14.1 12.1 99.7 17.1 1.2 4.0 2.0 .'} 2.7 
HOL D.} 4.7 24.6 13.0 28.} 14.5 1.1 .lI 13.2 
HYR 7.6 12.0 13.1 18.4 9.2 17.1 1.6 .6 4.1 
SV( 9.2 10.5 00.1 45.4 17.0 22.2 4.4 4.7 5.2 
Tll .0 .1 1> . 0 14.6 9.2 9,4 ],4 .1 12.0 
VIL 2~.2 12.0 14.' 19.7 20.6 10.8 ~., 6.9 6.9 
Combined rlak 10.53 )3.06 15.05 3.n 6.32 
xl 102.11 253.48 164.}8 31.20 92.54 
xf 04.7 21.91 6.55 16.71 16.32 
d. r. 13 13 13 lJ 13 
-95 6.60 21.49 10.39 2.10 4.34 
+95 '6. S'I ) 11.111. 24.10 5.07 9.20 
RUIl Span. IS . U ). L 21.U 7.0 9.0 4.5 3.9 1.4 11.2 
OEl1 123.7 25.1 328.6 23 . 4 10.6 4.1 9 . 1 9.5 10.6 
IIMI-As.lnd. 1.8 .2 38.2 9.4 20 . 0 10.7 2.3 .8 5.5 
!lAM-Mr. Bl. 1.2 .1 11.0 7.} 43.4 10.9 3.3 3.2 1.1 
BRG-Al •• 01. 14.5 7 . 9 4J.4 10.1 81.9 14.8 2.3 1.1 2.9 
ono va (O.X) 4, 8 vs (O.X) 4 vs (O+X) 8, X vs (O+X) 4, X va 
JUJ 1.0 .6 25 .1 14.9 }.5 0 . 0 1.0 .6 1.1 
TSU 9.5 7. I 13.0 10.9 5.9 14.5 6.11 4.6 4.2 
Ja". Co .. hlnod rlskl . 114 16.2 4.4' J.IU 2.0 
xi 5.57 }J.4 22.5 3.'12 0.7J 
x~ 2.11 .41 .69 1. 26 1.65 
-95 11.26 6.'0 2.39 1.01 1.41 

























xi = chi square for alQniflcance (] ·d.f.) of rel.Uvo risk differing from unity. X~ = chi l,ItL1<Jre ror hoterogeneity between 
the Indlviduol U. f. = degrees of freedom for X~. -95 and + 95 ore tho 95~ rlaks. limil.o l ur u.u combined rlak. 
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Caucasian patients, in American Black s, but not signifi· 
cantly in African Blacks or Japanese . An increase of DRW8 
in Japanese patients may slrI, <; tilllte for the increase of OR3 
in Caucasian patients. It slloulLl be pointed out, however, 
that the definitions of OR4 and ORW8 in Japanese are not 
as clear as in Caucasians. Finally, the decrease of OR2 is a 
characteristic of all populations studied. However, anum· 
ber of OR2 positive lOOM patients were observed, but 
about 75% of these were either OR3 or OR4 positive. The 
frequency of patients lack ing both 0 R3 and 4 ranged from 
2.4 to 20.8% in Caucasians, 20.0 to 30.8% in Blacks, and 
was 37.5% in Asian Indians. In Japanese, 6.9 to 21.8% of 
the patients lacked both OR4 and ORW8. The associations 
were the same in the two S f!': ( '~ 
The relative risk for some DR phenotypes (Table 8). 
'X' indicates antigens OR 1, 2, 5, 7, and ORW8, and '0' 
indicates absence of detectable 0 R antigens. The relative 
risks were calculated against the absence of OR3 and 4 in 
patients and controls. It can be seen that the 0 R3,4 pheno· 
type has the highest risk in Caucasians and OR4,ORW8 the 
highest in Japanese. However, when calculating the relative 
risks for the OR3 and OR4 phenotypes, it should be noted 
that the OR3 and OR4 phenotypes comprise both homozy· 
gotes (OR3,3 and DR4,4) and heterozygotes (DR3,O and 
OR4,O). It seems likely that the relative risks for these. 
heterozygote s are of the same order of magnitude as those 
for OR3,X and OR4,X, which are much lower than for the 
OR3 and DR4 phenotype, while the relative risks for 
the true homozygotes, DR3,3 and DR4.4, probably are 
higher. Nevertheless, when the HLA·DR genotype distribu· 
tion of propositi who had been reliably HLA·OR genotyped 
by family studies (mainly familial cases) was analyzed, the 
picture seen in Table 9 emerged. Here patients who might 
be OR3,O and DR4,O heterozygous were classified as OR3,3 
and DR4,4 homozygotes. When comparing these patient 
genotype frequencies with those expected in Caucasian 
controls on the basis of gene frequencies obtained from the 
analysis by Baur and Oanilovs it appears that the relative 
risk for the OR3,4 heterozygotes by far exceeds that for 
each of the two homozygotes. Unfortunately, significant 
testing of the relative risks in Table 9 was difficult because 
the control frequencies were obtained indirectly via gene 
frequencies. Another weakness is that the patient samples 
were obtained from different populations showing con· 
siderable variations in their associations between H LA·O R 
and IODM. 
Affected sibpairs. It can be seen from Table 10 that 
there were 134 families with at least two affected sibpairs; 
in 12 families there were more than two affected sibpairs 
and in these cases we selected the two eldest affected sibs 
Table 9. HLA·OR genotype distribution of propositi with familial lOOM
 
lOOM Controls Rclati ve 
nil r.rJln ~ y"" Number Per cent Per cent Risk
 
------- - - -- -- -
315 4 
10.7 1.2 97.9 
3/3 or 3/ 0 8 
3/ 4 46 41.1 2.6 173.6 
4/ 4 or 4/ 0 4 
9.8 1.4 76.9 
4/ 4 7 
3/X or 3/0 8 7.1 16.9 4. 6 
4/X or 4/0 29 25.9 18.5 15.4 
X/ x, r/_~, and Il / O 6 5.4 59.3 ( 1.00) 
__ - - _ _ 0 - _ _ _ _ -
l ot a l 112 
All patients who might be ORw3/3 or 4/4 homozygous have been cla
ssified 
as if they were homozygous. In contrast, the corresponding frequ
encies for 
control s invol ves onl)' homozygotes. Control genotype frequencies
 were 
" ,, ' """l ed from control gene frequencies assU!!ling Hardy-Weinberg 
equili-
brium. These gene frequencies are "averages" between European an
d North 
American values (Baur ,\, Oanilovs, this volume): p3=.llO, p4=.12
0, 
pX+po=.770. The relative risks were calculated against the genot
ypes 
not involving ORw3 or ~. 
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for analysis; In nine f!lmili :~:: o ne of the parents was also 
affected. When HLA-DR typing failed, sibpairs were classi-
fied by ABC antigens. Not ail affected sibpairs could be 
unequivocally assigned as sharing 2, 1, or 0 haplotypes, and 
the doubtful pairs were divided with weights according to 
the proportions between the unequivocal pairs sharing 2, 1, 
or 0 haplotypes. The 'adjusted total' was used in the 
analysis according to the formula of Thomsen and Bodmer 
(9). The results of th is analysis are shown in Figure 1, 
where we have also included the results of previously 
published data. There is to our knowledge no overlap 
between these published data and the Workshop material. It 
appears that the Workshop material shows almost precisely 
the same distribution between pairs sharing 2, 1, and 0 
haplotypes as that seen in the published data. In the com-
bined material, 59% share both, 37% share one, and 5% 
share no haplotypes. The abscissa of the figure is the 
frequency of the putative 'diabetes gene' while the or· 
dinate is the chi square (with 2 dt) for the goodness of fit 
between the observed distribution of the three classes 
(sharing 2, 1, and 0 ha plo types) and those expected ac-
cording to the two simple hypotheses, dominant and 
Table 10. Affected sibpalr: number of haplotypes shared (18D)* 
-
LAB. code 2 (1-2) 1 (0-1) 0 N 
BER 5 1 6 2 14
 
BRA 5 2 7 
BRG 4 2 4 1 11 
BRT 1 1 
BSH B 1 2 1 12 
CEP 4 ) 2 1 10 
OHI 1 1 2 
GUT 1 1 2 
IIMI I I 
KAS 4 ) 1 B 
KRE 5 2 I 1 10 
HOL 1 1 
HYR I 1 
RAr 5 5 6 1 17 
sur 1 1 
SVE 11 B 1 20 
T 11 ) 3 6 
\IlL 6 I 2 1 ID 
A: no ut her f i r s l 
degr ee rc l. a ffec 
ted 54 14 36 6 3 Jl3 
B: additional sib' 
affected (first 
pair included) 9 0 1 0 2 12 
C: affected 
parent(s) 5 1 2 0 1 9 
Total 6e I 
" -_._-
15 39 6 6 IS !, 
Adjusted. I totaJ 7B - 49 - 7 134 
• IBO = Identical by descent 
£ xpl a na t ion : 
Not all sibpairs could unambitiously be classified as sharing 2
, 1 or zero of 
the parental haplotypes (IBO), and thus two aubgroups for doubtf
ul cases had 
to be considered. 
At · 1 yplca example is that one of the parents carries only AI, BB, O
R) and can 
have given two indistinguishable haplotypes to the children. 
The two doubt fill 5 b J t u groups >lere a er divided with weights according to the 
proporUon~ between the definite cases sharing 2, J and zero haplotypes, th
us 
giving the "adjusted total". 
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recessive lboth with or without complete penetrance). It 
appears that the minimum X
2 for the dominant model is 
16.9 (P<O.OOl) which makes this model unlikely. The 
minimum X2=0.44 for the recessive model does not corres· 
pond to significant P values, but ifaX
2.value of 5.99 
('VP=0.05) is used, the lowest acceptable frequency of the 
'diabetes gene' is 0.234. 
A number of H LA recombinants was seen in the family 
material. However, because we were informed by one 
investigator that at least one family was included because it 
contained a recombinant child and because attempts to rule 
out extra pat ern ity (by typing for other genetic marker s) 
had generally not been done, we did not estimate the 
recombination fraction(s). 
Figure 1. Analysis of haplotype distribution of affected sibpairs. 
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\ I 
\\ I I 
\\ X.? :: O.MI I / 
/ 
\\ I / 
,~;- ... :~ ... "" 
.1 .2 .3 .'1 .5 .6 .7 .n .9 1. 
Number of shared haplotypes 2 1 0 
8th Workshop study number (I) 78 49 7 
Other data* 76 48 5 
Total (11) 154 97 12 
Percent 58.6 36.9 4.6 




(2 d.f.) for the goodness of fit between the observed distribution (58.6
, 36.9, and 4.6%) wIth those expec. 
ted to the dominant (DOM) and recessive (REC) models. 
Curves T are for the Workshop data alone and curves '11' are for all avail
able data. 
The minimum X2 for curve '11 DOM' Is 16.9 at a gene frequency of 0.
04 while the minimum X2 for '" REC' is 0.44 at a 
gene frequency of 0.30. 
*other data: Barbosa et al (19) (18 pairs), Cudworth (20) (40 pairs)
, Moller and Persson, personal communication (8 
pairs), Ryder et at (3) (28 pairs), Splelman etcit (11) (15 pairs + nonpubllshed pairs), 
Suclu.Foca et al (21) (14 pairs). 
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Finally, the segregatlons of the A 1·88 and A2·815 
haplotypes were studied: both male and female patients 
received each of these hapl .. , 1',<; f"lU~II'r' fr'~quently from 
the fathers and the mothers. III'~ lilldings of Cudworth et al 
(16) could thus not be confirmed in the Workshop study. 
Age-at-onset and HLA-DR Earlier studies {1nl havp. 
indicated that OR4 positive patients tend to have an earlier 
onset of lOOM than other patients and, accordingly, we 
analyzed the frequencies of variolls HLA-OR phenotypes 
for patients with various ages-at-onset (Table 11). Only 
Caucasian patient samples of reasonable size have been 
included. When testing the six different OR phenotypes in 
the four age·at·onset groups (0 to 10, 11 to 20, 21 to 30, 
and >30 years) in a 6x4 contingency table, highly signifi· 
cant (P<10-4) heterogeneity was found, indicating that the 
OR associations vary between the four groups. There is no 
significant difference between the two groups with onset 
before 21 years or between the two groups with onset over 
20 years, but there is significant (P<0.025) difference 
between the groups with omr t 11 to 20 and 21 to 30 years, 
respectively, and a highly significant (P<0.001) difference 
between onset less and more than 20 years. Accordingly, an 
age·at·onset about 20 years divides the entire material into 
two groups with different phenotype distributions: the 
OR3,X, OR3, and ORWX,X phenotypes show increased 
frequencies with increasing age·at-onset, whereas the 
DR3,4, OR4, and perhaps the OR4,X phenotypes decrease. 
It may be noted that the difference s between the two 
groups with onset before and after 20 years is unlikely to 
be due to a decreasing frequency of OR3,3 and OR4,4 
homo zygotes because the OR3 phenotype frequency 
actually showed an increase whereas the OR4 phenotype 
frequency did not ..:hange notably until onset after 30 
years. One criticism which may be raised against this 
analysis concerns the fact that we have had to pool differ· 
ent patient samples in order to get sufficient numbers in 
each group. This may explain some of the heterogeneity 
because the different samples were truncated differently in 
terms of age-at-onset, but it seems unlikely that this should 
explain all the heterogeneity. 
Age-at-onset and BfF 1 type. Seven laboratories (BER, 
BSH, OEM, KAS, RUB, SVE, TII) provided information on 
258 Bf typed propositi (22.5% were F 1 positive). There was 
a trend that the age·at-onset was lower for the F 1 positive 
patients than for the F 1 negatives but the difference 
was not significant. 
Month-at-onset and HLA-DR. Two laboratories (BER 
and SVE) provided informati'on about month·at·onset for 
all patients studied and Figure 2 shows the distribution of 
month·at-onset for various HLA-OR3 and 4 phenotypes. It 
appears that D R4 positive patients significantly more 
frequently had onset in the last three months of the year 
Table 11. HLA-DRW phenotype frequencies U) in four age-at-onset groups. 
Aa. at Onset :0-10 Ar:- at On!'(- t: 21-3u [,R", : 3. r J 3.4 4 4. r r. r N ['R", : J 11. 3 3.4 4 4. r I , I N 8ER 20.0 40.0 0.0 JoO.O 0.0 0.0 5 P,EI< 11.5 26.9 7.7 15.4 19.2 19.2 26 BSH 0.0 22_2 55.6 2:2.2 0.0 0.0 9 BSH 12.5 37.5 25.0 12.5 12.5 0.0 8 
"AS 24.1 6.9 48.3 6.9 10.3 3.4 29 "AS 0.0 0.0 0.0 0.0 100.0 0.0 1 He·l 0.0 14.3 28.6 35.7 14.3 7.1 14 HOl 0 MYR 0.0 12.5 12.5 50.0 25.0 0.0 8 MYR 12.5 12.5 12.5 111.8 25.0 1B.8 16 SVE 12.5 4.2 37.5 37.5 8.3 0.0 24 SVE 0 TII 0.0 3.1 43.8 18.8 18.8 15.6 32 Tll 0.0 0.0 100.0 0.0 0.0 0.0 1 VIl 0.0 11.1 33.3 11.1 38.9 5.6 18 VIl 25.0 0.0 25.0 50.0 0.0 0.0 4 
sum 7.9 9.4 38.1 23.0 15.8 5.8 139 sum 12.5 21.1, 14.3 17.9 19.6 H.3 56 
Aae at Onut:11-20 AQ. at Onset:)=31 
[.k .. " 3. I 3 3.4 4 4. I r • I N [,RII : 3. I 3 3.4 I, 4 I r N r, r BER 13.5 13.5 21.6 16.2 21.6 13.5 37 BER 0.0 33.3 16.7 33.3 16.7 0.0 6 BSH 0.0 0.0 69.2 15.4 0.0 15.4 13 BSH 0.0 25.0 25.0 25.0 0.0 25.0 4 f{AS 16.7 16.7 41.7 0.0 25.0 0.0 12 KAS 0 MOL 0.0 0.0 33.3 33.3 16.7 16.7 6 MOL 0 HYR 5.0 0.0 30.0 20.0 25.0 20.0 20 MYR 0.0 50.0 0.0 0.0 0.0 50.0 8 SVE 5.0 12.5 45.0 20.0 10.0 7.5 40 SVE 0 TII 0.0 0.0 27.3 36.4 27.3 9.1 11 TIl 
VIl 10.0 20.0 50.0 10.0 0.0 10.0 10 0 VIl 33.3 11.3 8.3 0.0 B.3 41.7 12 
sum 7.4 9.4 37.6 18.1 16.1 11.4 H9 su,. 13.3 26.7 10.0 '10.0 6.7 33.3 30 
FbI- the ~riso!t l""tJ.Iee:n suns 14x6 table): 
2 - 47.13 with 15 eLf., p _ txlO-5 X 
If the ORw)(,)( phenotype Je exclud"d from the analysis: ~ =)2.0 (p<.005) indicating that 
the overall heterogeneity ja not Bolely dve to an increa ~ of the ORw)(.)( phenotype with 
1ncreasing age-at-onset. If phenotypes involving ORw4 are excluded' xi-4 I ( ) i d' ti that th OR 3)( d DRw • -. n.s. n lca ng 
OR 4 i e ;' at) 3 hove constant freqvenciea in all four age-at-onset groups when w 11 exc uded. 
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compared to DR4 negatives. When less complete data from 
other laboratories (MOL, MYR, KAS, and VIL) were 
analyzed in a similar way, the same trend was observed, but 
it was not significant (P = 0.211. It should be noted that 
the difference seen in FiollrP. 2 may well be a chance 
deviation because many"" " " '11 .:nlllhillaliof15 of months 
can be made and, accordillyly, we only consider this ob-
servation a lead for further studies: it definitely needs 
confirmation. 
Anti-Islet cell antibodies (leA). Four laboratories 
(BER, DEM, MYR. RUB) provided information on 172 
patients investigated for ICA, usually several years after 
diagnosis. Fifty-six patients had ICA. The frequencies of 
DR3 and 4 did not differ between patients with and with-
out ICA. However. these data are probably not suited for 
testing possible differences. 
Hardy-Weinberg equilibrium in patients and controls. It 
can be shown by algebra that Hardy·Weinberg structure for 
H LA antigens may be present in a patient sample if a 
disease is recessive and if the patients are ascertained by 
their disease from a background population in Hardy-
Weinberg equilibrium with respect to H LA and the disease 
locus (3). Moreover, there should not be an excess of 
DR3,4 heterozygotes if the inheritance is intermediate 
(Ryder, unpublished data). All patients and control samples 
of reasonable sizes were tested for Hardy-Weinberg equili-
brium using the gene counting method of maximum likeli· 
hood. and it appears from Table 12 that in almost all 
samples there is a slight excess of DR3,4 (Caucasians and 
Blacks) or DR4,DRW8 (Japanese) heterozygotes among the 
patients, whereas the controls show no such excess. 
Discussion 
Th is study has confirmed earlier observations of 
association between IDDM and DR3 and 4 in Caucasians 
including Jews, Basques, and Asian Indians. Moreover, an 
association with DR4 has been demonstrated for the other 
ethnic groups studied: African and American Blacks and 
Japanese. The association between DR4 and IDDM thus 
seems to be universal. In contrast, the association with DR3 
seems only to hold for CaucaSians and Blacks whereas this 
antigen appears to be substituted by DRW8 in Japanese 
IDDM patients. A limited number of DR2 positive patients 
were observed but th is antigen still shows the strongest 
negative association with IDDM. Most DR2 positive patio 
ents were either DR3 or DR4 positive. In Caucasians, only 
about 10% of the patients carry neither DR3 nor 4. 
It appeared that the deviations seen for H LA-B?, 88, 
Figure 2. Month·at-onset for various OR phenotypes. 
















M>OC -- .. 4 -..- K><>< .. -J 
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DR phenotype 3, 4 J or 3, X 4 or 4, X X, X 
Figure 2. Month-at-onset for various OR phenotypes 
Dat~ from ~he two only complete sets of data (BER and SVE) are shown. l=January, 2=Febr
uary etc. 24% of 88 OR4. 
poslt/ve patrents and 4% of 46 DR4·negative patients had onset during 
the last three months of the year (P=O.003). 
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Table 12. Hardy-Weinberg (OR3,4) 
Patients Controls 
local assign. L.A. assign. local assign. 
lab. obs expo N obs. expo N ob~. expo N 
BER 11 13.5 74 1 1.2 53 
BOO 3 3.3 17 4 2.B 17 1 1.B 44 
BRA-Ashk.jew 10 B.O 35 5 4.5 17 2 1.3 46 
BRA-Nan-A. 17 12 . 11 33 16 11.5 30 1 .5 35 
BRG-Am.B1. 4 3.9 25 4 3.1 30 0 .2 36 
.BRT 3 2.1 13 2 1.3 13 4 1.9 74 
BSH 17 11.9 34 17 10.7 34 2 4.1 5B 
eEP 13 10.1 34 1 1.2 57 
OEl·\ 15 11.B 49 0 .6 44 
HAI1-As.Ind. 3 1.3 16 3 0.9 11 0 . 1 41 
~IAII-Afr. B1. 4 2.9 2 1.9 11 1 .7 54 
KAS 19 12.9 42 6 4.4 1B 0 1.3 63 
KRE 11 6.B 37 10 4.2 39 0 1.0 52 
MOL 6 5.3 19 7 4.0 83 
~\YR 9 7.9 53 5 4.4 150 
RAF 4 2.1 133 
RUB-Sp. 3 3.B 1 1.0 26 
RUB-Nan-Sp. - - 25 
SY[ 27 22.2 64 27 21.2 64 7 9. 6 174 
TII 10 5.0 29 4 1.4 49 
YIL 13 9.4 43 6 5.3 44 6 1.5 75 
Tota1 2Cauc. 
\187 146.~ ~ ~
X 11 .'26 11.14 1.30 
Grand2tota1 
,198 154.5/ ~ ,47 39.2.-
X. 12:25 12.70 1.26 
Sign test 16+/3-; p=.002 7+/10-; n.s. 
OR4, B Jaeanese 
JUJ 11 B.O 29 1 2.8 104 
TSU 12 8.9 61 
SAJ 9 6.D 5) (, 2 . / 116 
Tata1 2Jap •. ~ ~ 'X. 3.62 .41 
Table 13. Genetic models for lOOM 
JI[A Genes alone 
Al 01e Locus al 0..;, a11eles: 0 a 'diabetes' gene 
d = normal allele 
Genotypes: 0/0 O/d d/d 
i'enetrance : f2 fl f 0 
1) dcminant f2 = fl>O, f = 0 
0 
2) recessive f 2>o, fl = fo = 0 
3) interrrediate f 2>fl >O, fo = 0 
blthree (or nore) alleles: !!Ore o::rrplicated =de1s l<ohich 
nay involve overdcrninance, etc. 
Bl Two or noTe loci: O::Jlpllcated node1s which nay involve exnplarentation, 
epistasis, etc . 
JI[A and tbn-HLA r-enes 
AI HLA ~s nay be necessary ( a sine qua ron) 
BI fILII genes may rot be necessary in all cases 
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815, and 818 are entirely Cn'Y1I"i;]ry to deviiltions of DR2, 
3, and 4 (Table 6). 
There were rather small differences between familial 
and nonfamilial lOOM concerning OR associations - in fact, 
statistical significance was only obtained when pooling 
patients having only DR3, DR4, or both. The small magni-
tude of these differences indicates that H LA plays approxi-
mately the same role in nonfamilial as in familial lOOM. In 
both cases, H LA seems to play a major role in the predis-
position. 
Table 13 lists various ~Jl!IIClic models which may 
explain the genetics of lOOM (and of other H LA related 
disorders). The models have been listed in increasing order 
of complexity. The first three models (dominant, recessive, 
and intermediate) involve only two alleles at one locus 
within the HLA system: a 'diabetes' susceptibility allele, 0, 
and a normal allele, d. The differences between these three 
models are due to different penetrances for the three 
genotypes: DID, Old, and (l ,'d IV10dels involving three (e.g., 
, two different susceptibility genes and one normal allele) or 
, more alleles at one locus give rise to more complicated 
situations which become even worse if two or more loci are 
involved. When clarifying the genetics of a disorder it seems 
rational first to exclude the simpler models before attemp-
ting to fit the rriore complicated ones. The major problem 
with the complicated models is that they involve so many 
variables that it is possible to fit almost every model by 
changing one or more of these variables. 
The Workshop more than doubled the number of 
HLA-typed affected sibpairs available. Although the dis-
tribution of pairs sharing two, one, or no H LA haplotypes 
did not change, the increasing number made it possible to 
exclude the dominant model and provided strong indirect 
evidence against the recessive one because the minimal 
'diabetes' gene frequency compatible with the observations 
was 0.234. This would correspond to a minimum frequency 
of (0_234)2=0.055 of homozygotes in the population and, 
since the frequency of II1DM is 0.003 (17), the pe ne-
trance for these homozygotes would be only 0.003/0.055= 
0.055 or 5.5% which is much too low. Indeed, it is not 
higher than the frequency of IODM among siblings of all 
lOOM propositi (18), which it obviously should be because 
only a fraction of these sibs would be homozygous and 
susceptible. Accordingly, we think that these results are 
incompatible both with a dominant and with a recessive 
mode, which confirms earlier analyses using the same 
approach (3). However, tll'! rpr,lIlts in Figure 1 do not rule 
')ut the possibility that the 'diabetes' gene (D) may act in 
tin intermediate way with a dose effect giving higher pene-
trance for homozygotes than for heterozygotes (i.e., the 
third model in Table 13). 
The intermediate model involves certain predictions 
which may be used to test its validity. Firstly, it may be 
predicted that If heterogeneity exists within IDDM then 
th is heterogeneity should -reflect di fferences between the 
two 'diabetes' genotypes, DID and Old. Although we 
cannot determine these genotypes, it is inherent in the 
intermediate model that the 'diabetes' gene (D) must be 
positively associated with HLA·DR3 and DR4 (and nega· 
tively associated with DR2). and most DID homozygotes 
would be either DR3/3 or DR4/4 homozygous or DR3/4 
heterozygous. Accordingly, these OR genotypes may be 
used as markers for homozygosity on the postulated 
'diabetes' locus, As pointed out by W.F. 80dmer (personal 
communication). an intermediate model with a high pe ne· 
trance in homo zygotes and a low penetrance in hetero· 
zygotes would imply an overweight of homozygotes among 
familial cases and an overweight of heterozygotes among 
nonfamilial cases. Evidence that this is so can be seen from 
Table 5 which shows that there is an excess of the pheno· 
types DR3, DR4, and DR3,4 in familial cases as compared 
with nonfamilial cases. However, the excess is not striking 
and barely significant. 
A more pronounced heterogeneity was found when the 
OR phenotypes were analyzed for patients in various 
age·at·onset groups (Table 11 I. However, th is heterogeneity 
is probably not due to differences between DID homozy· 
gotes and Old heterozygotes (I.e., to a dose effect according 
to the intermediate model) because patients who had only 
DR3 or DR4 did not have earlier onset than DR3,X or 
DR4,X patients, respectively. Accordingly, we think that 
the age·at·onset heterogeneity may reflect different etiolog-
ical mechanisms for the different OR phenotypic groups. 
It is possible that the high frequency of DR3 and 4 negative 
patients in the older age·at·onset groups to some extent 
may reflect the existence of phenocopies (e.g., misclassi· 
fication of non-lOOM patients as lOOM patients) but we do 
not think that this can explain all the heterogeneity, 
mainly because the DR3 and OR3,X phenotypes show 
steady increases with increasing age·at·onset. In fact, when 
disregarding DR4 positive patients, DR3 is equally in· 
creased in all age·at·onset ,groups. It seems likely to us that 
the heterogeneity observed may be due to the possibility 
that two different HLA factors, one associated with DR3 
and one with DR4, each confers susceptibility to lOOM by 
Its own mechanism. The OR3·associated factor may exert 
its effect 'throughout life' while that associated with 
OR4 may act mainly in young individuals. The main 
reservation concerning this conclusion is that the different 
patient samples on which Table 11 was based were trun. 
cated in different ways, and we think it necessary that the 
hypothesis should be tested in a few homogeneous popula. 
tions. 
The analysis of ICA did not provide any evidence for 
heterogeneity in this material. 
Other predictions which can be made on the basis of 
the Intermediate model re.!ate to the distribution of OR 
phenotypes among the patients. Firstly, it can be shown by 
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algebra (Ryder, unpublished) that under this model there 
should be no excess of DR3,4 heterozygotes among the 
patients. It appears from Table 12 that there was a small 
but almost universal excess of D R3,4 heterozygotes. 
Secondly, it can also be shown by algebra that the inter-
mediate model should not lead to a relative risk for DR3,4 
heterozygotes which is higher than both the relative risk for 
DR3,3 homozygotes and the relative risk for DR4,4 homo-
zygotes (Svejgaard, unpublished). It appears from Table 9 
that the relative risk for DR3,4 heterozygotes is almost 
twice as high as that for the two homozygotes. However, 
both of these statements are based on the assumption that 
the patients are drawn from a background population 
which is in Hardy-Weinberg equilibrium both for DR and 
for the 'diabetes' locus. Whereas this may be true for DR it 
may not be the case for the 'd iabetes' locus because the 
fertility of IDDM patients is probably reduced. Neverthe-
less, these findings, together with the age-at-onset hetero-
geneity, make us reluctant to accept the intermediate 
model. However, before leaving all three two-allele models 
and accepting more complicated ones (Table 13), we feel 
that more HLA studies foclI sing on possible heterogeneity 
of IODM in homogenc' " I , ·"p :Jia t iulls i!re indicated be-
cause the weakness of the Uttl Workshop data is the cause 
for the possible heterogeneity between the various popula-
tions studied. 
Finally, we wish to stress that the analyses performed 
are not exhaustive because the time available was rather 
limited. 
Conclusions 
IODM is associated with DR4 in all populations studied 
(Caucasian, Black, and Japanese) and with DR3 in most 
populations. About 90% of Caucasian IDDM patients are 
either DR3 and/or DR4 positive. In Japanese, DRW8 may 
substitute for DR3. IDDM may occur in DR2 positive 
individuals, but usually only when DR3 or 4 is present, too . 
The associations observed for H LA-B8, B 15, B 18, and 
B7 are secondary to the DR associations. 
Some DR phenotYfJe associations may be stronger in 
familial than in nonfamilial IODM, but the differences are 
minor. 
The distribution of haplotype sharing (two, one, or 
none) among affected sibpairs is incompatible with a 
dominant mode of inheritance for IODM susceptibility and 
leads to an unacceptable, high gene frequency for the 
recessive model but does not rule out an intermediate 
model. 
The DR phenotype associations show significant 
heterogeneity between groups of p!ltients with different 
ages-at-onset: DR4 is mainly associated with early age-at-
onset IODM whereas DR3 is equally associated with IDDM 
at all ages. This observation argues against the intermediate 
model. 
. The relative risk for DR3,4 heterozygotes is higher 
than for DR3,3 and DR4,4 homozygotes and there is an 
excess of DR3,4 heterozygotes when the patient samples 
are tested for Hardy-Weinberg equilibrium. These obser-
vations are also incompatible with the intermediate model. 
More studies concerning possible heterogeneity of 
IODM in homogeneous populations are warranted before 
the Intermediate model may be finally disproved and before 
more complicated models are accepted. It is apparent from 
the Workshop study that the method of ascertainment 
should be very clearly defined in future studies. 
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The association between lOOM and HLA is well established although th
e Illode of 
inheritance of the disease remains far from cfear. Extensive sludies have
 been carried 
oul in European Caucasians, in Japanese and in American Blacks bUI slu
dies in other 
populalions and ethnic groups have been much less extensive. A number 
of inleresling 
facls emerged from the 8th International Workshop. 1I appeared Ihat th
e associalion 
wilh OR4 was universal, that with DR3 not so and ORw8 appeared to 
substitute in 
Japanese. The increase in frequency of the B locus alleles appeared to be
 secondary to 
those of the DR locus, but they were of interest because of their heleroge
neily. 
The 2nd AOHWS provided a unique opportunity to document the HLA a
ssociations 
with lOOM widely in the region. 
Reports of associations between NIODM and HLA have been isolated and
 in general 
have been confined to special forms of diabetes in selected populations. It
 was thoughl 
that significant data could emerge from the study of selected patienl 
groups which 
would not fulfil the crite.fia for IDDM, and thus it was decided to include
 such groups 
in the study. 
The aims of the study were: 
I. To document the association of HLA antigens and lOOM in populatio
ns wilhin the 
Asia -Oceania region. It was decided that in this workshop, Caucasian p
atienls Would 
not be studied to maximise the availability of serum for non-caucasoid st
udies. 
2. To examine the heterogeneity of the disease by careful documentatio
n of clinical 
features, age of onset and complications and the correlation of these w
ith HLA and 
other markers. 
3. To study other specially selected groups of diabetic subjects. Criteria f
or accerlance 
of patients was as follows: 






(b) NIDDM - no criteria were established except that patients studied should be 
relatively homogeneous . 
In both cases, it was requested that sufficient patients with age and sex matched 
controls be typed for the study to be self-contained. 
Clinical data were requested as outlined in the Disease Card (Table I) for patients 
with IDD~l; a further special card was generated for NIDDM. 
Results 
IDDM. No families were studied . The number of unrelated patients and controls 
typed in each laboratory is indicated in Table 2. In almost all laboratories the numbers 
studied were small and sampling error is inevitable. Despite some heterogeneity it was 
decided to pool the data from the two laboratories typing Chinese, the two laboratories 
typing Japanese and the two laboratories typing Indians and to analyse this as well as 
the data from individual laboratories. In this way, all possible associations would be 
visualised. In some cases associations were gained by pooling, in some, lost. In Tables 
3 to 7 the phenotype frequencies of all antigens showing any significant change in 
frequency in an)' patient group are shown and the corresponding Relative Risk and 
probability valucs are sh(mn in Table 7. Phcnotypic frequencies of C~ • Bf and GLO 
are shown in Table 8. Gill studies \\ill be reported else\\ here. 
Chinese. Positive associations were shown with OR3 (RR 3.5) and DR\\'9 (RR 9.3) in 
the Shanghai Chincse (CHE) with BfF in the Peking Chinese (YGE), and OR3 (RR 3.1) 
and DRw9 (RR 6.7) in the' combined Chinese. OR4 was not increased. Some of the 
observed differences between the two Chinese populations may be due to the small 
samples studied and it will be of interest to extend the observations to larger samples 
in both centres. The association of DR3 with lOOM in Peking confirms the observation 
of Maeda et al. in Taiwanese Chinese (1), and marks a distinctive difference between 
the Chinese and hp;!nnt' 1 ()[)[\.! patients. . 
Japallese. JiJ' i " ,\ ('1 e 11\' pwitil(.' associations in the Nagasaki patients (H IR) but the 
Tokyo (SAS) st1ld) showed positive associations with Aw24 (RR 8.7), B40 (RR 4), Bw54 
(RR 4.8) and with I>R4 (RR 4). In the combined Japanese, the association was sustained 
with Aw24 (RR 11.1) and delllonstrated with ORw9 (RR 2.96). 
/lIdiall.\. III the NOllh Illlii;IIIS, StlOllg positive associations were found with 13\\49 (RR 
12.7), DIU (RR I'}') alld illS , (RI{ IJ.2), an extrelllely rare allele. These findings arc 
striking and ilkntii\ a ,u,ccptiblc haplotype in this population. DR4 was also significantly 
increased in thc P;llicllts (RI{ ~.5). 
The posi\ive associations in the South African Indians were with Bw60 (RR 6.6), Cwj-
(RR 10) ana DR3 (RR 5.2). Although B8 was increased, the increase did not reach 
significant levels. There was no difference in the frequency of the B5 splits, Bw51, Bw52 
and Bu in patients and controls. This was an unexpected finding but may have been due 
10 the lack of discriminatory antisera or to the selection of subjects from predominantly 
,\ryan rather than Dravidiall stock. Hammond has previously reported significant 
associations with B8, 13\\52 and Bu in Dravidiall Indians (2). 
Thais. There were no significant associations in the Thais although both OR4 and · 
OR .... 9 were slightly increased. This small study shoutd be regarded as preliminary and 
a large sample will need to be typed before definite conclusions can be reached. 
Ataoris. IDDI\I is excessively rare in Polynesians who are prone to develop the insulin 
independent fOllll ul the disease . Nevertheless six patients were found for this study. 
Although it would be inappropriate to report antigen frequencies in this slllall sampl~ 
it is of special interest. Three of the six patients were OR3 positive, another two DR4 
positive and the sixth DR9 positive. Two of the DR3 positive individuals were also B8 
positive, and both the DR4 positive individuals were B40 positive. It is possible that 
as in the Chi~ese, "?DI\J is. associated in the Maoris with DR3, however these patient~ 
may reflect Caucasold admIxture and a larger study to clarify this will be of interest. 
Clinical SllIdics 
An attempt was made to analyse the clinical data with regard to severity and the 
occurrence of the complications of diabetes, even though numbers of patients were 
sm~1I and data often inco.rnplet~. No significant associations with ketonuria, ptoteinuria, 
retinopathy or neurological signs were found with any antigen in any popUlation. 
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Furthermore, no correlations could be found with the level of control as
 assessed by the 
allending physician. 
Age of "II"ct was analysed in all groups, and the only significant asso
ciation found 
was for IJIZ-1 alld onset below twenty year s of age in the Pc~ing Chine
se. 
Patients frol1l three laboratories VAI, HIR, CHI were sCleellcu for au
to·antibodies. 
The screen comprised the following antibodies: anti lIuclear factor, 
smooth muscle, 
striatiollal muscle, mitochondria, heart, thyroid and thyroglobulin. 
Three patients only were positive for any of these, all were North Ind
ians and their 
relevant details are as follows: 
Years of 
Al\tibody Age at Treatment 
[)ctected Titre Onset Since Diag- B8 DR3 
Ilosis 
VAI I1I Parietal 1/ 125 29 8 + + 
VAI 120 Striational 1/ 5 15 2 + + 
VAI134 Parietal 1125 13 I + + 
Islet-cell ""tilwd\ \(.> h lITre carried out on the Japanese. Indian and 
Thai paticnts 
and all \\('rc negative. 
Ma III re Onset Diabetes 
Two populations were studied, Pima Indians and Maoris. In both case
s, the disease 
was associated ""' itll obesity and inappropriate diet. It was not insulin de
pendent and age 
of onset varied. The incidence of MOO in the Maori is now known, bu
t it is extremely 
high in the Pima, reaching 69 u,'0 in women between the ages of 55 and 
64 years (3). 
There were no significant associations with any HLA antigens in the rim
a. However, 
the extremely high frequency of OR3 in both patients (80Dio) and cont
rols (70 l'jo) is of 
considerable interest and raises a number of important questions about 
the contribution 
of this antigen to the extreme propensity of the rima to devclope dia
betes. It will be 
of interest to study other North American Indian Tribes which do
 not have this 
susceptibility, for their OR status, especially those which may be 
ethnically close 
neighbours of the Pima. 
There '.1 ('I': li t) '~ i g l1iri r: aJ1t a ~ ~ociatioIlS ill the f\1aori either but ollly e
1evell patients 
were stlldi ; ·illlll dcfillilc cOIlc\u)iuns call not be reached. However it was
 of interest that 
eight of the eleven individuals were either OR3 or OR4 positive, t\
\'o of the three 
n:nlailling. lIere I)R\\Y pmitilc and onc DRI\R positive. BR and HI5 \\e
re not detected 
in any (If the patiellt .... B41) (Ill\' 60 and (1) I\ere-slightly illcreased . 
No clillical dl'tail , . I\ne supplied for either group both of which arc i
n\'olvl'd ill 011 
going '> tlldin. 
Conclusiul/s 
Although the majority of patient groups studied was too small for defini
te conclusions 
to be drawn, a Ilumber of significant or suggestive findings emerge
 which warrant 
further study. These include: 
I. The association of J[)[)M with DR3 and ORw9 in Chinese . 
2. The possible association of IDOM in Japanese with ORw9. 
3.[ hc association of Bw4Y and [)RJ and the rare allele IHS , in tlte No
rth Indians, 
and of D RJ. B\\'60 and Cw J in t he Asian [nd ians. 
4. In all ethnic groups except the Thais OR2 was decreased altho
ugh this was 
significant in only three laboratories. 
5. No associations were found for mature onset diabetes, but the very h
igh frequency 
of DrO ill the Pima and their extreme susceptibility 10 diabetes raises a
 number of 
interesting questions. 
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Table I 
PIITIENT CODING FORM ( O~') AOflWC 11 
---- -
.--.--~ 
Ql. - Ca rd numbe r 
0 2 
0 3 
Qi Typ ing laboratory 
0 5 Use 
~ '-
Ind i vidua l lP-number 






Pedigr ee numbe r 
11 IIscc r ta inme nt: proband = 1 o the r = 0 
1 2 llJDH i n fi r s t deg ree r e l a ti ves = 1 iso la t ed case = 0 I 
13 Ot he r t ypes of OM in f i r s t deqr e e r
e la ti ves = 1 no = 0 I 
Famil y 
14 lOOM in o the r r e lative yes = 1, no = 0 
I 
hi s t o ry 
1 5 I- IIge 
1 6 
at onset (ye a rs ) 
!2 I- I,'onth 
J 8 
o f onse t (0 1 = Janua r y , .. .. .... , 1 2 = Dec embe r ) 
11 ~ 'H,? l ? ht. i n ~ f-- F[ es~?n t. 
kilograms 




rr e r; ent I", l'-Jilt in ccntirncte[s 
24 -- -- --- ------- _ .. 
2S 1- _XLi.:! u
(lc_~_~~ _~.f...t..(~~_C i c!os is no = 0, ;ie s = 1 
26 
~ ()utat i t:.tn of in!=;uli n t.r e atment (yea r s ) 
27 --- -- -.----- .. --
~ I-
~ I- Pr esent ins u l i n rpqu i [ (\ n~n t (IU p r. kg. day , t wo dec ima l




33 Ty[Je of insulin ( f ill out name (s ) : 
li f--- ' 
3 5 Spcc i l':s o f i n s ulin l l-'ork = P, Beef - B, 1-1 ixcd - 1-' , Ot he r - Xl 
l§. f--
r!.. '--- Pr £'!:; c nt fa sting blood g lucose 
(mg pr. 100 ml) 
38 
39 -
!Q - Pr esent pos tprandial blood g lu
cose (mg pr. 100 ml) 
41 
!?f---
!1f- Pr esent dai l y glucose excr e tion in 
urine (g pr. 24 hours) 
44 f------.- -- - .. -.. _- - -
4 5 Kc t O l l .l~~"':~ • .l~~ ( ' S'2 n t 1 '{ 
4 6 Heti nolJa t hy presen tly 
47 Abnormal t e ndon r e fl e xe s pr esentl y No = 0, Y
e s = 1 
4 8 IDecr eased vibration s ense pr esently 
4 9 Proteinuria presently 
~~ lib IIlc (pr ese nt) 
5 1 
52 Ph;isician 's assessment o f c ontr o l 1 - good , 2 - mod e rate, 3 - poor 
21 _ 
~ .- Pr eG'2nt ser um-c rea tin





Fas ting C-pep tide l evel (p ico- mo l pr. litr e , two decimal p laces) 
S9 
342 
~0f-- I-'-'!~{I __ ..,~~"'.~ .<le t_"c tell : °1 pre~ent ~ 11 car li('[ = 21 nol inve~ti~<lteu = blank 
~ - 1" ,\ f !r :.:: t. inv e st i tj.Jted (years after dia qnosis) 
~~ 1-1--._--- - -~ f- l CA pers isted (years after diagnosis, if still present = 99 ) 
64 
6!J PCA never detected - ° IJcesent - 1 ear lier = 2, not inves t i'.l <l tcu bl<lnk -- -~f--
67 
PCA fir st investigated (years a fter d iagi,os is) 
~- peA i -lI?r s iri Led (yea rs after diagnosis , if still present = 99) 
~I-
investi'lated blank -70 /IT hA never de tected = °1 present = 11 earlier = 21 not - -
~I-
72 
AThA fi rst inVestigated (year s after diag nosis ) 
-~I- AThA persisted (ye ars after diagnosis, if still present = 99) 
74 
l?1- Other endocr ine disorders, 00 = no 05 = IIYI,el·~unadotrop ic 76 
01 = Graves' disease hypergunauism Give comments, name(s) of other 
02 Hypothyroidism 06 = lu iopa th ic "],[,0-= chronic dise ases and name, fu ll 
03 = Addison's discil se I'dratllyroiuism audrcr;s anu phone number o f the 
04 = fer nicious ana e lllia 07 = Othcr pE:'rson wh o (i l1,:d O\J t this form: 
(use reverse side) example: 13 = both Graves ' and Addison's t1isease 
Tab l e 2 
2nd AOIIWS - Diabetic Study 
Labu ra tory Ethnic Type of No . of No . of 
Group Diabetes ~ - iltienls Co ntr ols Code 
.. ~~-.------- - --. ----.-
Chen - Shang hui Chinese lOOt-I 35 53 CIIE 
Ye - Pek ing Ch in'~s e !DUM 15 15 YGY 
Sasazuki - To kyo Ja panese IDU~I 15 75 SAS 
Hirota - Nagasaki Jap<:lI\c s e IIJOH 14 36 III R 
Chiewsilp - Bangkok Thai lOON 13 20 CIII 
11 a IIImond - Durban Asian Indians lOOM 20 35 111\1-1 
Vaidya/Mehra - N. Delhi North Indians lOOM 36 40 VAI 
Woodf icld - Auckland Polynesians - ~laor i IDDH 6 \-100 
fong - We 11 i nq ton Polynesians - Maori MUD 11 79 fOI~ 
l\mos/K() ~.,,; t :/11 Durham N.A. Indians - Pima MUD 39 53 N ·lO 
343 
TatJ l c 3 
2nd 1I0 11\,S - Via tJc tic Stud y 
l\ntigen Frequ t! nc ie s 
1\ Locus - - --
Al A2 All Aw24 
Ft s Cants Pt s Conts Pt s Cants Pt s c onts 
lVVH 
YGY Chincse .067 . 067 .667 .733 .133 
.133 .133 .533 
CHE Chine se 0 .019 .516 .423 .091 .36
5 .485 .404 
Comb ined Chinese . 021 .029 .563 .493 .104 .31
3 .375 .433 
-
Sf,S J apanese 0 . 013 .400 .38 7 0 0 
. 867 .4 27 
HI ll J ilpa ne se 0 0 .142 .5 00 . 071 .111 
.786 .472 
Comb ined J apane s e 0 .009 .276 .432 . 034 .03
6 .820 .441 
CHI Thai 0 0 .4 60 .600 .460 .300 
.460 .350 
HMI II s i a n Indi ans .100 . 400 .300 .286 .250 .2 86 . 350 
.200 
VIII No r t h I nd i ans .139 .350 .444 .22 5 .0 83 .300 .2 2 2 
. 2 50 
Combined Indi a ns . 1 25 .373 .393 .253 .143 .293 .268 
.227 
I-lOO - .. 
FOi l T r ! ~ 1:0 , .• i 0 . 076 .4 55 .430 .455 .329 .5 45- .5 57 

















































































































































































































































































































































































































































































































































































































































































































































































































































































SAS Ja!:all'-? s e 
IIIR Jap anese 
Combined Japanese 
CHI Thai 
HMI Asian Indians 
VAI North Indians 
Combined Indians 
MOD -
FON Poly. Mao ei 
AHO 11 . 1\;>' . lndii'H'ls 
2nd AOIIWS - Dialietic S tudy 
Antigen Frequencies 
Cwl Cw2 
Pts Co nts Pts Cants Fts 
.133 .067 .067 0 .467 
.143 .133 .057 .033 .371 
.140 .103 .060 .029 .400 







.071 .305 0 0 .429 .583 
.241 .243 0 0 .586 .532 
.200 .182 0 0 .800 .727 
0 .057 0 0 .200 0 
0 .075 .056 .075 .111 .050 
0 .067 .036 • O ~ O .143 .027 
.455 .367 0 0 0 .127 
0 0 .125 .173 .475 .423 
~- . -. -
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HLA-A, B, C and DR antigens in young South African blacks 
with Type 1 (insulin-dependent) diabetes nlellitus 
M.A. K. Omar', M.G. Ha11ll11nnd~ and A.C.Asmal' 
'Department of Medicine, Uni\ C'i 'i l: It! "<,Ita\' Durban and ' Nntallnstitute or IlI1Illunology. l'iIl Cll)\\Il. S()ulh !\rricl 
Summary. The HLA status of South Afric<Jn black Type 1 (in-
sulin-dependent) diabetic palic nl~ with age of onset under 35 
years was compared with that of healthy black control sub-
jects. H LA-A. Band C anligens were determined in 94 pat -
ients and 995 conlrol subjecls, while DR typing was carried 
out on 56 patients and 195 control subjects. There was a signif-
icant increase in the frequency of DR4 in patients as com-
pared with control subjects (p < 0.0 1; relative risk 3.4). 
DR3 / DR4 heterozygosity was associated with a greater rela-
tive risk for developing Type 1 diahetes mellitll s (3 .7) than the 
The assocIatIon between- Type 1 (insulip-dependent) 
diabetes mellitlls and the H LA system has been docu-
mented in many studies involving different population 
groups. HLA antigens associated with Type 1 diabetes 
in White Caucasoids include CW3, CW4, 88, 815, 
DW3, DW4, DR3 and DR4 [1]. In the Japanese, the dis-
ease has been associated with HLA-DYT and 8W54 [2, 
3] while in South African Indians an association with 
B8 has been shown [4]. Other studies have shown a rela-
tionship with DR3 and DR4 in American blacks [5] and 
with either B8 or 814, which ;1\"(' cross-reacting antigens, 
in South African blacks /i,1 I1 t" thus eviden( that there 
are differences in the specilic allelic associations among 
various ethnic groups. 
There is little information on the relationship be-
tween Type 1 diabetes mellitus and antigens at the 0 lo-
cus of the HLA systems ill populatiolls other than Cau-
casoids. Therefore a group of South African blacks with 
the disease was studied to evaluate the frequencies of 
H LA-A, B, C and the recently-discovered serologically-
detected DR antigens, which appear to be controlled by 
genes located at the same locus as the H LA DW anti-
gens [7] 
Patients and methods 
All the patients and control subjects were blacks of Zulu descent. 
H LA-A, B, and C antigens were determined in 94 patients wilh Type 1 
diabetes and 995 control suhject ',. " hil'" HL!\-DR antigens were de-
presence of DRJ alone (relative risk 1.6). A significant nega-
tive association was observed between the presence of BW42 
and Type 1 diabetes in this population sample (p < 0.04: rela-
tive risk 0.3). A similar trend was observed with regard to 
DR2, the correcled p value just attaining statistical signifi-
cance (p < 0.05; relative risk 0.1). 
Key words: HLA-A, 13, C DR antigens, Type 1 diabetes, South 
African blacks, 138/ 1314, DR4, BW42, DR2, DR3/ DR4. 
termined in 56 patients with Type 1 diabetes and 195 controls. Classi-
fication of patients as having Type 1 diabetes was based on the revised 
criteria recommended by the National Diabetes Data Group and the 
WHO : all had always been dependent on insulin for control of symp-
toms and prevention of basal ketosis [8,9]. 
A total of 180 antisera were used in a two-stage microlympho-
cytotoxicity test to determine HLA-A, -B, and -C specificit ies, Lym-
phocytes were isolated on a Ficoll -Hypaque density gradient [10]. 
H LA-DR specificities were determined in an extended incubation 
microlymphocytotoxicity test, using T-cell-depleted. B-cell-enriched 
Iymphocytes. The frequency differences between the patients and 
controls were tested for significance by means of the chi-squared test 
(without Yates' correction), The resulting probabilities were multi-
plied by the number of <;pecificilies tested in order 10 determine the 
corrected value [11). 
Relative risk was calculated according to the method of WoolI' 
[12). 
Results 
At the A and C loci there was no difference in the fre-
quency of any of the antigens between patients and con-
trol subjects. The lower frequency of A30 in patients 
(23.4% versus 38.4%) was not significant after correct-
ing for the number of antigens being tested (Table 1). 
The frequency of B 14 was increased in patients as 
compared with control subjects (12.8% versus 5.2%), 
but this was not significant after correcting the {J value 
(Table 2). Similarly the frequency of B8, although in-
creased in patients (22.3% versus 12.8%), did not attain 
significance level after correction for the number of an-
350 
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Table 1. Percentage frequencies of HLA-A and -B antigens in pat-




































































































12.8 rr 2.7 



















• p uncorrected < 0.005; h p uncorrected < 0.05; c p uncorrected 
< 0.001; d p corrected < 0.04; rr= relative risk 
tigens tested (Table 1). Since HLA-B8 and -814 form 
part of a cross-reacting group of antigens, the presence 
of either of these antigens in the patients was compared 
with that in the control subjects. The difference is highly 
significant (34% versus 17.7%, p< 0.04, relative risk 2.4; 
Table 1). 
There was a lower frequency of HLA-BW42 in pat-
ients as compared with control subjects (9.6% versus 
24.8%, relative risk 0.3), the difference being significant 
even after correction for the number of antigens tested 
(Table 1). 
At the OR locus, Type 1 diabetes mellitus in the 
hlack patients was associated with a significant increase 
in the frequency of OR4 (32.1 % versus 12.3%; relative 
risk 3.4) even after correcting the p value (Table 2). The 
frequency of OR2 is lower in patients than in control 
21 
Table 2. Percentage frequencies of DR antigen in patients and control 
subjects 
HLA antigen Percentage frequency in 
Control subjects 















DR3/any other antigen 
DR3/DR blank 
DR4/any other antigen 



















42.9 rr 1.3 













"pcorrected<0.05 ; h I' corrected <0.01; rrrelative risk 
Table 3 Linkage disequilibrium between HLA-B locus antigens and 







Haplotype L\X 10-' MSE 
frequency 
XHt' 
72 51 3.4" 
48 35 2.7" 
34 21 1.7' 
34 13 0.8' 
15 - 27 1.2' 
6/SE = delta/standard error. 
a 1'<0.01; b 1'<0.05; 'notsignificant 
Diabetic patients 
Haplotype L\XIO' MSE 
frequency 
X 10' 
3.1 18 0.7' 
8 6 0.6c 
65 37 1.2' 
53 45 1.9" 
50 36 1.4' 
subjects (3.6% versus 2 t %), the difference just attaining 
a level·of statistical significance after correction for the 
number of antigens being tested (Table 2). The frequen-
cy of OR3 is only slightly higher in patients than in con-
trol subjects, there being no significant difference. 
HLA-OR3 and OR4 were found together in 8.9% of 
patients and in only 2.5% of control subjects (relative 
risk 3.7; Table 2). Thus the relative risk of 0R3/0R4 
heterozygosity was much greater than that for OR3 
alone (relative risk 1.3) but only slightly higheJ;- than that 
for OR4 alone (relative risk 3.4). 
The occurrence of specific OR antigens together 
with certain B locus antigens in the same haplotype is· 
shown in Table 3. Whereas there are significant linkage 
disequilibra between OR2 and 87 (~x 1000=35, 
p< 0.05 and between OR3 and BW42 (~x 1000= 51; 
p < 0.01) in control subjects, these phenomena are not 
seen in the patients (~x 1000= 18, p> 0.05 and 
~ x 1000=6, p> 0.05 respectively; Table3). The HLA-
0R3/B8 haplotype is present in a greater proportion of 
351 
22 
diabetic patients (6.5" ;,) Iltan conlrol sul1jects (3.4%) but 
there is no significant linkage disequilibrium in either 
group (Table 3). 
Discussion 
In white Caucasoids two distinct forms of Type 1 diabe-
tes have been recognised and these may be distinguish-
·able on the basis of HLA studies [13). There is an auto-
immune variety which is associated with OR3 and OW3 
and less strongly with HR [13). The other type hasan ear-
lier age of onset all , l ".' lIds to be associated with OR4 
and DW4, but less slrollgly with 815 and CW3 [1]. 
The present study has demonstrated a significant 
association between Type 1 diabetes in South African 
blacks and the presence of HLA-OR4. Such an associa-
tion has been observed in virtually all the ethnic groups 
studied thus far [14]: However, an association with OR3 
could not be shown among the Zulu patients here, un-
like the findings in European Caucasoids [1] and Amer-
ican blacks [5]. It is possible though that such a relation-
ship is still present but masked by the relatively small 
sample size. 
The presence of OR3/0R4 heterozygosity in South 
African blacks was associated with a much greater sus-
ceptibility to Type 1 diabetes than that associated with 
possession of OR3 alone, but in comparison with OR4 
alone, ORJ/ OR4 did not greatly increase the risk. In 
white Caucasoids, however, the relative risk associated 
with possession of both ORJ and DR4 has been found 
to be much greater than that associated with DR3 alone 
or DR4 alone [1]. Studies in white Caucasoids have es-
tablished a negative correlation between Type 1 diabe-
tes and the presence of DR2. Such a trend was also ob-
served among the South African blacks with Type 1 
diabetes, the corrected p value being significant at the 
0.05 level. In addition, there was a significant negative 
correlation with BW42 in these patients. It is difficult to 
gauge the significance of such findings at present, since 
a decreased frequcll" " Ilr;1I1 <lIllil!l'n (IS opposed to an 
increased frequ ency 1 ~ ' I" i r e s a much larger sample size 
to become evident [15J. The negative correlation be-
tween B7 and Type 1 diabetes shown in white Cauca-
soids [1] was not seen in the black patients described 
here, nor has it been ohserved in Alllerican blacks [5). 
Previously it had l1e<.'n shown that there was a close 
correlation between Type 1 diabetes in South African 
blacks of Zulu origin and the presence of either B8 or 
B 14, which are cross-reacting antigens, thus raising the 
possibility that the same susceptibility gene might be as-
sociated with either of these antigens in this population 
group [6]. The findings in this study, which was ex-
tended to involve a larger number of patients, con-
firmed such a relationship. 
The black patients with Type 1 diabetes did not 
show any increase in the frequencies ofCW3, B15, and 
B 18 as has been found in European Caucasoids, nor of 
352 
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BW54 and 812 as observed in Japanese [1 - 3). Studies in 
American blacks or Nigerians have not shown any sig-
nificant association at the B locus [15-17]. Patel et al. 
did find an increased frequency of B8 in the former, but 
the corrected p value was not significant [18], as has 
been the case with the black patients reported in this 
study. 
In a study on a small number of Nigerians with 
Type 1 diabetes none of the patients had A30, whereas it 
was present in 15% of the 226 controls [17). Such a trend 
has also been observed in this study done on patients 
who are ethnically related to Africans in the rest of Afri-
ca [19]. 
Linkage disequilibrium between antigens of the B 
locus and those of the DR locus was observed in this 
study, but the degree to which this phenomenon oc-
curred was different in control subjects and patients. 
DR2 and B7 were found together far more frequently in 
the former. However, the frequency of 87 if present 
alone does not differ much between patients and con-
trol subjects, thereby supporting the well-known con-
clusion that the relationship between Type 1 diabetes 
and the HLA system is stronger at the 0 locus than the 
B locus [1]. 
Linkage disequilibrium involving the OR3 - 88 
haplotype, which has been a constant finding in white 
Caucasoids [1], was not a significant finding in the black 
patients studied here. However, a significant association 
was seen between OR3 and BW42 in the black control 
subjects, whilst the frequency of this haplotype was 
much lower in the patients. 
AckllOlrledgemelll. This study was supported by South African Medi-
cal Resea rch Council. 
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study is short, non-invasive and inexpensive and can be repeated 
many times during the average stay in hospital. The radiation 
dose is well within the safety limits prescribed by most hospital 
radiation safety committees. Previous reports have shown a 
strong negative correlation between the degree of steatorrhoea 
measured by 4-day stool fat c811cctions and the peak excretion 
rate of breath "C02 after the lie- labelled fat test. 2 
This test made it possible to demonstrate a general significant 
improvement (2\1 times) in fat absorption after supplementation 
with B tablets of pancreatic extract (equivalent to 96000 U 
lipase). It is generally accepted that antacids and histamine-2 
blockers reduce steatorrhoea when given with pancreatic enzymes 
containing in excess of 30000 U lipase.4 The failure of such 
manipulations to increase absorption in our patients could be 
explained by the unique design of the encapsulated enzymes 
used . In addition to pancreatic enzymes, they have an outer coat 
of bromelin - a proteolytic enzyme - designed for release in the 
acid medium of the normal stomach. The enteric-coated pan-
creatic enzymes are then released into the duodenum where they 
are activated by the relatively higher pH. This would also explain 
why in the patient with achlorhydria the simultaneous admini-
stration of acid actually increased fat absorption. 
In conclusion, our findings would suggest that in order to 
optimize control of pancreatic steatorrhoea, gastric acid studies 
should always be performed initially and enteric-coated prepara-
tions should be reserved for those patients with normal or high 
secretion rates. The use of the HC fat test permits a rapid 
assessment of the adequacy of therapy. The resulting improve-
ment in fat absorption might then be expected to improve the 
depleted nutritional state of patients with chronic pancreatitis. 
We thank Mr 'C. van der Plank and the pharmacy staff at the King 
Edward VIII Hospital for assistance in preparing the labelled fat test 
meal. 
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Studies of the relationship between insulin-dependent diabetes 
mellitus (IDDM) and the HLA system have shown clear 
associations between the disea'se and certain HLA antigens . 
. High frequencies ofHLA B8, B15, BIB, Cw3, Cw4, Dw3, Dw4, 
DR3 and DR4 have been found in Whites with the disease. I 
Studies in other popUlation groups have shown an association 
with BI2 and B54 among the Japanese,z·3 and with DR3 and 
DR4 among American Blacks.4 Thus it can be seen that there are 
diffe.rences in ~he specific allelic associations among the various 
ethmc groups. 
In a previous article a strong association between IDDM and 
HLA BB among South African Indians was reported.5 The 
present study was undertaken to evaluate the relationship 
between ID.DM in Indians and HLA A, Band C antigens and 
the serologically detected OR antigen which appear to be 
controlled at the same locus as the Ow antigens.6 
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Subjects and methods 
The patients and controls were all Indians, descendants of 
Indians who migrated from the Indian subcontinent towards the 
latter half ofthe last century. They comprised North Indians of 
Aryan descent and South Indians of Dravidian descent. As far as 
could be ascertained none of them was of mixed descent. All the 
patients were diagnosed as having IDD~ on the. basis of the 
revised criteria recommended by the National Diabetes Data 
Group and the World Health Organization, i.e. they had alw~ys 
depended on insulin for 111(' ("pntro1 (lf~ymrtom~ lInd preventlon 
ofbasa1 ketosis.7,R Sixty-t'T h i I 'a l iCllts wcre tY1'cJ for HLA A, B 
and C antigens, while DR sl'cc: il"icities were determined in 35 of 
these. The frequencies of HLA A, Band C antigens in the 
patients were compared with those in a group of 760. healthy 
Indian controls, while the frequency of HLA DR antigen was 
compared with that determined in 235 healthy controls. 
A total of IBO antiscra WlIS used in a two-stage microlympho-
cytotoxicity test to determine HLA A, Band C specificities, the 
1ymphocytes being isolated on a Ficoll-Hypaque density gra-
dient .. Typing for DR specificities was performed by means of 
an extended incubation microlymphocytotoxieity test using T-
cell-depleted B-cell-enriched Iymphocytes. The differences in 
frequencies in the patients and the controls were tested for 
significance by means of the chi-squared test (without Yates' 
correction). To determine the corrected P value the resulting 
probabilitic;s were multiplied by the number of antigens tested. la 
Relative risk was calculated according to the methods of Woo If. I I 
Results 
Results are shown in Table!; I - Ill. At the A locus there is an 
increase in the frequency of Aw24 in patients compared with 
controls, even after the P value is corrected (42,6% v. 26,B%; 
corrected P < 0,04). The frequency of BB antigen is higher in 
patients than in controls (19,1% v. 6,B%), the difference being 
significant even when the P value is corrected (corrected P < 
0,04). There is no difference between patients and controls as 
regards the frequency of B7 antigen. 
As regards the D locus, there is a significant increase in the 
frequency of DR3 in patients compared with controls (31,4% v. 
12,B%; correctedP< 0,035; relative risk 3,1). The frequencies of 
TABLE I. PERCENTAGE FREQUENCY OF SELECTED HLA 
ANTIGENS IN INDIANS WITH lOOM AND IN CONTROLS 
0/0 frequency 
HLAantigen Controls Patients 















·Uncorrected P < 0,001: corrected P < 0,04. 
AA = relative risk. 














TABLE 11. PERCENTAGE FREQUENCY OF HLA OR ANTIGENS 
IN PATIENTS AND CONTROLS 
% frequency 









One antigen 63,8 
DR3/DR4 8,6 
DR3/any other antigen 20,0 
DR3/DR blank 2,9 
DR4/any other antigen 17,1 
DR4/DR blank 11,4 
·Uncorrected P < 0,05: corrected P < 0.035. 
















DR4 and DR2 in patients and controls did not differ significantly. 
However, the presence ofDR3/DR4 heterozygosity is associated 
with a much greater relative risk (7,25) than is the presence of 
DR3 alone. . 
Comparison of the two Indian subgroups, viz. North (Aryan) 
Indians and South (Dravidian) Indians, shows an increased 
frequency of HLA BB in the former (P < 0,0 I), but the corrected 
P value was not significant. The increase in the frequency of BB 
was particularly marked in the 29 North Indian patients in whom 
onset of IDDM was before the age of 30 years compared with 
controls (20,7% v. 6,1 %; uncorrected P < 0,005), the corrected P 
value falling just short of significance. The 23 Dravidians in 
whom onset ofIDDM was before the age of 20 years also showed 
an increase in the frequency of this antigen compared with 
controls (26,1% v. 7,3%), but the difference just failed to attain 
significance after correcting for the number of antigens tested 
(uncorrected P < 0,005). 
HLA DR4 was strongly associated with IDDM among the 
Aryans compared with controls (45,5% v. 9,1%; corrected P < 
0,035; relative risk B,3). There was a similar although weaker 
association with DR3 in this subgroup (45,5% v. 12,1 %; relative 
risk 6); however, the difference was not significant when 
correcting for the number of antigens tested (uncorrected P < 
0,05). Although the frequency of DR7 appeared to be lower in 
patients than in controls as regards both Aryans and Dravidians, 
the difference was not significant . . 
Discussion 
In Whites two distinct forms of IDDM have been recognized 
and these may be distinguished on the basis of HLA studies. I, '2 
There is an auto-immune variety associated with DR3 and Dw3 
. and less strongly So with BB.'2 In the other type oflDDM age of 
onset is earlier, and it tends to be associated with DR4 and Dw4 
and less strongly so with B15 and Cw3.1 
A close correlation has been shown between IDDM in South 
African Indians and the presence of HLA BB.5 This study, 
extended to involve a larger number of patients, confirmed such 
a relationship. The significant association with the presence of 
DR3 observed was not surprising in the light of recent work 
suggesting that the relationship between IDDM and HLA BB is 
secondary to the association with DR3. In Whites and American 
Blacks a relationship with DR3 has also been noted, I •• although 
355 
TABLE Ill. PERCENTAGE FREQUENCIES OF HLA OR ANTIGENS AND SELECTED A AND B ANTIGENS IN THE INDIAN SUBGROUPS 
% frequency in Aryans % frequency in Dravidians 
Patients with onset at: Patients with onset at: 
HLA antigens 




















•• P< 0.005 . 





















IFour patients and 23 controls could not be grouped. 
!Four patients and 3 controls could not be grouped. 




















Relative risk: 1 = 3.6; 2 = 5,9; 3 = 3.7; 4 = 4.5; 5 = 6.0; 6 = 8.3. 




















in the latter group a signifi "" I" ;" " :r ,, :iaLiOJl wilh BR has not been 
found. 4.13 
Population studies so far have demonstrated a close correlation 
between IDDM and the presence of HLA DR4 in virtually all 
ethnic groups,14 In contrast, such a relationship could not be 
established here if all the Indian patients studied were compared 
with controls. However, in rhe Aryan subgroup a significant 
association was seen, although the small number of patients 
studied calls for caution in reaching any definite conclusion. The 
relationship between the presence of DR3 and IDDM was also 
seen in Aryans. 
In contrast, neither DR3 nor DR4 tended to be associated 
with the disease in Dravidians. Notwithstanding the relatively 
small number of patients studied, there was a trend towards a 
much greater relative risk in patients showing DR3/DR4 
heterozygosity compared with those possessing DR4 alone or 
even DR3 alone. Such findings have been well documented in 
studies on Whites with IDDM.I The association between 
IDDM and HLA Aw24 seen in this study has notbeenobservea 
in other populations. This appears to support the concept that 
the disease is heterogeneous also in terms of HLA associations. 
A significant negative correlation between IDDM and the 
presence ofHLA B7, DR2 and DR7, which has been observed in 
Whites;·t5 was not seen in the Indian patients. Srikanta et ai.,16 
however, have observed a significant decrease in the frequency of 
B7 in North Indians of India. Moreover, South African Blacks 
with IDDM also have a lower frequency of DR2,11 
Indians with IDDM do not show increased frequencies of 
Cw3, B 15 and B 18, as has been observed in Whites, I or of Bw54 
and B12, found in Japanese.2,l Such findings serve to emphasize 
the ethnic variability in the association between IDDM and the 
HLA system. 
The demonstration of a dose correlation between ID D M and 
the presence of DR3 and B8 antigens raises questions as to the 
importance of auto-immunity in the pathogenesis of IDDM in 
Indians. In this respect the determination of islet cell and other 
antibodies could provide useful clues. Studies are in progress to 
< 35 yrs 'Controls < 20 yrs < 30 yrs < 35 yrs 
N=31 N= 491 N= 23 N= 30 N=33 
25,7 34,0 13,0 16,7 18,2 
41,9 28,7 47,8 46,7 42,4 
6,5 1,0 0,0 0,0 0,0 
16,1 14,5 17,4 16,7 18,2 
19,4*3 7,3 26,1**4 20,0 18,2 
9,7 9,6 13,0 16,7 18,2 
9,7 12,0 8,7 10,0 12,1 
22,6 19,1 17,4 20,0 21,2 
32,3 31,1 26,1 30,0 33,3 
N= 11 N= 166 N= 14 N= 18 N= 20 
0,0 2,4 0,0 0,0 0,0 
36,4 42,8 21,4 27,8 25,0 
45,5* 12,7 21,4 16,7 20,0 
45,5**8 25,3 35,7 38,9 35,0 
9,1 18,1 26,8 27,8 30,0 
18,2 11,5 14,3 16,7 15,0 
18,2 28,3 14,3 11,1 10,0 
27,3 59,0 64,3 61,1 65,0 
evaluate the presence of such antibodies and their relationship to 
HLA antigens. 
This'study was supported by the South African Medical Research 
Council. 
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HLA antigens and non-insulin-dependent 
in young South African diabetes 
Indians 
mellitus 
M. A. K. OMAR, I ,1 C~. HAMfvl0ND, M. A. SEEDAT, A. C. ASMAL 
t, " 
~', . i' . : .: 
antigens were determined in 84 
Iean' Indian patients with non-insullnl ::: 
diabetes mellitus (NIDDM) in whom aga :'.::i 
, .35 years and hi . 760 healtHY , : . ,; ',::,';-.. ,~>.~~~~~):_:~) ,';.' «; ~: " .' " .,':~ .;:;~_~f:/>:~. ~ ::;.~~>~-: 
. of Aw24. 815 and 8W6i .' 
n"tionllC! but the . 
It has recently become quite clear that the genetic mechanisms 
involved in the pathogenesis of insulin-dependent diabetes 
meIlitus(IDDM) and non-insulin dependent diabetes mellitus 
(NIDDM) are quite distinct from each other.I ,2 Therefore, 
while an association between IDDM and certain HLA agents 
has been established in numerous studies involving various 
population groups/-6 the relationship between IDDM and the 
HLA system is not clear. 
Studies confined to young Indians with IDDM have shown 
an increased frequency of HLA B8.6 This study was undertaken 
to evaluate the relationship between NIDDM in young Indians 
and the antigens of the HLA system. 
Subjects and methods 
Ei?hty-four Indians with NIDDM were studied. They com-
pnsed 40 Aryans (North Indian origin) and 41 Dravidians 
(South ~n~ian origin); 3 could not be classified as either Aryan 
or Dravldlan. The age of onset of the disease in all the patients 
Department of Medicine, University of Natal and Natal 
Institute of Immunolo~:\ , ()lIrh:lII ' 
M: A. K. OMAR, M.D .. 1'. ' . .1 '.' '. I ). ,\I .H.c. r . (Present address: Joslin 
DIabetes Center, Boston, Mass., USA) 
M. G. HAMMOND, PH-D. 
M. A. SEEDAT, M .II. (RD., M .R.C,!'. 
A. C. ASMAL, M.D., PIU)., F.C. I' . (S. A.), MKCI'. (Present address: 
Joslin Diabetes Center, Boston, Mass .• USA) 
was under 35 years. Diagnosis of diabetes mellitus and classifi-
cation as NIDDM were based on the revised criteria recom-
mended by the National Diabetes Data Group and the World 
Health Organization's Expert Committee on Diabetes 
Mellitus. 7•8 In all the patients the condition was controlled by 
means of diet (with or without oral hypoglycaemic agents) and 
they had never shown ketosis at any time. HLA A, Band C 
antigens were determined in all 84 patients and in 760 healthy 
controls. The latter included 491 Dravidians and 246 Aryans; 
23 could not be classified into these two subgroups. 
A total of 180 antisera were used in a two-stage micro-
Iymphocytotoxicity test to determine HLA A, Band C speci-
ficities, the Iymphocytes being isolated on a Ficoll-Hypaque 
density gradient.9 The differences in frequencies in the patients 
and the controls were tested for significance by means of the 
chi-squared test (without Yates' correction). The resulting 
probabilities were then multiplied by the number of antigens 
tested in order to determine the corrected P value. IO 
Results 
Results are shown in Tables I-Ill. Increased frequencies of 
HLA Aw24 and Bw61 are seen in the Indians with NIDDM. 
However, the differences were not significant when corrections 
were made for the number of antigens being tested. The 
increased frequency of BI5 in patients compared with controls 
(19,0% v. 9,1%) just fails to attain statistical significance if the 
P value is corrected (uncorrected P < 0,005). 
Among the Aryans there was a much higher frequency of 
HLA BI5 in patients than in controls (27,5% v. 7,3%), the 
difference being significant even after correcting for the number 
of antigens tested (corrected P < 0,012). No such difference 
was found between Dravidian patients and controls. Although. 
~he frequency of Bw61 was also higher in Aryan patients than 
ID Aryan controls (P < 0,05); the corrected.p value fails to 
attain statistical significance. Dravidians with NIDDM showed 
a.higher frequency of HLA Aw24 (48,8% v. 28,7%), but the 
dIfference was not significant once the P value was corrected. 
Discussion 
Studies in whites with NIDDM have so far been unable to 
establish a clear relationship between the disease and the HLA 
system. 3,II,12 In other population groups, however such an 
.. h 13-15 . ' assocIation as been shown; an IDcrease in the frequency 
of B35 has been shown in a study involving a small number of 
Xhosas with NIDDM,I} and in Pima Indians with the disease 
an ass.ociation with HLA A2 has been shown (particularly in 
those ID whom age of onset was under 35 years).14 
Among the Indians reported in this study a higher frequency 
of Bw61 was found in patients than in controls (uncorrected 
P<.0,05) .. Serjeantson et al.15 have shown the same thing in Fiji 
Indlan.s ":lth NIDDM.15 However, the findings of their study 
w~re slgmficant even after correcting for the P value, whereas 
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less, since both the "';11;11 Indians and the Fiji Indians have 
similar origins, identical IILA associations are not unexpected. 
Unlike Fiji Indians, Natal Indians do not show any linkage 
disequilibrium between Bw61 and Aw24. 
The significant relationship between HLA BI5 and NIDDM 
in North Indians is somewhat unexpected, since the same 
antigen has been associated with IDDM in whites. 3 However, 
this finding serves to highlight the heterogeneity of diabetes 
mellitus. The fact that in Pima Indians a relationship with 
NIDDM has been shown at a different 10cus13 serves to 
emphasize the heterogeneity of such associations, as has been 
shown in IDDM. 
This study was supported by the South African Medical Re-
search Council. 
REFERENCES 
I. Bamett AH, Eff C, Leslie RDG, Pykc DA. Diahetes in identical twins: a 
stud V of 200 pairs. DiabclOlogica 1981; 20: 87-93. 
2. Gotilieb MS, Soeldner JS, Kyner JL, Glcason RE. Oral glucose stimulated 
insulin release in non-diabetic twin siblings of diabetic twins. Diabetes 1974; 
23: 684-692. 
3. Christv M, Green A, Christau B tI al. Studies of the HLA system and 
insulili-dcrendcnt diahetes mellitus. Diabetes Care 1979; 2: 209-214. 
4. Rode)' GE, White N, Frazer TE, Duquesnoy RJ, SantIago JV. HLA-DR 
specificities among Black Americans with juvenile onset diahetes. N Engl] 
Med 1979; 301: 8\0-812. 
5. Hammond MG, Asmal AC, Omar MAK. HLA and insulin-dependent 
diabetes in South African Negroes. DiabelOlogica 1980; 19: 101-102. 
6. Hammond MG, Asmal AC. HLA and insulin-dependent diabetes in South 
African Indians. Tissue Antigens 1980; 15: 244. 
7. National Diabetes Data Group. Classification and diagnosis of diabetes 
mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 
1039-\057. 
8. World Health Organization Expert Committee. Report on diabetes. WHO 
Techn Rep Sa 1980; 646: 8-14. 
9. Boyum A. Separation of leucocytes from blood and bone marrow: Intro-
duction. Scand] Clin Lab Invest 1968; 21: suppl 97: 7. 
10. Svejgaard A, Jersild L, Staub-Nielsen . L, Bodmer WF. HLA antigens and 
disease: statistical and genetical considerations. Tissue Antigens 1974; 4: 
95-105. 
11. Nelson PG, Pyke DA, Cudworth AG, Wood row JC, Batchelor JR. Histo-
compatibility antigens in diabetic identical twins. Lancet 1975; ii: 193-194. 
12. Platz P, Jakobsen BK, Thomsen BS et al. No evidence of linkage between 
HLA and maturity onset type of diabetes in young people. Diabtlologica 
1982; 23: 16-18. 
13. Briggs BR, Jackson WP, Du Toit ED, Botha MC. The histocompatibility 
(HLA) antigen distribution in <;Iiabetes in Southern African Blacks (Xbosa). 
Diabetes 1980; 29: 68-71. 
14. Knowles WC, Williams RC, Butler WJ, Petit DJ, Lissc JR, Mann DL. 
HLA-A2 and type 11 diabetes. Diabetes 1981; 30: suppl 1,219. 
IS. Serjeantson SW, Ryan Dr, Ram P, Zimmet P. HLA and non insulin 
dependent diabetes in Fiji Indians. Med] AusI 1981; 1:462-463. 
P OS tpart Ul11-S terilisasies 
private praktisyn 
en die 
V. P. DE VILLlERS 
Departement VerIoskunde en Ginekologie, Universiteit van 
StelIenbosch, ParowvalIei, en Paarl-hospitaal, Paarl, KP 
V. P. DE VILLIERS, F.R.C.o.G.,Senior Lektor en Eerste Spesialis 
Die Paarl-hospitaal is lank reeds gevestig as 'n sentrum vir 
pOStpartum sterilisasies. I Vanaf 1968 is hierdie klein operasie 
deur die algemene praktisyns van die Paarl beskikbaar gestel 
aan enige vrou wat hierdie ingreep vrywillig aangevra het. Sy 
het die basiese reg om permanente chirurgiese kontrasepsie 
aan te vra om sodoende le sorg dat sy en haar gesin teen enige 
verdere ongewenste en onbeplande swangerskappe beskerm 
~ord.2 ~aa.rdevolle ondervinding in die uitvoer van die ingreep 
IS oor dIe ,are opgedoen, en verskillende basiese tegnieke is 
ondersoek. 3 • e , • 
Onlangs is 'n nuwe tegniek (die Filshie-klemaanwending) 
onJersoek met die bog op spoed van die prosedure, permanensie 
en die beste omkeerbaarheid.4.5 Die effek van buisafbinding op 
maandstondepatrone is al in 1975 deur die Paarl-hospitaal 
ondersoek en beskryf.2 
Al hierdie bevindings is onlangs deur 'ngroot multisentriese 
en meer wetenskaplik gefundeerde ondersoek bevestig.6 Sterili-
sasie veroorsaak nie maandstondeafwykings nie, maar aangesien 
elke vrou se maandstondepatroon veranderlik is, kan nie-
verwante veranderings natuurlik in die individuele geval voor-
kom. Postpartum~sterilisasies is so 'n veilige prosedure7 en het 
so 'n groot aanvraag in die Paarl geskep, dat 4704 vrouens 
teen die einde van 1983 reeds die operasie ondergaan het 
(ongeveer 20% van alIe vrouens in die Paarl verlos). As die 
p.r~sedure op 'n jong gesonde vrou uitgevoer .word, is die 
359slko van dood minimaal. 
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The HLA system and diabetes mellitus 
The HLA system, also known as the major histocompati-
bility complex, constitutes a complex group of antigens 
determined by genes located on the short arm of the 
sixth chromosome where they are closely linked with 
genes controlling various immune responses and some 
components of the complement cascade. HLA A, B, C 
and 0 antigens are determined by four different loci, 
each with a large number of alleles. The recently des-
cribed OR antigens appear to be controlled at the same 
locus as the HLA 0 antigens . I - J • 
The HLA svstem is characterized by extreme poly-
morphism at e;ch locus. At the same time pronounced 
linkage disequilibrium occurs between the various loci, 
that is, certain pairs of HLA antigens are found together 
in a population at a greater frequency than would be 
expected from multiplying their individual frequencies 
together. 
In recent years numerous studies have shown clear 
associations between the HLA systems and various 
diseases. I Although the mechanisms through which HLA 
antigens confer disease susceptibility are obscure, several 
hypotheses have been suggested: (i) through direct effects 
of the HLA antigens (e.g. interference with ligand-
receptor interaction on all cell surfaces); (ii) through 
effects of different but closely linked or functionally 
related genes in the HLA region (e.g. immune response 
genes); and (iiz) through effects of genes in linkage 
disequilibrium with HLA by pure coincidence, the HLA 
antigens here being 'inert' markers. 
After Nerup et al. 4 had produced definite evidence 
showing an increased frequency of HLA B8 and BI5 in 
patients with insulin-dependent diabetes mellitus 
(lOOM), many studies using two approaches (viz. popu-
lation studies and family studies) have provided un-
equivocal evidence of an association between lOOM 
and the HLA system. S 
The antigens associated with lOOM in white 
Caucasian populations include HLA Cw3, Cw4, B8, 
B15, B18, 03, OR3m, 04 and DR4.4.5 In addition, a 
relationship has been found with complement factors 
Bf, C4 and C2, which are determined at loci closely 
linked with the HLA complex.s HLA B7 and 02, 
however, show a negative correlation with the disease.s 
I t has now become clear that the presence of certain 
O-Iocus antigens is far more important in determining 
susceptibility to lOOM than those at other loci, and 
that the latter associations, being secondary to those 
involving the 0 - OR antigens, could be explained on 
the basis of linkage disequilibrium.4.s Thus the relation-
ships between lOOM and HLA B8 and BI5 are secon-
dary to the presence of 03 and 04 respectively. 
Similarly, the degree of negative correlation is greater 
with OR2 than with B7. 
On the oasis of the HLA studies two distinct forms of 
II)DM have oeen recognized in while Caucasoids. l 
There is an auto-immune variety, which is associated 
with Dw3 and less strongly so with BS, the presence of 
persistent islet antibodies, and an increased risk of 
micro-angiopathy. The other type which is associated 
with B I 5 and C3 appears to have an earlier age of onset 
and to show an increased antibody response to exogenous 
insulin . It shows a stronger association with Ow4, and is 
not associated with auto-immune disease or persistence 
of islet-cell antibody . 4 . ~ The presence of both B8 and 04 
is characterized by an increased relative risk and an 
increased prevalence of the disease among twins, i.e . the 
presence of both allelic groups confers an additive risk 
of developing the disease. 
Although little work has been done on non-Caucasoids, 
certain definite associations between lOOM and the 
HLA system have been established. The presence of 
OR4 or 04 appears to be a risk factor in virtually all 
ethnic groups studied so far. 7 In addition, among 
Japanese the disease has been associated with HLA 
OYT and B54, in American blacks with OR3 and 
OR4,s- ll and in South African blacks of Zulu descent 
with HLA DR4 but not with OR3.13 In neither the 
Japanese nor the black groups studied in South Africa, 
Nigeria and America has a relationship between lOOM 
and B8 been shown, although such a relationship has 
been a constant finding in white Caucasoids. 8- ls 
In South African Indians with lOOM a strong asso-
ciation with HLA B8 is shown. 16 It is thus evident that 
there are differences in the specific allelic associations 
among various ethnic groups. 
Since a decreased frequency of an antigen, as opposed 
to an increased frequency, requires a much larger sample 
size to become evident,'7 studies in non-Caucasoids so 
far have not shown any obvious negative associations 
between lOOM and HLA antigens. None the less, 
possession of HLA OR2 or Bw42 does appear to protect 
against the development of ID OM in South African 
blacks. 13 A negative correlation between the disease and 
HLA B7 has been shown in a group of Indians in 
India,!8 but not in South African Indians. 
So far almost all studies on white Caucasoids have 
shown no association between non-insulin-dependent 
diabetes mellitus (NIDDM) and the HLA system.4.5 In 
other population groups, however, such an association 
has been shown, although it is not as strong as with 
lOOM. In Fiji Indians with NIOOM a positive corre-
lation with HLA Bw6 I has been shown, as well as in 
Natal Indians in whom, however, the finding fails to 
reach statistical significance. '9 Of particular interest is 
the association between HLA BI5 and NIOOM in 
Natal Indians of North Indian origin, since this antigen 
has been associated with lOOM in white Caucasoids.20 
Other antigens that have been found to be associated 
with the disease are A2 in young Pima Indians and B35 
in a small group of Xhosas .1 1.22 Among white Caucasoids 
only a Finnish group has shown an association between 
NIOOM and HLA antigens. 23 
In conclusion, there seems little doubt that diabetes 
mcllitus is a heterogeneous entity even in terms of HLA 
associations. 
The support of the South African Medical Research Council is 
gratefully acknowledged. 
M. A. K. Omar 
M. G3Mtmmond 
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, Mo~.an, V., Snehalatha. c., Ramachandran,. A.: Jayas~ree. R .• 
and' .'isw:m:! than , M.: Pancreatic ~ta cell function In tropIcal pan· 
cl!':ntic diab<.t~.;. Metab. Clin. Exp. 1983; 32:1091-92. 
Fat Atrorhy in 
Hur:lan Insulin Therapy 
Fat .trophy i3 generally considered to be an imm~nolog.ic 
rea.;ticn to imp'Jrities contained in insulin preparatlo~. I It 
was 5"!en fairly frequently l:,efore the introduction of hIghly 
purified insulins, but in recent years the incidence seems .to 
have decreased markedly, probably due to the increased punty 
of currently available insulins. To my kno~ledge, fa~ ~trophy 
bs never previously been reported m patients recelvmg hu-
man insulin. . , A 24-yr·oId woman d~·.'f'!oreJ insulin-dependent d,a?etes 
in April 1983. She '''.' +<cqucnrly :;{aoilized. on ~ smgle 
morning injection of v.>rc ine monocomponent Insulm (6 U 
Actra~,-i insulin and 15 U Monotard insul.in, Novo, Joha.n-
nesburg, South Africa) before breakfast WIth exce!len.t dm-
bete3 c:or.lool, as evidenced by intensive self-monltormg of 
blood glucc~1:.. She subsequently married and moved to an· 
other c' ,y but ret~rned '0 see me in January 1985 when sh~ 
was experiencing prc;olem~ with staphylococcal skin. infec· 
tions. Her insulin regimen was unchanged and her dIabetes 
control remained g(lod, \\.ith a glycosylated HbA\c level of 
6.9% (normal range 5.8-8.8%). At that stage she had noted 
small areas of fat a'ro~hy on both thighs in are~ distant from 
the' skin infections. Exa'llination revealed two shdlow in· 
dentations, 1-2 cm in dia:neter, on .d··'! anterior aspect of 
both thigh!;. Sh~ was changed to the id~ntical dose of semi· 
synthetic human insulm (Novo Actrapid-:.-IM and Monotaro· 
HM). 
She returned to see me in September 1985 and reported 
that the a1eas of fat attnrh : ' ~1 enlarged. Examination showed 
a large area up to 5 cm dia:'lcter and 1 cm deep on each 
thigh. Her diabetes control had remained good, with a gly. 
cosylated HbAIc of 5.9%. She was then chang.ed to biosyn-
thetic human insuiin lHumulin.R .. nd Humulin·N, EIi Lilly, 
Id;a.1 •. polis, IN) alld has retumec.l !10me to see whether the 
area.; . i I .. t atrophy wii! contint:e to progress or start .~gres· 
sing. I am awaiting follow.up when she next visits Cape 
Town. 
This mt:st presumably be an extremely rare complication 
of:wman insulin tnt'~py, and it would be interesting to know 
whether this has been noted elsewhere. 
M. S. ROSMAN. R:P(SA) 
Address correspondel'~e to Dr. M. S. "R )snan, 28 GiIlian Pa. 
rade, West Pynble, Ne\\' SOUlh Wales 2071, Australia. 
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HLA and NIDDM 
in the Young 
In the South African Indian the presentation of diabetes 
in the young is atypical in that insulin-dependent diabetes 
mellirus (IDDM) is rare, whereas non-insulin.dependent di· 
abetes mellitus (NlDDM) in the young is common. I- J This 
syndrome of NIDDM in the young is uniformly accepted to 
Qc: a subset ofNIDDM with the strongest gene.tic compo~en~ 
and appears to segregate in an autosomal dominant fashIOn: 
In the previous studies in which the HLA status of CaucasOId 
patients with NIDDM in the young were investigated, this 
syndrome does not appear to be associated or linked to the 
HLA system. 5-a In an attempt to ascertain whether the HLA 
system was involved in a non·Caucasian population, the HLA 
antigens of four IndIan families with NIDDM in the young 
(25 members) were determined. 
Twelve patients belonged to families in which NlDDM was . 
transmitted via one parent through three successive genera· 
tions. NlDDM in the young was categorized according t') the 
following criteria: age <30 yr at diagnosis, duration of dia-
betes > 2 yr (as defined by WHO criteria9). aketonuric but 
symptomatic presentation, and prevention ot ketonuria and 
control of symptoms without insulin therapy 
HLA.A, ·B, and ·C antigens of all ;1mily melT'. b~rs were 
determined by the standard two-stage microl\'Tnpho-:vtotox • . 
icity test , IO by use of 180 local and exchan~.ed sera to define 
the specificities. HLA.DR.fntigens were dehned by [he \c'ng' 
incubation technique (Ninth International Hnl0colOpatibil-
;ty Workshop) with 120 local and exchange \era. Lymphc· 
cytes were isolated on a Ficoll·Hypaque density gradient, 11 
and T- and B-cells were sepa.-ated by means of straws con-
taining nylon wool. 11 . 
The HLA haplotypes, ages, 2·h plasma glucose levels {after 
75 goral glucose}, and body mass indices of the families are 
shown in Table I. It is evident that in none of the families 
did the diabetic state segregate with an HLA haplotype: or a 
combinatior. of haplotypes. In addition, it appears that no 
HLA type is more freq'Jent in the .diabetic than in the non· 
diabetic family members. 
In 1976. Nelson and Pyke5 stlldied 13 diabetic and 9 non· 
diabetic members of families w · t'.~ NIDDM in the young. They 
reported that the gene involved ill not linked to the HLA·B 
locus. Puring the same year Barbosa ll suggested th:lt there 
was ar, association between the HLA haplotypes A3 and 
BW15 and the hyperglycemic trait. He later confirmed this 
suggestion. 14 
Faber er al. 6 HLA-typed a family with NlDDM in the young 
for A, B, C, and 0 antigens. They demonstrated that there 
was no association between specifkHLA ar.dgens and NIDDM 
in the young, whereas Platz et al. 7 performed HLA typing for 
A, B, and C a .... tigens on 53 members of one family. They 
also concluded that there was no significant positive linkage 
of HLA type with NIDDM in the young. More recently, 
Barbosa8 stdied 10 large families with NIDDM in the young 
and found that the disorder was neither associated nor linked 
4:6 D1ABITES C. .... RE. VOL 9 NO. 4. JULY.AUGUST 1986 
362 
TABLE 1 













































































M, male . F, femal~; BMI, body mass index. 
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a A2 C- BSI OR'-
b A28 C-
c A2 Cwl 
B8 OR) 
B37 ORIO 
d Al Cw6 B57 OR7 
b Al8 Cw- B8 OR) 
c A2 Cwl B37 ORIO 
a AIB Cw- B3 OR) 
d Al Cw6 B57 OR7 
b A28 Cw- BB OR) 
c Al Cwl. B37 ORIO . 
b Al8 Cw - 88" OR) 
c A2 Cwl B37 ORIO 
a A2 Cw- BSI OR-
d Al Cw6 B57 OR7 
b A2B Ce- BB OR) 
d Al Cw6 B547 OR7. 
a Al Cw- 862 OR-
b AI Cw- ·· B57 
e MJ Cw- 861 
A- Cw- B-









c AJJ Cw- 861 
b Al Cw- 857 
c' AJJ Cw- 861 
b Al Cw- BSi 
c MJ Cw - 861 
a A2 Cw- B60 
e A- Cw- B44 
a A2 Cw- B60 
b Al Cwl B55 
a AZ Cw- B60 
A- Cw- B44 
c A24 Cw- B35 
d A- Cw- B58 























d A24 Cw- B35 OR4 
a A28 Cw- BS2 
b A31 Cw- BSI 
c Al Cw- B60 
d Al Cw- B60 
a A28 Cw- B52 
c Al Cw- B60 
b AJI Cw- B51 
c Al Cw- B60 
b A31 Cw- B5! 
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to HLA types. Thus far all [he studies were confined to Cau-
cllsoid patients. In an attempt to determine whether a similar 
situation per.,:.,ed in a non·Caucasoid population, we studied 
a migrant AsiL. group. In our study, a further ~ntigen HLA-
DR was also .r.c.dsured. Similar findings were observed in this 
group of Indian patierts. It thus appears that with respect to 
HLA status, NIDDNi in the young in Indians is in no way 
dif(erent,ro.ii ttn.t which manifests itself in Caucasoids. 
C NAllXXJ. MBChB 
I.JlALAL. MD 
M. G. HAMMOND. I'ttD 
M. A. K. OMAR, MD 
S. M. JOUBERT. FRC(Path) 
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Multiple Herpetic Whitlows 
in a Child Performing 
Self .. Monitoring of 
Blood Glucose 
Self-monitoring of blood glucose (SMBG) has become the 
recommended tool for management of type I diabetes. In our 
diabetes clinic we have noted no bacterial infections of any 
significance in the 400 patients using this procedure 2-4 times 
daily over a period of 4 yr. Ryan et al.l described two cases 
of digital sepsis with osteomyelitis and gangrene eventually 
requiring amrutation in immunocompromised hosts undergo. 
ing dialysis or renal transplantation. Knezevic and Mastaslia1 
reported a similar case. This commWlication concerns a proven 
case of multiple digital herpes simplex whitlows in a boy 
performing 5MBG on a regular basis for 3 yr. 
j.F., a 9-yr-old boy requiring insulin since the age of 20 
mo and also mildly asthmatic, developed painful erythema-
tous, indurated, and vesicular lesions on the tips of the middle 
three fingers of each hand (Figure 1~. There was moderate 
bilateral enlargement of the epitroclear and axillary lymph 
nodes. general malaise, anorexia, and low-grade fever. A 
crusted herpetic lesion was noted on the lower lip and the 
patient had a history of recurrent labial herpes for 1 yr before 
this event. On admission the child's blood glucose was 416 
mg/dl and he required intensified insulin treatment. There 
was no \(etosis or acidosis. 
TABLE I 
Immunologic inve.lTigarions on parient and mother 
Tem Patient Mother Nonnal range 
IgG (mg/dl) 1225 1400 700-1600 
IgM (mg/d\) 105 74 36-260 
IgA (mg/dl) 295 155 46-490 
IgD (mg/dl) C~6 1.0 0-41 
IgE (U/ml) 800 65 0.3-215 
CJ (mg/cil) \35 . 129 88-m 
C4 (mr,/dl) 25.5 36 13-72 
CH50 classic (U/m\) 141 158 90-160 
CH50 alrernative (U/ml) 17 27 13-30 
Rheumatoid factor Positive Negative Necative 
Antinuclear antibody Negative Negative Negative 
E rosettes (%) 78 81 65-88 
OKT3 (%) 6',' 64 51-87 
OKT4 (%) 38 28 15-52 
OKT8 (%) 21 14 13-44 
B cells (%) 16 12 6-14 
PHA =ponse (cpm) 184.2]3 171,766 >150.000 
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HLA Class I and 11 Antigens in South 
African Indians With NIDDM 
MAHOMED A.K. OMAR, MICHAEL G. HAMMOND, AYESHA A. MOTALA, AND MAHOMED A. SEEDAT 
The relatIonship between the HLA system and non-
Insulin-dependent diabetes mellltus (NIDOM) In South 
African Indians, a migrant Indian group, was evaluated 
by testing HLA-A, -B, and -C antigens In 184 patients 
and 1444 control subjects and HLA-OR antigens in 
104 patients and 330 control subjects. There was a 
significant Increase in the frequency of HLA-Bw61 In 
patients compared with control subjects (27.7 vs. 18%, 
P = .00155), although the degree of association was 
not very strong (relative risk 1.7). A similar association 
has been noted in Fiji Indians, another migrant Indian 
group. However, no relationship could be established 
at the OR locus. It i~ suggested that the relatively high 
frequency of the Bwfi 1 allele in South African Indians 
could, in the presence of some environmental factor 
like obesity, confer increased susceptibility to NIOOM. 
Diabetes 37:796-99, 1988 
South African Indians, like other migrant Indian groups, show a high prevalence of non-insulin-dependent diabetes mellitus (NIDDM) (1) . On the basis of studies showing a high concordance rate 
of the disease in identical twins, there is little doubt that 
genetic factors play a role in the pathogenesis of the disease, 
although the precise mechanism remains obscure (2) . Pre-
vious studies have highlighted the paucity of any relationship 
between NIDDM and the HLA system of antigens among 
Caucasians (3-6). Data based on the detection of only HLA 
class I antigens (HLA-A, -B, and -C) have shown some as-
sociations in young Pima Indians, Chinese, certain Pacific 
population groups, young South African Indians of northern 
Indian origin, and South African Blacks of Xhosa descent 
From the Department of Medicine, University of Natal, and the Natal Institute 
of tmmunology, Natat, South Africa. 
Address correspondence and reprint requests to Professor MAK. Omar, 
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(6-13) . HLA-Bw61 has been shown to be associated with 
the disease in a small study involving Fiji Indians, another . 
migrant Indian group, but no relationship has been estab-
lished at the HLA-DR locus (9). Apart from this and a small 
family study showing no association between NIDDM of the 
young in Indians and HLA class 11 (HLA-DR) antigens (14), 
data on any possible association between classic NIDDM 
and HLA class 11 antigens in non-Caucasian populations are 
virtually nonexistent. Our study was therefore undertaken to 
evaluate the relationship between NIDDM and HLA class I 
and 11 antigens in a I~rge group of South African Indians with 
NIDDM. . 
PATIENTS AND METHODS 
One hundred eighty-four unrelated subjects with NIDDM, 
diagnosed and classified on the basis of the revised World 
Health Organization diagnostic criteria, were selected for the 
study (15). They were patients attending the Diabetes Clinic 
of King Edward VIII Hospital, which is a teaching hospital 
attached to the University of Natal Medical School. The mean 
age at diagnosis was 48 ± 10 yr (SO) with a range of 35-
70 yr, and the mean duration of disease was 10 ± 6 yr with 
a range of 2-30 yr. None of the patients had ever had ketosis, 
and their diabetes had been controlled by diet alone or by 
diet and oral hypoglycemic agents for 2=2 yr. They did not 
have malnutrition-related diabetes, which is extremely rare 
in this population group (16). In addition, 1444 healthy con-
trol subjects with no history of diabetes mellitus were studied, 
none being a first- or second-degree relative of other control 
subjects or of the patients studied. Because the control sub-
jects did not undergo a glucose tolerance test, it is possible 
that the odd case of asymptomatic diabetes was missed in 
this group. However, because virtually all HLA studies have 
similar control data, our control group should be a reason-
able basis for comparison. 
The sex distribution of the diabetic subjects was 149 
women and 35 men and that of the control subjects was 626 
women and 818 men. Thus, owing to the relatively small 
number of diabetic men, it would be difficult to evaluate any 
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TABLE 1 
Frequency of HLA-OR (class 11) antigens and genes in South 
African tndians 
- -- "- - -
Control subj'x!s Patients 
(n = 330) (n = 104) 
Antigen Antigen 
frequency Gene frequency Gene 
Antigen (%) frequency (%) frequency 
ORl 5.2 0.0263 8.7 0.0444 
OR2 39.7 0.2234 48.1 0.2795 
OR3 13.0 0.0672 11 .5 0.0592 
OR4 20.6 0{)189 24.0 0.1282 
OR5 16.1 0.0840 14.4 00747 
ORw6 14.2 00737 18.3 0.0961 
OR7 28.2 0.1526 221 0.1173 
ORw8 2.4 0.0120 7.7 00392 
ORw9 0.6 0.0030 1.0 0.0050 
ORwl0 8.8 0.0450 11.5 0.0592 
One antigen 50.9 0.2034 32.7 0.0966 
sex-dependent differences in HLA distribution among the 
patients. The reason for the fema le predominance among 
the diabetic subjects may lie in women being more likely 
than men to seek medical attention for the disease. This 
reason notwithstanding, however, previous epidemiological 
studies involving this population group have established a 
higher prevalence rate of NIDDM in women (1,16). 
The Indians in Natal are descendants of migrant Indians 
who emigrated from India between 1860 and 1911 . All were 
born in Natal and represent third , fourth , and fifth genera-
tions. They can be divided into two major groups, Dravidians 
from southern India and Aryans from northern India (17). The 
Dravidian Indians in Natal are mainly Tamil and Telugu 
speaking. The Aryan Indians are more conveniently divided 
by religion into Hindus from the northeast and Muslims from 
the northwest. The Hindus in Natal are mainly Hindi speaking, 
although there are a few Gujarati speakers. The Muslims 
speak mainly Urdu, but there are also Gujarati speakers (17). 
There has been virtually no intermarriage between the In-
dians and other ethnic groups in South Africa because of 
the Group Areas Act (an apartheid legislation) . 
The control group comprised randomly selected staff and 
blood donors, many of who had been typed for International 
Histocompatibility Testing Workshops. Both the patient and 
control groups had similar socioeconomic backgrounds. 
The HLA class I antigens were determined in all patients 
and control subjects by a two-stage Iymphocytotoxicity test 
(18) with 180 antisera. They consisted of local sera that have 
been requested for use in International Histocompatibility 
Testing Workshops, local sera that have been verified with 
International Workshop sera , and sera that have been ex-
changed with other laboratories worldwide. Similarly. 120 
sera helped to define the class II antigens on B-Iymphocyte 
enriched Iymphocyte suspensions prepared with the aid of 
straws packed with nylon wool (19) . The class 11 antigens 
were determined in 104 patients and 330 control subjects 
(Table 1). 
The definition of Bw60 with operationally monospecific 
antisera is clear, but the definition of Bw61 depends on the 
difference in reaction patterns between the broad antigen 
B40 and Bw60 (20,21). This means that it is not possible to 
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detect Bw61 in the presence of Bw60, and, therefore, -3% 
of the patients with both 8060 and Bw61 were counted as 
having 8w60 and a "blank." Thus, the frequency of 8w61 
was underestimated by -3% in the patients and by -2% in 
the control subjects. However, the antigen frequencies in 
Table 2 have not been modified because there are many 
other cross-reacting groups where antigens may be "hid-
den," e.g., Al0, B5, B15, and further corrections would have 
been necessary to allow for homozygosity. 
Differences in HLA frequencies were tested for signifi-
TABLE 2 
Frequency of HLA class I antigens and genes in South 
African Indians 
Control subjects Patients 
(n = 1444) (n = 184) 
Antigen Antigen 
frequency Gene frequency Gene 
Antigen (%) frequency (%) frequency 
Al 28.7 0.1556 20.7 0.1094 
A2 31 .5 0.1723 35.3 0.1956 
A3 12.7 0.0656 14.1 0.0731 
All 27.8 0.1502 25.5 01368 
A23 1.3 0.0065 0 0 
A24 28.7 0.1556 35.3 0.1956 
A25 1.7 0.0085 1.6 0.0080 
A26 6.6 0.0335 4.4 0.0222 
A28 12.8 0.0661 11 .6 0.0587 
A29 1.2 0.0060 1.6 0.0080 
A30 3.2 0.0161 2.7 0.0135 
A31 3.5 0.0176 8.2" 0.0418 
A32 4.4 0.0222 3.3 0.0166 
A33 14.3 0.0742 15.2 0.0791 
Aw36 0.3 0.0015 0 0 
One antigen 21.3 0.0478 20.7 0.0409 
B7 13.2 0.0683 16.3 0.0851 
B8 6.2 0.0314 10.3 0.0528 
B13 7.1 0.0361 6.0 0.0304 
B14 0.5 0.0025 0 0 
B15 10.1 0.0518 11.4 0.0587 
B16 3.5 0.0176 3.8 0.0191 
817 '21.3 01128 12.0 0.0619 
B18 3.8 0.0191 3.8 0.0191 
B21 3.4 0.0171 3.8 0.0191 
Bw22 4.3 0.0217 3.3 0.0166 
B27 2.1 0.0105 3.8 0.0191 
B35 20.9 . 0.1106 20.1 0.1061 
B37 5.9 0.0299 3.8 0.0191 
Bw41 0.3 0.0015 0 0 
Bw47 0.2 0.0010 1.1 0.0055 
Bw42 0 0 0 0 
B44 12.7 0.0656 120 0.0619 
B45 0.3 0.0015 0 0 
851 16.7 0.0873 19.6 01033 
Bw52 139 0.0720 12.5 0.0645 
Bw53 0.8 0":0040 0.5 0.0025 
B51 3.5 0'.0176 2.7 0.0135 
8w60 11.5 0.0592 10.9 0.0566 
Bw61t 18.0 0.0944 27.7t 0.1497 
Bw70 3.3 0.0166 1.6 0.0080 
One antigen 16.8 0.0488 13.0 0.0269 
Cwl 5.7 0.0290 7.6 0.1087 
Cw2 3.8 0.0192 1.6 0.0080 
Cw3 11.4 0.0587 10.3 0.0529 
Cw4 15.7 0.0818 228 0.1214 
Cw5 1.4 00070 1.6 0.0080 
"P = ,0022, uncorrected; P = .0954, corrected; relative risk 2.5, 
tP = .0016, uncorrected; P = .0689, corrected; relative risk 1.8. 
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cance with the xl-test (without Yates' correction), and the 
probability was corrected by multiplying the P value by the 
number of comparisons made, i.e., the number of different 
antigen tests (22). When an antigen was shown to be as-
sociated with NIDDM in a population group elsewhere, an 
uncorrected P value < .01 was considered significant 
798 
(22,23). Relative risk was calculated according to the formula 
recommended by Woolf (24). 
RESULTS 
The frequencies of various HLA antigens in patients and 
control subjects are shown in Tables 1 and 2. At the A, C, 
and DR loci there were no significant differences in the fre-
quency of any of the antigens between patients and control 
subjects. There was a significant increase in the frequency 
of Bw61 in patients compared with control subjects (27.7 vs. 
18%, P = .00167). Despite the fact that the corrected P 
value fell short of statistical significance (P = .0689), the 
difference remains significant, due to a prior hypothesis, 
because the same antigen has been shown to be associated 
with NIDDM in another migrant Indian group (12,23). 
Although increased frequencies of HLA-A31 and -Cw4 
were seen in the patients compared with control subjects, 
the differences were not significant when the P value was 
corrected. 
There were no significant differences in the frequencies 
of any of the HLA antigens between control subjects <35 yr 
and those >35 yr (Table 3). 
DISCUSSION 
Although a relationship between insulin-dependent diabetes 
mellitus (IDDM) and the HLA system of antigens has been 
clearly established. their association with NIDDM remains 
controversial (3,6.25). Caucasians show an inconsistent re-
lationship at the class I locus of genes (6). Pooled data from 
several independent studies have shown a significant as-
sociation with HLA-B8, and a study in Scandinavia has es-
tablished a relationship at the Cw4 locus (6.26) . South Af-
rican Indians. however, show a significant increase in the 
frequency of HLA-Bw61. This finding is of particular interest 
in light of a previous study showing an association between 
the same antigen and NIDDM in Fijian Indians (10), another 
migrant population group with the same origin as South Af-
rican Indians, Le., India. The uncorrected P value in the 
latter study (P = .01) was much higher than that in this 
study (P = .0015). In contrast, the relative risk in the Fijian 
study was higher (4.8), possibly because of the relatively 
lower frequency of HLA-Bw61 (9%) in the control group and 
the smaller number of patients (n == 58) and control subjects 
(n = 47) studied. Young South African Indians with NIDDM 
have also been found to show a somewhat weak relationship 
at the Bw61 locus (11). 
The frequency of HLA-Bw61 is much higher among Indi-
ans originating from the Indian subcontinent compared with 
Caucasians or Blacks (27). In fact, it is virtually nonexistent 
among Black population groups (27). Thus, it is tempting to 
speculate that the high prevalence of diabetes in South Af-
rican Indians compared with other population groups is due 
to the increased frequency of this antigen. Yet, Indians f(Q.m 
southern India and northern India, in whom the frequencies 
of Bw61 are as high as 16% and 15%, respectively (27), 
show much lower prevalence rates of NIDDM (28,29), 
thereby seemingly negating such a hypothesis. However, it 
is possible that in the presence of an environmental factor, 
e.g., obesity, which appears to be a risk factor for diabetes 
among South African Indians (1), HLA-Bw61 confers in-
DIABETES, VOL. 37. JUNE 1988 
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creased susceptibility to the disease. at least in a proportion 
of subjects. 
Like lOOM, NIOOM also seems to be characterized by 
differences in the specific allelic associations among the 
various ethnic groups. Thus, South African Indians with 
NIOOM do not show an increased frequency of A2 as seen 
in Pima Indians (7), of 654 as seen in the Chinese (8), of 
622 as seen in Micronesians and Polynesians (9,29), or of 
6w62 (615) as seen in Papuans (New Guinea; 13) In ad-
dition, no relationship could be established with HLA-6w41, 
which shows a weak association with NIOOM in South African 
Xhosas (12) . At the C locus, there was a weak association 
with HLA-Cw4 (P .013, uncorrected; P .598, corrected), 
which shows a strong relationship with NIOOM in Scandi-
navians (26; P .002, corrected) In regard to the age distri-
bution of the control subjects, only 26% were >35 yr of age, 
when the mean age of the diabetic subjects was 48 yr. 
Hence, based on the observation that the prevalence of 
diabetes increases with age, it is quite possible that further 
significant associations (e.g .. HLA-A31) would have mani-
fested themselves had there been a larger number of older 
control subjects. Despite these limitations, there appeared 
to be no significant differences between the HLA distribution 
of control subjects >35 yr and those <35 yr of age. 
In most population groups studied thus far, lOOM shows 
a stronger association with the class 11 antigens than with 
the class I antigens (3,6,25) . South African Indians with 
NIOOM, however, do not show such a tendency, because 
no relationship could be established with any of the HLA 
class 11 antigens. Caucasians with the disease also do not 
show any consistent relationship involving HLA class 11 an-
tigens (6). In regard to other population groups, i.e., Me-
lanesians, Polynesians, Papuans, Pima Indians, and Indians 
from India, published data on the relationship between 
NIOOM and HLA class 11 antigens are not available. 
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Rheumatoid arthritis (RA) patien
ts present with a 
variety of syndromes. There are m
arked differences in the 
severity of the arthritis and in th
e prominence of other 
features such as episcleritis, vascu
litis, peripheral neuro-
pathy, pulmonary disease, hyper
splenism, and nodule 
formation. A minority of patients
 with typical adult RA 
can be distinguished because they d
o not make rheumatoid 
factor (RF). In children the disease 
takes three main forms : 
(a) systemic onset with fever; (
bl polyarticular onset, 
sometimes associated with rheumat
oid factor and nodules; 
and (c) pauciarticular onset. 
In previous studies (1-6) includin
g that of the 7th 
International Histocompatibility W
orkshop (71. HLA-DW4 
and DR4 were found to be increase
d in adult RA in Cauca-
sians having erosive arthritis by X-r
ay and with positive R F 
tests. This increase was not obs
erved in patients with 
Table 1. HLA-OR antigens in unrela
ted adult RA patients. 
Group Number 
Antigen Frequency (t) 
Studied Subjec ts ORI OR2 
OR3 OR4 OR5 OR'll6 OR7 
Oml8 
Caucasians 
Control 662 17.4 24 .9 2
1.0 24 . 9 19.2 6.3 22.4 
6.8 
RA 329 20.1 13.4**- 1
6 .. I 47.4'" 7.3'" 2.4* 14 . 3** 
3.7 
Japanese 
Control 792 10.7 35.6 
1.9 40 . 7 3.4 9.5 0.6 
16 .8 
RA 104 15.4 24.0' 0.
0 62.5'" 4.8 8.7 0.0 
21.4 
Negroes 
Control 193 10.9 35.2 29
.5 9.8 26 . 4 12.4 19 . 7 
20 . 2 
RA 56 17 . 9 28.6 16.1 3
5.7'" 10. 7' 0.0' 21.4 1
6.1 
, = P <0.05, .. = p <0.01. ... = p <0 . 00
1 
Table 2. HLA-OR antigens In unrela
ted adult RA patients of other ethni
c groups. 
Subjects E thn i c Number 
Antigen Frequency (X) 
StudIed Group I Subjects ORI OR2 
OR3 OR4 OR5 OR'W6 OR7 ORWS 
Hungarian 
Control 22 66 9. 1 53.1 34.
8 . 10. 6 10.6 4.5 9.1 19.7 
RA 41 22 .0 17.1'" 24.4 39.
0'" 14.6 4.9 12.9 0.0 
latlnoamerlcan 
Control M.V 19 10 .5 36.8 26.3 5.3 
26.3 0.0 42. I 21. I 
RA 41 10.0 22.5 22.5 57.5
"· 15.0 5.0 22.5 10.0 
Jewish 
Control 24 38 2.6 13.2 10.5 31.6
 42 . I 15.8 31.6 5.3 
RA 25 24 .0' 20.0 0.0 48.0 
32.0 0.0 36.0 
Control 25 22 13 .6 22.7 9.1 22.
7 45 . 5 9. 1 22 . 7 4.5 
RA 15 26 . 7 46.7 20.0 26.7 20.0
 6.7 13.3 
Asian Indian 
Control 13 10 20.0 50.0 0.0 10.0 0.0 0
.0 20.0 10.0 
RA 17 0.0 70. 6 5.9 23.5 23.5 0.0
 23.5 5'. 9 
I 22 = Hungarian; M.V = Mexican and V
enezuelan; 
Asian Indian 
24 = Ashkenazl; 25 = Non-Ashkenazf; 13" 
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juvenile rheumatoid arthritis (JRAl.(8). 
For the present study patients were classified using the 
criteria of the American Rheumatism Association for adult 
RA (9) and those of the JRA criteria subcommittee (10) 
for children with arthritis. Detailed clinical information was 
collected on all patients submitted to the study. The final 
diagnostic classification was performed by computer 
on the basis of objective criteria and verified by the partici-
pating clinicians_ Data on R F included information about 
number of tests on record, time between first and last test, 
consistency of results, and average titer. Adult patients with 
negative R F tests were required to have been tested at least 
twice and to meet criteria for classification as either defi-
nite or classical adult RA. 
Unrelated Adult RA. As in previous studies small 
deviations were observed in the frequencies of some H LA-
A,B, and C antigens in patients with adult AA. The impor-
tant differences were in the antigens of the HLA-DR series. 
No data on HLA-D typing was submitted. In the major 
population groups (Table 1) the highly significant increase 
of H LA-DR4 was uniformly present. Several antigens were 
decreased including DR2, DR5, DAW6, and OR7_ Similar 
changes, with a major increase of DR4, were also observed 
in the Hungarian population and in Latinoamericans typed 
in Mexico and Venezuela (Table 2). The remaining three 
populations in Table 2, did not show an increase in DA4. 
There were no significant differences in antigen fre-
quencies when the patients were separated by sex (Table 3) 
or age of onset of disease (Table 4) . 
To evaluate. the possibility of a relationship between 
HLA-DR antigens and severity of AA, three approaches 
were takEm. Clinical activity was evaluated on the basis of 
morning stiffness, joint pain, joint tenderness and joint 
swell ing (11), the most severe · functional grade was deter-
mined according to Steinbrocker and coworkers (12). and 
the relative rate of progression was scored by the clinicians 
as slow, moderate, or rapid. Data obtained by the last 
method are shown in Table 5. There was no evidence from 
any of these analyses of a correlation between severity of 
disease and the HLA-DR antigens in patients with definite 
or classical adult AA. The absence of correlation between 
severity of disease and presence of OR4 may depend in part 
on the selection of a patient population having only defi-
nite or classical RA and has been observed previously in 
such groups (13,14). 
The majority of adult RA patients had positive tests 
for A F. In addition, 46 A F negative Caucasian patients 
were accepted in the study according to criteria given 
above. Interestingly, the frequency of DA4 in this group of 
definite or classical RA without AF was no different from 
that of controls (Table 6). To further examine the rela-
tionship between AF and HLA, the RF positive group was 
subdivided according to AF titer. Patients with high titer 
AF had a higher frequency of DA4 than those with low 
titer (Table 6) . 
Thus, it appears that seropositive and seronegative RA 
are separate diseases with different immunogenetic factors. 
These findings confirm earl ier reports by Jaraquemada and 
coworkers (15) and Dobloug and coworkers (16) who 
observed correlation between presence of RF and DR4. In 
view of the data suggesting correlation between DR4 and 
titer of A F, the possibility of an effect of DA4 on the 
immune response to autologous IgG should be considered. 
However, it is known .that most normal individuals can 
make both IgM and IgG R F if properly challenged (17) and 
DW4 was not increased in patients having RF due to 
conditions other than AA (18). 
Groups of patients having extraarticular manifestations 
of RA were small, with the exception of those with subcu- ' 
taneous nodules (Table 7). When the HLA-DR antigens 
Table 3. HLA-DR antigens In RA patients In relation to sex. 
Subset Number Antigen frequency (t) 





























44 05 05 16 06 
46 09 02 15 03 
80 ID ID 00 30 
58 04 08 00 19 
11 17 00 11 33 
39 10 00 22 14 
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Table 4. HLA-OR antigens In RA p
atients in relation to age at onset o
f disease. 
Age at Number 
Antigen Frequency (%) 
Onset Subjects ORI OR2 
OR3 OR4 OR5 ORw6 OR7 ORwB 
Caucasians 
17- 39 yrs 92 IB 15 13
 41 11 02 16 04 
>40 yrs 202 22 14 
15 47 06 03 15 04 
Japanese 
17- 39 yrs 39 05 26 
00 64 05 10 00 \3 
>40 yrs 65 22' 23 
00 62 05 OB 00 27 
Uegroes 
\7-39 yrs 23 13 30 
17 39 13 00 35 \3 
>40 yrs 33 21 27 
15 33 09 00 12 IB 
* p <0.05 
Table 5. HLA-OR antigens in RA p
atients In relation to rate of progre
ssion of the disease. 
Progression Number 
Antigen Frequency ( X) 
Score I Subjects ORI OR2 OR3 
OR4 OR5 ORW6 OR7 ORwB 
Caucasians 
1 BD 20 19 16
 46 11 01 24* 04 
2 132 22 13 
16 45 OB 04 11 05 
3 75 20 13 09 
45 03 01 13 04 
Japanese 
1 34 27 24 00 
59 00 09 00 27 
2 4B 13 21 00 
65 06 13 00 21 
3 lB 06 2B 00 
67 11 00 00 17 
Negroes 
1 20 10 10 25* 
30 15 00 20 30 
2 23 26 39 09 
39 09 00 13 09 
3 12 17 42 17 
33 OB 00 33 OB 
*p <0_05 
IProgresslon scores; 1 • slow. 2 = moderate. 3 = rapid 
Table 6 . HLA-OR antigens in Cau
casian RA patients in relation to rh
eumatoid factor. 
Group RF Humber Antigen Frequen
cy (X) 
Studied Sta tus Subjects ORl OR2 OR3 OR4 OR
5 ORW6 OR7 ORWB 
Contro 1 s 662 17 25 21 25 19 
06 22 07 
RA Neg 46 24 17 13 24 13 02 2
6 02 
RA Pos 227 20 13 \7 52'" 06 03 1
3 04 
RA low 76 20 20 lB 33 13 05 15 03 
R~ Med 117 17 11 09 52 03 03 10 04 
nil High 4B 29 13 15 5B(» 04 00 17 OB 
H> P <0.001 for difference 'from con
trols 
(') p <0 . 05 for difference between l
ow and high t Iter groups 
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were compared in each case with the RA population 
without the extraarticular condition in question, few 
significant deviations were observed. Two groups of pa· 
tients with pulmonary disease developing in coal miners 
were submitted by Darke: patients with pulmonary nodules 
(Caplan's syndrome) appeared to have an increase in DR3; 
patients with pulmonary fibrosis had an increase in OR 1 
(Table 7). Neither of these would be significant if the 
P values were corrected for the number of antigens tested. 
Further studies will be of interest. 
Family studies in adult RA. Family studies were 
performed by the following laboratories: Batchelor, Braun, 
Dawkins, Engelfriet, Hammond, Sasazuki, and Stastny. 
There were 28 families with at least two members having 
adult RA and meeting the criteria established for the study. 
The frequency of DR4 in these families was quite high, 
but there was no difference between the affected and the 
unaffected first degree relatives (Table 8). The families 
contained 67 sib pairs. In 21 cases the index case and the 
sib both had RA; in 45 instances the sib was unaffected 
(Table 91. The distribution of shared haplotypes was dif· 
ferent in the two groups. There were only three affected 
sibs that shared no haplotype with the primary case. One 
was from a family in which seven sibs had the disease, with 
two affected haplotypes inherited from a DR4 homozygous 
mother. The other two were instances of RF positive 
propositi having sibs who were RF negative (Table 9). 
These results appear to confirm the different nature of 
factor positive and factor negative RA. If the three subjects 
are not considered then all the affected sib pairs shared at 
least one haplotype, whereas among the unaffected sibs 
22% had no haplotype in common with the index case. Th is 
difference between affected and unaffected sibs suggests a 
major effect of HLA genes on the development of RA. 
Unrelated JRA. Data on JRA were submitted by seven 
laboratories (Table 10). The overall frequencies of HLA-DR 
antigens in Caucasians with JRA showed an increase in DR5 
and DRW8. The frequency of DR4 was not elevated. 
HLA·DR5 appeared to be highest in the systemic onset 
group. DRW8 was increased in patients with pauciarticular 
and polyarticular onset. 
Previous results had shown the absence of DW4 and 
DR4 and the increased frequency of DW/DRW8 among 
patients with JRA (191. The increased frequency of 
DW/DR5 has also been recently observed (20,21). Because 
of the clinical heterogeneity of JRA, large numbers of 
patients are needed and careful attention must be given to 
their classification. Further work will be needed to clarify 
the relationships of the clinical subsets with HLA·D and 
DR. 
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Table 10. HLA-OR antigens in Cauca
sian patients with juvenile arthritis (
JA). 
lAB Onset I No. ORl OR2 
OR3 OR4 DR5 
BER Pauci 3 0 
Poly 4 0 
DAW Poly 0 
Syst 0 
ENG Pauel 5 3 
Poly 3 0 
Syst 2 0 
PTR Paucf 6 0 
Poly 2 0 
Syst 3 0 
STA Paucl 41 10 
Poly 16 3 
Sys,t 12 2 
sur Paud . 19 
Poly 4 
Syst 3 
All Paucl 74 19 
Poly 30 13 
Syst 21 14 














































































































I Classification a~cordlng to clinical fonn 
of onset: Pavel _ Pauchrtlcu-
lar, Poly· Polyarticular, Syst
 • Systemic 
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Publication Number S120 from the Departments of Clinical Iml1lunology Royal Perth 
Hospital alld Queen Elizabeth 11 I\leuical Centre, Perth, Westcrn Australia. 
lladpulllld 
In the Eighth International Workshop, the illcrear,eu prC\alellce of DR4 in rhl'ulllatoid 
arthritis (RA) was confirmed in Caucasoids, Japancsc and Ncgroius. This incrcase \\a~ 
however not observed ill Jews while in A<;ian Indians the findings I\ere inconclusive 
(Stastny, 19S0). There . were no studies of S611th East Asian ethnic group\ . Atll'lIIpts to 
relate disease sel'Crily, age of onsel or sex with DR4 were ncgative though DR-l "as only 
increascd in the "seropositive" rhelllllaloids. Chromosomc 6 lIIarkers other than I1 LA 
\\ere not <;It/died and there was no attempt to identify a particular haplotype associated 
with disease. 
III this study, the following majur queQiol1$ I\ere considered: 
(i) Is DR4 associated with disease in a ,number of ethnic groups III the South East 
A~ian regi(ln when the disease definition is well slandardiled! 
(ii) Does I>R4 relate to disease \el'erity, ~ex Or serorositility,! 
(iii) I" there arWlher chrulllosonlc 6 marker ~ trongly a~socjated with RA and can a 
ullique di\ea~e associated harlotype be identified? 
In this report, we present our findings in relation to these quesliom. 
,\1 et Iwds 
Patients illcluded in this study were required to hale sYlIllllelrical small j(lint synoviti\ 
(tenderness and swelling) involving at least PIP, MCP, \\ri\t or 1\"1' joint s with at least 
one joint frol11 each side inv(llved, together with radiological erosiom typical of RA, at 
least in\ohing PIP, t-.ICP, wrist or MTP joints, while thc exclusions lislt'd in the ARA 
criteria were not to be present. 
In addition, sera \\ere sent ttl the Perth Laboratory to enanle a \Iandardilcd testing 
for rheulllaloid factor using the Rhellmaton (Denlsr) tesl. Whenever possible, additional 
E DT A plasma sam pies were collected for com plem ent allotyping. 
Results and Discu.s~ioll 
The numbers studied in the various ethnic groups are shown in table I . In\ufficient 
numbers of Chinese I\ere typcd though additional cases will be studied. In all groups 
felllales were predulllinant and, as shown in table I, lIIost were scrt1positi\'C oased 011 
the tesling of the available serum sample on the laboratory's submi<;<;ion I\hen this 
information was available. Seropositivity was ctlnsiucreu ,lIi illlporlant requircrllcnt lur 
disease definition and for confirmation in a study involving a number of different 
centres. 
DR4 Definition 
In j·his Workshop, definition of DR4 \\as cOlllplicated by a lack of 1Il0IH)<;pl.'cific <;cra. 
ES ~ l.'n lia lIy t wo III onspeci fie sera 634 and 813 were u sed as key sera. 01 her longer 0 R4 
sera 631, 633, 636, 640 and SII (\\ith DR7 and 'or DRW9 cxllas) \\ere also uscd. These 
criteria are very silllilar to those recoIIIIIIl.'nded by the DR4 antigen chairman. The 
reactiun patterns of these defining sera "cre not different between RA patients and 
COli trois. Cells with inc.olllplete DR typing data or unsuitable OR serolugical data (eg 
apparent presence of tnplets or hyper reactive cells) were excluded in the analysis. 
HL" AI/tigel/ Frequencies 
The frequllcies of OR antigens ill the various racial groups are presented in lable 2. 
A highly significant increase of DR4 is present in Caucasoids (in both laboratory groups 
348 
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and the combilled data) and in Asian Indians from Ihe Vaidya laborat
ory. There was 
only a rnarginClI inl:re<lsc in DR4 in those Asian Indians residing in Afric
a al.ld type~ by 
Or /lanllllolld. This group may represent a more hcterogeneous pop
ulallon derIved 
frol11 different regions of the Indian subcontinent and further radiological
 and serological 
studie~ of disease eriteria are needed. Interestingly. Woodrow et al (1981
) failed to show 
an increase in DR4 in Asian Indians residing in England. though inform
ation regarding 
di<lgnostic crileria \\a~ lacking. 
In the J<lrane~e. the resolts are less clear. In one laboratory (SAl) 
there was an 
increased frequency of DR4 (81 0/0 versus 51% in controls. RR = 4.1 x: = 4.62). Howe
ver, 
in the cOlllbined Japanese data the frequency of DR4 in RA was 67.1~0 
(table 2), which 
though similar to that found in the 8th International Workshop RA
 study (62 .50io, 
n = 104) was not significanlly higher than in controls where the fre
quency of DR4 
seemed ulle'(pectculy high. For example, the frequency of DR4 in the
 total Japanese 
disease study controls including laboratories SAl anu SEK was 39.1~0 
(n = 371) which 
is also similar to frequency in the controls of the 8th International Wor
kshop RA stuuy 
(40.7%, n = 792) . Ta kcn together \\ i th previous reports (Stastr! y 198
0, N akai et aI, 
1981) it is apparent that the frequency of DR4 is increased in Japanese
 rheumatoids. 
III Thais, there was a slight but not statistically significant increase in D
R4 (RR 1.8, 
Xl 0.52). Intercstingly (here was a similar non significant increase in DR
9 (table 2). 
Givcn the present frequcncies, it woulu require about four times the num
bers of patients 
<Il1d controls to show a statistically significant (at the 51170 le\el) increase
 in DR4. These 
data suggest that Thais RA may be exceptional in that they do not
 show a strong 
association with DR4 though further cases are required . On the othcr han
d these patients 
diu appear to have rheumatoiu arthritis: they had a symmetrical polyarth
ritis, most were 
seropositive and x- rays show typical symmetrical erosions in the major
ity. 
As reporteu in previous studies there was a decrease in (he frequency 
of OR7 in all 
racial groups except Japanese and a decrease in DR2 in Caucasians, As
ian Indians and 
Japanese. These were mostly not significant and apparently secondary 
to the increased 
frequency of OR4. 
The ollly' si!!nifi , ;' :1' dn jaiillll \ o f Ihe HLA A [3 C antigens occurred 
ill Caucasians 
amollg "holl1 III \ f: I < (2~2 "1I ill RA \"("r'iUS 11 .3
0; 0 ill controls) and CW3 (45 .60io 
\CfSUS 22.9'):0 ) wele \Iightly inerea~cu. These increases were not significant
 when corrected 
fur the !lumber of antigclls stuuied and are apparently secondary to the
 known linkage 
uisequilibrium betwcen the se alltigens alld DR4. 
Rci:.Jliollship 10 Se\' and Seropositi\ it.\." 
When <I\aibblc, all ca , e<; were tested for rheumatoid faclor 011 the s
erum samples 
proviued and clas, ifieJ Oil this hasis as seropositive or seronegative. T
he frequency of 
OR4 \\as\.silllilar ill bOlh groups as shown in table 3. DR4 was not 
associated with 
seropositivity in the Thai patients. 
Oata on the presence of rheumatoid factor at any stage during the clinica
l course were 
incomplete and inadequa(iey standardizcd. However, data from the 
Caucasoid and 
Inuian laburatories suggest a relationship between DR4 and high titre rhe
umatoid factor. 
The influence of sex on the prevalence of DR4 is shown in table 4. Th
e numbers of 
males are small but there is no obvious sex difference. 
COl/lp/cmelll !\larkcrs 
Suitable typing has only becn undertaken on Caucasoid patients. A ra
re C48 allele 
designatcd C4B3 ha~ been observeu in 7 out of 43 patients but none of th
e Caucasoid 
~on.tr.ols stlldied :t ., 1' ;111 .of the Second AOH \VC (table 5). The phenotypes of these 
l/Iul\lduals ate P!c\cllted III table 6. All seven individuals share the antig
ens HFS, C4A3, 
C~C and DR4, SIX of the seven having B\V62. These results suggest that RA is
 associated 
With a rare haplotype (BW62), BFS; C4A3; C4B3; C2C; OR4. \\-' het
her similar rare 
haplotypes can be identified ill any other racial groups awaits further s
tudy. 
Conclusion 
The data pre~ented while confirming the strong association of OR4 \vith R
A in some 
races a.uds support to the view that OR4 is not associated with R
A in all races. 
Accordll~gly! the fil'di!lg of an association with C4H3 and a particular hap
loype in 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Association of C4B) wi lh RA ill Ca uc asoids 
C4B3 
+ 
RA .. 7 36 
NON RA 0 53 
p~O.OO5 
Table 6 
Caucasian RA Patients - C4 B3 Positive 
A C B Bf C4A C4B C2 DR 
JAC 2, 11 3, 5 62, 44 S S 3 3 C 4
 3 
FAU 2, 24 3, 2 62, 14 S S 3 3 C 4 
RID 1 , 32 3, 7 62, 8 S S 3 3 C 4 
GIB 2, 28 3, 5 62, 44 S S 3 3 C 
{I 
CAR 3 3, 4 62, 22 S F 3 3 C 4 
HUN 2 3 62, 50 S F 3 3 C 4 
JlIN 6, 9 8, 37 S F 3 3 C 4 
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HLA Associations with Rheumatoid Arthritis 
In African Blacks 
GIRISII M. MODl', MICIIAEL G. HAMMOND, ;1I1d PRETvllLLA DEVI NAIDOO 
A/wrac/. The IILA-A, n, C and DR lInligens were delermined in a group nf 100 blllcks wilh 
dassical (II' definite dlelmlalnid m'lhritis (RA) in Uurhan, Scmlh Africll. Fifly-six of Ihese palienls 
,It· re alsn lesll'" fill' Ihe HQ antigens. There was a signilkllnl assncialiCIII nr IILA-1)1{4 wilh 
RA h :2 = 77.2; P < 0.(001). The frelJllellc~' or I>R4 in RA was 44% ill cClln)lllrison willt 10% 
ill cCllltruls (rcllllh'e risk 7.4). An nnllsulIllindillg "'liS II significanl increase in Ihe frell"ellCJ 
nf IILA-ml in 35% of palients wHh RA clllnpared tn 12.5% of cllntruls (11<0.0001; relathe 
risk .Ul). There "as 1111 linkage disequilibrium hdween DR4 and BR tn explain the laller 
assncial inn. (.l RII('IIII/%/ 1989; 16: IJ26- 8) 
Kc,l' IlIde.rillg Toms: 
RHEUMATOID ARTIIRITIS BLACKS HLA-DR4 I-ILA-B8 
The IILA·DR4 antigen is associated with rheumaloid arthritis 
(RA) in Caucasians. Alllcric3n blacks anu lIIany other 
populations' •. However, norlllal rrequencies or DR4 h3ve 
been reporteu in Asians in Britain' 3nu Jews~ . American 
3nd Arrican blacks with 3nkylosing spondylitis have a lower 
prevalence or IILA-1327 than Caucasiansh • Our survey wns 
undertaken 10 determine whether the HLA associations with 
RA in Arrican blacks were similar to Caucasians and Ameri-
can blacks or whether there were genetic dirrerences. 
l\IATERIALS AND l\IETIlODS 
A group or ILK) unrelalcJ hlacks wilh classical or dclinile RA 7 who allcndcd 
Ihe rheulllal"I,,!!y clinic at Ihe King Etlward Vlllllospilal in Durban. SOIHh 
Africa were ~I\ldied . All the palienls werc or Zulu de~ccnt. The Olcan age 
or Ihe palicnts was 43. 7 year~ (range 21 tu 66 years) and the female :male 
rali" was 3.8: I . 
The IfLA -A.1l and C anligc n~ were idenlified II sing a 2 slage Iym· 
ph(x:ytotoxicily Ic~ l" and IRO anliser:t . The HLA-DR and DQ anligens were 
defined wilh 120 anli~era on R ce ll enriched Iymphoc yte sllspensions pre-
r ated hy Ihe II se "r slraws packed with nylon w(lolq . The HLA-A.B .C and 
DR anlige ns were delermincJ in all 100 patienls . The OQ antigens were 
al ~o Ic,led dming Ihe c"ur~e or Ihe sl\l(ly and were determined in 56 patienls . 
The conlrol group consisled of bluod donors and ~taff who were also or 
Zulu descen!. The HLA-A.B and C anligens were determined in 1985 con· 
trois. DR anligens in 513 and DQ anligens in 340 controls. 
The dirrer ence in frequency o r Ihe va rious anligens belween patienls and 
conlrols were tested rill significance hy lIleans or the X2 test (without Yates ' 
cnrr.ection) . The resulting pmha\:lilities were multiplied by the numbe r of 
IILA specificilies tesled to dclenl1inc Ihe correcletl \'alue. Relative risk was 
From II,e Vq'onmell/ of M,'dicillc . Uni\'(·l".<il." of Natal , Vurbon mId 
lit,. Nlllol In.llilule or /lmllllnololil' . Pillelml'll. SOllllt Africa. 
SIII'I,or/,'t! hy Ill(' SOItlIt Afri,.,m Mcd;n,' R" .,r ",.,", C(lIlIIdl. lite A,.,It/,;li., 
fiJ/lI/d"lim' ",,,Ill,,. An"/,;Ii., R" ." :,,,.,'" hllld ,~r IIt<, Un;.,,.r.,;I)' of N(//"I. 
G.M. Mody. MV. MRCP, So,;or Leclllrer. Dc",,/,llIIrlll (If Medidll/? 
UII;I'Cl".<il." of Naltll; M. G. /lallllll(lIId. PltD. '/toad. Trall.lplm(/aliOl' 
Unil. Nlltnllll.llilllle of 1/lI/I/I/IIoIogy; P.D. Naidoo. FCP (SA). SCllior 
t,.,.l/trel'. [)('I'"rtllletll '~f Mcdidll(' , Ullil'('I".<ily of N"/,,I. 
Add,r.1'.l ,r'I'Ir.H., for "' ·/";I/I.f It> /Jr. G. M. M"d.". U''I"""",,.III of 
Mcdi,.illc. Ullil 'enil), or NUlal. p.a. B"x 17039. Cm'R,.l/a 4013, SoulIt 
Africn. 
S"I""illcd M",,.It 22. 1989 f('l ·i.lioll ""c"l'led .1,,/,' 20. 1989. 
1326 
caknlnlcd acnlTdill!! III S\'e.i!!'wnl. cl al"'. Hnpllltype frcq\le"cie~ were (al-
culnlcd hy the II,clh"ds Ill' MallhiUT.. Cl aI" . 
RESULTS 
there was no significant association or RA with any of the 
HLA-A and C antigens . The rrequency of the HLA-B anti-
gens in controls anu patients with RA are shown in Table 
I. There was a significant increase in the prevalence of HLA-
138 which was nOled in 12 .5% or the controls and 35% or 
patients with RA (p < 0.0001; relative risk 3.8). There was 
no linkage disequilibrium between DR4 and 138 to explain 
the increased rrequency or 138. 
The results or the DR and DQ antigens are shown in Table 
2. There was a significant association or DR4 with RA (x2 
= 77 .2; P < 0 .0001). There was no significant increase in 
the rrequency of the DQ antigens . The results of some of 
the haplotype frequencies in patients with RA and controls 
are shown in Table 3. 
DISCUSSION 
A significant association between HLA-DR4 amI RA, which 
has been reported in American blacks, Caucasians and other 
populations, is confirmed in African blacks'-~. The preva-
lence of DR4 . in controls and patients with RA is about 30 
and 70%, respectively , in Caucasians ' 2, 7 and 22 % in 
American blacks4 and 10 and 44% in Arrican blacks. 
Thererore, although American and Arrican blacks with RA 
show a significant association with DR4. the frequency of 
DR4 is lower in both patients with RA and controls in com-
parisoll wilh Caucasians . 
The DR3 and DR4 subsets and DQw4 were not tested at 
the lime orthis study. There was no increase in the frequency 
of DQw3 in our patients with RA . The DR4-DQw3 haplo-
type showed significant linkage disequilibrium in the African 
black controls as noted in other populations D • However, 
there was no linkage disequilibrium between DR4 and DQw3 
in the African blacks with RA. Singal, et 0114 have shown 
771(' }OImlll/ of R111'I/IIIIIIO/ogy 1989; /6: /0 
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Table I . HL~·B lIntigens ill COlltrols alld plIticnts lI'it" RA 
IILA anligcns Conlrols RA Palicnls \' 
R·R* 
tn = I'.IS)) tn = lOO) 
01 % If! 
B7 22.4 26 .m 0 .70 
1.2 
B8 12 .5 .'5 .00 41.11 
3 .8 
BD 3.4 .1 .IX) tUl-l 
0 .9 
BI-I 5 .5 5 .(X) 0 .05 
0 .9 
HI5 3.4 4 .00 0 . 1/ 
1.2 
1116 3 .6 I.m 1.9
0 0 .3 
1117 37.2 34()() OAI 
0 .9 
BIS 5 .5 8.(X) 10X 
1.5 
B21 2() 3.(X) 0.52 
1.5 
B22 0 . 1 000 (l.O
S n.o 
B27 0 .3 0 .00 (U
O 0 .0 
B35 6 .9 to. 00 1.39 1.5
 
B37 0 . 1 000 010 0
0 
B-1 I 1.9 3.00 065 1.6 
842 21.3 1-100 3 .03 0 .6 
B-I4 15 .3 12 .()() 0 .79 0 .8 
845 9 .2 4.00 3 . 18 
OA 
847 n . 1 000 0 . 10 0
.0 
B-I8 01 0 .00 0 .05 0
.0 
BSI 1.3 1.00 (l .OS 0.8 
BS2 0 000 0 0
 
B53 1.5 (l . ()() 1.53 0
.0 
BSI 0 0.00 0 0 
B60 0 . 1 1.00 5 .36 10.00 
B61 (LI 000 0 .05 0
.0 
870 23.5 20 .0() 064 08 
* R · I~ : rdalive ri .,~ 
Table 2. flLA-DR alld DQ all/igcl/S ill cOlltrols and patiellts 
IILA · I>R Conlrols RA Palicnls X~ R·R 
Anligcns (n=513) In = IOO) 
']i. % 
DRI 4 .7 4.0 0 .09 0.8 
DR2 24 .2 15 .0 4 .01 0 .6 
OR3 35 .3 31.0 0 .68 0 .8 
DR4 9 .6 44 .0 77.17 7 .4 
DRS 32 .2 n .o 4 .08 0 .6 
DRw6 17 .9 15 .0 0 .50 O.S 
DR7 15 .4 IS.O (UlI 1.0 
DRw8 3 .9 3.0 0 . 19 0.8 
OR9 O.R 00 (1.78 0 .0 
DRwlO 2. 1 6.0 4 .61 2.9 
.. - . ~ . - - --- -
IILA · DQ /n=340) (n=56) 
Anligens 0/.. % . _ . . _-_. -_ .... - - _ . . . "- - -
DQwl 62 .7 -14.6 6 .50 0.5 
DQw2 22.4 2l!.6 1.0-1 1.4 
DQw3 30 .0 35.7 0 .74 1.3 
/I/ot/\' , .. I Ill: ilIA ill Mllch II 'illt Rcl 
T<lble 3. Esti/l1ated "aplotype ji'eqllellcil'J ill COll/rols wul 
1'(/li{'ll(J with RA 
IIAPI.OTYPE Frcqucncy/IO.O()() Delta 
Dclta /SE* 
Palienls 
DR-I ·DQw3 89 31 0.7 
DR4 · BX 37 -12 
-OA 
DR3· B8 49 16 
0 .0 
DR .' ·Bw-l2 4X .16 2 .
1 ** 
DR-I ·BI7 I/O (d
 2.~** 
Conllllls 
flR-I · D(.Iw3 25 20 2.8** 
DR-I · B8 2 - I 
-0.2 
DR3 ·1l8 30 18 
2.S~* 
DR3 ·Bw42 63 42 4.5*" 
IJR4 · B 17 16 5 0 .7 
• SE - standard error. 
.* p«U)5. 
*.* p<O.OI. 
th<.ll <.Ill DR4 positive palicnts with RA carried Ihc DQw3 .
1 
slIhlype in comparison with 19% of healthy DR4 positive 
conlrols. We did not sludy the DQw3 slIbtypcs in (1111' paticnt
s 
ami therefore there Illay still be an association between DR4 
and DQw3 . I, 
An unusual finding in Ihe African blacks wilh RA was the 
significant increase in the frequency of the IILA-B8 antigen
 
which is associated wilh many other autoil1llllune diseases IS
, 
The significant linkage disequilibrium betwecn DR4 and 817 
in Ihe patients but not in controls may reOect differences in 
the frequencies of the Class III complemenl genes which lie 
belween the 8 and OR loci. 
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HLA ASSOCIATIONS WITH RHEUMATOID ARTHRITIS 
AMONG THE VARIOUS MIGRANT INDIAN COMMUNITIES 
IN SOUTH AFRICA 
G.M. MODY AND M.G. HAMMOND 
Department of Medicine, University of Natal and King Edward VIII Hospital, 
Durban the Natal Institute of Immunology, Pinetown, South Africa. 
SUMMARY 
Rheumatoid arthritis (RA) in Indians has been shown to be associated with 
HLA DR4 in North India and with DR1 in the United Kingdom. We studied 
a migrant Indian population in South Africa to determine their genetic 
associations with RA. A group of 123 unrelated RA patients from three 
communities (Hindi, Muslims and Tamils) were studied. Only the Muslims 
showed a significant association with DR4 whereas the Hindi and Tamils 
showed a significant association with DRlO. This survey shows that the indian 
community is a heterogenous group regarding the HLA association with RA 
and different associations are noted in the various communities. 
INTRODUcnON 
The association of HLA DR4 with rheumatoid arthritis (RA) has been 
documented in Caucasians, American and African Blacks, Japanese and many 
other communities. 
Mehra et al. 1 have shown a strong association with DR4 in a group of 40 
North Indian patients with RA in India. The frequency of DR4 was 70% in 
RA patients compared to 12% in controls. In the United Kingdom, Woodrow 
et al. 2 studied a group of 35 Indians with RA and found a significant 
association with DRl and not DR4; DRl was detected in 60% of patients with 
RA compared to 17 % of controls. 
Indians from India first arrived in South Africa in 1860 to work in the sugar 
cane fields in Natal. Presently there are nearly one million Indians in South 
Africa. The three major groups of Indians are the Hindi and Muslims, who 
are North Indians of Aryan descent and Tamils, who are South Indians of 
Dravidian descent. Previous surveys have shown that there are differences in 
the prevalence of the various Class I antigens in control groups of Muslims, 
Hindi and Tamils in South Africa. 3,4 
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This survey was undertaken to determine whether there were any differences 
in the genetic associations with RA among the various migrant Indian 
communities in South Africa when compared to Indians in India and the 
United Kingdom. 
PATIENTS AND METHODS 
A group of 123 unrelated Indians with classical or definite RAs who were 
attending the rheumatology clinic at King Edward VIII Hospital were studied. 
The study population consisted of 53 Tamils, 39 hindi and 31 Muslims. The 
mean age of the patients was 44.7 years and the female to male ratio was 5.8 
to 1. The number of patients and controls in the various communities who 
were studied for the HLA A, B, C, DR and DQ antigens is shown in Table 1. 
The control group consisted of 1458 normal adults who were either staff or 
randomly selected blood donors of Indian descent. HLA Class I antigens were 
determined in all patients and control subjects by a two-stage 
microlymphocytotoxicity test (1) with 180 antisera. They consisted of local 
sera that have been requested for use in International Histocompatibility 
Testing Workshops, local sera that have been verified with International 
Workshop sera and sera that have been exchanged with other laboratories 
worldwide. Similarly, 120 sera were used to defme the Class II antigens on 
B-Iymphocyte enriched lymphocyte suspensions prepared with the aid of straws 
packed with nylon wool (2). The Oass IT antigens were determined in 446 
control subjects except that there were only 319 control subjects that were 
tested for HLA DQ antigens. Although over 2000 individuals have been tested 
for HLA DQ locus antigens in our laboratory the majority were Caucasoid or 
patients with selected diseases. As a consequence, only 319 normal, healthy 
Indian individuals have been tested for HLA DQ antigens. The difference in 
the frequency of each antigen in patients and controls was tested for 
significance by means of the chi-squared test (without Yate's correction). The 
resulting probabilities were multiplied by the number of specificities tested to 
determine the corrected value. Relative risk was calculated according to Woolf 
et al. 8 • Haplotype frequencies were calculated by the method of Mattiuz et 
al.9 • 
RESULTS 
There were no significant associations of RA with the HLA C locus antigens 
in any of the Indian communities. The HLA antigens which showed a 
significant association in the different communities are summarised in Table 
2. 
The Tamils showed a significantly increased frequency of HLA A2, B37 and 
~R~O and although!>~ w~ also increased, the difference was not statistically 
SIgnificant. The HmdI patients showed a significant increase only in DRlO. 
They also. had an increase of B44 and a reduction in the frequency of DR5. 
The Muslims showed a significant association with B21 and DR4. 
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DISCUSSION 
When the results of the HLA associations with RA in our study are compared 
with Indians from North India' and the United Kingdom2, we note that a 
significant association with DR4 was only seen in North India and in our 
. Muslim patients. 
In the United Kingdom Woodrow et al.2 found an increased frequency of only 
DR1 among their Indian patients. At the time of their study only DR1 to DR7 
were being tested. Since then DR8 to DRlO have been defined together with 
many splits and many DR1 antisera contain antibodies to DRlO. Thus the 
increase in DR1 which was seen in The United Kingdom may be related to the 
increased DR10 which we saw in our Hindi and Tamil patients. A significant 
association with HLA DR1 and not DR4 has also been reported in Jews10 • 
Although American" and African Blacksl2 have also shown a significant 
association of DR4 with RA, the frequency of DR4 was only 22 % and 44 % 
in American and African blacks respectively. The frequency of DR4 in 
Caucasians'3 with RA is about 70%. We have found that although there is a 
significant association of DR4 or DRlO in our Indian communities, the 
frequency of these antigens is less than 40%in all the communities. Thus there 
may be other subsets or epitopes which were not studied in this survey which 
may show a stronger association with RA. 
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Table 1 
NUMBER OF PATIENTS AND CONTROLS WHO WERE TESTED 
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1. Introduction 
Yc>Iumc4 IY~.J. 1"0. 
Association between histocompatibility type and the 
ability to make anti-Rh antibodies 
The HL-A types of Rh-negative women with and without anti-Rh antibodies 
were examined. In those who made Rh antibodies, there was an excess of 
HL-A I, and a deficiency of HL-A2 and W J 0, approaching the conventional 
level of significance. There was, however, a highly significant lack, in the 
antibody-making group ; of subjects with only one antigen detected at the 
first (LA) locus. The capacity to make anti-Rh antibodies and that to make 
cytotoxic anti-HL-A antibodies were strongly correlated. 
We started this investigation because Jerne [I) had predicted 
that the ability to make antibodies against certain nonhisto-
compatibility antigens should be correlated with histocompa-
tibility type, and further, that individuals possessing a wide 
range of histocompatibility alleles should be able to make a 
wider variety of antibodies against nonhistocompatibility 
antigens than individuals with a smaller assortment of histo· 
compatibility alleles. The major histocompatibility system 
of man (HL-A) is determined by genes at two close.ly linked 
loci, called "LA" and "FOUR". It occurred to us, therefore, 
that a subject who was heterozygous at both these loci, and 
thus had at least four different HL-A factors, might be ex-
pected to make a wider variety of antibodies more readily 
than a subject who was homozygous at one of the loci (three 
factors), and particularly than one who was homozygous 
Conespondence: Peter Brain, The Natallnslitutc of ImmunOlogy, 
P.O_ Box 2356, Durban, South Africa 
at both loci (two factors). An earlier attempt by one of us 
[2] to show this effect wit11 the isoagglutinins of the ABO 
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blood group system was inconclusive. We decided. therefore. 
10 examine nexI the ahility to make anti-Rh 3nlihodies in 
terms of HL-A type. \Ve chose this system because Mollison. 
Frame and Ros5 [:'] have shown that some Rh negative women 
m<lke these antibodies readily: where<ls others. given the same 
stimulus hy intravenous injection of Rh positive cells. make 
anti-Rh antibodies with difficulty or not at all. About 50 f7r 
of Wl)men fall into each of the two groups. and the difference 
i, presumably genetically determined. Such control. of course. 
need not in this case be of the kind postulated hy Jernc: 
Mollison et al. suggest that it may be connected with Rh 
genotype. and it might equally well be due to the effect of 
an immune response gene belonging to neither the HL-A nor 
the Rh system. The system was attractive to us . however, 
because it seemed to provide a clear distinction between 
two classes of individuals in the ability to make a particular 
antibody, and because we were equipped to test for both 
the Rh and the HL-A factors. 
In this paper, therefore, we compare the HL-A types of two 
groups of Rh negative women, those who made Rh antibodies 
and those who did not. We looked both for a specific effect 
of particular HL-A alleles, and for the effect of homozygosity 
or heterozygosity at one or both loci, on the ability to make 
anti-Rh antibodies. As an afterthought, we decided to examine 
also the frequency with which the two groups of women made 
antibodies against HL-A antigens, since such antibodies, like 
those in the Rh system. are frequently made during pregnancy 
against antigens which the fetus. but not the mother, possesses. 
2. Materials and methods 
There were 96 women in the group of Rh negative subjects 
who made antibodies against factors included in the Rh system. 
Exact data on pregnancies was available for 93 of them, who 
had had a total of 344 pregnancies , a mean of 3.7 per subject. 
The control group consist ed of 78 Rh negative women whose 
husbands were all Rh positive: none had had fewer than two 
pregnancies, and Rh antibodies had been sought in all preg-
nancies, but never detected. This group had a total of 233 
pregnancies, mean 3.0. Since ABO incompatibility between 
fet us and mother has been thought [4] to influence sensitiza-
tion to Rh antigens, we obtained where possible the ABO 
groups of the husbands (those of the women were known). 
Such data for both partners were available in respect of 
63 women in the group making antibodies ; 71 % of the 
couples were compatible, in the sense that the mother could 
not bear by that husband a child incompatible with herself 
in terms of ABO. In the control group there were data for 
50 couples, of whom 60 % were compatible. This difference 
between the groups was not significant at the conventional 
level (X
2 
= 1.6 for 1 d.L P = 0.2). The random popUlation 
cited for reference in Table 1 consisted of 454 normal un-
related blood donors and staff members of either sex: none 
of them had been examined because of any disease, o'r for 
pregnancy. All the subjects in alJ three groups were 
Caucasians of Western European origin. 
Rh grouping and antibody detection were done by conven-
tional method s in the laboratories of a large transfusion 
service. HL-A typing was by the two-stage microcytotoxicity 
test [5]; 60 sera were used to test for the following antigens: 
first (LA) locus: HL-AI, 2, 3, 9,10, I 1,28; W19, 29, 31; 
second (FOUR) locus: HL-A5, 7, 8,12,13,14,17,27; W5, 
10,15,22. 
Eur. J. Immunol. 1974.4: 223-225 
At the same time. the serum of every woman in the first 
two groups was examined for cytotoxic anti-HL-A antibod-
ies. using a panel of cells from 12 donors selected to possess 
all the antigens mentioned above. The data were transferred 
to punch cards and a computer program was used to calcu-
Iatl' phenotype and gene frequencies, with haplotype and 
delta (gametic aSSOCIation) values from phenotypic data 
according to Mattiuz et a!. [6]. 
3. Results 
Table I shows the phenotype frequencies of the HL-A anti-
gens in the two groups and in the random Caucasian popula-
tion. The proportions of women in the two groups who made 
cytotoxic HL-A antibodies are also compared. The symbols 
'X' and 'Y' are used to indicate subjects in whom only one 
antigen was detected at the first and at the second locus 
respectively. The l values are for comparisons between the 
frequencies of HL-A antigens in the two groups of Rh nega-
tive women, but probabilities obtained from tables of t 
have been corrected as described by Walford [7] by multi-
plying them by the reciprocal of the frequency of the speci-
ficity concerned in the general popUlation. 
Tablc I. HL-A antigen frequencies in Rh negative women with and 
without Rh antibodies, and in the general population 
Antigen Random Rh negative women 
Caucasian With anti-Rh Without anti-Rh Cor-
population antibodies 
(454 sub- (96 sub-
jects) jects) 
(%) No. (%) 
HL-A 1 30.6 39 40.7 
HL-A 2 45.2 38 39.6 
HL-A 3 29.7 38 39.6 
HL-A 9. 16.3 23 24.0 
HL-AIO' 9.0 
j 1.0 
HL-AIO" 6 6.3 
HL-All 11.7 13 13.5 
HL-A28 7.9 8 8.3 
Wl9 9.0 3 3.1 
W29 4.0 3 3.1 
W31 3.3 3 3.1 
X (only one antigen detected 
at first locus) 
33.3 17 
HL-A 5 9.9 9 
HL-A 7 25 .1 24 
HL-A 8 22.0 32 
HL-A12 29.1 26 
HL-AI3 6.2 4 
HL-AI4 5.1 10 
HL-A17 8.8 5 
HL-A27 8.4 3 
WS 15.2 17 
WlO 15.0 3 
WlS 10.8 11 
W22 3.3 6 
Y (only one antigen detected 










































41.1 42 43.8 42 53.9 
Cytotoxic 
HL-A antibodies 16/93 17.2 1/78 1.3 
a) Probability by Fisher's exact method. 
rected 
X2 p p 
< < 
6.02 0.025 .08 
6.48 0.025 .06 
3.08 0.1 .33 








11.57 0.001 .003 
0.22 
0.82 
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Table 2. Ilaplotype frequencies with coefficients of gametic associa-
tion (L\) and standard errors (S.E.) in Rh negative women with and 
without anti-Rh antibodies, and in the general population (all figures 
x 103) 
Random Caucasian Rh negative women 
with anti-Rh without population 
antibodies anti-Rh anti-
bodies 
Haplotype Freq. S.E. t>, Freq. S.E. 
t>, Freq. S.E_ t>, 
HL-A 1/8 87 14.9 67.8 120 34.5 78.0 64 39.5 52.9 
HL-A 2/12 73 14.4 31.7 48 29.1 17.1 130 44.0 52.2 
HL-A 3/7 63 14.0 41.5 78 31.5 48.5 39 37.5 24.3 
IIL-A 1/17 20 12.3 12.0 20 26.5 13.5 6 34.6 5.6 
12.1 12.9 16 26.2 13.4 13 35.2 10.1 W 29/HI-A 12 16 
HL-A 2/W 10 30 12.7 10.1 3 24.8 -0.8 10 34.9 -16.3 
W 28/HL-AI2 9 11.8 2.1 10 25.6 1.9 39 37.5 30.8 
HL-A 9/W 10 10 11.9 3.8 4 24.9 1.7 31 36.8 27.0 
4. Discussion 
We do not know. of course, that all the women in the control 
group have had the opportunity of making anti-Rh antibodies; 
some, with husbands heterozygous for Rh, Illay never have 
had an Rh positive fetus. It is safe to say, however, that a 
good proportion of them will have been exposed to Rh anti-
gens. 
Of the individual H L-A factors studied, HL-A I, 2 and W 10 
show differences in frequency between the two groups that 
approach the conventional level of significance, and a more 
extensive study might give interesting results. The only highly 
significant difference obtained, however, is in the proportions 
from the two groups having only one antigen detected at the 
first locus. Such subjects are far less common in the group 
that made antibodies than in the control group. We may safely 
assume that many of the subjects in whom only one antigen 
was detected at one locus are in fact homozygous for that 
antigen and not heterozygous for it and an unknown factor, 
since we have antisera against all the known factors that 
occur commonly in Caucasians. At the second locus this 
effect is less marked, though the figures show the same trend. 
Such an effect of homozygosity might be expected from 
Jerne's theory. Our finding, however, that the ability to 
make Rh antibodies was strongly correlated in this study 
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with the capacity to make antibodies in the ilL-A system, 
would not be expected at all. It probably has quite a different 
explanation. One possibly is that fetal material, bearing both 
Rh and IlL-A nntigcns, crosses the placenta readily in some 
women and not in others: but this will not explain Mollison's 
nonresponding women, who received their antigens by intra-
venous injection. Another might he that some pregnant women 
respond more readily than others to all)' foreign antigens on 
the fetus, owing to the lessened activity of some mechanism 
whose function it is to damp down nonspecifically the im-
mune response: such mechanisms have been described by 
several authors, for example Hill et al.l8J. 
We do not feel that we ought to try to explain our findings 
at this stage: if the effects of individual llL-A factors, and 
particularly of homozygosity at one or both loci, nre sub-
sequent Iy confirmed by other studies, we may then profit-
ably consider whether they are a direct effect of HL-A geno-
type, or of an immune response gene linked to HL-A. Since 
wc have exhausted our material, it will not be possible for 
us to carry out such studies in the near future: we are there-
fore publishing this preliminary report in the hope that other 
laboratories will investigate the subject. 
This work was supported by a grant to r.B. from the Medical Research 
COllncil of SOllth Africa. 
Received June 26, in revised form November 11. 1973. 
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Human leucocyte antigen status in African women with 
eclampsia 
NICHOLAS JOHNSON, JACK MOODLEY, MICHAEL G. HAMMOND 
Summary. Investigation of the HLA system in 53 African eclamptic or 
imminently eclamptic women showed that they were significantly more 
likely to be heterozygous at the B locus than were normal controls. This 
did not apply to the A or D related loci. 
The aetiology of eclampsia remains unknown, 
but suggestions that it may be an immunogenetic 
disorder date back to the beginning of the cen-
tury (Beer & Need 1985). Redman et al. (1978) 
reported that women who had only one detect-
able surface antigen determined by the HLA-B 
locus were at an increased risk of developing 
pre-eclampsia in pregnancy. This work has yet to 
be confirmed. To examine this association we , 
studied the HLA system in women who devel-
oped eclampsia and compared it with that found 
in the normal population. 
Patients and methods 
The study included 53 black African women 
from Zululand admitted to the labour ward of 
King Edward VIII hospital who had systolic 
blood pressures greater than 160 mmHg and 
diastolic blood pressures greater than 115 
mmHg, gross oedema and at least 2+ pro-
teinuria by standard turbinometric methods in a 
catheter specimen of urine. Forty-two patients 
had already suffered at least one seizure before 
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admission and the remaining 11 all complained 
of headache, nausea and visual disturbances. All 
were either irritable or had intellectual clouding 
and an independent observer described those 
who had not had a seizure as being hyper-reftexic 
with clonus before therapy. Patients with a 
history of neuropathology, diabetes, hyper-
tension, renal disease, recurrent miscarriage or a 
recent blood transfusion were all excluded. 
Patients who were still protein uric or hyperten-
sive (>140/90 mmHg) 12 days after delivery 
were also excluded. Three patients with 
eclampsia did not know their parents, but the 
remainder denied that they could be the product 
of consanguineous marriage or matings. 
The control group for the A and B locus of the 
HLA system consisted of 1416 blood donors of 
the same tribe and resident within the same hos-
pital catchment area and 412 of them also acted 
as controls for the DR locus. 
The HLA, A, Band DR antigens were deter-
mined by a two-stage lymphocytotoxicity test 
(Terasaki & McClelland 1964). Patients with 
only one antigen per locus were considered to be 
homozygous at that locus. Frequency differ-
ences between the eclamptic patients and the 
controls were tested for significance with the 
X2- tes t. The formula given by Haldane (1956) 
was used to combine data from the available 
published series with the data presented. Rela-
tive risk was defined as the number of times 
more often the disease occurred in women posi-
tive for that antigen than in those negative for 
that antigen (Woolf 1955). 
Results 
Clinical details of the subject group are recorded 
in Table 1. Women with eclampsia or imminent 
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Table 1. Clinical details of patients with eclampsia 
Variable 
No. of patients 
No. with previous viable pregnancy 
Nulliparous 


















eclampsia were less likely to have only one 
detectable antigen at the B locus than were the 
normal population, the difference was statis-
tically significant (P < 0·01, X2 = 7·4) . The rela-
tive risk in patients in whom both antigens were 
detected at the B locus is thus increased to 2·3. 
This does not apply to the A locus or at the OR 
locus (Table 2). No specific A, B or OR antigen 
occurred more commonly in eclamptic patients. 
Discussion 
Two antigen types are inherited, one from each 
parent. If only one antigen can be detected, then 
it can be inferred that the individual has eithe,r 
inherited the same antigen from each parent, 
thus making her homozygous at that locus, or 
that she has an antigen yet to be discovered. As it 
is believed that over 98% of the B locus antigens 
are known to us, the finding of a single B locus 
antigen is presumed to be synonymous with 
homozygosity. Pregnant Zulu women suffering 
from eclampsia or imminent eclampsia are less 
likely to have only one detectable human lym-
phocyte antigen at the B locus than are the 
normal, healthy population from the same tribe 
and district. Our eclamptics are more likely to be 
heterozygous at the B locus. It is perhaps signifi-
cant that women born of a consanguineous rela-
tionship, and thus relatively homozygous, have 
some protection from developing eclampsia in 
pregnancy (Stevenson et al. 1976). However, 
heterozygosity in edamptics does not occur at 
the A or OR locus, this observation is unlikely to 
be related. 
Our data contradict the findings of Redman et 
al. (1978). They studied 80 Oxfordshire women 
suffering from pre-eclampsia and computed a P 
value of 0·025 supporting an association 
between pre-eclampsia and homozygosity at the 
B locus. Simon et al. (1980) also reported that 
French pre-eclamptic patients were relatively 
homozygous, but they only recruited 26 patients 
(six were homozygous) and their control group 
was limited to 16 men, none of whom was homo-
zygous. However, Persitz et al. (1983) investi-
gated 40 women in Israel, and Scott et al. (1976) 
studied 46 women from Iowa with eclampsia and 
pre-eclampsia and both studies failed to show 
such a relation. It is difficult to understand why 
English pre-eclamptic patients should tend 
towards homozygosity at the A and more par-
ticularly at the B locus yet Africans with 
eclampsia are more likely to be heterozygous. 
An immunogenetic explanation seems unlikely. 
It is true, however, that some disorders are asso-
ciated with an HLA type only in certain races, 
e.g. HLA-B54 is associated with juvenile 
diabetes mellitus in Japanese, but not in Cauca-
sians. No condition yet described is associated 
with such marked polarization as demonstrated 
here. If the explanation of such conflicting 
results is not within the different racial study 
groups then it may be with the disease. We have 
presumed that pre-eclamptics become eclamp-
tics and therefore the two groups are compar-
able. However, patients presenting with acute 
eclampsia may have a different genotype com-
pared with those presenting with protein uric 
hypertension in pregnancy. Finally, it must be 
noted that 30% of our control population are 
Table 2. Frequency of human leucocyte antigen (HLA) homozygosity in patients with eclampsia and in normal 
controls 
Eclamptic patients Normal controls 
HLA locus n (%) n (%) 
A 19153 (35·8) 374/1416 (26·4) 
B 7/53 (13·2) 435/1416 (30· 7)· 
DR 22/53 (41·5) 223/412 (54·1) 
Significance of difference between the two groups. • P < 0·01, "I: =7·4. 
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homozygous. This remarkably high figure may 
be a reflection of African tribal society and the 
immobility of its members due to political and 
economic constraints. Such nuclear commu-
nities are not a feature of Oxfordshire, Iowa or 
France. 
The history of HLA associations with certain 
diseases has been a major breakthrough in our 
understanding of the genetics of many diseases. 
The exciting work by Redman et al. (1978) asso-
ciating pre-eclampsia with homozygosity at the 
B locus promoted many ideas and strengthened 
the immunogenetic interest in the subject. It is 
not clear why in African women we found a 
significant association between heterozygosity 
and eclampsia, just the opposite of what we 
expected. If all the available literature is 
gathered it conflicts and when it is summated no 
trend emerges. Eclampsia is either independent 
of HLA status or the association is so compli-
cated it defies present comprehension. 
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Jl.BSTPAcr 
The HLA status of 37 babies who were born to ?~rican r.others 
suffering fron eclampsia was determined. The B35 antigen was 
roore preval~'1t L'1 babies born to eclamptic mothers tb~'1 one 
would expect (p=O · 01). The nt...rrn1::er of shared antigens tetween 
roother and baby at the A and B locus was similar to that of a 
normal copulation. .. ~ 
INTRODUCTION 
There is no published evidence to sUPfCrt the hY};Xlthesis 
that eclampsia has an association with any mate~..al hurran 
leucocyte antigen (HIA) . Canbining the literature 
(2,12-14,16-19) a total of 330 pre-ecla~ptic or ecl&uptic 
mothers have been studied and no HLA association with the 
disease b~s emerged. Two hundred and seventeen fathers r..ave 
Copyright © 1991 by Marcel Dekker, Inc. 
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teen studied and they are indistinguishable fran the nomal 
fOpulation. F.ooever there are no studies of babies torn to 
eclamptic rrothers a..'1d there are onl ytwo pa,Pers reporting on 
the infant delivered. to pre-eclamptic mothers. scott et al 
( 18) measured the HLA status at the A locus in 10 babies l::orn 
to pre-eclamptic mothers and no trend emerged. Kilpatrick et 
al (14) studied 41 cases of rriild and severe pre-eclampsia aDd 
suggested an association with the fetal DR4 antigen. 
Cooper et al (8) recent I y e.xarni.ned the inheri tabili ty of 
eclampsia a'1d concluded that the fetal ga'1otype influa'1ces the 
susceptibility to the disease . HQ presumes that 
are the human leucocyte antigen (HLA) genes or are 




regarding the HLA status of African babies l::orn to eclamptic 
mothers. 
PATIENTS AND METHODS 
Thirty seva'1 black African females of Zulu origL' wTIO 
presa'1ted with a diagnosis of eclampsia or severe 
pre-eclampsia were studied over a one year ,Period. Only 
mothers with all the classic features of the disease were 
included (systolic blood pressure greater than 160 mm of 
mercury, a diastolic pressure greater than 115 mm of mer~i; 
grcss oedema and at least 2 pluses of proteinuriameasULred on 
400 
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a catheter specimen of urine with Ames sticks). 
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Thirty 
mothers had already suffered at least one seizure before 
admission, the remaining seven all had irritability or 
intellectual clouding and were hyperreflexic with clonus. 
MJthers with previous hypertension (Cooking bleed pressure 
>1 4 0/80 ) or a past historj of renal disease or those wb~ had 
not fully recovered by the seventh post-partum day to an 
aproteinuric normotensive state were excluded. As far as 
possible, sa11ples were collected consecutively but 11 cases 
were lost, either because insufficient bleed was obtained 
(n=4) or because of administrative reasons (rrothers delivering 
late on Friday night or on Saturday; n=7). 
The HIA, A, B a..."1d DR antigens were determined by a 2 
stage lymphocytotoxicity test (21) on 20 ml of cord blcx::::d 
obtained at the time of delivery. In 3 cases of stillbirth, 
cord bleed was insufficient and blood was taken by cardiac 
puncture fron the stilll:::orn infant. We were unable to measure 
the paternal HLA antigens. 
The prevalence of the A and B locus on the HIA systsn iL'l 
the no~al population was deteDnL'led by analysing 1416 blcx::::d 
donors of the same tribe and resident within the same hospital 
catchment area. Four hundred and twelve of these also acted 
as controls for the DR locus. If orily 1 antigen per locus 
could l::e detected, patients were considered to l::e harczygous 
at that locus. 
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Statistical analysis waS performed by Chi squared 
testing. As this the first study of its kind, we had no 
preconceived hypothesis to test and therefore multiple 
comparisons were performed and the p value was corrected by 
the Bonferoni inequality method (10) 
RESULTS 
The frequency of the HI.J'>.~ antigens in the nor:rnal 
population and in the fetus 1::orn to eclamptic mothers is sha-.n 
in table I. The B35 and the B14 antigen were more prevalent 
in babies born fo sufferers from eclampsia than one would 
expect (835 frequency = 22% cowpared with 6.7% . ..' 111 I . ne 
controls - Chi squared = 12.2, P corrected for multiple 
comparisons of the mean = 0·01; B14 frequencf = 16% compared 
with 7.5% in the control population - Chi squared = 7.1; P = 
I 
0·2 when corrected for multiple comparisons of the mean). The 
B8 antigen frequency was lcwer 1..'1 babies tom to eclarnptics 
but this probably occures by chance (Chi squared = 5.6, P 
corrected for multiple comparisons of the mean = 0·5). When 
compared with a control group babies tom to eclamptic mothers 
shcwed no variation in the numl:er of antigens at any locus and 
no specific A or D related antigen recurred more carmonly. 
The sample includes 3 neonatal deaths and 3 fresh stillbirtb~. 
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DISCJSSION 
The evidence that there is an immunogenetic aetiology to 
eclampsia is overwhelming (5.15). Hd~ever there is also SQITe 
evidence that there is a direct genetic component to the 
aetiol~i of the disease. Eclampsia rBs a familial trait 
( 3 • 4 • 7 ) is commoner if 
different racial stock (1) 
the subject's parents are fram 
and there is same protection fram 
the disease if the rrother is the prcxiuct of a consanguineous 
mating (20) 
This genetic link has been investigated by ~xamining the 
maternal histocompatability cCITpl~~. Jenkins et al 
(12) 
suggested that pre-eclampsia may be more common if the mother 
and father possess the same HLA antigens and RedITan et al (17) 
did suggest an excess of homozygosity at the B locus but this 
has not been confirmed (13) 
~~ation of family trees involving cases of eclampsia 
suggest that the irberited susceptibility of the disease may 
be linked to the fetus rather than the mother(S) 
OUr finding that the frequeI1CY of B35 antigen is 
significa~tly increased in the fetus born to an eclarr~tic 
mother (22% cm.pared with 5.7%) adds further support to the 
suggestion that the disease may be influenced by the genetics 
of the conceptus. As Ccovadia et al (g) has de.monstrated G1at 
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TABLE I Distribution of hunan lymphocyte a~tigens 
IJXUS A FETUS CONTROL 
ANTIGEN n = 37 1416 
1 2.7% 6.4% 
2 24% 21% 
3 13% 13% 
11 0% 0.1% 
23 22% 18% 
24 5 . 4% 4.9% 
25 16% 14% 
26 22% 10% 
28 16% 21% 
29 14% 17% 
30 22% 37% 
31 2.7% 6.0% 
32 2.7% 2.3% 
33 2.7% 2.2% 
hanozygous 35% 26% 
U:X:::US B FETUS mNTROL 
ANTIGEN n =37 1416 
5 0% 1% 
7 14% 20% 
8 0% 13% 
13 8.1% 4% 
14 16% 6% 
15 2.7% 4% 
16 0% 3% 
17 30% 39% 
18 14% 5% 
21 0% 2% 
22 0% 0.07% 
27 0% 0.3% 
35 22% 6 . 7% 
37 0% 0.07% 
40 0% 0.6% 
41 0% 1.5% 
42 14% 24% 
44 19% 15% 
45 5.4% 8.6% 
47 0% 0.1% 
53 0% 1.6% 
70 24% 14% 
hanozygous 32% 30% 
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TABLE I (continued) 



























neonates of Zulu decent are indistinguishable fran the nonral 
bleed donating members of the same society, our study and 
control groups hre lL~ely to be represa~tative of the fetus 
born to eclamptic and non eclamptic mothers respectively. 
Therefore our finding invites speculation on a possible 
mechanism that would explain the disease association. 
Because of linkage disequilibrium: (HLA genes associated 
with other specific ge..'1es) any association 1::etween any ~IA 
antigen and a disease means L'1at either (i) the allele 
responsible for the expression for the HLA antige..'1 is directly 
involved iI1 the pathogenesis of eclampsia, or (ii) L~e .ELA 
gene is associated with a second gene which is responsible for 
deteDnining eclampsia susceptibility. 
If the HIA gene was pathoge..'1ic it would r,ave to act as 
either a receptor for a noxious or infective agent, act as a 
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carrier for a carrier-hapten canplex or thirdly I act as a 
antigen that is familiar to the mother thus i..rlducing an 
auto immune response (5). This explanation seems unlikely for 
the following reasons; 
1) The trophoblast that is exposed to the rrother is free of 
transplant antigens. 
2) If pre-eclampsia depended uPJn a sLigle fatal gene
 
expressed on the fetal side the influence of parity would be 
diffiCJlt to ~~lain. 
3) It would be difficult to understand why exposL~g the mother 
to a blocd transfusion or to her par---ners leucocytes decreases 
the incidence of the disease rather than L~creasing it (11). 
Thus our obServed association is more l.L1(ely to be due to the 
involv~~nt of genes closely l.L~ed with the HLA cowplex. In 
other words theHLA genes are probably not involved with the 
causation of the disease but they are neutral markers of it. 
As the immune response genes and the HLA genes are spatially 
! 
intiwately related on the short ~~ of chromosome 6 and a 
functional link is kna.-m to exist in a..'1imals (22) it is 
plausible that there is an imnune resporlse gene associated 
with both the B35 antigen and ecl~psia susceptibility. 
The presence of the disease in only a ~ll fraction of 
those carrying the antigen may be explained by the following. 
1) The association is due to a second as yet undiscovered 
allele located at a different but closely linked l~~ and 
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this gene OCCJrs with a different frequency than the B35 
antigen. 
2) Eclampsia is influenced by enviro~ental factors and the 
fetal genoty~ ~~ot be expected to influence more trat L~e 
susceptibility to the disease. 
3) Other genetic factors not li..'1ked to the B35 antigerl nay 
contribute to the disease susceptibility. 
4) Eclampsia is aLuost certainly a disease with a 
multifactorial aetiology a~d therefore the observed 
association nay only be apparent in a subset of the 
FOpulation. 
Unfortunately our current knowledge of immunology and 
eclampsia permits little more tha~ speculation . However it is 
possible that the fetal genotype nay possess the genetic ~ake 
up to influence patholoqf in the mother. 
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HLA AND SELECTIVE MATING 
Michael G Hammond! 
ABSTRACT 
The selection of a mate by female semi-wild mice is influenced by the major 
histocompatibility complex (MHC)!. The role of the MHC in human mate 
selection is investigated by analysing the distribution of human leucocyte 
antigens (HLA) in couples. The frequency of sharing of HLA antigens 
showed no significant differences from that expected by chance but there are 
significant differences in the frequencies of some of the HLA B locus antigens 
in males selected by females with specific HLA antigens. 
ABBREVIATIONS 
MHC major histocompatibility complex 
BSR basal sharing rate 
INTRODUCTION 
Potts et al. I showed that female semi-wild mice selected males that were 
disparate for MHC. The lack of homozygous progeny can be explained if the 
female avoids mating with males that possess the same MHC antigens. Does 
this selection process occur in humans? 
METHODS 
The data base I chose for analysis consisted of 837 couples who were typed for 
HLA to determine paternity of their offspring. There were a further 27 males 
from paternity investigations involving two men. All subjects were 
Caucasian. 
The number of couples who shared HLA antigens at the A, B or C locus was 
counted. The probability of two random people sharing HLA antigens was 
calculated using the formulae of Koyama et al. 2 and defined as the basal 
sharing rate (BSR). The BSR was calculated using the gene frequencies in 
males, females and in the combined frequencies. The BSR was also 
calculated using the gene frequencies in 643 blood donors as a control 
population. The significance of the differences were determined with the chi-
! Natal Institute of Immunology, PO Box 2356, Durban, South Africa. 
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squared test. Couples where the man was shown not to be the father were 
then removed from the data base and the calculations repeated. 
Another data base was built up consisting of couples drawn from family studies 
performed for transplantation. Ninety one couples were analysed in the same 
way. The results are shown in Table 1. 
RESULTS AND DISCUSSION 
If selection by females is on the basis of avoiding males who possess the same 
MHC antigens, then the degree of sharing would be lower than that expected 
by chance. There were no significant differences in the sharing rate when 
comparing all possible pairwise combinations at each locus using the chi-square 
test. No significant differences were observed in couples where there was no 
exclusion. The sharing rate in family couples was slightly higher but not 
significantly so. If selection based on HLA was present, then two men 
selected by the same woman would be expected to have some HLA antigens 
in common. The sharing rate of 27 male pairs in this category was not 
significantly different. 
However, this does not rule out the possibility that the MHC genes are 
involved in mate selection in human populations. Perhaps the possession of 
specific antigens forms the basis of selection? This was investigated by 
frequency analysis of the males chosen by females possessing specific HLA 
alleles. Those antigens which were significantly increased (p<0.01) in 
frequency in males are shown in Figure 1. If the increase was highly 
significant (p<0.001), the frequency is shown in a box. The matrix has 44 
x 44 entries so that about 20 entries would be expected to be increased by 
chance and about two entries with p < 0.001 but there are 38 frequencies that 
are significantly increased and ten of these have a probability less than 0.001. 
This indicates that at least some of the HLA antigens may be involved in mate 
selection. 
Most of the increases are in the lower right quadrant of the matrix so that the 
HLA B locus antigens appear to be more influential. Linkage disequilibrium 
may account for significant increases at adjoining loci; e.g. the significant 
increase in the frequency of HLA B27 probably accounts for the increased 
frequency of Cw2. There are three entries on the diagonal. Do females with 
HLA A2, HLA B37 and HLA B51 prefer males with the same antigen? 
This contradicts the overall finding that there was no increase in shared 
antigens and may be due to chance. An analysis of frequencies that were 
significantly decreased produced a matrix (Figure 2) with only ten entries 
which is lower than would be expected. None of the decreases were 
significant at p < 0.00 1. 
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These findings suggest that in humans, females do not appear to select males 
on the basis of avoiding males with the same antigens as themselves or by 
avoiding males with a specific antigen but rather on the basis of selecting 
males with specific antigens, dependent on their own antigenic phenotype. 
The HLA B locus appears to be more important than HLA A or HLA C but 
another independent survey is needed to determine which of the more than 30 
antigens at this locus are important for mate selection. It may also be that, as 
in the many disease associations that have been reported, the Class n antigens 
(HLA DR, DQ, DP) have a more important role. 
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Matrix showing percentage frequencies of HLA antigens that 
are significantly increased (p < 0.01) in males selected by 
females with the HLA antigen shown at the top of the matrix. 
Frequencies in boxes are significantly increased with p < 0.001. 
Significance was determined by the chi-squared test. 
Matrix showing percentage frequencies of HLA antigens that 
are significantly decreased (p < 0.01) in males selected by 
females with the HLA antigen shown at the top of the matrix. 
There were no frequencies significantly decreased with 
p < 0.001. Significance was determined by the chi-squared test. 
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Table 1 Observed and expected sharing of HLA antigens in percent. 
HLA LOCUS 
A B C 
Number of antigens tested 14 23 7 
Observed in 864 couples 46.5 21.9 11.9 
Observed in 653 couples 45.8 20.7 12.1 
with no exclusion 
Observed in 27 male pairs 37.0 25.9 7.4 
Observed in 91 families 47.3 30.8 6.6 
BSR 864 males 43.2 22.8 10.9 
BSR 837 females 43.6 25.3 10.9 
BSR 1701 both 43.3 23.9 10.8 
BSR 643 controls 40.3 27.1 10.5 
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Clearly established genetic factors" associ-
ated with duodenal ulcer are blood group 
o and non-secretor status. In a search for 
further genetic factors Rotter et al. (1979) 
determined the HLA antigens of 77 
patients with duodenal ulcer and found a 
significant increase" in the frequency of 
HLA-B5 in the 54" Caucasian patients. We 
therefore decided to test Indians with 
duodenal ulcer because the frequency of 
B5 in the Indian population is relatively 
high (34%) and a survey of duodenal ulcer 
in Indians by Robbs & Moshal (1979) has 
shown that Durban may be regarded as an 
area of high prevalence and that this 
dIsease is a major problem in the Indian 
population. 
A total of 180 antisera were used in a 
two-stage microlymphocytotoxicity test to 
determine the HLA antigens of 94 Indians 
with duodenal ulcer (confirmed by endo-
scopy). 
The antigen B5 IND was assigned to 
those B5 cells that are not Bw51 or Bw52 
and probably includes the recently de-
scribed antigen Bu (Laundy et al. 1978). 
The antigen frequencies are listed in 
Table 1. The distribution of antigens at the 
A and B loci conformed to Hardy-Weinberg 
equilibrium. In contrast to the findings of 
Rotter et al. (1979), the frequency of B5 
was decreased and the frequency of Bw51 
was small enough to give an uncorrected P 
value of less than 0.01. The frequency of 
Bw52 was approximately the same in the 
patients and the controls. 
There was an increased frequency of 
B40.2 (uncorrected P < 0.01) and a 
decrease in the frequency of B40.1. None 
of these differences retained their signifi-
cance after correcting for the number of 
antigens tested. The splitting of B5 and 
840 into subdivisions still poses problems 
which may be solved in the future by 
better sera and International Workshops. 
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Table 1 
Percentage frequency of HLA antigens in Indians with duodenal ulcer (DU) 
Control DU Control DU 
HLA 632 94 HLA 632 94 
Al 27.9 30.9 B7 12.5 14.9 
A2 31.3 29.8 B8 5.9 4.3 
A3 14.6 11.7 BB 6.8 2.1 
All 27.5 31.9 B14 0.3 1.1 
Aw23 0.6 0 B15 10.9 11.7 
Aw24 27.1 31.9 B16 2.2 3.2 
A25 1.9 2.1 B17 21.2 22.3 
A26 6.3 5.3 B18 3.0 1.1 
A28 14.4 5.3 Bw21 1.7 2.1 
A29 0.8 2.1 Bw22 2.5 4.3 
Aw30 4.0 3.2 B27 2.5 7.4 
Aw31 3.5 2.1 Bw35 20.6 19.1 
Aw32 2.5 0 B37 4.1 7.4 
Aw33 7.4 12.8 B40 29.1 35.1 
1 Antigen 30.2 30.9 B40.1 13.4 6.4 
B40.2 15.7 28.7· 
Bw42 0 0 
Bw44 12.0 10.6 
Bw45 0.2 1.1 
B5 34.2 25.5 
Bw51 22.5 10.6· 
Bw52 8.4 10.6 
Bw53 1.9 1.1 
BS IND 3.3 4.3 
1 Antigen 28.3 25.5 
• P (uncorrected) < 0.01. 
Details of ethnic subgroup and phenotype of each patient have been submitted to the HLA and 
Disease Registry. 
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Measles, Histocompatibility Leukocyte Antigen Polymorphism, and 
Natural Selection in Humans 
H. M. Coovadia, A. Wesley, M. G. Hammond, and 
P. Kiepiela 
From Ihe Deportment of Pediotrics and Child Health, 
Medical School; and tire Nolol Institute of Imlllunology, 
University of Notal, Durban, South Africa 
Profound lymphocytopenia «2,000 lymphocytes/mm J ) occurring within two days of 
rash in 69 South African black children with measles predicted either death or progres-
sion to chronic lung disease in 51 (770/0) of 66 children who were followed for at least six 
weeks. Lymphocytopenia was significantly associated with the presence of histocom-
patibility leukocyte antigen (HLA) A W32 (P = 0.01), with a relative risk of 5.5. There 
was a trend toward an association between the presence of particular antigens in the 
HLA complex and the various indices of humoral and cellular immunity studied. These 
findings are discussed in terms of variation in the clinical spectrum of the disease and in 
relation to the evolution of HLA polymorphism. 
The consequences of infection with measles virus 
are recovery, chronicity, or death. This clinical 
spectrum is determined by the severity of immuno-
paresis at the onset of illness [1]. One component 
of this immunoparesis is the sp~cific antibody re-
sponse, which, if impaired, leads to severe disease 
if cell-mediated immunity is also impaired [2]. The 
ability of the human host to produce antibody to 
measles virus is controlled by genes linked to the 
histocompatibility leukocyte antigen (HLA) com-
plex [3-5], but there is little evidence to suggest 
that clinical outcome is under a similar innuence 
[5]. In both experimental animals [6, 7] and in hu-
mans [8-10], genes linked to the major histocom-
patibility complex control immune responsiveness 
and can therefore modify the course and outcome 
of infectious illnesses [11-13]. 
It is believed that the extreme polymorphism of 
the HLA system has arisen during evolution 
through the process of natural selection [14]. In-
fectious diseases, which have taken a massive toll 
of human life throughout history, may have ex-
erted selective pressure on antigens of the HLA 
complex. Several investigators have studied the as-
sociation between particular antigens of the HLA 
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complex and infections [12, 15], but few [la, 16] 
have linked the HLA complex with the clinical 
features or immune responses of a disease that has 
been and still is a major human killer. Even in the 
absence of protein-calorie malnutrition, measles 
can be a severe disease in children in developing 
countries [17]. We report a study of the HLA 
system in relation to both clinical severity and im-
mune responsiveness in children with measles. 
Subjects and Methods 
HLA frequencies were determined in 69 South 
African black children with severe measles. 
Nutritional status. The nutritional status of 
the patients studied was satisfactory. All patients 
were between the 10th and 75th Harvard percen-
tiles for weight [18], with serum albumin levels of 
>30 g/Iiter and without any of the clinical features 
of protein-calorie malnutrition. 
Age and sex distribution. The median age of 
the 33 female children was 12 months (range, 25 
months); that of the 36 male children was about 16 
months (range, 54 months). 
Definitio" of severe measles. Severe measles 
was defined by the presence of a count in peripher-
al blood of <2,000 lymphocytes/mm J within two 
days of the appearance of rash. This degree and 
timing of lymphocytopenia have been shown to be 
indicative of subsequent death or progression to 
chronic chest disease in 770/0 of patients [17]. 
Outcome of measles. The clinical outcome 
was assessed six weeks after the onset of rash, 
when patients were classified as having recovered, 
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died, or developed chronic chest disease. Recovery 
or chronicity was determined by the presence or 
absence of pneumonia, respectively, detected 
radiologically [17]. Bronchopulmonary changes 
were graded on a total of 11 points; an abnormal 
score was ~4. Children with an abnormal score 
were classified as having chronic chest disease, 
and those with a score of <4 were classified as re-
covered. Chronic chest disease or death was a 
poor outcome, and recovery was a good outcome. 
Control subjects. Because the attack rate for 
measles is almost 100070, the frequencies of parti-
cular HLA types among healthy adult black 
Africans, many of whom were studied for interna-
tional workshops [19, 20], were used as the normal 
distribution. The African population of Durban, 
South Africa, consists mainly of Zulus, and the 
patients and control subjects were of pure descent. 
The possibility that a comparison of HLA fre-
quencies in infants with HLA frequencies in adults 
may not be valid was investigated by comparing 
frequencies in normal infants (never infected with 
measles virus). Cord blood specimens from 51 
black neonates and sera from 32 black infants 
younger than five years of age who were subjects 
of paternity disputes were tested for HLA types. 
Immunologic tests. The results of immuno-
logic tests (table I) performed within 48 hr of the 
onset of measles rash were used for correlations 
with HLA typing. The criteria are based on pre-
vious observations of Iymphocyte subpopulations 
[17] and are arbitrary cutoff points for titers of CF 
and HAI antibodies, inhibition index (see below), 
and levels of C3. Immune functions were categor-
ized as good or poor. 
HLA typing. The patients were typed for 
HLA-A, -B, and -C specificities using 180 antisera 
in a two-stage Iymphocytotoxicity test [21]. Lym-
phocytes were isolated on a Ficoll-Hypaque den-
sity gradient. Differences in HLA frequencies 
were tested for significance with a X2 test (without 
Yates's correction), and the resulting probabilities 
were corrected by multiplying by the number of 
antigens tested . 
Lymphocyte subpopulatiolls. Mononuclear 
cells were obtained from defibrinated peripheral 
blood that had been passed through columns of 
Ficoll-Hypaque. Lymphocyte subpopulations were 
counted in a single preparation by means of sheep 
erythrocytes and by an immunofluorescence 
method for detecting immunoglobulins [22]. Pe-
143 
Table 1. Criteria used for categorizing immune func-
tions in African children with severe measles within 48 
hr of the onset of rash. 
Response 
Function Good Poor 
CF antibody titer ?:1:8 <1:8 
HAI antibody titer >1:8 ~1:8 
Inhibition index· Positive Negative 
T cells (cells/ mm') ?:I,268 <1,268 
B cells (cells/mm') ?:556 <556 
Null cells {cells/ mm,)t ?:1I6 <116 
C3 (mg/lOO ml) ?:70 <70 
NOTE. The criteria are based on previous observations or 
Iymphocyte subpopulations 1171 and are arbitrary cutorr points 
ror the other runctions . 
• See Subjects and Methods. 
t Cells lacking surrace markers or B or T cells. 
ripheral Iymphocytes were classified as rosetting 
cells (T), fluorescing cells (B), cells with no 
markers (null), and those with both markers. 
Antibodies to measles virus. Titers of CF anti-
body to measles virus were measured in sera by a 
microtiter method using specific antigen. Titers of 
measles-specific antibody were also measured by 
the HAI test with antigen from Behringwerke 
(Marburg, Federal Republic of Germany). 
Inhibition of leukocyte migration. Leukocytes 
obtained by dextran sedimentation of whole blood 
that had been treated with heparin were incubated 
for 24 hr in agarose petri dishes in the presence or 
absence of measles virus CF antigen. The degree 
of migration was measured by projection. The 
percentage migration inhibition was calculated as 
follows: (the extent of migration with antigen/the 
extent of migration without antigen) X 100. The 
percentage inhibition index was calculated as: 
100% - the percentage migration inhibition. 
C3. Levels of C3 in plasma were measured by 
radial immunodiffusion. 
Results 
The clinical outcome at six weeks could be assessed 
in 66 of the 69 children with severe measles. Five 
children died, the illness progressed to chronic 
cht~t disease in 46 children, and 15 children 
recovered. 
There were no significant differences in the fre-
quencies of HLA types among the 51 neonates, 
the 32 subjects of paternity disputes, and the 1,081 
423 
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Table 2. Percentage frequency of individual antigens 
of the histocompatibility leukocyte antigen (HLA) com-
plex in South African black children with severe measles 
and in control subjects . 
Controls Patients 
HLA type (n = 1,132) (n = 69) 
AI 6.4 11.6 
A2 21.3 10.1 
A3 13 . 1 7.2 
All 0.1 1.4 
AW23 18.4 14.5 
AW24 3.8 4.3 
A25 15 .3 20.3 
A26 8.8 11.6 
A28 21.1 26.1 
A29 16.2 20.3 
AW30 37.5 26.1 
AW31 9.3 7.2 
AW32 2.0· \0.1· 
AW33 2.7t 4.3 
One antigent 24.0 24 .6 
B7 18.2 21.7 
B8 14.1 \0.1 
BI3 4.4 1.4 
BI4 5.7 1.4 
BI5 4.9 1.4 
BWI6 2.4 4.3 
B17 38.7 44 .9 
BI8 4.9 5.8 
. BW21 1.1 1.4 
BW22 0 0 
B27 0.3 0 
BW35 6.3 7.2 
B37 0 0 
BW41 2.1 t 0 
BW42 24.7 15.9 
BW44 15.7 15.9 
BW45 7.6 8.7 
BW46 0 0 
BW51 1.8 4.3 
BW52 0 0 
BW53 3.4 1.4 
BW60 1.0 2.9 
BW61 0 0 
One antigent 42.7 50.7 
NOTE. Severe measles was defined by the presence of a 
count in peripheral blood of <2,000 Iymphocytes/mm' within 
two days of the onset of rash . The control group comprised 
1,081 randomly chosen adults and 51 neonates. 
• P < 0.016 (corrected for the number of antigens tested) . 
t Of 146 controls . 
t Only one antigen detected at the A or B locus. 
randomly chosen adults. The A W32 antigen was 
found in two (3.96,10) neonates and one (3.1 %) of 
the infants younger than five years of age - three 
(3.6%) of the combined group. Nineteen (1.8%) 
of the 1,081 randomly chosen adults possessed the 
A W32 antigen. We therefore combined as the con-
Cool'adia et al. 
trol group the randomly chosen adults and the 
neonates and excluded the infants tested in pater-
nity disputes; the frequencies of HLA types in the 
control group were compared with those in the pa-
tients with severe measles. 
There was a significant excess of HLA-A W32 in 
the group of 69 children with severe measles 
«2,000 lymphocytes/mm 3) as compared with the 
control group (corrected P = 0.016) (table 2). The 
relative risk of developing lymphocytopenia in in-
dividuals possessing HLA-A W32 was 5.5. None 
of the other HLA types examined showed signifi-
cant variations between patients with measles and 
the control group when corrections were made for 
the number of antigens tested. 
The distribution of HLA types in children with 
a good clinical outcome from severe measles was 
similar to that in those with a poor outcome, and 
neither clinical subgroup had a significantly dif-
ferent distribution of HLA types from that 
detected in normal persons. HLA-A W32 (as 
would be expected from its deviation from a nor-
mal distribution in the control group) was in-
creased in comparison to the control group in both 
clinical subgroups . 
No other individual HLA types and the param-
eters of immunity studied were significantly asso-
ciated (table 3). However, there was a trend to-
ward the presence of HLA-Al in good responders 
in tests of humoral and cellular immunity - CF 
and HA! antibodies; T, B, and null cells; and in-
hibition index-and toward the presence of HLA-
A W32 in good responders for T, B, and null cells. 
There was a similar trend toward the absence of 
HLA-BW42 (a common HLA type in blacks) 
among good responders for CF and HA! an-
tibodies and T and B cells. A25 and A29 antigens 
were associated with a poor response for some 
components of the immune response (table 3). 
The presence of particular HLA-C types did not 
correlate with lymphocytopenia, clinical outcome, 
or immune responses. 
Patients with a good T -cell response also had a 
good B-cell (X2 = 24.8; uncorrected P < 0.0001) 
and good null-cell (X 2 = 6.4; uncorrected P < 
0.02) response. Those with a good null-cell re-
sponse also had a good B-cell response (X 2 = 6.8; 
uncorrected P < 0.01) . 
Discussion 
Measles, like most other infections, causes minor 
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Table 3. Percentage frequency of nine antigens of the histocompatibility leukocyte antigen complex in 69 South 
African black children with severe measles . 
Only one 
Immune function, antigen at 
response (11) AI A25 A29 AW30 AW32 B7 BI8 BW42 BW51 the B locus 
CF antibodies 
70.6 
Good (17) 17 .6 17.6 17.6 29.4 5.9 17 .6 1.8 5.9 0 
Poor (37) 8.1 18.9 21.6 24.3 10.8 27 .0 5.4 16.2 5.4 
37 .8 
HAI antibodies 
Good (11) 27 .3 9.1 9.1 36.4 9.1 36.4 9.1 0 0 54 .5 
Poor (24) 8.3 33.3 33 .3 25 .0 8.3 20.8 4.2 25.0 0 50.0 
Inhibition index· 
Good (20) 25 .0 25 .0 15.0 35.0 5.0 30.0 0 15 .0 5.0 55.0 
Poor (15) o · 33.3 40.0 20.0 13.3 20.0 6.7 13.3 13.3 33 .3 
T cells 
Good (19) 2\.1 5.3 5.3 31.6 21.1 21.1 5.8 5.3 10.5 57 .9 
Poor (37) 10.8 29 .7 32.4 21.6 S.I 27.0 2.7 13.5 2.7 45.9 
B cells 
Good (11) 27 .3 0 0 36.4 27.3 18.2 9.1 0 0 63 .6 
Poor (42) 11.9 26.2 26.2 21.4 9.5 28 .6 7.1 9.5 7.1 45 .2 
Null cellst 
Good (16) 25.0 IS.8 6.3 IS.S 25 .0 IS.S 6.3 12.5 6.3 50.0 
Poor (35) 11.4 20.0 2S.6 28 .6 8.6 25.7 S.6 S.6 5.7 51.4 
C3 
Good (22) 13.6 18.2 13 .6 18.2 13.6 31.S 9.1 22 .7 4.5 40.9 
Poor (40) · 12.5 22.5 25 .0 35.0 10.0 15.0 5.0 10.0 5.0 55 .0 
NOTE. Severe measles was defined by the presence of a count in peripheral blood of <2,000 Iymphocytes/ mm l within two days 
of the onset of rash . See table I for definitions of good and poor immune responses. 
• See Subjects and Methods. 
t Cells lacking surface markers of B or T cells. 
effects in the vast majority of children in the de-
veloped world. Among poorer nations, the ad-
verse effects of protein-calorie malnutrition in 
children with measles result in high morbidity and 
mortality. However, even when protein-calorie 
malnutrition has been carefully excluded, measles 
remains a severe disease in a significant minority 
of hospitalized African children [17]. The propor-
tion of this minority of children with severe mea-
sles can vary between communities, and the prob-
able reason for this variation may be a genetic pre-
disposition in some individuals to the development 
of severe disease. We have shown in the present 
report that this genetic tendency indeed may be the 
case. 
Severe lymphocytopenia during exanthem in 
measles has been unequivocally demonstrated to 
be a reliable index of severity [I, 17]. More than 
three-quarters of children with counts of <2,000 
lymphocytes/mm3 at the onset of measles subse-
quently die or develop prolonged chest disease. 
This degree of lymphocytopenia, however, is 
detected in only a small proportion (90/0) of all 
African children with measles. I The present study 
has shown that the development of severe lymph-
ocytopenia in African children with measles is 
linked to the presence of HLA-A W32. The anti-
body response in humans with measles has also 
been reported to be under the control of genes 
linked to the HLA system [3-5]. Kreth et al. have 
demonstrated that there is a major histocom-
patibility complex-restricted killing of target cells 
infected with measles virus by cytotoxic T cells 
[23], but this observation was not confirmed by 
Perrin et al. [24]. There is suggestive, although not 
conclusive, evidence in measles-inexperienced 
populations vaccinated against measles virus to in-
dicate that the febrile response may be influenced 
by HLA genes [5]. Taken together, these findings 
lead to the conclusion that HLA-linked genes 
determine immune responsiveness and may in-
fluence clinical outcome in measles. The results of 
, H. M. Coovadia, "Host Allergic Respon~e in Children with 
Measles Infection," M.D. thesis, University of Natal, Congel-
la, Durban, South Africa, 1977, p. 85 . 
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the current study reinforce the concept that within 
a community there is a group that is genetically 
susceptible to the development of severe measles. 
The degree of susceptibility might vary between 
populations, depending on the frequency of the 
HLA-linked susceptibility. The variation may be 
the effect of dissimilar historical and evolutionary 
pressures exerted on different populations. 
Because the linkage disequilibrium pattern for 
alleles at HLA loci differs among populations, 
susceptibility to severe measles may be detected 
with antigens other than HLA-A W32 in other 
populations. 
Although we used profound lymphocytopenia 
as a marker of severe clinical measles, 23070 of 
these children subsequently recovered. Associa-
tions with particular HLA types were not detected 
in the subgroup who recovered or in those who did 
not in comparisons between the subgroups and 
with the control group. The numbers in the sub-
groups were, however, small, so that factors other 
than lymphocytopenia could also have influenced 
the outcome. These factors may be under separate 
genetic control. The trend towards linkage be-
tween the presence of particular HLA types and 
the various parameters of immunity studied (table 
3) supports this suggestion. Paradoxically, the 
presence of HLA-A W32, which is associated with 
severe lymphocytopenia, showed a trend toward 
good responses for T, B, and null cells (table 3). 
However, the tend~ncy toward an association be-
tween the presence of HLA-A W32 and poor re-
sponses for CF antibodies and inhibition index 
and the failure to detect a correlation between 
clinical outconie and particular HLA types suggest 
that severe measles is only indicated by lymphocy-
topenia (and therefore the presence of HLA-
A W32); the outcome is the result of a more com-
plex interplay of immune reactions [25] which the 
present study has not elucidated. 
An important application of associating the 
presence of HLA types with particular diseases 
has been the classification of diseases intocate-
gories according to the degree of association with 
one or another locus of the HLA complex. Two 
examples are the association of ankylosing spon~ 
dylitis with B-Iocus antigens and of autoimmune 
diseases with 0- and OR-locus antigens [26]. Tests 
for detecting 0- and OR-locus antigens were un-
available for this study. However, the association 
of occurrence of severe measles with an A-locus 
gene is unusual. Two diseases that have shown an 
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associatIOn with A-locus antigens are idiopathic 
hemachromatosis with HLA-A3 and pemphigus 
with HLA-AlO. An explanation for this associa-
tion may be found in Zinkernagel's hypothesis 
that clinical outcome is dependent on both host 
immune responsiveness and virus cytopathogen-
icity [27]. Accentuated host responsiveness results 
in autoimmune diseases, whereas low responsive-
ness predisposes to damage by acute virus infec-
tions. It is therefore not unexpected that suscepti-
bility to the damaging effects of measles virus 
relates to a locus different from that associated 
with autoimmune diseases. The immune response 
to measles has been shown to be frequently 
associated with A-locus genes [4, 5]. The finding 
of an association between severe measles and a 
particular HLA type suggests that during previous 
measles epidemics of catastrophic proportions, in-
dividuals without that HLA type or other linked 
types at this locus would have been favored for 
survival. This hypothesis would be an example of 
linkage disequilibrium in which HLA-A W32 oc-
curs in combination with another susceptibility 
antigen more frequently than would be expected. 
Although the relative risk for persons possess-
ing HLA-A W32 of developing severe measles (5.5) 
is considerably less than that for persons possess-
ing HLA-B27 of developing ankylosing spondy-
litis and for those possessing O-locus antigens of 
developing autoimmune diseases [28], it is similar 
to calculated risks for HLA types and other infec-
tious diseases (for example, tuberculosis and 
leprosy) [15]. These relative values are in accord-
ance with the idea that associations with particular 
HLA types are more likely to be detected in auto-
immune diseases, which have little effect on the 
survival of the species, rather than with infectious 
diseases, which can have major effects [27J. 
The comparison of HLA frequencies between 
children with measles and adult control subjects is 
not inappropriate. The HLA distributions among 
neonates, infants, and adults of the ethnic group 
studied were similar, and the distribution of HLA 
types in the patients conformed to Hardy-
Weinberg equilibrium (x\! for heterogeneity at 
the A locus = 89.25, P = 0.5; X2 !20 for hetero-
geneity at the B locus = 93.4, P> 0.95). 
The mechanisms of genetic control of lympho-
cytopenia in measles are not known. They could, 
however, involve some of the explanations re-
viewed by Svejgaard et al. [29]- in particular, those 
relating to immune response genes, molecular 
Measles alld /lLA Polymorphism 
rrumlcry, and virus receptor function. HLA-A W32 
may in fact serve this last mentioned function. 
We have demonstrated an HLA-Iinked genetic 
control (which is probably polygenic) of severe 
measles, discussed the findings in terms of varia-
tion in clinical spectrum of the illness among indi-
viduals and between communities, and noted the 
implications for evolution of HLA polymorphism. 
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rheumatic heart disease 
I. E. HAFFEJEE*. M. G . HAMMONot AND A . MOOSA* 
... /)epartmcnt o( f'acdiatrics and Child lI('allh, KinR !:lhl'ard Vlllllospital and FacilIty o( Medicinc. Ullil'crsity 
of Nawl, /)lIr;'all, SOllth A(rica and tNatallmtitlltc o( 11I1I1l/II/()I()~y, Dllrhan, SOllth Africa 
Rccc;l'ci/: 24 NOI'clllhcr 1981 
SUMMARY The high incidence of rheumatic heart disease (RHD) in black South African 
children has been attributed mainly to poor socio-economic status and over-crowding. In order to 
clucida te whether other factors. in particular genetic. were responsible, the H LA-status of 61 black 
children with rheumatic heart disease was compared with that of 1165 normal controls. Overall, 
no differences were found. except a higher incidence of HLA-B25 and BW51 in the group with 
rheumatic heart disease. when the difference was not of statistical significance. Moreover. when the 
patients were considered in two groups. viz. (a) a "surgical" group which required cardiac surgery 
and (b) a "non-surgical" group in which cardiac failure was absent or could be easily con-
trolled by medical therapy. the difference between the two groups was also not of statistical sig-
nificance, though there was a higher incidence of H LA-A 10 (which includes H LA-A25 and A26) 
in the "non-surgical" group. 
These data appear to agree with the results of other studies which found no significant association 
between HLA-status and RHO. . .J 
Introduction 
It is well recognized that the incidence of rheumatic 
heart disease (RHO) in South African blacks is high . 
III 1972 the Soweto survey showed a prevalence rate 
of 6·9 per 1000 black children between the ages of two 
and 18 years (I). Chesler cl a/. working at Rarag-
wanath Hospital. lohannesourg. found an incidence 
or acute rheumatic fever of the order of 10·6 cases per 
1000 paediatric admissions over a period or three 
years, of whom !n:~:, had carditis (2). In a recent joint 
survey of hospital admissions for rheumatic fever 
carried out in Cape Town. Ouroan and 10hannes-
ourg (3). carditis was present in 70" .;, of olack children 
presenting with rheumatic fever ror the first time. 
It has also been noted by various authors that 
rheumatic heart disease is much more severe in the 
Correspondence to: I. E.llafTejec. Department of Paediatrics 
and Child I lealth. Faculty of Medicine. University of Natal. 
P.O. Box 17039. Congclla. Durhan. 4013. South Africa . 
()~n 49J6/ H~10IOOI7 + Of) $02 .00;0 
olack child. and tends to occur at a relatively younger 
age (4) . In the Baragwanath study (2). 13 ·4X, were 
below fiVe years of age. Most workers attribute the 
high incidence of rheumatic heart disease in develop-
ing countries to' overcrowding and poor socio-
economic status: the truth of this is undisputed. 
However. some reports (5.6) indicate that there may 
be a familial susceptibility to the acquisition of group 
A-haemolytic streptococci and of rheumatic fever. 
Stevenson and Cheeseman (7). in a study of 462 
families with 2038 children. found that inheritance was 
an important factor in rheumatic fever but that it did 
not follow a Mendelian pattern. Others have found a 
higher incidence of ABO non-secretors in rheumatic 
suojects than among healthy school children (8). 
although the numoers were too small to warrant 
definite conclusions. A lower frequency or blood 
group 0 has also been reported in rheumatic 
children (8- 10). Recently. attention has oeen focused 
on a possible association between acute rheumatic 
fClter and/or rheumatic heart disease on the one hand 
© 19H2 Liverpool School of Tropical Medicine 
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and histocompatibility antigens (HLA-antigcns) on 
the other (11 - 17) (Table I). Since these antigens are 
genetically inherited, a strong association between a 
particular HLA-antigen and a specific disease might 
favour predisposition to that disease in individuals 
possessing such an antigen. It will be observed from 
Table I that such an association has not becn con-
sistently reported by previous workers. 
Because of the high incidence of rheumatic heart 
disease in black South Africans and of the tendency 
for many of them to develop severe or advanced 
cardiac lesions early in life, it was thought that HLA-
testing in this particular group of individuals might 
shed some light on the subject. 
Definitions 
Materials and methods 
From 24 April 1979 to I May 1980, 61 children, 
aged five to eleven, were admitted to the general 
paediatric wards of King Edward VIII Hospital, 
Durban, with rheumatic heart disease. Fifty-three had 
active carditis according to the Modified Jones 
Criteria (18) . In one carditis was thought to be 
probably active, in two there was complicating in-
fective endocarditis an<;l in the remaining five, without 
active carditis, there were established mitral valvular 
lesions due to well-documented previous attacks of 
rheumatic carditis . None of the children were related. 
Children witfi acute rheumatic fever without carditis 
were not included in the study. In only one case 
was there a family history of "heart disease" . In 54 
there was no family history of eithcr rheumatic fever 
or rheumatic heart disease, and in six no family history 
could be obtained . Thirteen ~f the 53 children with 
active carditis were seen during their first attack of 
carditis, and in a further eight the attack was 
probably the first. In 23, an active carditis was super-
imposed upon chronic rheumatic heart disease, in 
three the attack was thought to be probably a re-
currence, and in six we were unable to ascertain 
whether their carditis was caused by an initial attack 
or a recurrence (Table 11). Thus, at the time of in-
vestigation at least 28 children (probably 31) had 
established rheumatic heart disease with valvular 
lesions. Informed consent for investigation was ob-
tained from the parents, and, in some cases where the 
child was old enough, from the patient. 
HLA-Typing 
The patients werc typed for filA A-B-C anti-
gens using 180 antisera in a two stage Iymphocyto-
toxicity test (19). lymphocytes were isolatcd on a 
Ficoll-Hypaque dcnsity gradient (20) . Typing was for 
the following antigens : HLA-A I, 2, 3, 11, 25, 26, 28, 
29; A W23, A W24, A W30, A W3), A W32 and A W33; 
HLA-B7, 8, 13, 14, 15, 17, 18, 27, 37; BWI6, 
BW2), AW22, BW35, AW41, BW42, BW44, BW45, 
BW46, BW51, BW52, BW53, BW60 and BW61; and 
CWI, CW2, CW3, CW4 and CW5 (a total of 42 
antigens) . 
The HLA antigen frequencies in 61 patients were 
compared with those in a healthy control popUlation 
consisting of randomly chosen blood donors and stalT, 
many of whom were typed for International Work-
shops (21, 22). All the patients and controls were 
typed in the laboratories of the Natal Institute of 
Immunology using standardized National Institute of 
Health technique (23) . The Negro population of 
Durban consists mainly of Zulus and the patients and 
controls studied by us were of pure descent. Com-
parisons of HLA frequencies in children and adults 
show no significant differences (24). The same applies 
to sex (25, 26) and to place of residence, i.e. whether 
rural or urban (27). 
Statistical methods 
HLA antigen frequencies in patients and controls were 
compared using the Chi square (xl) test. Yates' cor-
rection was used when expected values were less than 
four . The resulting probabilities were corrected (for 
multiple testing) by mUltiplying by the. number of com-
parisons made, i.e . the number of dilTerent antigens 
tested. 5% was taken as the level of significance. 
Results 
Clinical data: 
(i) Age oJ children: Figure I shows the age distribution 
of the 61 children; the peak at seven to nine years of 
age is in keeping with the findings of Nadas and 
Fyler (28). There was, however, an appreciable pro-
portion of cases in the five to six year age group. 
(ii) Sex: There were 34 males and 27 fcmales, giving 
a male-to-female ratio of I· 3: I. 
(iii) Urhan vs. rural place oJ residence: Thirty-two 
(52, 5~~) children came from rural areas and 29 
(47 · 5/~) from urban homes. The relatively large per-
centage of children from rural areas can probably be 
explained by the fact that King Edward VIII Hospital 
is a referral hospital serving the whole of Natal and 
K waZulu and that many cases are referred from out-
lying peripheral hospitals in the rural areas: over-
~_~owding in rural huts is probably an additional 
factor. 
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Caughey D. E. et al. (12) (a) Caucasian 
(h) Maori 
Leirisalo M. et al. (13) Caucasian 
10ysey V. C. et al. (14) Caucasian 
Ward C. et al. (15) Caucasian 
Murray G. C. et al. (16) Caucasian 
(Mexican-
American) 
Matsumori A. et al. (17) lapanese 












Table 11 Summary of cases admillcd lI'ith actil'e carditis 
Active carditis: first attack 
Active carditis: probable first attack 
Active carditis superimposed on chronic RHO 
Active carditis in patients with probable chronic 
RHO 
Active carditis (uncertainty re first or repeat attack) 







(iv) Other major manifestations ~)f rheumatic fever: Of 
the 53 children with active carditis, only seven had 
associated polyarthritis, five rheumatic nodules, and 
three Sydenham's chorea either in the past or on 
subsequent admissions to hospital. No child had ery-
thema marginatum. Sixteen children had joint pains 
only, without clinical evidence of arthritis. and four 
others gave a history of joint pains in the past. 
(v) Cardiac lesions: The valvular lesions are sum-
marised in Table Ill. It will be noted that mixed 
mitral valve disease accounted for 60% of the cases. 
Mitral stenosis, either as an isolated lesion or as the 
Disease 
• Rheumatic fever and/ 
or Rheumatic heart 
disease 
• Rheumatic fever ± 
R.II.D. 
• Rheumatic fever ± 
R.II .D. 
Rheumatic fever 





(i) No history or rheu-
matic fever 
(ii) With history of rheu-
matic fever 
Rheumatic fever with 
arthritis 
Carditis in only 18% 
cases 











'" Z 5 













TA3 TB8; lAIO 
lBW35 
No association 
T BW 15 when compared 
to I group of controls 
but not when compared 





? some role in familial 
cases 
., 
5 6 7 8 9 10 11 
AQe (years) 
Figure 1 Age incidence of black children with rheumatic 
heart disease (King Edward VIII Hospital. 24 April 1979 to 
I May 1980). 
doniihant lesion In mixed mitral valve disease, was 
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present in 16~i;, of the patients. This figure is much 
higher than that quoted by others (29). Pericarditis. 
as manifested by a friction rub, was present in eight 
(14 '7'i ;,) of the 61 children. 
(vi) Cardiac fai/lIre: 51 (83'6~--;, ) of the 61 children 
were admitted in cardiac failure. Of these, nine had left 
ventricular failure. the remainder biventricular failure. 
In 21 of the 51 patien ts with cardiac failure, active 
carditis was responsible: these patients later recovered 
when a negative C-reactive protein and return of a 
previously elevated ESR to normal indicated cessation 
of active carditis. In seven additional children on 
admission failure was precipitated by exertion: but 
subsequently when haemodynamic problems de-
veloped failure became persistent. In the remaining 
23 children (of whom 13 had active carditis super-
imposed upon chronic rheumatic heart disease). 
failure was considered to be the result of haemo-
dynamic disturbance caused by the valvular lesions. 
Cardiomegaly. as evidenced by a cardio-thoracic ratio 
of more than 0 ·50 on an antero-posterior chest 
radiograph. was present in 56 (91'8~-;',J of the children . 
The vast majority of these, on admission (38 cases, or 
62/;; of the total) had a cardio-th o racic ratio greater 
than 0·60. 
Table III VlIh"I/ar IcsillllJ 
.Mixed mitral (Obminant mitral incompetence) 31 
Mixed mitral (Dominant mitral stenosis) 6 
Pure mitral incompetence 4 
Pure mitral stenosis 4 
Combined mitral and aortic incompetencc 15 
Aortic incompetence alonc I 
Total 61 
HLA-Studies 
(i) Frequenc)': Table IV shows the percentage 
frequency of HLA A-B-C antigens in black South 
African children with rheumatic heart disease, com-
pared with 1165 controls. A higher frequency of 
HLA-A25, AIO and BW51 was found in children 
with rheumatic heart disease, but the differences were 
not statistically significant (after correction). 
(ii) Presence of only (J single antigen at eitlrcr tlrc A or 
B loCI/.\": The number of children with only one 
detectable antigen at the A or B locus was compared 
with the control popUlation (Table V). Again, no 
significant differences were shown, indicating that 
homozygosity for a particular H LA-antigen does nn! 
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Table IV Pcrcelllllge frequen cy (d' JI LA llllligcn.f ill Soulh 
Africall /Il'gro childrCII lI 'i,h rI,culllalic hcarl di.H'(}.H' (}I/(//or 
rhcumatic carditis 
RI/D/ 
Control Carditis Control Carditis 
HLA 1165 61 JlLA 1165 61 
----~--".-
------ --
AI 6·4 9·11 137 111 ·2 21 ·J 
A2 21·2 164 138 In 11 ·5 
AJ 1]·2 11 ·5 BI] 4·5 () 
All () · I 0 BI4 5·11 4·9 
AW23 18·5 19·7 1315 5 I 16 
AW24 J.9 3·3 BWI6 2·,5 3·3 
A25 15·2 24 ·6' RI7 311 ·11 41 ·0 
A26 8·7 11 ·,5 BI8 4·6 8·2 
AIO n9 36.1 2 
A28 20·9 18·0 BW21 1·0 1·6 
A29 163 8·2 BW22 0 0 
AW30 37·7 37·7 B27 03 1·6 
AW31 9·5 8·2 BW35 6·2 4·9 
AW32 2·1 0 B37 0 0 
AW33· 2·7 1·6 13W41· 1·1 1·6 
BW42 24 ·6 no 
Only I A 
antigen 
detected 26·1 29·,5 BW44 15·8 14·11 
BW45 n 6·6 
BW46 0 0 
CWI 1·2 0 BW51 17 6.6
3 
CW2 14·6 11 '3 BW52 0 0 
CW3 8·8 6·6 BW53 I,] J.3 
CW4· 18 ·2 18 ·0 BW60 1·6 1·6 
CWS· 1·7 3-3 BW61 0 0 
Only I B 
antigen 
detected 4"S.g 42-6 
RHO = Rheumatic heart disease. ~ 
• Number of controls = 165. 
, 12 = 3·9 P < 0·05 (uncorrected) . 
212 = 4· 7 P < 0·05 (uncorrected). 
3 X2 = 4·8 P < O'OS (uncorrected). 
Table V H LA alld rhl'llmatic heart disease/carditis palient 
lI'illr only a single d('lcctahle antigen al lire A or B lo('[ls 
One HLA-A Antigen 
One HLA-B Antigen 
(No significant dilTerence). 
Controls 






n = 61 
29-6 
42·6 
appear to be a factor 111 the predisposition 
rheumatic heart disease. 
(ii) H LA-status i" re/ati<m to snail,l' of va/I'1I1t 
lesions: The higher incidence of HLA-A25 in t~ 
patients with rheumatic heart disease. though n( 
statistically significant, was further analysed aCCOf( 
11 LA al/tixcl/.\' in childrcl/ I\ 'ith rheumatic heart disease 21 



























Comparison with controls : • X2 = 7·7 
corrected). 
[' < 0·01 (un-
t X2 = 10·2 [' < 0005 (unco rrected) . 
ing to the severity of the cardiac lesions . The 
children were subdivided into two groups. viz. 
(a) A "surgical" group consisting of 19 children 
who required cardiac surgery due to severe 
haemodynamic problems. In 13 of them 
surgery was carried out after the acute 
carditis had subsided. the cause for the 
failure being residual val ve disease. Three 
died hefore surgery could be performed; and 
the remaining three. though booked for 
surgery did not turn up. 
(h) A "non-surgical" group which included all 
children without any haemodynamic prob-
lems and not in cardiac failure. as well as 
those ,fho were in failure but were 
adequately controlled by medical means 
alone. 
As shown in Table VI. though there was 
a much higher incidence of HLA-A25 and 
A26 (together known as H LA-A I 0) (30) in 
the "non-surgical" than in the "surgical" 
group. the difference was not statistically 
significant. 
Discussion 
A number of workers (11 - 17) have tried to show 
possible associations between H LA-status on the one 
hand and rheumatic fever and /or rheumatic heart 
disease on the other. As Table I shows. the results 
have been conflicting. This could be due to one or 
more of the following (16) : 
(a) Variation in patient selection: some workers 
grouped acute rheumatic fever (with or 
without carditis) and rheumatic heart disease 
together; others studied patients with acute 
rheumatic fever only. One study included 
heart disease preSllllled 10 be due to rheu-
matic fever. We included only children with 
heart disease due either to well-documented 
rheumatic fever in the past or to active 
rheumatic carditis. Children with acute 
rheumatic fever but without carditis were ex-
cluded . 
(b) Possible lack of racial homogeneity: it is 
known that certain HLA-associations are 
stronger in some races than in others. notably 
the association between HLA-B27 and 
ankylosing spondylitis. in . which the fre-
quency of this antigen in whites with this 
disease is 94~~ and in blacks only 481.,. All 
our patients were black. 
(c) The use of too few specific antisera in 
identifying the HLA-antigens. as well as the 
presence of cross-reacting antibodies: these 
can result in errors in detection of HLA-
antigens and in an inability to identify the 
total HLA-antigen complement on the cell 
surface. We used 180 anti sera in this study. 
Our results do not show any definite associations 
between rheumatic heart disease and HLA-status, 
though we found a higher incidence of H LA-A25 and 
BW51 in our patients with rheumatic heart disease and 
carditis. Moreover, we found that the incidence of 
HLA-A 10 (which includes A25 and A26) (30). was 
higher. albeit not significantly. in the patients whose 
lesions were classified as "non-surgical" than in those 
with gross haemodynamic problems due,;o valvular 
lesions severe enough to warrant surgery. Thus on the 
figures obtained. it appears that there is no definite 
association between HLA-status and RHO. with or 
without active carditis. although there seems to be a 
trend towards a high incidence of HLA-A25 in that 
condition. A larger series might clarify the significance 
of this observation. 
The incidence of only one detectable antigen at 
either A or B locus in patients with RHO was no 
different from that in the control population (Table 
V). Homozygosity for any particular H LA-antigen. 
therefore. is not likely to be a factor in the 
increased predisposition to RHO in the black South 
African child. This finding is at variance with that of 
Falk et al. (11) who found that the number of anti-
gens detected on Iymphocytes from rheumatic 
patients was significantly lower than that found on 
cells from non-rheumatic individuals. the majority of 
their patients. however. were of Caucasian origin. 
Finally, the propensity forthe black African child 
to develop RHO at an early age. with a high incidence 
or severe valvular lesions. is confirmed in this study. 
Overcrowding and poverty. the rool causes of this 
--malady, appear far more important than genetic 
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factors. although the latter cannot be excluded 
altogether as HLA-antigens at the 0 locus. and some 
at the C locus. were not tested for in this study. 
The financial assistance given to IEH and AM by the South 
African Medical Research Council is graterully acknowl-
edged . 
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Male transmission of the gene for isolated gonadotropin-releasing 
hormone deficiency 
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Kogie Reddi, M.B., Ch,B.*t 
Amanda Richards, M.B., Ch.B.:!: 
Michael G. Hammond, Ph.D,§ 
Septimus M, Joubert, M.8c., M,B ., Ch.B.* 
South African Medical Research Coullcil Preclinical Diagnostic Chemistry Research Ullit, 
. University 'of Natal, Congella, and The Natal Institute of Immunology, Durban, Republic of S",;,h A/;-;ca 
Three black women, daughters of the same father but three unrelated mothers, 
presented with isolated gon.adotropin deficiency (lGD). Clinically, the patients had no 
midline defects and intact smell and taste senses. Biochemically, the esselltial feature 
was very low unstimulated and slimulated follicle-stimulating hormone and 
luteinizing hormone levels, even after primillg with gonadotropin-releasing IZUl'lllOlIe 
over a 5-day period. Growth hormone response to insulin-induced hypoglycemia was 
somewhat blunted, but prolactin, cortisol, and thyroid-stimulating hormone responses 
were quite normal, All three patients had the 46,xX karyotype; clinical or biochemiwl 
aberrations could not be demonstated in any of the remaining family members. The 
disorder was, apparently, transmitted by the deceased father, who manifestly did 11(11 
have an IGD deficiency nor any ot'the midline stigmata associated wilh IGD . The 
mode of inheritance seems most likely to be autosomal dominant with variable 
penetrance. Fertil Steril 43:225, 1985 
The syndrome of isolated gonadotropin defi-
ciency <IGDI, follicle-stimulating hormone (FSH), 
and luteinizing hormone (LID has been well char-
acterized in terms of the clinical and endocrine 
presentation, J, 2 It is now generally 'recognized 
t11at the syndrome is the result of a congenital 
deficiency of hypothalamic gonadotropin-releas-
ing hormone (GnRH). Kallman et al.:J first drew 
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attention to an occurrence of the syndrome in 
three kindreds. Subsequently, reports suggested 
that the disorder was transmitted by female car-
riers to male offspring.4, 5 
In this article, a black 1:lIJlily is reported in 
which a father had three apparently affected 
daughters by three umelaled mothers. 
Three half sisters presenled to the gynecologic 
endocrine clinic within 12 Illonths with delayed 
puberty and primary amenorrhea. They had the 
same father, but each had a different unrelated 
mother (Fig. 11. 
CASE HEPOHTS 
CASE I m.6) 
N. N. first presented to the gynecologic clinic at 
the age of 18 with primary amcnorrhea and un-








1 2 3 4 
1962 4 1966 196B 1970 
BB Bu D14 Bu BI4 Bu BB Bu BB Bu 
Cw7 Cw3 Cw7 Cw2CwB C:w3 CwB Cw2 Cw7 Cw3 
Al\A26 
OR3 Blank 
Al1A30 A:>er 26 A:>BIA30 A IIA26 A30r32 Bu B5B 
Cw2 Cw6 
ORB OR4 
derwent laparoscopy; an infantile uterus and 
normal ovaries and fallopian tubes were found. 
She was seen again a t the age of 28, when she was 
noted to be eunuchoid (arm span greater than 
height by 8 cm). There was scanty pubic and axil-
lary hair, and breast devell)pment was retarded .. 
CASE 2 (11.1) 
G. N. presented for the first time at the age of 
20 with amenorrhea, 110 breast development, and 
scanty pubic and axillary hair and was also eu-
nuchoid. 
CASE 3 (11.7) 
P. N. was 25 years old when she was seen at the 
clinic with features similar to those of patients 1 
and 2. 
There were no midline facial defects or anosmia 
in any patient. X-rays of the skull and ophthal-
mologic examination were normal in all three 
patients. 
Unstimulated LH and FSH levels Were less 
than the reference range in all three patients 
(reference range, LH , 3.5 to 30 mIU/ml; FSH, 3 to 
16 mIU/ml). Plasma estrndiol was low in all three 
patients (reference range, 30 to 80 pg/mD. 
There was no withdrawal bleeding after medi-
cation with medroxyprogesterone acetate (Pro-
vera, The Upjohn Company, Kalamazoo, MD, 15 
mg/day for 5 days, but t.he patients did bleed on 
Ovral (0.05 mg ethinyl estradiol, 0.5 mg norges-
trel; Wyeth, Isando, HSA) withdrawal after 21 
days of medication. 
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Figure 1 
HLA status of family memo 
1957 bers studied. The probable 
A30lBlank 
HLA status of the deceased 
flu B7 father was based on those of 
Cw2 Blank the children begotten by 
ORB OR7 
mother 1.l. 
GnRH, 100 (.lg, thyrotropin-releasing hormone 
(TRH, 200 (.lg), and insulin tolerance test.s (insu-
lin, 0.1 to 0.15 U/kg body weight) were performed 
in all three patients. In addition, GnRH (100 (.lg) 
was given subcutaneously for 5 days, and the in-
travenous stimulation was repeated at the end of 
the period of priming. The GnRH test was also 
performed on all available nonaffected members 
of the family. Unfortunately, two of the mothers 
(1.2 and 1.3) were not available to be studied, and 
the father had died in 1980 of an unknown cause. 
Human leukocyte antigen (HLA) typing was per-
formed as published previously.6 ' 
RESULTS 
The genetic relationships and HLA status of 
each patient are shown in Figure 1. Each patient 
allegedly had the same father but a different 
mother 0.1, 2, 3). The presumed HLA status of 
the father was determined by study of the family 
members ILl to 5. It is obvious from Figure 1 that 
the disorder is not linked to HLA type, and the 
disorder appeared to be transferred from father to 
daughters. 
The results of the GnRH test in patients and 
relatives are shown in Tables 1 and 2. Although 
two of the affected patients demonstrated an in-
creased response of LH to stimulation after prim-
ing, these values did not reach the reference 
~range concentrations for unaffected patients in 
the follicular phase of the cycle. Thyroid function 
was normal in the three patients, and dynamic 
testing of the hypothalamic-pituitary axis showed 
Fertility and St!'rilit.v 
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Table I. FSH and LH (U/lJ Before and After.lnjection ofCnRH (100 fJ.g) 
FSII LlI 
Patient" 
- 15 min o min 15 min 30 min 60 min -15 min o min 15 min 30 min 60 min 
N.N. 
Pre 2.0 2.4 4.4 5.4 5.7 <3 <3 :3.5 4.5 3.8 
Post 2.0 2.2 1.4 2.0 1.3 <3 <3 14.0 17.0 9.6 
G. N. 
Pre < 1.6 < 1.6 3.2 6.1 8.1 <3 <3 4.1 3.2 <3 
Post 2.1 < 1.6 3.5 5.9 7.1 <3 <3 7() 12.0 12.8 
P.M. 
Pre < 1.6 < 1.6 < 1.6 < 1.6 < 1.6 <3 <3 <3 <3 <3 
Post < 1.6 < 1.6 < 1.6 < 1.6 < 1.6 <3 <3 < 3 <3 <3 
apre, test done before priming; Post, test done after priming with 100 fJ.g GnRIl daily for 5 days. 
normal responses to insulin-induced hypoglyce-
mia and TRH stimulation. Serum and urine os-
molality levels indicated that the posterior pitu-
itary function was normal. 
Prestimulation gonadotropin concentrations 
and levels after GnRH stimulation in other mem-
bers of the family are shown in Table 2. Mother 
(1.1) is postmenopausal, and one of her daughters 
m.2) was pregnant. Patient 11.5, although 12 
years old and prepubertal, had a normal adult 
pattern increase of FSH and LH. 
All family members had a karyotype appropri-
ate to the phenotypic sex. 
DISCUSSION 
In the present study, the probable HLA status 
of the deceased father was based on those of the 
children begotten by the mother 1.1 in Figure 1. 
The HLA typing of the two daughters born to 
mothers I.2 and 1.3, respectively, is consistent 
with the haplotype assigned to the presumed fa-
ther. Objective evidence supporting the paternity 
claim of patients 11.6 and 11.7, therefore, exists. If 
this is correct, this family is p~obably unique in-
asmuch as it demonstrates that the disorder can 
be transmitted by a male to his daughters with-
out manifestly expressing the disorder himself. 
As far as could be ascertained, the father did not 
have other associated features of IGD, such as 
midline defects. It was 1101. possible to establish 
whether subtle features, sllch as anosmia or hy-
posmia, were present in the deceased father. 
Other studies'" 7 have showl1 more than one 
member of the same family alrected by IGD, and 
in the majority of recorded instances female to 
male transmission appeared more likely. In the 
two kindreds described by Santen and Paulsen,5 
male to male transmission of anosmia was clearly 
demonstrated, but they did not unequivocally 
show transmission of IGIl. III both these families, 
male to male transmissioll, therefore, clearly ex-
cludes an X-linked condit.ion . 
In the present study tlH! IlIode of inheritance 
seems most likely to Iw autosomal dominant with 
variable penetrance. This b ~upported by the ab-
sence of the syndrome ill pat.ients 11.2 and 11.5, 
coupled with the eisorder Leing milder in the fa-
ther and of varying severity ill the three affected 
daughters. Autosomal recessive inheritance is 
Tllble 2. FSII and LH (U/lJ ill Members of the Family Shown ill Figure r 
Case 
FSII 1.11 
- 15 mill o mill 15 mill 30 mill 60 min -15 min o mill 15 rnin 30 min 60 min 
1.1 tJ . N., 153.2 73.1 187.0 157.7 
47 yrsl 
223.0 110.1 107.:! :> 200 :> 200 > 200 
11.2 (G. N .. Pregnant 
20 yrsl 
11.3 (G . N., 8.2 6.4 10.0 12.0 
17 yrsl 
12.4 7.1 12.2 40.0 39.0 
11.4 (G. N., 6.0 4.4 6.1 7.1 8.6 7.0 5.5 41)./:) 42.6 32.4 15 yrsl 
11 .5 (C . N., 17.5 
12 Y"sl 
15.0 30.0 26.3 25 .6 12.0 16.2 !)t; . 1 66.0 · 59.0 
"GnHH (100 fIg) was injected intravenouoly at time O. 
Vo!. 43, No. 2, February 1985 
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most unlikely, beC:llI ~I' I hi' Ihrt'(' lIIothers are un -
related. There is 110 ('\·idl'nce of fILA linkage of 
IGD in this study. 
The present study . U 11 'n're)l't'. COil firms the het-
erogeneity of the ~.\'lIdlOlll(· of IGU, in that the 
youngest affected p;dil'1I1 fiLl) was JI10re severely 
affected than the otl)(·J' I wo. both in t.erms of clini-
cal features and the 1'I'~ I)( ' II ~e to GIIHlI before and 
after priming of tlH' piluilnry gl<llld . lIowever, 
none of the patiel1l~ showed :lIly of the associated 
features ofanosmiH. dpfl palate , and hare lip; the 
present family may. illdppd. have a condition un-
related to that Of~(Jllll' "I' tilt' p<lt.i ent.s reported ill 
other series. 
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Associations between HLA Antigens and Nephrotic Syndrome in 
African and Indian Children in South Africa 
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Abstract. The nephrotic syndrome (NS) reported from Southern Africa is distinguished by unusual characteristics 
in African children and typical features among Indian children. A genetic basis for these differences is explored in 44 
African and 33 Indian children with NS in this paper. HLA associations were detected in the 20 Indian children with 
minimal change NS (MCNS) and 12 African children with membranous NS. Previous studies ofHLA antigens, which 
have all been performed on Caucasian children with MCNS or steroid-responsive NS (SRNS), have detected 
associations with HLAB and OR locus genes. In this report HLA Bw44, which is part of HLA B12, was found to be 
significantly more frequent in Indian children with MCNS or SRNS than in controls (45 and 12%, respectively, 
p < 0.04; relative risk 5.8). In contrast, African children with membranous nephropathy had a significantly increased 
frequency of HLA Bw21 (15% in patients and 1% in controls, p < 0.04; relative risk 22.1). HBsAg was positive in 9 of II 
patients tested in the latter group. We conclude that the interaction between heredity and environmental factors is 
central to the pathogenesis of membranous nephropathy and similar considerations may be important in the 
development of MCNS. 
Introduction 
The spectrum of nephrotic syndrome (NS) in Durban, 
South Africa, offers a study in contrasts between the 
expected pattern of the disease as seen in children in most 
parts of the world and that peculiar to African children in 
the non-malarious zones of Africa [I]. 
The former is illustrated by Indian children, the ma-
jority of whom have typical minimal change nephrosis 
(MCNS).In comparison, African children have 'obvious' 
glomerular lesions, of which one of the commonest types 
is membranous nephropathy. The aetiology is unknown 
in the majority of these children except for a likely causal 
relationship between HBsAg and membranous NS [2-4]. 
Significant associations have been detected between spe-
cific HLA antigens and MCNS (5), steroid-responsive NS 
(SRNS) [6-8), with [8, 9), and without [5, 7, 9), atopy and 
focal glomerulosclerosis [10). We therefore investigated a 
possible genetic predisposition to the development of 
discrete categories of NS in Indian and African children 
in South Africa. 
Patients and Methods 
HLA frequencies were determined in a total of 77 nephrotic 
children, of whom 33 were Indian and 44 African. The nephrotic 
syndrome was defined according to 3 criteria: hypo-albuminaemia 
« 3 g/ l), gross proteinuria (> 2 g/ m2124 h or 3 g/ l on random 
samples) and severe oedema. Patients were routinely investigated 
for most of the known causes of the NS including the detection of 
HBsAg by radio-immuno-assay. Steroid responsiveness was 
equated with MCNS in Indian children. This is in accordance with 
the practice adopted by other workers [6, 7) and was supported by 
the excellent outcome on follow-up (more than 5 years in all child-
ren). 
HLA Typing 
The patients were typed for HLA A, Band C specificities using 
180 antisera in a two-stage Iymphocytotoxicity test (11). Lympho-
cytes were isolated on Ficoll-Hypaque density gradient. Differences 
in HLA frequencies were tested for significance with a X2-test 
(without Yates correction). and the resulting probabilities were 
corrected by multiplying by the number of antigens tested. The 
relative risk was calculated according to the method of Svejgaard et 
al. (12). 
Controls 
There were 952 African and 856 Indian normal adult controls. 
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Table I. Percentage frequency of individual antigens tested in 
the H LA complex in Indian minimal change nephrotic children and 
adult controls 
HLA type Controls (n = 952) Patients (n = 20) 
AI 28 30 
A2 32 40 
A3 14 10 
All 27 IS 
Aw23 0 
Aw24 29 15 
A25 2 0 
A26 7 0 
A28 13 20 
A29 0 
Aw30 3 5 
Aw31 3 0 
Aw32 3 5 
Aw33 10 25 
One antigen 28 35 
B7 13 15 
B8 6 0 
BI3 7 10 
BI4 0.2 0 
B15 10 30 
Bwl6 2 0 
BI7 21 20 
BI8 4 0 
Bw21 2 5 
Bw22 3 0 
B27 2. 0 
Bw35 20 20 
B37 5 5 
Bw411718 0.2 0 
Bw44 (12) 12 4S* 
Bw45 (12) 0.2 0 
Bw51 19 10 
Bw52 12 10 
Bw53 I 0 
Bw60 16 5 
Bw61 15 20 
Y 25 S 
*Significant difference: corrected p < 0.04. 
The HLA distribution among neonates, infants and adults of the 
African subjects have been shown to be similar and conform to 
Hardy- Weinberg equilibrium (13). 
Results 
Of the 33 Indian and 44 African children, significant 
HLA associations were detected in 20 Indian children 
with MeNS and 12 African children with membranous 
nephropathy. Only these results will be presented. Four-
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Table 11. Percentage frequency of individual antigens tested in 
the HLA complex in African membranous nephrotic children and 
adult controls 
HLA type Controls (n = 856) Patients (n = 13) 
AI 6 8 
A2 20 31 
A3 13 0 
All 0.2 0 
Aw23 18 33 
Aw24 5 0 
A25 15 17 
A26 9 8 
A28 20 23 
A29 18 23 
Aw30 39 38 
Aw31 8 8 
Aw32 2 0 
Aw33 0 
One antigen 25 33 
B7 19 4 
B8 13 8 
BI3 4 0 
BI4 5 15 
B15 S 8 
Bwl6 3 0 
BI7 39 31 
BI8 4 8 
Bw21 I IS* 
B27 0.4 0 
Bw35 6 8 
B37 0 0 
Bw411718 0 
Bw42 25 0 
Bw44 (12) 16 23 
Bw45 (12) 8 0 
Bw51 0 
Bw52 0 0 
Bw53 I 0 
?40 I 0 
Bu 8 23 
Y 37 IS 
*Significant difference : corrected p<O.04. 
teen of the Indian MeNS and 11 of the African membra-
nous NS cases were males. The mean age of the Indian 
children was 4.9 years and Africans 8 years. All the 
African and 13 Indian children had renal biopsies and 7 
of the Indian children were steroid sensitive. Nine of the 
1I African patients with membranous nephropathy were 
positive for HBsAg. 
The percentage frequency of individual antigens 
tested in the HLA complex in Indian MeNS and African 
membranous NS and their controls are shown in tables I 
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Table Ill. Signilicant HLA associations 
Race HLA Histological Corrected p 
Relative 
type risk 
Africans Bw21 membranous <0.04 
22.1 
Indians Bw44 minimal change · <0.04 
5.S 
Table IV. Studies of signilicant H LA associations with nephrotic 
syndrome: with special reference to relative risk 
NS HLA antigens RR Reference 
SRNS B 12 (atopic) 77IOIIISOII et al. [9] 
SRNS AI, BS,(non-atopic) 77IOIIISOII et a. [9] 
MCNS BS 2.SI Noss et a!. [5] 
SRNS BS 3.5 o 'Regall et a!. (7) 
SRNS DR7 (atopic) 4.4 de MOllzon-Calllboll et al. [S) 
MCNS BI3 4.65 Noss et a!. (5) 
MCNS Bw44 (12) 5.S present study 
SRNS DRw7 5.9 Aljiler et al. (6) 
MEM Bw21 22.1 present study 
SRNS = Steroid-responsive nephrotic syndrome; MCNS = 
minimal change nephrotic syndrome; MEM = membranous; RR= 
relative risk. 
and II, respectively. The frequency of HLA Bw44 was 
increased in Indian MCNS compared to controls (45 vs. 
12%, respectively, p<O.04; relative risk 5.8). The fre-
quency of Bw21 was increased in African children with 
membranous nephropathy compared to healthy controls 
(15 vs. 1%, respectively, p < 0.04; relative risk 22.1). There 
were no significant association between HLA antigen 
frequencies and the other histological groups among 
either Indians and Africans. Number of patients in most 
of these sub-groups are, however, small. Results are sum-
marised in table Ill. Table IV compares the relative risk 
of developing NS (MCNS or SRNS) with particular HLA 
frequencies documented in other reports. The current 
study reveals a relative risk for the development of 
MCNS in the Indian child, which is close to the highest 
reported, and an exceedingly high risk for developing 
membranous nephropathy in the African child. 
Discussion 
Previous studies of HLA associations and NS [5-9,14] 
have all been performed on Caucasian children with 
MCNS or SRNS. Most of these studies report associa-
tions between NS and HLA B and OR locus genes, while 
some of these show that the relationships are more pro-
nounced in the presence of atopy and occasionally corre-
late with response to therapy. 
In different studies HLA B12, HLA B8 and HLA OR7 
have been significantly associated with SRNS. HLA BI2 
and HLA OR7 have been associated with atopy in pa-
tients with this disease and a significant relationship was 
also detected between HLA BI2 and a shortened remis-
sion after cyclophosphamide therapy. 
In different races, different antigens are found in 
linkage disequilibrium. HLA B8 is in linkage disequilib-
rium with HLA OR3 [15] and HLA BI2 is in linkage 
disequilibrium with HLA OR7 in Caucasian populations 
[8]. The Indian population also shows linkage disequilib-
rium between these same antigens while in the African 
population different antigens are found in linkage dis-
equilibrium [16]. 
We should perhaps note that the HLA BI2 antigen can 
be split into two parts, Bw44 and Bw45. The frequency of 
Bw45 in the Caucasian and Indian populations is so low 
that HLA Bw44 and HLA BI2 can be regarded as synony-
mous. In the African population, however, the frequency 
ofBw45 is about 8%and HLA Bw44 is about 16%[16]. 
Alfiler et al. [6] found that the increased frequency of 
HLA OR7 was not accompanied by that of HLA B12. In 
the present study the frequency of H LA Bw44 was signifi-
cantly increased in Indian children with SRNS or MCNS 
(45% in patients vs. 12% in controls; p < 0.04). The relative 
risk was 5.8. This means that the Indian child with HLA 
Bw44 is 5.8 times more susceptible to the development of 
MCNS as compared to an Indian child without HLA 
Bw44. This finding supports previous studies in Cauca-
sian children [8, 9] in which an association with HLA BI2 
has been detected. Taken together, these results suggest 
that HLA OR7 (which was not tested in the current study) 
is probably the most important antigen in these relation-
ships. 
In contrast, the African children with membranous 
nephropathy had a significantly increased frequency of 
HLA Bw21 (15% in patients vs. 1% in controls; p<0.04). 
The relative risk in this group was 22.1. Therefore the 
African child carrying HLA Bw21 has a 22-fold chance 
over a child without HLA Bw21 of developing membra-
nous nephropathy. Caucasian adults with membranous 
nephropathy have been shown to have an increased fre-
quency ofDR3 [17]. There is good evidence to suggest that 
even within the same racial group, adult membranous 
nephropathy is dissimilar to the childhood form of the 
disease [17]. Therefore, our findings in African patients 
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cannot be compared with studies in these adults. In a 
previous publication, HBsAg had been causally linked 
with membranous nephropathy in African patients [2]. 
The HB,Ag has recently been regarded as an important 
cause of membranous nephropathy [3, 4]. Some of these 
patients are included in this study: of 11 membranous 
patients tested, 9 were positive for HB,Ag. The number of 
patients who were HBsAg negative was too few to allow 
meaningful comparison in HLA frequencies between the 
two groups. The incidence of H BsAg in Black adult males 
is 8.7%, females 3.9%, males 5-10 years 20% and females 
5- 10 years 21% [18] whereas in Indian technologists the 
incidence in the males was 0.85% and fema les 0.39% [19]. 
Figures are not available for Indian children. There is 
some evidence to suggest that there is a genetic predispo-
sition to the development of HBsAg infection [20]. 
In brief, the association of Indian MCNS with Bw44 
reinforces our earlier observation [I] that Indian children 
resemble other Caucasian children in nearly all respects 
for this disease . Further, the results obtained in African 
patients imply that there is a genetic susceptibility among 
children to the development of membranous nephropa-
thy in response to HBsAg infection. These conclusions 
suggest that both heredity and environment may be im-
portant in the pathogenesis of membranous nephropa-
thy. It will be important to note whether the use of HBsAg 
vaccines will reduce complications, including membra-
nous nephropathy, induced by this virus. 
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Introduction 
Systemic ) Ilfl1r: '?rythematosus (SLE) is an auto immune connect
ive tissue 
disease thaL has shown associations with HLA antigens. Tiw
ari and 
Terasaki reviewed an overall increase in B8 and an associa
tion with DR2 
and DR3 in Caucasians (1). A report by Hashimoto (2) showe
d a positive 
association with DR2 and another by Kameda (3) a negative 
association 
with DR4 in Japanese but these results were not confirmed 
yet. In this 
report, patients with SLE from various ethnic groups in th
e Asian-
Oceania region were tested for HLA using the same set of ty
ping sera to 
find out whether HLA was associated with SLE or not. 
Materials and Methods 
The HLA types of 46 Japanese, 26 Northern Chinese, 82 Sout
hern Chinese 
and 23 Northern Indian patients were determined. In additio
n 15 
Australian Caucasoids, 8 Af~ican Black, one Sichuan Chines
e and one 
Southern Indian were determined du~ing the 3rd AOH Worksho
p. The 
diagnosis of SLE was made according to the reviced c~iteri
a of the 
American Rheumatism Association (4). The frequency ot each
 antigen in 
the patiellL groups was compared with that of normal contro
ls in the 
corresponding ethnic group. Calculation were done only in 
Japanese, 
Northern Chinese, Southern Chinese and Northern Indian, be
cause of the 
small number of patients in other ethnic groups. A subgrou
p of Japanese 
patients with nephritis (lupus nephritis jLN) was also ana
lysed. HLA 
Class III antigens were determined in the Japanese patient
s by Dr. 
Serjeantson and compared with those of Japanese normal con
trols. The 
statistical significance of the difference in frequency of
 each HLA 
antigen between patiens and controls was determined by chi
 square 
calculation and P value was corrected (Pc) by multiplying 
by the number 
of tested antigens. Relative risk (RR), etio10gic fraction
 (EF) and 
preventive fraction (PF) were calculated according to Svej
gaard et a1 
( 5) • 
Results and Discussions 
HLA antigens positively or negatively associated with SLE with a P
 
value less than 0.05 are listed in the following Tables. In
 Table 1, 
HLA antigens associated with total SLE as well as lupus ne
phritis in 
Japanese are listed. The frequency of A24 was decreased an
d Bw6 was 
increased in SLE patients and All, A3~ a d B 54 . 
d i th 442 n w were lncrease n e 
subgroUp with nephritis but the only difference that was st
ill 
significant after correction was the decreased frequency of
 DQW3. The 
frequency of DR2 was higher in SLE than in controls (46% vs 
35%) in 
Japanese without significance. As shown in Table 2, the freq
uency of 
C4A3 and C4BO was lower in the patient group while C4AO was 
increased 
as has been reported in Caucasian patients (6). In Northern
 Chinese 
statistically higher occurrence of HLA-B15 and DR2 among pa
tients with 
SLE was observed as shown in Table 3. CWl and DQWl were also
 observed 
more frequently in SLE than controls, probably due to linkag
e 
disequilibrium. DR2 was also significantly more frequent in
 SLE in 
southern Chinese. The tendency of higher occurence of B15 w
as observed, 
too, but it was not significant after correction (Table 4). 
The higher 
frequency of BW4 in Southern Chinese was different from res
ults of the 
other ethnic groups, in which rather BW6 was increased in f
requency. 
Amongst the Indian patients, SLE was associated rather stron
gly with 
DR4 and B37, (Table 5). Since B37 is rather infrequent in N
orthern 
Indians the EF of this antigen was rather low. Almost 100% 
occurence of 
BW6 was observed in patients with SLE including the 15 Aust
ralian 




HLA-DR2 was primarily associated with SLE in the Chinese an
d probably 
in the Japanese as well. DR4 was the primary antigen associa
ted with 
SLE patients from Northern India. The association of C4AO, 
a class III 
antigen, wi th SLE in Japanese as well as in Caucasians' is s
uggestive of 
a common :aetiology. 
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Table 1 HLA Antigens associated with SLE(Japanese) 
---~ .. ---
HLA L'isease Freq.(%) Freq. (%) RR EF, : PF P "P
c, 
in Pat. in Cont. 
All SLE 26 17 1.7 0.11 
NS NS 
LN 35 2.7 0.22 0.05 
NS 
A31 SLE 20 13 1.7 0.07 
NS NS , 
LN 29 2.9 0.19 0.05 
NS -. 
BW54 SLE 24 19 1.9 0.11 
NS NS 
LN 35 3.3 0.24 0.025 
NS 
BW6 SLE 100 89 .. , 0.025 NS 
LN 100 . , Ns NS . · 
. ; i . " r . : . . :.. ; : ., ... " 
A24 SLE 48 • ' 'f 68 0.43 : 0.34 0.01 . 
NS · 
LN 47 0.42 0.39 
NS , . NS 
DQW3 SLE 24 55 0.26 0.40 0.0002 
0.005 
LN 18 0.17 0.46 0.003 0.05 
SLE SLE TOTAL N=46 
LN Lupus nephritis . N=17 
Control N=404 
, 
, " f ; ! I \ 
Table 2 HLA Class III Antigens associated with SLE(Japane
se) i 
Class III Freq. (%) Freq. (%) RR EF PF ., P Pc .. . 
in Pat. ·in Cont. , ,~ ) 
C4A3 67 88 0.3 0.63 0.02 NS 
C4AO ' . 27 8 4.3 0.2 0.02 NS 
C4BO 2 12 0.1 ; , - 0.01 I . 0.04, ... NS I 
'1 I' 
t i 
Pat. . Patients with SLE N=55 . . 
Cont. Normal Control · N=50 . :r 
444 
Table 3 HLA An ti gens associated with SLE(Chinese N
orth) 
HLA Freq.(%) Freq. (%) RR EF PF 
P Pc 
in Pat. in Cont. 
815 50 20 4.0 0.37 0.0004
 0.02 
CWl 46 23 2.7 0.29 0.02
 NS 
DR2 69 33 4.4 0.53 0.0003
 0.004 
DQW1 84 59 3.7 0.61 0.02 
NS 
SLE N=26 Controls N=405-431 
Table 4 HLA Antigens associated with SLE(Chinese South) 
HLA Freq.(%) Freq.(%) RR EF PF P 
Pc 
in Pat. in Cont. 
A10 0 · 7 0 0.009 
NS 
815 33 21 1.8 0.15 0.02 NS 
816 16 7 2.3 0.09 0.02 NS 
:8W4 64 39 2.8 0.41 0.0003 0.01 
8W6 98 82 12.3 0.90 0.002 NS 
DR2 52 30 2.4 0.30 0.002 0.03 
DR4 13 26 0.4 0.15 0.03 NS 
DR5 15 27 0.4 0.15 0.04 NS 
DQWl 67 48 2.2 0.37 0.006 NS 
DQW2 11 4 3.0 0.07 0.02 NS 
SLE N=61-82 Control N=313-356 
Table 5 HLA Antigens Associated with SLE(Indian North) 
HLA Freq. (%) Freq. (%) RR EF PF P Pc 
in Pat. in Cont. 
A23 8.7 0.8 11.5 0.07 0.02 NS 
837 17 0.8 25.6 0.16 0.0001 0.006 
CW4 43 21 2.8 0.28 0.02 NS 
DR4 47 7 11.5 0.43 . 0.00001 0.0001 
DR7 0 24 0 0.008 NS 
SLE N:::23 Control N:::123 
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Introduction 
Thyrotoxic Graves' disease is a relatively common disorder in
 many ethnic 
groups and its association with the HLA system has been studi
ed in some detail. 
Associations with B8 and DR3 have been shown consistently in 
Caucasians, and 
DR3 is particularly associated with relapse of th~ disease fo
llowing ' withdrawal 
of therapy (see review in 11). In Japanese the disease is as
sociated with 
B35" '6, especially in patients with disease onset below the age of
 30 years & 
but there is no clear association with HLA-DR antigens. Sim
ilarly in Chinese, 
there is a strong association with HLA Bw46
1 ,s particularly ih patients ~ith 
early-onset disease, but there is no clear association with H
LA-DR antigens. 
Also in Chinese there is evidence for an association with B5 
in patients ,with 
disease onset above age 35 years
S; Thyrotoxic periodic paralysis is a ' common 
complication of Graves' disease in Chinese and the associatio
n with HLA-Bw46 
is particularly strong in patients with this complications. 
Hashimoto's thyroiditis is less common than Graves' disease i
n all ethnic 
groups, an d ra 1- h~r l es s information is available on HLA associations with th
is 
disease. 111 " ,1 II casians there is a weak association with B8
3 and a significant 
association with DR3
7. In Japanese there is an association with B35
8 but 
there is no clear association with HLA-DR antigens. In Chine
se there is 
some evidence for an association of Hashimoto's thyroiditis w
ith Bw46 and B5 12 • 
Aims of the study 
1. Graves' Disease 
HLA associations with Graves' disease are fairly ciear in Cau
casians 
but there is a need in non-Caucasians in the Region to:-
a) determine whether HLA associations exist in previously uns
tudied 
populations 
b) clarify previously reported HLA-DR associations 
c) confirm HLA CBsociations with ~at'ly and lat~ onset disease 
d) determine ~hether HLA associations exist with relapse follo
wing withdrawal 
: ' of therapy . " ,), , I~ ; ' ; '. " " 1 
'i 
P, ' " : ' ! r 
( . 1 \ ··: f I ( ~ , ' 
The In<lior aims were to clarify and confirm previously reporte
d HLA-B 
associations in non-Caucasians and to determine whether HLA-D
R associations 
exist in these ethnic groups. 
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Materials and Methods 
contributors were invited to HLA type as many patients as practicable 
. h Graves' disease and/or Hashimoto's thyroiditis using the 3AOH serum 
"at 1 . h • nd to include an adequate number of normal contro s. SInce t e maJor 
s:t :as to confirm or clarify previous findings, contributors were requested 
~~muse patients who had not been previously included in published surveys. 
contributors were requested to complete a brief questionnaire on each 
t' ent gi ving details of disease category, clinical features, age at onset·, 
~:s~ciated diseases, and history of relapse if therapy had been withdrawn. 
Results 
Table 1 provides a summary of the patient categories submitted by each 
laboratory. Unfortunately, some ,of the questionnaire data were not available 
at the time of preparation of this report and complete analyses were not 
always possible. 
Graves' disease 
Table 2 shows a comparison of antigen frequencies in con~rols and 
patients with Graves' disease for antigens shown to be of interest in previous 
studies. There was a slight increase in the frequencies of Bw46 and DRw9 
in Northern Chinese patients but not at a statistically significant level. 
In Southern Chinese patients, however, there was a highly significant 
increase in the frequencies of DRw9 and Bw46 conferring relat~ve risks of 
2.6 and 2.2 respectively. In Thai patients there was an extremely significant 
excess of Bw46 (relative risk 4.0). In all ethnic groups studied B5 was 
show~ to have a negative association with Graves' disease but : in no case 
was this statistically significant. 
In view of the small numbers of patients of other ethnic groups only 
speculative suggestions may be made as to possible HLA associations with 
Graves' disease in these ethnic groups. Of the 11 African Black patients 
45.4% had' A23 compared with 20.9% of controls, 54.5\ had Bw59 compared with 
39.2% of controls, and DR3 had the s'ame frequencies in patients and controls 
'as BwS8. Of the 8 Southern Indian patients 62.5\ had All compared with 24.6\ 
of controls and 62.5% had B35 compared with 26.6% of controls~ In Northern 
Indian patients 6 of the 7 (86%) had DR2 compared with 45% of !controls. 
I 
Age at onset data was not available for the Southern Chi~ese patients 
:with Graves' disease although it is reported elsewhere in this volume that 
the frequency of Bw46 was significantly higher in patients with disease onset 
,belOW age 30 years 2. 
Table 3 shows the age at onset for Thai and Thai Chinese ;patients with 
Graves' disease. In both Thai and Thai Chinese patients it m~y be seen that 
~W46 had an increased frequency irrespective of age at onset whereas the 
I~creased frequency of DRw9 appeared to relate particularly to early-onset 
dIsease. 
There was insufficient data available to compare the HLA associations 
in patients with and without periodic pat-alysis or relapse following withdrawal 
of therapy. ; 
Additional information on patients with Graves' disease included in 
this study is given in references 2 and 10. 
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Hashimoto's thyroiditis 
Table 4 shows the frequencies of B5, Bw46 and DRw9 in patients with 
Hashimoto's thyroiditis . In Southern Chinese both Bw46 and DRw9 were 
strongly associated with the disease, conferring relative risks of 3.1 and 
2.6 respectively, whereas in Sichuan Chinese only Bw46 had a statistically 
. • f' , . Slgnl lcant assoclatlon. 
There were no statistically significant associations between Hashimoto's 
thyroiditis and Bw46 or DRw9 in either, Thai or Thai Chinese. 
There was no evidence for an association with BS in any of the ethnic · 
groups studied. 
Additional information on patients with Hashimoto's thyroiditis studied 
as part of this Workshop is given in references 9 and 10 .. 
Conclusions 
Graves' disease 
Bw46 has a stat i sti ca lly significant association with Graves' disease 
in Southern Chine se and Thais but not in Thai Chinese or Northern Chinese. 
DRw9 is strongly associated with Graves' disease in Southern Chinese but 
not in the other ethnic groups studied. 
Hashimoto's thyroiditis 
Bw46 is strongly associated with Hashimoto's thyroiditis in Southern 
Chinese and Sichuan Chinese but not in Thai or Thai Chinese. DRw9 is strongly 
associated with this disease in Southern Chinese but not the other ethnic 
groups studied . . 
I • ; ; 
.. ! . , 
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Northerll Chinese 



















Number of patients studied 













Distribution of selected HLA antigens 
in patients with Graves' disease 
Ethnic origin Antigen Patients Controls 
, obs % obs % 
Northern chinese (0=71) (n=430) 
B5 13 1B,3 92 21.4 
Bw46 15 21.1 55 12.8 
DRw9 25 35.2 105 25.3 .. 
Southern Cilill ':se (n=62 ) (n=407) 
B5 5 B.l 65 16.0 
Bw46 28 45.2 112 27.6 
DRw9 32 51.6 120 32.5 
Thai Chinese (n= 36) (n=86 ) 
85 2 5.5 7 B.l 
Bw46 13 36.1 17 19.8 
DRw9 11 30.5 22 25.6 
Thai (n= SS) (n=13B) 
B5 2 3.6 17 12.3 
Bw46 25 415.5 24 ·17.4 
DRw9 17 30.9 25 IB.1 

















Distribution of selected HLA antigens 
in patients with Graves' disease of 
early and late onset 
Antigen Early onset Late onset 
«30 years) ( >30 years) 
Controls 







(n=19) (n:. 17) 
B5 0 0 2 11.8 
Bw46 7 36 . 8 6 35.3 
DRw9 7 36.8 4 23.S 
(n= 30) (n=25 ) 
B5 1 3.3 1 4.0 
Bw46 16 53.3 9 , 36.0 
DRw9 12 40 . 0 5 20.0 
Table 1.1 
Distribution of selected HLA ;antigens 
~n patients with Hashimoto's thyroiditis 
, 
Antigen Patients Controls 
obs % obs % 










BS 4 8.3 65 16.0 0 . 4 1.40 
Bw46 26 54.~ 112 27.6 3.1 13.19 





Sichuan Chinese (n=59) 1 (n=145) 
Bs 9 15.3 18 12.4 ' 1.3 0.09 
Bw46 30 50.9 40 27.6 ;2.7 9.06 
DRw9 28 47.S 57 39.3 1.4 0.8 , 
Thai Chinese (n=18) (n=86) 
B5 4 22.2 7 8.1 3.2 1. 81 
Bw46 7 38.9 17 19.8 2.6 2.08 
DRw9 8 44.4 22 25.6 2,3 1. 74 
Thai (n=27) (n=138) 
BS : 3 11.1 17 12.3 0.9 0.02 
Bw46 9 33.3 24 17.4 2.4 2.66 
DRw9 7 25.9 25 18.1 1.6 0.45 
,,: RR = Re lat i ve risk 
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Histoconlpatibility antigens in Indian patients with 
myocardial infarction 
'M. SEWDARSEN, 2M. G. HAMMOND, IS. VYTHlLlNGUM and 28. ApPADOO 
'Coronary Care Unit, f{. K. Khan Hospital, Chatsworth and 2The Nata
l Institute of Immunology, 
Durban, RSA 
The frequency of HLA-A, 8, C and OR tissue antigens in \03 Indian men aged 40 
years or under who had experienced a myocardial infarction was cOll1par
e~ with the 
frequency in 760 healthy Indial} controls. No significant differences in a
ntigen fre-
quencies were found. The findings in this study provide no support for e
ither a ge-
netic or an immunological basis for myocardial infarction in young Indi
an men. 
Received for pllblication 27 May, accepted 6 October 1986 
Hypertension, hyperlipidaemia, smoking, di-
abetes mellitus are well known risk factors for 
the development of myocardial infarction 
(Kannel & McGee 1979). The frequent occur-
rence of coronary events in family members is 
well established and suggests that genetic fac-
tors may contribute to the development of 
coronary artery disease (Epstein ~964). The 
mechanism by which heredity exerts an inOu-
ence on the incidence of coronary artery dis-
ease has been questioned for many years. It is 
uncertain whether the familial aggregation of 
coronary heart disease is mediated by familial 
clustering of risk factors or by some unknown 
mechanism (Schweitzer et al. ]962, McKwick 
1959). The studies investigating the relation-
ship of histocompability (HLA) antigens to 
the presence of coronary artery disease have 
not indicated a clear association (SCOlt et al. 
1976, Logan et al. ] 977) . Significant correla-
tions have been demonstrated between the 
frequency of the antigen HLA-B8 and A I-B8 
452 
and the 'death nite from coronary artery dis-
ease (Mathews 1975). Other investigators 
have been unable to confirm this association 
(ScOIl et al. 1976, Logan et al. 1977). 
We therefore undertook this study in which 
the frequencies of HLA tissue antigens in 
young Indian males with myocardial infarc-
tion was compared with those in a healthy 
control group. 
Material and methods 
One hundred and three I ndian male patients 
with myocardial infarction between the ages 
of 24--40 years (mean 36 yrs) were selected for 
HLA typing. The criteria for the diagnosis of 
myocardial infarction were based on a history 
of chest pain supported by unequivocal elec-
trocardiographic findings accompanied by a 
transient rise in creatine kinase activity . The 
myocardial infarction was pi'csumed to be due 
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to coronary atherosclerosis. The presence of 
diabetes Illellitus, hypcrtension, hyperlipidae-
mia (serum cholesterol> 6.5 mmols/I) and 
history of corPllar), hC;lIt disease in first de-
gree relatives \\Tll' ohtaincd from all patients. 
None of the patients were insulin dependent 
diabetics. Patients with valvular heart disease 
and cardiolll),op"thy were excluded. Of the 
103 patients 4~ werc of North Indian origin 
(Aryans), 4.1 of South Indian origin (Oravi-
dians) and 12 could not be classified into 
either of these two groups . 
HLA-A, Band C antigens were determined 
in all patients "nd in R76 controls . The latter 
comprised of 3D Aryans, 47R Oravidians, and 
75 could not be cI;lssilied. The IILA-OR anti-
gens were deterlllined in 93 patients (Aryans 
= 41; Oravidi;lI1s = 41. unclassified = 11) and 
165 controls (Ar)""ns = 36; Oravidians = 121; 
unclassified = ~). 
The patients wcrc typed for HLA-A, Band 
C antigens using I~() antisera in a 'two-stage 
Iymphocytotoxic tcst C1erasaki & McClelland 
1(64). HLA-DI{ antigens were detected on B 
Iymphocytes with 12() antisera in a long in-
cubation two-stage Iymphocytotoxic test (Te-
rasaki et af. 1(78). Lymphocytes were isolated 
on a Ficoll-Hypaque density gradient (Boyum 
1(68) and T and B cells separated by the ny-
lon wool method (Terasaki et af. 1(78). 
All the patients and controls were typed in 
the lab()fatories of the Natal Institute of Im-
munology with "ntisera that have been used in 
International Workshops or obtained by se-
rum exchangc fmlll otherlahoratories. (Ham-
mond et a!. IlJ75, I I} 77 , 19RO a-e, 1984 a-e, 
1986 a-c). 
Statistical analysis was performed using the 
chi-squared test. The resulting probabilities 
were multiplied hy the number of antigens 
tested to determinc the corrected p value. 
Table I . 
FreqllCllcy of 11 LA-A alld B alltigens ill 1lIdia" males 
with myocardial infarctioll. 
Frequcncy (%) 
IILA antigen Controls Patients 
(n=R76) (n= IOJ) 
AI 2R .1 n.2 
A2 30.9 31.1 
A3 13.6 13.(i 
All 2R.S 33.0 
A23 1.3 1.9 
A24 28.9 28.2 
A25 1.7 1.0 
A2(i 6.2 3.9 
A2R 12.3 13.(i 
A29 1.6 0.11 
A30 2.3 1.9 
A31 3.8 5.8 
1\32 4.9 2.9 
A33 16.2 14.6 
One antigen 19.8 20.4 
137 13.4 7.8 
B8 6.4 (i.8 
1313 6.4 6.8 
1314 (J.6 (I. 0 
1315 10.4 12.6 
1316 3.8 . 1.9 
1317 21.2 19.4 
BIR 2.9 3.9 
132\ 3.S 3.9 
1322 S.O 2.9 
1327 1.9 3.9 
B35 20.4 14.6 
1337 6.\ 5.8 
1341 0.2 1.0 
1342 0.1 (l.O 
B44 I3.S 16.5 
1345 0.2 0.(1 
1347 0.1 (l .(l 
1351 16.4 17.5 
B52 14.3 14.6 
1353 O.S (1.0 
1360* 10.3 20.4 
1361 19.0 20.4 
1370 4.0 4.9 
One antigcn IS.9 12.6 
* == P < tJ.OOS. 
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nesults 
The frequencies of the HLA antigens in pa-
ticnts with myocardial infarction and in the 
control group are shown in Tables 1 and 2. At 
the A and 0 R loci no antigen showed an ob-
served frequency significantly different from 
the control population. At thc B locus B60 
has a significantly greater frequency in the pa-
tients than the controls (p < 0.0(5). This dif-
ference was not significant when correction 
was made for the number of antigens tested 
(50 antigens). Furthermore there was no sig-
nificant difference in the frequency of 
IILA-A, B, C and OR antigens between pa-
tients. with a history of diabetes, hypertension, 
hyperlipidaemia and coronary artery disease 
in first degree relatives as compared to those 
patients without these risk factors. Similarly, 
the frequency of HLA arHigens studied was 
not significantly different in the Aryan and 
Dravidian patients and the.ir respective con-
trol populations. However 87 and OR I anti-
gens \\jere observed to occur with decreased 
frequency in the Aryans with myocardial in-
Jt,Mc 2. 
Frcqucncy of /J LA-DR alltigells ill Illdiall males 
I\';t" myocardial illfarctioll . 
Frequency ('X,") 
IILA antigen Controls Patients 
(n= 165) (n=93) 
DRI 8.5 8.6 
DR2 37.0 47.3 
DIU 13.9 15 . 1 
DR4 23.0 19.4 
DR5 15.8 11.8 
DR6 18.8 21.5 
DR7 31.5 30.1 
DR8 3.6 3 .2 
DRY 1.2 (1.0 
DRill IIU 12.9 
DR12 0.6 0.0 
Onc antigen 35.2 30. 1 
farction as compared to the Aryan control 
group (O'}'o vs 11.2% and 2.4/X, vs 19.5%, re-
spectively) but this was not statistically signifi-
cant when the p value was corrected for the 
number of antigens tested. 
Discussion 
Although associations between specific dis-
eases and HLA antigens have been well docu-
mented for certain disorders (Ritzman 1976), 
no such clear association has yet been estab-
lished between coronary artery disease and 
the HLA antigens . Stone et al. (1981) demon-
strated a statistically significant frequency of 
HLA-BW 38 in patients with prematurt coro-
nary artery disease but this statistical signifi-
cance was lost when allowance was made for 
the number of antigens tested. The findings of 
Mathews (1975) were based on mortality fig-
ures. 
Our data, in accordance with others have 
also failed to demonstrate a significantly in-
creased incidence of any HLA antigens in pa-
tients with myocardial infarction (Scott et al. 
1976, Logan et aJ. 1977). Although the fre-
quency of the antigen H LA- BoO in the pa-
tients (20.4%) was significantly higher than 
the controls (10.3%) the significance was lost 
when the p valuc was Illultiplied hy the num-
ber of antigens (50) tested . COlllparing the 
HLA profiles of North alld South Indians re-
vealed a similar trend viz no difference in the 
frequency of the fILA antigens between pa-
tients and their respective controls . 
Our failure to demonstrate a significant in-
crease in the frequency of any IILA antigen in 
patients with myocardial infarction probably 
serve to highlight the hetcrogenicity of factors 
involved in the genesis of coronary artery dis-
ease. Also it is possihle that since we are deal-
ing with a common disease thc control popu-
lation included individuals who would have la-
ter in life developed a myocardial infarction. 
454 
24 SEWDARSEN ET AL. 
Also the genetic i"f1uence on any common 
disease may he "Hected by environmental fac-
tors (Rose IlJ77) . llence without proper con-
trol of these factors it may be difficult to iden-
tify genetically the high risk group for coro-
nary artery disease . 
In conclusion this study has demonstrated 
that there appears to be no clear association 
between the 11 LA antigens and myocardial in-
farction in young I"dian men and hence gives 
no support for either a genetic predisposition 
or for an immunological basis for myocardial 
infarction in our patients. 
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HLA-A, B, DR, and DQ antigens in black patients 
with severe chronic rheumatic heart disease 
BREMINAND MAHARtd, M.B., F.CP.(S.A .), MICHAEL G. HAMMOND, PH .D., 
BRoUSHIAPATHY ApPADOO, NAT . DIP. MED. TECH ., WILLlAM P. LEARY, D.PHIL, F.R.CP. , 
AND DENNIS J. PUDIFIN, M.B., F.R.CP. 
ABSTRACT To determine whether genetic factors could be involved in the pathogenesis of rheumat-
ic heart disease, we performed HLA-A and HLA-B typing in 120 black patients with severe chronic 
rheumatic heart disease requiring cardiac surgery , and HLA-DR and HLA-DQ typing in 103 and 97 of 
these patients. respectively . The HLA typing was done by a standard Illicrolymphocytotoxicity meth-
od . Patients were 12 to 60 years old (mean 27.6 ± 14.5). No differences in HLA-A, HLA-B, and 
HLA-DQ frequencies between patients and controls were noted . HLA-DR I antigen was present in 
12.6% of patients compared with 2.7% of normal control subjects (corrected p< .045; relative risk = 
5.2) and the HLA-DR w6 antigen was present in 31 . I % of patients compared with 15% of control 
subjects (corrected p< .045 ; relative risk = 2.6). These findings suggest that genetically determined 
immune-response factors may play a role in the pathogenesis of severe chronic rheumatic heart disease . 
Circulation 76, No. 2, 259-261, 1987. 
THE HLA antigens, which are encoded by closely 
arranged genes. on the short arm of the sixth chromo-
some, influence the predisposition to several diseases . I 
Some diseases with initially weak associations with 
HLA-A and HLA-8 antigens have been found to have 
stronger associations with HLA -DR antigens . 2 Since a 
genetic predisposition to the development of rheumatic 
fever has been documented /" 4 and since there is little 
information on the relationship between antigens at the 
DR-Iocus of the HLA system and chronic rheumatic 
heart disease, we performed HLA typing ih a group of 
black patients with this disease to determine whether 
genetic factors could be involved in the pathogenesis 
of rheumatic heart disease . 
Patients and methods 
HLA-A and HLA-B typing was carried out in 120 black 
patients with severe chronic rheumatic heart disease. as delined 
by the World Health Organization,5 who required cardiac sur-
gery at the Cardiothoracic Surgical Unit. Wentworth Hospital, 
Durban , and HLA-DR and HLA-DQ typing was performed in 
103 and 97 of these patients . respectively. The distribution of 
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valvular lesions was as follows: isolated mitral stenosis, 36 
patients: mitral stenosis plus aortic incompetence, one patient; 
mitral stenosis and aortic incompetence with aortic stenosis 
(mixed aortic valve disease), one patient; mitral incompetence 
alone , five patients; mitral plus aortic incompetence , 18 pa-
tients; mitral stenosis with mitral incompetence (mixed mitral 
valve disease), 32 patients; mixed mitral valve disease plus 
aortic incompetence. 17 patients; mixed mitral valve disease 
plus mixed aortic valve disease , three patients; mixed aortic 
valve disease, three patients; isolated aortic incompetence , four 
patients. I n each case the rheumatic etiology~f the valve lesions 
was confirmed by inspection of the valve at surgery or on 
histologic examination of the valve . Many patients were having 
their second or third operation . There were 80 female and 40 
male patients between 12 and 60 years old . Their mean age was 
27.6 ± 14.5 years; 60% of the patients fell within the 12 to 25 
year age group. The control group consisted of 1416 normal 
adults for the HLA-A and HLA-B typing, 220 for the HLA-DR 
and 64 for the HLA-DQ typing . Although over 2000 individuals 
have been tested for the HLA-DQ locus in our laboratory the 
majority were Caucasoid or patients with selected diseases.6 As 
a consequence, only 64 normal healthy black individuals had 
undergone DQ typing. 
The HLA-A and HLA-B antigens were identilied with a two-
stage Iymphocytotoxicity test. 7 These antigens were defined 
with 180 antisera. which consisted of local serum samples that 
had been requested for use in International Histocompatibility 
Workshops, local samples that had been veri lied by use in 
parallel with the International Workshop samples. and samples 
that had been exchanged with other laboratories worldwide .8- 12 
Similarly, 120 serum samples were used to define the HLA-DR 
and HLt\-DQ antigens in B cell-enriched Iymphocyte suspen-
sions prepared with the use of straws packed with nylon wool. 13 
The differences in frequency of the various antigens between 
patients and controls were tested for significance by means of 
the chi:~q.uare test (without Yates' correction). The resulting 
probabthttes were multiplied by the number of HLA specific-
259 
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TABLE I 
Frequencies of HLA-A antigens (%) 
Control 
Patients subjects 
Antigen (n= 120) (n= 1416) 
AI 9.2 6.4 
A2 25.0 21.4 
A3 14.2 12.6 
All 0 0.1 
A23 15.8 18.3 
A24 2.5 4.9 
A25/34 14.2 13.5 
A26 14.2 10.5 
A28 21.7 20.9 
A29 18.3 17.1 
A30 25.8 37.4 
A31 7.5 6.0 
A32 2.5 2.3 
Aw33 2 .5 2.2 
One antigen 26 .7 26.4 
P = NS for all comparisons. 
ities tested to determine the corrected value. Relative risk was 
calculated according to the method of Svejgaard et a\.14 
Results 
The percentage of frequencies of the HLA-A, HLA-
B, HLA-DR, and HLA-DQ antigens in patients with 
TABLE 2 
Frequencies of HLA-B antigens (%) 
Patients control 
Antigen (n= 120) (n= 1416) 
B5 1.7 1.3 
B7 20.8 20.4 
B8 12.5 12.9 
BI3 3.3 3.8 
BI4 8.3 5.7 
BI5 5.0 4.0 
BI6 1.7 3.3 
BI7 42 .5 38.6 
BI8 7 .5 5.2 
B21 4.2 1.8 
Bw22 0 0.1 
B27 0 0.3 
B35 6.7 6.7 
B37 0 0.1 
B40 0 0.6 
Bw41 1.7 1.5 
Bw42 16.7 23.5 
B44 12 .5 15.0 
B45 11.7 11.6 
Bw53 0.8 1.6 
Bw70 30.8 24.6A 
One antigen 11.7 20.4 
P = NS for all comparisons . 
An = 220. 
260 
TABLE 3 
Frequencies of HLA-DR antigens (%) 
Control 
Patients subjects 
Antigen (n= 103) (n=220) 
DRI 12.6 2.7 
DR2 23.3 23.6 
DR3 34.0 33.6 
DR4 13.6 12.3 
DR5 30.1 32.3 
DRw6 31.1 15 .0 
DR7 15.5 12.3
A 




DRwlO 2.9 2.6 
One antigen 34.0 42.0 
pc = corrected p value. 
An = 138. 
BRelative risk = 5.2. 
















chronic rheumatic heart disease and the control sub-
jects are shown in tables I to 4. There was no differ-
ence in the frequency of any of the antigens at the A, 
B, and DQ loci between patients and control subjects. 
The HLA-DRI antigen was found in 12.6% of pa-
tients compared with 2.7% of normal control subjects. 
This increased frequency of DR I remained significant 
after correcting the p value (relative risk: 5.2). The 
frequency of HLA-DRw6 was also increased in pa-
tients compared with controls (31.1 % vs 15%), and 
this difference also remained significant after correct-
ing the p value (relative risk: 2.6) (table 3). 
Discussion 
Associations between disease and the HLA system 
may involve class I (HLA-A, HLA-B or HLA-C) or 
class Il (HLA-DR or HLA-DQ) antigens. In this study, 
no differences in frequency of any of the HLA-A, B, or 
DQ antigens in black patients with severe chronic 
rheumatic heart disease and control subjects were 
TAULE 4 
Frequencies of HLA-DQ antigens (%) 
Control 
Patients subjects 
Antigen (n=97) (n=64) 
DQwl 65.0 68 .8 
DQw2 21.7 23.4 
DQ· ... 3 21.7 31.3 
One antigen 92 76.5 
P = NS for all comparisons. 
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found. Our observations support the impression ob-
tained from analysis of previous studies lS- 21 that no 
association exists between rheumatic heart disease and 
any of the antigens at the A or B loci. Confirmation of 
a lack of an association between this disease and the 
HLA-OQ antigens will have to await further studies 
since these antigens were not tested in previous investi-
gations . 
However, we found an increased frequency of both 
HLA-OR I and HLA-ORw6 antigens in our patients 
with severe rheumatic heart disease; the differences in 
frequencies in patients and controls remained signifi-
cant after correcting for the total number of HLA anti-
gens tested. The corrected p value would be < .0 I in 
each case if a correction were made only for the num-
ber of OR antigens tested, as is done by some work-
ers .21 - 23 
Our study shows that severe chronic rheumatic heart 
disease in blacks is associated with certain OR anti-
gens. This implies that genetically determined im-
mune-response factors may play a role in the patho-
genesis of chronic rheumatic heart disease in some 
individuals . Support for this conclusion is provided by 
a recent report of an association between certaitl HLA-
OR antigens and rheumatic fever;~ the majority of pa-
tients in this study developed mitral and/or aortic in-
competence. 
We thank Professor B. T. Le Roux , Head of the Department 
of Cardiothoracic Surgery, Wentworth Hospital, Durban, for 
permission to study patients under his care and Mrs . Peta Gor-
don for typing the manuscript. 
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HLA Class I and 11 Antigens in South African Blacks with 
Graves' Disease 
MAHOMED A. K. OMAR, MICHAEL G. HAMMOND, RAJESII K. OESAI, 
AYESHA A. MOTALA, NAZIMUDDIN AIJOO, AND MAIIOMED A. SEEDAT 
Departmellt (~r Medicille, Ullit-er.fity of Natal, Durball, SOli III Africa; Nalo/llIstilllle (~r 
Iml1/1l1lology alld Departmellt of Chemical Pathology, Ullil'CI"Jity of Natal, COII[?ella. SOllth Africa 
A study was done to evaluate the relationship between Graves' disease and the HLA 
system in South African Blacks of Zulu descent. One hundred and three patients with 
Graves' disease and 1416 control subjects were typed for HLA A, B, and C antigens 
while 11 LA OR antigens were done on 63 of the former and 330 of the laller. There was 
a significant increase in the frequency of HLA OR3 in patients compared to control 
subjects (57.1% vs 36.1%; P corrected = 0.014). A relationship was also seen at the ORI 
locus (14.3% vs 4.6%; P corrected = 0.023). (:) 1990 Academic Press. Inc. 
INTRODUCTION 
The association between Graves' disease and the HLA system has aroused 
considerable interest in recent years. High frequencies of HLA B8 and OR3 have 
been found in White Caucasoids with the disease, whereas associations with HLA 
B35 and HLA B46 have been shown in Japanese and Chinese, respectively (1-5). 
A previous study involving a South African Black group with Graves' disease 
could not establish any definite relationship at the HLA Class I locus (6). Thus it 
can be seen that there appears to be an ethnic variability in the association be-
tween HLA antigens and Graves' disease. 
The present study was undertaken to evaluate the relationship between HLA 
Class I and Class 1I antigens and Graves' disease in South African Blacks of Zulu 
descent. 
PATIENTS AND METHODS 
The patients studied were all Blacks of Zulu descent who had Graves' disease 
diagnosed on the basis of history, clinical, and biochemical signs of hyperthyroid-
ism, the presence of a diffuse goiter on examination, and the finding of diffuse 
uptake of radio la be led /J'I on a thyroid scan. The HLA status of the patients was 
compared to a group of unrelated healthy Black control subjects of Zulu descent. 
The control group comprised randomly selected staff and blood donors, many of 
whom have been typed for international histocompatibility workshops. There 
were 103 unrelated patients and 1416 unrelated control subjects who were typed 
for HLA A, B, and C antigens by means of a two-stage microlymphocytotoxicity 
test (7) using a total of 180 antisera. 
HLA DR antigens were determined on 63 of these patients and 330 unrelated 
control subjects by means of a microlymphocytotoxicity test using B cell-enriched 
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Iymphocytes prepared with the aid of straws packed with cotton wool (8
). These 
Class 1I antigens were defined using 120 antisera. 
The sera used for typing the various Class 1 and II antigens consisted o
f local 
sera that have been requested for use in international histocompatibili
ty work-
shops, local sera that have been verified by using in parallel with
 international 
workshop sera, and sera that have been exchanged with other laboratorie
s world-
wide. 
Differences in HLA frequencies were tested for significance with the X
2 test 
(without Yate's correction) and the probability was corrected by multip
lying the 
P value by the number of comparisons made, i.e., the number of different 
antigens 




The results are shown in Tables 1-3. There was an increase in the freque
ncy of 
BLA B8 in patients compared to control subjects (23.3% vs 12.9%) but t
he P 
value was not significant after a correction was made for the number of
 antigens 
tested. Similarly, the association with HLA B 13 (9.7% vs 3.8%) loses signific
ance 
once the P value is corrected. 
At the DR locus there is a significant increase in the frequency of DR3 
(57.1 % 
vs 36.1%; P corrected 0.014), even after correction for the number of
 antigens 
TABLE I 
FREQUENCY OF HLA ANTIGENS IN PATIENTS AND C
ONTROL SUnJECTS 
Patients Controls Paticnts Controls 
Paticnts Controls 
Antigen (1/ = 103) (1/ = 1416) (1/ = 103) (/I = 1416) 
(11 = 63) (11 = 330) 
(/I = 103) % % Antigen % % Antig
ens % % 
AI 7.8 6,4 B5 1.0 1.3 
OR le 14.3 4.6 
A2 19.4 21.4 B7 22.3 20.4 
OR 2 20.6 24,2 
A3 9,7 12,6 BS" 23,3 1
2.9 OR 3d 57.1 36.1 
BI3" 9.7 2.3 OR 4 19.1 9.9 
All 0 0.1 BI4 11.7 5.7 
OR 5 22.2 35 ,1 
An 27.2 18,3 BI5 2.9 4.0 
ORW 6 14,3 14,3 
A24 3.9 4.9 BI6 4.9 3.3 O
R 7 12.7 15,3 
A25/34 15.5 23.5 BI7 38.S 3S ,6 O
RW 9 0 0,5 
A26 9.7 10.5 BI8 3.9 5,2
 ORWIO 1,6 2,4 
A2S 24,3 20,9 B21 1.0 I,S 
A29 13.6 17.1 BW22 0 1.0 
A30 39,S 37.4 B27 1,0 0.3 
A31 5,S 6.0 B35 4.9 6.7 
A32 1.0 2.3 BJ7 0 0,1 
AW33 2,9 2.2 B40 1.0 0,6 
One antigen 19,4 26,4 BW41 1,9 1.5 
BW42 16,5 23.5 
B44 12.6 15.0 
B45 7,8 8.S 
BW53 0 1.6 
BW70 19,4 24,6" 
One antigen 15.5 20,4 
No/e . ruc. P uncorrected; pc. P corrected. RR. relative risk. 
" rue = 0.003; re 0. 12, RR 2.03. 
" pile = 0.004; re 0. 13, RR 2.69. 
C pile = 0.002; pc 0.023. RR 3.48. 
d rue = 0.001; pc 0.014, RR 2.35 . 
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tested. In addiliop., a significant association is seen with ORI (14.3% vs 4.6%; P 
corrected 0.023). 
The occurrence of specific OR antigens together with certain B locus antigens 
in the same halotype is shown in Table 2. There is a significant linkage disequi-
librium between OR3 BS. The high frequency of this haplotype in the patients with 
Graves' disease is due to the association of DR3 with the disease, while the 
increased frequency of HLA BS can be explained by it being in linkage disequi-
librium with OR3. In fact, as can be seen in Table 3, the primary association is 
with HLA DR3 since the strongest relationship is seen in HLA BS negative 
patients. 
, Linkage disequlibrium was also seen between OR3 BW42, bulllot between OR3 
B17. 
DISCUSSION 
The association between Graves' disease and HLA B8 and OR3 has been firmly 
established in White Caucasoids (1-3, 9). Moreover, it has now become clear that 
the presence of OR} is far more important in determining susceptibility to Graves' 
disease than HLA BS which is then associated with the disease by virtue of being 
in linkage disequilibrium with OR3 (1). 
South African Blacks with Graves' disease, as shown in this study, certainly 
show a significant relationship with HLA OR3 and DR I. It appears that to date no 
other non-Caucasoid groups studied, viz: Japanese, Chinese, Thai, and American 
Blacks, has shown an association between Graves' disease and HLA OR} (4, 5, 
11, (2). These observations p~ovide further support for the existence of hetero-
geneity in HLA associations relevant to Graves' disease. 
A high frequency of HLA BS was found in patients with Graves' disease com-
pared to controls. Although the corrected P value was greater than 0.05, this 
association does become significant when it is considered in the light of a priori 
hypothesis since the same antigen has been found to be significantly increased (P 
uncorrected < 0.0 I) in a previous study involving another group of South African 
Blacks (6, 9). Moreover, the association could well be a secondary phenomenon 
as this antigen occurs in linkage disequilibrium with DR3 as shown in this study. 
Since both South African Blacks and American Blacks presumably have the 
same origin, the lack of any relationship at the DR locus among the latter is 
TABLE 2 












" Significant linkage disequilibriull1 . 
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TABLE 3 
OCCURRENCE OF HLA DR3 TOGETlIER WITH SELECTED HLA 13 Loc us ANTIGENS IN PATIENTS 
WITH GRAVES' DISEASE 
B8 positive patients 
B8 negative patients 
BW 42 positive patients 
BW 42 negative patients 
B 17 positi ve patients 
B 17 negative patients 






23 (36 .5%) 







somewhat surprising (12). Of interest also is the absence of any negative associ-
ation with HLA B7 or BW42, as has been found in the previous study on South 
African Blacks (5). In addition, this study did not find an increase in HLA B 17, 
which is associated with Graves' disease in South Nigerians, another African 
Black group (2). 
A previous study defined a clear association between insulin-dependent diabe-
tes mellitus and HLA DR4 in South African Blacks of Zulu descent (14). How-
ever, no association was found with HLA DR3 (14). In contrast, Graves' disease 
affecting the same popUlation group is associated with HLA DR3. 
In conclusion, this study, having been the only one thus far to show a significant 
relationship between HLA DR3 and Graves' disease involving a non-Caucasoid 
group, underlines the need for more population-based studies involving groups 
other than Caucasoids to evaluate such associations. 
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HLA-A, B, OR, and OQ Antigens in Black Patients with Idiopathic 
Dilated Cardiomyopathy 
Breminand Maharaj, MB, ChB, FCP(SA), and Michael G. Hammond, PhD 
T he HLA antigens, which 
are encoded by closely 
arranged genes on the short arm of the sixth chromo-
some, influence the predisposition to several diseases. I 
Some with initially weak associations with HLA-A and 
HLA-B antigens have been found to have stronger associ-
ations with HLA-DR antigens.2 Since a genetic predispo-
sition to the development of idiopathic dilated cardiomy-
opathy has been postulated, and since there is little infor-
mation on the relation between antigens at the DR and 
DQ loci of the HLA system and idiopathic dilated cardio-
myopathy,3-5 we performed HLA typing in a group of 
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TABLE I Frequencies of HLA-A Antigens.(%) 
Pts Control Subjects 
Antigen (n=62) (n = 1.416) 
Al 11.3 6.4 
A2 27 .4 21.4 
A3 16.1 12.6 
All 0.0 0.1 
A23 12.9 18.3 
A24 3.2 4.9 
A25/34 14.5 13.5 
A26 9.7 10.5 
A28 19.4 20.9 
A29 12.9 17.1 
A30 35.5 37.4 
A31 4.8 6.0 
A32 3.2 2.3" 
Aw33 8.1 2.2 
One antigen 21.0 26.4 
Difference not Slgnihcant for all comparisons. 
• Uncorrected D <0.005. 
TABLE III Frequencies of HLA-OR Antigens (%) 
Pts Control Subjects Corrected 
Antigen (n= 57) (n =412) p Value p Value 
DRI 12.3 4.6 <0.025 NS 
DR2 29.8 24.0 NS NS 
DR3 28.1 36.2 NS NS 
DR4 7.0 10.0 NS NS 
DR5 38.6 35.2 NS NS 
DRw6 24.6 14.6 NS NS 
DR7 14.0 15.3 NS NS 
DRw8 5.3 2.9 NS NS 
DR9 0 .0 0.7 NS NS 
DRwIO 8.8 2.2 <0.01 NS 
DRI +DRwIO 21.J 6.8 <0.CXXJ5 <0.02" 
One antigen 31.6 54.4 <0.002 NS 
• Relatrve risk. 3.7. 
NS - not sIgnificant. 
black patients with this disease to determine if immuno-
genetic factors could be involved in the pathogenesis of 
idiopathic dilated cardiomyopathy. 
HLA-A and HLA-B typing was carried out in 62 
black patients with idiopathic dilated cardiomyopathy 
who had been admitted and evaluated at King Edward 
VIII Hospital, Durban, and HLA-DR and HLA-DQ 
typing was performed in 57 of these individuals; all had 
evidence of global hypokinesis on echocardiography. 
None had any disease other than idiopathic dilated car-
diomyopathy; habitual alcoholics and hypertensives 
were excluded. Coronary angiography was not per-
formed in any of the patients because coronary artery 
disease is rare in the black population of South Africa. 6.7 
Patients were aged between 17 and 63 years. The control 
group consisted of 1,416 normal adults for the HLA-A 
and HLA-B typing, 220for the HLA-DR typing and 198 
for the HLA-DQ typing. Although over 2,000 individl 
uals have been tested for the HLA-DQ locus in ou~ 
laboratory, the majority were caucasoid or patients with 
TABLE 11 Frequencies of HLA-8 Antigens (%) 
Pts Control Subjects 
Antigen (n =62) (n = 1.416) 
85 0.0 1.3 
87 29.0 204 
88 9.7 12.9 
813 1.6 3.8 
814 1.6 5.7 
815 6.5 4.0 
816 4.8 3.3 
817 37 .1 38.6 
818 3.2 5.2 
821 1.6 1.8 
8w22 1.6 0 .07 
827 1.6 0.3 
835 11.3 6.7 
837 
.. 
0 .0 0.01 
840 0 .0 0.6 
8w41 1.6 1.5 
8w42 21.0 23.5 
844 14.5 15.0 
8w47/47 0.0 
. .. . 
0.1 
8w53 0 .0 1.6 
8w70 25.8 14.2 
One antigen 17.7 30.7 
DiHerenc! not significant for atJ comoansons. 
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selected diseases.8 Only 198 normal healthy black indi-
viduals had undergone DQ typing. 
The HLA-A and HLA-B antigens were identified 
with a 2-stage Iymphocytotoxicity test. 9 These antigens 
were defined with 180 antisera, which consisted of local 
serum samples that had been requested/or use in Inter-
national Histocompatibility Workshops, 10Cfll samples 
that had been verified byuse in parallel with the Interna-
tional Workshop samples and samples' tHat had been 
exchanged with other laboratories worldwide-. 10-14 Simi-
larly; 120 serum samples were used to define the H LA-
DR and HLA-DQ antigens in B cell-enriched lympho-
cyte suspensiCins prepared with the use of straws packed 
with nylon wool.15 The difference in frequency of the 
various antigens between patients and control subjects 
was tested for significance by means of the chi-square 
lest (without Yates' correction). The resulting p values 
were multiplied by the number of H LA antigens tested to 
determine the corrected p value. Relative risk was calcu-
lated according to the method of Svejgaard et af.l6 
The percentage frequencies of the HLA-A, HLA-B, 
HLA-DR and HLA-DQ amigens in patients with idio-
pathic dilated cardiomyopathy and the control subjects 
are listed in Tables I to IV. With respect to the dIffer-
ences noted, only the increased frequency of the closely 
related antigens, HLA-DRI and DRwlO (21.1 vs 6.8%), 
remained significant after correcting the p value (relative 
risk 3.7). 
Associations between disease and the HLA system 
may involve class I (HLA-A, B or C) or class II antigens 
(D-locus antigens). In this study, no differences in fre-
quency of any of the HLA-A, B or DQ antigens between 
black patients with idiopathic dilated cardiomyopathy 
and control subjects were detected. However, we found 
an increased frequency of the HLA-DRl and DRwlO 
antigens in our patients with idiopathic dilated cardiomy-
opathy; the differences in frequencies between patients 
and control subjects remained significant after correcting 
for the total number of HLA antigens tested. The correct-
ed p value would be <0.005 if a correction were made 
only for the number of DR antigens tested, as is done by 
some investigators. 17· l8 · . 
Zerbe etal4 were unable to find an association be-
tween this disease and any of the class I and class II 
antigens in white patients. Another group observed an 
increased frequency of HLA-B27 and HLA-DR4 anti-
gens and an underrepresentation of the HLA-DR6 in 
cauc~so.id patients with idiopathic dilated cardiomyopa-
thy3; It IS not stated whether the p values were corrected 
for the number of antigens tested. An increased frequen-
cy of HLA-DR4 antigen was also noted in another group 
of caucasoid patients with this disease.s Confirmation of 
a lack of an association between this disease and the 
HLA-DQ antigens will have to await further studies 
since these antigens were not tested in previous investiga-
tions. 
Our study shows that idiopathic dilated cardiomyopa-
thy in blacks is associated with certain DR antigens. This, 
together with the results of the study by Anderson et aP 
and those of Limas and Limas,s implies that genetically 
determined immune-response factors may play a role in 
the pathogenesis of this condition in some individuals. 
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HLA antigens in donovanosis (granuloma inguinale) 
Nigel O'Farrell, Michael Hammond 
Abstract 
Objective-To compare the frequencies of 
HLA antigens in patients with donovanosis and 
in contro'~. 
Desig71-1 fLA Class I, Class 11 and DQ antigens 
were detected in patients with genital ulcera-
tion caused by donovanosis and in a control 
group. 
Setting-City Health STD Clinic, King 
Edward VIII Hospital, Durban, South Africa_ 
Participants-Sixty (47 men, 13 women) 
patients with donovanosis. 
Results-HLA B57 was detected in nine of 60 
(15%) with donovanosis and 75 of 1478 (5-1%) 
con trois (RR = 3' 3 Xl = 11'0, p = 0'001, p 
corrected = 0'026)_ 
C01lciusio1ls-A possible link behveen dono-
vanosis and HLA B57 could be explained by co-
existing aIIeles or imlnune response genes in 
linkage disequilibrium altering disease sus-
ceptibili ty. 
Introduction 
Donovanosis is a genital ulcerative disease (GUD) 
found in diverse geographical locations where poor 
socio-economic conditions prevail and is commoner 
in dark-skinned races.' Donovanosis is generally 
regarded as a sexually transmitted disease (STD) but 
the modes of infection and transmission are not yet 
established with certainty. The causative agent, 
CalymmatobacteriulIl gramilolllatis, has been isolated 
from faeces, and transmission through auto-inocula-
tion is suggested.
2 The organism possesses a capsule 
and is similar to klebsiella strains but its biochemical 
and bacterial characteristics are not well defined.
3 
Although previously thought to be uncommon in 
Southern A rrica, donovanosis has recently emerged 
asa <; i.!!," li ; " "(; \I, ~ , ' ,,"(;IIJ)illJ)lIrhan . II119RR4171 
cases \\l'll' diClgllused by the prescnce of Donovan 
bodies on direct microscopy using the RapiDitf 
technique,5 a simple bench diagnostic staining 
method. 
._ ... . _- - -- ---------
City.'" :I'i.'. :.; n I Department, King Edward VIII 
liospltal, l,flogclla, Durban South Africa 
NigcIO ' Farrcll ' , 
Transplantation Unit, Natal Institute of Immun-
ology, Pinctowl1, Natal, South Africa 
Mich:1cl II :lIlllllolJd 
Most bacterial STDs are readily transmitted from 
male to female and female to male. However, variable 
transmission rates of infection with C grmlU/ol1latis 
are reported from different populations, The 
prevalence of disease amongst regular sexual part-
ners varies from I % in the USA' and I % in Papua 
and New Guinea7
 to 50% in India. A The apparent 
racial predominance amongst blacks and variability 
in transmission suggests that host susceptibility 
factors may be relevant in the disease process . 
No clear association between a single HLA antigen 
and a particular STD has been described but don-
ovanosis has been suggested as one STD with a 
reasonable chance of such a link,9 \V/e therefore 
investigated the frequency ofHLA antigens amongst 
Zulu patients with donovanosis attending a STD 
clinic in Durban, 
Patients and Methods 
Sixty Zulu patients (47 men, I3 women) attending 
the City Health STD Clinic at King Edward VIII 
Hospital, Durban with genital ulcerative lesions of 
donovanosis were entered into the study. Donovan-
osis was diagnosed by the detection of Donovan 
bodies on tissue smears stained with RapiDifP and 
examined bydirect microscopy. Specific (TPHA)and 
non-specific (RPR) serological tests for syphilis were 
performed. Laboratory facilities for identifying her-
pes simplex virus, chancroid and lymphogranuloma 
venereum infections were unavailable. 
The control group consisted of 1478 normal 
subjects who were either staff or randomly selected 
blood donors of the same ethnic origins as the 
patients, HLA Class I antigens were determined in 
all patients and control subjects by a two-stage 
microlymphocytotoxicity test'O with 180 sera consist-
ing of: 1. local ser:a requested for use in international 
histocompatihility workshops; 2. local sera verified 
with international workshop sera; 3. sera exchanged 
with other laboratories worldwide. 
Similarly 120 sera Were used to define the Class I I 
antigens on B-Iymphocyte enriched Iymphocyte sus-
pension prepared with the aid of straws packed with 
nylon WOOL " Class I I antigens were determined in '51 
patients and ') \) Cllntrols except that 111.1\ I)(~ 
antigens were tested in 129 controls. 
Statistics 
Differcnccs in fILA frequcncies were tested for 
significance with the l test and the probability 
467 
H LA alllige1ls i1l d01lovanosis (grallllloma i;iglli1lale) 
Table 1 Freq/lency of HLA Class I allligem in patients 
with dOllova//Osis alld normal COlllro/s 
Cmllrols ])V11ova11osis 
Relalive 
HLA N = 1478 (~~ ) N = 60(%) X' ri
sk 
AI 123 (832) 3 (500) 0 -85 06
 
A36 12 (081) I (1 -67) 050 21
 
A2 358 (24 -22) 15 (25 -0) 0 -02 
10 
A3 165 (11 Iti) I:? (
2()'()) 4 -42 2-0 
A21 281 ( I ') ,11 : :1 15(0) 7-52 0 -2 
.-\1·1 81 \5 -IH) h (10-00) 221 19
 
A25 55 (372) 0 (0-00) 2-32 00 
A26 173 (1171 ) 5 (8-33) 064 07
 
A34 124 (8 -39) 6 (1000) 0-19 
1-2 
A28 319 (21 -58) 21 (3500) 6-03 2-0
 
A29 213 (1441) 7 (11 -67) 0 -35 08
 
A30 455 (3078) 16 (2667) 0-46 08
 
A31 57 (386) 3 (500) 020 1-
3 
A32 28 (lR9) 2 (333) 062 
1-8 
A33 58 (392) 2 (3 33) 0 -05 08 
A43 2 (0 14). 0 (0-00) 0-08 0 -0 
A66 1 (007).. 0 (000) 0-04 00 
137 348 (23 -55) 15 (2500) 007 11 
B8 189 (12- 79) 10 (1667) 077 1-4 
813 45 (3-04) I (1 -67) 0 -38 05 
BI4 88 (595) I (1 -67) 194 03 
BI8 80 (541) I (167) 1-62 0-3 
1121 29 (1-96) 2 (3-33) 055 1-7
 
1322 I (0-07) 0 (0'00) 0 -04 0 -0
 
827 5 (0-34) 0 (000) 0 -20 -0 -0
 
835 109 (7 37) 8 (1333) 2-91 1-9
 
837 2 (0-14) 0 (000) 008 00 
U38 29 (196) 2 (3 -33) 0 -55 1-7 
B39 24 (1-62) I (1-67) 000 1-0 
B41 27 (183) 2 (3-33) 0 -71 1-9 
B42 296 (2003) 12 (2000) 0 -00 1-0 
B44 233 (1576) 11 (18 -33) 0 -29 1-2 
U45 139 (940) I (167) 417 0 -2 
U47 I (0-07) 0 (000) 004 00 
U48 I (007) 0 (0 -00) 0 -04 0 -0 
U51 16 (108) _ 0 (000) 0-66 00 
U52 20 ( 1-35) 2 (3-33) 1-60 2-5 
U53 20 (1-35) 2 (333) 1-60 2-5 
U57 75 (507) 9 (15 -00) 1100 33 
U58 471 (3187) 21 (35 -00) 0 -26 1-2 
1160 I (007) 0 (000) 004 00 
U62 10 (068) 0 (000) 0 -41 0 -0 
U63 40 (271 ) I (167) 0 -24 06 
B70 407 (27 -54) 9 (15 -00) 4-59 0 -5 
corrected by multiplying the p value by the number 
of comparisons made, that is, the number of antigens 
tested.'2 Relative risks were calculated according to 
the formulae recommended by Woolf.'J 
Results 
The frequencies of HLA A and B antigens in the 
patients and controls are shown in table I and of 
HLA DR and DQ antigens in table 2. HLA B57 was 
detected in nine of 60 (15%) with donovanosis and 75 
of 1478 (5 ' 1%) controls (RR = 3'3, '/ = 1I·0, p = 
0'001, P corrected = 0 -026). HLA A23 was detected 
in three of60 (5%) with donovanosis and 281 of 1478 
(19 'O'Yo) controls (RR = 0'2, -l = 7'5, P < 0 '01, p 
not significant after correction). 
Positive serological tests for syphilis (TPHA and 
RPR were detected in 14 (10 men and four women). 
401 
- Table 2 Freq/le/lcy of HLA Class II allligells ill patiellls 
wilh dOlloval/(JSis alld Ilormal co//lrols 
Comrols /)V"VV"",,sis 
Relative 
Ill. A N = 513 ('H,) N = 53(%) X' risk 
DRI 24 (468) (189) 089 
0 -4 
DR2 124 (2417) lti no 19) 0 -93 14 
DIU Ii'll i152H ) _?I 11 -10) I 
}7 I -I 
J)RI I" I q · -; ") I r;' I)OI !lH
; ll6 
1)1{') 111~ ( \ : ~ . I " .. ~ . () I " 203 06 
J)R6 '1 2 (i , -'Il ) " i ll 31 ) 
147 06 
DR7 79 (15 -·10) III ( 18-87) 044 
1-3 
DR8 20 (390) 3 (566) 0 -38 15 
DR9 4 (0-78) 2 (377) 411 
5-0 
DRill 11 (2 -14) 4 (755) 5-44 
3-7 
N= 176 N = 5.1 
))Q\'\'I 1~] ( flO - t~ , h 7
 (12) 004 0-9 
I )(2'C~ ~, , ) ".; I ', I f , .
~ J Ou7 13 
DQ\'\-l I~ , 2 j .in ! . IU 19) 086 14 
Discussion 
There are few reports linking HLA antigens and 
STDs. Amongst Chinese prostitutes in Singapore 
HLA AWl9 and HLA BI7 were associated with 
syphilis and gonorrhoea and HLA All and HLA 
B 15 conferred relative resistance.'~ Behcet's disease, 
although not a STD, does cause genital ulceration 
and is associated with HLA B5. '5 The development 
of disease may be related to early sexual intercourse 
or adolescent infection. '6 Our findings of a possible 
link between HLA B57 and donovanosis and a trend 
towards resistance to disease with HLA A23 could be 
explained by co-existing allelcs or immune response 
genes in linkage disequilibrium altering disease sus-
ceptibility. 
Donovanosis is a STD about which little is known 
despite its recognition in the nineteenth century. It 
differs from most bacterial STDs in having a long 
incubation period and a variable transmission rate to 
regular sexual partners thereby suggesting inherent 
differences in host susceptibility. The causative 
organism C gramtiomalis shares some features of 
klebsiella strains including a prominent capsule but 
its bacterial characteristics are still not yet clearly 
defined. Klebsiella extracts are more likely to interact 
with HLA B27 than other HLA antigens producing 
an altered-self major histocompatibility complex that 
may trigger reactive arthritis. '7 
Donovanosis has nn I y n: n: 11 I I y heen recognised as 
a significant cause of GUlJ amongst the local Zulu 
population.~ Whether this reflects a new epidemic or 
increased awareness following the introduction of a 
rapid diagnostic test is uncertain. Elsewhere in South 
Africa donovanosis occurs in East Transvaal 
amongst the Swazis 'R but is otherwise uncommon. 
The highest prevalence of dunovanusis worldwide 
is in Dutch New Guinea and Papua New Guinea. '9 
However, HLA B57 was not identified amongst 
468 
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natives ofthe Highlands and Coastal Areas.
2o Further 
studies of HLA status and donovanosis are required 
amongst population groups from endemic areas to 
clarify possible immunopathological mechanisms of 
disease and assess the role of genetic factors. 
Address for correspondence: Dr Nigel O'Farrell, 
Lydia Der:utment, St Thomas' Hospital, London 
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onset of activity (Iorazepam). Similarly, for 
acute behavioural episodes such as violence 
the choices have generally been intramus-
cular lorazepam or antipsychotics such as 
haloperidol or chlorpromazine. In addition 
to delayed onset of effects, intramuscular 
anti psycho tics have been associated with 
acute extra pyramidal side effects, orthostatic 
hypotension, and extreme sedation . 
Over the past year we have used the 
benzodiazepine midazolam intra muscularly 
to treat patients with acute seizures or 
extreme behavioural episodes. In the United 
States midazolam is currently approved for 
use as a pre-anaestlletic agent, and not for 
treatment of seizures.' It has, however, been 
successfully used in clinical situations to treat 
acute seizures including status epilepticus, 
and severe behavioural problems often with 
almost inimediate effects.' " Midazolam is a 
highly lipophilic water soluble drug which 
allows for excellent intramuscular absorption 
and rapid CNS penetration. Intramuscular 
(lM) administration can result in sedation 
within five to 15 minutes with peak effects 
noted within 30- 60 minutes. Th~ drug pos-
sesses a short half-life of 1'5 to 3·5 hours, 
although in some patients residual psycho-
motor effects may be noted for up to eight 
hours . Although there have been reports of 
respiratory problems with the intravenous 
administration of midazolam, especially in 
elderly patients, this has not been reported 
after intramuscular use. Warnings of respira-
tory problems specifically only mention 
intravenous administration. 
After previously published reports of suc-
cess witll IM midazolam for the treatment of 
acute seizures and behavioural emergencies, 
we have been treating patients with this 
medication. We present four cases involving 
clinical use of IM midazolam, rwo for acute 
seizures and two for behavioural control. 
Case I: A 26 year old white male suffered a 
head injury on the 9 February 1985 second-
ary to a motor vehicle accident. The patient 
has had persistent problems witll late on~et 
prolonged seizures which often needed 
admission to hospital for acute treatment 
despite receiving intramuscular lorazepam. 
These admissions averaged at least one per 
month between 1989- 90. In early 1990 
lorazepam was switched to IM midazolam 
10 mg. Since the change to midazolam, no 
further admissions have been necessary for 
treatment of acute seizures, despite no sig-
nificant changes in the primary anticonvul-
sant drug treatment. 
Case 2: A 22 year old white male suffered a 
head injury on 2 January 1986 when he was 
hit by a car. He developed frequent and 
prolonged late-onset seizures, both focal and 
generalised. On 3 April 1990 he developed 
right-sided twitching of the face and extrem-
ities for seven to 10 minutes, without second-
ary generalisation. IM midazolam 15 mg 
stopped d,e seizures "wid!in five minutes." 
On 25 June 1990 he developed prolonged 
generalised tonic-clonic seizures. IM mid-
azolam 15 mg was administered and the 
seizures ceased within five minutes with the 
patient falling asleep. Sedation was the only 
reported adverse effect. 
Cou 3: A 52 year old black male suffered a 
head injury in May 1987 secondary to a fall. 
Post traumatically he developed seizures, and 
paranoi.d psychosis with prolonged agitated, 
aggresSIve, and combative behaviours. On 6 
April 1990 he became euphoric, paranoid, 
very agitated and threatened physical abuse 
to staff members. He refused medications 
and also cigarettes. Mter IM midazolam 
5 mg he fell asleep for one hour and awoke 
amnesic about the episode. 
Cau 4: A 39 year old black male, had 
primary behavioural problems including 
chronic violence to od,ers and agitation . The 
patient has had a chronic idiopathic seizure 
disorder since 1980. In 1988, he developed 
an episode of status epilepticus leading to 
anoxic encephalopatl!y with resulting severe 
cognitive impairment, chronic paranoid psy-
chosis, aggressive behaviours, and visual and 
auditory hallucinations. Intramuscular mid-
azolam has been used on numerous occa-
sions to treat agitation resulting in alleviation 
of agitation and violence as well as a reduc-
tion in psychosis without significant sedation 
or long term "after effects." These positive 
effects have lasted for a day, sometimes for 
eight to 12 hours . 
Although seizures after brain injury can 
sometimes be self-limiting, the known rapid 
onset of midazolam and our knowledge of 
these patients' seizure histories makes this 
possibility unlikely. While some patients 
(such as case 4) may respond to very low 
doses, d,e general dosage guideline for mid-
azolam is 0· 15 to 0·30 mglkg.' 
Side effects were reported ranging from 
slight letllargy to sleep. In most cases, dlis 
lasted for one to two hours and the patients' 
recovery was uneventful. Only case 4 demon-
strated prolonged effects~ven at a very low 
dose. Intramuscular midazolam appears to 
be a safe, rapidly effective drug for treatment 
of both acute seizures and behavioural emer-
gencies and deserves further study. 
BRUNO A WROBLEWSKI 
Grtentry Rehabilitation Cmur, and 
Department of Rehabilitation M edicine, 
7iifu Univenit)' School of Medid"., B01l0n, J\.fA, 
USA 
ANTHONY B JOSEPII 
Department of Psychiatry, 
Harvard Medical Sellnol, 
Boston, AlA, USA 
Correspondence to: Dr Wroblewski. 
1 Versed: Product information. Nutley NJ, HolT-
man-LaRoche. 1986. 
2 Egli /1.·1, Albani C . Relief of Matus epilepticus 
after IM adminisl .. lion of Ihe new Short-
Acting benzodia7.epine mida7.0lam. 7welrh 
Ifb,ld Cone"" of N eurology, 20- 25 Sep-
lember 1981, Kyolo. Japan. Princeton, Ex-cerpll Medica, 44 (abs 137). 
3 Jaw.d S, Oxley J, Wilson J, Richens A. A 
pharmacodynamic e"alul lion of midazolam 
as an anliepileplic compound. J Neural Neu-
ra1llrll /',yclriatry 1986;49: I 050-4. 
4 Galvin GM, Jelinek GA. MidalOl.",: an eITec-
tive intravenous agent ror seizure control. 
Arch ""'0'/1 M ed 1987;4:169-72. 
5 M.yhu. FE. IM mid.zolam for statu. epilepti-
cus in the Emer(!ency Department. An" 
Emerg Med 1988;17:643- 5: 
6 Von Alb<rl HII. Midazolam for Ihe Ir.atment of 
SI ales of restlessness and excilalion. In: Stef-
fen. J. ed. Midazolam in anesthesiology. 1nl 
Symposium Darmstadt, 28- 29 October 
1983. Basle, Swilurl.nd: Roehe Scientific 
Service, 1986:255-58. 
7 Mendo1-a R, Dienderediian All, Adams J, 
An.nth r Midazolam in acute psychotic 
patients with hyperarousal. J Cli" Psychiatry 
19117;48:7, 291-2. 
8 Bond WS, "".ndos LA, Kurtl MD. Midazol.m 
for aggressivity and violence in three menIally 
retarded patients. Am J Ps)'€hiarry 1989;146:7,925-6. 
9 Dundee JW, nalliday NJ, Harper KW. Mid-
Awlam . A review or its pharmacological 
properties and therapeutic use. Drugs 1984;28:519-43. 
329 
IILA profile and HTLV-J associated 
myelopathy (HMlfTSP) In Natal, .South 
Arrlca 
Myelopathy associated with HTLV-I (HAM! 
TSP) is an important cause of neurological "' 
disability in the Zulus in NataL' To explore 
the role of host factors in the patllOgenesis of 
this disorder we examined the HlA profiles 
in 40 HAtvVrsp patients. The results were 
also compared witl! rwo antibody positive 
patients with adult T-cell leukaemiallympho-
ma (ATLL). The control group consisted of 
normal adults who were either staff or 
randomly selected blood donors of the same 
etlmic origin as tl!e patients. Class I antigens 
were tested in 1848 controls, DR antigens in 
556 and DQ in 340. 
Standard techniques' , using 180 antisera 
for Class I antigens and 120 antisera for 
Class n antigens, were employed. Differ-
ences in HLA frequencies were tested for 
significance with the Chi square test (without 
Yates's correction) and the probability was 
corrected by multiplying the P-value by the 
number of comparisons made, that is, the 
number of antigens tested" Relative risks 
were calculated according to the formulae 
recommended by Woolf.' TI,e difficulties of 
establishing negative correlations which may 
indicate a "protective" antigen have been 
discussed by Svejgaard er 01." Haplotype 
frequencies were estimated by the method of 
Mattiuz er aC 
The HlA frequencies of the large number 
of controls was typical of the Soutllern 
African black population. There was virtual 
absence of All, B22, B40, Bw54, Bw52, 
Cwl and DR9 whilst high frequencies of 
A23, A30, Bw42, B58, B70, Cw2 and DR5 
were observed. In the patient group an 
increased frequency of only one antigen-
Bw57-reached statistical significance 
(table) at the I % level after correction for the 
number of Class I antigens tested. The 
increased frequencies of A24 (12 ,5% vs 6 ·0 
%), B7 (32 '5% vs 23 ·4%) and DR2 (37 ' 1% 
vs 24%) were of borderline significance. 
There were no significant differences in tl,e 
frequencies of HlA C and HLA DQ anti-
gens. TIle joint occurrence of A24, B7, DR2, 
DQwl was found in 3f35 patients (8 '6%) but 
was present in only 3· 1 % of the control 
group. The two patients with lymphoma! 
leukamia had tlle following antigens: HLA 
A2, A30, B8, B-, Cw2, Cw-, DR7, DR-, 
DRw53, DQwl and DQw- and HlA Aw31, 
A-, B35, B45, Cw-, DRw8, DRw52, DQw3, 
DQw-. There were no significant d ifferences 
in the estimated haplotype frequencies 
berween patients and controls. 
In contrast to our largely negative findings 
Usuku et al" found specific IllA haplotypes 
in 70% of their HAM patients. Furthermore, 
none of the HAM associated HLA ha polo-
types were seen in ATLL. 111e joint occur-
rence of A24, B7, DR2, DQwl found in 
8 '8% of our patients, has been reported by 
the Japanese,' altl!ough DR2 was usually 
found with different B-Iocus antigens. 11,e 
other HLA antigens associated with HAM! 
TSP in the Japanese"-AII, Bw54, Bw52, 
are not found in the Zulus. · Also those 
antigens associated with ATll.. in Japanese 
lire rare in the local black population. 
There is accumulating evidence that the 
neurological injury in HAlvVfSP is immune 
mediated. 'o A more rermed examination of 
the HLA system may yet prove fruitful. The 
recent molecular genetic study by Usuku er 
al" showed a relationship berween a partic-
ular amino acid sequence of the HLA-DR I 
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Table lHIlC Class 1 allligm jrequellcies in Zulu co"irol subjects alld patients wit" HAM ITSP. 
Control 
N = 1848 % 
B7 432 23·3 
B8 235 12·7 
BI3 62 3·3 
BI1 112 6 '0 
BI8 95 5' 1 
B21 35 1·8 
Bw22 I 0 ·0 
B27 8 0·4 
B35 135 7·3 
B37 2 01 
B38 32 1·7 
B39 29 1·5 
Bw41 33 1·7 
Bw12 368 19·9 
BH 303 16-4 
Bot5 174 9·4 
Bw47 2 0·1 
B",48 I 0·0 
BSI 20 1-0 
Bw52 I 00 
Bw53 29 1,5 
DwS7 88 4-1 
Bw58 5B5 31 ,6 
Bw60 I 0·0 
Bw61 0 00 
Bw62 12 0·6 
Bw63 43 2-3 
Bw70 512 27 ·7 
N = number; R-R = relative risk. 
chain and the succeptibility to HAM. We 
have already established control frequencies 
in the Zulus for HLA polymorphism using 
PCR amplified DNA, dot-blots and oligo-
nucleotide probes and hope to embark on a 
project to determine if any of these DNA 
markers are relevant to HAMrrSP. 
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ExtrapyramIdal symptoms In a patient 
treated with flu~'oxamlne 
A 77 year old woman had a longstanding 
history of recurrent major depressive epi-
sodes. She was treated with several tricyclic 
and heterocyclic antidepressants. Approx-
imately six months before she came under 
our care, she started taking neuroleptics for 
the first time in her life . Flupenthixol I mg 
three times daily was prescribed in combina-
tion with the tricyclic antidepressant meli-
tracene for a major depressive episode with 
psychotic features . 
After a few months, marked orofacial 
involutary movements were noted. All psy-
choactive drugs were discontinued and the 
orofacial dyskinesia disappeared gradually 
over the following month. The depression 
relapsed, however, and treatment was started 
with fluvoxamine, a serotonin-re uptake 
inhibiting antidepressant. The initial dose of 
50 mg was gradually increased to 200 mg. By 
the time she had been on Huvoxamine for six 
weeks, she was transferred to our psychoger-
iatric ward . 
On initial neurological examination, a mild 
akinetic-rigid syndrome And hyperactive ten-
don reflexes were found. Blood pressure fell 
from 130/80 to 90150 mm Hg when the 
palient changed from the supine to standing 
position. A CT scan showed mild generalised 
brain atrophy with a slightly more pro-
nounced cerebellar atrophy. The akinetic-
rigid syndrome deterio rated considerably 
over the following eight months, eventually 
leading to multiple falls . No tremor was 
[",turs to t", Editor 
noted . Meanwhile, the depressive symptoms 
had substantially improved. As an explana-
tio n for her neurological symptoms, a multi-
ple system atrophy was suspected , altho ugh 
Parkinson's disease was also considered . 
Before starting a drug trial with levodopa, 
we wanted to rule out the possibility that the 
Parkinsonism was drug-induced. Fluvoxa-
mine was therefore reduced to a daily dose of 
100 mg. The extrapyramidal symptoms h ad 
already markedly decreased one week later. 
The nuvoxamine was now completely with-
drawn, resulting in an almost complete dis-
appearence of the extrapyramidal symptoms 
over a period of two weeks. One month after 
the cessation of fluvoxamine, only a mild 
decrease in arm swing was left; the hyper-
active tendon reflexes were unchanged . The 
orthostatic hypotension had also disap-
peared. An MRI scan of the brain showed 
mild atrophic changes and some periven-
tricular and deep subcortical white matter 
hyperintensities. There was no signal attenua-
tion in the putamen on T2-weighted images 
as has been described in striatonigral 
degeneration and other multisystem atro-
phies. Neither were there changes in the 
posterior fossa suggestive of olivopontocer-
ebellar atrophy. A rechallenge with the 
offending drug was considered unacceptable 
because of the risk of serious injury when 
falls reoccurred. 
Our patient presented with a severe aki-
netic-rigid syndrome and orthostatic hypo-
tension almost completely reversible after 
withdrawal of the antidepressant nuvoxamine 
which she had been taking for several 
months. Extrapyramidal and autonomic side 
effects are not usually described with this 
selective serotonin-re uptake inhibitor. As far 
as we know, the occurrence of orthostatic 
hypotension is very unusual with this drug 
that has no known antagonist activity for alfa-
adrenergic receptors . The association 
between selective serotonin-re uptake inhibi-
tors and extrapyramidal side-effects as well as 
akathisia has already been reported, however, 
although mainly for f1uoxetine. ,- , A possible 
explanatio n is that increased serotonergic 
activity may exert an inhibitory action on 
nigrostriatal dopaminergic neurons: Pre-
existing compromised nigrostriatal function 
caused by Parkinson's disease, other degen-
erative neurological disorders or dopamine-
blocking agents might predispose patients to 
this adverse effect . Our patient had no such 
conditions. A causative role for the neu-
roleptics she had taken some months before 
the treatment with fluvoxamine is very 
unlikely because the extrapyramidal syn-
drome reached its maximum severity almost 
one year after the complete withdrawal of the 
antipsychotics. Finally, it could be argued 
that a dose of 200 mg of fluvoxamine is 
relatively high for an elderly patient, adding 
to the risk of developing side-effects. 
Cl in icians should be aware of this rare but 
potentially serious neurological complication 
of treatment with selective serotonin-reup-
take inhibiting antidepressants, especially in 
patients with pre-existing neurological dis-
ease or already compromised extrapyramidal 
function due to neuroleptic medication. 
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PATERNITY CALCULATIONS IN COURT 
To the Editor: 
Li and Chakravarti [1] introduce their article with the observation that "the 
purpose of conducting genetic marker tests ... is to ascertain whether the 
accusation (of paternity) is true or false". This is the crux of the issue and the 
results of any tests should only be used to help the court make its decision. 
If the tests exclude the accused man then the court uses this information to 
decide that the accusation is false. If the tests do not exclude the accused, then 
the court still has to decide whether the accusation is true or false. If the 
accusation is indeed false, but not revealed by the tests, then the accused man 
has been chosen at random as far as his genetic make-up is concerned. Thus, 
the question to be asked is "what is the probability that a man, chosen at 
random and subjected to the same tests, would not be excluded". This is not 
the same as Steinberg's [2] contention that the question to be asked is "what 
is the probability that an accused male among the non-excluded males is the 
father". In fact, it is not reasonable to ascribe different probabilities to 
different non-excluded males, when ANY of the non-excluded males could be 
the father. I must emphasise that "not reasonable" is in the context of court 
proceedings and not in an academic environment. 
Dodds [3] states that" ... the legal profession prefer the probability that a 
random man would not be excluded ... ". The legal correspondent of the 
British Medical Journal [4] describes a case where "The evidence was to the 
effect that 998 out of 1000 men tested at random would have been excluded 
from paternity by the test". 
If several men are tested to determine the paternity of one child, and none of 
the men can be excluded, then the "probability of a random man not being 
excluded" applies equally to all the men. Therefore, from a legal point of 
view, none of the men can be considered more likely than any of the other 
men because of his phenotype. laffee [5] makes the point that you only need 
to cast a reasonable doubt on the case against the accused man. The court 
will have to decide on other grounds or ask for additional tests to be carried 
out. 
The probability of paternity, the likelihood of paternity, the paternity index 
and/or other statistics are based on gene frequencies. The probability that a 
random man would not be excluded should be based on phenotype frequencies. 
In the lll..A system, haplotype frequencies are often used but even when gene 
frequencies at each locus are used the calculations are not a true reflection of 
"a random man not being excluded". 
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The complexity of the HLA system and the phenomenon of linkage 
disequilibrium within this complex gives rise to incorrect interpretations if 
gene frequencies or haplotype frequencies are used. 
The difficulty is best illustrated with an example: 
My database consists of over 26,000 HLA typed people. 
Random Caucasian population 
Observed (direct count) number 
of people with both antigens 
Estimated HF = 3.39% 
N = 2268 
A2 = 48.63% 
B7 = 26.15% 
= 272/2268 
= 11.99% 
= 77 12268 
Haplotype frequencies were estimated by the method of Mattiuz et al. [6]. 
If a child receives A2 and B7 from his father then any man with these two 
antigens can not be excluded 
i.e. a probability of 272 1 2268 = 0.1199 
= 11.99% Ratio 1: 8.3 
Using estimated HF's the probability is = 0.0339 
= 3.39% Ratio 1 : 29.5 
After many paternity investigations, it is likely that several cases would have 
occurred where the biological father must have possessed the antigens HLA A2 
and HLA B7 and the accused men would all have been assigned a probability 
of 3.39% (the frequency of men with the A2 and B7 antigens on the same 
chromosome), whereas, in fact, some of those men should have been excluded 
because they do not carry the A2 and B7 antigens on the same chromosome. 
We know this is so because 11.99 % of random men have both antigens but the 
haplotype frequency is only 3.39%. 
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Now, the question arises, which of the men should be excluded? Probability
 
theory tells us that 
(272-77)/272 = 71.69% 
of the accused men carry the A2 and B7 alleles on different chromosomes, so
 
that seven out of ten men should be excluded by probability theory. The
 
probabilty using HP's could be modified, which would result in a probability
 
somewhere between 3.39% and 11.99% but then seven of the ten men would
 
be worse off while the other three would be better off. Aicken and Kaye [7]
 
quote Essen-Moller to make the point that every individual decision must be
 
granted perfect independence. 
The judge should not be presented with a probability that is "on the average"
 
correct, because he has to decide each case individually. It is therefore 
preferable to use the probability that a random man possesses these two alleles
 
(on any chromosome) for all cases. 
Therefore, the probability of 11.99% should be used for all the men in these
 
cases. Alternatively, full family studies must be done on each man to 
determine his haplotypes and then, and only then, can estimated haplotype
 
frequencies be used. 
Naturally, in each individual case the true probability is 3.39% and some
 
theorists modify this result with the probability of the alleles being found on
 
the same chromosome but this is only of academic interest and should not be
 
used in a court of law. 
Many laboratories do not have large databases of phenotype date and rely on
 
published tables of allele and haplotype frequencies. However, using the
 
formulae of Mayr and Pausch [8] it is possible to calculate backwards from
 
frequency tables to phenotypes. 
M.G. HAMMOND 
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